Citrus Sinensis ID: 046010
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 523 | 2.2.26 [Sep-21-2011] | |||||||
| Q8GYA4 | 669 | Cysteine-rich receptor-li | yes | no | 0.439 | 0.343 | 0.568 | 5e-80 | |
| O65468 | 676 | Cysteine-rich receptor-li | no | no | 0.441 | 0.341 | 0.574 | 1e-78 | |
| Q9C5S9 | 674 | Cysteine-rich receptor-li | no | no | 0.441 | 0.342 | 0.574 | 2e-78 | |
| Q8L7G3 | 659 | Cysteine-rich receptor-li | no | no | 0.439 | 0.349 | 0.564 | 5e-78 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.441 | 0.274 | 0.584 | 2e-76 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.441 | 0.272 | 0.602 | 6e-76 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.441 | 0.272 | 0.588 | 1e-75 | |
| Q8W4G6 | 627 | Cysteine-rich receptor-li | no | no | 0.330 | 0.275 | 0.613 | 2e-75 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.437 | 0.274 | 0.567 | 3e-73 | |
| Q8RX80 | 659 | Cysteine-rich receptor-li | no | no | 0.441 | 0.350 | 0.568 | 5e-73 |
| >sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 299 bits (765), Expect = 5e-80, Method: Compositional matrix adjust.
Identities = 132/232 (56%), Positives = 178/232 (76%), Gaps = 2/232 (0%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
++ QLDW RR II G+ARG+LYLH+DSRL + HRDLKASN+LLD +MNPKI+DFGMARI
Sbjct: 438 KKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARI 497
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH 413
FG +Q E NTS++VGTYGYM+PEYA+ G S+KSDV+SFGVL+LEIISGKKNS FY ++
Sbjct: 498 FGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDG 557
Query: 414 GQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473
L++Y W LW NG LEL+DP + ++C E+++C+HIGLLCVQEDPA+RP +S++ +
Sbjct: 558 AHDLVSYAWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVL 617
Query: 474 MLASDTVSLPQPTQPAFSVGRIIARSGQSSSSYSK--ICSVNEVTLSDVSPR 523
ML S+TV+LP P QP I + + + SK + SV++ +++D+ PR
Sbjct: 618 MLTSNTVTLPVPRQPGLFFQSRIGKDPLDTDTTSKSLLGSVDDASITDIHPR 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 294 bits (753), Expect = 1e-78, Method: Compositional matrix adjust.
Identities = 135/235 (57%), Positives = 183/235 (77%), Gaps = 4/235 (1%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
T++ QLDW +R +II GIARG+LYLH+DSRL + HRDLKASN+LLD ++NPKI+DFGMAR
Sbjct: 442 TKQTQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMAR 501
Query: 353 IFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSE 412
IFG +Q + NTS++VGTYGYMAPEYA+ G S+KSDV+SFGVL+LEIISG+KNS F S+
Sbjct: 502 IFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESD 561
Query: 413 HGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVA 472
Q LL +TW+LW N AL+L+DP++ +C +E+++CIHIGLLCVQEDPA RP +S+V
Sbjct: 562 GAQDLLTHTWRLWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQEDPAKRPTISTVF 621
Query: 473 VMLASDTVSLPQPTQPAFSVGRIIAR----SGQSSSSYSKICSVNEVTLSDVSPR 523
+ML S+TV+LP P QP F + + S QS+++ S S+++ ++D+ PR
Sbjct: 622 MMLTSNTVTLPVPRQPGFFIQSSPVKDPTDSDQSTTTKSTPASIDDELITDLYPR 676
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C5S9|CRK6_ARATH Cysteine-rich receptor-like protein kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 293 bits (750), Expect = 2e-78, Method: Compositional matrix adjust.
Identities = 135/235 (57%), Positives = 186/235 (79%), Gaps = 4/235 (1%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
T++ QLDW +R +II GIARG+LYLH+DSRL + HRDLKASN+LLD ++NPKI+DFGMAR
Sbjct: 440 TKQIQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMAR 499
Query: 353 IFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSE 412
IFG +Q + NTS++VGTYGYMAPEYA+ G S+KSDV+SFGVL+LEIISG+KNS F S+
Sbjct: 500 IFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFGESD 559
Query: 413 HGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVA 472
Q LL + W+LW N +AL+L+DP++ ++C +E+++CIHIGLLCVQEDPA RP +S+V
Sbjct: 560 GAQDLLTHAWRLWTNKKALDLVDPLIAENCQNSEVVRCIHIGLLCVQEDPAKRPAISTVF 619
Query: 473 VMLASDTVSLPQPTQPAFSVG-RIIA---RSGQSSSSYSKICSVNEVTLSDVSPR 523
+ML S+TV+LP P QP F + R + S QS+++ S S+++ +++D+ PR
Sbjct: 620 MMLTSNTVTLPVPRQPGFFIQCRAVKDPLDSDQSTTTKSFPASIDDESITDLYPR 674
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8L7G3|CRK7_ARATH Cysteine-rich receptor-like protein kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 292 bits (747), Expect = 5e-78, Method: Compositional matrix adjust.
Identities = 132/234 (56%), Positives = 179/234 (76%), Gaps = 4/234 (1%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
++ QL W +R II GIARG+LYLH+DSRL + HRDLKASN+LLD +MNPKI+DFGMARI
Sbjct: 426 KKGQLYWTQRYHIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARI 485
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH 413
FG +Q + NTS++VGTYGYM+PEYA+ G S+KSDV+SFGVL+LEIISG+KN+ F ++
Sbjct: 486 FGMDQTQQNTSRIVGTYGYMSPEYAMRGQFSMKSDVYSFGVLVLEIISGRKNNSFIETDD 545
Query: 414 GQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473
Q L+ + W+LW NG AL+L+DP + SC +E+++C HIGLLCVQEDP RP MS+++V
Sbjct: 546 AQDLVTHAWRLWRNGTALDLVDPFIADSCRKSEVVRCTHIGLLCVQEDPVKRPAMSTISV 605
Query: 474 MLASDTVSLPQPTQPAFSV----GRIIARSGQSSSSYSKICSVNEVTLSDVSPR 523
ML S+T++LP P QP F V G S QS+++ S S+++ ++SD+ PR
Sbjct: 606 MLTSNTMALPAPQQPGFFVRSRPGTNRLDSDQSTTNKSVTVSIDDKSMSDLDPR 659
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 287 bits (734), Expect = 2e-76, Method: Compositional matrix adjust.
Identities = 138/236 (58%), Positives = 172/236 (72%), Gaps = 5/236 (2%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
TR + L+W++R IINGIARGLLYLH+DSR ++ HRDLKASNVLLD M PKISDFGMAR
Sbjct: 608 TRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMAR 667
Query: 353 IFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSE 412
IFG + E+NT +VVGTYGYM+PEYA+ G+ S+KSDVFSFGVLLLEIISGK+N GFY S
Sbjct: 668 IFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSN 727
Query: 413 HGQSLLAYTWKLWCNGEALELMDPV----LKQSCMAAELLKCIHIGLLCVQEDPADRPNM 468
+LL + W+ W G LE++DP+ L E+L+CI IGLLCVQE DRP M
Sbjct: 728 RDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVM 787
Query: 469 SSVAVMLASDTVSLPQPTQPAFSVGRIIARSGQSSSSY-SKICSVNEVTLSDVSPR 523
SSV VML S+T ++PQP +P F +GR + SSS+ C+VN++TLS + R
Sbjct: 788 SSVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 285 bits (729), Expect = 6e-76, Method: Compositional matrix adjust.
Identities = 141/234 (60%), Positives = 175/234 (74%), Gaps = 3/234 (1%)
Query: 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA 351
T++A +DWK R SII GIARGLLYLH DSRL++ HRDLK SNVLLD EMNPKISDFGMA
Sbjct: 617 ETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMA 676
Query: 352 RIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLS 411
RIFGGNQNE+NT +VVGTYGYM+PEYA+ G+ SVKSDV+SFGVLLLEI+SGK+N+ S
Sbjct: 677 RIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSS 736
Query: 412 EHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSV 471
EHG SL+ Y W L+ +G + EL+DP ++ +C E L+CIH+ +LCVQ+ A+RPNM+SV
Sbjct: 737 EHG-SLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASV 795
Query: 472 AVMLASDTVSLPQPTQPAFSVGR--IIARSGQSSSSYSKICSVNEVTLSDVSPR 523
+ML SDT +L P QP F+ R I + SS I S NE+T + V R
Sbjct: 796 LLMLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITSTVVLGR 849
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 284 bits (726), Expect = 1e-75, Method: Compositional matrix adjust.
Identities = 139/236 (58%), Positives = 172/236 (72%), Gaps = 5/236 (2%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
TR + L+W++R IINGIARGLLYLH+DSR ++ HRDLKASNVLLD M PKISDFGMAR
Sbjct: 612 TRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMAR 671
Query: 353 IFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSE 412
IFG + E+NT +VVGTYGYM+PEYA+ G+ S+KSDVFSFGVLLLEIISGK+N GFY S
Sbjct: 672 IFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSN 731
Query: 413 HGQSLLAYTWKLWCNGEALELMDPV----LKQSCMAAELLKCIHIGLLCVQEDPADRPNM 468
+LL + W+ W G+ LE++DP+ L E+L+CI IGLLCVQE DRP M
Sbjct: 732 RDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVM 791
Query: 469 SSVAVMLASDTVSLPQPTQPAFSVGR-IIARSGQSSSSYSKICSVNEVTLSDVSPR 523
SSV VML S+T ++PQP +P F VGR + SS+ C+VN+VTLS + R
Sbjct: 792 SSVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 283 bits (724), Expect = 2e-75, Method: Compositional matrix adjust.
Identities = 122/199 (61%), Positives = 163/199 (81%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
++ QLDW RR +I GIARG+LYLH+DSRL + HRDLKASN+LLD +MNPK++DFG+ARI
Sbjct: 427 KQNQLDWTRRYKVIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKLADFGLARI 486
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH 413
FG +Q + NTS++VGT+GYMAPEYA+ G SVKSDV+SFGVL+LEIISGKKN+ FY ++
Sbjct: 487 FGMDQTQENTSRIVGTFGYMAPEYAIHGQFSVKSDVYSFGVLVLEIISGKKNNSFYETDG 546
Query: 414 GQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473
L+ + W+LW NG AL+L+DP++ +C +E+++CIHI LLCVQEDPA+RP +S++ +
Sbjct: 547 AHDLVTHAWRLWSNGTALDLVDPIIIDNCQKSEVVRCIHICLLCVQEDPAERPILSTIFM 606
Query: 474 MLASDTVSLPQPTQPAFSV 492
ML S+TV+LP P QP F V
Sbjct: 607 MLTSNTVTLPVPLQPGFPV 625
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 276 bits (706), Expect = 3e-73, Method: Compositional matrix adjust.
Identities = 134/236 (56%), Positives = 174/236 (73%), Gaps = 7/236 (2%)
Query: 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGM 350
+ +RA+LDW +R+ I+ GIARG+LYLH+DSRL++ HRDLKASN+LLD EM PKISDFGM
Sbjct: 602 HEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGM 661
Query: 351 ARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYL 410
ARIFGGNQ E TS+VVGT+GYMAPEYA+ G S+KSDV+SFGVL+LEII+GKKNS F+
Sbjct: 662 ARIFGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSAFH- 720
Query: 411 SEHGQSLLAYTWKLWCNGEALELMDPVLKQSCM-AAELLKCIHIGLLCVQEDPADRPNMS 469
E +L+ + W LW NGEA E++D ++ Q E++KCI IGLLCVQE+ +DR +MS
Sbjct: 721 -EESSNLVGHIWDLWENGEATEIIDNLMDQETYDEREVMKCIQIGLLCVQENASDRVDMS 779
Query: 470 SVAVMLASDTVSLPQPTQPAFSVGRIIARSGQSSSSYSKIC--SVNEVTLSDVSPR 523
SV +ML + +LP P PAF+ R R G++ + SVN+VT SD+ R
Sbjct: 780 SVVIMLGHNATNLPNPKHPAFTSAR--RRGGENGACLKGQTGISVNDVTFSDIQGR 833
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RX80|CRK18_ARATH Cysteine-rich receptor-like protein kinase 18 OS=Arabidopsis thaliana GN=CRK18 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 275 bits (704), Expect = 5e-73, Method: Compositional matrix adjust.
Identities = 132/232 (56%), Positives = 170/232 (73%), Gaps = 1/232 (0%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
T+R QLDW R +II GI RG+LYLH+DSRLK+ HRDLKASN+LLD +MNPKI+DFGMAR
Sbjct: 428 TKRNQLDWTMRRNIIGGITRGILYLHQDSRLKIIHRDLKASNILLDADMNPKIADFGMAR 487
Query: 353 IFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFY-LS 411
IFG +Q +NT +VVGT+GYM+PEY G S+KSDV+SFGVL+LEIISGKKNS FY +
Sbjct: 488 IFGVDQTVANTGRVVGTFGYMSPEYVTHGQFSMKSDVYSFGVLILEIISGKKNSSFYQMD 547
Query: 412 EHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSV 471
+L+ Y WKLW N EL+DP + Q + E+++ IHIGLLCVQE+PADRP MS++
Sbjct: 548 GLVNNLVTYVWKLWENKSLHELLDPFINQDFTSEEVIRYIHIGLLCVQENPADRPTMSTI 607
Query: 472 AVMLASDTVSLPQPTQPAFSVGRIIARSGQSSSSYSKICSVNEVTLSDVSPR 523
ML + +++LP P P F + S+S S CSV+E T++DV+PR
Sbjct: 608 HQMLTNSSITLPVPLPPGFFFRNGPGSNPGQSNSKSFACSVDEATITDVNPR 659
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 523 | ||||||
| 296088918 | 519 | unnamed protein product [Vitis vinifera] | 0.908 | 0.915 | 0.469 | 1e-121 | |
| 224113927 | 381 | predicted protein [Populus trichocarpa] | 0.428 | 0.587 | 0.738 | 8e-98 | |
| 224076400 | 666 | predicted protein [Populus trichocarpa] | 0.439 | 0.345 | 0.719 | 2e-96 | |
| 356546303 | 662 | PREDICTED: cysteine-rich receptor-like p | 0.437 | 0.345 | 0.7 | 6e-93 | |
| 356554939 | 662 | PREDICTED: cysteine-rich receptor-like p | 0.437 | 0.345 | 0.7 | 9e-93 | |
| 356554943 | 670 | PREDICTED: cysteine-rich receptor-like p | 0.437 | 0.341 | 0.695 | 2e-91 | |
| 255555021 | 686 | ATP binding protein, putative [Ricinus c | 0.432 | 0.329 | 0.684 | 8e-91 | |
| 356510387 | 647 | PREDICTED: cysteine-rich receptor-like p | 0.432 | 0.349 | 0.709 | 1e-90 | |
| 358346817 | 626 | Cysteine-rich receptor-like protein kina | 0.437 | 0.365 | 0.682 | 3e-89 | |
| 358346648 | 573 | Cysteine-rich receptor-like protein kina | 0.437 | 0.399 | 0.682 | 4e-89 |
| >gi|296088918|emb|CBI38478.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 441 bits (1135), Expect = e-121, Method: Compositional matrix adjust.
Identities = 241/513 (46%), Positives = 324/513 (63%), Gaps = 38/513 (7%)
Query: 28 YIYHFCNNTV-NFTRNSTYQSNLNLLLSTLRSNATHGSSDKFSEGFYNATASQDPDKVYG 86
++Y+ C+N V N+T NSTY++NLN LL++L SN ++ GFYN +A Q+ DKV
Sbjct: 28 FLYYRCSNGVGNYTNNSTYKANLNTLLTSLSSN------NEIDYGFYNFSAGQNSDKVNA 81
Query: 87 LFLCRGDVSAETCKDCVNFATSDITQRCPLQKETVIWYDHCLLRYSGISFFSTMDTKPAK 146
+ LCRGDV C+ C+N + +T+ CP QKE + WYD C+LRYS S F T P
Sbjct: 82 IALCRGDVMPTACRSCINDSRIQLTRLCPNQKEAIGWYDGCMLRYSNDSIFGKAQTSPTF 141
Query: 147 AWQNRQN-STGGLFNQQVRNLMNEAVNQAL--NTTKMFGTVKKNYTASQTLYGLVQCTPD 203
N QN S FNQ + NLM ++A + + F T + N T+ Q++YGL+QCTPD
Sbjct: 142 TMWNLQNVSNVEDFNQVLGNLMASLRSKAASGDWRRKFATEEANVTSFQSIYGLMQCTPD 201
Query: 204 LSRHDCSTCLRLAISSFDECFSINIGGRMMYPSCNFRYELYPFYDDPSIVTPPPVFLSPP 263
LS CS CL AI+ C + GR++ PSCN RY Y FYD
Sbjct: 202 LSELSCSNCLEGAINEIPTCCNRRKAGRVVKPSCNLRYATYHFYD--------------I 247
Query: 264 SPGSVTSSKGKGRKAIWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRL 323
+ + + T T RRAQLDW+RR II GIARGLLYLHEDSRL
Sbjct: 248 TAANAPPPSPPSADLSPPPLANTTSTQDLIRRAQLDWERRYKIIGGIARGLLYLHEDSRL 307
Query: 324 KVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVI 383
++ HRDLKASN+LLD EMNPKISDFGMAR+F +Q + +TS++VGTYGYMAPEYA+ G
Sbjct: 308 RIIHRDLKASNILLDAEMNPKISDFGMARLFLVDQTQGSTSRIVGTYGYMAPEYAMHGHF 367
Query: 384 SVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCM 443
SVK+DV+SFGVL+LE++SG++N+ F +SE+ + LL+Y WK W G A L+DP ++ S +
Sbjct: 368 SVKTDVYSFGVLVLELVSGQRNNCFRVSENIEHLLSYAWKNWREGTATNLIDPTMRISSI 427
Query: 444 AAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTVSLPQPTQPAF----SVGRII--- 496
+E+++CIHIGLLCVQE+ ADRP M+S+A+ML S ++SLP P+ PAF S+ R +
Sbjct: 428 -SEIMRCIHIGLLCVQENEADRPTMASIALMLNSYSLSLPVPSHPAFFMNTSMNRDMSLE 486
Query: 497 ----ARSGQSS--SSYSKICSVNEVTLSDVSPR 523
+R QS+ S S SVNE +++D PR
Sbjct: 487 LEDNSRVAQSNYLPSRSSHFSVNEASITDPYPR 519
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113927|ref|XP_002316616.1| predicted protein [Populus trichocarpa] gi|222859681|gb|EEE97228.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 364 bits (934), Expect = 8e-98, Method: Compositional matrix adjust.
Identities = 167/226 (73%), Positives = 201/226 (88%), Gaps = 2/226 (0%)
Query: 298 LDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGN 357
LDW+RR+SIINGIARGLLYLHEDSRL++ HRDLK SN+LLD+EMNPKISDFGMARIFGGN
Sbjct: 158 LDWQRRLSIINGIARGLLYLHEDSRLRIIHRDLKTSNILLDYEMNPKISDFGMARIFGGN 217
Query: 358 QNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSL 417
Q+E+NT+++VGTYGYMAPEYA+ G+ SVKSDVFSFGVLLLEIISG+KN GF+LSE G+SL
Sbjct: 218 QSEANTNRIVGTYGYMAPEYAMVGLFSVKSDVFSFGVLLLEIISGEKNVGFHLSEEGESL 277
Query: 418 LAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLAS 477
L + WKLW +G+ LELMDP+L++S +A E+L+CIHIGLLCVQEDPADRP MSSV MLAS
Sbjct: 278 LTFAWKLWSDGQGLELMDPMLEKSGVATEVLRCIHIGLLCVQEDPADRPTMSSVLHMLAS 337
Query: 478 DTVSLPQPTQPAFSVGRIIARSGQSSSSYSKICSVNEVTLSDVSPR 523
DT++LP P QPAFS+GR +A GQSS+ K+CS NE+T+S +SPR
Sbjct: 338 DTITLPIPKQPAFSIGRFVAMEGQSSN--QKVCSSNELTISVLSPR 381
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224076400|ref|XP_002304937.1| predicted protein [Populus trichocarpa] gi|222847901|gb|EEE85448.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 359 bits (922), Expect = 2e-96, Method: Compositional matrix adjust.
Identities = 167/232 (71%), Positives = 201/232 (86%), Gaps = 2/232 (0%)
Query: 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA 351
S R QLDW+RR+SIINGIARGLLYLHEDSRL++ HRDLKASN+LLD+EMNPKISDFGMA
Sbjct: 437 SAMRVQLDWQRRLSIINGIARGLLYLHEDSRLRIIHRDLKASNILLDYEMNPKISDFGMA 496
Query: 352 RIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLS 411
RIFGGN +E+NT+++VGTYGYMAPEYA+ G+ SVKSDVFSFGVL+LEIISGK+N GF+LS
Sbjct: 497 RIFGGNHSEANTNRIVGTYGYMAPEYAMEGLSSVKSDVFSFGVLMLEIISGKRNGGFHLS 556
Query: 412 EHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSV 471
E G+SLL +TWKLW G+ LELMD +L++S +A E+LKCIHIGLLCVQEDP DRP MSSV
Sbjct: 557 EEGKSLLNFTWKLWSEGKGLELMDSLLEKSSVATEVLKCIHIGLLCVQEDPVDRPTMSSV 616
Query: 472 AVMLASDTVSLPQPTQPAFSVGRIIARSGQSSSSYSKICSVNEVTLSDVSPR 523
VMLA D +P PT+PAFSVGRI+A +++SS ++ SVN+VTLS+V PR
Sbjct: 617 VVMLAGDNFKIPIPTKPAFSVGRIVAE--ETTSSNQRVSSVNKVTLSNVLPR 666
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356546303|ref|XP_003541568.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 347 bits (891), Expect = 6e-93, Method: Compositional matrix adjust.
Identities = 161/230 (70%), Positives = 197/230 (85%), Gaps = 1/230 (0%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
++ QLDW R+SIINGIA+GLLYLHEDSRLKV HRDLKASN+LLD EMNPKISDFG+AR
Sbjct: 434 KKRQLDWNLRLSIINGIAKGLLYLHEDSRLKVIHRDLKASNILLDDEMNPKISDFGLARA 493
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH 413
F QN++NT++V+GTYGYM+PEYA+ G+ SVKSDVFS+GVL+LEII GKKNSGFYLSE
Sbjct: 494 FEKGQNQANTNRVMGTYGYMSPEYAMEGLFSVKSDVFSYGVLVLEIICGKKNSGFYLSEC 553
Query: 414 GQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473
GQSL Y WK+WC G++LELMDPVL++SC+ +E++KCIHIGLLCVQED ADRP MS+V V
Sbjct: 554 GQSLTLYAWKIWCAGKSLELMDPVLEKSCIESEVMKCIHIGLLCVQEDAADRPTMSTVVV 613
Query: 474 MLASDTVSLPQPTQPAFSVGRIIARSGQSSSSYSKICSVNEVTLSDVSPR 523
MLASD +SLP+P QPAFSVGR+ G S+S SK S+N+VT++++ PR
Sbjct: 614 MLASDKMSLPEPNQPAFSVGRMTLE-GASTSKSSKNLSINDVTVTNILPR 662
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356554939|ref|XP_003545798.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 347 bits (890), Expect = 9e-93, Method: Compositional matrix adjust.
Identities = 161/230 (70%), Positives = 197/230 (85%), Gaps = 1/230 (0%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
++ QLDWK R+SIINGIARG+LYLHEDSRL+V HRDLKASNVLLDH+MNPKISDFG+AR
Sbjct: 434 KKKQLDWKLRLSIINGIARGILYLHEDSRLRVIHRDLKASNVLLDHDMNPKISDFGLARA 493
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH 413
F Q ++NT++V+GTYGYMAPEYA+ G+ SVKSDVFSFGVL+LEII GKKNSGFYLSE
Sbjct: 494 FSKGQKQANTNRVMGTYGYMAPEYAMEGLFSVKSDVFSFGVLVLEIICGKKNSGFYLSEC 553
Query: 414 GQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473
GQ LL Y WK+WC G+ LEL+DPVL++SC+ +E++KCIHIGLLCVQED ADRPNMS+V V
Sbjct: 554 GQGLLLYAWKIWCAGKFLELLDPVLEESCIESEVVKCIHIGLLCVQEDAADRPNMSTVVV 613
Query: 474 MLASDTVSLPQPTQPAFSVGRIIARSGQSSSSYSKICSVNEVTLSDVSPR 523
MLASDT+ LP+P +PAFSVGR +A S+S S S+N++T+S++ PR
Sbjct: 614 MLASDTMVLPKPNRPAFSVGR-MALGDASTSKSSNKHSINDITISNILPR 662
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356554943|ref|XP_003545800.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 342 bits (878), Expect = 2e-91, Method: Compositional matrix adjust.
Identities = 160/230 (69%), Positives = 193/230 (83%), Gaps = 1/230 (0%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
++ QLDW R+SIINGIA+GLLYLHEDSRLKV HRDLKASN+LLD EMNPKISDFG+AR
Sbjct: 442 KKRQLDWNLRLSIINGIAKGLLYLHEDSRLKVIHRDLKASNILLDDEMNPKISDFGLARA 501
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH 413
F QN++NT +V+GTYGYM+PEYA+ G+ SVKSDVFS+GVL+LEII GKKNSGFYLSE
Sbjct: 502 FEKGQNQANTKRVMGTYGYMSPEYAMEGLFSVKSDVFSYGVLVLEIICGKKNSGFYLSEC 561
Query: 414 GQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473
GQSL Y WKLWC G+ LEL+DPVL++SC+ +E++KCIHIGLLCVQED ADRP MS+V V
Sbjct: 562 GQSLTLYAWKLWCAGKCLELLDPVLEESCIESEVVKCIHIGLLCVQEDAADRPTMSTVVV 621
Query: 474 MLASDTVSLPQPTQPAFSVGRIIARSGQSSSSYSKICSVNEVTLSDVSPR 523
MLASD + LP+P QPAFSVGR+ +S S SK S+N+VT+S++ PR
Sbjct: 622 MLASDKMPLPKPNQPAFSVGRMTLEDASTSKS-SKNLSINDVTVSNILPR 670
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555021|ref|XP_002518548.1| ATP binding protein, putative [Ricinus communis] gi|223542393|gb|EEF43935.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 340 bits (873), Expect = 8e-91, Method: Compositional matrix adjust.
Identities = 156/228 (68%), Positives = 199/228 (87%), Gaps = 2/228 (0%)
Query: 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFG 355
+LDW+RR+SII+GIARGLLYLHEDSRL++ HRDLKASN+LLD++MNPKISDFGMARIFG
Sbjct: 461 VRLDWQRRLSIISGIARGLLYLHEDSRLRIIHRDLKASNILLDYDMNPKISDFGMARIFG 520
Query: 356 GNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQ 415
GN ++S T+++VGTYGYM+PEYA+ G+ S+KSD+FSFGVLLLEIISG++N+ FY+ E G+
Sbjct: 521 GNDSKS-TNRIVGTYGYMSPEYAMEGLFSMKSDIFSFGVLLLEIISGRRNNRFYVEEEGE 579
Query: 416 SLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVML 475
SLL + WKLW + LEL+DP + S +A E+LKC+HIGLLCVQ+DPA+RP MSSV VML
Sbjct: 580 SLLTFAWKLWNKDQGLELLDPAVVNSSVAIEVLKCVHIGLLCVQDDPAERPTMSSVVVML 639
Query: 476 ASDTVSLPQPTQPAFSVGRIIARSGQSSSSYSKICSVNEVTLSDVSPR 523
ASDT++LPQP +PAFS+G+ +ARS SSS+ K+ SVN+VTLS+VSPR
Sbjct: 640 ASDTITLPQPRKPAFSIGQFVARSATSSSN-PKVSSVNQVTLSNVSPR 686
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356510387|ref|XP_003523920.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 340 bits (871), Expect = 1e-90, Method: Compositional matrix adjust.
Identities = 161/227 (70%), Positives = 192/227 (84%), Gaps = 1/227 (0%)
Query: 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGG 356
L+WK R++IINGIA+GLLYLHEDSRL+V HRDLKASN+LLDHEMNPKISDFG+AR FGG
Sbjct: 422 HLEWKNRLNIINGIAKGLLYLHEDSRLRVIHRDLKASNILLDHEMNPKISDFGLARTFGG 481
Query: 357 NQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQS 416
+Q ++NT +VVGTYGYMAPEYA+ G+ SVKSDVFSFGVLLLEIISGK++S FYLS+ GQS
Sbjct: 482 DQKQANTIRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKRSSKFYLSDQGQS 541
Query: 417 LLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLA 476
LL Y W LWC + LELMDP++++SC+ +E+LKC+HIGLLCVQED ADRP MSSV MLA
Sbjct: 542 LLIYAWNLWCERKGLELMDPIIEKSCVRSEVLKCMHIGLLCVQEDAADRPKMSSVVHMLA 601
Query: 477 SDTVSLPQPTQPAFSVGRIIARSGQSSSSYSKICSVNEVTLSDVSPR 523
SDTVSL PT+PAFSVGR + + SS+ S SVNE T+S+V PR
Sbjct: 602 SDTVSLSVPTRPAFSVGRAVTER-ECSSNTSMHYSVNEATVSEVIPR 647
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|358346817|ref|XP_003637461.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355503396|gb|AES84599.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 335 bits (860), Expect = 3e-89, Method: Compositional matrix adjust.
Identities = 157/230 (68%), Positives = 189/230 (82%), Gaps = 1/230 (0%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
+R LDWK R++IINGIA+GLLYLHEDSRL+V HRDLKASNVLLD EMNPKISDFG+AR
Sbjct: 398 KRKLLDWKLRLNIINGIAKGLLYLHEDSRLRVIHRDLKASNVLLDQEMNPKISDFGLARA 457
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH 413
F +Q + NT +VVGTYGYMAPEYA+ G+ SVKSDVFSFGVLLLEII G++N GFYL+EH
Sbjct: 458 FEKDQCQENTRRVVGTYGYMAPEYAMEGLYSVKSDVFSFGVLLLEIICGRRNGGFYLAEH 517
Query: 414 GQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473
GQSLL Y+W LWC ++LEL+DP+LK + E++KCIHIGLLCVQED DRP MS+V V
Sbjct: 518 GQSLLVYSWNLWCEDKSLELLDPILKNTYTTNEVIKCIHIGLLCVQEDAVDRPTMSNVVV 577
Query: 474 MLASDTVSLPQPTQPAFSVGRIIARSGQSSSSYSKICSVNEVTLSDVSPR 523
MLASDT++LP P PAFSVGR + G+S+S S SVNEVT++++ PR
Sbjct: 578 MLASDTMTLPNPNHPAFSVGRKVVE-GESTSKASNDPSVNEVTVTNILPR 626
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|358346648|ref|XP_003637378.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355503313|gb|AES84516.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 335 bits (858), Expect = 4e-89, Method: Compositional matrix adjust.
Identities = 157/230 (68%), Positives = 189/230 (82%), Gaps = 1/230 (0%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
+R LDWK R++IINGIA+GLLYLHEDSRL+V HRDLKASNVLLD EMNPKISDFG+AR
Sbjct: 345 KRKLLDWKLRLNIINGIAKGLLYLHEDSRLRVIHRDLKASNVLLDQEMNPKISDFGLARA 404
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH 413
F +Q + NT +VVGTYGYMAPEYA+ G+ SVKSDVFSFGVLLLEII G++N GFYL+EH
Sbjct: 405 FEKDQCQENTRRVVGTYGYMAPEYAMEGLYSVKSDVFSFGVLLLEIICGRRNGGFYLAEH 464
Query: 414 GQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473
GQSLL Y+W LWC ++LEL+DP+LK + E++KCIHIGLLCVQED DRP MS+V V
Sbjct: 465 GQSLLVYSWNLWCEDKSLELLDPILKNTYTTNEVIKCIHIGLLCVQEDAVDRPTMSNVVV 524
Query: 474 MLASDTVSLPQPTQPAFSVGRIIARSGQSSSSYSKICSVNEVTLSDVSPR 523
MLASDT++LP P PAFSVGR + G+S+S S SVNEVT++++ PR
Sbjct: 525 MLASDTMTLPNPNHPAFSVGRKVVE-GESTSKASNDPSVNEVTVTNILPR 573
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 523 | ||||||
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.439 | 0.343 | 0.568 | 2.2e-122 | |
| TAIR|locus:2121651 | 676 | CRK8 "cysteine-rich RLK (RECEP | 0.441 | 0.341 | 0.574 | 9.7e-118 | |
| TAIR|locus:2115728 | 675 | CRK25 "cysteine-rich RLK (RECE | 0.439 | 0.340 | 0.531 | 4.3e-113 | |
| TAIR|locus:2121636 | 659 | CRK7 "cysteine-rich RLK (RECEP | 0.439 | 0.349 | 0.564 | 8.9e-113 | |
| TAIR|locus:2121626 | 830 | CRK23 "cysteine-rich RLK (RECE | 0.443 | 0.279 | 0.536 | 1.9e-108 | |
| TAIR|locus:2121686 | 645 | CRK19 "cysteine-rich RLK (RECE | 0.441 | 0.358 | 0.557 | 8.1e-108 | |
| TAIR|locus:2077147 | 676 | CRK4 "cysteine-rich RLK (RECEP | 0.441 | 0.341 | 0.531 | 1.2e-102 | |
| TAIR|locus:2123111 | 669 | CRK34 "cysteine-rich RLK (RECE | 0.439 | 0.343 | 0.544 | 1.3e-94 | |
| TAIR|locus:2141201 | 679 | CRK29 "cysteine-rich RLK (RECE | 0.445 | 0.343 | 0.523 | 3.8e-93 | |
| TAIR|locus:2141762 | 665 | CRK26 "cysteine-rich RLK (RECE | 0.430 | 0.338 | 0.502 | 1.7e-90 |
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 729 (261.7 bits), Expect = 2.2e-122, Sum P(2) = 2.2e-122
Identities = 132/232 (56%), Positives = 178/232 (76%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
++ QLDW RR II G+ARG+LYLH+DSRL + HRDLKASN+LLD +MNPKI+DFGMARI
Sbjct: 438 KKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARI 497
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH 413
FG +Q E NTS++VGTYGYM+PEYA+ G S+KSDV+SFGVL+LEIISGKKNS FY ++
Sbjct: 498 FGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDG 557
Query: 414 GQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473
L++Y W LW NG LEL+DP + ++C E+++C+HIGLLCVQEDPA+RP +S++ +
Sbjct: 558 AHDLVSYAWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVL 617
Query: 474 MLASDTVSLPQPTQPAFSVGRIIARSGQSSSSYSK--ICSVNEVTLSDVSPR 523
ML S+TV+LP P QP I + + + SK + SV++ +++D+ PR
Sbjct: 618 MLTSNTVTLPVPRQPGLFFQSRIGKDPLDTDTTSKSLLGSVDDASITDIHPR 669
|
|
| TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 720 (258.5 bits), Expect = 9.7e-118, Sum P(2) = 9.7e-118
Identities = 135/235 (57%), Positives = 183/235 (77%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
T++ QLDW +R +II GIARG+LYLH+DSRL + HRDLKASN+LLD ++NPKI+DFGMAR
Sbjct: 442 TKQTQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMAR 501
Query: 353 IFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSE 412
IFG +Q + NTS++VGTYGYMAPEYA+ G S+KSDV+SFGVL+LEIISG+KNS F S+
Sbjct: 502 IFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESD 561
Query: 413 HGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVA 472
Q LL +TW+LW N AL+L+DP++ +C +E+++CIHIGLLCVQEDPA RP +S+V
Sbjct: 562 GAQDLLTHTWRLWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQEDPAKRPTISTVF 621
Query: 473 VMLASDTVSLPQPTQPAFSVGRIIAR----SGQSSSSYSKICSVNEVTLSDVSPR 523
+ML S+TV+LP P QP F + + S QS+++ S S+++ ++D+ PR
Sbjct: 622 MMLTSNTVTLPVPRQPGFFIQSSPVKDPTDSDQSTTTKSTPASIDDELITDLYPR 676
|
|
| TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 640 (230.4 bits), Expect = 4.3e-113, Sum P(2) = 4.3e-113
Identities = 127/239 (53%), Positives = 170/239 (71%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
+R LDW+RR II GIARG+LYLH DSRL + HRDLKASN+LLD +M+PKISDFGMARI
Sbjct: 437 KRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARI 496
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH 413
FG +Q ++NT ++VGTYGYM+PEYA+ G SVKSDV+SFGVL+LE+I+GKKNS FY +
Sbjct: 497 FGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKNSSFYEEDG 556
Query: 414 GQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473
L+ Y WKLW LEL+D ++ + E+++CIHI LLCVQED ++RP+M + V
Sbjct: 557 LGDLVTYVWKLWVENSPLELVDEAMRGNFQTNEVIRCIHIALLCVQEDSSERPSMDDILV 616
Query: 474 MLASDTVSLPQPTQPAFSVGRII----ARSGQSSSSYSKIC-----SVNEVTLSDVSPR 523
M+ S TV+LP P + F + + RSG S+S +S SV++ +++ V PR
Sbjct: 617 MMNSFTVTLPIPKRSGFLLRTMKDSRDPRSGGSASDHSATSKSLPLSVDDSSITIVYPR 675
|
|
| TAIR|locus:2121636 CRK7 "cysteine-rich RLK (RECEPTOR-like protein kinase) 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 709 (254.6 bits), Expect = 8.9e-113, Sum P(2) = 8.9e-113
Identities = 132/234 (56%), Positives = 179/234 (76%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
++ QL W +R II GIARG+LYLH+DSRL + HRDLKASN+LLD +MNPKI+DFGMARI
Sbjct: 426 KKGQLYWTQRYHIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARI 485
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH 413
FG +Q + NTS++VGTYGYM+PEYA+ G S+KSDV+SFGVL+LEIISG+KN+ F ++
Sbjct: 486 FGMDQTQQNTSRIVGTYGYMSPEYAMRGQFSMKSDVYSFGVLVLEIISGRKNNSFIETDD 545
Query: 414 GQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473
Q L+ + W+LW NG AL+L+DP + SC +E+++C HIGLLCVQEDP RP MS+++V
Sbjct: 546 AQDLVTHAWRLWRNGTALDLVDPFIADSCRKSEVVRCTHIGLLCVQEDPVKRPAMSTISV 605
Query: 474 MLASDTVSLPQPTQPAFSV----GRIIARSGQSSSSYSKICSVNEVTLSDVSPR 523
ML S+T++LP P QP F V G S QS+++ S S+++ ++SD+ PR
Sbjct: 606 MLTSNTMALPAPQQPGFFVRSRPGTNRLDSDQSTTNKSVTVSIDDKSMSDLDPR 659
|
|
| TAIR|locus:2121626 CRK23 "cysteine-rich RLK (RECEPTOR-like protein kinase) 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 672 (241.6 bits), Expect = 1.9e-108, Sum P(2) = 1.9e-108
Identities = 126/235 (53%), Positives = 169/235 (71%)
Query: 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA 351
+T + QLDW RR II GIARG+LYLH+DSRL + HRDLKA N+LLD +MNPK++DFGMA
Sbjct: 596 TTMKRQLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMA 655
Query: 352 RIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFY-L 410
RIFG +Q E+NT +VVGTYGYMAPEYA+ G S+KSDV+SFGVL+ EIISG KNS Y +
Sbjct: 656 RIFGMDQTEANTRRVVGTYGYMAPEYAMYGQFSMKSDVYSFGVLVFEIISGMKNSSLYQM 715
Query: 411 SEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSS 470
+ +L+ YTW+LW NG L+L+DP + ++ +CIHI LLCVQED DRPNMS+
Sbjct: 716 DDSVSNLVTYTWRLWSNGSQLDLVDPSFGDNYQTHDITRCIHIALLCVQEDVDDRPNMSA 775
Query: 471 VAVMLASDTVSLPQPTQPAFSVGRIIARSGQSSSSYSKI--CSVNEVTLSDVSPR 523
+ ML + ++ L P QP F + G+ SS ++ CS+++ +++ V+PR
Sbjct: 776 IVQMLTTSSIVLAVPKQPGFFFRGRHEQVGEVGSSVDRLALCSIDDASITSVAPR 830
|
|
| TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 670 (240.9 bits), Expect = 8.1e-108, Sum P(2) = 8.1e-108
Identities = 130/233 (55%), Positives = 167/233 (71%)
Query: 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA 351
ST + +LDW RR II GIARG+LYLH+DSRL + HRDLKA N+LLD +MNPKI+DFGMA
Sbjct: 414 STMKMKLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMA 473
Query: 352 RIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFY-L 410
RIFG +Q E+ T +VVGTYGYM+PEYA+ G S+KSDV+SFGVL+LEIISG KNS Y +
Sbjct: 474 RIFGMDQTEAMTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGMKNSSLYQM 533
Query: 411 SEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSS 470
E +L+ YTW+LW NG EL+DP + +E+ +CIHI LLCVQED DRP MSS
Sbjct: 534 DESVGNLVTYTWRLWSNGSPSELVDPSFGDNYQTSEITRCIHIALLCVQEDAEDRPTMSS 593
Query: 471 VAVMLASDTVSLPQPTQPAFSVGRIIARSGQSSSSYSKICSVNEVTLSDVSPR 523
+ ML + ++L +P P F ++G S S S CSV+E +++ V+PR
Sbjct: 594 IVQMLTTSLIALAEPRPPGFFFRSKQEQAGPSIDS-STHCSVDEASITRVTPR 645
|
|
| TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 648 (233.2 bits), Expect = 1.2e-102, Sum P(2) = 1.2e-102
Identities = 127/239 (53%), Positives = 171/239 (71%)
Query: 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA 351
ST ++ LDW RR II GIARG+LYLH+DSRL + HRDLKA N+LL +MN KI+DFGMA
Sbjct: 439 STMQSLLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLGDDMNAKIADFGMA 498
Query: 352 RIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLS 411
RIFG +Q E+NT ++VGTYGYM+PEYA+ G S+KSDV+SFGVL+LEIISGKKNS Y
Sbjct: 499 RIFGMDQTEANTRRIVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGKKNSNVYQM 558
Query: 412 EHGQS---LLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNM 468
+ G S L+ YTW+LW NG LEL+DP + + E+ +CIHI LLCVQE+ DRP M
Sbjct: 559 D-GTSAGNLVTYTWRLWSNGSPLELVDPSFRDNYRINEVSRCIHIALLCVQEEAEDRPTM 617
Query: 469 SSVAVMLASDTVSLPQPTQPAF----SVGRIIARSGQSSSSYSKICSVNEVTLSDVSPR 523
S++ ML + +++L P +P F S + + S + S +CSV++ ++++V+PR
Sbjct: 618 SAIVQMLTTSSIALAVPQRPGFFFRSSKHEQVGLVDRLSINTSALCSVDDASITNVTPR 676
|
|
| TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 681 (244.8 bits), Expect = 1.3e-94, Sum P(2) = 1.3e-94
Identities = 128/235 (54%), Positives = 177/235 (75%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
++ +LDW RR +II GIARG+LYLH+DSRL + HRDLKASN+LLD +MNPKI+DFGMARI
Sbjct: 435 KQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARI 494
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFY-LSE 412
FG +Q+++NT ++ GT+GYM+PEYA+ G S+KSDV+SFGVL+LEIISGKKNS FY + +
Sbjct: 495 FGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNSSFYNIDD 554
Query: 413 HGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVA 472
G +L+ + W+LW NG LEL+DP + +S ++E +CIHI LLCVQEDPADRP + ++
Sbjct: 555 SGSNLVTHAWRLWRNGSPLELVDPTIGESYQSSEATRCIHIALLCVQEDPADRPLLPAII 614
Query: 473 VMLASDTVSLPQPTQPAFSV-GRIIARSG---QSSSSYSKICSVNEVTLSDVSPR 523
+ML S T +L P P F + GR + + G S+S S S+N+ ++++ PR
Sbjct: 615 MMLTSSTTTLHVPRAPGFCLSGRDLEQDGVEYTESTSRSIPGSINDASITEFYPR 669
|
|
| TAIR|locus:2141201 CRK29 "cysteine-rich RLK (RECEPTOR-like protein kinase) 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 620 (223.3 bits), Expect = 3.8e-93, Sum P(2) = 3.8e-93
Identities = 125/239 (52%), Positives = 168/239 (70%)
Query: 290 IYSTRRAQL-DWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDF 348
I+ T + QL DW R +I GIARGLLYLHEDSR ++ HRDLKASN+LLD EMNPKI+DF
Sbjct: 442 IFDTEKRQLLDWVVRYKMIGGIARGLLYLHEDSRFRIIHRDLKASNILLDQEMNPKIADF 501
Query: 349 GMARIFGGNQNESN--TSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNS 406
G+A++F Q ++ TS++ GTYGYMAPEYA+ G SVK+DVFSFGVL++EII+GK+N+
Sbjct: 502 GLAKLFDSGQTMTHRFTSRIAGTYGYMAPEYAMHGQFSVKTDVFSFGVLVIEIITGKRNN 561
Query: 407 --GFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPAD 464
G E + LL++ W+ W L ++DP L E+L+CIHIGLLCVQE A
Sbjct: 562 NGGSNGDEDAEDLLSWVWRSWREDTILSVIDPSLTAGSRN-EILRCIHIGLLCVQESAAT 620
Query: 465 RPNMSSVAVMLASDTVSLPQPTQPAFSVGRIIARSGQSSSSYSKICSVNEVTLSDVSPR 523
RP M++V++ML S + +LP P +PAF + ++ S SSS+ S N+VT+S+ SPR
Sbjct: 621 RPTMATVSLMLNSYSFTLPTPLRPAFVLESVVIPSNVSSSTEGLQMSSNDVTVSEFSPR 679
|
|
| TAIR|locus:2141762 CRK26 "cysteine-rich RLK (RECEPTOR-like protein kinase) 26" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 583 (210.3 bits), Expect = 1.7e-90, Sum P(2) = 1.7e-90
Identities = 116/231 (50%), Positives = 163/231 (70%)
Query: 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFG- 355
+L+W+ R II G+ARGLLYLH+DSRL++ HRDLKASN+LLD EM PKI+DFGMAR+F
Sbjct: 437 ELEWEIRYKIIGGVARGLLYLHQDSRLRIIHRDLKASNILLDEEMTPKIADFGMARLFDI 496
Query: 356 GNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQ 415
+ + T+++VGT+GYMAPEY + G S K+DV+SFGVL+LEIISGKKNSGF +
Sbjct: 497 DHTTQRYTNRIVGTFGYMAPEYVMHGQFSFKTDVYSFGVLVLEIISGKKNSGFSSEDSMG 556
Query: 416 SLLAYTWKLWCNGEALELMDPVLK--QSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473
L+++ W+ W G AL L+D +L S + +++CI+IGLLCVQE A+RP+M+SV +
Sbjct: 557 DLISFAWRNWKEGVALNLVDKILMTMSSYSSNMIMRCINIGLLCVQEKVAERPSMASVVL 616
Query: 474 MLASDTVSLPQPTQPAF-SVGRIIARSGQSSSSYSKICSVNEVTLSDVSPR 523
ML T++L +P++PAF S ++ S S +K + N T ++ PR
Sbjct: 617 MLDGHTIALSEPSKPAFFSHSNAVSDSSSSLGHNAKTSNYNSNT--ELYPR 665
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 523 | |||
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 4e-34 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-29 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-28 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-27 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-27 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-25 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-25 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-24 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-23 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 1e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-20 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-20 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-19 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-17 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-17 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-17 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-16 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-16 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-15 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-13 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-13 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-12 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-12 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-11 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-11 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-11 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-11 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-11 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-11 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-11 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-10 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-10 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-10 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-09 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-09 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-08 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-08 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-08 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-08 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 5e-08 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-08 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-07 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-07 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-07 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-07 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-07 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-05 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-05 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-04 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.002 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.002 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.003 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.003 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 4e-34
Identities = 48/110 (43%), Positives = 65/110 (59%), Gaps = 7/110 (6%)
Query: 30 YHFCNNTVN---FTRNSTYQSNLNLLLSTLRSNATHGSSDKFSEGFYNATASQDPDKVYG 86
+H C++ + T NST++SNLN LLS+L SNA + +GF T+ PD VYG
Sbjct: 1 FHLCSSNTSGNYTTANSTFESNLNALLSSLSSNA----ASSSGKGFAAGTSGAAPDTVYG 56
Query: 87 LFLCRGDVSAETCKDCVNFATSDITQRCPLQKETVIWYDHCLLRYSGISF 136
L CRGD+SA C+ C+ A S++ + CP +K IWYD C LRY F
Sbjct: 57 LAQCRGDLSASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 9e-29
Identities = 41/113 (36%), Positives = 61/113 (53%), Gaps = 7/113 (6%)
Query: 289 TIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH-EMNPKISD 347
+ +L + I+ I GL YLH + HRDLK N+LLD K++D
Sbjct: 80 DLLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLAD 136
Query: 348 FGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGV-ISVKSDVFSFGVLLLEI 399
FG++++ +++ T +VGT YMAPE LG S KSD++S GV+L E+
Sbjct: 137 FGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 7e-28
Identities = 59/189 (31%), Positives = 78/189 (41%), Gaps = 36/189 (19%)
Query: 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGM 350
Y +R L I I RGL YLH + HRDLK N+LLD KI+DFG+
Sbjct: 88 YLSRGGPLSEDEAKKIALQILRGLEYLHS---NGIIHRDLKPENILLDENGVVKIADFGL 144
Query: 351 ARIFGGNQNESNTSKVVGTYGYMAPE-YALGGVISVKSDVFSFGVLLLEIISGK------ 403
A+ + + S T+ VGT YMAPE G K DV+S GV+L E+++GK
Sbjct: 145 AKKLLKS-SSSLTT-FVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGE 202
Query: 404 -KNSGFYLSEHGQS-LLAYTWKLWCNG--EALELMDPVLKQSCMAAELLKCIHIGLLCVQ 459
L L + W +G EA +L+ L
Sbjct: 203 NILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIK------------------KCLNK- 243
Query: 460 EDPADRPNM 468
DP+ RP
Sbjct: 244 -DPSKRPTA 251
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 51/157 (32%), Positives = 70/157 (44%), Gaps = 19/157 (12%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I L YLH + HRDLK N+LLD + + K++DFG+AR + VGT
Sbjct: 106 ILSALEYLHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGT 159
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGE 429
YMAPE LG D++S GV+L E+++GK F G L +K +
Sbjct: 160 PEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGK--PPFP----GDDQLLELFKKIGKPK 213
Query: 430 ALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRP 466
P S A +L++ LL DP R
Sbjct: 214 -PPFPPPEWDISPEAKDLIR----KLLVK--DPEKRL 243
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 61/192 (31%), Positives = 85/192 (44%), Gaps = 24/192 (12%)
Query: 288 PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISD 347
P S ++ L K +S IA+G+ YL K HRDL A N L+ ++ KISD
Sbjct: 92 PVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISD 148
Query: 348 FGMAR-IFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKK- 404
FG++R ++ + T + +MAPE G+ + KSDV+SFGVLL EI + G
Sbjct: 149 FGLSRDVYDDDYYRKKTGGKLPIR-WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
Query: 405 NSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPAD 464
G E +L Y G L + + EL+ C Q DP D
Sbjct: 208 YPGLSNEE----VLEYL----RKGYRLPKPEYCPDE---LYELMLS------CWQLDPED 250
Query: 465 RPNMSSVAVMLA 476
RP S + L
Sbjct: 251 RPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 59/183 (32%), Positives = 83/183 (45%), Gaps = 29/183 (15%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR- 352
R +L +S IARG+ YL HRDL A N L+ + KISDFG++R
Sbjct: 95 NRPKLSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRD 151
Query: 353 IFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLS 411
++ + K+ +MAPE G + KSDV+SFGVLL EI + G++ Y
Sbjct: 152 LYDDDYYRKRGGKL--PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQ---PYPG 206
Query: 412 EHGQSLLAYTWKLWCNGEALELMDPVLKQSC---MAAELLKCIHIGLLCVQEDPADRPNM 468
+ +L Y K NG L +C + +L+C EDP DRP
Sbjct: 207 MSNEEVLEYL-K---NGYRLPQPP-----NCPPELYDLMLQCWA-------EDPEDRPTF 250
Query: 469 SSV 471
S +
Sbjct: 251 SEL 253
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 58/185 (31%), Positives = 82/185 (44%), Gaps = 29/185 (15%)
Query: 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA 351
R +L +S IARG+ YL HRDL A N L+ + KISDFG++
Sbjct: 94 KNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLS 150
Query: 352 R-IFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFY 409
R ++ + + K+ +MAPE G + KSDV+SFGVLL EI + G++ Y
Sbjct: 151 RDLYDDDYYKVKGGKL--PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEE---PY 205
Query: 410 LSEHGQSLLAYTWKLWCNGEALELMDPVLKQSC---MAAELLKCIHIGLLCVQEDPADRP 466
+L Y K G L +C + +L+C EDP DRP
Sbjct: 206 PGMSNAEVLEYL-K---KGYRLPKPP-----NCPPELYKLMLQCWA-------EDPEDRP 249
Query: 467 NMSSV 471
S +
Sbjct: 250 TFSEL 254
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 50/158 (31%), Positives = 79/158 (50%), Gaps = 17/158 (10%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I GL YLH + HRD+K +N+L+D + K++DFG A+ G + T V GT
Sbjct: 110 ILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGE 429
+MAPE G +D++S G ++E+ +GK SE G + +A +K+ +GE
Sbjct: 167 PYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP----WSELG-NPMAALYKIGSSGE 221
Query: 430 ALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPN 467
E+ + S A + L+ C++ DP RP
Sbjct: 222 PPEIPE---HLSEEAKDFLRK------CLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 98.7 bits (247), Expect = 3e-23
Identities = 59/194 (30%), Positives = 74/194 (38%), Gaps = 40/194 (20%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
+L K + + IA+G+ YL HRDL A N L+ + KISDFG++R
Sbjct: 94 KHGEKLTLKDLLQMALQIAKGMEYLES---KNFVHRDLAARNCLVTENLVVKISDFGLSR 150
Query: 353 IFGGNQNESNTSKVVGTYG---YMAPEYALGGVISVKSDVFSFGVLLLEIIS-------G 402
+ K G +MAPE G + KSDV+SFGVLL EI + G
Sbjct: 151 DI---YEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPG 207
Query: 403 KKNSGFYLS-EHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQED 461
N E G L C E ELM L C D
Sbjct: 208 MSNEEVLELLEDGYRLPRP---ENCPDELYELM--------------------LQCWAYD 244
Query: 462 PADRPNMSSVAVML 475
P DRP S + L
Sbjct: 245 PEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 3e-23
Identities = 49/163 (30%), Positives = 76/163 (46%), Gaps = 28/163 (17%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I +GL YLH ++ + HRD+K SN+L++ + KI+DFG++++ ++ NT VGT
Sbjct: 108 ILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF--VGT 163
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK------KNSGFYLSEHGQSLLAYTWK 423
YM+PE G S +D++S G+ LLE GK F+ L+
Sbjct: 164 VTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF------ELMQAI-- 215
Query: 424 LWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRP 466
C+G L + E C+Q+DP RP
Sbjct: 216 --CDGPPPSLPA-----EEFSPEF---RDFISACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-20
Identities = 34/99 (34%), Positives = 46/99 (46%), Gaps = 2/99 (2%)
Query: 149 QNRQNSTGGLFNQQVRNLMNEAVNQ-ALNTTKMFGTVKKNYTASQTLYGLVQCTPDLSRH 207
+ F + L++ + A ++ K F + A T+YGL QC DLS
Sbjct: 9 SGNYTTANSTFESNLNALLSSLSSNAASSSGKGFAAGT-SGAAPDTVYGLAQCRGDLSAS 67
Query: 208 DCSTCLRLAISSFDECFSINIGGRMMYPSCNFRYELYPF 246
DC +CL A+S C GGR+ Y SC RYE YPF
Sbjct: 68 DCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 51/168 (30%), Positives = 74/168 (44%), Gaps = 30/168 (17%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
I + +GL YLHE K+ HRD+K SN+L++ K+ DFG++ G S
Sbjct: 105 IAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVS----GQLVNSLAKT 158
Query: 366 VVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLW 425
VGT YMAPE G SVKSD++S G+ L+E+ +G+ F
Sbjct: 159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR----FPYPPENDPPDG------ 208
Query: 426 CNGEALELMD-------PVLKQSCMAAELLKCIHIGLLCVQEDPADRP 466
EL+ P L + + LC+ +DP +RP
Sbjct: 209 ----IFELLQYIVNEPPPRLPSGKFSPDF---QDFVNLCLIKDPRERP 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (221), Expect = 6e-20
Identities = 38/94 (40%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I L YLH L + +RDLK N+LLD + + K++DFG+A+ S T+ GT
Sbjct: 102 IVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELS--SEGSRTNTFCGT 156
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
Y+APE LG D +S GVLL E+++GK
Sbjct: 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 6e-19
Identities = 37/130 (28%), Positives = 67/130 (51%), Gaps = 12/130 (9%)
Query: 279 IWIAI----GTTIPTIYSTRRAQLDWKRRIS-IINGIARGLLYLHEDSRLKVFHRDLKAS 333
+WI + G ++ + + L + +I+ + + +GL YLH + HRD+KA+
Sbjct: 72 LWIVMEFCSGGSLKDLLKSTNQTLT-ESQIAYVCKELLKGLEYLHS---NGIIHRDIKAA 127
Query: 334 NVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFG 393
N+LL + K+ DFG++ + + +VGT +MAPE G K+D++S G
Sbjct: 128 NILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLG 184
Query: 394 VLLLEIISGK 403
+ +E+ GK
Sbjct: 185 ITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 7e-19
Identities = 54/172 (31%), Positives = 82/172 (47%), Gaps = 28/172 (16%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+A G+ YL E HRDL A N+L+ ++ K++DFG+AR+ + S+ K+
Sbjct: 113 VAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--P 167
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGE 429
Y + APE A G S KSDV+SFG+LL E+ + +GQ + Y N E
Sbjct: 168 YKWTAPEAASHGTFSTKSDVWSFGILLYEMFT-----------YGQ--VPYPGMN--NHE 212
Query: 430 ALELMDPVLKQSCMAAELLKCIH----IGLLCVQEDPADRPNMSSVAVMLAS 477
+ + + C A KC I L C +P DRP+ ++ L +
Sbjct: 213 VYDQITAGYRMPCPA----KCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 34/94 (36%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+ +GL YLHE V HRD+KA+N+L + K++DFG+A + + VVGT
Sbjct: 108 VLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGT 162
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
+MAPE S SD++S G ++E+++G
Sbjct: 163 PYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 1e-17
Identities = 32/101 (31%), Positives = 51/101 (50%), Gaps = 17/101 (16%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+ L YLH K+ HRD+K N+ L K+ DFG++++ + + T VVGT
Sbjct: 112 LCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGT 166
Query: 370 YGYMAPE------YALGGVISVKSDVFSFGVLLLEIISGKK 404
Y++PE Y + KSD++S G +L E+ + K
Sbjct: 167 PYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 38/98 (38%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
I + +GL YLH K+ HRD+K SN+LL + K+ DFG++ G S
Sbjct: 110 IAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGT 162
Query: 366 VVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
GT YMAPE G S+ SDV+S G+ LLE+ +
Sbjct: 163 FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 82.9 bits (203), Expect = 4e-17
Identities = 54/188 (28%), Positives = 81/188 (43%), Gaps = 15/188 (7%)
Query: 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMN-PKISDFG 349
R+ L + I+ I L YLH + HRD+K N+LLD + K+ DFG
Sbjct: 91 KIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFG 147
Query: 350 MARIFGGNQNESN----TSKVVGTYGYMAPEYALGGV---ISVKSDVFSFGVLLLEIISG 402
+A++ + S+ S VGT GYMAPE LG S SD++S G+ L E+++G
Sbjct: 148 LAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTG 207
Query: 403 KKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDP 462
F E S + T K+ + L S + + +DP
Sbjct: 208 L--PPFE-GEKNSSATSQTLKIILELP-TPSLASPLSPSNPELISKAASDLLKKLLAKDP 263
Query: 463 ADRPNMSS 470
+R + SS
Sbjct: 264 KNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 33/95 (34%), Positives = 55/95 (57%), Gaps = 5/95 (5%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+ GL YLH + + HRD+K SN+L++++ K++DFG+AR + + T++V+ T
Sbjct: 109 LLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-T 164
Query: 370 YGYMAPEYALGGVI-SVKSDVFSFGVLLLEIISGK 403
Y PE LG + D++S G +L E+ GK
Sbjct: 165 LWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 7e-17
Identities = 42/114 (36%), Positives = 55/114 (48%), Gaps = 6/114 (5%)
Query: 290 IYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFG 349
IY+ R I I GL +LH + ++ +RDLK NVLLD N +ISD G
Sbjct: 84 IYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLG 140
Query: 350 MARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
+A G + GT GYMAPE G V D F+ G L E+I+G+
Sbjct: 141 LAVELKGGKK---IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 1e-16
Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+ +GL YLH V HRD+K+ N+LL + + K++DFG A +++ N+ VVGT
Sbjct: 125 VLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGT 179
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISG 402
+MAPE K D++S G++ +E+ G
Sbjct: 180 PYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 53/160 (33%), Positives = 78/160 (48%), Gaps = 25/160 (15%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+A G+ YL + + HRDL A NVL+ K++DFG+AR+ + E+ G
Sbjct: 112 VASGMAYLEAQNYI---HRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GA 164
Query: 370 ---YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWC 426
+ APE AL S+KSDV+SFG+LL EI++ +G+ + Y
Sbjct: 165 KFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT-----------YGR--MPYPG--MT 209
Query: 427 NGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRP 466
N E L+ +D + C + I L C +EDP DRP
Sbjct: 210 NAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRP 249
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 41/130 (31%), Positives = 66/130 (50%), Gaps = 11/130 (8%)
Query: 279 IWI-----AIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKAS 333
+WI G+ + T + L + +I+ +GL YLH K HRD+KA
Sbjct: 73 LWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAG 128
Query: 334 NVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFG 393
N+LL+ E K++DFG++ + NT V+GT +MAPE + K+D++S G
Sbjct: 129 NILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNNKADIWSLG 186
Query: 394 VLLLEIISGK 403
+ +E+ GK
Sbjct: 187 ITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 14/97 (14%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTS----- 364
IA G+ YL HRDL A N+L+ + KI+DFG+AR+ ++ +
Sbjct: 112 IAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPI 168
Query: 365 KVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
K + APE A G ++KSDV+SFG+LL EI++
Sbjct: 169 K------WTAPEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 34/112 (30%), Positives = 53/112 (47%), Gaps = 21/112 (18%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ----------- 358
I L YLH + HRDLK N+LLD +M+ KI+DFG A++ N
Sbjct: 111 ILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167
Query: 359 -------NESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
N + VGT Y++PE SD+++ G ++ ++++GK
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 36/95 (37%), Positives = 49/95 (51%), Gaps = 6/95 (6%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I L YLH + HRD+K N+LLD + + I+DF +A + ++TS GT
Sbjct: 109 IVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GT 162
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKK 404
GYMAPE SV D +S GV E + GK+
Sbjct: 163 PGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 41/104 (39%), Positives = 61/104 (58%), Gaps = 9/104 (8%)
Query: 300 WKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQN 359
W+ I I+ G+A +LH K+ HRD+K+ N+ LD N KI D G+A++ N N
Sbjct: 104 WRFFIQILLGLA----HLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156
Query: 360 ESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
+NT +VGT Y++PE + KSDV++ GV+L E +GK
Sbjct: 157 FANT--IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 6/98 (6%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
I + GL YL+ R + HRD+K SN+L++ K+ DFG++ G S
Sbjct: 108 IAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADT 161
Query: 366 VVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
VGT YM+PE GG +VKSDV+S G+ ++E+ GK
Sbjct: 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 37/96 (38%), Positives = 52/96 (54%), Gaps = 11/96 (11%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
IA G+ YL K HRDL A N ++ ++ KI DFGM R + E++ + G
Sbjct: 128 IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYYRKGGK 180
Query: 370 ----YGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+MAPE GV + KSDV+SFGV+L E+ +
Sbjct: 181 GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (186), Expect = 4e-15
Identities = 39/95 (41%), Positives = 55/95 (57%), Gaps = 10/95 (10%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371
RGL Y H S ++ HRDLK N+L++ + K++DFG+AR FG T +VV T
Sbjct: 109 RGLAYCH--SH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLW 163
Query: 372 YMAPEYALGGV---ISVKSDVFSFGVLLLEIISGK 403
Y APE LG +V D++S G + E+I+GK
Sbjct: 164 YRAPEILLGSKHYSTAV--DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 5e-15
Identities = 57/193 (29%), Positives = 79/193 (40%), Gaps = 45/193 (23%)
Query: 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354
R Q++ KR + + I +G+ YL + HRDL A N+L++ E KISDFG+A++
Sbjct: 103 RDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVL 159
Query: 355 GGNQNESNTSKVVGTYG-----YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFY 409
E V G + APE S SDV+SFGV L E+ F
Sbjct: 160 ----PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYEL--------FT 207
Query: 410 LSEHGQSLLAYTWKLWCNGEALELMDPVLKQS--CMAAELLK----------C----IHI 453
+ QS A E L ++ Q ELLK C +
Sbjct: 208 YGDPSQSPPA---------EFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDL 258
Query: 454 GLLCVQEDPADRP 466
LC + +P DRP
Sbjct: 259 MKLCWEAEPQDRP 271
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 47/168 (27%), Positives = 77/168 (45%), Gaps = 35/168 (20%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
II + L Y+H+ V HRD+KA+N+L+ + N K+ DFG+A + NQN S S
Sbjct: 106 IIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRST 160
Query: 366 VVGTYGYMAPEYALGGVI-SVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKL 424
VGT +MAPE G K+D++S G+ + E+ +G
Sbjct: 161 FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP------------------- 201
Query: 425 WCNGEALELMD-------PVLKQSCMAAELLKCIHIGLLCVQEDPADR 465
+ + +A M P L+ + + L + + C+ E+P +R
Sbjct: 202 YSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFV---AACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 9e-15
Identities = 40/96 (41%), Positives = 53/96 (55%), Gaps = 9/96 (9%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR--IFGGNQNESNTSKVV 367
I GL +LHE + +RDLK NVLLD E + KI+DFGM + I GG TS
Sbjct: 105 IVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT----TSTFC 157
Query: 368 GTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
GT Y+APE D ++ GVLL E+++G+
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 60/196 (30%), Positives = 86/196 (43%), Gaps = 48/196 (24%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
I++GIA YLH R + HRD+K SN+L++ N KI+DFG++RI + N+S
Sbjct: 177 ILSGIA----YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS- 228
Query: 366 VVGTYGYMAPE-------------YALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSE 412
VGT YM+PE YA D++S GV +LE G+ F +
Sbjct: 229 -VGTIAYMSPERINTDLNHGAYDGYA--------GDIWSLGVSILEFYLGR--FPFGVGR 277
Query: 413 HGQSLLAYTW-KLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSV 471
G W L C A+ + P + + E I C+Q +PA R S
Sbjct: 278 QGD------WASLMC---AICMSQPPEAPATASREFRHFIS---CCLQREPAKRW---SA 322
Query: 472 AVMLASDTVSLPQPTQ 487
+L + QP Q
Sbjct: 323 MQLLQHPFILRAQPGQ 338
|
Length = 353 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 53/176 (30%), Positives = 72/176 (40%), Gaps = 31/176 (17%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+A G+ YL HRDL A NVLL + KISDFGM+R G ++ + G
Sbjct: 104 VAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAG-SDYYRATTAGR 159
Query: 370 Y--GYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWC 426
+ + APE G S KSDV+S+GV L E S G K Y G
Sbjct: 160 WPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKP---YGEMKGA----------- 205
Query: 427 NGEALELMDPVLKQSCMAAELLKC----IHIGLLCVQEDPADRPNMSSVAVMLASD 478
E + +++ + +C I L C + P DRP S + D
Sbjct: 206 --EVIAMLESGERLPRPE----ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 52/194 (26%), Positives = 77/194 (39%), Gaps = 47/194 (24%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
T QL + + G+ YL E HRDL A NVL+ ++ K+SDFG+A+
Sbjct: 100 TLAQQLGFALDV------CEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK 150
Query: 353 IFGGNQNESNTSKVVGTY--GYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYL 410
E++ + G + APE S KSDV+SFG+LL EI S + Y
Sbjct: 151 -------EASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP--YP 201
Query: 411 SEHGQSLLAYTWKLW-------CNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPA 463
+ ++ + K + C E ++M C + DPA
Sbjct: 202 RIPLKDVVPHVEKGYRMEAPEGCPPEVYKVM-------------KDCWEL-------DPA 241
Query: 464 DRPNMSSVAVMLAS 477
RP + LA
Sbjct: 242 KRPTFKQLREQLAL 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 35/98 (35%), Positives = 56/98 (57%), Gaps = 5/98 (5%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
I+ + GL YLHE+ HRD+KA+N+LL E + K++DFG++ ++ NT
Sbjct: 103 ILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-- 157
Query: 366 VVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
VGT +MAPE K+D++S G+ +E+ G+
Sbjct: 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 37/95 (38%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 314 LLYLHE-----DSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVG 368
LL L+E D V HRDLK +N+ LD N K+ DFG+A+I G + S VG
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS--SFAKTYVG 172
Query: 369 TYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
T YM+PE KSD++S G L+ E+ +
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 47/134 (35%), Positives = 71/134 (52%), Gaps = 12/134 (8%)
Query: 277 KAIWIAI-----GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLK 331
KA+ I + GT I + LD +I++ + LL LH + HRDLK
Sbjct: 72 KALMIVMEYAPGGTLAEYIQKRCNSLLDED---TILHFFVQILLALHHVHTKLILHRDLK 128
Query: 332 ASNVLLD-HEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVF 390
N+LLD H+M KI DFG+++I ++S VVGT Y++PE G + KSD++
Sbjct: 129 TQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPELCEGKPYNQKSDIW 185
Query: 391 SFGVLLLEIISGKK 404
+ G +L E+ S K+
Sbjct: 186 ALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 34/92 (36%), Positives = 54/92 (58%), Gaps = 4/92 (4%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
IA G+ ++ R HRDL+A+N+L+ + KI+DFG+AR+ N+ +
Sbjct: 111 IAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-P 166
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+ APE G ++KSDV+SFG+LL EI++
Sbjct: 167 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 60/234 (25%), Positives = 103/234 (44%), Gaps = 38/234 (16%)
Query: 242 ELYPFYDDPSIVTPPPVFLSPPSPGSVTSSKGKGRKAIWIAIGTTIPTIYSTRRAQLDWK 301
+L P Y ++V+ P+++ VT GKG ++ G L
Sbjct: 62 KLVPLY---AVVSEEPIYI-------VTEFMGKGSLLDFLKEGDG---------KYLKLP 102
Query: 302 RRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES 361
+ + + IA G+ Y+ R+ HRDL+A+N+L+ + KI+DFG+AR+ N+ +
Sbjct: 103 QLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159
Query: 362 NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYT 421
+ APE AL G ++KSDV+SFG+LL E+++ +
Sbjct: 160 RQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR---------------VP 203
Query: 422 WKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVML 475
+ N E LE ++ + C + LC ++DP +RP + L
Sbjct: 204 YPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 5e-14
Identities = 55/164 (33%), Positives = 74/164 (45%), Gaps = 26/164 (15%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLL--DHEMNPKISDFGMARIFGGNQNESNTSKVV 367
+ARG+ +L S+ K HRDL A NVL+ DH M KI+DFG+AR T+
Sbjct: 141 VARGMEFL--ASK-KCIHRDLAARNVLVTEDHVM--KIADFGLARDIHHIDYYRKTTNGR 195
Query: 368 GTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS--GKKNSGFYLSEHGQSLLAYTWKLW 425
+MAPE V + +SDV+SFGVLL EI + G G + E +KL
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--------LFKLL 247
Query: 426 CNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMS 469
G +E P + + C H E P+ RP
Sbjct: 248 KEGYRME--KPQNCTQELYHLMRDCWH-------EVPSQRPTFK 282
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 6e-14
Identities = 38/107 (35%), Positives = 56/107 (52%), Gaps = 25/107 (23%)
Query: 309 GIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVV- 367
I + L YLH +L V HRD+K SNVL++ K+ DFG++ G +S +K +
Sbjct: 111 SIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDS-VAKTID 163
Query: 368 -GTYGYMAPE----------YALGGVISVKSDVFSFGVLLLEIISGK 403
G YMAPE Y VKSDV+S G+ ++E+ +G+
Sbjct: 164 AGCKPYMAPERINPELNQKGY------DVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 9e-14
Identities = 36/93 (38%), Positives = 52/93 (55%), Gaps = 6/93 (6%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371
G+ +LH++ + HRDLK SN+LL++ KI DFG+AR +G T VV T
Sbjct: 117 SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY-TQLVV-TLW 171
Query: 372 YMAPEYALG-GVISVKSDVFSFGVLLLEIISGK 403
Y APE LG S D++S G + E+++ K
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 39/101 (38%), Positives = 61/101 (60%), Gaps = 8/101 (7%)
Query: 303 RISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN 362
+ISI + RGL YL E + K+ HRD+K SN+L++ K+ DFG++ G +S
Sbjct: 103 KISI--AVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSM 154
Query: 363 TSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
+ VGT YM+PE G +V+SD++S G+ L+E+ G+
Sbjct: 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 46/157 (29%), Positives = 80/157 (50%), Gaps = 19/157 (12%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+A G+ Y+ R+ HRDL+++N+L+ + KI+DFG+AR+ N+ +
Sbjct: 111 VAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF-P 166
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGE 429
+ APE AL G ++KSDV+SFG+LL E+++ + + G + N E
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR-----VPYPGMN----------NRE 211
Query: 430 ALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRP 466
LE ++ + C + + L C ++DP +RP
Sbjct: 212 VLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 36/99 (36%), Positives = 50/99 (50%), Gaps = 9/99 (9%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFG------MARIFGGNQNESNT 363
I L YLH + HRDLK N+L+D + K++DFG + R N +E
Sbjct: 102 IVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158
Query: 364 SKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISG 402
++VGT Y+APE LG S D +S G +L E + G
Sbjct: 159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 39/108 (36%), Positives = 62/108 (57%), Gaps = 10/108 (9%)
Query: 298 LDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGN 357
L+W +I A+G+ YL E+ RL HRDL A NVL+ + KI+DFG+A++ +
Sbjct: 112 LNWCVQI------AKGMSYL-EEKRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162
Query: 358 QNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKK 404
+ E + +MA E L + + KSDV+S+GV + E+++ G K
Sbjct: 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 44/166 (26%), Positives = 76/166 (45%), Gaps = 21/166 (12%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I + Y+H+ + HRD+K N+ L K+ DFG+++I G + + T VVGT
Sbjct: 110 IVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGT 164
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGE 429
YM+PE G + KSD+++ G +L E+++ K+ + + L K+
Sbjct: 165 PYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR------TFDATNPLNLVVKIVQGNY 218
Query: 430 ALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVML 475
+ S ++EL+ +H +Q+DP RP V
Sbjct: 219 TPVV-------SVYSSELISLVH---SLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 37/94 (39%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I GL +LH+ ++ +RDLK NVLLD++ N +ISD G+A Q++ T GT
Sbjct: 106 IISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGT 160
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
G+MAPE G D F+ GV L E+I+ +
Sbjct: 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 37/106 (34%), Positives = 60/106 (56%), Gaps = 13/106 (12%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR----IFGGNQNE 360
+ GL YLH + HRDLKA N+L+D + KISDFG+++ I+ N+
Sbjct: 112 FFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYD---ND 165
Query: 361 SNTSKVVGTYGYMAPE--YALGGVISVKSDVFSFGVLLLEIISGKK 404
N S + G+ +MAPE ++ S K D++S G ++LE+ +G++
Sbjct: 166 QNMS-MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 47/167 (28%), Positives = 72/167 (43%), Gaps = 31/167 (18%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKV--- 366
+ GL YLH + HRD+K +N+ LDH K+ DFG A +NT+ +
Sbjct: 108 LLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK-----NNTTTMGEE 159
Query: 367 ----VGTYGYMAPEYALGGVISVK---SDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLA 419
GT YMAPE GG +D++S G ++LE+ +GK+ +E
Sbjct: 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----Q 214
Query: 420 YTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRP 466
+ + G + D L+ S + L C++ DP RP
Sbjct: 215 IMFHV-GAGHKPPIPDS-LQLSPEGKDFLD------RCLESDPKKRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 40/96 (41%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR--IFGGNQNESNTSKVV 367
IA GL +LH + +RDLK NV+LD E + KI+DFGM + IFGG T
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----KTTRTFC 162
Query: 368 GTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
GT Y+APE D ++FGVLL E+++G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 39/108 (36%), Positives = 54/108 (50%), Gaps = 20/108 (18%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
I+ RGL YLHE+ KV HRD+K N+LL K+ DFG++ NT
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF- 173
Query: 366 VVGTYGYMAPEYALGGVIS----------VKSDVFSFGVLLLEIISGK 403
+GT +MAPE VI+ +SDV+S G+ +E+ GK
Sbjct: 174 -IGTPYWMAPE-----VIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 43/108 (39%), Positives = 59/108 (54%), Gaps = 15/108 (13%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR--IFGGNQNESNTSKVV 367
I GL +LH+ + +RDLK NVLLD + + KI+DFGM + + G E S
Sbjct: 105 IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG----EGKASTFC 157
Query: 368 GTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQ 415
GT Y+APE G + D +SFGVLL E++ G+ S F HG+
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ--SPF----HGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 6e-13
Identities = 37/114 (32%), Positives = 59/114 (51%), Gaps = 6/114 (5%)
Query: 290 IYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFG 349
IY+ L+ +R I I G+L+LH + + +RD+K NVLLD + N ++SD G
Sbjct: 84 IYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLG 140
Query: 350 MARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
+A + ++ GT GYMAPE S D F+ G + E+++G+
Sbjct: 141 LAVELKDGK---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 6e-13
Identities = 36/106 (33%), Positives = 59/106 (55%), Gaps = 16/106 (15%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGM-ARIFGGNQNESNTS 364
++ + +GL YLH + ++ HRD+KA N+LL + + KI+DFG+ A + G
Sbjct: 107 VLKEVLKGLEYLHSNGQI---HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVR 163
Query: 365 K-VVGTYGYMAPEYALGGVIS------VKSDVFSFGVLLLEIISGK 403
K VGT +MAPE V+ K+D++SFG+ +E+ +G
Sbjct: 164 KTFVGTPCWMAPE-----VMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-13
Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 5/99 (5%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTS 364
+I+ I +GL YLH + ++ HRD+KA+NVLL + + K++DFG+A Q + NT
Sbjct: 105 TILREILKGLDYLHSERKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT- 160
Query: 365 KVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
VGT +MAPE K+D++S G+ +E+ G+
Sbjct: 161 -FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 9e-13
Identities = 40/122 (32%), Positives = 66/122 (54%), Gaps = 4/122 (3%)
Query: 280 WIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH 339
++A G+ + + S ++ + I IA G+ Y+ R HRDL+A+NVL+
Sbjct: 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSE 138
Query: 340 EMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEI 399
+ KI+DFG+AR+ N+ + + APE G ++KSDV+SFG+LL EI
Sbjct: 139 SLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKSDVWSFGILLYEI 197
Query: 400 IS 401
++
Sbjct: 198 VT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-12
Identities = 35/92 (38%), Positives = 56/92 (60%), Gaps = 4/92 (4%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
IA G+ Y+ R+ HRDL+A+N+L+ + K++DFG+AR+ N+ +
Sbjct: 111 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-P 166
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+ APE AL G ++KSDV+SFG+LL E+ +
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 40/93 (43%), Positives = 55/93 (59%), Gaps = 6/93 (6%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371
RGL YLHE+ + HRDLK SN+LL + KI+DFG+AR +G T KVV T
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK-PMTPKVV-TLW 173
Query: 372 YMAPEYALGGVISVKS-DVFSFGVLLLEIISGK 403
Y APE LG + D+++ G +L E+++ K
Sbjct: 174 YRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 52/171 (30%), Positives = 76/171 (44%), Gaps = 26/171 (15%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+ RGL LHE K+ HRDLK++N+LL KI D G++++ N +GT
Sbjct: 112 LLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM----AKTQIGT 164
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGE 429
YMAPE G S KSD++S G LL E+ + +S+ +K+ G+
Sbjct: 165 PHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA------PPFEARSMQDLRYKV-QRGK 217
Query: 430 ALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTV 480
P+ + +L I +Q P RPN + LAS V
Sbjct: 218 Y----PPI--PPIYSQDLQNFIR---SMLQVKPKLRPNCDKI---LASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 32/108 (29%), Positives = 56/108 (51%), Gaps = 3/108 (2%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
+ + + ++ GIA G+ YL S + HRDL A N+L++ + K+SDFG++R
Sbjct: 99 NDGKFTVGQLVGMLRGIASGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
++ T + APE + SDV+SFG+++ E++S
Sbjct: 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 38/101 (37%), Positives = 61/101 (60%), Gaps = 8/101 (7%)
Query: 303 RISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN 362
++SI + RGL YL E + ++ HRD+K SN+L++ K+ DFG++ G +S
Sbjct: 107 KVSI--AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSM 158
Query: 363 TSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
+ VGT YM+PE G SV+SD++S G+ L+E+ G+
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 38/112 (33%), Positives = 56/112 (50%), Gaps = 6/112 (5%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
R+ L S + + +GL + H + HRDLK N+L++ E K++DFG+AR
Sbjct: 90 DRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLAR 146
Query: 353 IFGGNQNESNTSKVVGTYGYMAPEYALG-GVISVKSDVFSFGVLLLEIISGK 403
FG T VV T Y APE LG S D++S G + E++S +
Sbjct: 147 SFGS-PVRPYTHYVV-TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 38/92 (41%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I+RG+ YL E +K+ HRDL A NVL+ KISDFG++R + SK
Sbjct: 136 ISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIP 192
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+MA E + + +SDV+SFGVLL EI++
Sbjct: 193 VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 48/162 (29%), Positives = 68/162 (41%), Gaps = 29/162 (17%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+ + YL + HRDL A N L+ + K+SDFG+AR +Q S+ GT
Sbjct: 109 VCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GT 161
Query: 370 ---YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWC 426
+ PE S KSDV+SFGVL+ E+ S K + Y + +
Sbjct: 162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK-------------MPY--ERFS 206
Query: 427 NGEALE--LMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRP 466
N E +E L + +A + I C E P DRP
Sbjct: 207 NSEVVESVSAGYRLYRPKLAPT--EVYTIMYSCWHEKPEDRP 246
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 40/116 (34%), Positives = 62/116 (53%), Gaps = 18/116 (15%)
Query: 303 RISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN 362
RI++ + +GL YL LK+ HRD+K SN+L++ K+ DFG++ Q ++
Sbjct: 99 RIAV--AVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVST-----QLVNS 148
Query: 363 TSKV-VGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK-------KNSGFYL 410
+K VGT YMAPE G + SDV+S G+ +E+ G+ KN G +
Sbjct: 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM 204
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 4e-12
Identities = 37/100 (37%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTS 364
S + RGL YLH + HRDLK +N+L+ + K++DFG+AR F G+ N T
Sbjct: 106 SYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTH 161
Query: 365 KVVGTYGYMAPEYALGGVI-SVKSDVFSFGVLLLEIISGK 403
+VV T Y APE G V D++S G + E++
Sbjct: 162 QVV-TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 4e-12
Identities = 32/88 (36%), Positives = 44/88 (50%), Gaps = 6/88 (6%)
Query: 316 YLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375
YLH + +RDLK N+LLD K+ DFG A+ Q T GT Y+AP
Sbjct: 108 YLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAP 161
Query: 376 EYALGGVISVKSDVFSFGVLLLEIISGK 403
E L D +S G+LL E+++G+
Sbjct: 162 EIILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 37/93 (39%), Positives = 54/93 (58%), Gaps = 9/93 (9%)
Query: 313 GLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR--IFGGNQNESNTSKVVGTY 370
GL +LH + +RDLK NV+LD + + KI+DFGM + +FG ++ S GT
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----DNRASTFCGTP 160
Query: 371 GYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
Y+APE G + D +SFGVLL E++ G+
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 38/96 (39%), Positives = 55/96 (57%), Gaps = 9/96 (9%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR--IFGGNQNESNTSKVV 367
I GL +LH + +RDLK N+LLD + + KI+DFGM + + G ++ T
Sbjct: 105 IICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFC 157
Query: 368 GTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
GT Y+APE LG + D +SFGVLL E++ G+
Sbjct: 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 43/114 (37%), Positives = 60/114 (52%), Gaps = 3/114 (2%)
Query: 288 PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISD 347
I QL +K +S +ARG+ YL +SR + HRDL A NVL+ + KI+D
Sbjct: 121 FDITKVPEEQLSFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIAD 177
Query: 348 FGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
FG+AR TS +MAPE V + +SDV+SFG+L+ EI +
Sbjct: 178 FGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 5e-12
Identities = 39/92 (42%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+ARG+ +L SR K HRDL A N+LL KI DFG+AR + +
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+MAPE V + +SDV+SFGVLL EI S
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 5e-12
Identities = 39/97 (40%), Positives = 54/97 (55%), Gaps = 7/97 (7%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN--TSKVV 367
I RGL YLH V HRDLK SN+L++ + KI DFG+AR +++E T VV
Sbjct: 112 ILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 368 GTYGYMAPEYALGGVISVKS-DVFSFGVLLLEIISGK 403
T Y APE L K+ D++S G + E+++ K
Sbjct: 169 -TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 33/92 (35%), Positives = 57/92 (61%), Gaps = 4/92 (4%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
IA G+ ++ + + + HRDL+A+N+L+ + KI+DFG+AR+ N+ +
Sbjct: 111 IAEGMAFIEQRNYI---HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-P 166
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+ APE G ++KSDV+SFG+LL+EI++
Sbjct: 167 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 36/99 (36%), Positives = 59/99 (59%), Gaps = 5/99 (5%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTS 364
+++ I +GL YLH + ++ HRD+KA+NVLL + + K++DFG+A Q + NT
Sbjct: 105 TMLKEILKGLDYLHSEKKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT- 160
Query: 365 KVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
VGT +MAPE K+D++S G+ +E+ G+
Sbjct: 161 -FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 38/101 (37%), Positives = 61/101 (60%), Gaps = 8/101 (7%)
Query: 303 RISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN 362
++SI + +GL YL E + K+ HRD+K SN+L++ K+ DFG++ G +S
Sbjct: 107 KVSI--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSM 158
Query: 363 TSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
+ VGT YM+PE G SV+SD++S G+ L+E+ G+
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-12
Identities = 51/203 (25%), Positives = 79/203 (38%), Gaps = 52/203 (25%)
Query: 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354
R +LD ++ + + I +G+ YL + HRDL N+L++ E KI DFG+ ++
Sbjct: 102 RERLDHRKLLLYASQICKGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158
Query: 355 GGNQN-----ESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-------- 401
++ E S + + APE SV SDV+SFGV+L E+ +
Sbjct: 159 PQDKEYYKVREPGESPIF----WYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSP 214
Query: 402 --------GKKNSGFYLSEHGQSLLAYTWKL----WCNGEALELMDPVLKQSCMAAELLK 449
G G + H LL +L C E +M
Sbjct: 215 PAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIM--------------- 259
Query: 450 CIHIGLLCVQEDPADRPNMSSVA 472
C DP+ RP+ S +A
Sbjct: 260 -----KECWNNDPSQRPSFSELA 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 38/106 (35%), Positives = 59/106 (55%), Gaps = 5/106 (4%)
Query: 298 LDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGN 357
LD + +I+ I +GL YLH + ++ HRD+KA+NVLL K++DFG+A
Sbjct: 98 LDETQIATILREILKGLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154
Query: 358 QNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
Q + N VGT +MAPE K+D++S G+ +E+ G+
Sbjct: 155 QIKRN--TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 39/112 (34%), Positives = 56/112 (50%), Gaps = 3/112 (2%)
Query: 290 IYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFG 349
+ R + L + +S +A+G+ +L + HRDL A NVLL H KI DFG
Sbjct: 130 LRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFG 186
Query: 350 MARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+AR + N +MAPE V + +SDV+S+G+LL EI S
Sbjct: 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 49/175 (28%), Positives = 76/175 (43%), Gaps = 36/175 (20%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR-IFGGNQNESNTSKVVG 368
IA G++YL + HRDL N L+ +++ KI DFGM+R ++ ++ +V G
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVY-----TTDYYRVGG 182
Query: 369 T----YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKL 424
+M PE + + +SDV+SFGV+L EI + K + LS
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS------------- 229
Query: 425 WCNGEALELMDPVLKQSCMAAELLKC----IHIGLLCVQEDPADRPNMSSVAVML 475
N E +E + Q + C I L C + DP R N+ + L
Sbjct: 230 --NEEVIE----CITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 39/98 (39%), Positives = 55/98 (56%), Gaps = 9/98 (9%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKV--- 366
I RGL Y+H + V HRDLK SN+LL+ + KI DFG+ARI + +T +
Sbjct: 115 ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLTEY 169
Query: 367 VGTYGYMAPEYALGGVISVKS-DVFSFGVLLLEIISGK 403
V T Y APE L K+ D++S G +L E++S +
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 38/97 (39%), Positives = 52/97 (53%), Gaps = 8/97 (8%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+ L YL E+ LK+ HRD+K SN+LLD N K+ DFG I G + ++ G
Sbjct: 116 TVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFG---ISGQLVDSIAKTRDAGC 170
Query: 370 YGYMAPEYALGGVIS---VKSDVFSFGVLLLEIISGK 403
YMAPE V+SDV+S G+ L E+ +GK
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 36/92 (39%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+A G+ YL K+ HRDL A N+L+ + K+SDFG+AR+ + SK+
Sbjct: 109 VAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKL--P 160
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+ APE S KSDV+S+GVLL E+ S
Sbjct: 161 VKWTAPEALKHKKFSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 40/105 (38%), Positives = 56/105 (53%), Gaps = 3/105 (2%)
Query: 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGG 356
Q+ +K +S +ARG+ YL + K HRDL A NVL+ KI+DFG+AR
Sbjct: 133 QMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNN 189
Query: 357 NQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
T+ +MAPE V + +SDV+SFGVL+ EI +
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 37/93 (39%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I L++LH+ + +RDLK NVLLDHE + K++DFGM + G N TS GT
Sbjct: 105 ITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGT 159
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISG 402
Y+APE + D ++ GVLL E++ G
Sbjct: 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 34/103 (33%), Positives = 61/103 (59%), Gaps = 7/103 (6%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGN----QNE 360
+ + I +GL YLH +R + HRD+K +N+L+D++ KISDFG+++ N +
Sbjct: 110 NFVRQILKGLNYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTN 166
Query: 361 SNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
+ G+ +MAPE + K+D++S G L++E+++GK
Sbjct: 167 GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 29/77 (37%), Positives = 43/77 (55%), Gaps = 12/77 (15%)
Query: 313 GLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF---------GGNQNESNT 363
G+ YLHE+ + HRD+KA+N+L+D++ KI+DFG+AR + GG
Sbjct: 127 GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183
Query: 364 SKVVGTYGYMAPEYALG 380
+ +V T Y PE LG
Sbjct: 184 TNLVVTRWYRPPELLLG 200
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 40/104 (38%), Positives = 53/104 (50%), Gaps = 3/104 (2%)
Query: 298 LDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGN 357
LD + I IA G+ YL S HRDL A N L+ + KISDFG++R
Sbjct: 121 LDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177
Query: 358 QNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
SK + +M PE L G + +SD++SFGV+L EI S
Sbjct: 178 DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 44/162 (27%), Positives = 75/162 (46%), Gaps = 18/162 (11%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+ L ++H ++ HRD+K +NV + K+ D G+ R F +++ +VGT
Sbjct: 115 LCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGE 429
YM+PE + KSD++S G LL E+ + + S FY + +L + K+ +
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDK--MNLYSLCKKI-EKCD 224
Query: 430 ALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSV 471
P L + EL + C+ DP RP++S V
Sbjct: 225 Y-----PPLPADHYSEELRDLVSR---CINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 47/155 (30%), Positives = 68/155 (43%), Gaps = 31/155 (20%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
+R + + + + + G+ YL + V HRDL A N L+ K+SDFGM R
Sbjct: 92 AQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTR 148
Query: 353 IFGGNQNESNTSKVVGT---YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKK----- 404
+Q S+T GT + +PE S KSDV+SFGVL+ E+ S K
Sbjct: 149 FVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204
Query: 405 ----------NSGFYL------SEHGQSLLAYTWK 423
N+GF L S+ L+ + WK
Sbjct: 205 RSNSEVVETINAGFRLYKPRLASQSVYELMQHCWK 239
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 37/95 (38%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I RGL Y+H V HRDLK SN+L++ + KI DFG+ARI + + V T
Sbjct: 117 ILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVST 168
Query: 370 YGYMAPEYALG-GVISVKSDVFSFGVLLLEIISGK 403
Y APE L V+ D++S G + E++ GK
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 30/71 (42%), Positives = 44/71 (61%), Gaps = 7/71 (9%)
Query: 313 GLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN---TSKVVGT 369
GL Y+H R K+ HRD+KA+N+L+ + K++DFG+AR F ++N T++VV T
Sbjct: 131 GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-T 186
Query: 370 YGYMAPEYALG 380
Y PE LG
Sbjct: 187 LWYRPPELLLG 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 42/105 (40%), Positives = 57/105 (54%), Gaps = 3/105 (2%)
Query: 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGG 356
QL +K +S +ARG+ YL + K HRDL A NVL+ + KI+DFG+AR
Sbjct: 130 QLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHN 186
Query: 357 NQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
T+ +MAPE V + +SDV+SFGVLL EI +
Sbjct: 187 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 4/95 (4%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA-RIFGGNQNESNTSKVVG 368
I G+ YLH + + HRD+K +N+L D N K+ DFG + R+ + + V G
Sbjct: 113 ILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTG 169
Query: 369 TYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
T +M+PE G K+DV+S G ++E+++ K
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-11
Identities = 45/164 (27%), Positives = 67/164 (40%), Gaps = 24/164 (14%)
Query: 311 ARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTY 370
A G+ YL +S+ HRDL A N L+ KISDFGM+R G +
Sbjct: 103 AAGMEYL--ESK-NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI 159
Query: 371 GYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEA 430
+ APE G + +SDV+S+G+LL E S Y N +
Sbjct: 160 KWTAPEALNYGRYTSESDVWSYGILLWETFSL--GDTPYPG-------------MSNQQT 204
Query: 431 LELMDPVLKQSC---MAAELLKCIHIGLLCVQEDPADRPNMSSV 471
E ++ + E+ + + L C DP +RP+ S +
Sbjct: 205 RERIESGYRMPAPQLCPEEIYR---LMLQCWAYDPENRPSFSEI 245
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 31/97 (31%), Positives = 52/97 (53%), Gaps = 15/97 (15%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371
+G+ Y+H + HRDLK +N+L+ + KI+DFG+AR+F + + + V T
Sbjct: 110 KGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRW 165
Query: 372 YMAPEYALG------GVISVKSDVFSFGVLLLEIISG 402
Y APE G GV D+++ G + E+++G
Sbjct: 166 YRAPELLYGARKYDPGV-----DLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 4e-11
Identities = 40/108 (37%), Positives = 57/108 (52%), Gaps = 19/108 (17%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
I+ + + L Y+H S V HRDLK SN+LL+ + K++DFG+AR E+ +
Sbjct: 112 IMYQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL-SELEENPENP 167
Query: 366 V----VGTYGYMAPEYALG------GVISVKSDVFSFGVLLLEIISGK 403
V V T Y APE LG GV D++S G +L E++ GK
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRYTKGV-----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 38/100 (38%), Positives = 57/100 (57%), Gaps = 6/100 (6%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTS 364
S + + +G+ Y H S +V HRDLK N+L+D E K++DFG+AR F G + T
Sbjct: 103 SYLYQLLQGIAYCH--SH-RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTH 158
Query: 365 KVVGTYGYMAPEYALGG-VISVKSDVFSFGVLLLEIISGK 403
+VV T Y APE LG S D++S G + E+++ +
Sbjct: 159 EVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 35/93 (37%), Positives = 58/93 (62%), Gaps = 6/93 (6%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371
+G+ + HE+ +V HRDLK N+L++ K++DFG+AR FG N + +++VV T
Sbjct: 111 KGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TFSNEVV-TLW 165
Query: 372 YMAPEYALGG-VISVKSDVFSFGVLLLEIISGK 403
Y AP+ LG S D++S G ++ E+I+G+
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 6e-11
Identities = 57/189 (30%), Positives = 82/189 (43%), Gaps = 37/189 (19%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP----KISDFG 349
R + L K + +A+G YL E+ HRD+ A N LL + P KI+DFG
Sbjct: 109 RPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFG 164
Query: 350 MAR-IFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGF 408
MAR I+ + + + +M PE L G+ + K+DV+SFGVLL EI S
Sbjct: 165 MARDIYRASYYRKG-GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS------- 216
Query: 409 YLSEHGQSLLAYTWKLWCNGEALEL------MDPVLKQSCMAAELLKCIHIGLLCVQEDP 462
+ Y + N E +E +DP + C I C Q P
Sbjct: 217 ------LGYMPYPGR--TNQEVMEFVTGGGRLDP--PKGCPGP----VYRIMTDCWQHTP 262
Query: 463 ADRPNMSSV 471
DRPN +++
Sbjct: 263 EDRPNFATI 271
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 45/112 (40%), Positives = 59/112 (52%), Gaps = 19/112 (16%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+A+G+ +L + HRD+ A NVLL KI DFG+AR N+SN V G
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI---MNDSNYV-VKGN 273
Query: 370 ----YGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKK-------NSGFY 409
+MAPE V +V+SDV+S+G+LL EI S GK NS FY
Sbjct: 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY 325
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 54/173 (31%), Positives = 79/173 (45%), Gaps = 35/173 (20%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+ARG+ YL S+ + HRDL A N+L+ KI+DFG++R E K +G
Sbjct: 133 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGR 184
Query: 370 YG--YMAPEYALGGVISVKSDVFSFGVLLLEIIS--GKKNSGFYLSEHGQSL-LAYTWK- 423
+MA E V + SDV+S+GVLL EI+S G G +E + L Y +
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 244
Query: 424 -LWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVML 475
L C+ E +LM C +E P +RP+ + + V L
Sbjct: 245 PLNCDDEVYDLMRQ--------------------CWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 41/105 (39%), Positives = 57/105 (54%), Gaps = 3/105 (2%)
Query: 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGG 356
QL +K +S +ARG+ YL + K HRDL A NVL+ + KI+DFG+AR
Sbjct: 136 QLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 192
Query: 357 NQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
T+ +MAPE + + +SDV+SFGVLL EI +
Sbjct: 193 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-11
Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 30/218 (13%)
Query: 259 FLSPPSPGSVTSSKGKGRKAIWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLH 318
FL SP + S A L ++ I +A G+ YL
Sbjct: 98 FLRHRSPRAQCSLSHSTSSA----------RKCGLNPLPLSCTEQLCIAKQVAAGMAYLS 147
Query: 319 EDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR-IFGGNQNESNTSKVVGTYGYMAPEY 377
E K HRDL N L+ M KI+DFG++R I+ + +++ + + +M PE
Sbjct: 148 ER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR-WMPPES 203
Query: 378 ALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPV 437
+ +SDV+++GV+L EI S + ++ + ++ Y +G L
Sbjct: 204 IFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH--EEVIYYVR----DGNVL------ 251
Query: 438 LKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVML 475
SC L+ ++ LC + P+DRP+ +S+ +L
Sbjct: 252 ---SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 7e-11
Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 25/168 (14%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I GL YLH+ HRD+K +N+L+D K++DFGMA+ S G+
Sbjct: 111 ILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF---SFAKSFKGS 164
Query: 370 YGYMAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNG 428
+MAPE G + +D++S G +LE+ +GK +A +K+ +
Sbjct: 165 PYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKP------PWSQLEGVAAVFKIGRSK 218
Query: 429 EALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLA 476
E + D + S A + + L C+Q DP+ RP + A +L
Sbjct: 219 ELPPIPDHL---SDEAKDFI------LKCLQRDPSLRP---TAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 8e-11
Identities = 34/98 (34%), Positives = 51/98 (52%), Gaps = 18/98 (18%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+ L YLH L + +RDLK N+LLD + KI+DFG A+ G T + GT
Sbjct: 110 VVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLCGT 161
Query: 370 YGYMAPEYALGGVISVK-----SDVFSFGVLLLEIISG 402
Y+APE +I K D ++ G+L+ E+++G
Sbjct: 162 PEYLAPE-----IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 39/92 (42%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+ARG+ +L SR K HRDL A N+LL KI DFG+AR + +
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+MAPE V + +SDV+SFGVLL EI S
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 9e-11
Identities = 38/96 (39%), Positives = 50/96 (52%), Gaps = 11/96 (11%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
IA G+ YL L HRDL N L+ KI+DFGM+R N S+ +V G
Sbjct: 139 IASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR----NLYSSDYYRVQGR 191
Query: 370 ----YGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+MA E L G + KSDV++FGV L EI++
Sbjct: 192 APLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 9e-11
Identities = 35/106 (33%), Positives = 52/106 (49%), Gaps = 15/106 (14%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP----KISDFGMARIFGGNQNE 360
S++ I G+ YLH + V HRDLK +N+L+ E KI D G+AR+F
Sbjct: 112 SLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLF---NAP 165
Query: 361 SNTS----KVVGTYGYMAPEYALGGVISVKS-DVFSFGVLLLEIIS 401
VV T Y APE LG K+ D+++ G + E+++
Sbjct: 166 LKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 37/99 (37%), Positives = 51/99 (51%), Gaps = 3/99 (3%)
Query: 301 KRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE 360
K+ I + IA G+ YL+ + K HRDL A N ++ + KI DFGM R
Sbjct: 119 KKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 175
Query: 361 SNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEI 399
K + +M+PE GV + SDV+SFGV+L EI
Sbjct: 176 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 55/175 (31%), Positives = 82/175 (46%), Gaps = 37/175 (21%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+A G+ YL E + HRDL A NVL+ + KI+DFG++R E K +G
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYVKKTMGR 179
Query: 370 YG--YMAPEYALGGVISVKSDVFSFGVLLLEIIS--GKKNSGFYLSEHGQSLLAYTWKLW 425
+MA E V + KSDV+SFGVLL EI+S G G +E + L +++
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGYRME 238
Query: 426 ----CNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLA 476
C+ E ELM +Q C ++ P +RP + ++V L+
Sbjct: 239 KPRNCDDEVYELM----RQ----------------CWRDRPYERPPFAQISVQLS 273
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 41/115 (35%), Positives = 59/115 (51%), Gaps = 8/115 (6%)
Query: 290 IYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFG 349
IY A + R + I GL LH++ ++ +RDLK N+LLD + +ISD G
Sbjct: 91 IYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLG 147
Query: 350 MARIFGGNQNESNTSK-VVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
+A + E T K VGT GYMAPE + D ++ G LL E+I+G+
Sbjct: 148 LAV----HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 49/173 (28%), Positives = 80/173 (46%), Gaps = 32/173 (18%)
Query: 304 ISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE-MNPKISDFGMA-----RIFGGN 357
I+ + RGL YLHE+ ++ HRD+K +N+L+D +I+DFG A + G
Sbjct: 106 INYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAG 162
Query: 358 QNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFY-LSEHGQS 416
+ + +++GT +MAPE G DV+S G +++E+ + K S H
Sbjct: 163 EFQG---QLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH--- 216
Query: 417 LLAYTWKLWCNGEA---LELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRP 466
LA +K+ A E + P L+ + L C++ P DRP
Sbjct: 217 -LALIFKIASATTAPSIPEHLSPGLRD------------VTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 35/94 (37%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I+ L +LHE + +RDLK NVLLD E + K++D+GM + G + TS GT
Sbjct: 105 ISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGT 159
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
Y+APE G D ++ GVL+ E+++G+
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 35/98 (35%), Positives = 51/98 (52%), Gaps = 6/98 (6%)
Query: 307 INGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKV 366
I I L +LH+ L + +RD+K N+LLD E + ++DFG+++ F E
Sbjct: 111 IAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-EEERAYSF 166
Query: 367 VGTYGYMAPEYALGGVISVKS--DVFSFGVLLLEIISG 402
GT YMAPE GG D +S GVL E+++G
Sbjct: 167 CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 51/164 (31%), Positives = 70/164 (42%), Gaps = 21/164 (12%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+A+G+ +L SR K HRDL A N+LL KI DFG+AR + +
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIIS--GKKNSGFYLSEHGQSLLAYTWKLWCN 427
+MAPE V +++SDV+SFGVLL EI S G + E L
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK-------- 296
Query: 428 GEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSV 471
E + P M +L C H +P+ RP S +
Sbjct: 297 -EGTRMRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSEL 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 38/101 (37%), Positives = 51/101 (50%), Gaps = 3/101 (2%)
Query: 301 KRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE 360
+ I + IA G+ YL+ K HRDL A N ++ H+ KI DFGM R
Sbjct: 119 QEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY 175
Query: 361 SNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
K + +MAPE GV + SD++SFGV+L EI S
Sbjct: 176 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+A L +LH L + +RDLK N+LLD E + K++DFG+++ +E GT
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGT 161
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISG 402
YMAPE + +D +SFGVL+ E+++G
Sbjct: 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 37/100 (37%), Positives = 58/100 (58%), Gaps = 5/100 (5%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
IA+G++YL E ++ HRDL A NVL+ + KI+DFG+AR+ G++ E N
Sbjct: 118 IAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP 174
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIIS--GKKNSG 407
+MA E + +SDV+S+GV + E+++ GK G
Sbjct: 175 IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 39/122 (31%), Positives = 60/122 (49%), Gaps = 8/122 (6%)
Query: 280 WIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH 339
++A G+ + + S R+ L + + + YL ++ HRDL A NVL+
Sbjct: 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSE 137
Query: 340 EMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEI 399
+ K+SDFG+ + Q +T K+ + APE S KSDV+SFG+LL EI
Sbjct: 138 DNVAKVSDFGLTKEASSTQ---DTGKL--PVKWTAPEALREKKFSTKSDVWSFGILLWEI 192
Query: 400 IS 401
S
Sbjct: 193 YS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 40/96 (41%), Positives = 55/96 (57%), Gaps = 7/96 (7%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP-KISDFGMARIFGGNQNESNTSKVVG 368
I RG+ Y H S +V HRDLK N+L+D N K++DFG+AR F G + T +VV
Sbjct: 111 ILRGIAYCH--SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV- 165
Query: 369 TYGYMAPEYALGG-VISVKSDVFSFGVLLLEIISGK 403
T Y APE LG S D++S G + E+++ K
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 56/182 (30%), Positives = 84/182 (46%), Gaps = 27/182 (14%)
Query: 301 KRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE 360
K +++ ++ G+ YL E + HRDL A NVLL + KISDFG+++ G ++N
Sbjct: 95 KNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151
Query: 361 SNTSKVVGTY--GYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSL 417
+K G + + APE S KSDV+SFGVL+ E S G+K Y G +
Sbjct: 152 YK-AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP---YKGMKGNEV 207
Query: 418 LAYTWKLWCNGEALELMDPVLKQSCMAA--ELLKCIHIGLLCVQEDPADRPNMSSVAVML 475
+GE +E Q C +L+K LC +RP + V + L
Sbjct: 208 TQMIE----SGERME-----CPQRCPPEMYDLMK------LCWTYGVDERPGFAVVELRL 252
Query: 476 AS 477
+
Sbjct: 253 RN 254
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 36/105 (34%), Positives = 57/105 (54%), Gaps = 11/105 (10%)
Query: 298 LDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGN 357
DW ++ I + G+ LH+ + HRD+K N+L+D + K++DFG++R G
Sbjct: 96 EDWAKQY--IAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GL 148
Query: 358 QNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISG 402
+N+ K VGT Y+APE LG SD +S G ++ E + G
Sbjct: 149 ENK----KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 43/142 (30%), Positives = 63/142 (44%), Gaps = 6/142 (4%)
Query: 263 PSPGSVTSSKGKGRKAIWIAIGT---TIPTIYSTRRAQLDWKRRISIINGIARGLLYLHE 319
P V +K R+++ I LD + +S +A+G+ +L
Sbjct: 173 PGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS 232
Query: 320 DSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYAL 379
+ HRDL A N+LL H KI DFG+AR + N +MAPE
Sbjct: 233 KN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIF 289
Query: 380 GGVISVKSDVFSFGVLLLEIIS 401
V + +SDV+S+G+LL EI S
Sbjct: 290 NCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 5/95 (5%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I RGL YLH + HRD+K N+L++ KI DFG+AR+ ++++ T +VV
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 370 YGYMAPEYALGGV-ISVKSDVFSFGVLLLEIISGK 403
Y Y APE +G + D++S G + E++ +
Sbjct: 169 Y-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 38/115 (33%), Positives = 58/115 (50%), Gaps = 3/115 (2%)
Query: 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGG 356
QL + ++I + IA G++YL + L HRDL N L+ + KI DFGM+R
Sbjct: 118 QLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 174
Query: 357 NQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLS 411
+ + +M PE L + +SD++SFGV+L EI + K + LS
Sbjct: 175 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS 229
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 48/155 (30%), Positives = 78/155 (50%), Gaps = 18/155 (11%)
Query: 318 HEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEY 377
H SR +V HRD+K +NV + K+ D G+ R F +++ +VGT YM+PE
Sbjct: 121 HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177
Query: 378 ALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMD-P 436
+ KSD++S G LL E+ + + S FY G + Y+ C + +E D P
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQ--SPFY----GDKMNLYS---LC--KKIEQCDYP 226
Query: 437 VLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSV 471
L + EL + ++ +C+ DP RP+++ V
Sbjct: 227 PLPSDHYSEELRQLVN---MCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I+ L YLHE + +RDLK NVLLD E + K++D+GM + G + TS GT
Sbjct: 105 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGT 159
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
Y+APE G D ++ GVL+ E+++G+
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 4e-10
Identities = 53/174 (30%), Positives = 79/174 (45%), Gaps = 37/174 (21%)
Query: 311 ARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTY 370
ARG+ YL + + HRDL A N+L+ KI+DFG++R E K +G
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRL 173
Query: 371 G--YMAPEYALGGVISVKSDVFSFGVLLLEIIS--GKKNSGFYLSEHGQSLLAYTWKLW- 425
+MA E V + SDV+S+GVLL EI+S G G +E + L ++L
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGYRLEK 232
Query: 426 ---CNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLA 476
C+ E +LM +Q C +E P +RP+ + + V L
Sbjct: 233 PLNCDDEVYDLM----RQ----------------CWREKPYERPSFAQILVSLN 266
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 4e-10
Identities = 38/94 (40%), Positives = 55/94 (58%), Gaps = 8/94 (8%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I GL ++H +R V +RDLK +N+LLD + +ISD G+A F + ++ VGT
Sbjct: 106 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 158
Query: 370 YGYMAPEYALGGVISVKS-DVFSFGVLLLEIISG 402
+GYMAPE GV S D FS G +L +++ G
Sbjct: 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 40/102 (39%), Positives = 55/102 (53%), Gaps = 6/102 (5%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGN--QNESN 362
S I I GL Y+H + V HRDLK N+L++ + KI DFG+AR F N +N
Sbjct: 109 SFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF 165
Query: 363 TSKVVGTYGYMAPEYALGGVISVKS-DVFSFGVLLLEIISGK 403
++ V T Y APE L K+ DV+S G +L E++ K
Sbjct: 166 MTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 35/92 (38%), Positives = 57/92 (61%), Gaps = 3/92 (3%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
IA+G+ YL E+ RL HRDL A NVL+ + KI+DFG+A++ G ++ E +
Sbjct: 118 IAKGMNYL-EERRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+MA E L + + +SDV+S+GV + E+++
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-10
Identities = 37/98 (37%), Positives = 53/98 (54%), Gaps = 10/98 (10%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLD-HEMNPKISDFGMA-RIFGGNQNESNTSKVV 367
I GL YLH+ ++ HRD+K NVL++ + KISDFG + R+ G N T
Sbjct: 117 ILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN---PCTETFT 170
Query: 368 GTYGYMAPEYALGGV--ISVKSDVFSFGVLLLEIISGK 403
GT YMAPE G +D++S G ++E+ +GK
Sbjct: 171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 39/108 (36%), Positives = 59/108 (54%), Gaps = 6/108 (5%)
Query: 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGG 356
+D + S + I +G+L+ H +V HRDLK N+L+D++ K++DFG+AR F G
Sbjct: 97 YMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-G 152
Query: 357 NQNESNTSKVVGTYGYMAPEYALGGV-ISVKSDVFSFGVLLLEIISGK 403
T +VV T Y APE LG S D++S G + E+ + K
Sbjct: 153 IPVRVYTHEVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 7e-10
Identities = 38/137 (27%), Positives = 62/137 (45%), Gaps = 32/137 (23%)
Query: 281 IAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE 340
+A T++ +SI + I + Y+H S+ V HRDLK N+LL
Sbjct: 106 LAEKTSVGAF-------------LSIFHKICATIEYVH--SK-GVLHRDLKPDNILLGLF 149
Query: 341 MNPKISDFGMARIFGGNQNE-------------SNTS---KVVGTYGYMAPEYALGGVIS 384
I D+G A + + S+ + K+VGT YMAPE LG S
Sbjct: 150 GEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPAS 209
Query: 385 VKSDVFSFGVLLLEIIS 401
+D+++ GV+L ++++
Sbjct: 210 ESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 7e-10
Identities = 30/113 (26%), Positives = 50/113 (44%), Gaps = 6/113 (5%)
Query: 289 TIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDF 348
T + R L + + I I GL YLH ++ HRD+K N+ ++ I D
Sbjct: 145 TYLTKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDL 201
Query: 349 GMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
G A+ + GT APE + K+D++S G++L E+++
Sbjct: 202 GAAQF---PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 38/95 (40%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKV-VG 368
IA GL +LH + +RDLK NV+LD E + KI+DFGM + N + T+K G
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCG 163
Query: 369 TYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
T Y+APE D ++FGVLL E+++G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 36/116 (31%), Positives = 61/116 (52%), Gaps = 14/116 (12%)
Query: 304 ISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNT 363
+ ++ GIA G+ YL S + HRDL A N+L++ + K+SDFG++R+ E +
Sbjct: 110 VGMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL-----EDDP 161
Query: 364 SKVVGTYG------YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH 413
T G + APE + SDV+SFG+++ E++S + + +S H
Sbjct: 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 7e-10
Identities = 36/94 (38%), Positives = 50/94 (53%), Gaps = 5/94 (5%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
IA L YLHE + HRDLK NV L K+ D G+AR+ NQ + S ++GT
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDM-ASTLIGT 165
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
YM+PE + KSDV++ G + E+ + K
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 9e-10
Identities = 30/99 (30%), Positives = 45/99 (45%), Gaps = 5/99 (5%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTS 364
S I + + + Y H + HRD+K N+L+ K+ DFG AR T
Sbjct: 104 SYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160
Query: 365 KVVGTYGYMAPEYALGGVISVKS-DVFSFGVLLLEIISG 402
V T Y APE +G K DV++ G ++ E++ G
Sbjct: 161 YVA-TRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 2/93 (2%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
A L L + V +RDLK N+LLD++ + + DFG+ ++ + +++NT GT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISG 402
Y+APE LG + D ++ GVLL E+++G
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 36/98 (36%), Positives = 50/98 (51%), Gaps = 3/98 (3%)
Query: 304 ISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNT 363
+S +ARG+ +L + HRDL A NVLL KI DFG+AR + N +
Sbjct: 240 LSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK 296
Query: 364 SKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+MAPE + + SDV+S+G+LL EI S
Sbjct: 297 GSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 36/99 (36%), Positives = 51/99 (51%), Gaps = 14/99 (14%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+ RGL Y+H + V HRDLK SN+LL+ + KI DFG+AR ++ ++ V T
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVT 171
Query: 370 YGYMAPEYAL-----GGVISVKSDVFSFGVLLLEIISGK 403
Y APE L I DV+S G + E++ K
Sbjct: 172 RWYRAPELLLNCSEYTTAI----DVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 33/104 (31%), Positives = 56/104 (53%), Gaps = 14/104 (13%)
Query: 304 ISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNT 363
+ ++ GIA G+ YL S + HRDL A N+L++ + K+SDFG++R+ E +
Sbjct: 109 VGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL-----EDDP 160
Query: 364 SKVVGTYG------YMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
T G + APE + SDV+S+G+++ E++S
Sbjct: 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 39/114 (34%), Positives = 54/114 (47%), Gaps = 6/114 (5%)
Query: 290 IYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFG 349
IY+ D +R + I GL LH R ++ +RDLK N+LLD + +ISD G
Sbjct: 91 IYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLG 147
Query: 350 MARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
+A + VGT GYMAPE + D + G L+ E+I GK
Sbjct: 148 LAVEIPEGETIRGR---VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKV-VG 368
I+ GL +LH + +RDLK NV+LD E + KI+DFGM + + + T++ G
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCG 163
Query: 369 TYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
T Y+APE D +++GVLL E+++G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 1e-09
Identities = 36/103 (34%), Positives = 60/103 (58%), Gaps = 10/103 (9%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGM-ARIFGGNQNESNTSKVVGTY 370
+ L +LH + +V HRD+K+ NVLL + + K++DFG A+I +S S +VGT
Sbjct: 126 QALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTP 179
Query: 371 GYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH 413
+MAPE K D++S G++ +E++ G+ YL+E+
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP---YLNEN 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
++ + RG+ +LH ++ HRDLK N+L+ + KI+DFG+ARI+ E +
Sbjct: 112 LMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS---FEMALTS 165
Query: 366 VVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEI 399
VV T Y APE L + D++S G + E+
Sbjct: 166 VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 33/92 (35%), Positives = 55/92 (59%), Gaps = 3/92 (3%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
IA+G+ YL E +++ HRDL A NVL+ + KI+DFG+AR+ ++ E +
Sbjct: 118 IAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP 174
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+MA E L + +SDV+S+GV + E+++
Sbjct: 175 IKWMALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 37/111 (33%), Positives = 55/111 (49%), Gaps = 4/111 (3%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
R+ +L +S+ + G+ YL +S + HRDL A N L+ K+SDFGM R
Sbjct: 93 RQGKLSKDMLLSMCQDVCEGMEYLERNSFI---HRDLAARNCLVSSTGVVKVSDFGMTRY 149
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKK 404
++ S +S + PE S KSDV+SFGVL+ E+ + K
Sbjct: 150 VLDDEYTS-SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 51/180 (28%), Positives = 74/180 (41%), Gaps = 40/180 (22%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTS---KV 366
IA G+ YL E R HRDL A N+LL + KI DFG+ R N++ KV
Sbjct: 106 IANGMRYL-ESKRF--IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV 162
Query: 367 VGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWC 426
+ + APE S SDV+ FGV L E+ + +G+ W
Sbjct: 163 --PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT-----------YGEE----PW-AGL 204
Query: 427 NG-EALELMDPVLKQSCMAAELL--------KCIHIGLLCVQEDPADRPNMSSVAVMLAS 477
+G + L+ +D E L ++ L C +PADRP +++ L
Sbjct: 205 SGSQILKKIDK-------EGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 2e-09
Identities = 36/103 (34%), Positives = 60/103 (58%), Gaps = 10/103 (9%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGM-ARIFGGNQNESNTSKVVGTY 370
+ L +LH + +V HRD+K+ N+LL + + K++DFG A+I +S S +VGT
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTP 180
Query: 371 GYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH 413
+MAPE K D++S G++ +E+I G+ YL+E+
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP---YLNEN 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 33/102 (32%), Positives = 59/102 (57%), Gaps = 8/102 (7%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371
+ L +LH + +V HRD+K+ N+LL + + K++DFG Q++ +T +VGT
Sbjct: 126 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPY 180
Query: 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH 413
+MAPE K D++S G++ +E++ G+ YL+E+
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP---YLNEN 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
++ I RGL Y+H + HRDLK SN+ ++ + KI DFG+AR + +
Sbjct: 123 LVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTG 174
Query: 366 VVGTYGYMAPEYALGGVISVKS-DVFSFGVLLLEIISGK 403
V T Y APE L + ++ D++S G ++ E+++GK
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 36/127 (28%), Positives = 67/127 (52%), Gaps = 7/127 (5%)
Query: 281 IAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE 340
+A G + S ++ ++ + +++ ++ G+ YL + HRDL A NVLL ++
Sbjct: 75 MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQ 131
Query: 341 MNPKISDFGMARIFGGNQNESNTSKVVGTY--GYMAPEYALGGVISVKSDVFSFGVLLLE 398
KISDFG+++ G + + ++ G + + APE S +SDV+S+G+ + E
Sbjct: 132 HYAKISDFGLSKALGADDSYY-KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWE 190
Query: 399 IIS-GKK 404
S G+K
Sbjct: 191 AFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNT--SKVV 367
+ RGL Y+H V HRDLK SN+L++ + +I DFGMAR + E ++ V
Sbjct: 116 LLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 368 GTYGYMAPEYALG-GVISVKSDVFSFGVLLLEII 400
T Y APE L + D++S G + E++
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 36/94 (38%), Positives = 54/94 (57%), Gaps = 8/94 (8%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I GL ++H +R V +RDLK +N+LLD + +ISD G+A F + ++ VGT
Sbjct: 106 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 158
Query: 370 YGYMAPE-YALGGVISVKSDVFSFGVLLLEIISG 402
+GYMAPE G +D FS G +L +++ G
Sbjct: 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 46/182 (25%), Positives = 85/182 (46%), Gaps = 10/182 (5%)
Query: 298 LDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGN 357
L W+RR I GIA+ L +LH V +L +++D + P + + + +
Sbjct: 777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD 835
Query: 358 QNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSL 417
+S Y+APE I+ KSD++ FG++L+E+++GK + HG S+
Sbjct: 836 TKCFISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SI 888
Query: 418 LAYTWKLWCNGEALELMDPVLKQ--SCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVML 475
+ + + + +DP ++ S E+++ +++ L C DP RP + V L
Sbjct: 889 VEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
Query: 476 AS 477
S
Sbjct: 949 ES 950
|
Length = 968 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 34/91 (37%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 313 GLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372
G+ +LH + HRDLK SN+++ + KI DFG+AR G + T VV Y Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRY-Y 183
Query: 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
APE LG D++S G ++ E+I G
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 35/98 (35%), Positives = 54/98 (55%), Gaps = 15/98 (15%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR-IFGGN-----QNESNT 363
IA G+ YLH + V H+D+ A N ++D E+ KI+D ++R +F + NE+
Sbjct: 126 IACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP 182
Query: 364 SKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
K +MA E + S SDV+SFGVLL E+++
Sbjct: 183 VK------WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 35/104 (33%), Positives = 55/104 (52%), Gaps = 12/104 (11%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
I + +GL +L E+ + HRD+K +NVL++ K+ DFG++ GN S
Sbjct: 107 ITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKT 160
Query: 366 VVGTYGYMAPEYALGG------VISVKSDVFSFGVLLLEIISGK 403
+G YMAPE G +V+SDV+S G+ +LE+ G+
Sbjct: 161 NIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 36/100 (36%), Positives = 59/100 (59%), Gaps = 5/100 (5%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTS 364
S + + GL Y H+ + L HRD+K SN+LL+++ K++DFG+AR++ ++ T+
Sbjct: 120 SFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTN 176
Query: 365 KVVGTYGYMAPEYALGGVISVKS-DVFSFGVLLLEIISGK 403
KV+ T Y PE LG + DV+S G +L E+ + K
Sbjct: 177 KVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 36/98 (36%), Positives = 53/98 (54%), Gaps = 12/98 (12%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTS 364
+I +G +GL YLH + HRD+KA N+LL K++DFG A + + +N+
Sbjct: 119 AICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASL----VSPANS- 170
Query: 365 KVVGTYGYMAPEYALG---GVISVKSDVFSFGVLLLEI 399
VGT +MAPE L G K DV+S G+ +E+
Sbjct: 171 -FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 35/90 (38%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 313 GLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372
GL YLHE+ K+ +RDLK N+LLD E KI+DFG+ + G TS GT +
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEF 167
Query: 373 MAPEYALGGVISVKSDVFSFGVLLLEIISG 402
+APE + D + GVL+ E++ G
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 34/90 (37%), Positives = 51/90 (56%), Gaps = 5/90 (5%)
Query: 314 LLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373
L++LH R V +RDLK N+LLD E + K++DFGM + G N T+ GT Y+
Sbjct: 109 LMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYI 163
Query: 374 APEYALGGVISVKSDVFSFGVLLLEIISGK 403
APE D ++ GVL+ E+++G+
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 36/108 (33%), Positives = 56/108 (51%), Gaps = 15/108 (13%)
Query: 301 KRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE 360
K ++I+ L YL E V HRD+K SN+LLD N K+ DFG++ G +
Sbjct: 118 KMTVAIVKA----LHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGIS----GRLVD 167
Query: 361 SNT-SKVVGTYGYMAPEY----ALGGVISVKSDVFSFGVLLLEIISGK 403
S ++ G YMAPE +++DV+S G+ L+E+ +G+
Sbjct: 168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 35/92 (38%), Positives = 52/92 (56%), Gaps = 6/92 (6%)
Query: 313 GLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372
GL + H +V HRDLK N+L++ E K++DFG+AR FG + T +VV T Y
Sbjct: 112 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV-TLWY 166
Query: 373 MAPEYALGG-VISVKSDVFSFGVLLLEIISGK 403
APE LG S D++S G + E+++ +
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 16/95 (16%)
Query: 313 GLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK---VVGT 369
L +LH KV HRDLKA N+LL + + K++DFG++ +N+S K +GT
Sbjct: 115 ALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSA-----KNKSTLQKRDTFIGT 166
Query: 370 YGYMAPEYALGGVIS-----VKSDVFSFGVLLLEI 399
+MAPE K+D++S G+ L+E+
Sbjct: 167 PYWMAPEVVACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I L +LH +L + +RD+K N+LLD + ++DFG+++ F ++ E S GT
Sbjct: 114 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGT 169
Query: 370 YGYMAPEYALGGVISVKS--DVFSFGVLLLEIISG 402
YMAP+ GG D +S GVL+ E+++G
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 36/97 (37%), Positives = 51/97 (52%), Gaps = 11/97 (11%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR-IFGGN----QNESNTS 364
+A+G+ YL K HRDL A N +LD K++DFG+AR I+ N +
Sbjct: 107 VAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAK 163
Query: 365 KVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
V +MA E + KSDV+SFGVLL E+++
Sbjct: 164 LPV---KWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 53/185 (28%), Positives = 80/185 (43%), Gaps = 18/185 (9%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
T ++ LD + I IA G+ YL S H+DL A N+L+ +++ KISD G++R
Sbjct: 116 TVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172
Query: 353 IFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSE 412
K + +M PE + G S SD++SFGV+L EI S F L
Sbjct: 173 EIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS------FGL-- 224
Query: 413 HGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVA 472
Q ++ N E +E++ C + + C QE P+ RP +
Sbjct: 225 --QPYYGFS-----NQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIH 277
Query: 473 VMLAS 477
L S
Sbjct: 278 TRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 37/102 (36%), Positives = 52/102 (50%), Gaps = 12/102 (11%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTS 364
+I +G +GL YLH + + HRD+KA N+LL K++DFG A S +
Sbjct: 125 AITHGALQGLAYLHSHNMI---HRDIKAGNILLTEPGQVKLADFGSASK------SSPAN 175
Query: 365 KVVGTYGYMAPEYALG---GVISVKSDVFSFGVLLLEIISGK 403
VGT +MAPE L G K DV+S G+ +E+ K
Sbjct: 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 34/94 (36%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I L +LHE + +RDLK NVLLD + + K++D+GM + G TS GT
Sbjct: 105 ICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGT 159
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
Y+APE G D ++ GVL+ E+++G+
Sbjct: 160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 32/100 (32%), Positives = 53/100 (53%), Gaps = 21/100 (21%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK---VVG 368
+ L +LH V HRD+K+ ++LL + K+SDFG F Q + +VG
Sbjct: 126 KALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG----FCA-QVSKEVPRRKSLVG 177
Query: 369 TYGYMAPEYALGGVIS-----VKSDVFSFGVLLLEIISGK 403
T +MAPE VIS + D++S G++++E++ G+
Sbjct: 178 TPYWMAPE-----VISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 36/108 (33%), Positives = 61/108 (56%), Gaps = 3/108 (2%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
R LD +R ++ IA+G+ YL E ++ HR+L A N+LL + +I+DFG+A +
Sbjct: 102 HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADL 158
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+ + S+ +MA E L G + +SDV+S+GV + E++S
Sbjct: 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 6e-09
Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 8/97 (8%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLL-----DHEMNPKISDFGMARIFGGNQNESNTS 364
+A+G +YL ++ HRDL A N L+ D + KI DFG+AR +
Sbjct: 115 VAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG 171
Query: 365 KVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+ + +MAPE L G + +SDV+SFGVL+ EI++
Sbjct: 172 EGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 7e-09
Identities = 31/101 (30%), Positives = 57/101 (56%), Gaps = 6/101 (5%)
Query: 304 ISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNT 363
+ ++ GIA G+ YL E + HRDL A N+L++ + K+SDFG++R + ++
Sbjct: 109 VGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 165
Query: 364 SKVVG---TYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+ +G + APE + SDV+S+G+++ E++S
Sbjct: 166 TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 7e-09
Identities = 35/98 (35%), Positives = 48/98 (48%), Gaps = 3/98 (3%)
Query: 304 ISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNT 363
+ + IA G+ YL S L HRDL N L+ + KI+DFGM+R
Sbjct: 141 LHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQ 197
Query: 364 SKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+ V +MA E L G + SDV++FGV L EI+
Sbjct: 198 GRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 8e-09
Identities = 35/103 (33%), Positives = 60/103 (58%), Gaps = 10/103 (9%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGM-ARIFGGNQNESNTSKVVGTY 370
+ L +LH + +V HRD+K+ N+LL + + K++DFG A+I +S S +VGT
Sbjct: 126 QALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTP 179
Query: 371 GYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH 413
+MAPE K D++S G++ +E++ G+ YL+E+
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP---YLNEN 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 8e-09
Identities = 38/102 (37%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTS 364
+I +G +GL YLH + + HRD+KA N+LL K++DFG A I S +
Sbjct: 129 AITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIA------SPAN 179
Query: 365 KVVGTYGYMAPEYALG---GVISVKSDVFSFGVLLLEIISGK 403
VGT +MAPE L G K DV+S G+ +E+ K
Sbjct: 180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 9e-09
Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 5/99 (5%)
Query: 301 KRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE 360
+R +I + L YLH++ R + HRDL +N++L + I+DFG+A+ Q E
Sbjct: 113 ERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPE 167
Query: 361 SNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEI 399
S + VVGT Y PE K+DV++FG +L ++
Sbjct: 168 SKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 44/164 (26%), Positives = 81/164 (49%), Gaps = 23/164 (14%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I+ + YL + + + HRDL A N L+ K++DFG++R+ ++ T+
Sbjct: 113 ISSAMEYLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAK 166
Query: 370 Y--GYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCN 427
+ + APE S+KSDV++FGVLL EI + + +S + L+ ++L
Sbjct: 167 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEK 220
Query: 428 GEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSV 471
G +E P + C ++ + + C Q +P+DRP+ + +
Sbjct: 221 GYRME--RP---EGC-PPKVYELMR---ACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 5/93 (5%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
IA L YLH L + +RDLK N+LLD + + ++DFG+ + G ++ TS GT
Sbjct: 105 IASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGT 159
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISG 402
Y+APE D + G +L E++ G
Sbjct: 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 34/94 (36%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I L +LH +L + +RD+K N+LLD E + ++DFG+++ F + E T GT
Sbjct: 114 IILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGT 169
Query: 370 YGYMAPEYALGGVISVKS-DVFSFGVLLLEIISG 402
YMAPE G K+ D +S G+L+ E+++G
Sbjct: 170 IEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 50/183 (27%), Positives = 81/183 (44%), Gaps = 22/183 (12%)
Query: 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354
+ +L + + I + IA G++YL + HRDL N L+ + KI DFGM+R
Sbjct: 117 KGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV 173
Query: 355 GGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHG 414
+ +M PE + + +SDV+SFGV+L EI + K F LS
Sbjct: 174 YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS--- 230
Query: 415 QSLLAYTWKLWCNGEALELMDP--VLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVA 472
N E +E + VL++ + + + I +G C Q +P R N+ +
Sbjct: 231 ------------NTEVIECITQGRVLERPRVCPKEVYDIMLG--CWQREPQQRLNIKEIY 276
Query: 473 VML 475
+L
Sbjct: 277 KIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 33/92 (35%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371
RGL +LH +V HRDLK N+L+ K++DFG+ARI+ + + VV T
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLW 174
Query: 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
Y APE L + D++S G + E+ K
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 9/95 (9%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+ +GL Y+H + HRDLK N+ ++ + KI DFG+AR Q +S + V T
Sbjct: 127 MLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVT 178
Query: 370 YGYMAPEYALGGVISVKS-DVFSFGVLLLEIISGK 403
Y APE L + ++ D++S G ++ E+++GK
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 18/92 (19%)
Query: 316 YLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375
YLH + +RDLK N+LLD++ + K++DFG A+ + T + GT Y+AP
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAP 184
Query: 376 EYALGGVISVKS-----DVFSFGVLLLEIISG 402
E VI K D ++ GVLL E I+G
Sbjct: 185 E-----VIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 36/109 (33%), Positives = 57/109 (52%), Gaps = 14/109 (12%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR-IFGGN-QNESNTSKVV 367
IA G+ YL S HRDL A N +L+ M ++DFG+++ I+ G+ + SK+
Sbjct: 122 IASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL- 177
Query: 368 GTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-------GKKNSGFY 409
++A E V + SDV++FGV + EI++ G +NS Y
Sbjct: 178 -PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY 225
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 37/113 (32%), Positives = 62/113 (54%), Gaps = 11/113 (9%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
T ++ L+ + I+ IA G+ +L S V H+DL NVL+ ++N KISD G+ R
Sbjct: 116 TVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR 172
Query: 353 IFGGNQNESNTSKVVGT----YGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
++ K++G +M+PE + G S+ SD++S+GV+L E+ S
Sbjct: 173 ----EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 46/176 (26%), Positives = 67/176 (38%), Gaps = 38/176 (21%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
IA G+ YL + L HRDL N L+ + KI+DFGM+R + V
Sbjct: 138 IASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLP 194
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKK--------------NSGFYLSEHGQ 415
+MA E L G + SDV++FGV L E+ + K N+G + G+
Sbjct: 195 IRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGR 254
Query: 416 SLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSV 471
+ L C +LM + C D DRP + +
Sbjct: 255 QIYLSQTPL-CPSPVFKLM--------------------MRCWSRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 38/118 (32%), Positives = 59/118 (50%), Gaps = 15/118 (12%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR-IFGGN-QNESNTSKVV 367
IA G+ YL S HRDL A N +L +M ++DFG+++ I+ G+ + +K+
Sbjct: 122 IALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM- 177
Query: 368 GTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-------GKKNSGFY-LSEHGQSL 417
++A E V + KSDV++FGV + EI + G +N Y HG L
Sbjct: 178 -PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL 234
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
+I I RGL Y+H + HRDLK SN+ ++ + KI DFG+AR + +
Sbjct: 125 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 176
Query: 366 VVGTYGYMAPEYALGGV-ISVKSDVFSFGVLLLEIISGK 403
V T Y APE L + + D++S G ++ E+++G+
Sbjct: 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 35/98 (35%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTS 364
++ +G +GL YLH + + HRD+KA N+LL K+ DFG A I + +
Sbjct: 119 AVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APAN 169
Query: 365 KVVGTYGYMAPEYALG---GVISVKSDVFSFGVLLLEI 399
VGT +MAPE L G K DV+S G+ +E+
Sbjct: 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 318 HEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEY 377
H SR +V HRD+K +NV + K+ D G+ R F +++ +VGT YM+PE
Sbjct: 121 HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177
Query: 378 ALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPV 437
+ KSD++S G LL E+ + S FY + +L + K+ E + P
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAA--LQSPFYGDK--MNLFSLCQKI----EQCDY--PP 227
Query: 438 LKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSV 471
L + +L + + +C+ DP RP++ V
Sbjct: 228 LPTEHYSEKLRELVS---MCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 29/95 (30%), Positives = 49/95 (51%), Gaps = 18/95 (18%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371
+GL YLHE HRD+K +N+LL + + K++DFG++ + + +GT
Sbjct: 112 KGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPY 166
Query: 372 YMAPEYALGGVISV--------KSDVFSFGVLLLE 398
+MAPE V +V K D+++ G+ +E
Sbjct: 167 WMAPE-----VAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 32/87 (36%), Positives = 51/87 (58%), Gaps = 6/87 (6%)
Query: 313 GLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372
G+ Y+H+ ++ HRDLKA N+ L + + KI DFG++R+ G+ + + T GT Y
Sbjct: 118 GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYY 171
Query: 373 MAPEYALGGVISVKSDVFSFGVLLLEI 399
M+PE KSD++S G +L E+
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 36/98 (36%), Positives = 53/98 (54%), Gaps = 11/98 (11%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+ G+ YL + HRDL A N L+D + K+SDFG++R ++ S+ VG+
Sbjct: 109 VCEGMAYLESKQFI---HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGS 161
Query: 370 ---YGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GK 403
+ PE L S KSDV++FGVL+ E+ S GK
Sbjct: 162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 55/194 (28%), Positives = 77/194 (39%), Gaps = 28/194 (14%)
Query: 289 TIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDF 348
T T +L K I ++ A G+ YL HRDL A N L+ + KISDF
Sbjct: 82 TFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDF 138
Query: 349 GMARIFGGNQNESNTSKVVG-----TYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
GM+R + E G + APE G S +SDV+SFG+LL E
Sbjct: 139 GMSR-----EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAF--- 190
Query: 404 KNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPA 463
SL A + N + E ++ ++ C + C + DP
Sbjct: 191 ------------SLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPG 238
Query: 464 DRPNMSSVAVMLAS 477
RP+ S+V L S
Sbjct: 239 QRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 26/87 (29%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 325 VFHRDLKASNVLL---DHEMNPKISDFGMARIFGG-----NQNESNTSKVVGTYGYMAPE 376
+ HRDLK N+++ + K+ DFG+ + G + T++V+GT Y APE
Sbjct: 100 IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159
Query: 377 YALGGVISVKSDVFSFGVLLLEIISGK 403
G ++ SD++++G++ LE ++G+
Sbjct: 160 QLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 37/112 (33%), Positives = 55/112 (49%), Gaps = 18/112 (16%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGN-------- 357
I+ I GL LH+ HRDL +N+ ++ + KI+DFG+AR +G
Sbjct: 124 ILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 358 -----QNESNTSKVVGTYGYMAPEYALGG-VISVKSDVFSFGVLLLEIISGK 403
+ E TSKVV T Y APE +G D++S G + E+++GK
Sbjct: 181 DETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 36/97 (37%), Positives = 50/97 (51%), Gaps = 10/97 (10%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI-FGGNQNESNTSKVVGTY 370
R L Y+H + VFHRDLK N+L + + KI DFG+AR+ F + V T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 371 GYMAPEYALGGVISVKS----DVFSFGVLLLEIISGK 403
Y APE L G K D++S G + E+++GK
Sbjct: 171 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 38/115 (33%), Positives = 56/115 (48%), Gaps = 8/115 (6%)
Query: 290 IYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFG 349
IY+ + +R + I GL LH ++ +RDLK N+LLD + +ISD G
Sbjct: 91 IYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLG 147
Query: 350 MA-RIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
+A +I G VGT GYMAPE ++ D + G L+ E+I G+
Sbjct: 148 LAVKIPEGESIRGR----VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 31/104 (29%), Positives = 53/104 (50%), Gaps = 10/104 (9%)
Query: 301 KRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE 360
K+++++ IA G+ +L S + HRDL A N L+ + K+S +++ +
Sbjct: 117 KQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK----DVYN 169
Query: 361 SNTSKVVGTYG---YMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
S K+ ++APE S KSDV+SFGVL+ E+ +
Sbjct: 170 SEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
+I + RGL Y+H + HRDLK SNV ++ + +I DFG+AR Q + +
Sbjct: 123 LIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTG 174
Query: 366 VVGTYGYMAPEYALGGVISVKS-DVFSFGVLLLEIISGK 403
V T Y APE L + ++ D++S G ++ E++ GK
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 41/134 (30%), Positives = 61/134 (45%), Gaps = 15/134 (11%)
Query: 279 IWIAI-----GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKAS 333
+W+ + G+ I +T+ L + I I RGL +LH+ KV HRD+K
Sbjct: 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQ 140
Query: 334 NVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYAL-----GGVISVKSD 388
NVLL K+ DFG++ NT +GT +MAPE KSD
Sbjct: 141 NVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSD 198
Query: 389 VFSFGVLLLEIISG 402
++S G+ +E+ G
Sbjct: 199 LWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 38/115 (33%), Positives = 60/115 (52%), Gaps = 14/115 (12%)
Query: 304 ISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA-RIFGGN-QNES 361
+ + IA G+ YL S HRDL A N +L+ MN ++DFG++ +I+ G+ +
Sbjct: 115 VKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQG 171
Query: 362 NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-------GKKNSGFY 409
+K+ ++A E V + KSDV+SFGV + EI + G +NS Y
Sbjct: 172 RIAKM--PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 54/206 (26%), Positives = 83/206 (40%), Gaps = 23/206 (11%)
Query: 276 RKAIWIAI----GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLK 331
R+ I+I + G + ++ +L K+ + A G+ YL + HRDL
Sbjct: 64 RQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLA 120
Query: 332 ASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFS 391
A N L+ KISDFGM+R S+ K + + APE G S +SDV+S
Sbjct: 121 ARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSSESDVWS 179
Query: 392 FGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451
+G+LL E SL + N +A E ++ + SC
Sbjct: 180 YGILLWETF---------------SLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVY 224
Query: 452 HIGLLCVQEDPADRPNMSSVAVMLAS 477
+ C P +RP S + LA+
Sbjct: 225 KVMQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 4e-08
Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR---IFGGNQNESNTSKV 366
I G+ YLH + V HRD+K +NV+L K+ DFG AR G + SN K
Sbjct: 111 ILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS 167
Query: 367 V-GTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
+ GT +MAPE KSD++S G + E+ +GK
Sbjct: 168 MHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 39/115 (33%), Positives = 55/115 (47%), Gaps = 8/115 (6%)
Query: 290 IYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFG 349
IY+ D +R I + GL L R ++ +RDLK N+LLD + +ISD G
Sbjct: 91 IYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLG 147
Query: 350 MA-RIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
+A +I G VGT GYMAPE + D + G L+ E+I G+
Sbjct: 148 LAVQIPEGETVRGR----VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 31/91 (34%), Positives = 51/91 (56%)
Query: 314 LLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373
LL +H + HRD+K++N+LL K+ DFG ++++ ++ GT Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 374 APEYALGGVISVKSDVFSFGVLLLEIISGKK 404
APE S K+D+FS GVLL E+++ K+
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 5e-08
Identities = 20/48 (41%), Positives = 28/48 (58%), Gaps = 1/48 (2%)
Query: 477 SDTVSLPQPTQPAFSVGRIIARSGQSSS-SYSKICSVNEVTLSDVSPR 523
S+T +PQP QP F VGR + SSS + +VN+VT+S + R
Sbjct: 1 SETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 6e-08
Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHE-MNPKISDFGMARIFGGNQNESNTSKVVG 368
I+ GL ++H+ K+ HRD+K+ N+ L M K+ DFG+AR + + T VG
Sbjct: 110 ISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVG 164
Query: 369 TYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
T Y++PE + K+D++S G +L E+ + K
Sbjct: 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 36/106 (33%), Positives = 55/106 (51%), Gaps = 6/106 (5%)
Query: 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGG 356
+LD +R ++ + G+ +LH + HRDLK SN+++ + KI DFG+AR
Sbjct: 119 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--A 173
Query: 357 NQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISG 402
N T VV Y Y APE LG D++S G ++ E++ G
Sbjct: 174 CTNFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 7e-08
Identities = 35/95 (36%), Positives = 49/95 (51%), Gaps = 6/95 (6%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I RGL Y H R KV HRDLK N+L++ K++DFG+AR + S V T
Sbjct: 113 ILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVT 167
Query: 370 YGYMAPEYALGGV-ISVKSDVFSFGVLLLEIISGK 403
Y P+ LG S + D++ G + E+ SG+
Sbjct: 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 4/95 (4%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA-RIFGGNQNESNTSKVVG 368
I G+ YLH + + HRD+K +N+L D N K+ DFG + R+ + + V G
Sbjct: 115 ILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTG 171
Query: 369 TYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
T +M+PE G K+DV+S G ++E+++ K
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 7e-08
Identities = 37/97 (38%), Positives = 50/97 (51%), Gaps = 12/97 (12%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR-IFGGNQ----NESNTS 364
I G+ YLH HRDL A NVLLD++ KI DFG+A+ + G++ E S
Sbjct: 116 ICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 172
Query: 365 KVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
V + A E S SDV+SFGV L E+++
Sbjct: 173 PVF----WYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 8e-08
Identities = 33/120 (27%), Positives = 51/120 (42%), Gaps = 27/120 (22%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA------------------ 351
IA +L L +L HRD+K N+L+D + + K++DFG+
Sbjct: 107 IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHN 166
Query: 352 RIFGGNQNESNTSK---------VVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISG 402
+F N VGT Y+APE G ++ D +S GV+L E++ G
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 8e-08
Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371
RGL +LH + + HRDLK N+L+ K++DFG+ARI+ + + VV T
Sbjct: 119 RGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLW 172
Query: 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
Y APE L + D++S G + E+ K
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 8e-08
Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHE-MNPKISDFGMARIFGGNQNESN-TSKVVGT 369
RGL Y+H + V HRDLK +NV ++ E + KI DFG+ARI + + S+ + T
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 370 YGYMAPEYALGGVISVKS-DVFSFGVLLLEIISGK 403
Y +P L K+ D+++ G + E+++GK
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 34/95 (35%), Positives = 49/95 (51%), Gaps = 10/95 (10%)
Query: 313 GLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372
GL +LH + K HRD+K +N+LL E K+ DFG++ + NTS VGT +
Sbjct: 136 GLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFW 190
Query: 373 MAPEY-----ALGGVISVKSDVFSFGVLLLEIISG 402
MAPE L + DV+S G+ +E+ G
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 37/107 (34%), Positives = 56/107 (52%), Gaps = 6/107 (5%)
Query: 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGG 356
+LD +R ++ + G+ +LH + HRDLK SN+++ + KI DFG+AR G
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG- 177
Query: 357 NQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
+ T VV Y Y APE LG D++S G ++ E+I G
Sbjct: 178 -TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 4/95 (4%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA-RIFGGNQNESNTSKVVG 368
I +G+ YLH + + HRD+K +N+L D N K+ DFG + RI + + V G
Sbjct: 115 ILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTG 171
Query: 369 TYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
T +M+PE G K+DV+S ++E+++ K
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 30/100 (30%), Positives = 56/100 (56%), Gaps = 7/100 (7%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGM-ARIFGGNQNESNT 363
++ + + L YLH V HRD+K+ ++LL + K+SDFG A+I +++
Sbjct: 121 TVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKR 174
Query: 364 SKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
+VGT +MAPE + D++S G++++E++ G+
Sbjct: 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 33/93 (35%), Positives = 48/93 (51%), Gaps = 6/93 (6%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371
RGL Y H R KV HRDLK N+L++ K++DFG+AR + S V T
Sbjct: 115 RGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLW 169
Query: 372 YMAPEYALGGV-ISVKSDVFSFGVLLLEIISGK 403
Y P+ LG S + D++ G + E+ +G+
Sbjct: 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 33/92 (35%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+A G+ +L + HRDL A NVL+ KI DFG+AR + N +
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+MAPE + + SDV+SFG+LL EI +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 10/92 (10%)
Query: 313 GLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372
L YLHE+ K+ HRDLKA N+L + + K++DFG++ + +GT +
Sbjct: 115 ALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYW 169
Query: 373 MAPEYALGGV-----ISVKSDVFSFGVLLLEI 399
MAPE + K+DV+S G+ L+E+
Sbjct: 170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 52/206 (25%), Positives = 85/206 (41%), Gaps = 30/206 (14%)
Query: 272 KGKGRKAIWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLK 331
+ G A+ +A G P +L + + I IA G++YL + HRDL
Sbjct: 99 RAHGPDAVLMAEGNR-PA-------ELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLA 147
Query: 332 ASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFS 391
N L+ + KI DFGM+R + +M PE + + +SDV+S
Sbjct: 148 TRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 207
Query: 392 FGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDP--VLKQSCMAAELLK 449
GV+L EI + K + LS N E +E + VL++ + +
Sbjct: 208 LGVVLWEIFTYGKQPWYQLS---------------NNEVIECITQGRVLQRPRTCPKEVY 252
Query: 450 CIHIGLLCVQEDPADRPNMSSVAVML 475
+ +G C Q +P R N+ + +L
Sbjct: 253 DLMLG--CWQREPHMRLNIKEIHSLL 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 16/94 (17%)
Query: 314 LLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK---VVGTY 370
L YLH +K+ HRDLKA NVLL + + K++DFG++ +N + +GT
Sbjct: 123 LQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSA-----KNVKTLQRRDSFIGTP 174
Query: 371 GYMAPEYALGGVIS-----VKSDVFSFGVLLLEI 399
+MAPE + + K+D++S G+ L+E+
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 4/95 (4%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA-RIFGGNQNESNTSKVVG 368
I G+ YLH + + HRD+K +N+L D N K+ DFG + R+ + + V G
Sbjct: 115 ILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTG 171
Query: 369 TYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
T +M+PE G K+D++S G ++E+++ K
Sbjct: 172 TPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 46/146 (31%), Positives = 61/146 (41%), Gaps = 36/146 (24%)
Query: 266 GSVT----SSKGKGRKAIWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDS 321
GSVT ++KG K WIA Y R I RGL +LH
Sbjct: 104 GSVTDLVKNTKGNALKEDWIA--------YICRE--------------ILRGLAHLHAH- 140
Query: 322 RLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYAL-- 379
KV HRD+K NVLL K+ DFG++ NT +GT +MAPE
Sbjct: 141 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACD 196
Query: 380 ---GGVISVKSDVFSFGVLLLEIISG 402
+SD++S G+ +E+ G
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 6/93 (6%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371
RGL Y+H + HRDLK N+L+ + K++DFG+AR +++ +S+VV T
Sbjct: 114 RGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVV-TLW 168
Query: 372 YMAPEYALGGV-ISVKSDVFSFGVLLLEIISGK 403
Y P+ LG S D++ G + +E++ G+
Sbjct: 169 YRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 32/106 (30%), Positives = 56/106 (52%), Gaps = 11/106 (10%)
Query: 298 LDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGN 357
LDW +I + L ++H+ K+ HRD+K+ N+ L + K+ DFG+AR+
Sbjct: 104 LDWFVQICL------ALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154
Query: 358 QNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
+ T +GT Y++PE + KSD+++ G +L E+ + K
Sbjct: 155 VELART--CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 29/95 (30%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGM-ARIFGGNQNESNTSKVVG 368
+ + L LH V HRD+K+ ++LL H+ K+SDFG A++ ++ +VG
Sbjct: 125 VLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKSLVG 178
Query: 369 TYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
T +MAPE + D++S G++++E++ G+
Sbjct: 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 35/98 (35%), Positives = 48/98 (48%), Gaps = 3/98 (3%)
Query: 304 ISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNT 363
I + IA G+ YL S L HRDL N L+ KI+DFGM+R
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 364 SKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+ V +M+ E L G + SDV++FGV L EI++
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 3e-07
Identities = 34/104 (32%), Positives = 51/104 (49%), Gaps = 15/104 (14%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTS 364
SII I +GL ++H + FHRDLK N+L+ KI+DFG+AR E +
Sbjct: 103 SIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSR 152
Query: 365 KV----VGTYGYMAPEYAL-GGVISVKSDVFSFGVLLLEIISGK 403
V T Y APE L S D+++ G ++ E+ + +
Sbjct: 153 PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 18/99 (18%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I L YLH ++ +RDLK N+LLD E + K++DFG A+ + T + GT
Sbjct: 110 IVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGT 161
Query: 370 YGYMAPEYALGGVISVKS-----DVFSFGVLLLEIISGK 403
Y+APE VI K D ++ G+L+ E++ G
Sbjct: 162 PEYLAPE-----VIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 8/93 (8%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNT-SKVVGTY 370
RGL Y H + +V HRDLK N+L+ K++DFG+AR S T S V T
Sbjct: 114 RGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR---AKSVPSKTYSNEVVTL 167
Query: 371 GYMAPEYALGGV-ISVKSDVFSFGVLLLEIISG 402
Y P+ LG S D++ G + E+ +G
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 33/101 (32%), Positives = 54/101 (53%), Gaps = 21/101 (20%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR--IFGGNQNESNTSKVV 367
I+ L +LH + + +RDLK N+LLD + + K++DFG+ + I G + T
Sbjct: 109 ISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFC 161
Query: 368 GTYGYMAPEYALGGVISVKS------DVFSFGVLLLEIISG 402
GT YMAPE I ++S D +S G L+ ++++G
Sbjct: 162 GTIEYMAPE------ILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 32/86 (37%), Positives = 45/86 (52%), Gaps = 8/86 (9%)
Query: 317 LHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPE 376
LH L HRDLK N L+D + K++DFG+++ G +N+ VVG+ YMAPE
Sbjct: 117 LH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANS--VVGSPDYMAPE 168
Query: 377 YALGGVISVKSDVFSFGVLLLEIISG 402
G D +S G +L E + G
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 32/104 (30%), Positives = 51/104 (49%), Gaps = 7/104 (6%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I L YLH V +RD+K N++LD + + KI+DFG+ + G + + GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH 413
Y+APE D + GV++ E++ G+ FY +H
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 31/95 (32%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGM-ARIFGGNQNESNTSKVVG 368
+ R L YLH V HRD+K+ ++LL + K+SDFG A++ ++ +VG
Sbjct: 127 VLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQV---SKEVPKRKSLVG 180
Query: 369 TYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
T +MAPE + D++S G++++E+I G+
Sbjct: 181 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP-KISDFGMARIFGGNQNESNTSKVVGTY 370
+G+ + H + V HRDLK N+L+D + KI+D G+ R F +S T ++V T
Sbjct: 121 KGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSYTHEIV-TL 175
Query: 371 GYMAPEYALGGV-ISVKSDVFSFGVLLLEIISG 402
Y APE LG S D++S G + E+
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 37/109 (33%), Positives = 60/109 (55%), Gaps = 6/109 (5%)
Query: 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354
+ +++ K+++ I +G+ YL SR V HRDL A NVL++ E KI DFG+ +
Sbjct: 103 KNKINLKQQLKYAVQICKGMDYL--GSRQYV-HRDLAARNVLVESEHQVKIGDFGLTKAI 159
Query: 355 GGNQNESNTSK--VVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
++ E T K + + APE + + SDV+SFGV L E+++
Sbjct: 160 ETDK-EYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 36/107 (33%), Positives = 55/107 (51%), Gaps = 20/107 (18%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
I+ G GL +LH + ++ HRD+K +N+LL E K+ DFG++ + NTS
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS- 188
Query: 366 VVGTYGYMAPEYALGGVIS----------VKSDVFSFGVLLLEIISG 402
VGT +MAPE VI+ + DV+S G+ +E+ G
Sbjct: 189 -VGTPFWMAPE-----VIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 36/109 (33%), Positives = 57/109 (52%), Gaps = 6/109 (5%)
Query: 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354
+ +LD +R ++ + G+ +LH + HRDLK SN+++ + KI DFG+AR
Sbjct: 113 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169
Query: 355 GGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
G + T VV Y Y APE LG D++S G ++ E++ K
Sbjct: 170 G--TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 30/99 (30%), Positives = 51/99 (51%), Gaps = 4/99 (4%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTS 364
S I + + + + H++ + HRD+K N+L+ H K+ DFG AR + +N +
Sbjct: 104 SYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYT 159
Query: 365 KVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
+ V T Y +PE LG D++S G +L E+ G+
Sbjct: 160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 5/91 (5%)
Query: 313 GLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372
G+ ++HE +V HRD+K+ N+ L K+ DFG AR+ + T VGT Y
Sbjct: 112 GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYY 166
Query: 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
+ PE + KSD++S G +L E+ + K
Sbjct: 167 VPPEIWENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 6/93 (6%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371
RGL Y H + K+ HRDLK N+L++ + K++DFG+AR + S V T
Sbjct: 114 RGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLW 168
Query: 372 YMAPEYALGGV-ISVKSDVFSFGVLLLEIISGK 403
Y P+ LG S D++ G +L E+ +G+
Sbjct: 169 YRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 8e-07
Identities = 33/106 (31%), Positives = 52/106 (49%), Gaps = 6/106 (5%)
Query: 298 LDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGN 357
LD R + I RG+ + H + + HRD+K N+L+ K+ DFG AR
Sbjct: 97 LDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA- 152
Query: 358 QNESNTSKVVGTYGYMAPEYALGGVISVKS-DVFSFGVLLLEIISG 402
E T V T Y APE +G ++ D+++ G L+ E+++G
Sbjct: 153 PGEVYTD-YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 6/104 (5%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I L YLH S V +RDLK N++LD + + KI+DFG+ + G ++ + GT
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 159
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH 413
Y+APE D + GV++ E++ G+ FY +H
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-07
Identities = 36/106 (33%), Positives = 57/106 (53%), Gaps = 11/106 (10%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP-----KISDFGMARIFGGNQN 359
S++ I G+ YLH + V HRDLK +N+L+ E P KI+D G AR+F
Sbjct: 112 SLLYQILDGIHYLHANW---VLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLK 167
Query: 360 E-SNTSKVVGTYGYMAPEYALGGVISVKS-DVFSFGVLLLEIISGK 403
++ VV T+ Y APE LG K+ D+++ G + E+++ +
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 36/106 (33%), Positives = 57/106 (53%), Gaps = 11/106 (10%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP-----KISDFGMARIFGGNQN 359
S++ I G+ YLH + V HRDLK +N+L+ E P KI+D G AR+F
Sbjct: 112 SLLYQILDGIHYLHANW---VLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLK 167
Query: 360 E-SNTSKVVGTYGYMAPEYALGGVISVKS-DVFSFGVLLLEIISGK 403
++ VV T+ Y APE LG K+ D+++ G + E+++ +
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 31/99 (31%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTS 364
S + + +GL + H V HRDLK N+L++ K++DFG+AR F G ++
Sbjct: 103 SFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVRCYSA 158
Query: 365 KVVGTYGYMAPEYALGGVISVKS-DVFSFGVLLLEIISG 402
+VV T Y P+ G + S D++S G + E+ +
Sbjct: 159 EVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 5/93 (5%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+A + YLH L + +RDLK N+LLD + + ++DFG+ + G + E TS GT
Sbjct: 105 VASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGT 159
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISG 402
Y+APE D + G +L E++ G
Sbjct: 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371
GL Y+H + HRDLK N+ ++ + KI DFG+AR + + T VV T
Sbjct: 128 CGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVV-TRW 179
Query: 372 YMAPEYALGGVISVKS-DVFSFGVLLLEIISGK 403
Y APE L + ++ D++S G ++ E+++GK
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 27/80 (33%), Positives = 45/80 (56%), Gaps = 5/80 (6%)
Query: 323 LKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGV 382
L + +RDLK N+LLD + K++DFG A++ ++ T + GT Y+APE L
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIAPEILLNVG 204
Query: 383 ISVKSDVFSFGVLLLEIISG 402
+D ++ G+ + EI+ G
Sbjct: 205 HGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 33/104 (31%), Positives = 52/104 (50%), Gaps = 7/104 (6%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I L YLH K+ +RDLK N++LD + + KI+DFG+ + G + + GT
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGT 158
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH 413
Y+APE D + GV++ E++ G+ FY +H
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 35/109 (32%), Positives = 55/109 (50%), Gaps = 8/109 (7%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
R+ L KR S + + + L ++H R +FHRD+K N+L+ + K++DFG R
Sbjct: 93 RKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCR- 147
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYAL-GGVISVKSDVFSFGVLLLEIIS 401
G T + + T Y APE L G K D+++ G + EI+S
Sbjct: 148 -GIYSKPPYT-EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 7/104 (6%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I L YLH V +RDLK N++LD + + KI+DFG+ + G + + GT
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH 413
Y+APE D + GV++ E++ G+ FY +H
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 30/88 (34%), Positives = 49/88 (55%)
Query: 314 LLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373
+L L E K+ HRDLK++N+ L K+ DFG ++ + + + S GT Y+
Sbjct: 179 VLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238
Query: 374 APEYALGGVISVKSDVFSFGVLLLEIIS 401
APE S K+D++S GV+L E+++
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 35/114 (30%), Positives = 56/114 (49%), Gaps = 11/114 (9%)
Query: 301 KRRISIINGIA------RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354
KR I+I + +A R + YLHE+ + HRD+KA N+ ++H + + DFG A F
Sbjct: 176 KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA-CF 231
Query: 355 GGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGF 408
+ N + GT APE D++S G++L E+ + +S F
Sbjct: 232 PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC-HDSLF 284
|
Length = 391 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 5/93 (5%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
IA L YLH L + +RDLK N+LLD + + ++DFG+ + ++ TS GT
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGT 159
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISG 402
Y+APE D + G +L E++ G
Sbjct: 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 7e-06
Identities = 33/123 (26%), Positives = 52/123 (42%), Gaps = 9/123 (7%)
Query: 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGM 350
Y R L ++ I+I + L YLH + HRD+K N+ LD N + DFG
Sbjct: 175 YVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGA 231
Query: 351 ARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEI------ISGKK 404
A + + GT +PE K+D++S G++L E+ + GK+
Sbjct: 232 ACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291
Query: 405 NSG 407
Sbjct: 292 VKS 294
|
Length = 392 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 5/93 (5%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
IA L YLH + + +RDLK N+LLD + + ++DFG+ + G T+ GT
Sbjct: 105 IASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGT 159
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISG 402
Y+APE D + G +L E++ G
Sbjct: 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 36/115 (31%), Positives = 52/115 (45%), Gaps = 9/115 (7%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
+ LD I ++ L YL + HRD+ A NVL+ K+ DFG++R
Sbjct: 99 VNKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155
Query: 353 IFGGNQNES--NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKK 404
++ES SK +MAPE + SDV+ FGV + EI+ G K
Sbjct: 156 YL---EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVK 207
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 7/100 (7%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+A +L +H ++ HRD+K NVL+D + K++DFG A N+ ++ VGT
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLP-VGT 166
Query: 370 YGYMAPEY------ALGGVISVKSDVFSFGVLLLEIISGK 403
Y+APE G V+ D +S GV+ E+I G+
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 8/95 (8%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNT-SKVVG 368
+ RGL Y+H+ + HRDLK N+L+ K++DFG+AR S+T S V
Sbjct: 112 LLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR---AKSVPSHTYSNEVV 165
Query: 369 TYGYMAPEYALGGV-ISVKSDVFSFGVLLLEIISG 402
T Y P+ LG S D++ G + +E+I G
Sbjct: 166 TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 35/101 (34%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
IA +L L + + +RDLK N+LLD + + DFG+++ + +NT GT
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGT 159
Query: 370 YGYMAPEYALGGVISVKS-DVFSFGVLLLEIISGKKNSGFY 409
Y+APE L K D +S GVL+ E+ G S FY
Sbjct: 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGW--SPFY 198
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 29/99 (29%), Positives = 47/99 (47%), Gaps = 6/99 (6%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTS 364
II + + + H + HRD+K N+L+ + K+ DFG ARI G + +
Sbjct: 104 KIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTG--PGDDYT 158
Query: 365 KVVGTYGYMAPEYALGGV-ISVKSDVFSFGVLLLEIISG 402
V T Y APE +G DV++ G + E+++G
Sbjct: 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 44/187 (23%), Positives = 80/187 (42%), Gaps = 33/187 (17%)
Query: 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGG 356
QL + + ++ G+A G+ YL E + H+ L A VL++ ++ KIS F +
Sbjct: 103 QLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQ---- 155
Query: 357 NQNESNTSKVVGTYG------YMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFY 409
E + + T + APE S SDV+SFG+++ E++S G++ Y
Sbjct: 156 ---EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP---Y 209
Query: 410 LSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMS 469
GQ ++ + L P + + +L C Q++ +RP S
Sbjct: 210 WDMSGQDVIKAV------EDGFRLPAPRNCPNLLHQLMLDCW-------QKERGERPRFS 256
Query: 470 SVAVMLA 476
+ +L+
Sbjct: 257 QIHSILS 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 28/91 (30%), Positives = 49/91 (53%), Gaps = 8/91 (8%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371
+GL YLH ++ HRD+K +N+LL + K++DFG+A + + +GT
Sbjct: 117 QGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPY 171
Query: 372 YMAPEYAL---GGVISVKSDVFSFGVLLLEI 399
+MAPE A G + D+++ G+ +E+
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 45/157 (28%), Positives = 76/157 (48%), Gaps = 18/157 (11%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA-RIFGGNQNESNTSKVVG 368
+A +L + +L HRD+K NVLLD + +++DFG R+ +SN + VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VG 165
Query: 369 TYGYMAPEY--ALG---GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWK 423
T Y++PE A+ G + D +S GV + E++ G+ + FY +SL+ K
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE--TPFY----AESLVETYGK 219
Query: 424 LWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQE 460
+ + E + V S A +L++ L+C E
Sbjct: 220 IMNHKEHFQFPPDVTDVSEEAKDLIR----RLICSPE 252
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 18/157 (11%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKV-VG 368
IA +L +H +L HRD+K NVLLD + +++DFG NQ+ + S V VG
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSC--LKMNQDGTVQSSVAVG 165
Query: 369 TYGYMAPEYALG-----GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWK 423
T Y++PE G + D +S GV + E++ G+ + FY +SL+ K
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFY----AESLVETYGK 219
Query: 424 LWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQE 460
+ + E + + S A +L++ L+C +E
Sbjct: 220 IMNHEERFQFPSHITDVSEEAKDLIQ----RLICSRE 252
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 7e-05
Identities = 32/110 (29%), Positives = 55/110 (50%), Gaps = 10/110 (9%)
Query: 298 LDWKRRI------SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA 351
DWK R +I+ + + Y+H+ K+ HRD+K N+ L+ + + DFG A
Sbjct: 258 FDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTA 314
Query: 352 RIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
F + E+ VGT +PE G +D++S G++LL+++S
Sbjct: 315 MPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 38/137 (27%), Positives = 68/137 (49%), Gaps = 25/137 (18%)
Query: 276 RKAIWIAI----GTTIPTIYST----RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFH 327
R +WI + G ++ IY +Q+ + R ++ +GL YLH ++ H
Sbjct: 78 RDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGKM---H 129
Query: 328 RDLKASNVLLDHEMNPKISDFGM-ARIFGGNQNESNTSKVVGTYGYMAPEYAL----GGV 382
RD+K +N+LL + K++DFG+ A+I + +GT +MAPE A GG
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQI---TATIAKRKSFIGTPYWMAPEVAAVERKGGY 186
Query: 383 ISVKSDVFSFGVLLLEI 399
+ D+++ G+ +E+
Sbjct: 187 NQL-CDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (103), Expect = 2e-04
Identities = 33/99 (33%), Positives = 47/99 (47%), Gaps = 22/99 (22%)
Query: 324 KVFHRDLKASNVLLD-------------HEMN----PKISDFGMARIFGGNQNESNTSKV 366
+V HRDLK N+ L + +N KI DFG+++ G ES
Sbjct: 145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG---IESMAHSC 201
Query: 367 VGTYGYMAPEYALGGVISV--KSDVFSFGVLLLEIISGK 403
VGT Y +PE L S KSD+++ G ++ E+ SGK
Sbjct: 202 VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 10/96 (10%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP-KISDFGMAR-IFGGNQNESNTSKVV 367
+ R L Y+H + HRDLK N+L+D + K+ DFG A+ + G ++ S +
Sbjct: 179 LCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS----YI 231
Query: 368 GTYGYMAPEYALGGV-ISVKSDVFSFGVLLLEIISG 402
+ Y APE LG + D++S G ++ E+I G
Sbjct: 232 CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 35/129 (27%), Positives = 54/129 (41%), Gaps = 36/129 (27%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGM------------ARIFGGN 357
IA +L + +L HRD+K N+LLD + + K+SDFG+ RI
Sbjct: 107 IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166
Query: 358 ----------QNESNTSK--------------VVGTYGYMAPEYALGGVISVKSDVFSFG 393
+ S+ K VGT Y+APE L + + D +S G
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226
Query: 394 VLLLEIISG 402
V++ E++ G
Sbjct: 227 VIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 32/102 (31%), Positives = 48/102 (47%), Gaps = 16/102 (15%)
Query: 314 LLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI----FGGNQNESNTSK---- 365
L YLH + HRDLK N+L+ + K++DFG+++I N E + K
Sbjct: 114 LEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 366 -----VVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISG 402
V GT Y+APE L D ++ G++L E + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 30/138 (21%), Positives = 51/138 (36%), Gaps = 45/138 (32%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA-------------RIFGG 356
+A +L + +L HRD+K N+L+D + K+SDFG++ ++ G
Sbjct: 107 MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQG 166
Query: 357 NQNESNTSK--------------------------------VVGTYGYMAPEYALGGVIS 384
N++ VGT Y+APE L
Sbjct: 167 KSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226
Query: 385 VKSDVFSFGVLLLEIISG 402
+ D +S G ++ E + G
Sbjct: 227 QECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 8e-04
Identities = 30/88 (34%), Positives = 45/88 (51%), Gaps = 9/88 (10%)
Query: 327 HRDLKASNVLLDHEMNPKISDFGMARIFGGN-QNESNTSKVVGTYGYMAPEYALG----G 381
HRD+K N+LLD + K++DFG N +T+ VGT Y++PE G
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA--VGTPDYISPEVLKSQGGDG 222
Query: 382 VISVKSDVFSFGVLLLEIISGKKNSGFY 409
+ D +S GV L E++ G ++ FY
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG--DTPFY 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 27/98 (27%), Positives = 46/98 (46%), Gaps = 12/98 (12%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI-FGGNQNESNTSKVVG 368
+A GLL+LH + H DL N L +++ KI D+G+A + + + V
Sbjct: 109 VASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV- 164
Query: 369 TYGYMAPEYA-------LGGVISVKSDVFSFGVLLLEI 399
++APE L + KS+++S GV + E+
Sbjct: 165 PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 7/96 (7%)
Query: 307 INGIARGLL----YLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN 362
+ +AR LL Y+H + + HRD+K NVL++ + + DFG A G+ +
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 363 TSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLE 398
+ GT APE G + D++S G+++ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 35/126 (27%), Positives = 52/126 (41%), Gaps = 33/126 (26%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA--------RIFGGNQNES 361
IA +L + +L HRD+K N+LLD + + K+SDFG+ F N N S
Sbjct: 107 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166
Query: 362 NTS-------------------------KVVGTYGYMAPEYALGGVISVKSDVFSFGVLL 396
S VGT Y+APE + + D +S GV++
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 397 LEIISG 402
E++ G
Sbjct: 227 YEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 31/103 (30%), Positives = 47/103 (45%), Gaps = 7/103 (6%)
Query: 311 ARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTY 370
A +L L + + HRD+K N+LLD + K++DFG VGT
Sbjct: 149 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM-DETGMVRCDTAVGTP 207
Query: 371 GYMAPEYALG----GVISVKSDVFSFGVLLLEIISGKKNSGFY 409
Y++PE G + D +S GV L E++ G ++ FY
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG--DTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 19/47 (40%), Positives = 32/47 (68%), Gaps = 3/47 (6%)
Query: 307 INGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
I+ +A L YLH R + HRDLK N+L+ +E + K++DFG++++
Sbjct: 110 ISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.003
Identities = 38/144 (26%), Positives = 66/144 (45%), Gaps = 16/144 (11%)
Query: 322 RLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYALG- 380
+L HRD+K N+L+D + +++DFG +S VGT Y++PE
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 381 ----GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDP 436
G + D +S GV + E++ G+ + FY +SL+ K+ + E +
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGE--TPFY----AESLVETYGKIMNHKERFQFPAQ 232
Query: 437 VLKQSCMAAELLKCIHIGLLCVQE 460
V S A +L++ L+C +E
Sbjct: 233 VTDVSEDAKDLIR----RLICSRE 252
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 523 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.97 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.96 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.96 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.95 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.95 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.95 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.95 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.95 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.94 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.94 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.94 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.94 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.94 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.94 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.94 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.94 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.93 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.93 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.93 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.93 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.93 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.93 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.93 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.93 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.93 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.92 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.92 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.92 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.92 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.92 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.92 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.92 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.92 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.92 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.92 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.92 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.92 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.92 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.92 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.92 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.92 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.92 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.92 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.92 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.92 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.92 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.92 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.92 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.92 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.92 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.92 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.92 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.92 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.92 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.92 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.92 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.92 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.92 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.92 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.92 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.91 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.91 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.91 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.91 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.91 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.91 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.91 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.91 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.91 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.91 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.91 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.91 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.91 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.91 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.91 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.91 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.91 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.91 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.91 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.91 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.91 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.91 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.91 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.91 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.91 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.91 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.91 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.91 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.91 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.91 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.91 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.91 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.91 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.91 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.91 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.91 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.91 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.91 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.91 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.91 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.91 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.91 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.91 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.91 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.91 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.91 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.91 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.91 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.91 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.9 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.9 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.9 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.9 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.9 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.9 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.9 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.9 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.9 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.9 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.9 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.9 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.9 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.9 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.9 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.9 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.9 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.9 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.9 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.9 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.9 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.9 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.9 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.9 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.9 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.9 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.9 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.9 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.9 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.9 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.9 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.9 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.9 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.9 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.89 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.89 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.89 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.89 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.89 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.89 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.89 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.89 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.89 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.89 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.89 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.89 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.89 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.89 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.89 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.89 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.89 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.89 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.89 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.89 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.89 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.89 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.89 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.89 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.89 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.89 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.89 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.89 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.89 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.89 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.89 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.88 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.88 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.88 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.88 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.88 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.88 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.88 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.88 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.88 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.88 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.88 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.88 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.88 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.88 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.88 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.88 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.88 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.88 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.88 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.88 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.88 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.88 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.88 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.88 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.88 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.88 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.88 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.88 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.88 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.88 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.88 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.88 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.88 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.88 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.88 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.88 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.88 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.88 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.88 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.87 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.87 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.87 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.87 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.87 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.87 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.87 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.87 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.87 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.87 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.87 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.87 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.87 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.87 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.87 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.87 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.87 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.87 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.87 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.87 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.87 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.87 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.87 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.87 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.87 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.87 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.87 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.87 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.87 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.87 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.87 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.87 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.86 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.86 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.86 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.86 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.86 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.86 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.86 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.86 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.86 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.86 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.86 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.86 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.86 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.86 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.86 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.86 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.86 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.86 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.86 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.85 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.85 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.85 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.85 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.85 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.85 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.85 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.85 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.84 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.84 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.84 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.84 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.83 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.83 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.83 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.83 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.83 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.83 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.82 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.82 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.81 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.81 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.81 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.8 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.79 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.79 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.78 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.77 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.76 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.75 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.74 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.73 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.73 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.72 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.71 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.68 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.67 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.63 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.63 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.62 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.59 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.59 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.58 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.56 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.54 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.5 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.5 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.44 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.42 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.33 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.31 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.27 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.25 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.07 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.05 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.04 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 98.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 98.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 98.88 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.87 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.65 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.58 | |
| smart00090 | 237 | RIO RIO-like kinase. | 98.52 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.51 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 98.42 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 98.38 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 98.32 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.31 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 98.16 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 98.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.11 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 98.09 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.05 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.0 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 97.95 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 97.84 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 97.65 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 97.6 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 97.6 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 97.6 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 97.47 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 97.35 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 97.23 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 97.22 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 97.21 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.1 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 96.4 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 96.28 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.16 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 96.04 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 95.54 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 94.77 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 94.59 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 92.84 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 91.82 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 91.72 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 91.25 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 91.11 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 91.02 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 90.36 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 89.4 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 89.27 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 88.7 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 88.6 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 88.47 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 88.46 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 88.45 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 88.26 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 88.09 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 87.71 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 87.49 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 87.37 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 87.23 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 86.97 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 86.05 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 85.86 | |
| PLN02236 | 344 | choline kinase | 85.76 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 85.19 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 84.31 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 84.12 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 81.82 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=279.81 Aligned_cols=199 Identities=39% Similarity=0.649 Sum_probs=170.6
Q ss_pred eEeeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCC
Q 046010 278 AIWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGN 357 (523)
Q Consensus 278 ~~~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 357 (523)
..|++.|++.++++......|+|..+++|+.++|+||+|||+...++|||||||++|||+|++.++||+|||+++.....
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG 230 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence 45666787778888766558999999999999999999999988778999999999999999999999999999765331
Q ss_pred CCCccccce-eccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCc
Q 046010 358 QNESNTSKV-VGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDP 436 (523)
Q Consensus 358 ~~~~~~~~~-~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (523)
....... .||.+|++||++..+..+.|+||||||++++||++|+++.+.........+..|.+..+..+...+++|+
T Consensus 231 --~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~ 308 (361)
T KOG1187|consen 231 --DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDP 308 (361)
T ss_pred --ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCC
Confidence 1111122 7999999999999999999999999999999999999887655545555688999999999999999999
Q ss_pred ccc-CCccH-HHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 437 VLK-QSCMA-AELLKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 437 ~l~-~~~~~-~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
.+. ..... .++.++.+++.+|++.+|++||+|.||+++|+..
T Consensus 309 ~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 309 RLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred CccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 987 44443 6888999999999999999999999999999554
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=260.10 Aligned_cols=187 Identities=28% Similarity=0.395 Sum_probs=150.2
Q ss_pred eeEeeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC-CeeEeccccceecc
Q 046010 277 KAIWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM-NPKISDFGMARIFG 355 (523)
Q Consensus 277 ~~~~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~ 355 (523)
...|+..|+...+++..++..|++..+++|+.||++||.|||++++ ||||||||+|||++.++ .+||+|||+++...
T Consensus 118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 4778888999888887788999999999999999999999999973 99999999999999997 99999999998764
Q ss_pred CCCCCccccceeccCCCCchhhhc--CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccc
Q 046010 356 GNQNESNTSKVVGTYGYMAPEYAL--GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALEL 433 (523)
Q Consensus 356 ~~~~~~~~~~~~gt~~y~aPE~l~--~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (523)
... ...+...||+.|||||++. ...++.|+||||||+++|||+||+.||..... .+........+....
T Consensus 196 ~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~Rp~- 266 (362)
T KOG0192|consen 196 ISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLRPP- 266 (362)
T ss_pred ccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCCCC-
Confidence 322 2233368999999999999 56899999999999999999999999864332 222222222222222
Q ss_pred cCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCCCC
Q 046010 434 MDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTVSL 482 (523)
Q Consensus 434 ~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~l 482 (523)
.+......+..||.+||+.||++||++.+|+.+|+......
T Consensus 267 --------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 267 --------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred --------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 22224567788889999999999999999999999765433
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-30 Score=247.33 Aligned_cols=232 Identities=23% Similarity=0.274 Sum_probs=160.5
Q ss_pred CCccEEEEEEecCCCChhchHHHHHHHHHhhhhhcCCCcceEEEcCCeeEEeecCCCCCCCCCCCCCCCCCCCCCCCCcc
Q 046010 190 ASQTLYGLVQCTPDLSRHDCSTCLRLAISSFDECFSINIGGRMMYPSCNFRYELYPFYDDPSIVTPPPVFLSPPSPGSVT 269 (523)
Q Consensus 190 ~~~~vyglaQC~~Dls~~~C~~CL~~~~~~~~~~c~~~~g~~v~~~~C~~Ry~~~~f~~~~~~~~~~~~~~~~~~~~~~~ 269 (523)
..+++|++--=..+..+..+++=++.+--.-.-.++. .| +||-- ||.....
T Consensus 102 ~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spy----IV---~~yga-----F~~~~~~----------------- 152 (364)
T KOG0581|consen 102 PTGKIYALKVILLNIDPALQKQILRELEILRSCQSPY----IV---GFYGA-----FYSNGEE----------------- 152 (364)
T ss_pred CCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCC----ee---eEeEE-----EEeCCce-----------------
Confidence 4578999998888999999888777654322222221 11 12221 2222100
Q ss_pred ccCCCCceeEeeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-cCCCcEEecCCCCCcEEeCCCCCeeEecc
Q 046010 270 SSKGKGRKAIWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHE-DSRLKVFHRDLKASNVLLDHEMNPKISDF 348 (523)
Q Consensus 270 ~~~~~~~~~~~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~g~~~ivH~Dlkp~NIll~~~~~~kL~Df 348 (523)
......||-.|++-.. + .+.+++++...-+|+.+|++||.|||+ .+ ||||||||+|||++..|.+||+||
T Consensus 153 ----isI~mEYMDgGSLd~~-~-k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDF 223 (364)
T KOG0581|consen 153 ----ISICMEYMDGGSLDDI-L-KRVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDF 223 (364)
T ss_pred ----EEeehhhcCCCCHHHH-H-hhcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccc
Confidence 0011333334444322 2 223779999999999999999999996 55 999999999999999999999999
Q ss_pred ccceeccCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcC
Q 046010 349 GMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNG 428 (523)
Q Consensus 349 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 428 (523)
|.+..+... ....++||..|||||.+.+..|+.++||||||++++|+.+|+.|+..... ......+.... +..+
T Consensus 224 GVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-~~~~~~~Ll~~-Iv~~ 297 (364)
T KOG0581|consen 224 GVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-PYLDIFELLCA-IVDE 297 (364)
T ss_pred cccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-CCCCHHHHHHH-HhcC
Confidence 999877433 34578999999999999999999999999999999999999999865411 11122221111 1111
Q ss_pred CcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 429 EALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 429 ~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
....+ ... ....++.+++..||++||.+||++.|+++
T Consensus 298 ppP~l-----P~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 298 PPPRL-----PEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCCC-----Ccc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11111 111 13346778888999999999999999865
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=258.14 Aligned_cols=178 Identities=25% Similarity=0.359 Sum_probs=141.2
Q ss_pred eEeeeccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 278 AIWIAIGTTI---PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 278 ~~~ia~g~~~---~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
.+||.+..|. +.-+.+++++|+|.+++.+++||+.||.|||+++ |+|||||..|||++++.++||+|||+|..+
T Consensus 92 nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l 168 (592)
T KOG0575|consen 92 NVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQL 168 (592)
T ss_pred ceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeee
Confidence 6788888887 3334568899999999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCccccc
Q 046010 355 GGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELM 434 (523)
Q Consensus 355 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (523)
..+ ........||+.|.|||++.....+..+||||+||++|.|+.|++||+..... .....+...+ ..
T Consensus 169 e~~--~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk-------ety~~Ik~~~---Y~ 236 (592)
T KOG0575|consen 169 EYD--GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK-------ETYNKIKLNE---YS 236 (592)
T ss_pred cCc--ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH-------HHHHHHHhcC---cc
Confidence 533 23445689999999999999999999999999999999999999999643221 1222222111 11
Q ss_pred CccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH--Hhcc
Q 046010 435 DPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV--MLAS 477 (523)
Q Consensus 435 ~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~ 477 (523)
-| ........+||..+|+.||.+|||+++|+. ++.+
T Consensus 237 ~P-------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 237 MP-------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred cc-------cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 11 122235667888999999999999999974 5533
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=254.93 Aligned_cols=183 Identities=30% Similarity=0.428 Sum_probs=149.9
Q ss_pred eeEeeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccC
Q 046010 277 KAIWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGG 356 (523)
Q Consensus 277 ~~~~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 356 (523)
...|++.|++.+++-...+..+...+.+.++.||++||+||++++ +|||||.+.||||+++..+||+|||+++...+
T Consensus 279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCC
Confidence 456777888888777778899999999999999999999999998 99999999999999999999999999995543
Q ss_pred CCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccC
Q 046010 357 NQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMD 435 (523)
Q Consensus 357 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (523)
+... ......-+..|.|||.+..+.++.|+|||||||+||||+| |+.|++... +.++.+.++
T Consensus 356 ~~Y~-~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms----------------n~ev~~~le 418 (468)
T KOG0197|consen 356 DEYT-ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS----------------NEEVLELLE 418 (468)
T ss_pred Ccee-ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC----------------HHHHHHHHh
Confidence 3222 2222333678999999999999999999999999999999 666654222 122334455
Q ss_pred ccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 436 PVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 436 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
...+...+..++..+.+||..||+.+|++|||++.+...|+...
T Consensus 419 ~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 419 RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 55556667778888999999999999999999999999987753
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=227.08 Aligned_cols=184 Identities=25% Similarity=0.335 Sum_probs=141.7
Q ss_pred eEeeeccccc-----ccc--ccccccccCHHHHHHHHHHHHHHHHHHHhcC-CCcEEecCCCCCcEEeCCCCCeeEeccc
Q 046010 278 AIWIAIGTTI-----PTI--YSTRRAQLDWKRRISIINGIARGLLYLHEDS-RLKVFHRDLKASNVLLDHEMNPKISDFG 349 (523)
Q Consensus 278 ~~~ia~g~~~-----~~~--~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g-~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 349 (523)
+++|-+.+|- ..+ |..+++.+++..+|+++.|++.||..+|.+- +..|+||||||.||+++.+|.+||+|||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 4555555555 222 4677888999999999999999999999942 1239999999999999999999999999
Q ss_pred cceeccCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCC
Q 046010 350 MARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGE 429 (523)
Q Consensus 350 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 429 (523)
+++.+.... ......+||+.||+||.+.+..|+.|+||||+||++|||..-++||.. .+..+. .+.+.+++
T Consensus 174 L~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g------~n~~~L-~~KI~qgd 244 (375)
T KOG0591|consen 174 LGRFLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG------DNLLSL-CKKIEQGD 244 (375)
T ss_pred hHhHhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc------ccHHHH-HHHHHcCC
Confidence 999875432 223457999999999999999999999999999999999999999853 333333 33344443
Q ss_pred cccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 430 ALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 430 ~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
...+.+ ......+.+|+..|+..||+.||+.-.++..+.++
T Consensus 245 ~~~~p~--------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 245 YPPLPD--------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred CCCCcH--------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 332221 33455677888899999999999976666666554
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=240.00 Aligned_cols=185 Identities=25% Similarity=0.360 Sum_probs=139.4
Q ss_pred EeeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCC
Q 046010 279 IWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ 358 (523)
Q Consensus 279 ~~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 358 (523)
-+|+.|+|++++...-...|++..+..|++++++||.|||++| .||||||+.||||+.+|.+||+|||.+..+-...
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 3677899998887777777999999999999999999999999 9999999999999999999999999987654333
Q ss_pred CCc--cccceeccCCCCchhhhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCccccc
Q 046010 359 NES--NTSKVVGTYGYMAPEYALG--GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELM 434 (523)
Q Consensus 359 ~~~--~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (523)
.+. ......|++.|||||+++. ..|+.|+||||||++..||.+|..||..+.+..- + ... .++......
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv--L----l~t-Lqn~pp~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV--L----LLT-LQNDPPTLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH--H----HHH-hcCCCCCcc
Confidence 221 1156789999999999654 4599999999999999999999999965443211 1 111 112222111
Q ss_pred CccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 435 DPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 435 ~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
...+..+........+.+++..||++||++|||++++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111221112222346778889999999999999999864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=242.12 Aligned_cols=177 Identities=23% Similarity=0.318 Sum_probs=138.0
Q ss_pred eEeeeccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 278 AIWIAIGTTI---PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 278 ~~~ia~g~~~---~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
.+|+.++++- ++-|+.+-+.|++...+.++.+|+.||+|||++| ||||||||+|||+|++|.+||+|||.++.+
T Consensus 148 sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 4566666655 4456778899999999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC---------cc--ccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHH
Q 046010 355 GGNQNE---------SN--TSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWK 423 (523)
Q Consensus 355 ~~~~~~---------~~--~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 423 (523)
...... .. ...++||..|.+||++.....++.+|||+|||+||+|+.|++||.... ...+.+.+..
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N---eyliFqkI~~ 301 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN---EYLIFQKIQA 301 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc---HHHHHHHHHH
Confidence 543222 11 145899999999999999999999999999999999999999985322 1112221111
Q ss_pred hhhcCCcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 424 LWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 424 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
. +-.+.. .-...+.+|+.+.|..||.+|+|..+|.+.
T Consensus 302 l----------~y~fp~----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 302 L----------DYEFPE----GFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred h----------cccCCC----CCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1 111111 222456688889999999999999999653
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=238.75 Aligned_cols=181 Identities=24% Similarity=0.308 Sum_probs=134.3
Q ss_pred eEeeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC-CCCeeEeccccceeccC
Q 046010 278 AIWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH-EMNPKISDFGMARIFGG 356 (523)
Q Consensus 278 ~~~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~a~~~~~ 356 (523)
..|++.|+...++....+ +|++..++.+..||++||.|||++| |||+||||+|||++. ++.+||+|||.++....
T Consensus 95 mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 344445555555555555 8999999999999999999999999 999999999999999 79999999999987653
Q ss_pred C-CCCccccceeccCCCCchhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCccccc
Q 046010 357 N-QNESNTSKVVGTYGYMAPEYALGGV-ISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELM 434 (523)
Q Consensus 357 ~-~~~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (523)
. ..........||+.|||||++..+. ...++|||||||++.||+||++||... ..................+
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P~i- 244 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLPEI- 244 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCCCC-
Confidence 1 1122234578999999999998643 345999999999999999999998643 1111222222222222211
Q ss_pred CccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhc
Q 046010 435 DPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLA 476 (523)
Q Consensus 435 ~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~ 476 (523)
+..-.....+++.+|++.||++|||++++++..-
T Consensus 245 --------p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 245 --------PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred --------CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 1122345667888999999999999999987653
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=240.64 Aligned_cols=177 Identities=23% Similarity=0.327 Sum_probs=136.7
Q ss_pred eEeeecccccccc--ccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceecc
Q 046010 278 AIWIAIGTTIPTI--YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFG 355 (523)
Q Consensus 278 ~~~ia~g~~~~~~--~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 355 (523)
.+|+.+.+.-... -......++|.++..|++++++||+|||.+| |+|||||.+|||+..+|.+||+|||++..+.
T Consensus 344 eLWVVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 344 ELWVVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQIS 420 (550)
T ss_pred eeEEEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence 4566654444211 1334555999999999999999999999999 9999999999999999999999999998876
Q ss_pred CCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccC
Q 046010 356 GNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMD 435 (523)
Q Consensus 356 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (523)
..+. .....+||+.|||||++....|.+|.||||||++++||+-|.+||-... -++..+....++.. ++-
T Consensus 421 ~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~------PlrAlyLIa~ng~P-~lk- 490 (550)
T KOG0578|consen 421 EEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN------PLRALYLIATNGTP-KLK- 490 (550)
T ss_pred cccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC------hHHHHHHHhhcCCC-CcC-
Confidence 5443 4456799999999999999999999999999999999999999985422 22222333333321 111
Q ss_pred ccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 436 PVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 436 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+......+.+++.+||+.|+++|+++.|+++
T Consensus 491 ------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 491 ------NPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred ------CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 11222345668888999999999999999975
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=223.28 Aligned_cols=193 Identities=17% Similarity=0.249 Sum_probs=140.6
Q ss_pred CceeEeeeccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccc
Q 046010 275 GRKAIWIAIGTTI---PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA 351 (523)
Q Consensus 275 ~~~~~~ia~g~~~---~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 351 (523)
+++.+.....+|- +.........++.+.+.+++.|+++|+.|+|+++ +|||||||+||||+.++.+||+|||++
T Consensus 72 rkrklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFA 148 (396)
T KOG0593|consen 72 RKRKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFA 148 (396)
T ss_pred hcceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhh
Confidence 3444555555655 4444566777999999999999999999999998 999999999999999999999999999
Q ss_pred eeccCCCCCccccceeccCCCCchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCccccccc--------chHHHHH
Q 046010 352 RIFGGNQNESNTSKVVGTYGYMAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQ--------SLLAYTW 422 (523)
Q Consensus 352 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~--------~~~~~~~ 422 (523)
+.+.. .....+..+.|..|+|||.+.+ .+|....|||++||++.||++|.+.|+....-+.. +++...+
T Consensus 149 R~L~~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq 226 (396)
T KOG0593|consen 149 RTLSA--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQ 226 (396)
T ss_pred HhhcC--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHH
Confidence 98753 3344567788999999999987 78999999999999999999999988643322211 1122222
Q ss_pred HhhhcCCccc-ccCccccCCc-----cHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 046010 423 KLWCNGEALE-LMDPVLKQSC-----MAAELLKCIHIGLLCVQEDPADRPNMSSVA 472 (523)
Q Consensus 423 ~~~~~~~~~~-~~~~~l~~~~-----~~~~~~~~~~li~~cl~~dP~~RPs~~ei~ 472 (523)
..+....... +.-|...... .+....-+++++..||+.||.+|++-++++
T Consensus 227 ~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 227 SIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred HHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 3332222111 1111111100 112233578999999999999999999885
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-27 Score=227.91 Aligned_cols=159 Identities=26% Similarity=0.304 Sum_probs=124.4
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
.++...+++..+.-++.+|+.||.|||++| ||||||||+|||+|.+|.++|+|||+++..... ...+..+.||+.
T Consensus 116 L~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~--~~~t~tfcGT~e 190 (357)
T KOG0598|consen 116 LQREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD--GDATRTFCGTPE 190 (357)
T ss_pred HHhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC--CCccccccCCcc
Confidence 567788999999999999999999999999 999999999999999999999999999865322 233445899999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|||||++.+..|+..+|.||||+++|||++|.+||.... ........... ... .. +.--.....
T Consensus 191 YmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~------~~~~~~~I~~~-k~~-~~--------p~~ls~~ar 254 (357)
T KOG0598|consen 191 YMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED------VKKMYDKILKG-KLP-LP--------PGYLSEEAR 254 (357)
T ss_pred ccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc------HHHHHHHHhcC-cCC-CC--------CccCCHHHH
Confidence 999999999999999999999999999999999985332 22222222221 100 00 111123556
Q ss_pred HHhhhcccCCCCCCC----CHHHH
Q 046010 452 HIGLLCVQEDPADRP----NMSSV 471 (523)
Q Consensus 452 ~li~~cl~~dP~~RP----s~~ei 471 (523)
+++..+|+.||++|. .+.+|
T Consensus 255 dll~~LL~rdp~~RLg~~~d~~~i 278 (357)
T KOG0598|consen 255 DLLKKLLKRDPRQRLGGPGDAEEI 278 (357)
T ss_pred HHHHHHhccCHHHhcCCCCChHHh
Confidence 788889999999995 45554
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=240.00 Aligned_cols=167 Identities=30% Similarity=0.393 Sum_probs=128.3
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
.+..+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++...............++..|+
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 3467999999999999999999999998 9999999999999999999999999998653322222222344567899
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
|||.+.+..++.++||||||+++|||++ |..||...... . ........+..... +......+.+
T Consensus 244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--~----~~~~~~~~~~~~~~---------~~~~~~~l~~ 308 (338)
T cd05102 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--E----EFCQRLKDGTRMRA---------PENATPEIYR 308 (338)
T ss_pred CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--H----HHHHHHhcCCCCCC---------CCCCCHHHHH
Confidence 9999999999999999999999999997 99998643221 1 11111222211111 1122346778
Q ss_pred HhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 453 IGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
|+.+||+.||++|||+.||+++|++.
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-27 Score=229.93 Aligned_cols=190 Identities=23% Similarity=0.251 Sum_probs=140.2
Q ss_pred eEeeecccccccc---ccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 278 AIWIAIGTTIPTI---YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 278 ~~~ia~g~~~~~~---~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
.+++.+.+.-.-+ +..+++.+++..++.|+.||++||+|+|++| +.||||||+|||+..+..+||+|||+++.+
T Consensus 84 ~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 84 ILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 7777776655333 3566888999999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCccccceeccCCCCchhhhc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHH-----HHhhh--
Q 046010 355 GGNQNESNTSKVVGTYGYMAPEYAL-GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYT-----WKLWC-- 426 (523)
Q Consensus 355 ~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~-----~~~~~-- 426 (523)
. .....+..+.|..|+|||++. .+-|+.+.|||++|||++|+.+-++.|....+.+....+-.+ ++.|.
T Consensus 161 ~---SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 161 R---SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred c---cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 4 334456678899999999875 577999999999999999999999888643322111111000 01111
Q ss_pred -------cCCcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 427 -------NGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 427 -------~~~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
+-...+.....+.. .......++++++.+|+.+||.+|||+.|.+++
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~-L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKD-LLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhccCCCcCCCCChHH-hCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 11111111111111 112355678899999999999999999999875
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-28 Score=234.69 Aligned_cols=178 Identities=22% Similarity=0.289 Sum_probs=132.2
Q ss_pred ceeEeeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCC---CCeeEeccccce
Q 046010 276 RKAIWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE---MNPKISDFGMAR 352 (523)
Q Consensus 276 ~~~~~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~---~~~kL~Dfg~a~ 352 (523)
..+.|+..|-.++.|. .++.+.+..-+.+++||+.||.|||++| |+||||||+|||+..+ -.+||+|||+++
T Consensus 253 mVlE~v~GGeLfd~vv--~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 253 MVLEYVEGGELFDKVV--ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred EEEEEecCccHHHHHH--hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhh
Confidence 3455556666665554 4556888888999999999999999999 9999999999999876 568999999999
Q ss_pred eccCCCCCccccceeccCCCCchhhhcCCC---CCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCC
Q 046010 353 IFGGNQNESNTSKVVGTYGYMAPEYALGGV---ISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGE 429 (523)
Q Consensus 353 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 429 (523)
..+ .........||+.|.|||++.+.. +..+.|+||+||+||-+++|.+||....... .+.+ .+..+.
T Consensus 328 ~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~e----QI~~G~ 398 (475)
T KOG0615|consen 328 VSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKE----QILKGR 398 (475)
T ss_pred ccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHH----HHhcCc
Confidence 875 233455789999999999997654 2347899999999999999999986433221 1111 111222
Q ss_pred cccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 430 ALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 430 ~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.... .........+.++||.+||..||++|||+.|+++
T Consensus 399 y~f~------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 399 YAFG------PLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cccc------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1111 0111233457788999999999999999999864
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-27 Score=238.52 Aligned_cols=176 Identities=27% Similarity=0.405 Sum_probs=132.5
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
..+.+|+....+.|++||++|+.|||.++ |||||||..|||+.+++.|||+|||++.....-..........|...|
T Consensus 480 v~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilw 556 (678)
T KOG0193|consen 480 VQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLW 556 (678)
T ss_pred chhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhh
Confidence 34588999999999999999999999998 999999999999999999999999998754322222233456678899
Q ss_pred CchhhhcC---CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 373 MAPEYALG---GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 373 ~aPE~l~~---~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
||||+++. .+|++.+||||||+++|||++|..||.....+ + -+|.-+.-.-..|.... .......
T Consensus 557 mAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d--q-------IifmVGrG~l~pd~s~~---~s~~pk~ 624 (678)
T KOG0193|consen 557 MAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD--Q-------IIFMVGRGYLMPDLSKI---RSNCPKA 624 (678)
T ss_pred hcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh--h-------eEEEecccccCccchhh---hccCHHH
Confidence 99999874 46899999999999999999999998521111 1 11111111111111111 1244567
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHHHhccCCCCCC
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAVMLASDTVSLP 483 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~l~ 483 (523)
+.+|+..||..++++||.+.+|+.+|+..-.++|
T Consensus 625 mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~p 658 (678)
T KOG0193|consen 625 MKRLLSDCWKFDREERPLFPQLLSKLEELLPSLP 658 (678)
T ss_pred HHHHHHHHHhcCcccCccHHHHHHHHHHhhhccc
Confidence 7888899999999999999999998877654443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=225.82 Aligned_cols=124 Identities=31% Similarity=0.501 Sum_probs=111.3
Q ss_pred eEeeeccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCC------CCeeEecc
Q 046010 278 AIWIAIGTTI---PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE------MNPKISDF 348 (523)
Q Consensus 278 ~~~ia~g~~~---~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~------~~~kL~Df 348 (523)
.+|+.+.+|. +--|..+++.+++..++.++.||+.||++||+++ ||||||||+|||++.. -.+||+||
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 6788888888 4457888889999999999999999999999999 9999999999999875 45899999
Q ss_pred ccceeccCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 046010 349 GMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSG 407 (523)
Q Consensus 349 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~ 407 (523)
|+++.+. .........|++.|||||+++..+|+.|+|+||+|+++|++++|+.||.
T Consensus 160 GfAR~L~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 160 GFARFLQ---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred chhhhCC---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999875 2334456789999999999999999999999999999999999999986
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=237.44 Aligned_cols=181 Identities=26% Similarity=0.342 Sum_probs=142.2
Q ss_pred eeccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCC
Q 046010 281 IAIGTTI---PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGN 357 (523)
Q Consensus 281 ia~g~~~---~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 357 (523)
|.+.+|- +.-..+.+.++.......|..+|+.|+.|||.+. |||||||..||||+.+..+||+|||.++.....
T Consensus 189 IiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK 265 (904)
T ss_pred EeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence 3355554 2223567788999999999999999999999996 999999999999999999999999999876432
Q ss_pred CCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCcc
Q 046010 358 QNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPV 437 (523)
Q Consensus 358 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (523)
.....+.||..|||||++++.+.++|+||||||||||||+||..||..-...- .. | -+=...
T Consensus 266 ---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA------II---w------GVGsNs 327 (904)
T KOG4721|consen 266 ---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA------II---W------GVGSNS 327 (904)
T ss_pred ---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe------eE---E------eccCCc
Confidence 34456899999999999999999999999999999999999999975322110 01 1 111122
Q ss_pred ccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCCCC
Q 046010 438 LKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTVSL 482 (523)
Q Consensus 438 l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~l 482 (523)
+....+..++..+.-|+.+||+..|..||++++|+..|.-...++
T Consensus 328 L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 328 LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 333344455666777888999999999999999999997665444
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=232.80 Aligned_cols=173 Identities=25% Similarity=0.327 Sum_probs=134.5
Q ss_pred Eeeeccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCC-CCeeEeccccceec
Q 046010 279 IWIAIGTTI---PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE-MNPKISDFGMARIF 354 (523)
Q Consensus 279 ~~ia~g~~~---~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~a~~~ 354 (523)
+++.+.+|. ++-|..+++++.+.++.+++.||+.|++|+|++| |+||||||+|||++.+ +++||+|||++...
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 666666666 2334556899999999999999999999999999 9999999999999999 99999999999876
Q ss_pred cCCCCCccccceeccCCCCchhhhcCCC-CC-cchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCccc
Q 046010 355 GGNQNESNTSKVVGTYGYMAPEYALGGV-IS-VKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALE 432 (523)
Q Consensus 355 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s-~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (523)
. ..........|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||.. ......... +..+...
T Consensus 172 ~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d------~~~~~l~~k-i~~~~~~- 241 (370)
T KOG0583|consen 172 P--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD------SNVPNLYRK-IRKGEFK- 241 (370)
T ss_pred C--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC------ccHHHHHHH-HhcCCcc-
Confidence 3 2233455789999999999999877 76 789999999999999999999964 111111111 2221111
Q ss_pred ccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 046010 433 LMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVA 472 (523)
Q Consensus 433 ~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~ 472 (523)
+...+. ...+..|+.+||..||.+|+++.+|+
T Consensus 242 -~p~~~~-------S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 242 -IPSYLL-------SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred -CCCCcC-------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 011110 34667888999999999999999998
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-27 Score=229.37 Aligned_cols=172 Identities=24% Similarity=0.328 Sum_probs=132.7
Q ss_pred EeeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCC
Q 046010 279 IWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ 358 (523)
Q Consensus 279 ~~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 358 (523)
.|+..|++.+++ ..+..+++..+.-++++++.||.|||.++ .+|||||+.|||+..+|.+||+|||.+.......
T Consensus 91 ey~~gGsv~~lL--~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 91 EYCGGGSVLDLL--KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHhcCcchhhhh--ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh
Confidence 344455555554 33344588999999999999999999998 9999999999999999999999999998875443
Q ss_pred CCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccc
Q 046010 359 NESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVL 438 (523)
Q Consensus 359 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 438 (523)
.. ...++||+.|||||++....|+.|+||||||++.+||.+|.+|+....+... .-++....
T Consensus 166 ~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv----------------lflIpk~~ 227 (467)
T KOG0201|consen 166 KR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV----------------LFLIPKSA 227 (467)
T ss_pred hc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE----------------EEeccCCC
Confidence 32 3678999999999999988999999999999999999999999864443211 11111111
Q ss_pred cCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 439 KQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 439 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
...........+.+++..||.+||+.||++.++++
T Consensus 228 PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 228 PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 11111122345778888999999999999999864
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-26 Score=226.19 Aligned_cols=163 Identities=31% Similarity=0.428 Sum_probs=127.9
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..++.++.||+.||.|||+++ ++|+||||+||++++++.+||+|||++................++..|+||
T Consensus 119 ~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 195 (283)
T cd05048 119 SSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPP 195 (283)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCH
Confidence 46899999999999999999999998 999999999999999999999999999765333222223344567889999
Q ss_pred hhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 376 EYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 376 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
|.+.+..++.++||||||+++|||++ |..||...... .. ...+..+.... .+.....++.+|+
T Consensus 196 E~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~----~~~i~~~~~~~---------~~~~~~~~~~~l~ 259 (283)
T cd05048 196 EAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EV----IEMIRSRQLLP---------CPEDCPARVYALM 259 (283)
T ss_pred HHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HH----HHHHHcCCcCC---------CcccCCHHHHHHH
Confidence 99988899999999999999999998 99887532211 11 11122221111 1223346788899
Q ss_pred hhcccCCCCCCCCHHHHHHHhcc
Q 046010 455 LLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
.+||+.||.+||++.||++.|++
T Consensus 260 ~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 260 IECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHccCChhhCcCHHHHHHHHhc
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=211.96 Aligned_cols=164 Identities=27% Similarity=0.356 Sum_probs=127.0
Q ss_pred ccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccC
Q 046010 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTY 370 (523)
Q Consensus 291 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~ 370 (523)
|......+++++..+|++|+.+|+.|||.++ ||||||||+|||++++.++||+|||++..+... .......||+
T Consensus 113 yLts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~~G---ekLrelCGTP 186 (411)
T KOG0599|consen 113 YLTSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLEPG---EKLRELCGTP 186 (411)
T ss_pred HhhhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccCCc---hhHHHhcCCC
Confidence 4577788999999999999999999999998 999999999999999999999999999987532 3345678999
Q ss_pred CCCchhhhcC------CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccH
Q 046010 371 GYMAPEYALG------GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMA 444 (523)
Q Consensus 371 ~y~aPE~l~~------~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 444 (523)
+|+|||.+.- ..|+...|+|++|+++|.|+.|.+||-... .-...+.+.+++..- ....-.
T Consensus 187 gYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-------QmlMLR~ImeGkyqF------~speWa 253 (411)
T KOG0599|consen 187 GYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-------QMLMLRMIMEGKYQF------RSPEWA 253 (411)
T ss_pred cccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-------HHHHHHHHHhccccc------CCcchh
Confidence 9999998852 348889999999999999999999972110 001122222332211 111112
Q ss_pred HHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 445 AELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 445 ~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+......+|+.+||+.||.+|.|++|+++
T Consensus 254 dis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 254 DISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred hccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 33345678899999999999999999864
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-26 Score=235.55 Aligned_cols=167 Identities=29% Similarity=0.422 Sum_probs=126.4
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
...++++..+++++.||++||.|||+++ |+||||||+||++++++.+||+|||+++...............++..|+
T Consensus 205 ~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~ 281 (374)
T cd05106 205 DSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWM 281 (374)
T ss_pred CCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCcccee
Confidence 3456999999999999999999999998 9999999999999999999999999997654322211122233456799
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
|||++.+..++.++||||||+++|+|++ |+.||....... .. ......+. .... +......+.+
T Consensus 282 aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~----~~~~~~~~--~~~~-------~~~~~~~l~~ 346 (374)
T cd05106 282 APESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KF----YKMVKRGY--QMSR-------PDFAPPEIYS 346 (374)
T ss_pred CHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HH----HHHHHccc--CccC-------CCCCCHHHHH
Confidence 9999998899999999999999999997 999986432211 11 11111111 0000 0111346778
Q ss_pred HhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 453 IGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
++.+||+.||++|||+.+|+++|++.
T Consensus 347 li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 347 IMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 89999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=226.47 Aligned_cols=180 Identities=23% Similarity=0.313 Sum_probs=135.1
Q ss_pred eEeeeccccccc--cccccccc-cCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 278 AIWIAIGTTIPT--IYSTRRAQ-LDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 278 ~~~ia~g~~~~~--~~~~~~~~-l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
.+|+.+.+|-.. .+...... |++.++++++++++.||+|||.+| ||||||||+|+|++.+|.+||+|||.+..+
T Consensus 184 ~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsDFGVs~~~ 260 (576)
T KOG0585|consen 184 KLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISDFGVSNEF 260 (576)
T ss_pred ceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeeccceeeec
Confidence 677777777732 23334444 999999999999999999999999 999999999999999999999999999876
Q ss_pred cCC---CCCccccceeccCCCCchhhhcCCC----CCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhc
Q 046010 355 GGN---QNESNTSKVVGTYGYMAPEYALGGV----ISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCN 427 (523)
Q Consensus 355 ~~~---~~~~~~~~~~gt~~y~aPE~l~~~~----~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 427 (523)
... ..........||+.|+|||...++. .+.+.||||+||+||.|+.|+.||-. ...+....+ +
T Consensus 261 ~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~------~~~~~l~~K-I-- 331 (576)
T KOG0585|consen 261 PQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD------DFELELFDK-I-- 331 (576)
T ss_pred ccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc------chHHHHHHH-H--
Confidence 322 1222344578999999999987633 35688999999999999999999842 222221111 1
Q ss_pred CCcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHh
Q 046010 428 GEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVML 475 (523)
Q Consensus 428 ~~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L 475 (523)
+...+.....++....+.+||+++|++||++|.++.+|....
T Consensus 332 ------vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 332 ------VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred ------hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 111222222224456677899999999999999999997654
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=223.47 Aligned_cols=171 Identities=24% Similarity=0.334 Sum_probs=125.3
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..+++++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...............++..|+|
T Consensus 132 ~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~a 208 (304)
T cd05096 132 LPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMA 208 (304)
T ss_pred cccccHHHHHHHHHHHHHHHHHHHHCC---ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccC
Confidence 346899999999999999999999998 99999999999999999999999999986533222222233445778999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHhC--CCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIISG--KKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~elltG--~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
||.+..+.++.++||||||+++|+|+++ ..||..... ..........+......... ..+...+..+.+
T Consensus 209 PE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~ 279 (304)
T cd05096 209 WECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTD---EQVIENAGEFFRDQGRQVYL------FRPPPCPQGLYE 279 (304)
T ss_pred HHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCH---HHHHHHHHHHhhhccccccc------cCCCCCCHHHHH
Confidence 9999888999999999999999999974 455543221 11222222211111100000 011123356788
Q ss_pred HhhhcccCCCCCCCCHHHHHHHhcc
Q 046010 453 IGLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
|+.+||+.||++|||+.+|.++|++
T Consensus 280 li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 280 LMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred HHHHHccCCchhCcCHHHHHHHHhC
Confidence 9999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.5e-26 Score=223.38 Aligned_cols=172 Identities=24% Similarity=0.277 Sum_probs=127.9
Q ss_pred ccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcc
Q 046010 283 IGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN 362 (523)
Q Consensus 283 ~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 362 (523)
.|....+++......+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++....... .
T Consensus 84 ~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~ 157 (285)
T cd05631 84 GGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---T 157 (285)
T ss_pred CCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC---e
Confidence 344444444445567999999999999999999999998 9999999999999999999999999998753221 1
Q ss_pred ccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCc
Q 046010 363 TSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSC 442 (523)
Q Consensus 363 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 442 (523)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||........ ............ .. .
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~-~~---------~ 224 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---REEVDRRVKEDQ-EE---------Y 224 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---HHHHHHHhhccc-cc---------C
Confidence 2345689999999999999999999999999999999999999864322111 111111111110 00 1
Q ss_pred cHHHHHHHHHHhhhcccCCCCCCCC-----HHHHHH
Q 046010 443 MAAELLKCIHIGLLCVQEDPADRPN-----MSSVAV 473 (523)
Q Consensus 443 ~~~~~~~~~~li~~cl~~dP~~RPs-----~~ei~~ 473 (523)
+......+.+|+.+||+.||++||+ ++++++
T Consensus 225 ~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1112345678899999999999997 677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-26 Score=226.05 Aligned_cols=171 Identities=24% Similarity=0.265 Sum_probs=123.8
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .......++..|+
T Consensus 103 ~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~ 176 (290)
T cd07862 103 PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYR 176 (290)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceEeccCC---ccccccccccccc
Confidence 3456899999999999999999999998 999999999999999999999999999865422 2233456889999
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhh---cCCcc-------cccCccccC---
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWC---NGEAL-------ELMDPVLKQ--- 440 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~-------~~~~~~l~~--- 440 (523)
|||.+.+..++.++||||||+++|||++|+.||....... .+........ ..... ..+......
T Consensus 177 aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (290)
T cd07862 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIE 253 (290)
T ss_pred ChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHH
Confidence 9999988899999999999999999999999986432211 1111111000 00000 000000000
Q ss_pred CccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 441 SCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 441 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.........+.+++.+||+.||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 254 KFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000112345678999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-26 Score=231.28 Aligned_cols=166 Identities=30% Similarity=0.394 Sum_probs=128.2
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..+.+++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++..+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 457999999999999999999999998 99999999999999999999999999987543322222333455678999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||.+.+..++.++|||||||++|||++ |..||....... ............. .+......+.++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~---------~~~~~~~~~~~l 308 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGTRMR---------APEYATPEIYSI 308 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccCCCC---------CCccCCHHHHHH
Confidence 999999999999999999999999998 998885322110 1111111111111 111223467889
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+.+||+.+|++||++.||+++|+..
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=207.40 Aligned_cols=189 Identities=21% Similarity=0.251 Sum_probs=137.3
Q ss_pred eEeeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCC
Q 046010 278 AIWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGN 357 (523)
Q Consensus 278 ~~~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 357 (523)
+++.-+.+-+..+...+...|+..++..++.++++||+|||++. |+||||||.|+|++.+|.+||+|||+++.++..
T Consensus 78 lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 78 LVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred EEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 34444555556666788888999999999999999999999999 999999999999999999999999999988654
Q ss_pred CCCccccceeccCCCCchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcC---Ccccc
Q 046010 358 QNESNTSKVVGTYGYMAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNG---EALEL 433 (523)
Q Consensus 358 ~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 433 (523)
.... ...+-|..|+|||.+.+ ..|+...||||.||++.||+.|.+-|.... +.+.+....+.+..+ ++.++
T Consensus 155 ~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s---DidQL~~If~~LGTP~~~~WP~~ 229 (318)
T KOG0659|consen 155 NRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS---DIDQLSKIFRALGTPTPDQWPEM 229 (318)
T ss_pred Cccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc---hHHHHHHHHHHcCCCCcccCccc
Confidence 4332 23377899999999987 459999999999999999999886654222 222222222221111 11110
Q ss_pred ---cC--------ccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 434 ---MD--------PVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 434 ---~~--------~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
.| .......-......+++|+..+|..||.+|+++.|.+++
T Consensus 230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 00 000111222344566899999999999999999998765
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-26 Score=225.31 Aligned_cols=166 Identities=28% Similarity=0.361 Sum_probs=129.0
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++................++..|+||
T Consensus 118 ~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP 194 (291)
T cd05094 118 GELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 194 (291)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecCh
Confidence 45899999999999999999999998 999999999999999999999999998765332222222334567789999
Q ss_pred hhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 376 EYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 376 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
|.+.+..++.++||||||+++|+|++ |+.||...... ........+...+. .......+.+++
T Consensus 195 E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~~---------~~~~~~~~~~li 258 (291)
T cd05094 195 ESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-------EVIECITQGRVLER---------PRVCPKEVYDIM 258 (291)
T ss_pred HHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHhCCCCCCC---------CccCCHHHHHHH
Confidence 99998899999999999999999999 99887532221 11122222222211 111234677899
Q ss_pred hhcccCCCCCCCCHHHHHHHhccCCC
Q 046010 455 LLCVQEDPADRPNMSSVAVMLASDTV 480 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~~L~~~~~ 480 (523)
.+||+.+|++||++.+|+++|+....
T Consensus 259 ~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 259 LGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHcccChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999988744
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-26 Score=223.61 Aligned_cols=177 Identities=27% Similarity=0.372 Sum_probs=132.1
Q ss_pred ccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcc
Q 046010 283 IGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN 362 (523)
Q Consensus 283 ~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 362 (523)
.|.+..++. .+...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||.++..........
T Consensus 92 ~gsL~~~l~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 167 (279)
T cd05111 92 LGSLLDHVR-QHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYF 167 (279)
T ss_pred CCcHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCCCcccc
Confidence 444443332 33457999999999999999999999998 99999999999999999999999999987643322222
Q ss_pred ccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCC
Q 046010 363 TSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQS 441 (523)
Q Consensus 363 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 441 (523)
.....++..|++||.+.++.++.++||||||+++||+++ |+.||...... .....+..+.... .+.
T Consensus 168 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~--~~~---- 234 (279)
T cd05111 168 YSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-------EVPDLLEKGERLA--QPQ---- 234 (279)
T ss_pred cCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCCcCC--CCC----
Confidence 334456778999999998899999999999999999998 98887532211 1111122222111 111
Q ss_pred ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 442 CMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 442 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
.....+.+++.+||..||++|||+.|+++.|....
T Consensus 235 ---~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 235 ---ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred ---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11234567888999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=237.60 Aligned_cols=183 Identities=20% Similarity=0.198 Sum_probs=141.1
Q ss_pred ceeEeeeccccc-----cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEecccc
Q 046010 276 RKAIWIAIGTTI-----PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGM 350 (523)
Q Consensus 276 ~~~~~ia~g~~~-----~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 350 (523)
...+++.+.+|- +.+-.+....|++.++++|+.|+++|+.+||.. +++|||||||-+||||+.++..||+|||.
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 455666666666 233233455599999999999999999999999 47899999999999999999999999999
Q ss_pred ceeccCCCCCc-------cccceeccCCCCchhhh---cCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHH
Q 046010 351 ARIFGGNQNES-------NTSKVVGTYGYMAPEYA---LGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAY 420 (523)
Q Consensus 351 a~~~~~~~~~~-------~~~~~~gt~~y~aPE~l---~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~ 420 (523)
+.......... ..-....|+.|++||.+ .+..+++|+|||+|||+||.|+....||+...
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg---------- 262 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG---------- 262 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc----------
Confidence 86532222110 11134568999999976 57789999999999999999999999985311
Q ss_pred HHHhhhcCCcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 421 TWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 421 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
...++.........+....++.+||..||+.||.+||++-+|++.+...
T Consensus 263 ---------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 263 ---------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred ---------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 2233333333333456777889999999999999999999999888665
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-26 Score=233.43 Aligned_cols=170 Identities=28% Similarity=0.414 Sum_probs=128.4
Q ss_pred ccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccC
Q 046010 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTY 370 (523)
Q Consensus 291 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~ 370 (523)
.......+++..+++++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++...............++.
T Consensus 204 ~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 280 (375)
T cd05104 204 LEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280 (375)
T ss_pred HhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCc
Confidence 3455678999999999999999999999998 9999999999999999999999999998654332221222233456
Q ss_pred CCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 371 GYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 371 ~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
.|+|||.+.+..++.++||||||+++|||++ |..||...... ... .+....+.... . +.....+
T Consensus 281 ~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~----~~~~~~~~~~~--~-------~~~~~~~ 345 (375)
T cd05104 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKF----YKMIKEGYRML--S-------PECAPSE 345 (375)
T ss_pred ceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHH----HHHHHhCccCC--C-------CCCCCHH
Confidence 7999999999999999999999999999998 78887532211 111 11112111100 0 1111346
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+.+|+.+||+.||++||++.||+++|++.
T Consensus 346 l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 346 MYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 77899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.5e-26 Score=223.19 Aligned_cols=164 Identities=28% Similarity=0.401 Sum_probs=125.2
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
+..+++..++.++.|++.||.|||+++ |+||||||+||++++++.+||+|||+++...............+++.|+|
T Consensus 118 ~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 194 (283)
T cd05091 118 KSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMS 194 (283)
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccC
Confidence 346899999999999999999999998 99999999999999999999999999876533222222233445678999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||.+.++.++.++||||||+++|||++ |..||..... . ............. .+......+.++
T Consensus 195 PE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~----~~~~~i~~~~~~~---------~~~~~~~~~~~l 258 (283)
T cd05091 195 PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---Q----DVIEMIRNRQVLP---------CPDDCPAWVYTL 258 (283)
T ss_pred HHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---H----HHHHHHHcCCcCC---------CCCCCCHHHHHH
Confidence 999988889999999999999999998 7777643211 1 1111122222111 111233457789
Q ss_pred hhhcccCCCCCCCCHHHHHHHhcc
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
+..||+.+|++||++.+|++.|+.
T Consensus 259 i~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 259 MLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHhCCCcccCCCHHHHHHHhhC
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.2e-26 Score=223.69 Aligned_cols=163 Identities=20% Similarity=0.288 Sum_probs=125.8
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhc-CCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHED-SRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~-g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
.+.+.+++..++.++.|++.||.|||+. + ++||||||+||++++++.+||+|||+++..... .....++..
T Consensus 114 ~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~ 185 (283)
T PHA02988 114 DKEKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-----PFKNVNFMV 185 (283)
T ss_pred hhCCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccc-----cccccCccc
Confidence 3456799999999999999999999985 6 889999999999999999999999998764321 123457889
Q ss_pred CCchhhhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 372 YMAPEYALG--GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 372 y~aPE~l~~--~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
|+|||++.+ ..++.++||||||+++|||++|+.||...... .+.. .......... .+......
T Consensus 186 y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~~~---~i~~~~~~~~---------~~~~~~~~ 250 (283)
T PHA02988 186 YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EIYD---LIINKNNSLK---------LPLDCPLE 250 (283)
T ss_pred ccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HHHH---HHHhcCCCCC---------CCCcCcHH
Confidence 999999976 67999999999999999999999998633211 1111 1111111100 11123446
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+.+|+.+||+.||++|||+.||++.|+..
T Consensus 251 l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 251 IKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred HHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 77899999999999999999999999764
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=219.14 Aligned_cols=175 Identities=25% Similarity=0.354 Sum_probs=129.5
Q ss_pred cccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccc
Q 046010 284 GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNT 363 (523)
Q Consensus 284 g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 363 (523)
|....++-......+++..++.++.||++||+|||+++ ++||||||+||++++++.+||+|||++......... ..
T Consensus 87 ~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~~ 162 (263)
T cd05052 87 GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AH 162 (263)
T ss_pred CcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee-cc
Confidence 33333333334557999999999999999999999998 999999999999999999999999998765432111 11
Q ss_pred cceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCc
Q 046010 364 SKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSC 442 (523)
Q Consensus 364 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 442 (523)
.....+..|+|||.+.+..++.++||||||+++|||++ |..||..... ...+......... ..
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~---------~~ 226 (263)
T cd05052 163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVYELLEKGYRM---------ER 226 (263)
T ss_pred CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHCCCCC---------CC
Confidence 12233567999999998899999999999999999998 8888753211 1112222211111 11
Q ss_pred cHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 443 MAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 443 ~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+......+.+++.+||+.||++||++.+++++|+..
T Consensus 227 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 227 PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 112235677899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=228.74 Aligned_cols=172 Identities=26% Similarity=0.341 Sum_probs=133.7
Q ss_pred eEeeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCC
Q 046010 278 AIWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGN 357 (523)
Q Consensus 278 ~~~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 357 (523)
+.|+..|-.++ |..++++|++.++.+++.||+.|+.|+|..+ |+||||||+|+|+|..+++||+|||+|..-.
T Consensus 91 lEyv~gGELFd--ylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~-- 163 (786)
T KOG0588|consen 91 LEYVPGGELFD--YLVRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV-- 163 (786)
T ss_pred EEecCCchhHH--HHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc--
Confidence 34444555544 3467889999999999999999999999998 9999999999999999999999999998643
Q ss_pred CCCccccceeccCCCCchhhhcCCCCC-cchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCc
Q 046010 358 QNESNTSKVVGTYGYMAPEYALGGVIS-VKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDP 436 (523)
Q Consensus 358 ~~~~~~~~~~gt~~y~aPE~l~~~~~s-~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (523)
........+|+++|.+||++++.+|. .++||||.|||||.|++|+.||+ ++++.... .....+. .++
T Consensus 164 -~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd------DdNir~LL-lKV~~G~-f~M--- 231 (786)
T KOG0588|consen 164 -PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD------DDNIRVLL-LKVQRGV-FEM--- 231 (786)
T ss_pred -CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC------CccHHHHH-HHHHcCc-ccC---
Confidence 23344567899999999999999875 68999999999999999999995 22222211 1112221 111
Q ss_pred cccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 437 VLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 437 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
+.....++.+|+.+|+..||++|.|++||++.
T Consensus 232 ------Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 232 ------PSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ------CCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 11223466788899999999999999999873
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-25 Score=228.11 Aligned_cols=178 Identities=19% Similarity=0.216 Sum_probs=124.4
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..++..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++....... ........||+.
T Consensus 173 l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~gt~~ 248 (391)
T PHA03212 173 LAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKYYGWAGTIA 248 (391)
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-ccccccccCccC
Confidence 445567999999999999999999999998 9999999999999999999999999987532211 112234578999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccc----cchHHHHHHhhhc--CCc--------ccc----
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHG----QSLLAYTWKLWCN--GEA--------LEL---- 433 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~----~~~~~~~~~~~~~--~~~--------~~~---- 433 (523)
|+|||++.+..++.++|||||||++|||++|+.||........ ...+......... .+. .+.
T Consensus 249 y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~ 328 (391)
T PHA03212 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGL 328 (391)
T ss_pred CCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHH
Confidence 9999999998999999999999999999999987642211110 0011111100000 000 000
Q ss_pred -----cCccccCCc--cHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 434 -----MDPVLKQSC--MAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 434 -----~~~~l~~~~--~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
..+..+... .......+.+|+.+||+.||++|||++|+++
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 329 AKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000 0122446788999999999999999999974
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=204.24 Aligned_cols=182 Identities=24% Similarity=0.267 Sum_probs=132.7
Q ss_pred ccccccccc--cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC
Q 046010 283 IGTTIPTIY--STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE 360 (523)
Q Consensus 283 ~g~~~~~~~--~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 360 (523)
.|+..+.+- ..++..+++.++++|+.+|++||++||+.. +++.||||||.||++++++.++|.|||.+......-..
T Consensus 107 ~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~ 185 (302)
T KOG2345|consen 107 RGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEG 185 (302)
T ss_pred cccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccccceEeec
Confidence 455554433 344557999999999999999999999996 47999999999999999999999999988754211000
Q ss_pred -------ccccceeccCCCCchhhhc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCc
Q 046010 361 -------SNTSKVVGTYGYMAPEYAL---GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEA 430 (523)
Q Consensus 361 -------~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (523)
........|..|+|||.+. +...++++|||||||++|+|+.|..||+..... +..+.
T Consensus 186 ~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-GgSla------------ 252 (302)
T KOG2345|consen 186 SRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-GGSLA------------ 252 (302)
T ss_pred hHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-CCeEE------------
Confidence 0112345689999999874 455789999999999999999999999643331 11110
Q ss_pred ccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 431 LELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 431 ~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
.......+...........+.+++.+|++.||.+||++.+++..+...
T Consensus 253 LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 253 LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 011111111111122456778899999999999999999999988654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-25 Score=221.06 Aligned_cols=192 Identities=23% Similarity=0.281 Sum_probs=135.1
Q ss_pred eEeeeccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 278 AIWIAIGTTI---PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 278 ~~~ia~g~~~---~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
.+|+...+.- .-+......+|++.++..+++||+.||+|+|++| |+|||||.+|||||.+|.+||+|||+++++
T Consensus 192 siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 192 SIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred eEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 4555544444 2333566778999999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCccccceeccCCCCchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHH-----HHHhhhcC
Q 046010 355 GGNQNESNTSKVVGTYGYMAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAY-----TWKLWCNG 428 (523)
Q Consensus 355 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~-----~~~~~~~~ 428 (523)
...... ..+..+-|+.|+|||++.+ ..|+.+.|+||.||||.||+.|++.|....+.+....+-. ....|...
T Consensus 269 ~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 269 TPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred cCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 654433 3456778999999999987 4699999999999999999999988754322211111100 00111111
Q ss_pred Ccc--cccCccccCCcc-----HHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 429 EAL--ELMDPVLKQSCM-----AAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 429 ~~~--~~~~~~l~~~~~-----~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+. ..+.+...-... ..-....++|+..+|..||.+|.|+.++++
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111 111111100000 011245678888999999999999998764
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=222.41 Aligned_cols=179 Identities=23% Similarity=0.304 Sum_probs=127.6
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcc-ccceeccCCCCc
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN-TSKVVGTYGYMA 374 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~a 374 (523)
..+++.+++.++.||++||.|||+++ |+|+||||+||+++.++.+||+|||+++.......... .....++..|+|
T Consensus 102 ~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (283)
T cd05080 102 HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 178 (283)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeC
Confidence 46999999999999999999999998 99999999999999999999999999886543221111 112234567999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
||.+.+..++.++||||||+++|+|++|..|+....... .................+.++.......+......+.+++
T Consensus 179 PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 257 (283)
T cd05080 179 VECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILM 257 (283)
T ss_pred HhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHH
Confidence 999988889999999999999999999999975432110 0000000000000011111111111111222345778899
Q ss_pred hhcccCCCCCCCCHHHHHHHhccC
Q 046010 455 LLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
.+||+.+|++|||+++|+++|+..
T Consensus 258 ~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 258 KNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred HHHhccChhhCCCHHHHHHHHHHh
Confidence 999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-26 Score=241.46 Aligned_cols=168 Identities=29% Similarity=0.384 Sum_probs=138.6
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
..+|+..+.+.|+.||+.||+||-++. +|||||-.+|+||.++..|||+|||+++.+-..+.........-..+|||
T Consensus 597 ~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMp 673 (774)
T KOG1026|consen 597 PPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMP 673 (774)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCC
Confidence 455999999999999999999999997 99999999999999999999999999987654444444445556789999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||.++.++++.++|||||||+|||+++ |+.||.....+ .+.....++++ .+.+...+.++.+|
T Consensus 674 pEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~-------EVIe~i~~g~l---------L~~Pe~CP~~vY~L 737 (774)
T KOG1026|consen 674 PESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ-------EVIECIRAGQL---------LSCPENCPTEVYSL 737 (774)
T ss_pred HHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH-------HHHHHHHcCCc---------ccCCCCCCHHHHHH
Confidence 999999999999999999999999998 88887433322 22333333332 34566778899999
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccCCCC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASDTVS 481 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~~~~ 481 (523)
|+.||+.+|++||+++||-..|+.....
T Consensus 738 M~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 738 MLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 9999999999999999999999876443
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.2e-26 Score=226.87 Aligned_cols=180 Identities=24% Similarity=0.388 Sum_probs=131.8
Q ss_pred eeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCC
Q 046010 280 WIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQN 359 (523)
Q Consensus 280 ~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 359 (523)
++..|+....+. .....+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.......
T Consensus 89 ~~~~g~l~~~l~-~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 164 (316)
T cd05108 89 LMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164 (316)
T ss_pred cCCCCCHHHHHH-hccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCCCc
Confidence 334454444333 33456899999999999999999999998 99999999999999999999999999987643322
Q ss_pred CccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccc
Q 046010 360 ESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVL 438 (523)
Q Consensus 360 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 438 (523)
.........+..|++||.+.+..++.++||||||+++|||++ |+.||...... .+ ......+.... .
T Consensus 165 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~----~~~~~~~~~~~--~--- 232 (316)
T cd05108 165 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EI----SSILEKGERLP--Q--- 232 (316)
T ss_pred ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HH----HHHHhCCCCCC--C---
Confidence 222222334668999999999999999999999999999998 89887532211 11 11111111110 0
Q ss_pred cCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 439 KQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 439 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
+......+.+++.+||+.+|.+||++.+|+..|....
T Consensus 233 ----~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 233 ----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred ----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1112245678999999999999999999999987663
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-25 Score=210.16 Aligned_cols=210 Identities=25% Similarity=0.274 Sum_probs=150.2
Q ss_pred CCCCceeEeeecccccc---ccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEecc
Q 046010 272 KGKGRKAIWIAIGTTIP---TIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDF 348 (523)
Q Consensus 272 ~~~~~~~~~ia~g~~~~---~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Df 348 (523)
.|+....+||.+++|-. .+..+-++++...+++-++.|+++||+|||.+. |+|||||++|+|++..|.+||+||
T Consensus 145 vG~~~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDF 221 (419)
T KOG0663|consen 145 VGSNMDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADF 221 (419)
T ss_pred eccccceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEeccc
Confidence 45666679999999983 334555689999999999999999999999999 999999999999999999999999
Q ss_pred ccceeccCCCCCccccceeccCCCCchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhh--
Q 046010 349 GMARIFGGNQNESNTSKVVGTYGYMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLW-- 425 (523)
Q Consensus 349 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~-- 425 (523)
|+++.++... ...+..+-|+.|+|||++.+. .|+...|+||+|||+.||+++++.|......+. +....+..
T Consensus 222 GLAR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ---l~~If~llGt 296 (419)
T KOG0663|consen 222 GLAREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ---LDKIFKLLGT 296 (419)
T ss_pred chhhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH---HHHHHHHhCC
Confidence 9999886542 234557789999999999874 599999999999999999999988753322211 11111111
Q ss_pred ------hcCCc---------ccccCccccCCccHH-HHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCCCCCCCCCCC
Q 046010 426 ------CNGEA---------LELMDPVLKQSCMAA-ELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTVSLPQPTQPA 489 (523)
Q Consensus 426 ------~~~~~---------~~~~~~~l~~~~~~~-~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~l~~p~~p~ 489 (523)
..-.. .+..-..++..+... -...-.+|+..+|..||.+|.|++|.++- +...+.|.|..|.
T Consensus 297 Pte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~P~p~~P~ 374 (419)
T KOG0663|consen 297 PSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRETPLPIDPS 374 (419)
T ss_pred CccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--cccccCCCCCChh
Confidence 10000 000011111111111 12345678888999999999999987642 3345556666666
Q ss_pred cc
Q 046010 490 FS 491 (523)
Q Consensus 490 ~~ 491 (523)
+.
T Consensus 375 ~~ 376 (419)
T KOG0663|consen 375 MF 376 (419)
T ss_pred hc
Confidence 64
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.7e-25 Score=218.84 Aligned_cols=165 Identities=18% Similarity=0.192 Sum_probs=125.1
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC-----ccccceeccC
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE-----SNTSKVVGTY 370 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-----~~~~~~~gt~ 370 (523)
...++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.+...... .......||+
T Consensus 121 ~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~ 197 (294)
T PHA02882 121 KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTL 197 (294)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCc
Confidence 34678889999999999999999998 999999999999999999999999999876432211 1122346899
Q ss_pred CCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHH----HhhhcCCcccccCccccCCccHHH
Q 046010 371 GYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTW----KLWCNGEALELMDPVLKQSCMAAE 446 (523)
Q Consensus 371 ~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~~~~~~~ 446 (523)
.|+|||.+.+..++.++||||||+++|||++|+.||...... ........ .....+.. .. ...
T Consensus 198 ~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~--~~~~~~~~~~~~~~~~~~~~--------~~---~~~ 264 (294)
T PHA02882 198 YYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN--GNLIHAAKCDFIKRLHEGKI--------KI---KNA 264 (294)
T ss_pred cccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc--hHHHHHhHHHHHHHhhhhhh--------cc---CCC
Confidence 999999999999999999999999999999999999644221 11111111 11111110 00 111
Q ss_pred HHHHHHHhhhcccCCCCCCCCHHHHHHHhc
Q 046010 447 LLKCIHIGLLCVQEDPADRPNMSSVAVMLA 476 (523)
Q Consensus 447 ~~~~~~li~~cl~~dP~~RPs~~ei~~~L~ 476 (523)
...+.+++..||+.+|++||++.+|++.|.
T Consensus 265 ~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 265 NKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred CHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 355778889999999999999999999873
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9e-26 Score=216.73 Aligned_cols=191 Identities=26% Similarity=0.298 Sum_probs=135.8
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
.+.++.|+.+.+..++.||++||+|+|+.+ |+||||||+|++++.+-.+||+|||+++...........+..+.|..
T Consensus 116 ik~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRW 192 (359)
T KOG0660|consen 116 IKSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRW 192 (359)
T ss_pred HHcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeee
Confidence 455556999999999999999999999998 99999999999999999999999999998754423334467788999
Q ss_pred CCchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHH--------HHHhhhcCCcccccCccc---c
Q 046010 372 YMAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAY--------TWKLWCNGEALELMDPVL---K 439 (523)
Q Consensus 372 y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~l---~ 439 (523)
|+|||++.. ..|+.+.||||.|||+.||++|++.|.....-+...++.. ......+......+.... +
T Consensus 193 YRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~ 272 (359)
T KOG0660|consen 193 YRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPK 272 (359)
T ss_pred ecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCC
Confidence 999998865 6799999999999999999999998865433221111110 111111111111111000 0
Q ss_pred CC---ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH--HhccCCCCCCCC
Q 046010 440 QS---CMAAELLKCIHIGLLCVQEDPADRPNMSSVAV--MLASDTVSLPQP 485 (523)
Q Consensus 440 ~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~~~~~l~~p 485 (523)
.. .-+......++|+.+||..||.+|+|++|.++ .|+.....-.+|
T Consensus 273 ~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 273 QPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred CCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 00 00122346788999999999999999999975 355554444455
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-26 Score=222.13 Aligned_cols=173 Identities=31% Similarity=0.450 Sum_probs=125.8
Q ss_pred cccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccc
Q 046010 284 GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNT 363 (523)
Q Consensus 284 g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 363 (523)
|.....+.......+++..++.|+.||++||.|||+++ ++|+||+++||+++.++.+||+|||+.............
T Consensus 86 g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~ 162 (259)
T PF07714_consen 86 GSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKND 162 (259)
T ss_dssp EBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEES
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence 43334444445688999999999999999999999998 999999999999999999999999999876322222223
Q ss_pred cceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCc
Q 046010 364 SKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSC 442 (523)
Q Consensus 364 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 442 (523)
........|+|||.+....++.++||||||+++|||++ |+.||..... ... . .....+.....
T Consensus 163 ~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~---~-~~~~~~~~~~~--------- 226 (259)
T PF07714_consen 163 SSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEI---I-EKLKQGQRLPI--------- 226 (259)
T ss_dssp TTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHH---H-HHHHTTEETTS---------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc---ccc---c-cccccccccee---------
Confidence 33456778999999999889999999999999999999 6788643311 111 1 11122222111
Q ss_pred cHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHh
Q 046010 443 MAAELLKCIHIGLLCVQEDPADRPNMSSVAVML 475 (523)
Q Consensus 443 ~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L 475 (523)
+......+.+++..||+.||++||++.+|++.|
T Consensus 227 ~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 112234577899999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-25 Score=219.54 Aligned_cols=165 Identities=28% Similarity=0.375 Sum_probs=126.5
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
....+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||++................+++.|+
T Consensus 115 ~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~ 191 (280)
T cd05049 115 PMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWM 191 (280)
T ss_pred ccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceec
Confidence 3456899999999999999999999998 9999999999999999999999999987653222222222334567899
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
|||.+.+..++.++||||||+++|+|++ |..||...... ... .....+..... +......+.+
T Consensus 192 aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~----~~~~~~~~~~~---------~~~~~~~~~~ 255 (280)
T cd05049 192 PPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVI----ECITQGRLLQR---------PRTCPSEVYD 255 (280)
T ss_pred ChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHH----HHHHcCCcCCC---------CCCCCHHHHH
Confidence 9999999999999999999999999998 99997432221 111 11111111111 1122346778
Q ss_pred HhhhcccCCCCCCCCHHHHHHHhcc
Q 046010 453 IGLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
++.+||+.||++||++.||++.|++
T Consensus 256 li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 256 IMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHcCCCcccCCCHHHHHHHhhC
Confidence 9999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=221.67 Aligned_cols=179 Identities=25% Similarity=0.340 Sum_probs=131.7
Q ss_pred eeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC
Q 046010 281 IAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE 360 (523)
Q Consensus 281 ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 360 (523)
+..|....++. .....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++........
T Consensus 90 ~~~g~l~~~l~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~ 165 (279)
T cd05109 90 MPYGCLLDYVR-ENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165 (279)
T ss_pred CCCCCHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecccccce
Confidence 34455444432 33457999999999999999999999998 999999999999999999999999999876432222
Q ss_pred ccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCcccc
Q 046010 361 SNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLK 439 (523)
Q Consensus 361 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 439 (523)
.......++..|++||.+.+..++.++||||||+++|||++ |..||...... .. ............
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~----~~~~~~~~~~~~------ 232 (279)
T cd05109 166 YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EI----PDLLEKGERLPQ------ 232 (279)
T ss_pred eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HH----HHHHHCCCcCCC------
Confidence 11222334678999999988889999999999999999998 88887532211 11 111111111111
Q ss_pred CCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 440 QSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 440 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
+......+.+++.+||+.||++||++.++++.|+...
T Consensus 233 ---~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 233 ---PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred ---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1122346778899999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.1e-25 Score=227.61 Aligned_cols=180 Identities=21% Similarity=0.229 Sum_probs=129.1
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++................||..
T Consensus 176 l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~ 252 (392)
T PHA03207 176 VDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLE 252 (392)
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccC
Confidence 356678999999999999999999999998 99999999999999999999999999976644333333335678999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcc--c-----------ccCccc
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEAL--E-----------LMDPVL 438 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~-----------~~~~~l 438 (523)
|+|||++.+..++.++|||||||++|||++|+.||...........+....+........ . ......
T Consensus 253 y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (392)
T PHA03207 253 TNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVL 332 (392)
T ss_pred ccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccc
Confidence 999999999999999999999999999999999985433322111111111111000000 0 000000
Q ss_pred cCCcc-------HHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 439 KQSCM-------AAELLKCIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 439 ~~~~~-------~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
+.... ......+.+++.+||+.||++|||+.|++..
T Consensus 333 ~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 333 RPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 0112356678899999999999999998765
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-25 Score=222.29 Aligned_cols=193 Identities=23% Similarity=0.339 Sum_probs=153.1
Q ss_pred eeEeeecccccccc--ccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 277 KAIWIAIGTTIPTI--YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 277 ~~~~ia~g~~~~~~--~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
..+|+...+|.+.+ +..+++.|+++.+..++.|++.||.|||+++ |+|||+||.|||++..+.+|++|||+++..
T Consensus 74 ~~~~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m 150 (808)
T KOG0597|consen 74 AHLWVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAM 150 (808)
T ss_pred ceEEEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhc
Confidence 36788888887544 4788999999999999999999999999998 999999999999999999999999999976
Q ss_pred cCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCccccc
Q 046010 355 GGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELM 434 (523)
Q Consensus 355 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (523)
.. .........||+-|||||++.+.+|+..+|+|||||++||+.+|++||. ...+.+.+..+..+...
T Consensus 151 ~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~------a~si~~Lv~~I~~d~v~---- 218 (808)
T KOG0597|consen 151 ST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY------ARSITQLVKSILKDPVK---- 218 (808)
T ss_pred cc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch------HHHHHHHHHHHhcCCCC----
Confidence 53 3334566789999999999999999999999999999999999999983 22333333333222111
Q ss_pred CccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH--HhccCCCCCCCCCCCCcc
Q 046010 435 DPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV--MLASDTVSLPQPTQPAFS 491 (523)
Q Consensus 435 ~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~~~~~l~~p~~p~~~ 491 (523)
.+......++.++...|++||.+|.+..+++. +.++.-.....|..|.|.
T Consensus 219 -------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~ 270 (808)
T KOG0597|consen 219 -------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFD 270 (808)
T ss_pred -------CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhccccccccc
Confidence 11233456778888999999999999999864 445554455667777664
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=220.35 Aligned_cols=166 Identities=25% Similarity=0.328 Sum_probs=126.2
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
+...+++..++.++.||+.||+|||+++ |+||||||+||++++++.+||+|||+++...............++..|+
T Consensus 105 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T cd05075 105 CPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181 (272)
T ss_pred CcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccC
Confidence 3456899999999999999999999998 9999999999999999999999999998754322111122234567899
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
+||.+.+..++.++||||||+++|+|++ |+.||..... . ........+..... +......+.+
T Consensus 182 ~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~----~~~~~~~~~~~~~~---------~~~~~~~~~~ 245 (272)
T cd05075 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---S----EIYDYLRQGNRLKQ---------PPDCLDGLYS 245 (272)
T ss_pred CHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---H----HHHHHHHcCCCCCC---------CCCCCHHHHH
Confidence 9999998889999999999999999999 7888753211 1 11122222221111 1112345678
Q ss_pred HhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 453 IGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
++.+||+.||++|||+.+|++.|++.
T Consensus 246 li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 246 LMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=221.44 Aligned_cols=177 Identities=21% Similarity=0.252 Sum_probs=125.4
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....... ........++..|
T Consensus 92 ~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y 167 (287)
T cd07848 92 EMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NANYTEYVATRWY 167 (287)
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc-ccccccccccccc
Confidence 34567999999999999999999999998 9999999999999999999999999998753221 1122345688999
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHH--------HHHHhh-hcCCcccccCccccCC--
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLA--------YTWKLW-CNGEALELMDPVLKQS-- 441 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~--------~~~~~~-~~~~~~~~~~~~l~~~-- 441 (523)
+|||++.+..++.++|||||||++|+|++|+.||...........+. ..+..+ ..........+.....
T Consensus 168 ~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (287)
T cd07848 168 RSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQS 247 (287)
T ss_pred CCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCccc
Confidence 99999998889999999999999999999999986432211100000 000100 0000000000000000
Q ss_pred ----ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 442 ----CMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 442 ----~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
........+.+|+.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 248 LERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00112345789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-25 Score=224.22 Aligned_cols=193 Identities=23% Similarity=0.262 Sum_probs=128.9
Q ss_pred Eeeecccccccc--ccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccC
Q 046010 279 IWIAIGTTIPTI--YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGG 356 (523)
Q Consensus 279 ~~ia~g~~~~~~--~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 356 (523)
+++.+.++-..+ +..+...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 79 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 79 IYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 444444443222 2345567999999999999999999999998 99999999999999999999999999976432
Q ss_pred CCC-CccccceeccCCCCchhhhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchH--------HHHHHhh
Q 046010 357 NQN-ESNTSKVVGTYGYMAPEYALG--GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLL--------AYTWKLW 425 (523)
Q Consensus 357 ~~~-~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~--------~~~~~~~ 425 (523)
... ........++..|+|||++.+ ..++.++|||||||++|+|++|+.||............ ......+
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 211 112234578999999999876 67899999999999999999999998543211000000 0000000
Q ss_pred hcCCcccccC---ccccCCcc---HHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 426 CNGEALELMD---PVLKQSCM---AAELLKCIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 426 ~~~~~~~~~~---~~l~~~~~---~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
......+.+. ........ ......+.+++.+||+.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000 00000000 0112456789999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-25 Score=216.83 Aligned_cols=174 Identities=30% Similarity=0.450 Sum_probs=130.9
Q ss_pred ccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcc
Q 046010 283 IGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN 362 (523)
Q Consensus 283 ~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 362 (523)
.|....++.......+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||.+.........
T Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~-- 160 (261)
T cd05148 86 KGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL-- 160 (261)
T ss_pred cCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc--
Confidence 344444555555667999999999999999999999998 999999999999999999999999998765322111
Q ss_pred ccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCC
Q 046010 363 TSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQS 441 (523)
Q Consensus 363 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 441 (523)
.....++..|++||.+.+..++.++||||||+++|+|++ |+.||..... ...... ....... .
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~----~~~~~~~---------~ 224 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQ----ITAGYRM---------P 224 (261)
T ss_pred ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHH----HHhCCcC---------C
Confidence 113344667999999988889999999999999999998 7888753221 111111 1111100 1
Q ss_pred ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhcc
Q 046010 442 CMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 442 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
.+......+.+++.+||+.||++|||+.+|++.|++
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 225 CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 111223467789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=217.92 Aligned_cols=167 Identities=29% Similarity=0.407 Sum_probs=127.0
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcc-ccceeccCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN-TSKVVGTYG 371 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~-~~~~~gt~~ 371 (523)
.+...+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++........... .....++..
T Consensus 87 ~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~ 163 (257)
T cd05116 87 QKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK 163 (257)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCcc
Confidence 34457999999999999999999999998 99999999999999999999999999986543322111 112233578
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
|+|||.+....++.++||||||+++|||++ |+.||...... .. ......+...+ .+......+
T Consensus 164 y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~----~~~i~~~~~~~---------~~~~~~~~l 227 (257)
T cd05116 164 WYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EV----TQMIESGERME---------CPQRCPPEM 227 (257)
T ss_pred ccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHCCCCCC---------CCCCCCHHH
Confidence 999999988889999999999999999998 89998532211 11 11112211111 111223467
Q ss_pred HHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 451 IHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
.+++.+||+.||++||++.+|.+.|++.
T Consensus 228 ~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 228 YDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 7899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=221.55 Aligned_cols=166 Identities=27% Similarity=0.368 Sum_probs=127.0
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.||+.||+|||+++ ++||||||+||++++++.+||+|||++................++..|+|
T Consensus 114 ~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 190 (288)
T cd05093 114 PAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP 190 (288)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccC
Confidence 346999999999999999999999998 99999999999999999999999999876533222222223345678999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||.+.+..++.++||||||+++|+|++ |..||...... .. ......+..... .. .....+.+|
T Consensus 191 PE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~---~~----~~~i~~~~~~~~-----~~----~~~~~l~~l 254 (288)
T cd05093 191 PESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EV----IECITQGRVLQR-----PR----TCPKEVYDL 254 (288)
T ss_pred HHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHcCCcCCC-----CC----CCCHHHHHH
Confidence 999998889999999999999999998 88887432211 11 111222221111 01 122457889
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
+.+||+.||.+|||+.||++.|++..
T Consensus 255 i~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 255 MLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHHHccCChhhCCCHHHHHHHHHHHH
Confidence 99999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-25 Score=236.61 Aligned_cols=161 Identities=24% Similarity=0.271 Sum_probs=126.0
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.............||+.|+|
T Consensus 137 ~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~a 213 (496)
T PTZ00283 137 NRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213 (496)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeC
Confidence 457999999999999999999999998 99999999999999999999999999987643322333345678999999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
||++.+..++.++||||||+++|||++|+.||.... ....... ...+.... .+......+.+++
T Consensus 214 PE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------~~~~~~~-~~~~~~~~---------~~~~~~~~l~~li 277 (496)
T PTZ00283 214 PEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEVMHK-TLAGRYDP---------LPPSISPEMQEIV 277 (496)
T ss_pred HHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------HHHHHHH-HhcCCCCC---------CCCCCCHHHHHHH
Confidence 999999999999999999999999999999985321 1111111 11111111 1112234677889
Q ss_pred hhcccCCCCCCCCHHHHHHH
Q 046010 455 LLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~~ 474 (523)
.+||+.||.+||++.++++.
T Consensus 278 ~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 278 TALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHcccChhhCcCHHHHHhC
Confidence 99999999999999999764
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-25 Score=222.32 Aligned_cols=160 Identities=24% Similarity=0.264 Sum_probs=123.5
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..++..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++..... ........|++.
T Consensus 86 l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~~~gt~~ 160 (323)
T cd05571 86 LSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPE 160 (323)
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcccceecCcc
Confidence 445678999999999999999999999998 999999999999999999999999998753211 122334678999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||++.+..++.++|||||||++|||++|+.||...... ... ........ . + +......+.
T Consensus 161 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~----~~~~~~~~-~-----~----p~~~~~~~~ 223 (323)
T cd05571 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLF----ELILMEEI-R-----F----PRTLSPEAK 223 (323)
T ss_pred ccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHH----HHHHcCCC-C-----C----CCCCCHHHH
Confidence 99999999999999999999999999999999998532211 111 11111110 0 1 111234567
Q ss_pred HHhhhcccCCCCCCC-----CHHHHHH
Q 046010 452 HIGLLCVQEDPADRP-----NMSSVAV 473 (523)
Q Consensus 452 ~li~~cl~~dP~~RP-----s~~ei~~ 473 (523)
+++.+||+.||++|| ++.++++
T Consensus 224 ~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 224 SLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 889999999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-25 Score=215.28 Aligned_cols=165 Identities=31% Similarity=0.440 Sum_probs=125.3
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.....+++..+..++.|++.||.+||+++ ++|+||||+||+++.++.+||+|||+++........ .......+..|
T Consensus 95 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y 170 (261)
T cd05068 95 GAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE-AREGAKFPIKW 170 (261)
T ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-ccCCCcCceec
Confidence 33457999999999999999999999998 999999999999999999999999999876422111 11112234579
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
+|||.+.+..++.++||||||+++|+|++ |+.||..... ... .......... ..+......+.
T Consensus 171 ~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~----~~~~~~~~~~---------~~~~~~~~~~~ 234 (261)
T cd05068 171 TAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AEV----LQQVDQGYRM---------PCPPGCPKELY 234 (261)
T ss_pred cCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HHH----HHHHHcCCCC---------CCCCcCCHHHH
Confidence 99999988889999999999999999999 8888753211 111 1111111100 01112335678
Q ss_pred HHhhhcccCCCCCCCCHHHHHHHhcc
Q 046010 452 HIGLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
+++.+||+.+|++||++.+|++.|+.
T Consensus 235 ~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 235 DIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 89999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-25 Score=219.96 Aligned_cols=166 Identities=30% Similarity=0.371 Sum_probs=127.1
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++...............++..|+|
T Consensus 121 ~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 197 (290)
T cd05045 121 ERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMA 197 (290)
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccC
Confidence 456999999999999999999999998 99999999999999999999999999876533222222223345678999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||.+.+..++.++||||||+++|+|++ |..||..... ...+......... ..+......+.++
T Consensus 198 pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~---------~~~~~~~~~~~~~ 261 (290)
T cd05045 198 IESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-------ERLFNLLKTGYRM---------ERPENCSEEMYNL 261 (290)
T ss_pred HHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHhCCCCC---------CCCCCCCHHHHHH
Confidence 999988889999999999999999998 8888743221 1112222211111 1111223467789
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
+.+||+.+|++||++.||++.|++..
T Consensus 262 i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 262 MLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred HHHHccCCcccCCCHHHHHHHHHHHH
Confidence 99999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=221.54 Aligned_cols=166 Identities=31% Similarity=0.371 Sum_probs=126.9
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
....+++..+++++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++...............++..|+
T Consensus 125 ~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 201 (293)
T cd05053 125 PEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWM 201 (293)
T ss_pred cccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCcccc
Confidence 4567999999999999999999999998 9999999999999999999999999998654322211122233456799
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
|||.+.+..++.++||||||+++|||++ |..||...... ........+.... .+......+.+
T Consensus 202 aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~---------~~~~~~~~~~~ 265 (293)
T cd05053 202 APEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-------ELFKLLKEGYRME---------KPQNCTQELYH 265 (293)
T ss_pred CHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH-------HHHHHHHcCCcCC---------CCCCCCHHHHH
Confidence 9999988889999999999999999997 88887532211 1111111111111 11123456778
Q ss_pred HhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 453 IGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
|+.+||+.||++|||+.||++.|+..
T Consensus 266 li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 266 LMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHHHHcccCcccCcCHHHHHHHHHHh
Confidence 99999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-25 Score=217.81 Aligned_cols=166 Identities=25% Similarity=0.361 Sum_probs=126.8
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
....+++..++.++.|++.||.|||+++ ++||||||+||++++++.+||+|||+++................+..|+
T Consensus 106 ~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 182 (273)
T cd05035 106 LPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182 (273)
T ss_pred CcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCccceeeccccccccccccccCCcccc
Confidence 3457999999999999999999999998 9999999999999999999999999998654332222222233467899
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
+||.+.+..++.++||||||+++|||++ |..||..... ...... ...+.... .+......+.+
T Consensus 183 ~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~----~~~~~~~~---------~~~~~~~~~~~ 246 (273)
T cd05035 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDY----LRHGNRLK---------QPEDCLDELYD 246 (273)
T ss_pred CHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HHcCCCCC---------CCcCCCHHHHH
Confidence 9999988889999999999999999999 8888743221 111111 11111111 11123456788
Q ss_pred HhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 453 IGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
++.+||+.||++||++.||++.|++.
T Consensus 247 li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 247 LMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 99999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.9e-25 Score=218.07 Aligned_cols=171 Identities=25% Similarity=0.349 Sum_probs=126.2
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.++|+|||+++...............++..|+|
T Consensus 124 ~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 200 (296)
T cd05051 124 SKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMA 200 (296)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecC
Confidence 347999999999999999999999998 99999999999999999999999999876533322222333455778999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh--CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS--GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
||.+.+..++.++||||||+++|+|++ +..||.... ....+......+.......... .+.....++.+
T Consensus 201 PE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~ 271 (296)
T cd05051 201 WESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT---DQQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYE 271 (296)
T ss_pred HHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC---hHHHHHHHHhccccccccccCC------CccCCCHHHHH
Confidence 999988889999999999999999998 556664221 1112222221111111111111 11122356889
Q ss_pred HhhhcccCCCCCCCCHHHHHHHhcc
Q 046010 453 IGLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
++.+||+.||++|||+.||++.|++
T Consensus 272 li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 272 LMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHHhccChhcCCCHHHHHHHhcC
Confidence 9999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-25 Score=214.92 Aligned_cols=175 Identities=26% Similarity=0.446 Sum_probs=130.0
Q ss_pred ccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcc
Q 046010 283 IGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN 362 (523)
Q Consensus 283 ~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 362 (523)
.|....++.......+++..++.++.|++.||.|||+++ ++|+||||+||++++++.+||+|||.+......... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~ 159 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-A 159 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-c
Confidence 344444444444567999999999999999999999998 999999999999999999999999999865432211 1
Q ss_pred ccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCC
Q 046010 363 TSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQS 441 (523)
Q Consensus 363 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 441 (523)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ..... .+...... .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~----~~~~~~~~---------~ 223 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLE----QVERGYRM---------P 223 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHH----HHHcCCCC---------C
Confidence 112234567999999988889999999999999999999 8888753211 11111 11111100 1
Q ss_pred ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhcc
Q 046010 442 CMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 442 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
.+......+.+|+.+||+.+|++|||+.++.++|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111233467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-25 Score=217.45 Aligned_cols=175 Identities=27% Similarity=0.401 Sum_probs=130.9
Q ss_pred ccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcc
Q 046010 283 IGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN 362 (523)
Q Consensus 283 ~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 362 (523)
.|....++.......+++..++.++.||++||+|||+.+ ++|+||||+||+++.++.+||+|||.+......... .
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~ 160 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-A 160 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee-c
Confidence 344444444455667999999999999999999999998 999999999999999999999999999875432211 1
Q ss_pred ccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCC
Q 046010 363 TSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQS 441 (523)
Q Consensus 363 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 441 (523)
.....++..|+|||.+....++.++||||||+++|+|++ |+.||...... ... ..........
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~----~~~~~~~~~~--------- 224 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVM----SALQRGYRMP--------- 224 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHH----HHHHcCCCCC---------
Confidence 222345678999999988889999999999999999998 88888532211 111 1111111100
Q ss_pred ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhcc
Q 046010 442 CMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 442 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
........+.+++.+||+.+|++||++++|.++|+.
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 225 RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 011123457789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.2e-25 Score=203.92 Aligned_cols=153 Identities=25% Similarity=0.249 Sum_probs=121.5
Q ss_pred cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcccccee
Q 046010 288 PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVV 367 (523)
Q Consensus 288 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 367 (523)
+.-|.++.+++++..++-++.||+.||+|||+++ |++|||||+|||+|.+|.+||+|||+++... ..+....
T Consensus 131 lFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-----~rT~TlC 202 (355)
T KOG0616|consen 131 LFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS-----GRTWTLC 202 (355)
T ss_pred HHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec-----CcEEEec
Confidence 3445678889999999999999999999999999 9999999999999999999999999999863 2355789
Q ss_pred ccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHH
Q 046010 368 GTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAEL 447 (523)
Q Consensus 368 gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 447 (523)
||+.|+|||++....++.++|.|+|||++|||+.|.+||..... ++...+ +.++++. .+..-.
T Consensus 203 GTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------~~iY~K-I~~~~v~----------fP~~fs 265 (355)
T KOG0616|consen 203 GTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------IQIYEK-ILEGKVK----------FPSYFS 265 (355)
T ss_pred CCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------HHHHHH-HHhCccc----------CCcccC
Confidence 99999999999999999999999999999999999999854332 111111 1121111 111112
Q ss_pred HHHHHHhhhcccCCCCCC
Q 046010 448 LKCIHIGLLCVQEDPADR 465 (523)
Q Consensus 448 ~~~~~li~~cl~~dP~~R 465 (523)
..+.+|+...|+.|-.+|
T Consensus 266 ~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 266 SDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHHHHHHHHHhhhhHhh
Confidence 345567778888888888
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-25 Score=219.13 Aligned_cols=175 Identities=22% Similarity=0.250 Sum_probs=121.8
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
.+..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++...... .......++..|+
T Consensus 96 ~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--~~~~~~~~~~~y~ 170 (288)
T cd07871 96 CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--KTYSNEVVTLWYR 170 (288)
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC--ccccCceeccccc
Confidence 3446899999999999999999999998 9999999999999999999999999987643221 1223456788999
Q ss_pred chhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHH--------HHHHhhhc-CCcccccCccccCCc-
Q 046010 374 APEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLA--------YTWKLWCN-GEALELMDPVLKQSC- 442 (523)
Q Consensus 374 aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~--------~~~~~~~~-~~~~~~~~~~l~~~~- 442 (523)
|||.+.+ ..++.++||||||+++|+|++|+.||............. ..|..... .+......+......
T Consensus 171 aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (288)
T cd07871 171 PPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPL 250 (288)
T ss_pred ChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCch
Confidence 9998875 568999999999999999999999985432211110000 00110000 000011111000000
Q ss_pred ---cHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 443 ---MAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 443 ---~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
........++++.+||+.||.+|||++|+++
T Consensus 251 ~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 251 INHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0011245678999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-25 Score=214.87 Aligned_cols=166 Identities=27% Similarity=0.298 Sum_probs=125.2
Q ss_pred cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcccccee
Q 046010 288 PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVV 367 (523)
Q Consensus 288 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 367 (523)
.++.......+++..++.++.||+.||+|||+++ ++||||||+||+++.++.+||+|||++....... ....
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~ 160 (256)
T cd05082 89 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGK 160 (256)
T ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC-----CCCc
Confidence 3333334446899999999999999999999998 9999999999999999999999999987643211 1223
Q ss_pred ccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHH
Q 046010 368 GTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAE 446 (523)
Q Consensus 368 gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 446 (523)
.+..|+|||++.+..++.++||||||+++|+|++ |+.||.... .... ......+.... .....
T Consensus 161 ~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~-~~~~~~~~~~~---------~~~~~ 224 (256)
T cd05082 161 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDV-VPRVEKGYKMD---------APDGC 224 (256)
T ss_pred cceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHH-HHHHhcCCCCC---------CCCCC
Confidence 3567999999988889999999999999999997 888874221 1111 11111111111 11122
Q ss_pred HHHHHHHhhhcccCCCCCCCCHHHHHHHhcc
Q 046010 447 LLKCIHIGLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 447 ~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
...+.+++.+||+.+|++|||+.++++.|+.
T Consensus 225 ~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 225 PPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 3467788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-25 Score=227.24 Aligned_cols=168 Identities=25% Similarity=0.302 Sum_probs=131.5
Q ss_pred Eeeeccccc--cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccC
Q 046010 279 IWIAIGTTI--PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGG 356 (523)
Q Consensus 279 ~~ia~g~~~--~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 356 (523)
++..+.++. ++.+..+...+++..+.-++..|+.||+|||++| |||||||.+|||+|.+|.+||+|||+++....
T Consensus 444 l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCC
Confidence 444444433 2444566689999999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCc
Q 046010 357 NQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDP 436 (523)
Q Consensus 357 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (523)
....+..+.||+.|+|||++.+..|+..+|.|+|||+||||+.|..||....+++ ....+.+.+ +
T Consensus 521 --~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-------~FdsI~~d~------~ 585 (694)
T KOG0694|consen 521 --QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-------VFDSIVNDE------V 585 (694)
T ss_pred --CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHhcCC------C
Confidence 2335678999999999999999999999999999999999999999996433221 111111111 1
Q ss_pred cccCCccHHHHHHHHHHhhhcccCCCCCCCCH
Q 046010 437 VLKQSCMAAELLKCIHIGLLCVQEDPADRPNM 468 (523)
Q Consensus 437 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~ 468 (523)
.++.-...+.+.|+.++|..+|++|.-+
T Consensus 586 ----~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 ----RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1122334567889999999999999865
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-25 Score=221.80 Aligned_cols=178 Identities=28% Similarity=0.398 Sum_probs=130.2
Q ss_pred ccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcc
Q 046010 283 IGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN 362 (523)
Q Consensus 283 ~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 362 (523)
.|....++.......+++.+++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||+++..........
T Consensus 123 ~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 199 (302)
T cd05055 123 YGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVV 199 (302)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccccccCCCceee
Confidence 343334433333444899999999999999999999998 99999999999999999999999999886543322112
Q ss_pred ccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCC
Q 046010 363 TSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQS 441 (523)
Q Consensus 363 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 441 (523)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||...... . ........+....
T Consensus 200 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--~----~~~~~~~~~~~~~--------- 264 (302)
T cd05055 200 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--S----KFYKLIKEGYRMA--------- 264 (302)
T ss_pred cCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--H----HHHHHHHcCCcCC---------
Confidence 223345678999999998889999999999999999998 88887532211 0 1111111111000
Q ss_pred ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 442 CMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 442 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
.+......+.+++.+||+.+|++||++.||++.|++.
T Consensus 265 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 265 QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0111234677899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-25 Score=215.35 Aligned_cols=165 Identities=31% Similarity=0.357 Sum_probs=122.9
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.....+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||++.................+..|
T Consensus 86 ~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 162 (252)
T cd05084 86 TEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW 162 (252)
T ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceee
Confidence 33456899999999999999999999998 999999999999999999999999998754321111111112234569
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
+|||.+.++.++.++||||||+++|+|++ |..||...... ........... ...+......+.
T Consensus 163 ~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~~~ 226 (252)
T cd05084 163 TAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-------QTREAIEQGVR---------LPCPELCPDAVY 226 (252)
T ss_pred cCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-------HHHHHHHcCCC---------CCCcccCCHHHH
Confidence 99999998889999999999999999998 88887432211 11111111100 011112234678
Q ss_pred HHhhhcccCCCCCCCCHHHHHHHhc
Q 046010 452 HIGLLCVQEDPADRPNMSSVAVMLA 476 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~~L~ 476 (523)
+++.+||+.+|++|||+.+|+++|+
T Consensus 227 ~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 227 RLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHh
Confidence 8999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-25 Score=231.39 Aligned_cols=171 Identities=23% Similarity=0.247 Sum_probs=122.5
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC-CeeEeccccceeccCCCCCccccceeccCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM-NPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+..+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.+.... ......+++.
T Consensus 162 ~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~---~~~~~~~t~~ 235 (440)
T PTZ00036 162 RNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ---RSVSYICSRF 235 (440)
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccchhccCCC---CcccCCCCcC
Confidence 45678999999999999999999999998 99999999999999765 69999999998654222 1223567899
Q ss_pred CCchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhc----------CCcc-----cccC
Q 046010 372 YMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCN----------GEAL-----ELMD 435 (523)
Q Consensus 372 y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~-----~~~~ 435 (523)
|+|||++.+. .++.++|||||||++|||++|.+||....... .+......... .... ....
T Consensus 236 y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~---~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 312 (440)
T PTZ00036 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD---QLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKP 312 (440)
T ss_pred ccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCHHHHHHhchhhhcccCCccCc
Confidence 9999988764 68999999999999999999999985432211 11111111000 0000 0000
Q ss_pred ccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 046010 436 PVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVA 472 (523)
Q Consensus 436 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~ 472 (523)
..+....+.....++++|+.+||+.||.+|||+.|++
T Consensus 313 ~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l 349 (440)
T PTZ00036 313 KDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349 (440)
T ss_pred hhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 1111111112235678999999999999999999987
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-25 Score=213.27 Aligned_cols=175 Identities=27% Similarity=0.444 Sum_probs=130.2
Q ss_pred ccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcc
Q 046010 283 IGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN 362 (523)
Q Consensus 283 ~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 362 (523)
.|....++.......+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||.+......... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~ 159 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-A 159 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-c
Confidence 344444444444556899999999999999999999998 999999999999999999999999999765322211 1
Q ss_pred ccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCC
Q 046010 363 TSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQS 441 (523)
Q Consensus 363 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 441 (523)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... .. .......... .
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~----~~~~~~~~~~---------~ 223 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EV----LEQVERGYRM---------P 223 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHcCCCC---------C
Confidence 122345678999999988889999999999999999999 88887532211 11 1111111100 0
Q ss_pred ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhcc
Q 046010 442 CMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 442 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
.+......+.+++.+||+.||++||++++|+++|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 111234567788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.9e-25 Score=219.68 Aligned_cols=111 Identities=32% Similarity=0.498 Sum_probs=93.7
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEe----CCCCCeeEeccccceeccCCCCC-ccccceecc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLL----DHEMNPKISDFGMARIFGGNQNE-SNTSKVVGT 369 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll----~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~gt 369 (523)
...+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++........ .......+|
T Consensus 102 ~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t 178 (317)
T cd07868 102 PVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178 (317)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCcccc
Confidence 346899999999999999999999998 9999999999999 45678999999999876432211 123345789
Q ss_pred CCCCchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCC
Q 046010 370 YGYMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGF 408 (523)
Q Consensus 370 ~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~ 408 (523)
+.|+|||++.+. .++.++|||||||++|+|++|+.||..
T Consensus 179 ~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 999999998774 588999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.1e-25 Score=220.57 Aligned_cols=163 Identities=23% Similarity=0.274 Sum_probs=123.4
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.++..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++...... .......|++.|
T Consensus 85 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y 159 (312)
T cd05585 85 QREGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCGTPEY 159 (312)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--CccccccCCccc
Confidence 44567999999999999999999999998 9999999999999999999999999987542221 122345689999
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
+|||.+.+..++.++||||||+++|+|++|+.||.... ......... .... . .+......+.+
T Consensus 160 ~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~------~~~~~~~~~-~~~~-~---------~~~~~~~~~~~ 222 (312)
T cd05585 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN------VNEMYRKIL-QEPL-R---------FPDGFDRDAKD 222 (312)
T ss_pred CCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC------HHHHHHHHH-cCCC-C---------CCCcCCHHHHH
Confidence 99999999999999999999999999999999985321 111111111 1110 0 11112245678
Q ss_pred HhhhcccCCCCCCCCHHHHHHHhcc
Q 046010 453 IGLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
++.+||+.||++||++.++.+.|+.
T Consensus 223 li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 223 LLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred HHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 8899999999999876555555443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=216.63 Aligned_cols=158 Identities=28% Similarity=0.317 Sum_probs=121.1
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.+...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++...... .......|+..|
T Consensus 88 ~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y 162 (316)
T cd05592 88 QSSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPDY 162 (316)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccCCccc
Confidence 44567999999999999999999999998 9999999999999999999999999997643222 223345689999
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
+|||.+.+..++.++||||||+++|+|++|+.||..... .+.... ..... +.+ +......+.+
T Consensus 163 ~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~------~~~~~~-i~~~~------~~~----~~~~~~~~~~ 225 (316)
T cd05592 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE------DELFDS-ILNDR------PHF----PRWISKEAKD 225 (316)
T ss_pred cCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH------HHHHHH-HHcCC------CCC----CCCCCHHHHH
Confidence 999999998999999999999999999999999853221 111111 11110 001 1112235567
Q ss_pred HhhhcccCCCCCCCCHH-HHH
Q 046010 453 IGLLCVQEDPADRPNMS-SVA 472 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~-ei~ 472 (523)
++.+||+.||++||++. +++
T Consensus 226 ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 226 CLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred HHHHHccCCHHHcCCChHHHH
Confidence 88899999999999875 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=213.19 Aligned_cols=164 Identities=29% Similarity=0.411 Sum_probs=125.9
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+++...............++..|+|
T Consensus 113 ~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 189 (277)
T cd05032 113 LGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189 (277)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccC
Confidence 345889999999999999999999998 99999999999999999999999999876543322222233456778999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||.+.+..++.++||||||+++||+++ |+.||...... .. ......+...... ......+.++
T Consensus 190 PE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~----~~~~~~~~~~~~~---------~~~~~~~~~l 253 (277)
T cd05032 190 PESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EV----LKFVIDGGHLDLP---------ENCPDKLLEL 253 (277)
T ss_pred HHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HH----HHHHhcCCCCCCC---------CCCCHHHHHH
Confidence 999988889999999999999999998 88887432211 11 1111121111111 1124567789
Q ss_pred hhhcccCCCCCCCCHHHHHHHhcc
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
+.+||+.+|++|||+.+|++.|++
T Consensus 254 i~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 254 MRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HHHHcCCChhhCCCHHHHHHHhcC
Confidence 999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-25 Score=234.48 Aligned_cols=177 Identities=21% Similarity=0.260 Sum_probs=123.3
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHh-cCCCcEEecCCCCCcEEeCCCC----------------CeeEeccccceecc
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHE-DSRLKVFHRDLKASNVLLDHEM----------------NPKISDFGMARIFG 355 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~-~g~~~ivH~Dlkp~NIll~~~~----------------~~kL~Dfg~a~~~~ 355 (523)
.+...+++..++.|+.||+.||.|||+ .+ ||||||||+|||++.++ .+||+|||.+....
T Consensus 223 ~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~ 299 (467)
T PTZ00284 223 MKHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER 299 (467)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCc
Confidence 445679999999999999999999998 47 99999999999998765 49999999875421
Q ss_pred CCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHH-------HH-----
Q 046010 356 GNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYT-------WK----- 423 (523)
Q Consensus 356 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~-------~~----- 423 (523)
.......||..|+|||++.+..++.++|||||||++|||++|+.||...........+... |.
T Consensus 300 -----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~ 374 (467)
T PTZ00284 300 -----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGT 374 (467)
T ss_pred -----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccc
Confidence 1223467899999999999999999999999999999999999999643321111110000 00
Q ss_pred -----hhhc-CCcccccCcc-----ccCC--ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH--Hhcc
Q 046010 424 -----LWCN-GEALELMDPV-----LKQS--CMAAELLKCIHIGLLCVQEDPADRPNMSSVAV--MLAS 477 (523)
Q Consensus 424 -----~~~~-~~~~~~~~~~-----l~~~--~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~ 477 (523)
.+.. +......++. .... ........+.+|+.+||+.||++|||++|+++ +|.+
T Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 375 EEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLK 443 (467)
T ss_pred hhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccc
Confidence 0000 0000000000 0000 00011245679999999999999999999986 5544
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=225.66 Aligned_cols=109 Identities=23% Similarity=0.364 Sum_probs=95.2
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++.+++.|+.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...............||..|+|
T Consensus 254 ~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~A 330 (461)
T PHA03211 254 LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNA 330 (461)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcC
Confidence 457999999999999999999999998 99999999999999999999999999987543322222234568999999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIISGKKNS 406 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~elltG~~p~ 406 (523)
||++.+..++.++|||||||++|||++|..++
T Consensus 331 PE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 331 PEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred HHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 99999999999999999999999999988664
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.5e-25 Score=219.95 Aligned_cols=159 Identities=25% Similarity=0.290 Sum_probs=121.7
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCchh
Q 046010 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPE 376 (523)
Q Consensus 297 ~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE 376 (523)
.++.-.++.+..||+.++.+.|++| |||.||||.|+|+- .|.+||+|||.+..+..+.........+||+.||+||
T Consensus 456 ~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPE 531 (677)
T KOG0596|consen 456 IDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPE 531 (677)
T ss_pred CCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHH
Confidence 3442488889999999999999999 99999999999985 6789999999999987777666677789999999999
Q ss_pred hhcCC-----------CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccH-
Q 046010 377 YALGG-----------VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMA- 444 (523)
Q Consensus 377 ~l~~~-----------~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~- 444 (523)
.+... ..+.++||||||||||+|+.|+.||.... .. |.. +..+.++....+++.
T Consensus 532 Al~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~----~aK-----l~aI~~P~~~Iefp~~ 597 (677)
T KOG0596|consen 532 ALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQ----IAK-----LHAITDPNHEIEFPDI 597 (677)
T ss_pred HHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HH----HHH-----HHhhcCCCccccccCC
Confidence 88532 25689999999999999999999985321 11 111 112223322111111
Q ss_pred HHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 445 AELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 445 ~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.....++++|..||+.||++||++.|+++
T Consensus 598 ~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 598 PENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred CCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 11223889999999999999999999875
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=223.78 Aligned_cols=176 Identities=26% Similarity=0.311 Sum_probs=140.7
Q ss_pred eEeeeccccc-----cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccce
Q 046010 278 AIWIAIGTTI-----PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352 (523)
Q Consensus 278 ~~~ia~g~~~-----~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 352 (523)
.+.|.+++|- ..+-..++..++++.+++|+.|++.|+.|||++. |+|||||+.|||+++++.+||+|||+++
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK 154 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAK 154 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhh
Confidence 4677777777 3444566688999999999999999999999887 9999999999999999999999999999
Q ss_pred eccCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCccc
Q 046010 353 IFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALE 432 (523)
Q Consensus 353 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (523)
...... ......+||+.|+.||++.+.+|+.|+|||||||++|||++-+++|... +......+....
T Consensus 155 ~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~------~m~~Li~ki~~~----- 221 (426)
T KOG0589|consen 155 ILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS------NMSELILKINRG----- 221 (426)
T ss_pred hcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc------chHHHHHHHhhc-----
Confidence 875433 2345678999999999999999999999999999999999999998532 222222222111
Q ss_pred ccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 433 LMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 433 ~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
.-...+......+..++..||+.+|..||++.+++.+
T Consensus 222 -----~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 -----LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -----cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1112334455677788899999999999999999765
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-25 Score=217.35 Aligned_cols=163 Identities=28% Similarity=0.383 Sum_probs=123.1
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..++.++.|+++||.|||+.+ ++|+||||+||++++++.+||+|||+++...............++..|+||
T Consensus 114 ~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 190 (277)
T cd05062 114 APPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190 (277)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcCh
Confidence 34688899999999999999999998 999999999999999999999999998765332221112223456789999
Q ss_pred hhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 376 EYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 376 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
|.+.+..++.++||||||+++|||++ |..||...... .............. +......+.+++
T Consensus 191 E~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-------~~~~~~~~~~~~~~---------~~~~~~~~~~li 254 (277)
T cd05062 191 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-------QVLRFVMEGGLLDK---------PDNCPDMLFELM 254 (277)
T ss_pred hHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHcCCcCCC---------CCCCCHHHHHHH
Confidence 99998889999999999999999999 67887532211 11111111111111 111234677899
Q ss_pred hhcccCCCCCCCCHHHHHHHhcc
Q 046010 455 LLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
.+||+.||++|||+.|+++.|++
T Consensus 255 ~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 255 RMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHcCCChhhCcCHHHHHHHhhC
Confidence 99999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-25 Score=213.65 Aligned_cols=176 Identities=25% Similarity=0.408 Sum_probs=131.3
Q ss_pred ccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcc
Q 046010 283 IGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN 362 (523)
Q Consensus 283 ~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 362 (523)
.|....++.......+++..++.++.|+++||.|||+.+ ++|+||||+||+++.++.+||+|||.+......... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~ 159 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-A 159 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-c
Confidence 444444444444567899999999999999999999998 999999999999999999999999999765432211 1
Q ss_pred ccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCC
Q 046010 363 TSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQS 441 (523)
Q Consensus 363 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 441 (523)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .. .......... .
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~----~~~~~~~~~~---------~ 223 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EV----LDQVERGYRM---------P 223 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HH----HHHHhcCCCC---------C
Confidence 123345678999999988889999999999999999999 77777432211 11 1111111100 1
Q ss_pred ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 442 CMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 442 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
........+.+++.+||+.+|++||++.+++++|+..
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 1123345678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=217.76 Aligned_cols=154 Identities=26% Similarity=0.322 Sum_probs=119.1
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.+...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .......|++.|
T Consensus 93 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y 167 (323)
T cd05616 93 QQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDY 167 (323)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC--CccccCCCChhh
Confidence 44567999999999999999999999998 9999999999999999999999999987542211 122345689999
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
+|||++.+..++.++|||||||++|||++|+.||..... ..+.. . ...... . .+......+.+
T Consensus 168 ~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~---~-i~~~~~-~---------~p~~~s~~~~~ 230 (323)
T cd05616 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQ---S-IMEHNV-A---------YPKSMSKEAVA 230 (323)
T ss_pred cCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHH---H-HHhCCC-C---------CCCcCCHHHHH
Confidence 999999999999999999999999999999999853221 11111 1 111111 0 01112345678
Q ss_pred HhhhcccCCCCCCCCH
Q 046010 453 IGLLCVQEDPADRPNM 468 (523)
Q Consensus 453 li~~cl~~dP~~RPs~ 468 (523)
++.+||+.||++|++.
T Consensus 231 li~~~l~~~p~~R~~~ 246 (323)
T cd05616 231 ICKGLMTKHPGKRLGC 246 (323)
T ss_pred HHHHHcccCHHhcCCC
Confidence 8999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=214.51 Aligned_cols=170 Identities=25% Similarity=0.302 Sum_probs=126.5
Q ss_pred cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcccccee
Q 046010 288 PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVV 367 (523)
Q Consensus 288 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 367 (523)
.++.......+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++....... ......
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~~ 155 (277)
T cd05607 82 YHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRA 155 (277)
T ss_pred HHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeeccC
Confidence 4444455567999999999999999999999998 9999999999999999999999999987654221 223346
Q ss_pred ccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHH
Q 046010 368 GTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAEL 447 (523)
Q Consensus 368 gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 447 (523)
++..|+|||++.+..++.++||||||+++|+|++|+.||........ ........ ...... ... ....
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~-~~~~~~-~~~--------~~~~ 223 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRT-LEDEVK-FEH--------QNFT 223 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHh-hccccc-ccc--------ccCC
Confidence 78899999999988899999999999999999999999864322111 11111111 111110 000 0123
Q ss_pred HHHHHHhhhcccCCCCCCCCHHHHHHHh
Q 046010 448 LKCIHIGLLCVQEDPADRPNMSSVAVML 475 (523)
Q Consensus 448 ~~~~~li~~cl~~dP~~RPs~~ei~~~L 475 (523)
..+.+|+.+||+.||++||++.|+++.+
T Consensus 224 ~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 224 EESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred HHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 3567899999999999999998766433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-25 Score=218.32 Aligned_cols=170 Identities=24% Similarity=0.268 Sum_probs=122.5
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++....... ......++..|+|
T Consensus 102 ~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~a 175 (288)
T cd07863 102 PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQM---ALTPVVVTLWYRA 175 (288)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccccccCcc---cCCCccccccccC
Confidence 456999999999999999999999998 9999999999999999999999999998653221 1223467889999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcC---Ccc-------cccCccccC---C
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNG---EAL-------ELMDPVLKQ---S 441 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~-------~~~~~~l~~---~ 441 (523)
||.+.+..++.++|||||||++|+|++|++||....... ............ ... ....+.... .
T Consensus 176 PE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (288)
T cd07863 176 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQS 252 (288)
T ss_pred chHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH---HHHHHHHHhCCCChhhCcccccccccccCCCCCCchHH
Confidence 999998899999999999999999999999985332211 111111110000 000 000000000 0
Q ss_pred ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 442 CMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 442 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
........+.+++.+||+.||++|||+.|++.
T Consensus 253 ~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 253 VVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 01122345678999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-25 Score=183.29 Aligned_cols=103 Identities=49% Similarity=0.937 Sum_probs=78.4
Q ss_pred cCCCC-CC-ccc-cCCchHHHHHHHHHHHHHhhcCCCCCCCcccCeeeeeccCCCCeEEEEEEecCCCChhhHHHHHHHH
Q 046010 30 YHFCN-NT-VNF-TRNSTYQSNLNLLLSTLRSNATHGSSDKFSEGFYNATASQDPDKVYGLFLCRGDVSAETCKDCVNFA 106 (523)
Q Consensus 30 ~~~C~-~~-~~~-~~~s~f~~nl~~ll~~l~~~a~~~~~~~~~~~~~~~~~g~~~~~vyg~~qC~~D~~~~~C~~Cl~~a 106 (523)
|+.|+ |. ++| +++++|++||+.||+.|..+++.+.. .+|+++..|.++++|||++||++|+++++|..||+.|
T Consensus 1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~----~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a 76 (106)
T PF01657_consen 1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSS----KGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADA 76 (106)
T ss_dssp ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-----TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHH
T ss_pred CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccc----cCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHH
Confidence 68898 43 667 67888999999999999999875421 5798988888999999999999999999999999999
Q ss_pred HHhhhhcCCCcccceEecccceeeecCCcc
Q 046010 107 TSDITQRCPLQKETVIWYDHCLLRYSGISF 136 (523)
Q Consensus 107 ~~~~~~~C~~~~~a~i~~~~C~lry~~~~f 136 (523)
+..+..+|+.++||+||+++|+||||+++|
T Consensus 77 ~~~~~~~C~~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 77 VANISSCCPGSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp HCCHHHHTTSBSSEEEEESSEEEEEESS--
T ss_pred HHHHHHhCCCCceEEEECCCEEEEEECCCC
Confidence 999999999999999999999999999998
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=215.91 Aligned_cols=174 Identities=21% Similarity=0.241 Sum_probs=121.3
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.....++++.+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++....... .......+++.|
T Consensus 95 ~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y 169 (303)
T cd07869 95 KHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--HTYSNEVVTLWY 169 (303)
T ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC--ccCCCCcccCCC
Confidence 33466999999999999999999999998 9999999999999999999999999987543221 122335678999
Q ss_pred CchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCc---------ccccCccccC--
Q 046010 373 MAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEA---------LELMDPVLKQ-- 440 (523)
Q Consensus 373 ~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~-- 440 (523)
+|||++.+ ..++.++|||||||++|+|++|+.||...... ...+............ ..........
T Consensus 170 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (303)
T cd07869 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYS 247 (303)
T ss_pred CChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchhhccccccccccccC
Confidence 99998875 45788999999999999999999998643211 1111111111100000 0000000000
Q ss_pred CccH-------HHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 441 SCMA-------AELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 441 ~~~~-------~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.... .....+.+|+.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 248 PKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred CccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000 01235678999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.4e-25 Score=233.57 Aligned_cols=161 Identities=21% Similarity=0.211 Sum_probs=124.6
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.............||+.|+
T Consensus 162 ~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~ 238 (478)
T PTZ00267 162 EHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238 (478)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCcccc
Confidence 4557899999999999999999999998 9999999999999999999999999998764332222234456899999
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
|||++.+..++.++|||||||++|+|++|+.||..... ........ .+..... +......+.++
T Consensus 239 aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~-~~~~~~~---------~~~~s~~~~~l 302 (478)
T PTZ00267 239 APELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVL-YGKYDPF---------PCPVSSGMKAL 302 (478)
T ss_pred CHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHH-hCCCCCC---------CccCCHHHHHH
Confidence 99999999999999999999999999999999853211 11111111 1111100 11122457788
Q ss_pred hhhcccCCCCCCCCHHHHHH
Q 046010 454 GLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~ 473 (523)
+.+||+.||++||++.+++.
T Consensus 303 i~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 303 LDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHhccChhhCcCHHHHHh
Confidence 99999999999999999864
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.3e-25 Score=217.03 Aligned_cols=164 Identities=29% Similarity=0.426 Sum_probs=124.7
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
+..+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||+++...............++..|+|
T Consensus 118 ~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 194 (283)
T cd05090 118 KSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMP 194 (283)
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecC
Confidence 346899999999999999999999998 99999999999999999999999999986543322222233445678999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||.+.+..++.++||||||+++|||++ |..||..... ....+ ......... .+.....++.++
T Consensus 195 PE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~----~~~~~~~~~---------~~~~~~~~~~~l 258 (283)
T cd05090 195 PEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIE----MVRKRQLLP---------CSEDCPPRMYSL 258 (283)
T ss_pred hHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHH----HHHcCCcCC---------CCCCCCHHHHHH
Confidence 999988889999999999999999998 8888743211 11111 111111111 011123457788
Q ss_pred hhhcccCCCCCCCCHHHHHHHhcc
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
+.+||+.||++||++.+|+++|+.
T Consensus 259 i~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 259 MTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHcccCcccCcCHHHHHHHhhc
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-25 Score=216.90 Aligned_cols=166 Identities=25% Similarity=0.295 Sum_probs=126.9
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..++.++.||+.||+|||+++ ++|+||||+||++++++.+||+|||+++.+.............++..|+||
T Consensus 112 ~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~ap 188 (280)
T cd05043 112 QALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMAL 188 (280)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCH
Confidence 56999999999999999999999998 999999999999999999999999999865433222222223456789999
Q ss_pred hhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 376 EYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 376 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
|.+.+..++.++||||||+++|++++ |+.||...... .+ ........... ........+.+++
T Consensus 189 E~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~----~~~~~~~~~~~---------~~~~~~~~~~~li 252 (280)
T cd05043 189 ESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EM----AAYLKDGYRLA---------QPINCPDELFAVM 252 (280)
T ss_pred HHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HH----HHHHHcCCCCC---------CCCcCCHHHHHHH
Confidence 99988889999999999999999999 99998532211 11 11111111100 0111234577899
Q ss_pred hhcccCCCCCCCCHHHHHHHhccCCC
Q 046010 455 LLCVQEDPADRPNMSSVAVMLASDTV 480 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~~L~~~~~ 480 (523)
.+||+.||++|||+.+|+++|+....
T Consensus 253 ~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 253 ACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 99999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-25 Score=216.50 Aligned_cols=165 Identities=27% Similarity=0.372 Sum_probs=126.0
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||+++...............++..|+|
T Consensus 100 ~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~ 176 (266)
T cd05033 100 DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTA 176 (266)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccC
Confidence 457999999999999999999999998 99999999999999999999999999987642222222222334578999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||.+.+..++.++||||||+++|+|++ |..||...... .. ........... .+......+.++
T Consensus 177 Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~----~~~~~~~~~~~---------~~~~~~~~l~~l 240 (266)
T cd05033 177 PEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DV----IKAVEDGYRLP---------PPMDCPSALYQL 240 (266)
T ss_pred hhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HH----HHHHHcCCCCC---------CCCCCCHHHHHH
Confidence 999998889999999999999999998 98887432211 11 11111111100 011223467789
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+.+||+.+|++||++.||++.|++.
T Consensus 241 i~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 241 MLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHcCCCcccCcCHHHHHHHHHhh
Confidence 9999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=222.49 Aligned_cols=190 Identities=22% Similarity=0.258 Sum_probs=129.2
Q ss_pred EeeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCC
Q 046010 279 IWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ 358 (523)
Q Consensus 279 ~~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 358 (523)
.++.+.++-..+...-...+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 97 ~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~- 172 (355)
T cd07874 97 VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS- 172 (355)
T ss_pred eEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCCCc-
Confidence 3444444432222222346899999999999999999999998 999999999999999999999999999764322
Q ss_pred CCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccc-hHH--------------HHHH
Q 046010 359 NESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQS-LLA--------------YTWK 423 (523)
Q Consensus 359 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~-~~~--------------~~~~ 423 (523)
.......++..|+|||++.+..++.++||||||+++|+|++|+.||.......... ... ....
T Consensus 173 --~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (355)
T cd07874 173 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_pred --cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHH
Confidence 12234578899999999999899999999999999999999999986422110000 000 0000
Q ss_pred hhh-c-CCcccc-----c-Ccccc--CCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 424 LWC-N-GEALEL-----M-DPVLK--QSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 424 ~~~-~-~~~~~~-----~-~~~l~--~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
.+. . ...... . +.... ..........+.+|+.+||+.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000 0 000000 0 00000 00111123466789999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.3e-25 Score=212.97 Aligned_cols=166 Identities=33% Similarity=0.442 Sum_probs=126.3
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcc-ccceeccCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN-TSKVVGTYGY 372 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~-~~~~~gt~~y 372 (523)
+...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||.++.......... .....++..|
T Consensus 88 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y 164 (257)
T cd05060 88 KRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKW 164 (257)
T ss_pred hCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccc
Confidence 4447999999999999999999999998 99999999999999999999999999986643222111 1112234679
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
+|||.+.+..++.++||||||+++|+|++ |..||..... ...... ........ .+......+.
T Consensus 165 ~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~----~~~~~~~~---------~~~~~~~~l~ 228 (257)
T cd05060 165 YAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAM----LESGERLP---------RPEECPQEIY 228 (257)
T ss_pred cCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHH----HHcCCcCC---------CCCCCCHHHH
Confidence 99999988899999999999999999998 8999853321 111111 11111111 1112234677
Q ss_pred HHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 452 HIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+++.+||+.+|++||++.+|++.|++.
T Consensus 229 ~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 229 SIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.8e-25 Score=212.14 Aligned_cols=163 Identities=32% Similarity=0.413 Sum_probs=127.2
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.||++||.|||+++ ++|+||||+||+++.++.+||+|||.+................++..|+|
T Consensus 99 ~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 175 (262)
T cd00192 99 KSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMA 175 (262)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccC
Confidence 477999999999999999999999998 99999999999999999999999999987654332222334556789999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||.+....++.++||||||+++|+|++ |..||..... .. .......+.... .+......+.++
T Consensus 176 PE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~----~~~~~~~~~~~~---------~~~~~~~~~~~l 239 (262)
T cd00192 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EE----VLEYLRKGYRLP---------KPEYCPDELYEL 239 (262)
T ss_pred HHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HH----HHHHHHcCCCCC---------CCccCChHHHHH
Confidence 999988889999999999999999999 5888754311 11 111111111111 111224567789
Q ss_pred hhhcccCCCCCCCCHHHHHHHhc
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLA 476 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~ 476 (523)
+.+||+.+|++|||+.|+++.|+
T Consensus 240 i~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 240 MLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHccCCcccCcCHHHHHHhhC
Confidence 99999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.4e-25 Score=217.33 Aligned_cols=163 Identities=28% Similarity=0.364 Sum_probs=123.4
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||++................+++.|+||
T Consensus 117 ~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 193 (280)
T cd05092 117 GQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP 193 (280)
T ss_pred cccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCH
Confidence 45899999999999999999999998 999999999999999999999999998765332221222233456789999
Q ss_pred hhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 376 EYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 376 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
|.+.+..++.++||||||+++|+|++ |+.||...... .... . ...+..... +......+.+|+
T Consensus 194 E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~---~-~~~~~~~~~---------~~~~~~~~~~li 257 (280)
T cd05092 194 ESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT---EAIE---C-ITQGRELER---------PRTCPPEVYAIM 257 (280)
T ss_pred HHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH---HHHH---H-HHcCccCCC---------CCCCCHHHHHHH
Confidence 99998899999999999999999998 88887432211 1111 1 111111110 011234567899
Q ss_pred hhcccCCCCCCCCHHHHHHHhcc
Q 046010 455 LLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
.+||+.||.+||++.||++.|+.
T Consensus 258 ~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 258 QGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHccCChhhCCCHHHHHHHHhC
Confidence 99999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=218.78 Aligned_cols=162 Identities=26% Similarity=0.361 Sum_probs=122.7
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+...+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++..... ........|++.
T Consensus 87 ~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~ 161 (327)
T cd05617 87 MQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTTSTFCGTPN 161 (327)
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCceecccCCcc
Confidence 345567999999999999999999999998 999999999999999999999999998753211 112234578999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||++.+..++.++||||||+++|+|++|+.||........................ . + +......+.
T Consensus 162 y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~-----~----p~~~~~~~~ 231 (327)
T cd05617 162 YIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI-R-----I----PRFLSVKAS 231 (327)
T ss_pred cCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC-C-----C----CCCCCHHHH
Confidence 99999999999999999999999999999999999643332222222222332222111 0 0 111123567
Q ss_pred HHhhhcccCCCCCCCCH
Q 046010 452 HIGLLCVQEDPADRPNM 468 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~ 468 (523)
+++.+||+.||++|+++
T Consensus 232 ~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 232 HVLKGFLNKDPKERLGC 248 (327)
T ss_pred HHHHHHhccCHHHcCCC
Confidence 88899999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-25 Score=218.82 Aligned_cols=165 Identities=30% Similarity=0.368 Sum_probs=125.9
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.||++||.|||+++ ++||||||+||+++.++.+||+|||.++...............++..|+|
T Consensus 131 ~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~a 207 (304)
T cd05101 131 DEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMA 207 (304)
T ss_pred cccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeC
Confidence 456899999999999999999999998 99999999999999999999999999987643322222223345678999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||.+.+..++.++||||||+++|+|++ |..||.... ... ............ .+......+.+|
T Consensus 208 PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------~~~-~~~~~~~~~~~~---------~~~~~~~~~~~l 271 (304)
T cd05101 208 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------VEE-LFKLLKEGHRMD---------KPANCTNELYMM 271 (304)
T ss_pred chhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------HHH-HHHHHHcCCcCC---------CCCCCCHHHHHH
Confidence 999988889999999999999999998 677764221 111 111111111111 111233567788
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+.+||+.+|++||++.||++.|++.
T Consensus 272 i~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 272 MRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred HHHHcccChhhCCCHHHHHHHHHHH
Confidence 9999999999999999999999775
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=220.66 Aligned_cols=164 Identities=24% Similarity=0.293 Sum_probs=121.5
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.++..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....... .......|+..|
T Consensus 97 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y 172 (332)
T cd05614 97 YQRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK-ERTYSFCGTIEY 172 (332)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccccCC-CccccccCCccc
Confidence 34567999999999999999999999998 99999999999999999999999999876532221 122345789999
Q ss_pred CchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 373 MAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 373 ~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
+|||.+.+. .++.++||||||+++|||++|+.||.......... ......... ++.+. ......+.
T Consensus 173 ~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---~~~~~~~~~------~~~~~----~~~~~~~~ 239 (332)
T cd05614 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS---EVSRRILKC------DPPFP----SFIGPEAQ 239 (332)
T ss_pred cCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH---HHHHHHhcC------CCCCC----CCCCHHHH
Confidence 999998765 47889999999999999999999986432221111 111111111 11111 11223567
Q ss_pred HHhhhcccCCCCCCC-----CHHHHHH
Q 046010 452 HIGLLCVQEDPADRP-----NMSSVAV 473 (523)
Q Consensus 452 ~li~~cl~~dP~~RP-----s~~ei~~ 473 (523)
+++.+||+.||++|| +++++++
T Consensus 240 ~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 240 DLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 888999999999999 6667654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=9e-25 Score=215.32 Aligned_cols=162 Identities=31% Similarity=0.418 Sum_probs=121.3
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC---CeeEeccccceeccCCCCCccccceeccCCC
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM---NPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~---~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
..+++..++.++.||+.||+|||+++ ++|+||||+||+++.++ .+||+|||+++................+..|
T Consensus 111 ~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 187 (277)
T cd05036 111 SSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187 (277)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhh
Confidence 36999999999999999999999998 99999999999998765 5899999999865322211111222335679
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
+|||.+.+..++.++|||||||++|+|++ |..||...... .... ......... .+......+.
T Consensus 188 ~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~----~~~~~~~~~---------~~~~~~~~~~ 251 (277)
T cd05036 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVME----FVTGGGRLD---------PPKGCPGPVY 251 (277)
T ss_pred CCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHHcCCcCC---------CCCCCCHHHH
Confidence 99999998999999999999999999997 88887532221 1111 111111111 1112234677
Q ss_pred HHhhhcccCCCCCCCCHHHHHHHhc
Q 046010 452 HIGLLCVQEDPADRPNMSSVAVMLA 476 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~~L~ 476 (523)
+++.+||+.+|++||++.+|++.|+
T Consensus 252 ~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 252 RIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHHHcCCCcccCcCHHHHHHHhh
Confidence 8999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=221.50 Aligned_cols=174 Identities=24% Similarity=0.235 Sum_probs=123.2
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++..... .......++..|+|
T Consensus 120 ~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---~~~~~~~~t~~y~a 193 (364)
T cd07875 120 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRA 193 (364)
T ss_pred HhcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccccCCC---CcccCCcccCCcCC
Confidence 346899999999999999999999998 999999999999999999999999999765321 12234568899999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchH-H-------HHHH-------hh-h-cCCcc-----c
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLL-A-------YTWK-------LW-C-NGEAL-----E 432 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~-~-------~~~~-------~~-~-~~~~~-----~ 432 (523)
||++.+..++.++|||||||++|+|++|+.||...........+ . ..+. .. . ..... +
T Consensus 194 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (364)
T cd07875 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEK 273 (364)
T ss_pred HHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHh
Confidence 99999999999999999999999999999998643221100000 0 0000 00 0 00000 0
Q ss_pred ccCcccc---CCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 433 LMDPVLK---QSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 433 ~~~~~l~---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
....... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 274 LFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 00011123467789999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-25 Score=211.94 Aligned_cols=195 Identities=23% Similarity=0.302 Sum_probs=138.1
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCC-CCeeEeccccceeccCCCCCccccceeccC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE-MNPKISDFGMARIFGGNQNESNTSKVVGTY 370 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~ 370 (523)
...+.+++...++-+..||.+||.|||+.+ |+||||||.|||+|.+ |.+||+|||.|+.+..+. .......|.
T Consensus 116 ~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e---pniSYicSR 189 (364)
T KOG0658|consen 116 TRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE---PNISYICSR 189 (364)
T ss_pred hhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccCC---CceeEEEec
Confidence 455788999999999999999999999998 9999999999999987 899999999999875332 234567789
Q ss_pred CCCchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhc----------CCcccccCcccc
Q 046010 371 GYMAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCN----------GEALELMDPVLK 439 (523)
Q Consensus 371 ~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~ 439 (523)
.|+|||.+.+ ..|+.+.||||.||++.||+.|++-|...... +.+....+.+.. ....+...+.+.
T Consensus 190 yYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~---dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik 266 (364)
T KOG0658|consen 190 YYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV---DQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIK 266 (364)
T ss_pred cccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH---HHHHHHHHHhCCCCHHHHhhcCcccccccCcccc
Confidence 9999999987 56999999999999999999999988643222 222221111111 111111111111
Q ss_pred CC-----ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH-----HhccCCCCCC--CCCCCCcccccc
Q 046010 440 QS-----CMAAELLKCIHIGLLCVQEDPADRPNMSSVAV-----MLASDTVSLP--QPTQPAFSVGRI 495 (523)
Q Consensus 440 ~~-----~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~-----~L~~~~~~l~--~p~~p~~~~~~~ 495 (523)
.. .......+.++++.++|+.+|.+|.++.|++. .|+.....++ .|-.|.|.+.+.
T Consensus 267 ~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~~lp~lf~f~~~ 334 (364)
T KOG0658|consen 267 AHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGRPLPPLFNFKRA 334 (364)
T ss_pred cccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCCcCCCccCchHH
Confidence 11 12234457788999999999999999998853 4444433333 334455555443
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-24 Score=219.42 Aligned_cols=110 Identities=31% Similarity=0.476 Sum_probs=95.8
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.+...+++..+..++.|++.||.|||+++ .|+||||||+||+++.++.+||+|||++...... ......++..|
T Consensus 95 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~g~~~y 168 (331)
T cd06649 95 KEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSY 168 (331)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc----ccccCCCCcCc
Confidence 44567999999999999999999999863 3999999999999999999999999998765321 12345688999
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGF 408 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~ 408 (523)
+|||.+.+..++.++||||||+++|+|++|+.||..
T Consensus 169 ~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 169 MSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred CCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 999999998999999999999999999999999853
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-24 Score=208.99 Aligned_cols=176 Identities=28% Similarity=0.404 Sum_probs=130.1
Q ss_pred ccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCc-
Q 046010 283 IGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES- 361 (523)
Q Consensus 283 ~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~- 361 (523)
.|.+...+.......+++..++.++.|+++||+|||+++ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 344444443333357999999999999999999999998 9999999999999999999999999998764322211
Q ss_pred cccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccC
Q 046010 362 NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQ 440 (523)
Q Consensus 362 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 440 (523)
......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... .... ..........
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~---~~~~~~~~~~-------- 221 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILK---KIDKEGERLE-------- 221 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---HHHhcCCcCC--------
Confidence 1223456778999999988899999999999999999998 99997432111 1111 1111111100
Q ss_pred CccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhc
Q 046010 441 SCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLA 476 (523)
Q Consensus 441 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~ 476 (523)
.+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus 222 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 -RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 01122356778999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=219.52 Aligned_cols=162 Identities=27% Similarity=0.363 Sum_probs=121.9
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++..... ........|+..
T Consensus 87 ~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~ 161 (329)
T cd05618 87 MQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGTPN 161 (329)
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCccccccCCcc
Confidence 345568999999999999999999999998 999999999999999999999999998753211 112234578999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCccccc--ccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH--GQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
|+|||++.+..++.++||||||+++|+|++|+.||....... ......+.......... . + +......
T Consensus 162 y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~-----~----p~~~~~~ 231 (329)
T cd05618 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R-----I----PRSLSVK 231 (329)
T ss_pred ccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-C-----C----CCCCCHH
Confidence 999999999999999999999999999999999986322211 11112222222222111 1 1 1112345
Q ss_pred HHHHhhhcccCCCCCCCCH
Q 046010 450 CIHIGLLCVQEDPADRPNM 468 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~ 468 (523)
+.+++.+||+.||++||+.
T Consensus 232 ~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 232 AASVLKSFLNKDPKERLGC 250 (329)
T ss_pred HHHHHHHHhcCCHHHcCCC
Confidence 6788999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=214.87 Aligned_cols=160 Identities=23% Similarity=0.258 Sum_probs=122.2
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...... ........|++.
T Consensus 86 l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~gt~~ 160 (323)
T cd05595 86 LSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPE 160 (323)
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCccccccCCcC
Confidence 445667999999999999999999999998 999999999999999999999999998753211 112234568999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||++.+..++.++||||||+++|+|++|+.||...... .. ..... .... . +.. .....+.
T Consensus 161 y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~---~~~~~-~~~~-~-----~p~----~~~~~~~ 223 (323)
T cd05595 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RL---FELIL-MEEI-R-----FPR----TLSPEAK 223 (323)
T ss_pred cCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HH---HHHHh-cCCC-C-----CCC----CCCHHHH
Confidence 99999999999999999999999999999999998532211 11 11111 1110 0 111 1224566
Q ss_pred HHhhhcccCCCCCCC-----CHHHHHH
Q 046010 452 HIGLLCVQEDPADRP-----NMSSVAV 473 (523)
Q Consensus 452 ~li~~cl~~dP~~RP-----s~~ei~~ 473 (523)
+++.+||+.||++|| ++.++++
T Consensus 224 ~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 224 SLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 888899999999998 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.9e-25 Score=213.81 Aligned_cols=166 Identities=26% Similarity=0.367 Sum_probs=126.1
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCc-cccceeccCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES-NTSKVVGTYGY 372 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~gt~~y 372 (523)
.+..+++..+++++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||++.......... ......++..|
T Consensus 88 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y 164 (257)
T cd05115 88 KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKW 164 (257)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCccc
Confidence 4567999999999999999999999998 9999999999999999999999999987653322211 11112235689
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
+|||.+....++.++||||||+++|++++ |..||...... ........+...+ .+......+.
T Consensus 165 ~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~---------~~~~~~~~l~ 228 (257)
T cd05115 165 YAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-------EVMSFIEQGKRLD---------CPAECPPEMY 228 (257)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHHHHHCCCCCC---------CCCCCCHHHH
Confidence 99999988889999999999999999996 99998532211 1111222221111 1122345677
Q ss_pred HHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 452 HIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+++.+||+.+|++||++.+|.+.|+..
T Consensus 229 ~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 229 ALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=212.61 Aligned_cols=163 Identities=29% Similarity=0.430 Sum_probs=123.8
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC-----CeeEeccccceeccCCCCCccccceeccC
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM-----NPKISDFGMARIFGGNQNESNTSKVVGTY 370 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~-----~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~ 370 (523)
..+++.+++.++.||+.||.|||+++ ++|+||||+||+++.++ .+||+|||++................++.
T Consensus 101 ~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 177 (269)
T cd05044 101 PLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177 (269)
T ss_pred ccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCc
Confidence 45889999999999999999999998 99999999999999877 89999999987653322222222334567
Q ss_pred CCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 371 GYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 371 ~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
.|+|||.+.++.++.++||||||+++|+|++ |+.||...... ... .....+.... .+......
T Consensus 178 ~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~----~~~~~~~~~~---------~~~~~~~~ 241 (269)
T cd05044 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVL----QHVTAGGRLQ---------KPENCPDK 241 (269)
T ss_pred cccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHH----HHHhcCCccC---------CcccchHH
Confidence 8999999999999999999999999999998 99887532211 111 1111111110 11122356
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHHHhcc
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
+.+++.+||+.+|++||++.+|++.|++
T Consensus 242 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 242 IYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 7789999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-24 Score=218.35 Aligned_cols=161 Identities=21% Similarity=0.217 Sum_probs=123.0
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ........|++.
T Consensus 86 l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~ 160 (328)
T cd05593 86 LSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKTFCGTPE 160 (328)
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccccccccCCcC
Confidence 445567999999999999999999999998 999999999999999999999999998753211 112234568999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||.+.+..++.++|||||||++|+|++|+.||...... ..... ...... .+.. .....+.
T Consensus 161 y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~-~~~~~~------~~p~----~~~~~~~ 223 (328)
T cd05593 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFEL-ILMEDI------KFPR----TLSADAK 223 (328)
T ss_pred ccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHH-hccCCc------cCCC----CCCHHHH
Confidence 99999999889999999999999999999999998532211 11111 111110 0111 1223567
Q ss_pred HHhhhcccCCCCCCC-----CHHHHHHH
Q 046010 452 HIGLLCVQEDPADRP-----NMSSVAVM 474 (523)
Q Consensus 452 ~li~~cl~~dP~~RP-----s~~ei~~~ 474 (523)
+++.+||+.||++|| ++.|+++.
T Consensus 224 ~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 224 SLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 888999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=212.09 Aligned_cols=174 Identities=26% Similarity=0.419 Sum_probs=130.7
Q ss_pred cccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccc
Q 046010 284 GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNT 363 (523)
Q Consensus 284 g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 363 (523)
|....++....+..+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||.+........ ...
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~ 160 (260)
T cd05067 85 GSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TAR 160 (260)
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc-ccc
Confidence 44444444555667999999999999999999999998 99999999999999999999999999976542211 111
Q ss_pred cceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCc
Q 046010 364 SKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSC 442 (523)
Q Consensus 364 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 442 (523)
....++..|+|||.+....++.++||||||+++|++++ |+.||..... ... ........... .
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~----~~~~~~~~~~~---------~ 224 (260)
T cd05067 161 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEV----IQNLERGYRMP---------R 224 (260)
T ss_pred cCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHH----HHHHHcCCCCC---------C
Confidence 22345678999999988889999999999999999999 9999853221 111 11111111111 1
Q ss_pred cHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhcc
Q 046010 443 MAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 443 ~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
+......+.+++.+||+.+|++||++++|+++|+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11123467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=218.32 Aligned_cols=166 Identities=31% Similarity=0.398 Sum_probs=125.6
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++.++.+++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||.++...............++..|+|
T Consensus 128 ~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 204 (314)
T cd05099 128 EEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMA 204 (314)
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccC
Confidence 356999999999999999999999998 99999999999999999999999999986542221111122233467999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||.+.+..++.++||||||+++|+|++ |..||...... .. ..........+. +......+.++
T Consensus 205 PE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~~----~~~~~~~~~~~~---------~~~~~~~l~~l 268 (314)
T cd05099 205 PEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE---EL----FKLLREGHRMDK---------PSNCTHELYML 268 (314)
T ss_pred HHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHcCCCCCC---------CCCCCHHHHHH
Confidence 999998889999999999999999999 78887432211 11 111111111111 11223467789
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
+.+||+.+|++||++.||++.|++..
T Consensus 269 i~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 269 MRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 99999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=215.97 Aligned_cols=159 Identities=28% Similarity=0.347 Sum_probs=121.2
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..++..+++.++..++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++..... ........|+..
T Consensus 87 i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~ 161 (316)
T cd05620 87 IQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRASTFCGTPD 161 (316)
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCceeccCCCcC
Confidence 345567999999999999999999999998 999999999999999999999999998743211 112234568999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||++.+..++.++||||||+++|+|++|+.||..... ... ........ +.+.. ....++.
T Consensus 162 y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~----~~~~~~~~------~~~~~----~~~~~~~ 224 (316)
T cd05620 162 YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DEL----FESIRVDT------PHYPR----WITKESK 224 (316)
T ss_pred ccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHH----HHHHHhCC------CCCCC----CCCHHHH
Confidence 9999999999999999999999999999999999853221 111 11111110 01111 1123566
Q ss_pred HHhhhcccCCCCCCCCHH-HHH
Q 046010 452 HIGLLCVQEDPADRPNMS-SVA 472 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~-ei~ 472 (523)
+++.+||+.||++||++. +++
T Consensus 225 ~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 225 DILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHccCCHHHcCCChHHHH
Confidence 888999999999999984 565
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.8e-25 Score=213.56 Aligned_cols=162 Identities=27% Similarity=0.375 Sum_probs=122.6
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+||+|||.++....... .......++..|+|
T Consensus 94 ~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~ 169 (256)
T cd05059 94 KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSSQGTKFPVKWAP 169 (256)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc-cccCCCCCCccccC
Confidence 347899999999999999999999998 99999999999999999999999999876532211 11112223457999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||.+.+..++.++||||||+++|+|++ |+.||...... .. .......... ..+......+.++
T Consensus 170 Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~----~~~~~~~~~~---------~~~~~~~~~~~~l 233 (256)
T cd05059 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EV----VESVSAGYRL---------YRPKLAPTEVYTI 233 (256)
T ss_pred HHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HH----HHHHHcCCcC---------CCCCCCCHHHHHH
Confidence 999998899999999999999999999 78887532211 11 1111111100 0111234467889
Q ss_pred hhhcccCCCCCCCCHHHHHHHhc
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLA 476 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~ 476 (523)
+.+||+.+|++|||+.||+++|.
T Consensus 234 i~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 234 MYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred HHHHhcCChhhCcCHHHHHHHhC
Confidence 99999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-25 Score=222.32 Aligned_cols=165 Identities=22% Similarity=0.266 Sum_probs=124.5
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.+...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++..... ......|++.|
T Consensus 93 ~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y 164 (333)
T cd05600 93 NNLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDY 164 (333)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCccc
Confidence 45567999999999999999999999998 99999999999999999999999999876532 22345689999
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
+|||++.+..++.++|||||||++|||++|+.||....... .... ...+. .... .+... .........+.+
T Consensus 165 ~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~~-i~~~~--~~~~--~~~~~-~~~~~~s~~~~~ 235 (333)
T cd05600 165 MAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE---TWEN-LKYWK--ETLQ--RPVYD-DPRFNLSDEAWD 235 (333)
T ss_pred cChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH---HHHH-HHhcc--cccc--CCCCC-ccccccCHHHHH
Confidence 99999999999999999999999999999999985322211 1110 01111 0000 00000 000122346678
Q ss_pred HhhhcccCCCCCCCCHHHHHHH
Q 046010 453 IGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~~ 474 (523)
++.+||+.+|.+||++.+|++.
T Consensus 236 li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 236 LITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHhhChhhhcCCHHHHHhC
Confidence 8899999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-24 Score=225.79 Aligned_cols=169 Identities=27% Similarity=0.359 Sum_probs=129.6
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
......+++..++.++.||++||.|||+++ |+|+||||+||+++.++.+||+|||+++...............++..
T Consensus 228 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~ 304 (400)
T cd05105 228 DDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK 304 (400)
T ss_pred hcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcc
Confidence 344567999999999999999999999998 99999999999999999999999999986543322222233456778
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
|+|||.+.+..++.++||||||+++|+|++ |..||...... . ........+... ..+......+
T Consensus 305 y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--~----~~~~~~~~~~~~---------~~~~~~~~~l 369 (400)
T cd05105 305 WMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--S----TFYNKIKSGYRM---------AKPDHATQEV 369 (400)
T ss_pred eEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--H----HHHHHHhcCCCC---------CCCccCCHHH
Confidence 999999998899999999999999999997 88887532211 0 111111111111 0111234567
Q ss_pred HHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 451 IHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
.+++.+||+.||++||++.+|.++|++.
T Consensus 370 ~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 370 YDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred HHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 8899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=220.93 Aligned_cols=173 Identities=23% Similarity=0.230 Sum_probs=122.5
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++..... .......++..|+|
T Consensus 117 ~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~a 190 (359)
T cd07876 117 HMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYYRA 190 (359)
T ss_pred hccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCccccccC---ccCCCCcccCCCCC
Confidence 345899999999999999999999998 999999999999999999999999998754321 12234567899999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCccccccc------------chH----HHHHHhhhcC-C-----ccc
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQ------------SLL----AYTWKLWCNG-E-----ALE 432 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~------------~~~----~~~~~~~~~~-~-----~~~ 432 (523)
||.+.+..++.++||||||+++|+|++|+.||......... ... .......... . ..+
T Consensus 191 PE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (359)
T cd07876 191 PEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEE 270 (359)
T ss_pred chhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhh
Confidence 99999999999999999999999999999998643211000 000 0000000000 0 000
Q ss_pred ccCccccC---CccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 433 LMDPVLKQ---SCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 433 ~~~~~l~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
........ .........+.+|+.+||+.||++|||+.|+++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 271 LFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred hccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 000112345678999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=214.15 Aligned_cols=158 Identities=23% Similarity=0.254 Sum_probs=122.1
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..++..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++..... .....|++.
T Consensus 92 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~ 163 (291)
T cd05612 92 LRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPE 163 (291)
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC-----cccccCChh
Confidence 345667999999999999999999999998 999999999999999999999999998765321 223468899
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||.+.+..++.++||||||+++|+|++|+.||..... .... ........ + + +......+.
T Consensus 164 y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~------~~~~-~~i~~~~~-~-----~----~~~~~~~~~ 226 (291)
T cd05612 164 YLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP------FGIY-EKILAGKL-E-----F----PRHLDLYAK 226 (291)
T ss_pred hcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHH-HHHHhCCc-C-----C----CccCCHHHH
Confidence 9999999988899999999999999999999999853221 1111 11111110 0 0 111123567
Q ss_pred HHhhhcccCCCCCCCC-----HHHHHHH
Q 046010 452 HIGLLCVQEDPADRPN-----MSSVAVM 474 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs-----~~ei~~~ 474 (523)
+|+.+||+.||.+||+ ++++++.
T Consensus 227 ~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 227 DLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 8999999999999995 7777643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=216.30 Aligned_cols=111 Identities=32% Similarity=0.494 Sum_probs=93.5
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEe----CCCCCeeEeccccceeccCCCCC-ccccceecc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLL----DHEMNPKISDFGMARIFGGNQNE-SNTSKVVGT 369 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll----~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~gt 369 (523)
...+++..++.++.||+.||.|||+++ |+||||||+||++ +.++.+||+|||+++........ .......++
T Consensus 102 ~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t 178 (317)
T cd07867 102 PMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178 (317)
T ss_pred CccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceec
Confidence 346899999999999999999999998 9999999999999 55678999999999876432221 122345788
Q ss_pred CCCCchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 046010 370 YGYMAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGF 408 (523)
Q Consensus 370 ~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~ 408 (523)
..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 179 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 99999999876 4578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=218.26 Aligned_cols=166 Identities=25% Similarity=0.353 Sum_probs=124.0
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+.+++++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.... .........|+..
T Consensus 87 ~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt~~ 161 (329)
T cd05588 87 MQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDTTSTFCGTPN 161 (329)
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccccc--CCCccccccCCcc
Confidence 445678999999999999999999999998 99999999999999999999999999874221 1122334578999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCccccc--ccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH--GQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
|+|||++.+..++.++||||||+++|+|++|+.||....... ......+.......... . +.. .....
T Consensus 162 y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~-----~p~----~~~~~ 231 (329)
T cd05588 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-R-----IPR----SLSVK 231 (329)
T ss_pred ccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-C-----CCC----CCCHH
Confidence 999999999999999999999999999999999996432211 11111222222222111 1 111 12235
Q ss_pred HHHHhhhcccCCCCCCCC------HHHHH
Q 046010 450 CIHIGLLCVQEDPADRPN------MSSVA 472 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs------~~ei~ 472 (523)
+.+++.+||+.||.+||+ +.+++
T Consensus 232 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 232 ASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 678899999999999998 56665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=216.09 Aligned_cols=155 Identities=28% Similarity=0.340 Sum_probs=120.2
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++..... ........|++.
T Consensus 87 i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~ 161 (320)
T cd05590 87 IQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTTSTFCGTPD 161 (320)
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCcccccccCcc
Confidence 455668999999999999999999999998 999999999999999999999999998753221 112334568999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||.+.+..++.++||||||+++|+|++|+.||...... . ........... . +......+.
T Consensus 162 y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~-~~~~i~~~~~~------~----~~~~~~~~~ 224 (320)
T cd05590 162 YIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------D-LFEAILNDEVV------Y----PTWLSQDAV 224 (320)
T ss_pred ccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------H-HHHHHhcCCCC------C----CCCCCHHHH
Confidence 99999999989999999999999999999999998532211 1 11111111110 0 111234567
Q ss_pred HHhhhcccCCCCCCCCH
Q 046010 452 HIGLLCVQEDPADRPNM 468 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~ 468 (523)
+++.+||+.||++||++
T Consensus 225 ~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 225 DILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHHcccCHHHCCCC
Confidence 88999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=209.12 Aligned_cols=175 Identities=24% Similarity=0.277 Sum_probs=126.7
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..++...++.++.||+.||+|||+++ |+||||||.||+|+++|.+||+|||+++.+..... .....++|..|+||
T Consensus 115 ~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~--~yt~evvTlWYRaP 189 (323)
T KOG0594|consen 115 QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMR--TYTPEVVTLWYRAP 189 (323)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHHHhcCCcc--cccccEEEeeccCH
Confidence 46888999999999999999999998 99999999999999999999999999997643222 24456789999999
Q ss_pred hhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcC---Ccccc-----cCccccC-----C
Q 046010 376 EYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNG---EALEL-----MDPVLKQ-----S 441 (523)
Q Consensus 376 E~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-----~~~~l~~-----~ 441 (523)
|++.+. .|+...||||+||++.||++++.-|..... ...+....+....+ .+... .+..... .
T Consensus 190 EvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~ 266 (323)
T KOG0594|consen 190 EVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKD 266 (323)
T ss_pred HHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccc
Confidence 999886 699999999999999999999887754332 11111111111111 00000 0000000 0
Q ss_pred ccHHH---HHHHHHHhhhcccCCCCCCCCHHHHHHH--hccC
Q 046010 442 CMAAE---LLKCIHIGLLCVQEDPADRPNMSSVAVM--LASD 478 (523)
Q Consensus 442 ~~~~~---~~~~~~li~~cl~~dP~~RPs~~ei~~~--L~~~ 478 (523)
..... ....++++.+||+.+|.+|.|++.++++ +...
T Consensus 267 l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 267 LSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred hHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 00111 1367889999999999999999999886 5443
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-24 Score=211.99 Aligned_cols=172 Identities=26% Similarity=0.337 Sum_probs=129.1
Q ss_pred ccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcc
Q 046010 283 IGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN 362 (523)
Q Consensus 283 ~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 362 (523)
.|....++.......+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||.+......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----- 153 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----- 153 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence 344444544445567899999999999999999999998 999999999999999999999999998764221
Q ss_pred ccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCC
Q 046010 363 TSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQS 441 (523)
Q Consensus 363 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 441 (523)
......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...... . .......+...+
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~-~~~~~~~~~~~~--------- 217 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK------E-VKECVEKGYRME--------- 217 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH------H-HHHHHhCCCCCC---------
Confidence 112233567999999988899999999999999999998 88887532211 1 111111111111
Q ss_pred ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 442 CMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 442 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
.+......+.+++.+||+.+|++||++.+|++.|+++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 254 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEKE 254 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHccC
Confidence 1112235667899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-24 Score=211.44 Aligned_cols=170 Identities=24% Similarity=0.327 Sum_probs=123.2
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||++................++..|+||
T Consensus 124 ~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 200 (295)
T cd05097 124 PSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAW 200 (295)
T ss_pred CcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecCh
Confidence 35789999999999999999999998 999999999999999999999999998765322221122233456789999
Q ss_pred hhhcCCCCCcchhhHHHHHHHHHHHh--CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 376 EYALGGVISVKSDVFSFGVLLLEIIS--GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 376 E~l~~~~~s~ksDVwSlGvvl~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
|.+.++.++.++||||||+++|+|++ +..||..... ...+......+.......... .+......+.+|
T Consensus 201 E~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~l 271 (295)
T cd05097 201 ESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD---EQVIENTGEFFRNQGRQIYLS------QTPLCPSPVFKL 271 (295)
T ss_pred hhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh---HHHHHHHHHhhhhccccccCC------CCCCCCHHHHHH
Confidence 99988889999999999999999998 4455532211 111111111111111100000 011123478899
Q ss_pred hhhcccCCCCCCCCHHHHHHHhcc
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
+.+||+.||++||++.+|+++|+.
T Consensus 272 i~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 272 MMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHcCCCchhCcCHHHHHHHHhC
Confidence 999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=219.44 Aligned_cols=108 Identities=27% Similarity=0.386 Sum_probs=93.9
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.+...+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .......|+..|
T Consensus 149 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y 222 (357)
T PHA03209 149 KRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---PAFLGLAGTVET 222 (357)
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC---cccccccccccc
Confidence 45567999999999999999999999998 999999999999999999999999998753211 122345689999
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKKNS 406 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~ 406 (523)
+|||++.+..++.++|||||||++|||+++..++
T Consensus 223 ~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 223 NAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 9999999999999999999999999999876554
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.3e-24 Score=211.99 Aligned_cols=170 Identities=25% Similarity=0.349 Sum_probs=123.3
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.+||+|||++..+..............+..|++|
T Consensus 125 ~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p 201 (296)
T cd05095 125 VTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSW 201 (296)
T ss_pred cccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCH
Confidence 45889999999999999999999998 999999999999999999999999998765322211112223346789999
Q ss_pred hhhcCCCCCcchhhHHHHHHHHHHHh--CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 376 EYALGGVISVKSDVFSFGVLLLEIIS--GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 376 E~l~~~~~s~ksDVwSlGvvl~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
|....+.++.++||||||+++|||++ |..||...... .........+......... + .+......+.++
T Consensus 202 e~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~l 272 (296)
T cd05095 202 ESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE---QVIENTGEFFRDQGRQVYL-P-----KPALCPDSLYKL 272 (296)
T ss_pred HHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH---HHHHHHHHHHhhccccccC-C-----CCCCCCHHHHHH
Confidence 99888889999999999999999998 56676432211 1111111111111000000 0 011223567789
Q ss_pred hhhcccCCCCCCCCHHHHHHHhcc
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
+.+||+.||++||++.||++.|++
T Consensus 273 i~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 273 MLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHcCCCcccCCCHHHHHHHHhC
Confidence 999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=217.75 Aligned_cols=164 Identities=30% Similarity=0.367 Sum_probs=123.7
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++.++++++.||+.||+|||+++ ++||||||+||+++.++.+||+|||.+................++..|+||
T Consensus 135 ~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP 211 (307)
T cd05098 135 EQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 211 (307)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeCh
Confidence 46899999999999999999999998 999999999999999999999999998765322111111122334689999
Q ss_pred hhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 376 EYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 376 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
|.+.+..++.++||||||+++|+|++ |+.||..... .............+ .+......+.+|+
T Consensus 212 E~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~~~~---------~~~~~~~~~~~li 275 (307)
T cd05098 212 EALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-------EELFKLLKEGHRMD---------KPSNCTNELYMMM 275 (307)
T ss_pred HHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-------HHHHHHHHcCCCCC---------CCCcCCHHHHHHH
Confidence 99998889999999999999999998 7788743211 11111111111111 1112234677889
Q ss_pred hhcccCCCCCCCCHHHHHHHhccC
Q 046010 455 LLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
.+||+.+|++||++.+|++.|+..
T Consensus 276 ~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 276 RDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred HHHcccChhhCcCHHHHHHHHHHH
Confidence 999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=216.91 Aligned_cols=165 Identities=28% Similarity=0.352 Sum_probs=123.5
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++..... .........+..|+||
T Consensus 114 ~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aP 187 (297)
T cd05089 114 STLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEV---YVKKTMGRLPVRWMAI 187 (297)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEECCcCCCccccc---eeccCCCCcCccccCc
Confidence 45899999999999999999999998 99999999999999999999999999864211 1111112234579999
Q ss_pred hhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 376 EYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 376 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
|.+....++.++||||||+++|||++ |..||...... .. ......+.... .+......+.+|+
T Consensus 188 E~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~~----~~~~~~~~~~~---------~~~~~~~~~~~li 251 (297)
T cd05089 188 ESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---EL----YEKLPQGYRME---------KPRNCDDEVYELM 251 (297)
T ss_pred hhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HH----HHHHhcCCCCC---------CCCCCCHHHHHHH
Confidence 99988889999999999999999997 99998532211 11 11111111000 1111234567899
Q ss_pred hhcccCCCCCCCCHHHHHHHhccCCCCC
Q 046010 455 LLCVQEDPADRPNMSSVAVMLASDTVSL 482 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~~L~~~~~~l 482 (523)
.+||+.+|.+||++.+|++.|+......
T Consensus 252 ~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 252 RQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 9999999999999999999988765433
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-24 Score=220.83 Aligned_cols=176 Identities=21% Similarity=0.281 Sum_probs=123.8
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....... .......++..
T Consensus 94 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~~~~~ 169 (372)
T cd07853 94 IVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-KHMTQEVVTQY 169 (372)
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecccCcc-ccCCCCCcCCC
Confidence 345567999999999999999999999998 99999999999999999999999999986532221 12223467889
Q ss_pred CCchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHH----------------HHHHhhhc-CCcccc
Q 046010 372 YMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLA----------------YTWKLWCN-GEALEL 433 (523)
Q Consensus 372 y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~----------------~~~~~~~~-~~~~~~ 433 (523)
|+|||.+.+. .++.++|||||||++|||++|+.||...........+. .....+.. ......
T Consensus 170 y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (372)
T cd07853 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPS 249 (372)
T ss_pred cCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCc
Confidence 9999998774 47899999999999999999999986432211100000 00000000 000000
Q ss_pred cCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 434 MDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 434 ~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
..... .........+.+|+.+||+.||++|||+.|+++
T Consensus 250 ~~~~~--~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 250 LPVLY--TLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred hHHhc--ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 00000 001112346778999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=214.87 Aligned_cols=160 Identities=23% Similarity=0.260 Sum_probs=122.6
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+...+.+..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++...... .......|++.
T Consensus 91 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~ 165 (323)
T cd05584 91 LEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--TVTHTFCGTIE 165 (323)
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--CcccccCCCcc
Confidence 345667899999999999999999999998 9999999999999999999999999987542221 12233568999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||++.+..++.++||||||+++|||++|+.||..... ...... ...+.. . + +......+.
T Consensus 166 y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~------~~~~~~-~~~~~~-~-----~----~~~~~~~~~ 228 (323)
T cd05584 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR------KKTIDK-ILKGKL-N-----L----PPYLTPEAR 228 (323)
T ss_pred ccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH------HHHHHH-HHcCCC-C-----C----CCCCCHHHH
Confidence 9999999988899999999999999999999999853221 111111 111111 0 0 111224567
Q ss_pred HHhhhcccCCCCCCC-----CHHHHHH
Q 046010 452 HIGLLCVQEDPADRP-----NMSSVAV 473 (523)
Q Consensus 452 ~li~~cl~~dP~~RP-----s~~ei~~ 473 (523)
+++.+||+.||++|| ++.++++
T Consensus 229 ~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 229 DLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 889999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=211.97 Aligned_cols=162 Identities=26% Similarity=0.362 Sum_probs=123.2
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||.++....... .......++..|++
T Consensus 94 ~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~y~~ 169 (256)
T cd05113 94 GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSP 169 (256)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce-eecCCCccChhhCC
Confidence 347999999999999999999999998 99999999999999999999999999876532211 11112335567999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||.+.+..++.++||||||+++|+|++ |+.||...... . ............. +......+.++
T Consensus 170 pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~----~~~~~~~~~~~~~---------~~~~~~~~~~l 233 (256)
T cd05113 170 PEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---E----TVEKVSQGLRLYR---------PHLASEKVYAI 233 (256)
T ss_pred HHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---H----HHHHHhcCCCCCC---------CCCCCHHHHHH
Confidence 999988889999999999999999998 88887532221 1 1111111111100 01123567889
Q ss_pred hhhcccCCCCCCCCHHHHHHHhc
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLA 476 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~ 476 (523)
+.+||+.+|.+||++.+|++.|+
T Consensus 234 i~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 234 MYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHcCCCcccCCCHHHHHHhhC
Confidence 99999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=209.27 Aligned_cols=166 Identities=27% Similarity=0.313 Sum_probs=126.8
Q ss_pred cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcccccee
Q 046010 288 PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVV 367 (523)
Q Consensus 288 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 367 (523)
.++.......+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||++........ ......
T Consensus 88 ~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~ 162 (256)
T cd08529 88 KLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--FANTIV 162 (256)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc--hhhccc
Confidence 3333334567999999999999999999999998 99999999999999999999999999886643221 122346
Q ss_pred ccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHH
Q 046010 368 GTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAEL 447 (523)
Q Consensus 368 gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 447 (523)
++..|+|||++.+..++.++||||||+++|+|++|+.||...... .. ......+.... ......
T Consensus 163 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~-~~~~~~~~~~~---------~~~~~~ 226 (256)
T cd08529 163 GTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG------AL-ILKIIRGVFPP---------VSQMYS 226 (256)
T ss_pred cCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HH-HHHHHcCCCCC---------CccccC
Confidence 788999999999988999999999999999999999998533211 11 11111111111 111233
Q ss_pred HHHHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 448 LKCIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 448 ~~~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
..+.+++.+||+.+|++||++.+|++.
T Consensus 227 ~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 227 QQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 567889999999999999999998763
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=218.03 Aligned_cols=166 Identities=31% Similarity=0.371 Sum_probs=126.1
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+||+|||+++...............++..|+|
T Consensus 128 ~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 204 (334)
T cd05100 128 EEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMA 204 (334)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcC
Confidence 456899999999999999999999998 99999999999999999999999999986543222111222334567999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||.+.+..++.++||||||+++|||++ |..||..... . ............+. +......+.++
T Consensus 205 PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~-~~~~~~~~~~~~~~---------~~~~~~~l~~l 268 (334)
T cd05100 205 PEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV------E-ELFKLLKEGHRMDK---------PANCTHELYMI 268 (334)
T ss_pred HHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH------H-HHHHHHHcCCCCCC---------CCCCCHHHHHH
Confidence 999999899999999999999999998 7787743211 1 11111112111111 11223467789
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
+.+||+.+|++||++.||++.|++..
T Consensus 269 i~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 269 MRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HHHHcccChhhCcCHHHHHHHHHHHh
Confidence 99999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.7e-25 Score=216.08 Aligned_cols=172 Identities=27% Similarity=0.366 Sum_probs=123.3
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcc-ccceeccCCCC
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN-TSKVVGTYGYM 373 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~ 373 (523)
+..+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||++........... .....++..|+
T Consensus 102 ~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~ 178 (284)
T cd05081 102 RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY 178 (284)
T ss_pred CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEee
Confidence 456999999999999999999999998 99999999999999999999999999987543222111 11122344699
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccc---------cchHHHHHHhhhcCCcccccCccccCCccH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHG---------QSLLAYTWKLWCNGEALELMDPVLKQSCMA 444 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 444 (523)
|||.+.+..++.++||||||+++|||++|..++........ .............. .......
T Consensus 179 aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~ 249 (284)
T cd05081 179 APESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN---------GRLPAPP 249 (284)
T ss_pred CHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcC---------CcCCCCC
Confidence 99999888899999999999999999998776532111000 00000000001110 0001111
Q ss_pred HHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 445 AELLKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 445 ~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
.....+.+|+.+||+.+|++|||+.||++.|+..
T Consensus 250 ~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 250 GCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 2234678899999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=213.50 Aligned_cols=164 Identities=24% Similarity=0.291 Sum_probs=123.7
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.||+.||+|||+++ ++||||||+||+++.++.+|++|||.......... .......++..|+|
T Consensus 101 ~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~a 176 (266)
T cd05064 101 EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI-YTTMSGKSPVLWAA 176 (266)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccccch-hcccCCCCceeecC
Confidence 457999999999999999999999998 99999999999999999999999998765321111 11112234568999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||.+.+..++.++||||||+++||+++ |+.||...... .... ....+... ..+...+..+.++
T Consensus 177 PE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~----~~~~~~~~---------~~~~~~~~~~~~l 240 (266)
T cd05064 177 PEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIK----AVEDGFRL---------PAPRNCPNLLHQL 240 (266)
T ss_pred HHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHH----HHHCCCCC---------CCCCCCCHHHHHH
Confidence 999999999999999999999999875 99998532211 1111 11111110 1112234567788
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+..||+.+|++||++.+|++.|++.
T Consensus 241 i~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 241 MLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHcCCCchhCCCHHHHHHHHHhh
Confidence 9999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-24 Score=215.13 Aligned_cols=160 Identities=25% Similarity=0.308 Sum_probs=122.8
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+...+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++....... .......|+..
T Consensus 87 l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~ 161 (321)
T cd05591 87 IQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPD 161 (321)
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--ccccccccCcc
Confidence 345667999999999999999999999998 9999999999999999999999999987542211 12234568999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||++.+..++.++||||||+++|+|++|+.||...... .. .......... . +......+.
T Consensus 162 y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~----~~~i~~~~~~---~-------p~~~~~~~~ 224 (321)
T cd05591 162 YIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DL----FESILHDDVL---Y-------PVWLSKEAV 224 (321)
T ss_pred ccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HH----HHHHHcCCCC---C-------CCCCCHHHH
Confidence 99999999889999999999999999999999998633211 11 1111111110 0 001123567
Q ss_pred HHhhhcccCCCCCCC-------CHHHHHH
Q 046010 452 HIGLLCVQEDPADRP-------NMSSVAV 473 (523)
Q Consensus 452 ~li~~cl~~dP~~RP-------s~~ei~~ 473 (523)
+++.+||+.||++|| ++.++++
T Consensus 225 ~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 225 SILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred HHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 888999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=217.77 Aligned_cols=160 Identities=23% Similarity=0.216 Sum_probs=121.8
Q ss_pred ccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccC
Q 046010 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTY 370 (523)
Q Consensus 291 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~ 370 (523)
+..+...+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++..... ........|+.
T Consensus 86 ~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~ 160 (325)
T cd05604 86 HLQRERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTTTTFCGTP 160 (325)
T ss_pred HHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCcccccCCh
Confidence 3445678999999999999999999999998 999999999999999999999999998753211 11223456899
Q ss_pred CCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 371 GYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 371 ~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
.|+|||.+.+..++.++||||||+++|+|++|+.||..... ...... ...... .+.+ .....+
T Consensus 161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~-~~~~~~--~~~~--------~~~~~~ 223 (325)
T cd05604 161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV------AEMYDN-ILHKPL--VLRP--------GASLTA 223 (325)
T ss_pred hhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH------HHHHHH-HHcCCc--cCCC--------CCCHHH
Confidence 99999999999999999999999999999999999853221 111111 111111 0111 122456
Q ss_pred HHHhhhcccCCCCCCCCHHHHH
Q 046010 451 IHIGLLCVQEDPADRPNMSSVA 472 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~ 472 (523)
.+++.+||+.+|.+||++.+.+
T Consensus 224 ~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 224 WSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred HHHHHHHhccCHHhcCCCCCCH
Confidence 6888999999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=216.72 Aligned_cols=156 Identities=23% Similarity=0.254 Sum_probs=121.2
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .....|++.
T Consensus 109 l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~ 180 (329)
T PTZ00263 109 LRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLCGTPE 180 (329)
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC-----cceecCChh
Confidence 345667999999999999999999999998 999999999999999999999999999865322 123568999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||.+.+..++.++|||||||++|+|++|+.||..... .. .......+.. .+ . ......+.
T Consensus 181 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~-~~~~i~~~~~-~~-p--------~~~~~~~~ 243 (329)
T PTZ00263 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------FR-IYEKILAGRL-KF-P--------NWFDGRAR 243 (329)
T ss_pred hcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH------HH-HHHHHhcCCc-CC-C--------CCCCHHHH
Confidence 9999999998899999999999999999999999853211 11 1111112111 00 0 01123567
Q ss_pred HHhhhcccCCCCCCCC-----HHHHH
Q 046010 452 HIGLLCVQEDPADRPN-----MSSVA 472 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs-----~~ei~ 472 (523)
+|+.+||+.||.+||+ +++|+
T Consensus 244 ~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 244 DLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 8999999999999997 57765
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-24 Score=199.30 Aligned_cols=173 Identities=24% Similarity=0.343 Sum_probs=131.7
Q ss_pred ccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcc
Q 046010 283 IGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN 362 (523)
Q Consensus 283 ~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 362 (523)
++.|..-+...-++++++..+-++...+++||.||.++. .|+|||+||+|||+|+.|++||+|||.+-.+.+.. .
T Consensus 173 Ms~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---A 247 (391)
T KOG0983|consen 173 MSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---A 247 (391)
T ss_pred HHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc---c
Confidence 567776677777788999999999999999999999875 59999999999999999999999999987764332 2
Q ss_pred ccceeccCCCCchhhhcC---CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCcccc
Q 046010 363 TSKVVGTYGYMAPEYALG---GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLK 439 (523)
Q Consensus 363 ~~~~~gt~~y~aPE~l~~---~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 439 (523)
.++..|-+.|||||.+.- ..|+.++||||||+.++||.||+.||.....+. .. .....+.+. ..++....
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e~----ltkvln~eP-P~L~~~~g 320 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--EV----LTKVLNEEP-PLLPGHMG 320 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--HH----HHHHHhcCC-CCCCcccC
Confidence 345677889999998853 458899999999999999999999986533321 11 111122111 12221111
Q ss_pred CCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 440 QSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 440 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
-...+++++..||+.|+.+||...++++
T Consensus 321 ------FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 321 ------FSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ------cCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 2345677888999999999999998865
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-24 Score=218.07 Aligned_cols=161 Identities=24% Similarity=0.274 Sum_probs=122.5
Q ss_pred ccccccccCHHHHHHHHHHHHHHHHHHHh-cCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceecc
Q 046010 291 YSTRRAQLDWKRRISIINGIARGLLYLHE-DSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369 (523)
Q Consensus 291 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt 369 (523)
+..+...+++..++.++.||+.||.|||+ ++ |+||||||+|||++.++.+||+|||+++...... .......|+
T Consensus 85 ~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt 159 (325)
T cd05594 85 HLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGT 159 (325)
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cccccccCC
Confidence 34456679999999999999999999997 67 9999999999999999999999999987532211 122345689
Q ss_pred CCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 370 ~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
+.|+|||++.+..++.++||||||+++|+|++|+.||...... .. ......... . +.. .....
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~----~~~i~~~~~-~-----~p~----~~~~~ 222 (325)
T cd05594 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KL----FELILMEEI-R-----FPR----TLSPE 222 (325)
T ss_pred cccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---HH----HHHHhcCCC-C-----CCC----CCCHH
Confidence 9999999999999999999999999999999999998532211 11 111111110 0 111 12235
Q ss_pred HHHHhhhcccCCCCCCC-----CHHHHHH
Q 046010 450 CIHIGLLCVQEDPADRP-----NMSSVAV 473 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RP-----s~~ei~~ 473 (523)
+.+++.+||+.||++|+ ++.++++
T Consensus 223 ~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred HHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 67888999999999997 8888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-24 Score=210.23 Aligned_cols=162 Identities=27% Similarity=0.393 Sum_probs=122.4
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||.++....... .......++..|+|
T Consensus 94 ~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~y~a 169 (256)
T cd05114 94 QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSP 169 (256)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce-eccCCCCCchhhCC
Confidence 346899999999999999999999998 99999999999999999999999999876532211 11122234567999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||.+.+..++.++||||||+++|+|++ |+.||..... ...... ...+... ..+ ......+.++
T Consensus 170 PE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~----i~~~~~~--~~~-------~~~~~~~~~l 233 (256)
T cd05114 170 PEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEM----ISRGFRL--YRP-------KLASMTVYEV 233 (256)
T ss_pred hhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH----HHCCCCC--CCC-------CCCCHHHHHH
Confidence 999988889999999999999999999 8888743221 111111 1111110 011 1122467889
Q ss_pred hhhcccCCCCCCCCHHHHHHHhc
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLA 476 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~ 476 (523)
+.+||+.+|++||++.+|++.|.
T Consensus 234 i~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 234 MYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred HHHHccCCcccCcCHHHHHHhhC
Confidence 99999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.4e-24 Score=207.31 Aligned_cols=167 Identities=22% Similarity=0.287 Sum_probs=127.8
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
++..+++..++.++.||++||.|||+++ ++|+||||+||+++.++.++|+|||.+........ ......++..|+
T Consensus 99 ~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~ 173 (267)
T cd08228 99 QKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYM 173 (267)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccchhH--HHhcCCCCcccc
Confidence 3456899999999999999999999998 99999999999999999999999999887542211 122345778899
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
|||.+.+..++.++||||||+++|+|++|+.||...... ....... ........ .........+.++
T Consensus 174 aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~-~~~~~~~~--------~~~~~~~~~~~~l 240 (267)
T cd08228 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQK-IEQCDYPP--------LPTEHYSEKLREL 240 (267)
T ss_pred ChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHH-HhcCCCCC--------CChhhcCHHHHHH
Confidence 999998888999999999999999999999997432111 1111111 11111110 0112234567889
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+.+||+.+|++||++.+|++.|++.
T Consensus 241 i~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 241 VSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HHHHCCCCcccCcCHHHHHHHHHHh
Confidence 9999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=211.77 Aligned_cols=162 Identities=27% Similarity=0.288 Sum_probs=122.4
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
.+..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++........ ......+++.|+
T Consensus 90 ~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~g~~~y~ 164 (280)
T cd05608 90 ENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGFM 164 (280)
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--cccccCCCcCcc
Confidence 4567999999999999999999999998 99999999999999999999999999976543221 223356889999
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
|||.+.+..++.++||||||+++|+|++|+.||........ . ........... . ..+......+.++
T Consensus 165 aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~-~~~~~~~~~~~--------~--~~~~~~~~~~~~l 231 (280)
T cd05608 165 APELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--N-KELKQRILNDS--------V--TYPDKFSPASKSF 231 (280)
T ss_pred CHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--H-HHHHHhhcccC--------C--CCcccCCHHHHHH
Confidence 99999999999999999999999999999999854222111 0 01111111100 0 0111233456788
Q ss_pred hhhcccCCCCCCC-----CHHHHHH
Q 046010 454 GLLCVQEDPADRP-----NMSSVAV 473 (523)
Q Consensus 454 i~~cl~~dP~~RP-----s~~ei~~ 473 (523)
+.+||+.||++|| +++++++
T Consensus 232 i~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 232 CEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 8999999999999 6677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=217.28 Aligned_cols=165 Identities=27% Similarity=0.378 Sum_probs=125.7
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||+++...............++..|++
T Consensus 103 ~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~ 179 (303)
T cd05110 103 KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 179 (303)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCC
Confidence 446899999999999999999999998 99999999999999999999999999986543222222223345678999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||.+.+..++.++||||||+++|||++ |+.||...... ........+..... +......+.++
T Consensus 180 PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~~---------~~~~~~~~~~l 243 (303)
T cd05110 180 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR-------EIPDLLEKGERLPQ---------PPICTIDVYMV 243 (303)
T ss_pred HHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHCCCCCCC---------CCCCCHHHHHH
Confidence 999988889999999999999999997 88887432211 11111111111100 11123457788
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+..||..+|++||++.+|++.|+..
T Consensus 244 i~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 244 MVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-25 Score=239.35 Aligned_cols=166 Identities=29% Similarity=0.376 Sum_probs=131.2
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...|+..+.+.++.||++|+.|||++. +|||||..+|+|++....+||+|||+++.+-..+.........-...|||
T Consensus 796 ~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~ 872 (1025)
T KOG1095|consen 796 PSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMP 872 (1025)
T ss_pred CCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCC
Confidence 567999999999999999999999998 99999999999999999999999999995433333222222334578999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||.++.+.++.|+|||||||++||+++ |..||...... .+...+..+. +...+..++.+++++
T Consensus 873 PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~-------~v~~~~~~gg---------RL~~P~~CP~~ly~l 936 (1025)
T KOG1095|consen 873 PESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF-------EVLLDVLEGG---------RLDPPSYCPEKLYQL 936 (1025)
T ss_pred HHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH-------HHHHHHHhCC---------ccCCCCCCChHHHHH
Confidence 999999999999999999999999999 66776432221 1111111211 233455677889999
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
|.+||+.+|++||++..|++.+....
T Consensus 937 M~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 937 MLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred HHHHccCChhhCccHHHHHhhhhhhh
Confidence 99999999999999999999887653
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-24 Score=214.45 Aligned_cols=155 Identities=26% Similarity=0.310 Sum_probs=118.8
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...... ........|+..
T Consensus 92 ~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~gt~~ 166 (324)
T cd05587 92 IQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG--GKTTRTFCGTPD 166 (324)
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC--CCceeeecCCcc
Confidence 345567999999999999999999999998 999999999999999999999999998753211 112234568999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||++.+..++.++||||||+++|+|++|+.||..... .... .. ...... . + +......+.
T Consensus 167 y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~---~~-i~~~~~-~-----~----~~~~~~~~~ 229 (324)
T cd05587 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELF---QS-IMEHNV-S-----Y----PKSLSKEAV 229 (324)
T ss_pred ccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHH---HH-HHcCCC-C-----C----CCCCCHHHH
Confidence 9999999999999999999999999999999999853221 1111 11 111110 0 1 111223567
Q ss_pred HHhhhcccCCCCCCCCH
Q 046010 452 HIGLLCVQEDPADRPNM 468 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~ 468 (523)
+++.+||+.||.+|++.
T Consensus 230 ~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 230 SICKGLLTKHPAKRLGC 246 (324)
T ss_pred HHHHHHhhcCHHHcCCC
Confidence 88999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=216.68 Aligned_cols=160 Identities=28% Similarity=0.280 Sum_probs=123.3
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++..... ........++..
T Consensus 87 ~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~g~~~ 161 (318)
T cd05570 87 IQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVTTSTFCGTPD 161 (318)
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcC--CCcccceecCcc
Confidence 445568999999999999999999999998 999999999999999999999999998753211 112234568999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||.+.+..++.++|||||||++|+|++|+.||...... . ........... . +......+.
T Consensus 162 y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~------~-~~~~i~~~~~~------~----~~~~~~~~~ 224 (318)
T cd05570 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED------E-LFQSILEDEVR------Y----PRWLSKEAK 224 (318)
T ss_pred ccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH------H-HHHHHHcCCCC------C----CCcCCHHHH
Confidence 99999999999999999999999999999999998532211 1 11111111110 0 111234567
Q ss_pred HHhhhcccCCCCCCCCH-----HHHHH
Q 046010 452 HIGLLCVQEDPADRPNM-----SSVAV 473 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~-----~ei~~ 473 (523)
+|+.+||+.||++||++ .++++
T Consensus 225 ~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 225 SILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 89999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=217.81 Aligned_cols=160 Identities=24% Similarity=0.228 Sum_probs=121.5
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+...+++..++.++.||++||.|||++| |+||||||+||+++.++.+||+|||+++..... ........|++.
T Consensus 87 ~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~~~~~~gt~~ 161 (325)
T cd05602 87 LQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGTTSTFCGTPE 161 (325)
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCCcccccCCcc
Confidence 344567889999999999999999999998 999999999999999999999999998753221 112334568999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||++.+..++.++||||||+++|+|++|+.||..... ........ .... . +.+ .....+.
T Consensus 162 y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~-~~~~-~-~~~--------~~~~~~~ 224 (325)
T cd05602 162 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNIL-NKPL-Q-LKP--------NITNSAR 224 (325)
T ss_pred ccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH------HHHHHHHH-hCCc-C-CCC--------CCCHHHH
Confidence 9999999999999999999999999999999999853221 11111111 1110 0 111 1223567
Q ss_pred HHhhhcccCCCCCCCCHHHHHH
Q 046010 452 HIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+++.+||+.||.+||++.+.+.
T Consensus 225 ~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 225 HLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred HHHHHHcccCHHHCCCCCCCHH
Confidence 8888999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=209.16 Aligned_cols=174 Identities=25% Similarity=0.410 Sum_probs=129.3
Q ss_pred cccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccc
Q 046010 284 GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNT 363 (523)
Q Consensus 284 g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 363 (523)
|....++.......+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||.+........ ...
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~ 160 (260)
T cd05073 85 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAR 160 (260)
T ss_pred CcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc-ccc
Confidence 33333443444567899999999999999999999998 99999999999999999999999999876543211 112
Q ss_pred cceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCc
Q 046010 364 SKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSC 442 (523)
Q Consensus 364 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 442 (523)
....++..|+|||.+....++.++||||||+++|++++ |+.||..... ... ........... .
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~----~~~~~~~~~~~---------~ 224 (260)
T cd05073 161 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEV----IRALERGYRMP---------R 224 (260)
T ss_pred cCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHH----HHHHhCCCCCC---------C
Confidence 22345677999999988889999999999999999999 8888753211 111 11111111111 1
Q ss_pred cHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhcc
Q 046010 443 MAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 443 ~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
.......+.+++.+||+.+|++||++.++.++|+.
T Consensus 225 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11233467789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=212.53 Aligned_cols=165 Identities=28% Similarity=0.410 Sum_probs=124.6
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
....+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+||+|||++.................+..|+
T Consensus 123 ~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 199 (288)
T cd05050 123 NPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWM 199 (288)
T ss_pred cccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhc
Confidence 3456899999999999999999999998 9999999999999999999999999987653222111122233456799
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
|||.+.+..++.++||||||+++|+|++ |..||...... ........+.... .+.....++.+
T Consensus 200 aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-------~~~~~~~~~~~~~---------~~~~~~~~l~~ 263 (288)
T cd05050 200 PPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-------EVIYYVRDGNVLS---------CPDNCPLELYN 263 (288)
T ss_pred CHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHhcCCCCC---------CCCCCCHHHHH
Confidence 9999988899999999999999999997 77776422111 1111122222111 11122356788
Q ss_pred HhhhcccCCCCCCCCHHHHHHHhcc
Q 046010 453 IGLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
++.+||+.+|++|||+.||++.|++
T Consensus 264 li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 264 LMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHcccCcccCCCHHHHHHHhhC
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-24 Score=209.56 Aligned_cols=175 Identities=27% Similarity=0.411 Sum_probs=129.5
Q ss_pred ccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcc
Q 046010 283 IGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN 362 (523)
Q Consensus 283 ~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 362 (523)
.|....++.......+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||.+....... ...
T Consensus 85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~ 160 (261)
T cd05034 85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE-YTA 160 (261)
T ss_pred CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh-hhh
Confidence 344444444445567999999999999999999999998 9999999999999999999999999988764311 111
Q ss_pred ccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCC
Q 046010 363 TSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQS 441 (523)
Q Consensus 363 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 441 (523)
......+..|+|||.+.+..++.++||||||+++|++++ |+.||.... ....... ...... ..
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~---~~~~~~~----~~~~~~---------~~ 224 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT---NREVLEQ----VERGYR---------MP 224 (261)
T ss_pred hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHH----HHcCCC---------CC
Confidence 112234568999999998889999999999999999998 888874321 1111111 111100 00
Q ss_pred ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhcc
Q 046010 442 CMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 442 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
.+......+.+++.+||+.+|++||+++++++.|+.
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 225 RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 011123467789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=216.66 Aligned_cols=160 Identities=28% Similarity=0.402 Sum_probs=117.8
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCchh
Q 046010 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPE 376 (523)
Q Consensus 297 ~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE 376 (523)
.+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++...... .......|+..|+|||
T Consensus 164 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE 238 (353)
T PLN00034 164 IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--DPCNSSVGTIAYMSPE 238 (353)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc--ccccccccCccccCcc
Confidence 4677888999999999999999998 9999999999999999999999999998753221 1223457899999999
Q ss_pred hhcC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 377 YALG-----GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 377 ~l~~-----~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
.+.. ...+.++|||||||++|||++|+.||....... ........ ...... .........+.
T Consensus 239 ~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~-~~~~~~---------~~~~~~~~~l~ 305 (353)
T PLN00034 239 RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCAI-CMSQPP---------EAPATASREFR 305 (353)
T ss_pred ccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHHH-hccCCC---------CCCCccCHHHH
Confidence 8743 224568999999999999999999986222111 11111111 000000 01112334678
Q ss_pred HHhhhcccCCCCCCCCHHHHHHH
Q 046010 452 HIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
+|+.+||+.||++||++.||++.
T Consensus 306 ~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 306 HFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 89999999999999999999863
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=218.27 Aligned_cols=156 Identities=25% Similarity=0.233 Sum_probs=120.3
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..++..+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..... ........|++.
T Consensus 87 l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~ 161 (323)
T cd05575 87 LQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTTSTFCGTPE 161 (323)
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCccccccCChh
Confidence 345668999999999999999999999998 999999999999999999999999998753211 122334568999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||.+.+..++.++||||||+++|+|++|+.||..... .+.... ...... . +.. .....+.
T Consensus 162 y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~-i~~~~~-~-----~~~----~~~~~~~ 224 (323)
T cd05575 162 YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDN-ILNKPL-R-----LKP----NISVSAR 224 (323)
T ss_pred hcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHH-HHcCCC-C-----CCC----CCCHHHH
Confidence 9999999999999999999999999999999999853221 111111 111110 0 111 1234577
Q ss_pred HHhhhcccCCCCCCCCHH
Q 046010 452 HIGLLCVQEDPADRPNMS 469 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ 469 (523)
+++.+||+.||++||++.
T Consensus 225 ~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 225 HLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHhhcCHHhCCCCC
Confidence 889999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=209.26 Aligned_cols=163 Identities=28% Similarity=0.328 Sum_probs=122.7
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.+++.+|.|||+++ ++||||||+||+++.++.+||+|||.+.................+..|+|
T Consensus 87 ~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~ 163 (251)
T cd05041 87 KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTA 163 (251)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCC
Confidence 456899999999999999999999998 99999999999999999999999999876532211111112233567999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||.+.+..++.++||||||+++|+|++ |..||...... .. ........ . ...+......+.++
T Consensus 164 PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---~~----~~~~~~~~--~-------~~~~~~~~~~~~~l 227 (251)
T cd05041 164 PEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---QT----RERIESGY--R-------MPAPQLCPEEIYRL 227 (251)
T ss_pred hHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---HH----HHHHhcCC--C-------CCCCccCCHHHHHH
Confidence 999988889999999999999999999 77777433211 01 11111110 0 00111223467889
Q ss_pred hhhcccCCCCCCCCHHHHHHHhc
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLA 476 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~ 476 (523)
+.+||+.+|++||++.||++.|+
T Consensus 228 i~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 228 MLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHhccChhhCcCHHHHHHHhh
Confidence 99999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=210.82 Aligned_cols=165 Identities=26% Similarity=0.285 Sum_probs=121.3
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC--ccccceeccCCC
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE--SNTSKVVGTYGY 372 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~--~~~~~~~gt~~y 372 (523)
...+++..++.++.||++||.|||+.+ ++||||||+||+++.++.+||+|||+++........ .......++..|
T Consensus 92 ~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y 168 (262)
T cd05058 92 THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKW 168 (262)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccc
Confidence 345788889999999999999999998 999999999999999999999999998754322111 111123456789
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCC-CCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKK-NSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
+|||.+.+..++.++||||||+++|||++|+. ||.... ...... . ...+..... +......+.
T Consensus 169 ~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~---~-~~~~~~~~~---------~~~~~~~~~ 232 (262)
T cd05058 169 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---SFDITV---Y-LLQGRRLLQ---------PEYCPDPLY 232 (262)
T ss_pred cChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHH---H-HhcCCCCCC---------CCcCCHHHH
Confidence 99999988889999999999999999999654 443211 111111 1 111111000 011124677
Q ss_pred HHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 452 HIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+++.+||+.+|++||++.+|++.|++.
T Consensus 233 ~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 233 EVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred HHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-24 Score=211.98 Aligned_cols=166 Identities=26% Similarity=0.321 Sum_probs=122.7
Q ss_pred cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcccccee
Q 046010 288 PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVV 367 (523)
Q Consensus 288 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 367 (523)
.++...+...+++..+..++.||+.||+|||+++ |+|+||||+||++++++.+||+|||++....... .......
T Consensus 98 ~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~ 172 (272)
T cd06637 98 DLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFI 172 (272)
T ss_pred HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceeccccc--ccCCccc
Confidence 3333334567999999999999999999999998 9999999999999999999999999987653221 1223456
Q ss_pred ccCCCCchhhhc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCc
Q 046010 368 GTYGYMAPEYAL-----GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSC 442 (523)
Q Consensus 368 gt~~y~aPE~l~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 442 (523)
++..|+|||++. +..++.++||||||+++|+|++|+.||...... ......... ....... .
T Consensus 173 g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~------~~~~~~~~~-~~~~~~~----~-- 239 (272)
T cd06637 173 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RALFLIPRN-PAPRLKS----K-- 239 (272)
T ss_pred ccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH------HHHHHHhcC-CCCCCCC----C--
Confidence 888999999886 345788999999999999999999998532211 111111111 1001111 1
Q ss_pred cHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 443 MAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 443 ~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.....+.+|+.+||+.+|.+|||+.+|++
T Consensus 240 --~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 240 --KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred --CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 12235678999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-24 Score=208.37 Aligned_cols=165 Identities=27% Similarity=0.391 Sum_probs=124.7
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
+...+++..++.++.||++||.+||+++ |+|+||||+||++++++.++|+|||.+.... ..........++..|+
T Consensus 91 ~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~~~~~~~~~~y~ 165 (260)
T PF00069_consen 91 KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNENFNPFVGTPEYM 165 (260)
T ss_dssp HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STTSEBSSSSSSGGGS
T ss_pred cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--cccccccccccccccc
Confidence 6788999999999999999999999998 9999999999999999999999999998641 1222344566788999
Q ss_pred chhhhc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 374 APEYAL-GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 374 aPE~l~-~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
|||.+. +...+.++||||||+++|+|++|..||............. ..... ....... ........+.+
T Consensus 166 aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~---~~~~~-~~~~~~~------~~~~~~~~l~~ 235 (260)
T PF00069_consen 166 APEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE---KILKR-PLPSSSQ------QSREKSEELRD 235 (260)
T ss_dssp CHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH---HHHHT-HHHHHTT------SHTTSHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhh---hcccc-ccccccc------ccchhHHHHHH
Confidence 999998 7889999999999999999999999986441111111111 11000 0000000 00001267888
Q ss_pred HhhhcccCCCCCCCCHHHHHH
Q 046010 453 IGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~ 473 (523)
++.+||+.||++||++.++++
T Consensus 236 li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 236 LIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHSSSSGGGSTTHHHHHT
T ss_pred HHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.6e-24 Score=210.19 Aligned_cols=171 Identities=26% Similarity=0.280 Sum_probs=127.3
Q ss_pred cccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccc
Q 046010 284 GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNT 363 (523)
Q Consensus 284 g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 363 (523)
|....+++......+++..+..++.||+.||.|||+++ ++|+||||+||++++++.++|+|||++....... ..
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~~ 158 (285)
T cd05605 85 GDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---TI 158 (285)
T ss_pred CcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC---cc
Confidence 33334455545567999999999999999999999998 9999999999999999999999999988653221 12
Q ss_pred cceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCcc
Q 046010 364 SKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCM 443 (523)
Q Consensus 364 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 443 (523)
....++..|+|||.+.+..++.++||||+|+++|+|++|+.||...... ............. . ...+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~---~~~~~~~~~~~~~-~---------~~~~ 225 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK---VKREEVERRVKED-Q---------EEYS 225 (285)
T ss_pred ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh---hHHHHHHHHhhhc-c---------cccC
Confidence 2346789999999999888999999999999999999999998642221 1111111111110 0 0111
Q ss_pred HHHHHHHHHHhhhcccCCCCCCC-----CHHHHHH
Q 046010 444 AAELLKCIHIGLLCVQEDPADRP-----NMSSVAV 473 (523)
Q Consensus 444 ~~~~~~~~~li~~cl~~dP~~RP-----s~~ei~~ 473 (523)
......+.+|+.+||+.||++|| +++++++
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 226 EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 12334567889999999999999 7888854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-24 Score=208.36 Aligned_cols=165 Identities=24% Similarity=0.335 Sum_probs=126.5
Q ss_pred ccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceec
Q 046010 289 TIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVG 368 (523)
Q Consensus 289 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~g 368 (523)
++.......+++.+++.++.||+.||.+||+++ ++|+||||+||+++.++.++|+|||++........ ......+
T Consensus 90 ~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~ 164 (257)
T cd08223 90 KLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIG 164 (257)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCC--ccccccC
Confidence 333344567999999999999999999999998 99999999999999999999999999987643221 2234567
Q ss_pred cCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 369 TYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 369 t~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
+..|+|||.+.+..++.++||||||+++++|++|+.||.... ........ ..+.... .+.....
T Consensus 165 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~~~-~~~~~~~---------~~~~~~~ 228 (257)
T cd08223 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVYRI-IEGKLPP---------MPKDYSP 228 (257)
T ss_pred CcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHH-HhcCCCC---------CccccCH
Confidence 889999999999899999999999999999999999975321 11111111 1111111 1122335
Q ss_pred HHHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 449 KCIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
.+.+++.+||+.+|++||++.++++.
T Consensus 229 ~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 229 ELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHHHHHHHhccCcccCCCHHHHhcC
Confidence 67789999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=207.11 Aligned_cols=164 Identities=24% Similarity=0.319 Sum_probs=132.1
Q ss_pred cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcccccee
Q 046010 288 PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVV 367 (523)
Q Consensus 288 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 367 (523)
++-|+..++.|++.+++++++||..|+.|+|+++ ++|||||.+|||+|.++++||+|||++..+... .....+.
T Consensus 140 LYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~---kfLqTFC 213 (668)
T KOG0611|consen 140 LYDYISERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK---KFLQTFC 213 (668)
T ss_pred HHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc---cHHHHhc
Confidence 4456788999999999999999999999999998 999999999999999999999999999887432 3345789
Q ss_pred ccCCCCchhhhcCCCCC-cchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHH
Q 046010 368 GTYGYMAPEYALGGVIS-VKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAE 446 (523)
Q Consensus 368 gt~~y~aPE~l~~~~~s-~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 446 (523)
|++-|.+||++.+.+|. +..|.||||++||.|+.|.-||+..+.. ...+.+.++...+. ..
T Consensus 214 GSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-------~lvrQIs~GaYrEP-----------~~ 275 (668)
T KOG0611|consen 214 GSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-------RLVRQISRGAYREP-----------ET 275 (668)
T ss_pred CCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-------HHHHHhhcccccCC-----------CC
Confidence 99999999999998875 7899999999999999999998643321 11222233332222 12
Q ss_pred HHHHHHHhhhcccCCCCCCCCHHHHHHHh
Q 046010 447 LLKCIHIGLLCVQEDPADRPNMSSVAVML 475 (523)
Q Consensus 447 ~~~~~~li~~cl~~dP~~RPs~~ei~~~L 475 (523)
+....-||++||..||++|.|+.+|....
T Consensus 276 PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 276 PSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred CchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 23445688899999999999999997643
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.9e-24 Score=212.94 Aligned_cols=157 Identities=27% Similarity=0.311 Sum_probs=119.9
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
+..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++..... ........|++.|+|
T Consensus 95 ~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~g~~~y~a 169 (324)
T cd05589 95 TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF--GDRTSTFCGTPEFLA 169 (324)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC--CCcccccccCccccC
Confidence 457999999999999999999999998 999999999999999999999999998753211 122234568999999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
||.+.+..++.++||||||+++|+|++|+.||...... .. .......... . +......+.+++
T Consensus 170 PE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~-~~~i~~~~~~------~----p~~~~~~~~~li 232 (324)
T cd05589 170 PEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EV-FDSIVNDEVR------Y----PRFLSREAISIM 232 (324)
T ss_pred HhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HH-HHHHHhCCCC------C----CCCCCHHHHHHH
Confidence 99999989999999999999999999999998532211 11 1111111110 1 111234567889
Q ss_pred hhcccCCCCCCC-----CHHHHHH
Q 046010 455 LLCVQEDPADRP-----NMSSVAV 473 (523)
Q Consensus 455 ~~cl~~dP~~RP-----s~~ei~~ 473 (523)
.+||+.||++|| ++.++++
T Consensus 233 ~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 233 RRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred HHHhhcCHhHcCCCCCCCHHHHhh
Confidence 999999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-24 Score=208.03 Aligned_cols=165 Identities=22% Similarity=0.276 Sum_probs=116.2
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCchh
Q 046010 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPE 376 (523)
Q Consensus 297 ~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE 376 (523)
..++...+.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++................++..|+|||
T Consensus 96 ~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 172 (269)
T cd05042 96 MAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPE 172 (269)
T ss_pred cccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHH
Confidence 4578889999999999999999998 9999999999999999999999999986543222111222334567899999
Q ss_pred hhcC-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 377 YALG-------GVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 377 ~l~~-------~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
++.. ..++.++||||||+++|||++ |..||...... .. ...... .....+..+.+.. ....
T Consensus 173 ~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~---~~~~~~-~~~~~~~~~~~~~----~~~~ 241 (269)
T cd05042 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QV---LKQVVR-EQDIKLPKPQLDL----KYSD 241 (269)
T ss_pred HHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HH---HHHHhh-ccCccCCCCcccc----cCCH
Confidence 8743 356789999999999999999 67777432211 11 111111 1111222222221 2223
Q ss_pred HHHHHhhhcccCCCCCCCCHHHHHHHhc
Q 046010 449 KCIHIGLLCVQEDPADRPNMSSVAVMLA 476 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~RPs~~ei~~~L~ 476 (523)
.+.+++..|| .||++|||+++|+++|.
T Consensus 242 ~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 242 RWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 4456777888 59999999999999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=208.80 Aligned_cols=159 Identities=30% Similarity=0.405 Sum_probs=123.2
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||.++....... ....+..|+|
T Consensus 96 ~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~a 167 (256)
T cd05039 96 RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTA 167 (256)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-----cCCCcccccC
Confidence 347999999999999999999999998 99999999999999999999999999886532111 2234567999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||.+....++.++||||||+++|++++ |..||...... .+. .......... .+......+.++
T Consensus 168 pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~----~~~~~~~~~~---------~~~~~~~~~~~l 231 (256)
T cd05039 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVV----PHVEKGYRME---------APEGCPPEVYKV 231 (256)
T ss_pred chhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHH----HHHhcCCCCC---------CccCCCHHHHHH
Confidence 999988889999999999999999997 88887532211 111 1111111111 111223567789
Q ss_pred hhhcccCCCCCCCCHHHHHHHhcc
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
+.+||..+|++||++.||+++|++
T Consensus 232 i~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 232 MKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHHhccChhhCcCHHHHHHHHhc
Confidence 999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-24 Score=211.74 Aligned_cols=166 Identities=26% Similarity=0.359 Sum_probs=125.6
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||.++...............++..|++
T Consensus 103 ~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~ 179 (279)
T cd05057 103 KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMA 179 (279)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccC
Confidence 445999999999999999999999998 99999999999999999999999999987643222111112223567999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||.+....++.++||||||+++||+++ |+.||...... .. ......+.... .+......+.++
T Consensus 180 PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~----~~~~~~~~~~~---------~~~~~~~~~~~~ 243 (279)
T cd05057 180 LESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EI----PDLLEKGERLP---------QPPICTIDVYMV 243 (279)
T ss_pred HHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HH----HHHHhCCCCCC---------CCCCCCHHHHHH
Confidence 999988889999999999999999998 99998543211 11 11111111110 011122356788
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
+.+||..+|++||++.++++.|++..
T Consensus 244 ~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 244 LVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred HHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 89999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=205.53 Aligned_cols=167 Identities=24% Similarity=0.314 Sum_probs=126.8
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
.+..+++..++.++.||++||.|||+++ ++|+||||+||+++.++.++|+|||++........ ......++..|+
T Consensus 99 ~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~ 173 (267)
T cd08229 99 QKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYM 173 (267)
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccCCc--ccccccCCcCcc
Confidence 3557999999999999999999999998 99999999999999999999999999876532221 122345788999
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
|||.+.+..++.++||||||+++|+|++|..||...... .... ........ .+... .......+.++
T Consensus 174 ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~-~~~~~~~~-----~~~~~---~~~~~~~~~~l 240 (267)
T cd08229 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSL-CKKIEQCD-----YPPLP---SDHYSEELRQL 240 (267)
T ss_pred CHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHH-hhhhhcCC-----CCCCC---cccccHHHHHH
Confidence 999998888999999999999999999999997432111 1111 11111111 01111 11234467788
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+.+||+.||++|||+.+|++++++.
T Consensus 241 i~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 241 VNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred HHHhcCCCcccCCCHHHHHHHHhhh
Confidence 8999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.6e-24 Score=209.00 Aligned_cols=163 Identities=25% Similarity=0.366 Sum_probs=122.6
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCchh
Q 046010 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPE 376 (523)
Q Consensus 297 ~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE 376 (523)
.+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++...... ......++..|+|||
T Consensus 91 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE 163 (279)
T cd06619 91 KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPE 163 (279)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc----cccCCCCChhhcCce
Confidence 5788999999999999999999998 999999999999999999999999998765322 223456888999999
Q ss_pred hhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHhhh
Q 046010 377 YALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLL 456 (523)
Q Consensus 377 ~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~~ 456 (523)
.+.+..++.++||||||+++|+|++|+.||........................... .. ......+.+++.+
T Consensus 164 ~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~---~~~~~~~~~li~~ 235 (279)
T cd06619 164 RISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL-----PV---GQFSEKFVHFITQ 235 (279)
T ss_pred eecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC-----CC---CcCCHHHHHHHHH
Confidence 999888999999999999999999999998643322211111111111111111111 00 1122356788999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 046010 457 CVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 457 cl~~dP~~RPs~~ei~~~ 474 (523)
||+.+|++||+++|+++.
T Consensus 236 ~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 236 CMRKQPKERPAPENLMDH 253 (279)
T ss_pred HhhCChhhCCCHHHHhcC
Confidence 999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=204.67 Aligned_cols=167 Identities=23% Similarity=0.294 Sum_probs=127.6
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
.+..+++.+++.++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++....... .......++..|+
T Consensus 99 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~ 173 (267)
T cd08224 99 QKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYM 173 (267)
T ss_pred cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCCC--cccceecCCcccc
Confidence 3556899999999999999999999998 9999999999999999999999999987653221 1122346788899
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
|||.+.+..++.++||||||+++|+|++|+.||..... ..... ......+...... .......+.++
T Consensus 174 apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~-~~~~~~~~~~~~~--------~~~~~~~~~~~ 240 (267)
T cd08224 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSL-CKKIEKCDYPPLP--------ADHYSEELRDL 240 (267)
T ss_pred CHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHH-HhhhhcCCCCCCC--------hhhcCHHHHHH
Confidence 99999888899999999999999999999999743221 11111 1111111111110 11233467788
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+.+||+.+|++||++.+|+++|++.
T Consensus 241 i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 241 VSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred HHHHcCCCcccCCCHHHHHHHHHHh
Confidence 9999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=206.50 Aligned_cols=166 Identities=26% Similarity=0.368 Sum_probs=118.9
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.+................++..|+||
T Consensus 95 ~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 171 (269)
T cd05087 95 MTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAP 171 (269)
T ss_pred ccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCH
Confidence 35678888999999999999999998 999999999999999999999999998754322222222334567889999
Q ss_pred hhhcCC-------CCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHH
Q 046010 376 EYALGG-------VISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAEL 447 (523)
Q Consensus 376 E~l~~~-------~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 447 (523)
|++.+. .++.++||||||+++|||++ |+.||....... ..... ..........+.+... ..
T Consensus 172 E~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~~~~~~~~~~~~~~----~~ 240 (269)
T cd05087 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYT----VREQQLKLPKPRLKLP----LS 240 (269)
T ss_pred hHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHH----hhcccCCCCCCccCCC----CC
Confidence 988642 35789999999999999996 999985432211 11111 1111112222222211 12
Q ss_pred HHHHHHhhhcccCCCCCCCCHHHHHHHhc
Q 046010 448 LKCIHIGLLCVQEDPADRPNMSSVAVMLA 476 (523)
Q Consensus 448 ~~~~~li~~cl~~dP~~RPs~~ei~~~L~ 476 (523)
..+.+++..|| .+|++|||++||+..|+
T Consensus 241 ~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 241 DRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred hHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 34567888899 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-24 Score=218.38 Aligned_cols=164 Identities=24% Similarity=0.309 Sum_probs=123.0
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCC---------------
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ--------------- 358 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~--------------- 358 (523)
+...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 94 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~ 170 (350)
T cd05573 94 RKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170 (350)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccccccccccccc
Confidence 4478999999999999999999999998 9999999999999999999999999987654322
Q ss_pred ------------CCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhh
Q 046010 359 ------------NESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWC 426 (523)
Q Consensus 359 ------------~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 426 (523)
.........|++.|+|||.+.+..++.++|||||||++|+|++|+.||...... ........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~------~~~~~i~~ 244 (350)
T cd05573 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ------ETYNKIIN 244 (350)
T ss_pred ccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH------HHHHHHhc
Confidence 001223456899999999999999999999999999999999999998533211 11111111
Q ss_pred cCCcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCC-HHHHHHH
Q 046010 427 NGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPN-MSSVAVM 474 (523)
Q Consensus 427 ~~~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs-~~ei~~~ 474 (523)
....... + ........+.+++.+||+ ||.+||+ ++++++.
T Consensus 245 ~~~~~~~--p-----~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 245 WKESLRF--P-----PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred cCCcccC--C-----CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 0000000 0 000123456778889997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.7e-24 Score=213.85 Aligned_cols=156 Identities=22% Similarity=0.223 Sum_probs=119.7
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+...+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++..... ........|++.
T Consensus 87 l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~ 161 (321)
T cd05603 87 LQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETTSTFCGTPE 161 (321)
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCccccccCCcc
Confidence 345667999999999999999999999998 999999999999999999999999998753211 122334568999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||.+.+..++.++|||||||++|||++|+.||.... ......... ... .. .+......+.
T Consensus 162 y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~-~~~-~~---------~~~~~~~~~~ 224 (321)
T cd05603 162 YLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------VSQMYDNIL-HKP-LQ---------LPGGKTVAAC 224 (321)
T ss_pred cCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC------HHHHHHHHh-cCC-CC---------CCCCCCHHHH
Confidence 999999998889999999999999999999999985321 111111111 111 00 1112234577
Q ss_pred HHhhhcccCCCCCCCCHH
Q 046010 452 HIGLLCVQEDPADRPNMS 469 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ 469 (523)
+++.+||+.||.+||+..
T Consensus 225 ~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 225 DLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHccCCHhhcCCCC
Confidence 889999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-24 Score=211.02 Aligned_cols=161 Identities=29% Similarity=0.351 Sum_probs=121.5
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.+||+|||++..... .........+..|+||
T Consensus 107 ~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl~~~~~~---~~~~~~~~~~~~y~ap 180 (270)
T cd05047 107 STLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAI 180 (270)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCCccccch---hhhccCCCCccccCCh
Confidence 46899999999999999999999998 99999999999999999999999999853211 1111112235679999
Q ss_pred hhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 376 EYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 376 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
|++....++.++||||||+++|||++ |..||..... ... ..........+ .+......+.+|+
T Consensus 181 E~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~----~~~~~~~~~~~---------~~~~~~~~~~~li 244 (270)
T cd05047 181 ESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AEL----YEKLPQGYRLE---------KPLNCDDEVYDLM 244 (270)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---HHH----HHHHhCCCCCC---------CCCcCCHHHHHHH
Confidence 99988889999999999999999997 9999843211 111 11111111111 0111234577899
Q ss_pred hhcccCCCCCCCCHHHHHHHhccC
Q 046010 455 LLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
.+||+.+|.+|||+.++++.|++.
T Consensus 245 ~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 245 RQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred HHHcccChhhCCCHHHHHHHHHHh
Confidence 999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-24 Score=209.80 Aligned_cols=166 Identities=27% Similarity=0.402 Sum_probs=125.0
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcc-ccceeccCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN-TSKVVGTYGY 372 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~-~~~~~gt~~y 372 (523)
+...+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........... ......+..|
T Consensus 100 ~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y 176 (268)
T cd05063 100 HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW 176 (268)
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCcee
Confidence 3467999999999999999999999998 99999999999999999999999999876543221111 1112234579
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
+|||.+....++.++||||||+++|||++ |+.||..... .. ........... .........+.
T Consensus 177 ~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~----~~~~i~~~~~~---------~~~~~~~~~~~ 240 (268)
T cd05063 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HE----VMKAINDGFRL---------PAPMDCPSAVY 240 (268)
T ss_pred cCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HH----HHHHHhcCCCC---------CCCCCCCHHHH
Confidence 99999988889999999999999999997 9999743221 11 11111111100 01112335678
Q ss_pred HHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 452 HIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+++.+||+.+|++||++.+|++.|++.
T Consensus 241 ~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 241 QLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=213.71 Aligned_cols=169 Identities=24% Similarity=0.278 Sum_probs=120.4
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
+...+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++..... .....++..|+
T Consensus 111 ~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~ 182 (343)
T cd07878 111 KCQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYR 182 (343)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecCCC-----cCCcccccccc
Confidence 3457999999999999999999999998 999999999999999999999999999865321 22356789999
Q ss_pred chhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhh-----------cCCcccccCc--ccc
Q 046010 374 APEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWC-----------NGEALELMDP--VLK 439 (523)
Q Consensus 374 aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~--~l~ 439 (523)
|||++.+ ..++.++||||||+++|+|++|+.||....... .......... .......+.. ...
T Consensus 183 aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (343)
T cd07878 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID---QLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMP 259 (343)
T ss_pred CchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHHhcchhhHHHHhhcccccc
Confidence 9999876 568899999999999999999999985322110 0000000000 0000000000 000
Q ss_pred CC----ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 440 QS----CMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 440 ~~----~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.. ........+.+|+.+||+.||.+|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 260 QQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred chhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 00001124678999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=211.99 Aligned_cols=159 Identities=28% Similarity=0.364 Sum_probs=121.3
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.+...+++.++..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++...... ........|+..|
T Consensus 88 ~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y 162 (316)
T cd05619 88 QSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKTCTFCGTPDY 162 (316)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCceeeecCCccc
Confidence 34567999999999999999999999998 999999999999999999999999998753211 1122345689999
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
+|||.+.+..++.++|||||||++|+|++|+.||...... ... ....... +.+.. .....+.+
T Consensus 163 ~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~----~~i~~~~------~~~~~----~~~~~~~~ 225 (316)
T cd05619 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELF----QSIRMDN------PCYPR----WLTREAKD 225 (316)
T ss_pred cCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCC------CCCCc----cCCHHHHH
Confidence 9999999889999999999999999999999998532211 111 1111110 00111 11235678
Q ss_pred HhhhcccCCCCCCCCHH-HHHH
Q 046010 453 IGLLCVQEDPADRPNMS-SVAV 473 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~-ei~~ 473 (523)
++.+||+.||++||++. ++.+
T Consensus 226 li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 226 ILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHhccCHhhcCCChHHHHc
Confidence 88999999999999997 6643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=210.91 Aligned_cols=155 Identities=25% Similarity=0.326 Sum_probs=118.9
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+...+++.+++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++...... .......|++.
T Consensus 92 i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~--~~~~~~~gt~~ 166 (323)
T cd05615 92 IQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPD 166 (323)
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC--ccccCccCCcc
Confidence 345567999999999999999999999998 9999999999999999999999999987542211 12234568999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||++.+..++.++||||||+++|+|++|+.||..... .... .... .... . . +......+.
T Consensus 167 y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~---~~i~-~~~~-~-----~----p~~~~~~~~ 229 (323)
T cd05615 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELF---QSIM-EHNV-S-----Y----PKSLSKEAV 229 (323)
T ss_pred ccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHH---HHHH-hCCC-C-----C----CccCCHHHH
Confidence 9999999988999999999999999999999999853221 1111 1111 1110 0 0 111223567
Q ss_pred HHhhhcccCCCCCCCCH
Q 046010 452 HIGLLCVQEDPADRPNM 468 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~ 468 (523)
+++.+||+.+|.+|++.
T Consensus 230 ~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 230 SICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHHHHHcccCHhhCCCC
Confidence 88999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-24 Score=214.13 Aligned_cols=172 Identities=27% Similarity=0.378 Sum_probs=126.8
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCc-cccceeccCCCC
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES-NTSKVVGTYGYM 373 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~ 373 (523)
...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||.+.......... ......++..|+
T Consensus 103 ~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (284)
T cd05038 103 RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY 179 (284)
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCccccc
Confidence 346999999999999999999999998 9999999999999999999999999998764222111 111223456799
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCccccccc--------chHHHHHHhhhcCCcccccCccccCCccHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQ--------SLLAYTWKLWCNGEALELMDPVLKQSCMAA 445 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 445 (523)
+||.+.+..++.++||||||+++|+|++|+.|+......... .............. ....+..
T Consensus 180 ~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~ 250 (284)
T cd05038 180 APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE---------RLPRPPS 250 (284)
T ss_pred CcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCC---------cCCCCcc
Confidence 999998888999999999999999999999887532221100 01111111111111 1111112
Q ss_pred HHHHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 446 ELLKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 446 ~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
....+.+++.+||+.+|++||++.||+++|++.
T Consensus 251 ~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 251 CPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred CCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 235678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-24 Score=208.99 Aligned_cols=166 Identities=23% Similarity=0.305 Sum_probs=126.0
Q ss_pred cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcccccee
Q 046010 288 PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVV 367 (523)
Q Consensus 288 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 367 (523)
.++...+...+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||.+........ ......
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~ 161 (255)
T cd08219 87 QKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YACTYV 161 (255)
T ss_pred HHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc--cccccc
Confidence 3333344566899999999999999999999998 99999999999999999999999999876542211 122356
Q ss_pred ccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHH
Q 046010 368 GTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAEL 447 (523)
Q Consensus 368 gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 447 (523)
++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ....... ..+..... +....
T Consensus 162 ~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~~-~~~~~~~~---------~~~~~ 225 (255)
T cd08219 162 GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILKV-CQGSYKPL---------PSHYS 225 (255)
T ss_pred CCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHHH-hcCCCCCC---------CcccC
Confidence 78899999999888899999999999999999999999853211 1111111 11111111 11123
Q ss_pred HHHHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 448 LKCIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 448 ~~~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
..+.+++.+||+.||++||++.+|+..
T Consensus 226 ~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 226 YELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 456788999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.1e-24 Score=206.73 Aligned_cols=153 Identities=22% Similarity=0.337 Sum_probs=117.7
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC-------CeeEeccccceeccCCCCCccccceecc
Q 046010 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM-------NPKISDFGMARIFGGNQNESNTSKVVGT 369 (523)
Q Consensus 297 ~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~-------~~kL~Dfg~a~~~~~~~~~~~~~~~~gt 369 (523)
.+++..++.++.||+.||+|||+++ |+|+||||+||+++.++ .+||+|||++..... .....++
T Consensus 97 ~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~ 167 (259)
T cd05037 97 NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVER 167 (259)
T ss_pred CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCccccccc------ccccccC
Confidence 7999999999999999999999998 99999999999999887 799999999886532 2233456
Q ss_pred CCCCchhhhcCC--CCCcchhhHHHHHHHHHHHhC-CCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHH
Q 046010 370 YGYMAPEYALGG--VISVKSDVFSFGVLLLEIISG-KKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAE 446 (523)
Q Consensus 370 ~~y~aPE~l~~~--~~s~ksDVwSlGvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 446 (523)
..|+|||++.+. .++.++||||||+++|+|++| ..||...... .. ...+....... . ..
T Consensus 168 ~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~---~~----~~~~~~~~~~~-------~----~~ 229 (259)
T cd05037 168 IPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS---EK----ERFYQDQHRLP-------M----PD 229 (259)
T ss_pred CCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch---hH----HHHHhcCCCCC-------C----CC
Confidence 789999998876 789999999999999999995 6665432211 00 11111110000 0 01
Q ss_pred HHHHHHHhhhcccCCCCCCCCHHHHHHHhc
Q 046010 447 LLKCIHIGLLCVQEDPADRPNMSSVAVMLA 476 (523)
Q Consensus 447 ~~~~~~li~~cl~~dP~~RPs~~ei~~~L~ 476 (523)
...+.+++.+||..+|.+|||+.+|++.|+
T Consensus 230 ~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 230 CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 156778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=192.22 Aligned_cols=158 Identities=18% Similarity=0.154 Sum_probs=116.9
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
++..+++.+++.++.||++||.|||+++ ||+||+++.++.+|+ ||.+...... ...|++.|+
T Consensus 10 ~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~-------~~~g~~~y~ 71 (176)
T smart00750 10 RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE-------QSRVDPYFM 71 (176)
T ss_pred hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc-------cCCCccccc
Confidence 3567999999999999999999999884 999999999999999 9998865322 125789999
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHH--HHHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAEL--LKCI 451 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~--~~~~ 451 (523)
|||++.+..++.++||||||+++|||++|+.||...... ............... +... ....... ..+.
T Consensus 72 aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~------~~~~-~~~~~~~~~~~~~ 142 (176)
T smart00750 72 APEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPADD------PRDR-SNLESVSAARSFA 142 (176)
T ss_pred ChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccCC------cccc-ccHHHHHhhhhHH
Confidence 999999999999999999999999999999998532211 111111111111100 0000 0011111 2588
Q ss_pred HHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 452 HIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+++.+||+.+|++||++.|+++.+...
T Consensus 143 ~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 143 DFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHHHhcccccccCHHHHHHHHHHH
Confidence 999999999999999999999987543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-24 Score=218.91 Aligned_cols=113 Identities=27% Similarity=0.336 Sum_probs=97.6
Q ss_pred cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC--CeeEeccccceeccCCCCCccccc
Q 046010 288 PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM--NPKISDFGMARIFGGNQNESNTSK 365 (523)
Q Consensus 288 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~--~~kL~Dfg~a~~~~~~~~~~~~~~ 365 (523)
.++-.++-..|+...++.++.||+.||.+||+.+ |||+||||+|||+...+ .+||+|||.+..... ....
T Consensus 276 ellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q-----~vyt 347 (586)
T KOG0667|consen 276 ELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ-----RVYT 347 (586)
T ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccccCC-----ccee
Confidence 3333566677999999999999999999999998 99999999999997643 699999999987532 1226
Q ss_pred eeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 046010 366 VVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGF 408 (523)
Q Consensus 366 ~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~ 408 (523)
...+..|+|||++.+.+|+.+.||||||||+.||++|.+.|..
T Consensus 348 YiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 348 YIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred eeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 7788999999999999999999999999999999999877653
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.9e-24 Score=214.59 Aligned_cols=175 Identities=22% Similarity=0.271 Sum_probs=130.8
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..++..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... .....||+.
T Consensus 122 i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~ 193 (340)
T PTZ00426 122 LRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPE 193 (340)
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC-----cceecCChh
Confidence 445667999999999999999999999998 999999999999999999999999999865321 224578999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||++.+..++.++|||||||++|||++|+.||..... .. .......+.. . +. . .....+.
T Consensus 194 y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------~~-~~~~i~~~~~-~-~p----~----~~~~~~~ 256 (340)
T PTZ00426 194 YIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP------LL-IYQKILEGII-Y-FP----K----FLDNNCK 256 (340)
T ss_pred hcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH------HH-HHHHHhcCCC-C-CC----C----CCCHHHH
Confidence 9999999988899999999999999999999999853221 11 1111111111 0 11 1 1123456
Q ss_pred HHhhhcccCCCCCCC-----CHHHHHHH--hccC------CCCCCCCCCCCcc
Q 046010 452 HIGLLCVQEDPADRP-----NMSSVAVM--LASD------TVSLPQPTQPAFS 491 (523)
Q Consensus 452 ~li~~cl~~dP~~RP-----s~~ei~~~--L~~~------~~~l~~p~~p~~~ 491 (523)
+++.+||+.||++|+ +++++++. +++. ...++.|..|.+.
T Consensus 257 ~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~ 309 (340)
T PTZ00426 257 HLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYK 309 (340)
T ss_pred HHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCC
Confidence 888999999999995 89888764 3321 2344566666653
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.1e-24 Score=214.80 Aligned_cols=110 Identities=31% Similarity=0.485 Sum_probs=94.9
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.+...+++..+..++.||++||.|||+++ .|+|+||||+||+++.++.+||+|||++...... ......++..|
T Consensus 95 ~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----~~~~~~~~~~y 168 (333)
T cd06650 95 KKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSY 168 (333)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh----ccccCCCCccc
Confidence 44567999999999999999999999752 2999999999999999999999999998754321 12234678999
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGF 408 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~ 408 (523)
+|||.+.+..++.++|||||||++|+|++|+.||..
T Consensus 169 ~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred cCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 999999988899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=228.07 Aligned_cols=180 Identities=25% Similarity=0.359 Sum_probs=131.1
Q ss_pred ceeEeeecccccccc---cccccccc-CHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccc
Q 046010 276 RKAIWIAIGTTIPTI---YSTRRAQL-DWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA 351 (523)
Q Consensus 276 ~~~~~ia~g~~~~~~---~~~~~~~l-~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 351 (523)
...+||-|.+|...+ ++.++... .....|+++++|++||.|+|++| ||||||||.|||++.+..+||+|||++
T Consensus 668 ~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLA 744 (1351)
T KOG1035|consen 668 PLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLA 744 (1351)
T ss_pred ceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccc
Confidence 358999999999333 23333333 47899999999999999999999 999999999999999999999999999
Q ss_pred eecc------C----------CCCCccccceeccCCCCchhhhcCC---CCCcchhhHHHHHHHHHHHhCCCCCCCcccc
Q 046010 352 RIFG------G----------NQNESNTSKVVGTYGYMAPEYALGG---VISVKSDVFSFGVLLLEIISGKKNSGFYLSE 412 (523)
Q Consensus 352 ~~~~------~----------~~~~~~~~~~~gt~~y~aPE~l~~~---~~s~ksDVwSlGvvl~elltG~~p~~~~~~~ 412 (523)
.... . .......+..+||..|+|||++.+. .|+.|.|+||||+|++||+. ||....
T Consensus 745 t~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM-- 819 (1351)
T KOG1035|consen 745 TDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM-- 819 (1351)
T ss_pred hhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchH--
Confidence 8621 0 0111234567899999999999764 49999999999999999985 343211
Q ss_pred cccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 413 HGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 413 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
........++.+.+... +. +..++...-.++|+++++.||.+|||+.|++.
T Consensus 820 ----ERa~iL~~LR~g~iP~~--~~----f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 820 ----ERASILTNLRKGSIPEP--AD----FFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred ----HHHHHHHhcccCCCCCC--cc----cccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 11122333444444433 11 11122233457888999999999999998864
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.3e-24 Score=209.16 Aligned_cols=171 Identities=26% Similarity=0.307 Sum_probs=126.2
Q ss_pred cccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccc
Q 046010 284 GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNT 363 (523)
Q Consensus 284 g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 363 (523)
|....+++......+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++....... ..
T Consensus 85 ~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~~ 158 (285)
T cd05630 85 GDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TI 158 (285)
T ss_pred CcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc---cc
Confidence 33334454455567999999999999999999999998 9999999999999999999999999987643221 11
Q ss_pred cceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCcc
Q 046010 364 SKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCM 443 (523)
Q Consensus 364 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 443 (523)
....|+..|+|||.+.+..++.++||||||+++|+|++|+.||........... ....... .. ... .
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~---~~~~~~~--~~----~~~----~ 225 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVKE--VQ----EEY----S 225 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH---HHhhhhh--hh----hhc----C
Confidence 234688999999999998999999999999999999999999864322111001 1111000 00 001 1
Q ss_pred HHHHHHHHHHhhhcccCCCCCCCC-----HHHHHH
Q 046010 444 AAELLKCIHIGLLCVQEDPADRPN-----MSSVAV 473 (523)
Q Consensus 444 ~~~~~~~~~li~~cl~~dP~~RPs-----~~ei~~ 473 (523)
......+.+|+.+||+.||++||| +.|+++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 226 EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 112234678889999999999999 778775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.6e-24 Score=208.90 Aligned_cols=164 Identities=23% Similarity=0.338 Sum_probs=124.6
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..++.++.||+.||+|||+++ |+|+||||+||+++.++.+||+|||.++...............++..|++|
T Consensus 108 ~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p 184 (273)
T cd05074 108 FTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLAL 184 (273)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCH
Confidence 35899999999999999999999998 999999999999999999999999998865432222222233445789999
Q ss_pred hhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 376 EYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 376 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
|.+.+..++.++||||||+++|+|++ |+.||..... ... ........... .+......+.+++
T Consensus 185 e~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~----~~~~~~~~~~~---------~~~~~~~~~~~l~ 248 (273)
T cd05074 185 ESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEI----YNYLIKGNRLK---------QPPDCLEDVYELM 248 (273)
T ss_pred hHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHH----HHHHHcCCcCC---------CCCCCCHHHHHHH
Confidence 99988889999999999999999999 7788743221 111 11111111110 0112335788899
Q ss_pred hhcccCCCCCCCCHHHHHHHhccC
Q 046010 455 LLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
.+||+.+|++||++.+|++.|++.
T Consensus 249 ~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 249 CQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHcCCChhhCcCHHHHHHHHHhh
Confidence 999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-24 Score=217.46 Aligned_cols=165 Identities=28% Similarity=0.376 Sum_probs=124.4
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||++................++..|+||
T Consensus 174 ~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 250 (343)
T cd05103 174 KVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 250 (343)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECc
Confidence 45899999999999999999999998 999999999999999999999999998765322221222223456779999
Q ss_pred hhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 376 EYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 376 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
|.+.+..++.++||||||+++|+|++ |..||...... ... ......+..... +......+.+++
T Consensus 251 E~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~----~~~~~~~~~~~~---------~~~~~~~~~~~~ 315 (343)
T cd05103 251 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEF----CRRLKEGTRMRA---------PDYTTPEMYQTM 315 (343)
T ss_pred HHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHH----HHHHhccCCCCC---------CCCCCHHHHHHH
Confidence 99988889999999999999999997 88887532211 111 111111111110 001123577889
Q ss_pred hhcccCCCCCCCCHHHHHHHhccC
Q 046010 455 LLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
..||+.||++|||+.||++.|+..
T Consensus 316 ~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 316 LDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred HHHccCChhhCcCHHHHHHHHHHH
Confidence 999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-24 Score=214.40 Aligned_cols=162 Identities=28% Similarity=0.337 Sum_probs=121.9
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.||+.||+|||+++ ++||||||+||+++.++.+||+|||++..... .........+..|+|
T Consensus 118 ~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~a 191 (303)
T cd05088 118 ASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMA 191 (303)
T ss_pred cCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcEEeCccccCcccch---hhhcccCCCcccccC
Confidence 346899999999999999999999998 99999999999999999999999999864211 111112233567999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||.+.+..++.++||||||+++|+|++ |..||...... .... ........+ .+......+.+|
T Consensus 192 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~----~~~~~~~~~---------~~~~~~~~~~~l 255 (303)
T cd05088 192 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYE----KLPQGYRLE---------KPLNCDDEVYDL 255 (303)
T ss_pred HHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHH----HHhcCCcCC---------CCCCCCHHHHHH
Confidence 999988889999999999999999998 99988532211 1111 111110000 011122356789
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+.+||+.+|++||++.++++.|+..
T Consensus 256 i~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 256 MRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.7e-24 Score=210.36 Aligned_cols=164 Identities=29% Similarity=0.418 Sum_probs=124.2
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++...............++..|+||
T Consensus 114 ~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~p 190 (288)
T cd05061 114 PPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190 (288)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCH
Confidence 45678889999999999999999998 999999999999999999999999998765332222222233456789999
Q ss_pred hhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 376 EYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 376 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
|.+.++.++.++||||||+++|||++ |..||.....+ .. ......+..... +......+.+++
T Consensus 191 E~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~----~~~~~~~~~~~~---------~~~~~~~~~~li 254 (288)
T cd05061 191 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QV----LKFVMDGGYLDQ---------PDNCPERVTDLM 254 (288)
T ss_pred HHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHcCCCCCC---------CCCCCHHHHHHH
Confidence 99998899999999999999999998 67787432111 11 111111111111 111235678899
Q ss_pred hhcccCCCCCCCCHHHHHHHhccC
Q 046010 455 LLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
.+||+.||++|||+.++++.|++.
T Consensus 255 ~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 255 RMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHcCCChhHCcCHHHHHHHHHhh
Confidence 999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.1e-24 Score=204.96 Aligned_cols=163 Identities=28% Similarity=0.342 Sum_probs=123.4
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
+...+++..++.++.|++.+|.|||+++ ++|+||||+||+++.++.+||+|||++........ .......++..|+
T Consensus 86 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~ 161 (250)
T cd05085 86 KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQIPIKWT 161 (250)
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCCccccc
Confidence 3456899999999999999999999998 99999999999999999999999999875432211 1111223456799
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
|||++....++.++||||||+++|++++ |..||...... ............. .+......+.+
T Consensus 162 aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-------~~~~~~~~~~~~~---------~~~~~~~~~~~ 225 (250)
T cd05085 162 APEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-------QAREQVEKGYRMS---------CPQKCPDDVYK 225 (250)
T ss_pred CHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHHHcCCCCC---------CCCCCCHHHHH
Confidence 9999988889999999999999999998 88887532211 1111111111111 11122356788
Q ss_pred HhhhcccCCCCCCCCHHHHHHHhc
Q 046010 453 IGLLCVQEDPADRPNMSSVAVMLA 476 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~~L~ 476 (523)
++.+||+.+|++||++.|+++.|.
T Consensus 226 li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 226 VMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHcccCcccCCCHHHHHHHhc
Confidence 999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.7e-24 Score=213.12 Aligned_cols=175 Identities=24% Similarity=0.301 Sum_probs=121.6
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
.+..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++....... .......++..|+
T Consensus 97 ~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~ 171 (309)
T cd07872 97 CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT--KTYSNEVVTLWYR 171 (309)
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc--ccccccccccccc
Confidence 3456899999999999999999999998 9999999999999999999999999987643221 1122346788999
Q ss_pred chhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHH--------HHHHhhhcCCcccccC-ccccC---
Q 046010 374 APEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLA--------YTWKLWCNGEALELMD-PVLKQ--- 440 (523)
Q Consensus 374 aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~-~~l~~--- 440 (523)
|||.+.+ ..++.++||||||+++|+|++|+.||............. ..|..+.........+ +....
T Consensus 172 aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (309)
T cd07872 172 PPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPL 251 (309)
T ss_pred CCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCch
Confidence 9998865 458899999999999999999999986433221111110 0111111000000000 00000
Q ss_pred -CccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 441 -SCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 441 -~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.........+.+++.+||+.||.+|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 252 INHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000112345678999999999999999999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.7e-24 Score=207.07 Aligned_cols=157 Identities=22% Similarity=0.304 Sum_probs=117.4
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCC-------eeEeccccceeccCCCCCccccc
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMN-------PKISDFGMARIFGGNQNESNTSK 365 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~-------~kL~Dfg~a~~~~~~~~~~~~~~ 365 (523)
.+...+++..++.++.||++||+|||+++ |+||||||+||+++.++. +|++|||.+..... ...
T Consensus 97 ~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~------~~~ 167 (262)
T cd05077 97 RKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS------RQE 167 (262)
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccC------ccc
Confidence 34567999999999999999999999998 999999999999987664 89999998865421 123
Q ss_pred eeccCCCCchhhhc-CCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCcc
Q 046010 366 VVGTYGYMAPEYAL-GGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCM 443 (523)
Q Consensus 366 ~~gt~~y~aPE~l~-~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 443 (523)
..++..|+|||.+. +..++.++||||||+++|||++ |..|+...... ....... ... ....
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~~~~~~-~~~-~~~~-------- 230 (262)
T cd05077 168 CVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA-------EKERFYE-GQC-MLVT-------- 230 (262)
T ss_pred ccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-------HHHHHHh-cCc-cCCC--------
Confidence 45678899999886 4668899999999999999984 77776422111 0111111 110 1101
Q ss_pred HHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhc
Q 046010 444 AAELLKCIHIGLLCVQEDPADRPNMSSVAVMLA 476 (523)
Q Consensus 444 ~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~ 476 (523)
.....+.+|+.+||+.||++||++.+|++.|+
T Consensus 231 -~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 231 -PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 11245678999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-24 Score=212.82 Aligned_cols=172 Identities=23% Similarity=0.348 Sum_probs=125.7
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC-ccccceeccCCCC
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE-SNTSKVVGTYGYM 373 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~ 373 (523)
...+++..++.++.||+.||+|||+++ ++||||||+||+++.++.+||+|||++......... .......++..|+
T Consensus 103 ~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~ 179 (284)
T cd05079 103 KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY 179 (284)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCcccc
Confidence 346899999999999999999999998 999999999999999999999999998865432221 1122345667899
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccc--------cccchHHHHHHhhhcCCcccccCccccCCccHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSE--------HGQSLLAYTWKLWCNGEALELMDPVLKQSCMAA 445 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 445 (523)
|||.+.+..++.++||||||+++|+|++++.|....... ...............+.... ....
T Consensus 180 apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~ 250 (284)
T cd05079 180 APECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLP---------RPPN 250 (284)
T ss_pred CHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCC---------CCCC
Confidence 999998888999999999999999999987664221100 01111111111111111111 1112
Q ss_pred HHHHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 446 ELLKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 446 ~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
....+.+|+.+||+.+|++||++.+|++.|+..
T Consensus 251 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 251 CPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 345788899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.3e-24 Score=193.18 Aligned_cols=160 Identities=23% Similarity=0.264 Sum_probs=121.8
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCC---CCeeEeccccceeccCCCCCccccceeccC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE---MNPKISDFGMARIFGGNQNESNTSKVVGTY 370 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~---~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~ 370 (523)
++.-+++..+-+.++||+++|.|+|.++ |||||+||+|+++... --+||+|||++..+. .......+.||+
T Consensus 103 ~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~---~g~~~~G~~GtP 176 (355)
T KOG0033|consen 103 AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN---DGEAWHGFAGTP 176 (355)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC---CccccccccCCC
Confidence 3467899999999999999999999999 9999999999999543 348999999999875 233445678999
Q ss_pred CCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 371 GYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 371 ~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
+|++||+++..+|+..+|||+-|++||-|+.|..||-... ...+.+ .+..+.. ++-.+ .-.......
T Consensus 177 ~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~---~~rlye----~I~~g~y-d~~~~-----~w~~is~~A 243 (355)
T KOG0033|consen 177 GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYE----QIKAGAY-DYPSP-----EWDTVTPEA 243 (355)
T ss_pred cccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc---HHHHHH----HHhcccc-CCCCc-----ccCcCCHHH
Confidence 9999999999999999999999999999999999984211 111211 1111111 11000 011122355
Q ss_pred HHHhhhcccCCCCCCCCHHHHH
Q 046010 451 IHIGLLCVQEDPADRPNMSSVA 472 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~ 472 (523)
.+|+.+||..||.+|.|+.|.+
T Consensus 244 k~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 244 KSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred HHHHHHHhccChhhhccHHHHh
Confidence 6788899999999999998875
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=204.04 Aligned_cols=166 Identities=18% Similarity=0.277 Sum_probs=117.2
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..++.++.||++||+|||+++ ++|+||||+||+++.++.+||+|||++................++..|+||
T Consensus 94 ~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 170 (268)
T cd05086 94 RNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAP 170 (268)
T ss_pred ccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCc
Confidence 45677888999999999999999998 999999999999999999999999987643211111122345678899999
Q ss_pred hhhcC-------CCCCcchhhHHHHHHHHHHHhC-CCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHH
Q 046010 376 EYALG-------GVISVKSDVFSFGVLLLEIISG-KKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAEL 447 (523)
Q Consensus 376 E~l~~-------~~~s~ksDVwSlGvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 447 (523)
|++.. ..++.++||||||+++|||+++ ..||..... ..... . ...+......++.+... ..
T Consensus 171 E~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~---~-~~~~~~~~~~~~~~~~~----~~ 239 (268)
T cd05086 171 ELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---REVLN---H-VIKDQQVKLFKPQLELP----YS 239 (268)
T ss_pred hhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HHHHH---H-HHhhcccccCCCccCCC----Cc
Confidence 98743 2457899999999999999975 556532211 11111 1 11122223333333222 22
Q ss_pred HHHHHHhhhcccCCCCCCCCHHHHHHHhc
Q 046010 448 LKCIHIGLLCVQEDPADRPNMSSVAVMLA 476 (523)
Q Consensus 448 ~~~~~li~~cl~~dP~~RPs~~ei~~~L~ 476 (523)
..+.+++..|| .+|++||++++|++.|.
T Consensus 240 ~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 240 ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 35566778899 67999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-24 Score=216.75 Aligned_cols=163 Identities=22% Similarity=0.242 Sum_probs=122.8
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+...+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++...... .......|+..
T Consensus 89 l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~ 163 (318)
T cd05582 89 LSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVE 163 (318)
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--CceecccCChh
Confidence 345667999999999999999999999998 9999999999999999999999999987643221 12234568899
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||.+.+..++.++||||||+++|+|++|+.||..... ........ .... . + +......+.
T Consensus 164 y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~------~~~~~~i~-~~~~-~-----~----p~~~~~~~~ 226 (318)
T cd05582 164 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR------KETMTMIL-KAKL-G-----M----PQFLSPEAQ 226 (318)
T ss_pred hcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH------HHHHHHHH-cCCC-C-----C----CCCCCHHHH
Confidence 9999999988899999999999999999999999853221 11111111 1110 0 0 111223566
Q ss_pred HHhhhcccCCCCCCCCHHH--HHHHhc
Q 046010 452 HIGLLCVQEDPADRPNMSS--VAVMLA 476 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~e--i~~~L~ 476 (523)
+++.+||+.||++||++.+ +.+.++
T Consensus 227 ~li~~~l~~~P~~R~~a~~~~~~~~~~ 253 (318)
T cd05582 227 SLLRALFKRNPANRLGAGPDGVEEIKR 253 (318)
T ss_pred HHHHHHhhcCHhHcCCCCCCCHHHHhC
Confidence 8889999999999999655 444443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-24 Score=215.90 Aligned_cols=161 Identities=21% Similarity=0.247 Sum_probs=119.7
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..++..+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||++....... .......|+..
T Consensus 87 l~~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~ 161 (330)
T cd05586 87 LQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNTFCGTTE 161 (330)
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCccCccCCcc
Confidence 445678999999999999999999999998 9999999999999999999999999987532211 12234568999
Q ss_pred CCchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 372 YMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 372 y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
|+|||.+.+. .++.++|||||||++|+|++|+.||..... .+ .......+.. .+... .....+
T Consensus 162 y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------~~-~~~~i~~~~~-~~~~~--------~~~~~~ 225 (330)
T cd05586 162 YLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------QQ-MYRNIAFGKV-RFPKN--------VLSDEG 225 (330)
T ss_pred ccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------HH-HHHHHHcCCC-CCCCc--------cCCHHH
Confidence 9999998764 478999999999999999999999853221 11 1111111111 11110 112345
Q ss_pred HHHhhhcccCCCCCCC----CHHHHHH
Q 046010 451 IHIGLLCVQEDPADRP----NMSSVAV 473 (523)
Q Consensus 451 ~~li~~cl~~dP~~RP----s~~ei~~ 473 (523)
.+++.+||+.||++|| ++.++++
T Consensus 226 ~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 226 RQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 6788899999999998 4555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.4e-24 Score=216.13 Aligned_cols=176 Identities=27% Similarity=0.392 Sum_probs=133.7
Q ss_pred eEeee---cccccccccccccccc--CHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC-CCCeeEeccccc
Q 046010 278 AIWIA---IGTTIPTIYSTRRAQL--DWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH-EMNPKISDFGMA 351 (523)
Q Consensus 278 ~~~ia---~g~~~~~~~~~~~~~l--~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~a 351 (523)
.++|. .|+...++ ..+=++| ++..+-.+.+||++||.|||++. |||||||-+|+||+. .|.+||+|||.+
T Consensus 648 kIFMEqVPGGSLSsLL-rskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTs 723 (1226)
T KOG4279|consen 648 KIFMEQVPGGSLSSLL-RSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTS 723 (1226)
T ss_pred EEEeecCCCCcHHHHH-HhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccc
Confidence 44444 34444433 4444566 78888899999999999999997 999999999999975 688999999999
Q ss_pred eeccCCCCCccccceeccCCCCchhhhcCCC--CCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCC
Q 046010 352 RIFGGNQNESNTSKVVGTYGYMAPEYALGGV--ISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGE 429 (523)
Q Consensus 352 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 429 (523)
+.+. .....+..+.||+.|||||++-.++ |..++|||||||++.||.||++||........ ..+.-+-
T Consensus 724 KRLA--ginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkVGm 793 (1226)
T KOG4279|consen 724 KRLA--GINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKVGM 793 (1226)
T ss_pred hhhc--cCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhhcc
Confidence 8764 3344566789999999999997765 88999999999999999999999854332211 1111111
Q ss_pred cccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 430 ALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 430 ~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
. ......+.+-..++..+|++|+.+||.+||++.++++
T Consensus 794 y------KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 794 Y------KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred e------ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 0 0122334555677889999999999999999999975
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-24 Score=208.11 Aligned_cols=164 Identities=23% Similarity=0.280 Sum_probs=123.2
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcc-ccceeccCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN-TSKVVGTYG 371 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~-~~~~~gt~~ 371 (523)
.+...+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.......... .....++..
T Consensus 96 ~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~ 172 (263)
T cd06625 96 KAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY 172 (263)
T ss_pred HHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCcc
Confidence 34456899999999999999999999998 99999999999999999999999999876532211111 123456788
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||.+.+..++.++||||||+++|+|++|+.||..... .............. ..+......+.
T Consensus 173 y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~---------~~~~~~~~~~~ 237 (263)
T cd06625 173 WMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA------MAAIFKIATQPTNP---------QLPSHVSPDAR 237 (263)
T ss_pred ccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch------HHHHHHHhccCCCC---------CCCccCCHHHH
Confidence 9999999988899999999999999999999999753211 11111111111111 11112334567
Q ss_pred HHhhhcccCCCCCCCCHHHHHHH
Q 046010 452 HIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
+++.+||..+|++|||+.++++.
T Consensus 238 ~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 238 NFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHHhhcCcccCCCHHHHhhC
Confidence 88999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=207.92 Aligned_cols=171 Identities=26% Similarity=0.297 Sum_probs=125.9
Q ss_pred cccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccc
Q 046010 284 GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNT 363 (523)
Q Consensus 284 g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 363 (523)
|....+++......+++..+..++.|++.||.|||+++ |+||||||+||++++++.+||+|||++....... ..
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~ 158 (285)
T cd05632 85 GDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SI 158 (285)
T ss_pred ccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC---cc
Confidence 33334555555567999999999999999999999998 9999999999999999999999999987643211 12
Q ss_pred cceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCcc
Q 046010 364 SKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCM 443 (523)
Q Consensus 364 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 443 (523)
....++..|+|||.+.+..++.++||||||+++|+|++|..||........ ............ .. ...
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~~--~~----~~~--- 226 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLETE--EV----YSA--- 226 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhccc--cc----cCc---
Confidence 234688999999999988899999999999999999999999863321111 111111111111 00 111
Q ss_pred HHHHHHHHHHhhhcccCCCCCCCC-----HHHHHH
Q 046010 444 AAELLKCIHIGLLCVQEDPADRPN-----MSSVAV 473 (523)
Q Consensus 444 ~~~~~~~~~li~~cl~~dP~~RPs-----~~ei~~ 473 (523)
.....+.+|+..||+.||++||+ +.+++.
T Consensus 227 -~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 227 -KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred -cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 11234567888999999999999 666655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.5e-24 Score=207.70 Aligned_cols=166 Identities=23% Similarity=0.363 Sum_probs=123.4
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcccccee---ccC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVV---GTY 370 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~---gt~ 370 (523)
....+++.+++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++................ .+.
T Consensus 99 ~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 175 (269)
T cd05065 99 NDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPI 175 (269)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcce
Confidence 3557899999999999999999999998 9999999999999999999999999987654322211111111 134
Q ss_pred CCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 371 GYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 371 ~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
.|+|||.+.+..++.++||||||+++||+++ |..||...... ...... .... . ...+.+....
T Consensus 176 ~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i----~~~~--~-------~~~~~~~~~~ 239 (269)
T cd05065 176 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAI----EQDY--R-------LPPPMDCPTA 239 (269)
T ss_pred eecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHH----HcCC--c-------CCCcccCCHH
Confidence 7999999998899999999999999999886 99887432211 111111 1110 0 0001122345
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+.+++.+||+.+|++||++.+|+++|++.
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 67899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=215.25 Aligned_cols=147 Identities=22% Similarity=0.231 Sum_probs=117.0
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEe-CCCCCeeEeccccceeccCCCCCccccceeccCCCCchhhhc
Q 046010 301 KRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLL-DHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYAL 379 (523)
Q Consensus 301 ~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll-~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~ 379 (523)
.++..|+.+|+.|+.|||++| +|||||||+|||+ +..++++|+|||.++..... .....-|..|.|||++.
T Consensus 415 ~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~ 486 (612)
T KOG0603|consen 415 SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLA 486 (612)
T ss_pred HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhc
Confidence 778889999999999999999 9999999999999 58899999999999875432 33445688999999999
Q ss_pred CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHhhhccc
Q 046010 380 GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQ 459 (523)
Q Consensus 380 ~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~ 459 (523)
...+++++|+||||++||+|++|+.||...... .. .......+... ........+|+.+||+
T Consensus 487 ~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~e----i~~~i~~~~~s------------~~vS~~AKdLl~~LL~ 548 (612)
T KOG0603|consen 487 IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IE----IHTRIQMPKFS------------ECVSDEAKDLLQQLLQ 548 (612)
T ss_pred cCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HH----HHHhhcCCccc------------cccCHHHHHHHHHhcc
Confidence 999999999999999999999999998644333 11 11111121111 2223456688889999
Q ss_pred CCCCCCCCHHHHHH
Q 046010 460 EDPADRPNMSSVAV 473 (523)
Q Consensus 460 ~dP~~RPs~~ei~~ 473 (523)
.||.+||++.++..
T Consensus 549 ~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 549 VDPALRLGADEIGA 562 (612)
T ss_pred CChhhCcChhhhcc
Confidence 99999999999854
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.8e-24 Score=205.45 Aligned_cols=163 Identities=30% Similarity=0.415 Sum_probs=123.2
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
+...++++.++.++.|++.+|.+||+.+ ++|+||||+||+++.++.+||+|||.+......... ......++..|+
T Consensus 93 ~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~ 168 (256)
T cd05112 93 QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SSTGTKFPVKWS 168 (256)
T ss_pred CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-ccCCCccchhhc
Confidence 3456899999999999999999999998 999999999999999999999999998765432211 111223456899
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
|||.+.+..++.++||||||+++|+|++ |..||...... ... .. ...+. ....+.. ....+.+
T Consensus 169 aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~---~~-~~~~~--~~~~~~~-------~~~~~~~ 232 (256)
T cd05112 169 SPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVV---ET-INAGF--RLYKPRL-------ASQSVYE 232 (256)
T ss_pred CHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHH---HH-HhCCC--CCCCCCC-------CCHHHHH
Confidence 9999988889999999999999999998 88887532211 111 11 11110 1111111 2346788
Q ss_pred HhhhcccCCCCCCCCHHHHHHHhc
Q 046010 453 IGLLCVQEDPADRPNMSSVAVMLA 476 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~~L~ 476 (523)
|+.+||+.+|++||++.|++++|.
T Consensus 233 l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 233 LMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HHHHHcccChhhCCCHHHHHHhhC
Confidence 999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=202.35 Aligned_cols=163 Identities=23% Similarity=0.340 Sum_probs=125.6
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHh-cCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHE-DSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~-~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
.+...+++..+++++.|++.||.|||+ .+ ++|+||+|+||+++.++.+||+|||.+....... ......++..
T Consensus 105 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~ 178 (269)
T cd08528 105 EKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTIL 178 (269)
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecccceeeccccc---ccccccCccc
Confidence 345679999999999999999999996 56 9999999999999999999999999998654322 2334567889
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|++||.+.+..++.++||||||+++|+|++|+.||..... ..... ........... . ......+.
T Consensus 179 ~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------~~~~~-~~~~~~~~~~~----~----~~~~~~l~ 243 (269)
T cd08528 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------LSLAT-KIVEAVYEPLP----E----GMYSEDVT 243 (269)
T ss_pred CcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------HHHHH-HHhhccCCcCC----c----ccCCHHHH
Confidence 9999999988899999999999999999999999743211 11111 11111111110 0 01224577
Q ss_pred HHhhhcccCCCCCCCCHHHHHHHhc
Q 046010 452 HIGLLCVQEDPADRPNMSSVAVMLA 476 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~~L~ 476 (523)
+++.+||+.||++||++.||.++|+
T Consensus 244 ~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 244 DVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHHHCCCCCccCCCHHHHHHHhc
Confidence 8899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=208.36 Aligned_cols=168 Identities=27% Similarity=0.404 Sum_probs=124.6
Q ss_pred cccccccccCHHHHHHHHHHHHHHHHHHHhc-CCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceec
Q 046010 290 IYSTRRAQLDWKRRISIINGIARGLLYLHED-SRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVG 368 (523)
Q Consensus 290 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~g 368 (523)
++......+++..+..++.|++.||+|||+. + ++||||||+||+++.++.+||+|||++....... ......+
T Consensus 96 ~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~ 169 (288)
T cd06616 96 VYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI---AKTRDAG 169 (288)
T ss_pred HHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCC---ccccccC
Confidence 3444557899999999999999999999975 6 9999999999999999999999999987653221 1123457
Q ss_pred cCCCCchhhhcCC---CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHH
Q 046010 369 TYGYMAPEYALGG---VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAA 445 (523)
Q Consensus 369 t~~y~aPE~l~~~---~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 445 (523)
+..|+|||.+.+. .++.++||||||+++|+|++|+.||.... ......... ..+.. +.+.......
T Consensus 170 ~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~-~~~~~-----~~~~~~~~~~ 238 (288)
T cd06616 170 CRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQV-VKGDP-----PILSNSEERE 238 (288)
T ss_pred ccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhh-cCCCC-----CcCCCcCCCc
Confidence 8899999998766 68899999999999999999999985332 111111111 11111 1111111122
Q ss_pred HHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 446 ELLKCIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 446 ~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
....+.+|+.+||+.+|++|||+.+|++.
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 239 FSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 34567889999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.2e-24 Score=209.29 Aligned_cols=167 Identities=26% Similarity=0.329 Sum_probs=122.8
Q ss_pred ccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccce
Q 046010 287 IPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKV 366 (523)
Q Consensus 287 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 366 (523)
..++...+...+++..++.++.||++||.|||+.+ |+|+||||+||+++.++.++|+|||++....... ......
T Consensus 107 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 181 (282)
T cd06636 107 TDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTF 181 (282)
T ss_pred HHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhhhhccc--cCCCcc
Confidence 34444445567899999999999999999999998 9999999999999999999999999987543211 122345
Q ss_pred eccCCCCchhhhc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCC
Q 046010 367 VGTYGYMAPEYAL-----GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQS 441 (523)
Q Consensus 367 ~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 441 (523)
.++..|+|||.+. ...++.++||||||+++|+|++|+.||........ ....... . ...+.
T Consensus 182 ~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~------~~~~~~~-~-----~~~~~-- 247 (282)
T cd06636 182 IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA------LFLIPRN-P-----PPKLK-- 247 (282)
T ss_pred cccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh------hhhHhhC-C-----CCCCc--
Confidence 6788999999875 34578899999999999999999999853221100 0000000 0 00010
Q ss_pred ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 442 CMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 442 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.......+.+++.+||+.||.+||++.||++
T Consensus 248 -~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 248 -SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 1122346788999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=206.01 Aligned_cols=172 Identities=22% Similarity=0.253 Sum_probs=120.3
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
.+..+++..++.++.||++||.|||+++ |+|+||||+||+++.++.+||+|||+++...... .......++..|+
T Consensus 92 ~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~ 166 (284)
T cd07839 92 CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--RCYSAEVVTLWYR 166 (284)
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC--CCcCCCccccCCc
Confidence 3567999999999999999999999998 9999999999999999999999999987653221 1122345678999
Q ss_pred chhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHH-----------HHhhhcCCcccccCccccC-
Q 046010 374 APEYALGGV-ISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYT-----------WKLWCNGEALELMDPVLKQ- 440 (523)
Q Consensus 374 aPE~l~~~~-~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~l~~- 440 (523)
|||.+.+.. ++.++||||||+++|+|++|+.|+...... ....... |............ +....
T Consensus 167 aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 243 (284)
T cd07839 167 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEESWPGVSKLPDYKPY-PMYPAT 243 (284)
T ss_pred ChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH--HHHHHHHHHHhCCCChHHhHHhhhccccccc-CCCCCc
Confidence 999887644 789999999999999999999886322111 1111111 1000000000000 00000
Q ss_pred ----CccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 441 ----SCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 441 ----~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.........+.+++.+||+.||.+|||++++++
T Consensus 244 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 244 TSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred chhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000112346678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.2e-24 Score=207.12 Aligned_cols=173 Identities=26% Similarity=0.283 Sum_probs=133.8
Q ss_pred eEeeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCC
Q 046010 278 AIWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGN 357 (523)
Q Consensus 278 ~~~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 357 (523)
+-+|..|-...++|...+..+++..++-++.+|+.||++||+.. ||+|||||+|||+|+.|+++|+|+|++..+...
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 34455677778999999999999999999999999999999998 999999999999999999999999999987644
Q ss_pred CCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCcc
Q 046010 358 QNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPV 437 (523)
Q Consensus 358 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (523)
+. ....+||.+|||||++.++.|+...|.|||||++|||+.|+.||...........+ .+...+ ..
T Consensus 341 ~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEv---drr~~~-~~------- 406 (591)
T KOG0986|consen 341 KP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEV---DRRTLE-DP------- 406 (591)
T ss_pred Cc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHH---HHHHhc-ch-------
Confidence 32 23458999999999999999999999999999999999999998643332221111 111110 00
Q ss_pred ccCCccHHHHHHHHHHhhhcccCCCCCCCCHH
Q 046010 438 LKQSCMAAELLKCIHIGLLCVQEDPADRPNMS 469 (523)
Q Consensus 438 l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ 469 (523)
..++..-..++..|....|+.||++|.-..
T Consensus 407 --~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 407 --EEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred --hhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 011122233556677788999999997544
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=206.63 Aligned_cols=165 Identities=27% Similarity=0.319 Sum_probs=125.4
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+++......... .....++..|+|
T Consensus 101 ~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~a 176 (270)
T cd05056 101 KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK-ASKGKLPIKWMA 176 (270)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccccccee-cCCCCccccccC
Confidence 446899999999999999999999998 9999999999999999999999999988654332111 112234567999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||.+....++.++||||||+++|++++ |..||...... ... .....+..... +......+.++
T Consensus 177 PE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~----~~~~~~~~~~~---------~~~~~~~~~~l 240 (270)
T cd05056 177 PESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVI----GRIENGERLPM---------PPNCPPTLYSL 240 (270)
T ss_pred hhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHH----HHHHcCCcCCC---------CCCCCHHHHHH
Confidence 999988889999999999999999996 99998533211 111 11111111110 11223467788
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
+.+||..+|++|||+.++++.|++..
T Consensus 241 i~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 241 MTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=7e-24 Score=214.53 Aligned_cols=161 Identities=23% Similarity=0.260 Sum_probs=119.9
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++......... ......+++.|+|
T Consensus 96 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~a 171 (330)
T cd05601 96 EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIA 171 (330)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCce-eeecccCCccccC
Confidence 467999999999999999999999998 999999999999999999999999999876432221 2223468899999
Q ss_pred hhhhc------CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 375 PEYAL------GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 375 PE~l~------~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
||++. ...++.++||||||+++|+|++|+.||...... ................+ ......
T Consensus 172 PE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~~~~-------~~~~~~ 238 (330)
T cd05601 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQRFLKFPE-------DPKVSS 238 (330)
T ss_pred HHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCCccCCCC-------CCCCCH
Confidence 99986 456789999999999999999999998532211 11111111111111110 011224
Q ss_pred HHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 449 KCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+.+|+..||+ +|++||++.++++
T Consensus 239 ~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 239 DFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 56678888997 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=203.38 Aligned_cols=161 Identities=27% Similarity=0.362 Sum_probs=123.1
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
.+..+++..++.++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||++........ ......++..|+
T Consensus 92 ~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~ 166 (256)
T cd06612 92 TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWM 166 (256)
T ss_pred CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccccccCCcccc
Confidence 4567999999999999999999999998 99999999999999999999999999886543221 222345788999
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
|||.+.+..++.++||||||+++|+|++|+.||........ ........ .+.+ ..+......+.++
T Consensus 167 ~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~-----~~~~--~~~~~~~~~~~~~ 232 (256)
T cd06612 167 APEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-------IFMIPNKP-----PPTL--SDPEKWSPEFNDF 232 (256)
T ss_pred CHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-------hhhhccCC-----CCCC--CchhhcCHHHHHH
Confidence 99999888899999999999999999999999853222110 00000000 0000 0111223467789
Q ss_pred hhhcccCCCCCCCCHHHHHH
Q 046010 454 GLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~ 473 (523)
+.+||+.||++|||+.||++
T Consensus 233 i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 233 VKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHHHHhcChhhCcCHHHHhc
Confidence 99999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=195.83 Aligned_cols=184 Identities=21% Similarity=0.243 Sum_probs=136.0
Q ss_pred CceeEeeeccccc-----cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCC---CCeeEe
Q 046010 275 GRKAIWIAIGTTI-----PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE---MNPKIS 346 (523)
Q Consensus 275 ~~~~~~ia~g~~~-----~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~---~~~kL~ 346 (523)
+++.++|.+.+.- ..+-......+++.++..|++||..|+.|||+.+ |.||||||+|+|.... -.+||+
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEec
Confidence 3556666654444 4444566677999999999999999999999998 9999999999999654 468999
Q ss_pred ccccceeccCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhh
Q 046010 347 DFGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWC 426 (523)
Q Consensus 347 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 426 (523)
|||+++.... .........|+.|.|||++....|+...|+||+||++|-|++|.+||..... ..+..-....+.
T Consensus 207 DfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg---~aispgMk~rI~ 280 (400)
T KOG0604|consen 207 DFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG---LAISPGMKRRIR 280 (400)
T ss_pred ccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC---ccCChhHHhHhh
Confidence 9999987432 2334456678999999999999999999999999999999999999854332 222222223333
Q ss_pred cCCcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 427 NGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 427 ~~~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+.. ++.++ .-....+...++|+.+|..+|.+|.|+.+++.
T Consensus 281 ~gqy-~FP~p-----EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 281 TGQY-EFPEP-----EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ccCc-cCCCh-----hHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 2221 11111 11123445678889999999999999999864
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=222.48 Aligned_cols=169 Identities=21% Similarity=0.248 Sum_probs=117.3
Q ss_pred cCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCchhh
Q 046010 298 LDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEY 377 (523)
Q Consensus 298 l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~ 377 (523)
....+++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++.+..... .......|+..|+|||+
T Consensus 264 ~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~ 339 (501)
T PHA03210 264 PLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEI 339 (501)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchh
Confidence 446778899999999999999998 99999999999999999999999999987643222 12224578999999999
Q ss_pred hcCCCCCcchhhHHHHHHHHHHHhCCCC-CCCcccccccchHHHHH-----------------HhhhcCCcc---cccCc
Q 046010 378 ALGGVISVKSDVFSFGVLLLEIISGKKN-SGFYLSEHGQSLLAYTW-----------------KLWCNGEAL---ELMDP 436 (523)
Q Consensus 378 l~~~~~s~ksDVwSlGvvl~elltG~~p-~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~---~~~~~ 436 (523)
+.+..++.++|||||||++|||++|+.+ +..........+..... ..+...... ..+.+
T Consensus 340 ~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~ 419 (501)
T PHA03210 340 LAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPP 419 (501)
T ss_pred hcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhh
Confidence 9999999999999999999999998854 32211111111111100 000000000 00000
Q ss_pred cccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 437 VLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 437 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+... .....+.+++.+||+.||++|||+.|+++
T Consensus 420 ~~~~~---~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 420 LIRNL---GLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHhc---CCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000 01234567788999999999999999976
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.7e-24 Score=219.58 Aligned_cols=168 Identities=26% Similarity=0.324 Sum_probs=127.1
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.....+++..+++++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++...............++..|
T Consensus 231 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y 307 (401)
T cd05107 231 NESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKW 307 (401)
T ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCce
Confidence 33457999999999999999999999998 999999999999999999999999999865332222222234567889
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
+|||.+.+..++.++||||||+++|||++ |+.||...... .........+.... .+......+.
T Consensus 308 ~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~------~~~~~~~~~~~~~~---------~p~~~~~~l~ 372 (401)
T cd05107 308 MAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN------EQFYNAIKRGYRMA---------KPAHASDEIY 372 (401)
T ss_pred eChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch------HHHHHHHHcCCCCC---------CCCCCCHHHH
Confidence 99999998889999999999999999998 88887532211 11111111111110 1111234677
Q ss_pred HHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 452 HIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+|+.+||+.+|.+||+++||++.|++.
T Consensus 373 ~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 373 EIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=211.16 Aligned_cols=178 Identities=19% Similarity=0.240 Sum_probs=127.6
Q ss_pred eEeeeccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 278 AIWIAIGTTI---PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 278 ~~~ia~g~~~---~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
.+|+++.+.- ......+...|++..+..++.+++.||..||+.| +|||||||+|+|||..|++||+|||++..+
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred eeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence 4555555444 1223466778999999999999999999999999 999999999999999999999999998543
Q ss_pred cCC---------------C-----CCcc-----c--------------------cceeccCCCCchhhhcCCCCCcchhh
Q 046010 355 GGN---------------Q-----NESN-----T--------------------SKVVGTYGYMAPEYALGGVISVKSDV 389 (523)
Q Consensus 355 ~~~---------------~-----~~~~-----~--------------------~~~~gt~~y~aPE~l~~~~~s~ksDV 389 (523)
... . .... . ...+||+-|+|||++.+..|+..+|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 210 0 0000 0 02469999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCcccccc-cchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCC-
Q 046010 390 FSFGVLLLEIISGKKNSGFYLSEHG-QSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPN- 467 (523)
Q Consensus 390 wSlGvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs- 467 (523)
||||||+||||.|.+||....+... ..++.| ...+..+. + .....+..+||.+|+. ||++|.-
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nw-r~~l~fP~-----~--------~~~s~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNW-RETLKFPE-----E--------VDLSDEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-hhhccCCC-----c--------CcccHHHHHHHHHHhc-CHHHhcCc
Confidence 9999999999999999965443322 112111 11111111 0 1111567788888888 9999975
Q ss_pred --HHHHHH
Q 046010 468 --MSSVAV 473 (523)
Q Consensus 468 --~~ei~~ 473 (523)
+.||.+
T Consensus 437 ~G~~EIK~ 444 (550)
T KOG0605|consen 437 KGAEEIKK 444 (550)
T ss_pred ccHHHHhc
Confidence 566543
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=203.76 Aligned_cols=158 Identities=34% Similarity=0.450 Sum_probs=121.0
Q ss_pred cCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCchhh
Q 046010 298 LDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEY 377 (523)
Q Consensus 298 l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~ 377 (523)
+++..++.++.||+.||++||+.+ ++|+||||+||+++.++.++|+|||.+........... ....++..|++||.
T Consensus 100 ~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~~Pe~ 175 (258)
T smart00219 100 LSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKK-KGGKLPIRWMAPES 175 (258)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccccccc-ccCCCcccccChHH
Confidence 999999999999999999999998 99999999999999999999999999987643322111 12236788999999
Q ss_pred hcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHhhh
Q 046010 378 ALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLL 456 (523)
Q Consensus 378 l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~~ 456 (523)
+.+..++.++||||||+++++|++ |..||.... ..... ........... +......+.+++.+
T Consensus 176 ~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~---~~~~~----~~~~~~~~~~~---------~~~~~~~~~~~i~~ 239 (258)
T smart00219 176 LKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS---NEEVL----EYLKKGYRLPK---------PENCPPEIYKLMLQ 239 (258)
T ss_pred hccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---HHHHH----HHHhcCCCCCC---------CCcCCHHHHHHHHH
Confidence 988889999999999999999998 677764311 11111 11111111111 11134467789999
Q ss_pred cccCCCCCCCCHHHHHHHh
Q 046010 457 CVQEDPADRPNMSSVAVML 475 (523)
Q Consensus 457 cl~~dP~~RPs~~ei~~~L 475 (523)
||..||++|||+.|++++|
T Consensus 240 ~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 240 CWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HCcCChhhCcCHHHHHhhC
Confidence 9999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.3e-23 Score=210.95 Aligned_cols=114 Identities=25% Similarity=0.335 Sum_probs=97.3
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC-----------
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE----------- 360 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~----------- 360 (523)
..++..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 92 l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~ 168 (363)
T cd05628 92 LMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLP 168 (363)
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccccccccccccccc
Confidence 345678999999999999999999999998 999999999999999999999999998754321100
Q ss_pred ----------------------ccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 046010 361 ----------------------SNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGF 408 (523)
Q Consensus 361 ----------------------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~ 408 (523)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 169 SDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 001234689999999999999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.6e-23 Score=211.42 Aligned_cols=171 Identities=26% Similarity=0.289 Sum_probs=122.2
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCchh
Q 046010 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPE 376 (523)
Q Consensus 297 ~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE 376 (523)
.+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||.++...... ......++..|+|||
T Consensus 114 ~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE 187 (353)
T cd07850 114 DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPE 187 (353)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCCCCC---CCCCCcccccccCHH
Confidence 3899999999999999999999998 9999999999999999999999999998653221 122345788999999
Q ss_pred hhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCccccccc------------chHH---HHHHhhhcCC-------ccccc
Q 046010 377 YALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQ------------SLLA---YTWKLWCNGE-------ALELM 434 (523)
Q Consensus 377 ~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~------------~~~~---~~~~~~~~~~-------~~~~~ 434 (523)
.+.+..++.++||||||+++|+|++|+.||......... .... .....+.... ..+.+
T Consensus 188 ~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (353)
T cd07850 188 VILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELF 267 (353)
T ss_pred HHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhC
Confidence 999999999999999999999999999998643211000 0000 0000000000 00011
Q ss_pred Cccc----cCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 435 DPVL----KQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 435 ~~~l----~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
...+ ...........+.+++.+||+.||++|||+.|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 268 PDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred cccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 00001123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.9e-23 Score=204.16 Aligned_cols=162 Identities=22% Similarity=0.278 Sum_probs=119.9
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.....+++..++.++.||++||.|||+.+ ++||||||+||+++.++.+||+|||++....... .......++..|
T Consensus 95 ~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y 169 (282)
T cd06643 95 ELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYW 169 (282)
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--cccccccccccc
Confidence 34567999999999999999999999998 9999999999999999999999999987643211 122335678899
Q ss_pred Cchhhhc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHH
Q 046010 373 MAPEYAL-----GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAEL 447 (523)
Q Consensus 373 ~aPE~l~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 447 (523)
+|||++. +..++.++||||||+++|+|++|+.||...... ...... .......... +....
T Consensus 170 ~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~-~~~~~~~~~~-------~~~~~ 235 (282)
T cd06643 170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM------RVLLKI-AKSEPPTLAQ-------PSRWS 235 (282)
T ss_pred cCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH------HHHHHH-hhcCCCCCCC-------ccccC
Confidence 9999874 345778999999999999999999997532211 111111 1111111111 11123
Q ss_pred HHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 448 LKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 448 ~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
..+.+++.+||+.||.+||++.+|++
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 236 SEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 46778999999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=204.54 Aligned_cols=156 Identities=22% Similarity=0.310 Sum_probs=116.6
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCC--------eeEeccccceeccCCCCCccccc
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMN--------PKISDFGMARIFGGNQNESNTSK 365 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~--------~kL~Dfg~a~~~~~~~~~~~~~~ 365 (523)
++..+++..++.++.||+.||.|||+++ |+||||||+||+++.++. ++++|||.+..... ...
T Consensus 93 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~------~~~ 163 (258)
T cd05078 93 NKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP------KEI 163 (258)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccccccCC------chh
Confidence 3447899999999999999999999998 999999999999987765 58999998765421 223
Q ss_pred eeccCCCCchhhhcCC-CCCcchhhHHHHHHHHHHHhCC-CCCCCcccccccchHHHHHHhhhcCCcccccCccccCCcc
Q 046010 366 VVGTYGYMAPEYALGG-VISVKSDVFSFGVLLLEIISGK-KNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCM 443 (523)
Q Consensus 366 ~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 443 (523)
..++..|+|||.+.+. .++.++||||||+++|+|++|. .|+...... .. ...... ... .+
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~------~~-~~~~~~--~~~---------~~ 225 (258)
T cd05078 164 LLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ------KK-LQFYED--RHQ---------LP 225 (258)
T ss_pred ccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH------HH-HHHHHc--ccc---------CC
Confidence 4567889999998764 5789999999999999999995 444321111 00 001110 000 11
Q ss_pred HHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhc
Q 046010 444 AAELLKCIHIGLLCVQEDPADRPNMSSVAVMLA 476 (523)
Q Consensus 444 ~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~ 476 (523)
.....++.+++.+||+.||++|||+++|++.|+
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 226 APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 112245778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-23 Score=206.49 Aligned_cols=173 Identities=25% Similarity=0.265 Sum_probs=119.1
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
+..+++..++.++.||++||.|||+++ ++|+||||+||+++.++.+||+|||++....... .......++..|+|
T Consensus 95 ~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~a 169 (285)
T cd07861 95 GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--RVYTHEVVTLWYRA 169 (285)
T ss_pred CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc--ccccCCcccccccC
Confidence 367999999999999999999999998 9999999999999999999999999987653221 11223356788999
Q ss_pred hhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchH--------HHHHHhhhc-----CCcccccCccccC
Q 046010 375 PEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLL--------AYTWKLWCN-----GEALELMDPVLKQ 440 (523)
Q Consensus 375 PE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~--------~~~~~~~~~-----~~~~~~~~~~l~~ 440 (523)
||.+.+. .++.++||||||+++|+|++|+.||............ ...|..+.. ..........+..
T Consensus 170 PE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (285)
T cd07861 170 PEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRS 249 (285)
T ss_pred hHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHH
Confidence 9988654 4788999999999999999999998532211000000 000000000 0000000000000
Q ss_pred CccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 441 SCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 441 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.......++.+++.+||+.||++|||+.+|++
T Consensus 250 -~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 250 -AVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred -hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00012345678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-24 Score=205.67 Aligned_cols=191 Identities=21% Similarity=0.224 Sum_probs=140.1
Q ss_pred CCceeEeeecc-ccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC-------------
Q 046010 274 KGRKAIWIAIG-TTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH------------- 339 (523)
Q Consensus 274 ~~~~~~~ia~g-~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~------------- 339 (523)
++..+++..+| +.++.+-.++-.+++...+..+..||++++++||+.+ ++|.||||+|||+..
T Consensus 164 ghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 164 GHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred CceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 45567777788 5557777777788999999999999999999999998 999999999999932
Q ss_pred -------CCCeeEeccccceeccCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccc
Q 046010 340 -------EMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSE 412 (523)
Q Consensus 340 -------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~ 412 (523)
+..+||+|||.+.... ......+.|..|+|||++.+..++..+||||+||||.|+.+|...|+.....
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~-----e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDH-----EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred ceeccCCCcceEEEecCCcceec-----cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 2348999999998642 2235678899999999999999999999999999999999999888654422
Q ss_pred cccchHHH--------------HHHhhhcCCcccccCccc----------------cCCccHHHHHHHHHHhhhcccCCC
Q 046010 413 HGQSLLAY--------------TWKLWCNGEALELMDPVL----------------KQSCMAAELLKCIHIGLLCVQEDP 462 (523)
Q Consensus 413 ~~~~~~~~--------------~~~~~~~~~~~~~~~~~l----------------~~~~~~~~~~~~~~li~~cl~~dP 462 (523)
+...+.+. ..+.+..+ ..+.-+... .......+..++.+|+..||..||
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 21111111 11111111 111000000 001123556679999999999999
Q ss_pred CCCCCHHHHHH
Q 046010 463 ADRPNMSSVAV 473 (523)
Q Consensus 463 ~~RPs~~ei~~ 473 (523)
.+|+|+.|++.
T Consensus 395 ~~RiTl~EAL~ 405 (415)
T KOG0671|consen 395 ARRITLREALS 405 (415)
T ss_pred cccccHHHHhc
Confidence 99999999864
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-23 Score=204.16 Aligned_cols=162 Identities=24% Similarity=0.256 Sum_probs=122.2
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..++..+++..+..++.||+.||.|||+++ |+|+||||+||++++++.+||+|||++....... .....++..
T Consensus 88 i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~ 160 (279)
T cd05633 88 LSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHG 160 (279)
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC----ccCcCCCcC
Confidence 345567999999999999999999999998 9999999999999999999999999987543221 223468899
Q ss_pred CCchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 372 YMAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 372 y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
|+|||.+.+ ..++.++||||||+++|+|++|..||......... ........ ... ..+......+
T Consensus 161 y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~~------~~~----~~~~~~~~~~ 226 (279)
T cd05633 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLT------VNV----ELPDSFSPEL 226 (279)
T ss_pred ccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH----HHHHHhhc------CCc----CCccccCHHH
Confidence 999998864 55889999999999999999999998643222111 11111000 001 1112233466
Q ss_pred HHHhhhcccCCCCCCC-----CHHHHHHH
Q 046010 451 IHIGLLCVQEDPADRP-----NMSSVAVM 474 (523)
Q Consensus 451 ~~li~~cl~~dP~~RP-----s~~ei~~~ 474 (523)
.+++.+||+.||++|| +++|+++.
T Consensus 227 ~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 227 KSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 7888999999999999 59888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-23 Score=214.39 Aligned_cols=170 Identities=23% Similarity=0.357 Sum_probs=132.0
Q ss_pred cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCC-CCeeEeccccceeccCCCCCccccce
Q 046010 288 PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE-MNPKISDFGMARIFGGNQNESNTSKV 366 (523)
Q Consensus 288 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~~~~~~~~~ 366 (523)
+..|..+-++++.+.+++|++||++||.|||++. +||||||||-+||||+.+ |.|||+|+|+|..... ......
T Consensus 130 Lr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~----s~aksv 204 (632)
T KOG0584|consen 130 LREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK----SHAKSV 204 (632)
T ss_pred HHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc----ccccee
Confidence 4578888999999999999999999999999995 689999999999999865 8899999999987532 222347
Q ss_pred eccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHH
Q 046010 367 VGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAE 446 (523)
Q Consensus 367 ~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 446 (523)
+||+.|||||.+. ..|++..||||||+.++||+|+..||.... +..+ ..+....+....-+.. -.
T Consensus 205 IGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-----n~AQ-IYKKV~SGiKP~sl~k--------V~ 269 (632)
T KOG0584|consen 205 IGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-----NPAQ-IYKKVTSGIKPAALSK--------VK 269 (632)
T ss_pred ccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-----CHHH-HHHHHHcCCCHHHhhc--------cC
Confidence 8999999999887 789999999999999999999999985332 2222 2233333332222221 11
Q ss_pred HHHHHHHhhhcccCCCCCCCCHHHHHH--HhccC
Q 046010 447 LLKCIHIGLLCVQEDPADRPNMSSVAV--MLASD 478 (523)
Q Consensus 447 ~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~~ 478 (523)
..++.+||.+||.. .++|||+.|+++ +|...
T Consensus 270 dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 270 DPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred CHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 23566788899999 999999999985 45554
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-23 Score=212.80 Aligned_cols=182 Identities=25% Similarity=0.281 Sum_probs=126.3
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCc-cccceeccCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES-NTSKVVGTYGY 372 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~gt~~y 372 (523)
+...+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++.......... ......++..|
T Consensus 99 ~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y 175 (336)
T cd07849 99 KTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWY 175 (336)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCc
Confidence 3457999999999999999999999998 9999999999999999999999999987654322111 12235678899
Q ss_pred CchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcC-----------Cccccc---Ccc
Q 046010 373 MAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNG-----------EALELM---DPV 437 (523)
Q Consensus 373 ~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~---~~~ 437 (523)
+|||.+.+ ..++.++||||||+++|+|++|+.||....... ............ ...+.+ ...
T Consensus 176 ~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (336)
T cd07849 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFK 252 (336)
T ss_pred cChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcC
Confidence 99998755 468899999999999999999999985322110 000000000000 000000 000
Q ss_pred ccCC---ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH--hccCCCC
Q 046010 438 LKQS---CMAAELLKCIHIGLLCVQEDPADRPNMSSVAVM--LASDTVS 481 (523)
Q Consensus 438 l~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~--L~~~~~~ 481 (523)
.... ........+.+++.+||+.+|++|||+.|+++. |+.....
T Consensus 253 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 253 PKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred CcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 0000 001123467899999999999999999999886 6655433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-23 Score=202.60 Aligned_cols=172 Identities=26% Similarity=0.385 Sum_probs=129.6
Q ss_pred ccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcc
Q 046010 283 IGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN 362 (523)
Q Consensus 283 ~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 362 (523)
.|....++-......+++..++.++.|++++|.|||+.+ ++|+||+|+||+++.++.+||+|||.+........ .
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~ 157 (256)
T cd08221 83 GGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--M 157 (256)
T ss_pred CCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc--c
Confidence 344444443344567999999999999999999999998 99999999999999999999999999987643321 2
Q ss_pred ccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCc
Q 046010 363 TSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSC 442 (523)
Q Consensus 363 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 442 (523)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||..... ....... ..+.....
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~-~~~~~~~~--------- 221 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKI-VQGNYTPV--------- 221 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHH-HcCCCCCC---------
Confidence 2345678999999999888889999999999999999999999853221 1111111 11111111
Q ss_pred cHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHh
Q 046010 443 MAAELLKCIHIGLLCVQEDPADRPNMSSVAVML 475 (523)
Q Consensus 443 ~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L 475 (523)
.......+.+++.+||+.+|++||++.++++.+
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 112234677889999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-23 Score=210.14 Aligned_cols=177 Identities=22% Similarity=0.331 Sum_probs=135.4
Q ss_pred eEeeeccccc----cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 278 AIWIAIGTTI----PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 278 ~~~ia~g~~~----~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
.+||-+.+|- +-++..-+..|.+.++..+++|++.||.|||++. |||||||..|||+.-+|.++|+|||.+..
T Consensus 103 kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAK 179 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAK 179 (1187)
T ss_pred ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeeccccccc
Confidence 4666666665 5666777889999999999999999999999998 99999999999999999999999999865
Q ss_pred ccCCCCCccccceeccCCCCchhhhc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcC
Q 046010 354 FGGNQNESNTSKVVGTYGYMAPEYAL-----GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNG 428 (523)
Q Consensus 354 ~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 428 (523)
.. ........++||+.|||||+.+ ..+|+.++||||||++|.||..+.+|.....+ .. +.-.+...
T Consensus 180 n~--~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp------MR-VllKiaKS 250 (1187)
T KOG0579|consen 180 NK--STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP------MR-VLLKIAKS 250 (1187)
T ss_pred ch--hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch------HH-HHHHHhhc
Confidence 32 2223345689999999999874 57799999999999999999999988532211 11 11111222
Q ss_pred CcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 429 EALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 429 ~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+...++.| ..-...+-+++.+||..||..||++.+|++
T Consensus 251 ePPTLlqP-------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 251 EPPTLLQP-------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred CCCcccCc-------chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 22223222 223345678888999999999999998864
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.6e-23 Score=204.72 Aligned_cols=159 Identities=25% Similarity=0.317 Sum_probs=121.2
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++.+++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||.+........ ......++..|+||
T Consensus 111 ~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aP 185 (296)
T cd06654 111 TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAP 185 (296)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc--ccCcccCCccccCH
Confidence 46899999999999999999999998 99999999999999999999999999876432211 12234678899999
Q ss_pred hhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHhh
Q 046010 376 EYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGL 455 (523)
Q Consensus 376 E~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~ 455 (523)
|.+.+..++.++||||||+++|+|++|+.||...... ........... ... ..+......+.+++.
T Consensus 186 E~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~------~~~~~~~~~~~-~~~-------~~~~~~~~~l~~li~ 251 (296)
T cd06654 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGT-PEL-------QNPEKLSAIFRDFLN 251 (296)
T ss_pred HHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH------HhHHHHhcCCC-CCC-------CCccccCHHHHHHHH
Confidence 9998888999999999999999999999998532211 01011111110 000 011122345778999
Q ss_pred hcccCCCCCCCCHHHHHH
Q 046010 456 LCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 456 ~cl~~dP~~RPs~~ei~~ 473 (523)
+||..+|++||++.||++
T Consensus 252 ~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 252 RCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred HHCcCCcccCcCHHHHhh
Confidence 999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-23 Score=207.65 Aligned_cols=166 Identities=22% Similarity=0.313 Sum_probs=131.3
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeC-CCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLD-HEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
+....|.++.+.+++.||+.|+.|+|+.. +|||||||+|+.+. +-|.+||.|||++..+... .......|++.
T Consensus 110 KHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG---~kL~TsCGSLA 183 (864)
T KOG4717|consen 110 KHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG---KKLTTSCGSLA 183 (864)
T ss_pred hhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc---chhhcccchhh
Confidence 44567999999999999999999999987 99999999998765 5688999999999877533 33456789999
Q ss_pred CCchhhhcCCCCC-cchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 372 YMAPEYALGGVIS-VKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 372 y~aPE~l~~~~~s-~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
|.|||++.+..|. ++.||||||||||.|++|+.||+.....+. +.-++|-. -..+.....++
T Consensus 184 YSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImDCK--YtvPshvS~eC 246 (864)
T KOG4717|consen 184 YSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMDCK--YTVPSHVSKEC 246 (864)
T ss_pred ccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhccc--ccCchhhhHHH
Confidence 9999999999886 689999999999999999999964332211 11122221 12344556788
Q ss_pred HHHhhhcccCCCCCCCCHHHHHH--HhccCCCC
Q 046010 451 IHIGLLCVQEDPADRPNMSSVAV--MLASDTVS 481 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~~--~L~~~~~~ 481 (523)
.+||..||..||++|.+.+||+. +|+.....
T Consensus 247 rdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 247 RDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred HHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 89999999999999999999964 56555433
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.3e-23 Score=211.39 Aligned_cols=163 Identities=20% Similarity=0.218 Sum_probs=120.6
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
+..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........ .......|++.|+|
T Consensus 136 ~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~-~~~~~~~gt~~y~a 211 (370)
T cd05596 136 NYDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGTPDYIS 211 (370)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-ccCCCCCCCcCeEC
Confidence 346899999999999999999999998 99999999999999999999999999986532211 12234568999999
Q ss_pred hhhhcCC----CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 375 PEYALGG----VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 375 PE~l~~~----~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
||.+.+. .++.++|||||||++|||++|+.||..... .................+ .......+
T Consensus 212 PE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~~~~~~~-------~~~~s~~~ 278 (370)
T cd05596 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMDHKNSLTFPD-------DIEISKQA 278 (370)
T ss_pred HHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCCCcCCCCC-------cCCCCHHH
Confidence 9998653 478999999999999999999999853221 111111111111111110 01123466
Q ss_pred HHHhhhcccCCCCC--CCCHHHHHHH
Q 046010 451 IHIGLLCVQEDPAD--RPNMSSVAVM 474 (523)
Q Consensus 451 ~~li~~cl~~dP~~--RPs~~ei~~~ 474 (523)
.+++.+||+.+|++ ||++.|+++.
T Consensus 279 ~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 279 KDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHHHHHccChhhccCCCCHHHHhcC
Confidence 78888999999988 9999999653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.5e-23 Score=199.85 Aligned_cols=164 Identities=24% Similarity=0.340 Sum_probs=122.8
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
..+..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||.+....... .......++..|
T Consensus 93 ~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y 167 (262)
T cd06613 93 VTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AKRKSFIGTPYW 167 (262)
T ss_pred hhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--hccccccCCccc
Confidence 33467999999999999999999999998 9999999999999999999999999987653221 112234677889
Q ss_pred CchhhhcCC---CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 373 MAPEYALGG---VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 373 ~aPE~l~~~---~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
++||.+.+. .++.++||||||+++|+|++|+.||....... .. ... .... .....+. ........
T Consensus 168 ~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--~~----~~~-~~~~---~~~~~~~--~~~~~~~~ 235 (262)
T cd06613 168 MAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--AL----FLI-SKSN---FPPPKLK--DKEKWSPV 235 (262)
T ss_pred cCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HH----HHH-Hhcc---CCCcccc--chhhhhHH
Confidence 999998776 78899999999999999999999985322111 01 011 0000 0000111 12233456
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHH
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+.+++.+||+.+|.+|||+.+|+.
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhc
Confidence 789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.6e-23 Score=203.00 Aligned_cols=161 Identities=22% Similarity=0.309 Sum_probs=121.5
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
+..+++..++.++.||+.||.|||+++ |+||||||+||++++++.+||+|||++....... .......++..|+|
T Consensus 112 ~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~a 186 (292)
T cd06658 112 HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRKSLVGTPYWMA 186 (292)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCceeecCccccC
Confidence 346899999999999999999999998 9999999999999999999999999987543221 12234567889999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
||.+.+..++.++||||||+++|||++|+.||...... .... .... .+.+.+.. .......+.+++
T Consensus 187 PE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~----~~~~-----~~~~~~~~--~~~~~~~~~~li 252 (292)
T cd06658 187 PEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL---QAMR----RIRD-----NLPPRVKD--SHKVSSVLRGFL 252 (292)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHHh-----cCCCcccc--ccccCHHHHHHH
Confidence 99998888999999999999999999999998532211 1111 1111 00111111 011223566788
Q ss_pred hhcccCCCCCCCCHHHHHHH
Q 046010 455 LLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~~ 474 (523)
.+||+.||++|||++||++.
T Consensus 253 ~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 253 DLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHccCChhHCcCHHHHhhC
Confidence 89999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.9e-23 Score=201.51 Aligned_cols=162 Identities=25% Similarity=0.379 Sum_probs=122.9
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCc----cccceec
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES----NTSKVVG 368 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~----~~~~~~g 368 (523)
.+...+++..+..++.|++.||+|||+++ ++|+||+|+||+++.++.+||+|||.++......... ......+
T Consensus 98 ~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~ 174 (267)
T cd06628 98 NNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQG 174 (267)
T ss_pred HhccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCC
Confidence 44467899999999999999999999998 9999999999999999999999999988664221111 1123457
Q ss_pred cCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 369 TYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 369 t~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
+..|+|||.+.+..++.++||||||+++|+|++|+.||..... ........ .. ..+. .+.....
T Consensus 175 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-~~-----~~~~----~~~~~~~ 238 (267)
T cd06628 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ------LQAIFKIG-EN-----ASPE----IPSNISS 238 (267)
T ss_pred CcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH------HHHHHHHh-cc-----CCCc----CCcccCH
Confidence 8899999999888899999999999999999999999853211 11111110 10 1111 1112335
Q ss_pred HHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 449 KCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+.+++.+||+.||.+||++.||++
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 239 EAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHHHHHHHccCCchhCcCHHHHhh
Confidence 6678889999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-23 Score=207.86 Aligned_cols=180 Identities=21% Similarity=0.240 Sum_probs=123.1
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
.+..+++..++.++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||++....... .......++..|+
T Consensus 97 ~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~ 171 (301)
T cd07873 97 CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTYSNEVVTLWYR 171 (301)
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--Ccccccceeeccc
Confidence 3456899999999999999999999998 9999999999999999999999999987543221 1122345678999
Q ss_pred chhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchH--------HHHHHhhhcCCcc-cccCccccCC--
Q 046010 374 APEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLL--------AYTWKLWCNGEAL-ELMDPVLKQS-- 441 (523)
Q Consensus 374 aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~~-~~~~~~l~~~-- 441 (523)
|||.+.+ ..++.++||||||+++|+|++|+.||............ ...|..+...... ..-.+.....
T Consensus 172 ~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (301)
T cd07873 172 PPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCL 251 (301)
T ss_pred CcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccH
Confidence 9998865 44788999999999999999999998643221100000 0011111100000 0000000000
Q ss_pred --ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH--HhccC
Q 046010 442 --CMAAELLKCIHIGLLCVQEDPADRPNMSSVAV--MLASD 478 (523)
Q Consensus 442 --~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~~ 478 (523)
........+.+|+.+||+.||.+|||+.|+++ .++..
T Consensus 252 ~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 252 HNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred HhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 00111235678999999999999999999987 44443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.3e-23 Score=212.51 Aligned_cols=164 Identities=21% Similarity=0.234 Sum_probs=118.7
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCc-----------
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES----------- 361 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~----------- 361 (523)
.++..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+.......
T Consensus 93 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~ 169 (364)
T cd05599 93 MKKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169 (364)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccc
Confidence 34567999999999999999999999998 9999999999999999999999999987543211100
Q ss_pred -------------------------cccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccc
Q 046010 362 -------------------------NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQS 416 (523)
Q Consensus 362 -------------------------~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~ 416 (523)
......||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~---- 245 (364)
T cd05599 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQ---- 245 (364)
T ss_pred cccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHH----
Confidence 001235899999999999989999999999999999999999998533211
Q ss_pred hHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCC---HHHHHH
Q 046010 417 LLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPN---MSSVAV 473 (523)
Q Consensus 417 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs---~~ei~~ 473 (523)
.................. . .....+.+++.+|+. +|.+|++ +.|+++
T Consensus 246 --~~~~~i~~~~~~~~~~~~-~------~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 246 --ETYRKIINWKETLQFPDE-V------PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred --HHHHHHHcCCCccCCCCC-C------CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 111111110110011000 0 112345677778886 9999998 777765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.2e-23 Score=207.39 Aligned_cols=122 Identities=20% Similarity=0.239 Sum_probs=94.8
Q ss_pred cccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC---
Q 046010 284 GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE--- 360 (523)
Q Consensus 284 g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~--- 360 (523)
|....++.......+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+++.||+...........
T Consensus 84 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 84 GSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred CcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 33333333333456999999999999999999999998 999999999999999999999999865433211110
Q ss_pred --ccccceeccCCCCchhhhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 046010 361 --SNTSKVVGTYGYMAPEYALG--GVISVKSDVFSFGVLLLEIISGKKNSGF 408 (523)
Q Consensus 361 --~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvvl~elltG~~p~~~ 408 (523)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 01122345678999999876 4588999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=203.45 Aligned_cols=181 Identities=19% Similarity=0.197 Sum_probs=123.2
Q ss_pred cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCC-----Ccc
Q 046010 288 PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQN-----ESN 362 (523)
Q Consensus 288 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-----~~~ 362 (523)
.++.......+++..+..++.||++||.|||+++ |+|+||||+||+++.++.+||+||+.+........ ...
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence 3343334556899999999999999999999998 99999999999999999999999998875432111 111
Q ss_pred ccceeccCCCCchhhhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhh-----------hcCC
Q 046010 363 TSKVVGTYGYMAPEYALG--GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLW-----------CNGE 429 (523)
Q Consensus 363 ~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~ 429 (523)
.....++..|+|||.+.. ..++.++||||||+++|+|++|+.||....... ...+...... ....
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYEDS 242 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhcCC
Confidence 223456778999999876 358899999999999999999999986432111 1111000000 0000
Q ss_pred ccc----ccCccc----cCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 430 ALE----LMDPVL----KQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 430 ~~~----~~~~~l----~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
..+ ..++.. ...........+.+++.+||+.||++|||++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000 000000 00111122346778999999999999999999876
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-23 Score=205.20 Aligned_cols=175 Identities=23% Similarity=0.302 Sum_probs=125.5
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+...+++..++.++.||+.||.|||+++ ++|+||+|+||++++++.+||+|||++........ .......++..
T Consensus 91 ~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~ 166 (288)
T cd07833 91 EASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPLTDYVATRW 166 (288)
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccccCcccccC
Confidence 445566999999999999999999999998 99999999999999999999999999887643322 12233567788
Q ss_pred CCchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHH-----------hhhcCC------cccc
Q 046010 372 YMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWK-----------LWCNGE------ALEL 433 (523)
Q Consensus 372 y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~-----------~~~~~~------~~~~ 433 (523)
|+|||++.+. .++.++||||||+++|+|++|+.||....... .+..... .+.... ..+.
T Consensus 167 ~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (288)
T cd07833 167 YRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID---QLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEP 243 (288)
T ss_pred CcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHhhhcccCccccccccCCC
Confidence 9999999887 78999999999999999999999885332111 1100000 000000 0000
Q ss_pred cCc-cccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 434 MDP-VLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 434 ~~~-~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.++ .+....+......+.+++.+||+.+|++||++++|++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 244 SQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 0000111122467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4e-23 Score=204.12 Aligned_cols=176 Identities=21% Similarity=0.279 Sum_probs=122.6
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.+...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++........ ......++..|
T Consensus 92 ~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~ 166 (286)
T cd07847 92 KNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWY 166 (286)
T ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc--cccCccccccc
Confidence 34457999999999999999999999998 99999999999999999999999999987643221 12234567889
Q ss_pred CchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHH--------HHHhhhcCCcc-cccCccccCCc
Q 046010 373 MAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAY--------TWKLWCNGEAL-ELMDPVLKQSC 442 (523)
Q Consensus 373 ~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~-~~~~~~l~~~~ 442 (523)
+|||.+.+ ..++.++||||||+++|+|++|+.||......+....... ....+...... ....+......
T Consensus 167 ~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (286)
T cd07847 167 RAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETRE 246 (286)
T ss_pred CCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCccccc
Confidence 99999876 5578999999999999999999999864322111000000 00000000000 00000000000
Q ss_pred c-----HHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 443 M-----AAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 443 ~-----~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+ ......+.+++.+||+.+|++||++.|++.
T Consensus 247 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 247 PLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 012356778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.5e-23 Score=203.30 Aligned_cols=174 Identities=23% Similarity=0.263 Sum_probs=124.2
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+...+++..++.++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||.+....... .......++..
T Consensus 89 ~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~ 163 (283)
T cd05118 89 KDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYTHYVVTRW 163 (283)
T ss_pred HhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccccCccCccc
Confidence 344468999999999999999999999998 9999999999999999999999999998764432 11223456778
Q ss_pred CCchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcC---Cccc-----------ccCc
Q 046010 372 YMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNG---EALE-----------LMDP 436 (523)
Q Consensus 372 y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~-----------~~~~ 436 (523)
|+|||.+.+. .++.++||||||+++|+|++|+.||....... ............ .... ....
T Consensus 164 ~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05118 164 YRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID---QLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKK 240 (283)
T ss_pred ccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCchHhcccchhhhhhhhhhhccc
Confidence 9999998776 78999999999999999999999885332211 000000000000 0000 0000
Q ss_pred cc--cCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 437 VL--KQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 437 ~l--~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.. ..........++.+++.+||+.||.+||++.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 241 AGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred cccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00 00011223467889999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-23 Score=189.76 Aligned_cols=172 Identities=25% Similarity=0.317 Sum_probs=137.2
Q ss_pred eEeeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCC
Q 046010 278 AIWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGN 357 (523)
Q Consensus 278 ~~~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 357 (523)
..+.+.|..+..+...+..++++.....++.|++.||.|+|.+. +|||||||+|+|++.++.+||+|||.+..-.
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 34444677777777778899999999999999999999999998 9999999999999999999999999998643
Q ss_pred CCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCcc
Q 046010 358 QNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPV 437 (523)
Q Consensus 358 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (523)
........||.-|.|||...+...+.+.|+|++|++.||++.|.+||+..... ...+.+.. .++..+
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-------etYkrI~k---~~~~~p- 242 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-------ETYKRIRK---VDLKFP- 242 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-------HHHHHHHH---ccccCC-
Confidence 22344678999999999999999999999999999999999999999643311 11111111 111111
Q ss_pred ccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 438 LKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 438 l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
......+.++|.+|+..+|.+|....|+++
T Consensus 243 ------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 243 ------STISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ------cccChhHHHHHHHHhccCccccccHHHHhh
Confidence 122345668889999999999999999875
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-23 Score=203.04 Aligned_cols=161 Identities=25% Similarity=0.341 Sum_probs=117.4
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCC-CccccceeccCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQN-ESNTSKVVGTYGY 372 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~~gt~~y 372 (523)
+...+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++........ ........++..|
T Consensus 99 ~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y 175 (266)
T cd06651 99 AYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175 (266)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccc
Confidence 4456899999999999999999999998 99999999999999999999999999875432111 1112234578899
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
+|||.+.+..++.++||||||+++|+|++|+.||..... ............ .+.+ +......+.+
T Consensus 176 ~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~~~-----~~~~----~~~~~~~~~~ 240 (266)
T cd06651 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQPT-----NPQL----PSHISEHARD 240 (266)
T ss_pred cCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcCCC-----CCCC----chhcCHHHHH
Confidence 999999888899999999999999999999999853211 111111111110 1111 1111223334
Q ss_pred HhhhcccCCCCCCCCHHHHHH
Q 046010 453 IGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~ 473 (523)
++ +||..+|++||+++||++
T Consensus 241 li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 241 FL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HH-HHhcCChhhCcCHHHHhc
Confidence 44 688899999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-23 Score=202.82 Aligned_cols=158 Identities=28% Similarity=0.399 Sum_probs=122.1
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.||++||.|||+++ ++|+||+|+||++++++.++|+|||++....... .......++..|+|
T Consensus 95 ~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~a 169 (277)
T cd06642 95 PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMA 169 (277)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc--hhhhcccCcccccC
Confidence 356899999999999999999999998 9999999999999999999999999987654221 11223457888999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
||.+.+..++.++||||||+++|+|++|+.|+...... .... ...... .+. ........+.+++
T Consensus 170 PE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~----~~~~~~-----~~~----~~~~~~~~~~~li 233 (277)
T cd06642 170 PEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM---RVLF----LIPKNS-----PPT----LEGQYSKPFKEFV 233 (277)
T ss_pred HHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh---hHHh----hhhcCC-----CCC----CCcccCHHHHHHH
Confidence 99999888999999999999999999999997532211 0000 011111 111 1112345677899
Q ss_pred hhcccCCCCCCCCHHHHHH
Q 046010 455 LLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~ 473 (523)
.+||+.+|++||++.+|++
T Consensus 234 ~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 234 EACLNKDPRFRPTAKELLK 252 (277)
T ss_pred HHHccCCcccCcCHHHHHH
Confidence 9999999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-23 Score=203.90 Aligned_cols=165 Identities=25% Similarity=0.390 Sum_probs=124.2
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcc-ccceeccCCCC
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN-TSKVVGTYGYM 373 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~ 373 (523)
...+++.+++.++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||.+........... .....++..|+
T Consensus 100 ~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~ 176 (267)
T cd05066 100 DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 176 (267)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeec
Confidence 456899999999999999999999998 99999999999999999999999999987643222111 11122345799
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
+||.+.+..++.++||||||+++|++++ |..||...... .... ....... . .........+.+
T Consensus 177 ~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~----~~~~~~~--~-------~~~~~~~~~~~~ 240 (267)
T cd05066 177 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIK----AIEEGYR--L-------PAPMDCPAALHQ 240 (267)
T ss_pred CHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHH----HHhCCCc--C-------CCCCCCCHHHHH
Confidence 9999998889999999999999999886 99997532211 1111 1111110 0 001122346678
Q ss_pred HhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 453 IGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
++.+||+.+|.+||++.+|++.|++.
T Consensus 241 li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 241 LMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHcccCchhCCCHHHHHHHHHhh
Confidence 99999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-23 Score=201.10 Aligned_cols=159 Identities=26% Similarity=0.305 Sum_probs=124.4
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHH-----hcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceecc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLH-----EDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH-----~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt 369 (523)
..++++..++.++.||++||.||| +.+ ++|+||||+||+++.++.+||+|||++........ ......++
T Consensus 99 ~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~ 173 (265)
T cd08217 99 RKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS--FAKTYVGT 173 (265)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccccccccCCcc--cccccccC
Confidence 567999999999999999999999 776 99999999999999999999999999987643221 12234678
Q ss_pred CCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 370 ~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ... ......+... ..+......
T Consensus 174 ~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~----~~~~~~~~~~---------~~~~~~~~~ 237 (265)
T cd08217 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQL----ASKIKEGKFR---------RIPYRYSSE 237 (265)
T ss_pred CCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHH----HHHHhcCCCC---------CCccccCHH
Confidence 899999999988899999999999999999999999864321 111 1111111111 111223456
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
+.+++.+||+.+|++||++.+|++.
T Consensus 238 ~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 238 LNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHHHccCCcccCCCHHHHhhC
Confidence 7889999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=8e-23 Score=204.77 Aligned_cols=176 Identities=24% Similarity=0.346 Sum_probs=122.1
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHh-cCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHE-DSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTY 370 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~ 370 (523)
..+...+++..+..++.||++||.|||+ .+ ++|+||||+||+++.++.+||+|||++...... ......++.
T Consensus 90 l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~ 162 (308)
T cd06615 90 LKKAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTR 162 (308)
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc----ccccCCCCc
Confidence 3445679999999999999999999997 46 999999999999999999999999998754221 123356788
Q ss_pred CCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCc-----------------ccc
Q 046010 371 GYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEA-----------------LEL 433 (523)
Q Consensus 371 ~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~ 433 (523)
.|+|||.+.+..++.++||||||+++|+|++|+.||........................ .+.
T Consensus 163 ~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (308)
T cd06615 163 SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFEL 242 (308)
T ss_pred CccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHH
Confidence 999999998888999999999999999999999998532211100000000000000000 000
Q ss_pred cCcccc---CCcc-HHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 434 MDPVLK---QSCM-AAELLKCIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 434 ~~~~l~---~~~~-~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
.+.... ...+ ......+.+++.+||+.+|++||++.+|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 243 LDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred HHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 0000 0123357789999999999999999998765
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=210.20 Aligned_cols=167 Identities=22% Similarity=0.282 Sum_probs=117.5
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC-----------
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE----------- 360 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~----------- 360 (523)
..+...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+......
T Consensus 92 l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~ 168 (381)
T cd05626 92 LIRMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQ 168 (381)
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccc
Confidence 345567999999999999999999999998 999999999999999999999999987543110000
Q ss_pred ----------------------------------ccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 046010 361 ----------------------------------SNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNS 406 (523)
Q Consensus 361 ----------------------------------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~ 406 (523)
.......||..|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf 248 (381)
T cd05626 169 DSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPF 248 (381)
T ss_pred cccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCC
Confidence 0011346899999999999888999999999999999999999998
Q ss_pred CCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHhhh--cccCCCCCCCCHHHHHHH
Q 046010 407 GFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLL--CVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~~--cl~~dP~~RPs~~ei~~~ 474 (523)
....... .............. ... ......+.+++.+ |+..+|..||++.||++.
T Consensus 249 ~~~~~~~------~~~~i~~~~~~~~~-~~~------~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 249 LAPTPTE------TQLKVINWENTLHI-PPQ------VKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred cCCCHHH------HHHHHHccccccCC-CCC------CCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 6432211 11111110000000 000 0112244455555 566777779999999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=202.03 Aligned_cols=162 Identities=23% Similarity=0.287 Sum_probs=119.9
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.....+++..++.++.||+.+|.|||+.+ ++||||||+||+++.++.+||+|||++....... .......++..|
T Consensus 102 ~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y 176 (292)
T cd06644 102 ELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QRRDSFIGTPYW 176 (292)
T ss_pred hhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--cccceecCCccc
Confidence 34567999999999999999999999998 9999999999999999999999999887543221 122345678899
Q ss_pred Cchhhhc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHH
Q 046010 373 MAPEYAL-----GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAEL 447 (523)
Q Consensus 373 ~aPE~l~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 447 (523)
+|||.+. ...++.++||||||+++|+|++|+.||...... ..... ........... +....
T Consensus 177 ~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~-~~~~~~~~~~~-------~~~~~ 242 (292)
T cd06644 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLK-IAKSEPPTLSQ-------PSKWS 242 (292)
T ss_pred cCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHH-HhcCCCccCCC-------CcccC
Confidence 9999874 345678999999999999999999997532211 11111 11111111100 11223
Q ss_pred HHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 448 LKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 448 ~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
..+.+++.+||+.+|++||++.+|++
T Consensus 243 ~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 243 MEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 45778899999999999999999865
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=198.68 Aligned_cols=164 Identities=20% Similarity=0.280 Sum_probs=120.7
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.+...+++.+++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++...... ........++..|
T Consensus 98 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y 172 (267)
T cd06645 98 HVTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIGTPYW 172 (267)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc--ccccccccCcccc
Confidence 44567999999999999999999999998 999999999999999999999999998765321 1222345688999
Q ss_pred Cchhhhc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 373 MAPEYAL---GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 373 ~aPE~l~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
+|||.+. ...++.++||||||+++|+|++|+.||....... .. ................. .....
T Consensus 173 ~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--~~----~~~~~~~~~~~~~~~~~------~~~~~ 240 (267)
T cd06645 173 MAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--AL----FLMTKSNFQPPKLKDKM------KWSNS 240 (267)
T ss_pred cChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--hH----HhhhccCCCCCcccccC------CCCHH
Confidence 9999874 4568899999999999999999999974322111 01 11100100000000000 11235
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHH
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+.+++.+||+.+|++||++++|++
T Consensus 241 ~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 241 FHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhc
Confidence 678899999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-23 Score=203.47 Aligned_cols=157 Identities=28% Similarity=0.392 Sum_probs=121.8
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCchh
Q 046010 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPE 376 (523)
Q Consensus 297 ~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE 376 (523)
++++..++.++.||+.||.|||+++ ++|+||+|+||++++++.++|+|||++....... .......++..|+|||
T Consensus 94 ~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE 168 (274)
T cd06609 94 KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRNTFVGTPFWMAPE 168 (274)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc--cccccccCCccccChh
Confidence 7999999999999999999999998 9999999999999999999999999998764322 1223456788899999
Q ss_pred hhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHhhh
Q 046010 377 YALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLL 456 (523)
Q Consensus 377 ~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~~ 456 (523)
.+.+..++.++||||||+++|+|++|+.||...... .. . ............. . .....+.+++.+
T Consensus 169 ~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~---~~---~-~~~~~~~~~~~~~-----~---~~~~~~~~~l~~ 233 (274)
T cd06609 169 VIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM---RV---L-FLIPKNNPPSLEG-----N---KFSKPFKDFVSL 233 (274)
T ss_pred hhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH---HH---H-HHhhhcCCCCCcc-----c---ccCHHHHHHHHH
Confidence 999888999999999999999999999998532211 11 1 1111111111111 0 023356788999
Q ss_pred cccCCCCCCCCHHHHHH
Q 046010 457 CVQEDPADRPNMSSVAV 473 (523)
Q Consensus 457 cl~~dP~~RPs~~ei~~ 473 (523)
||+.+|++||+++++++
T Consensus 234 ~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 234 CLNKDPKERPSAKELLK 250 (274)
T ss_pred HhhCChhhCcCHHHHhh
Confidence 99999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.4e-23 Score=204.29 Aligned_cols=175 Identities=23% Similarity=0.268 Sum_probs=122.7
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
....+++..++.++.||++||.|||+++ ++|+||||+||+++.++.+||+|||.+....... .......++..|+
T Consensus 99 ~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~ 173 (293)
T cd07843 99 MKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL--KPYTQLVVTLWYR 173 (293)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc--ccccccccccccc
Confidence 3446999999999999999999999998 9999999999999999999999999988764322 1122345678899
Q ss_pred chhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcccccccchH--------HHHHHhhhc------CCcccccCccc
Q 046010 374 APEYALGGV-ISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLL--------AYTWKLWCN------GEALELMDPVL 438 (523)
Q Consensus 374 aPE~l~~~~-~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~--------~~~~~~~~~------~~~~~~~~~~l 438 (523)
|||.+.+.. ++.++||||||+++|+|++|+.||...........+ ...|..+.. ..........+
T Consensus 174 aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (293)
T cd07843 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQL 253 (293)
T ss_pred CchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhh
Confidence 999887644 688999999999999999999998643221110000 001111100 00000101111
Q ss_pred cCCccHH-HHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 439 KQSCMAA-ELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 439 ~~~~~~~-~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
....+.. ....+.+++.+||+.||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 254 RKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 1111111 2445678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-23 Score=209.48 Aligned_cols=177 Identities=27% Similarity=0.286 Sum_probs=125.5
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||++....... .......++..
T Consensus 99 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~ 173 (337)
T cd07858 99 IRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRW 173 (337)
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCCCc--ccccccccccC
Confidence 345567999999999999999999999998 9999999999999999999999999998653321 11223456889
Q ss_pred CCchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhh-----------hcCCccccc-----
Q 046010 372 YMAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLW-----------CNGEALELM----- 434 (523)
Q Consensus 372 y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~----- 434 (523)
|+|||.+.. ..++.++||||||+++|+|++|+.||...... .......... ......+.+
T Consensus 174 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (337)
T cd07858 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV---HQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPY 250 (337)
T ss_pred ccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCc
Confidence 999998865 46889999999999999999999998543211 0111000000 000000000
Q ss_pred --CccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH--hcc
Q 046010 435 --DPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVM--LAS 477 (523)
Q Consensus 435 --~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~--L~~ 477 (523)
+..... ........+.+++.+||+.+|++|||++|+++. |+.
T Consensus 251 ~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 251 TPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred ccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 000000 011234567899999999999999999999765 544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=202.08 Aligned_cols=161 Identities=19% Similarity=0.281 Sum_probs=122.0
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||++........ ......++..|+|
T Consensus 111 ~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~a 185 (297)
T cd06659 111 QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMA 185 (297)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccceecCccccC
Confidence 356899999999999999999999998 99999999999999999999999999875432211 1223567889999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
||.+.+..++.++||||||+++|+|++|+.||...... .... .+..... ..... .......+.+++
T Consensus 186 PE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~-~~~~~~~-~~~~~------~~~~~~~l~~~i 251 (297)
T cd06659 186 PEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV------QAMK-RLRDSPP-PKLKN------AHKISPVLRDFL 251 (297)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHH-HHhccCC-CCccc------cCCCCHHHHHHH
Confidence 99999888999999999999999999999998532211 1111 1111110 00000 011123567888
Q ss_pred hhcccCCCCCCCCHHHHHHH
Q 046010 455 LLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~~ 474 (523)
.+||+.+|++||++++|++.
T Consensus 252 ~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 252 ERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHhcCCcccCcCHHHHhhC
Confidence 99999999999999999883
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.9e-23 Score=205.95 Aligned_cols=178 Identities=22% Similarity=0.310 Sum_probs=121.5
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC--ccccceeccC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE--SNTSKVVGTY 370 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~--~~~~~~~gt~ 370 (523)
.....+++.+++.++.||++||.|||+++ ++|+||||+||+++.++.+||+|||++......... .......++.
T Consensus 111 ~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 187 (310)
T cd07865 111 NKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187 (310)
T ss_pred hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCc
Confidence 34457999999999999999999999998 999999999999999999999999999765432211 1122345678
Q ss_pred CCCchhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCC-----cccccCc-cccCCc-
Q 046010 371 GYMAPEYALGGV-ISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGE-----ALELMDP-VLKQSC- 442 (523)
Q Consensus 371 ~y~aPE~l~~~~-~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~-~l~~~~- 442 (523)
.|+|||.+.+.. ++.++||||||+++|+|++|+.||...........+........... ..+..+. .+....
T Consensus 188 ~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (310)
T cd07865 188 WYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQK 267 (310)
T ss_pred cccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccc
Confidence 899999887644 68899999999999999999998854332111111111100000000 0000000 000000
Q ss_pred --------cHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 443 --------MAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 443 --------~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.......+.+++.+||+.||.+|||++|+++
T Consensus 268 ~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 268 RKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0011235568999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-23 Score=203.37 Aligned_cols=162 Identities=23% Similarity=0.299 Sum_probs=122.4
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCchh
Q 046010 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPE 376 (523)
Q Consensus 297 ~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE 376 (523)
.+++..++.++.||+.||+|||+++ |+|+||||+||+++.++.++|+|||++....... ........++..|+|||
T Consensus 113 ~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE 188 (275)
T cd05046 113 PLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE-YYKLRNALIPLRWLAPE 188 (275)
T ss_pred CCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcccccccccCccc-ccccCCceeEEeecChh
Confidence 6999999999999999999999998 9999999999999999999999999987542211 11222345667899999
Q ss_pred hhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHhh
Q 046010 377 YALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGL 455 (523)
Q Consensus 377 ~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~ 455 (523)
.+.+...+.++||||||+++|+|++ |..||..... ... ......+...... .......+.+++.
T Consensus 189 ~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~----~~~~~~~~~~~~~--------~~~~~~~l~~~i~ 253 (275)
T cd05046 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEV----LNRLQAGKLELPV--------PEGCPSRLYKLMT 253 (275)
T ss_pred hhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHH----HHHHHcCCcCCCC--------CCCCCHHHHHHHH
Confidence 9988888999999999999999999 6777742211 111 1111111111100 1112346778999
Q ss_pred hcccCCCCCCCCHHHHHHHhcc
Q 046010 456 LCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 456 ~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
+||+.+|++||++.|+++.|++
T Consensus 254 ~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 254 RCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred HHcCCCcccCCCHHHHHHHhcC
Confidence 9999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=199.23 Aligned_cols=159 Identities=23% Similarity=0.289 Sum_probs=120.9
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC-CeeEeccccceeccCCCCCccccceeccCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM-NPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
.++..+++.+++.++.||++||.|||+.+ ++|+||||+||+++.++ .++|+|||.+...... ....++..
T Consensus 101 ~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~ 171 (267)
T PHA03390 101 KKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------SCYDGTLD 171 (267)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------ccCCCCCc
Confidence 34458999999999999999999999998 99999999999999998 9999999998765322 12357889
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||.+.+..++.++||||||+++|+|++|+.||....... .....+... . . ..... .......+.
T Consensus 172 y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~-~-~-~~~~~---------~~~~~~~~~ 238 (267)
T PHA03390 172 YFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKR-Q-Q-KKLPF---------IKNVSKNAN 238 (267)
T ss_pred ccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHh-h-c-ccCCc---------ccccCHHHH
Confidence 999999998889999999999999999999999986322211 111111111 1 1 00011 112334677
Q ss_pred HHhhhcccCCCCCCCC-HHHHHH
Q 046010 452 HIGLLCVQEDPADRPN-MSSVAV 473 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs-~~ei~~ 473 (523)
+++.+||+.+|.+||+ ++|+++
T Consensus 239 ~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 239 DFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHhccChhhCCchHHHHhc
Confidence 8889999999999996 588763
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.4e-23 Score=206.31 Aligned_cols=175 Identities=23% Similarity=0.273 Sum_probs=122.1
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC----CCCeeEeccccceeccCCCC-CccccceeccC
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH----EMNPKISDFGMARIFGGNQN-ESNTSKVVGTY 370 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~----~~~~kL~Dfg~a~~~~~~~~-~~~~~~~~gt~ 370 (523)
..+++..++.++.||+.||.|||+++ |+||||||+||+++. ++.+||+|||++........ ........++.
T Consensus 103 ~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 179 (316)
T cd07842 103 VSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI 179 (316)
T ss_pred cCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccc
Confidence 47899999999999999999999998 999999999999999 89999999999886543222 11223456788
Q ss_pred CCCchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCccccccc------chHHHHHHhhh------------cCCcc
Q 046010 371 GYMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQ------SLLAYTWKLWC------------NGEAL 431 (523)
Q Consensus 371 ~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~------~~~~~~~~~~~------------~~~~~ 431 (523)
.|+|||.+.+. .++.++||||||+++|+|++|+.||......... .........+. ..+..
T Consensus 180 ~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 259 (316)
T cd07842 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYD 259 (316)
T ss_pred cccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccch
Confidence 99999988764 5789999999999999999999998644332210 00000000000 00000
Q ss_pred ccc----CccccCCccH-------HHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 432 ELM----DPVLKQSCMA-------AELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 432 ~~~----~~~l~~~~~~-------~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
... .......... ....++.+++.+||+.||++|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 260 TLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred hhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 0000000000 12346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.6e-23 Score=201.17 Aligned_cols=166 Identities=22% Similarity=0.311 Sum_probs=121.3
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.++..+++..+..++.|+++||.|||+.+ |+|+||||+||+++.++.+||+|||++....... .......++..|
T Consensus 98 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y 172 (267)
T cd06646 98 HVTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI--AKRKSFIGTPYW 172 (267)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc--cccCccccCccc
Confidence 34567999999999999999999999998 9999999999999999999999999998653221 112234678899
Q ss_pred Cchhhhc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 373 MAPEYAL---GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 373 ~aPE~l~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
+|||.+. ...++.++||||||+++|+|++|+.||.......... .+.... ...+.... .......
T Consensus 173 ~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~~---~~~~~~~~--~~~~~~~ 240 (267)
T cd06646 173 MAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKSN---FQPPKLKD--KTKWSST 240 (267)
T ss_pred cCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecCC---CCCCCCcc--ccccCHH
Confidence 9999874 3457889999999999999999999974222111000 000000 00010100 1112346
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHHHh
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAVML 475 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~~L 475 (523)
+.+++.+||+.+|++||++++|++.|
T Consensus 241 ~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 241 FHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 77899999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=202.19 Aligned_cols=160 Identities=24% Similarity=0.322 Sum_probs=121.0
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
+..+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........ ......++..|+|
T Consensus 109 ~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~a 183 (296)
T cd06655 109 ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMA 183 (296)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc--cCCCcCCCccccC
Confidence 346899999999999999999999998 99999999999999999999999999876533221 1223467889999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
||.+.+..++.++||||||+++|+|++|+.||...... .......... ...... +......+.+++
T Consensus 184 PE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~------~~~~~~~~~~-~~~~~~-------~~~~~~~~~~li 249 (296)
T cd06655 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------RALYLIATNG-TPELQN-------PEKLSPIFRDFL 249 (296)
T ss_pred cchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcC-CcccCC-------cccCCHHHHHHH
Confidence 99998888999999999999999999999998532211 1111111111 000000 111223566888
Q ss_pred hhcccCCCCCCCCHHHHHH
Q 046010 455 LLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~ 473 (523)
.+||+.||++||++.+|+.
T Consensus 250 ~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 250 NRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHHhhcChhhCCCHHHHhh
Confidence 9999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=200.17 Aligned_cols=163 Identities=24% Similarity=0.300 Sum_probs=121.3
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
..+..+++..++.++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++........ ......++..|
T Consensus 116 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y 190 (286)
T cd06638 116 KRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFW 190 (286)
T ss_pred ccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceeecccCCC--ccccccCCCcc
Confidence 34567999999999999999999999998 99999999999999999999999999886542211 22234688999
Q ss_pred CchhhhcC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHH
Q 046010 373 MAPEYALG-----GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAEL 447 (523)
Q Consensus 373 ~aPE~l~~-----~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 447 (523)
+|||.+.. ..++.++||||||+++|+|++|+.||...... ..... ...........+ ....
T Consensus 191 ~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~------~~~~~-~~~~~~~~~~~~-------~~~~ 256 (286)
T cd06638 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM------RALFK-IPRNPPPTLHQP-------ELWS 256 (286)
T ss_pred cChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh------HHHhh-ccccCCCcccCC-------CCcC
Confidence 99998753 44788999999999999999999998532211 00000 011111111111 1112
Q ss_pred HHHHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 448 LKCIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 448 ~~~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
..+.+++.+||+.||++|||+.||++.
T Consensus 257 ~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 257 NEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 357789999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=233.94 Aligned_cols=175 Identities=25% Similarity=0.472 Sum_probs=134.2
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCchh
Q 046010 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPE 376 (523)
Q Consensus 297 ~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE 376 (523)
.++|.++.+++.||++||+|||......|+||||||+||+++.++..++. |+....... .....++..|+|||
T Consensus 776 ~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE 848 (968)
T PLN00113 776 NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPE 848 (968)
T ss_pred cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcc
Confidence 48999999999999999999995433349999999999999998888775 554433211 11235788999999
Q ss_pred hhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccC--CccHHHHHHHHHHh
Q 046010 377 YALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQ--SCMAAELLKCIHIG 454 (523)
Q Consensus 377 ~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~--~~~~~~~~~~~~li 454 (523)
++.+..++.++|||||||++|||++|+.||..... ....+..+.+...........+++.+.. ....++..++.+++
T Consensus 849 ~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 927 (968)
T PLN00113 849 TRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLA 927 (968)
T ss_pred cccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHH
Confidence 99999999999999999999999999999853222 2234445544444444444555555533 23456677889999
Q ss_pred hhcccCCCCCCCCHHHHHHHhccCC
Q 046010 455 LLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
.+||+.||++||+++||+++|++..
T Consensus 928 ~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 928 LHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred HhhCcCCchhCcCHHHHHHHHHHhh
Confidence 9999999999999999999998763
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-24 Score=225.63 Aligned_cols=178 Identities=22% Similarity=0.375 Sum_probs=142.6
Q ss_pred eeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCC
Q 046010 280 WIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQN 359 (523)
Q Consensus 280 ~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 359 (523)
||..|.+-..+- .+..++++.+..-++++|+.||+||-+.+ +|||||..+|||++.+..+|++|||+++.+.++..
T Consensus 711 yMENGsLDsFLR-~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 711 YMENGSLDSFLR-QNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhhCCcHHHHHh-hcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 344565554444 34466999999999999999999999998 99999999999999999999999999998754442
Q ss_pred Cccccce--eccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCc
Q 046010 360 ESNTSKV--VGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDP 436 (523)
Q Consensus 360 ~~~~~~~--~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (523)
...+.. .-..+|.|||.+....++.++||||||+++||.++ |.+||=. |.+.++..-++.
T Consensus 787 -~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd----------------mSNQdVIkaIe~ 849 (996)
T KOG0196|consen 787 -AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD----------------MSNQDVIKAIEQ 849 (996)
T ss_pred -ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc----------------cchHHHHHHHHh
Confidence 222222 12468999999999999999999999999999886 8888621 122233344455
Q ss_pred cccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 437 VLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 437 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
..+...+.+++..+.+||+.|||+|-.+||++.+|+..|.+.
T Consensus 850 gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 850 GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 556666778889999999999999999999999999999875
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=208.00 Aligned_cols=163 Identities=19% Similarity=0.213 Sum_probs=117.2
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
+..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....... ........||+.|+|
T Consensus 136 ~~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~a 211 (370)
T cd05621 136 NYDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVRCDTAVGTPDYIS 211 (370)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCC-ceecccCCCCcccCC
Confidence 346899999999999999999999998 9999999999999999999999999998753221 112234578999999
Q ss_pred hhhhcCC----CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 375 PEYALGG----VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 375 PE~l~~~----~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
||++.+. .++.++||||||+++|+|++|+.||..... .................. .......+
T Consensus 212 PE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~~~p~-------~~~~s~~~ 278 (370)
T cd05621 212 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTYSKIMDHKNSLNFPE-------DVEISKHA 278 (370)
T ss_pred HHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCcccCCCC-------cccCCHHH
Confidence 9998753 378899999999999999999999853221 111111111111111100 01112345
Q ss_pred HHHhhhcccCCCCC--CCCHHHHHHH
Q 046010 451 IHIGLLCVQEDPAD--RPNMSSVAVM 474 (523)
Q Consensus 451 ~~li~~cl~~dP~~--RPs~~ei~~~ 474 (523)
.+++..||+.++.+ |+++.|+++.
T Consensus 279 ~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 279 KNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHHHHHccCchhccCCCCHHHHhcC
Confidence 56777788755543 8899998775
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-22 Score=200.84 Aligned_cols=171 Identities=23% Similarity=0.244 Sum_probs=120.8
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..++.++.||++||.|||+++ |+|+||||+||+++.++.+||+|||++........ ......++..|+||
T Consensus 97 ~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aP 171 (298)
T cd07841 97 IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR--KMTHQVVTRWYRAP 171 (298)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCCc--cccccccceeeeCH
Confidence 37999999999999999999999998 99999999999999999999999999987643221 12233457789999
Q ss_pred hhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcC---------CcccccCccccCCc---
Q 046010 376 EYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNG---------EALELMDPVLKQSC--- 442 (523)
Q Consensus 376 E~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~~~--- 442 (523)
|.+.+ ..++.++||||||+++|+|++|..+|...... ............. ..............
T Consensus 172 E~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
T cd07841 172 ELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI---DQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLK 248 (298)
T ss_pred HHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH---HHHHHHHHHcCCCchhhhhhcccccccccccccCCcchh
Confidence 98865 45789999999999999999997776432211 1111111000000 00000000000011
Q ss_pred --cHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 443 --MAAELLKCIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 443 --~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
.......+.+++.+||+.||++|||+.||++.
T Consensus 249 ~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 249 QIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 11224567899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.7e-23 Score=201.81 Aligned_cols=157 Identities=22% Similarity=0.324 Sum_probs=116.5
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC-------CeeEeccccceeccCCCCCccccc
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM-------NPKISDFGMARIFGGNQNESNTSK 365 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~-------~~kL~Dfg~a~~~~~~~~~~~~~~ 365 (523)
..+..+++..+..++.||++||+|||+++ |+||||||+||+++..+ .+|++|||.+...... ..
T Consensus 109 ~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~ 179 (274)
T cd05076 109 KEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EE 179 (274)
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccCccceeeecCCccccccccc------cc
Confidence 34567899999999999999999999998 99999999999997654 3799999987643211 12
Q ss_pred eeccCCCCchhhhcC-CCCCcchhhHHHHHHHHHHH-hCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCcc
Q 046010 366 VVGTYGYMAPEYALG-GVISVKSDVFSFGVLLLEII-SGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCM 443 (523)
Q Consensus 366 ~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~ell-tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 443 (523)
..++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||....... ... ...... . +..
T Consensus 180 ~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~----~~~~~~--~-----~~~--- 242 (274)
T cd05076 180 RVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE---KER----FYEKKH--R-----LPE--- 242 (274)
T ss_pred cccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH---HHH----HHHhcc--C-----CCC---
Confidence 346778999998865 56899999999999999995 6888875322111 111 000000 0 000
Q ss_pred HHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhc
Q 046010 444 AAELLKCIHIGLLCVQEDPADRPNMSSVAVMLA 476 (523)
Q Consensus 444 ~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~ 476 (523)
.....+.+++.+||+.+|++|||+.+|++.|+
T Consensus 243 -~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 243 -PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11235778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.7e-23 Score=201.97 Aligned_cols=172 Identities=22% Similarity=0.287 Sum_probs=122.1
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.||++||+|||+.+ ++|+||||+||++++++.+||+|||.+........ .......++..|+|
T Consensus 94 ~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~ 169 (287)
T cd07840 94 EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-ADYTNRVITLWYRP 169 (287)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-ccccccccccccCC
Confidence 357999999999999999999999998 99999999999999999999999999987643321 11223456778999
Q ss_pred hhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcC---Cc--------------ccccCc
Q 046010 375 PEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNG---EA--------------LELMDP 436 (523)
Q Consensus 375 PE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~--------------~~~~~~ 436 (523)
||.+.+ ..++.++||||||+++|+|++|+.||........ ........... .. ......
T Consensus 170 PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (287)
T cd07840 170 PELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---LEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKR 246 (287)
T ss_pred ceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchhhccccccchhhhhccccccchh
Confidence 997765 4578999999999999999999999864332111 11111100000 00 000000
Q ss_pred cccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 437 VLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 437 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+...........+++++.+||+.+|++||+++++++
T Consensus 247 ~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 247 RLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred HHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000112456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-22 Score=202.61 Aligned_cols=163 Identities=20% Similarity=0.197 Sum_probs=121.4
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC------------
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE------------ 360 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~------------ 360 (523)
.....+++..++.++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 95 ~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~ 171 (316)
T cd05574 95 QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171 (316)
T ss_pred CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccc
Confidence 34567999999999999999999999998 999999999999999999999999998754321110
Q ss_pred ---------------ccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhh
Q 046010 361 ---------------SNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLW 425 (523)
Q Consensus 361 ---------------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 425 (523)
.......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... .......
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~------~~~~~~~ 245 (316)
T cd05574 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD------ETFSNIL 245 (316)
T ss_pred cccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH------HHHHHHh
Confidence 0112346788999999999888999999999999999999999998532211 0111111
Q ss_pred hcCCcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCC----HHHHHH
Q 046010 426 CNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPN----MSSVAV 473 (523)
Q Consensus 426 ~~~~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs----~~ei~~ 473 (523)
.. .. ...........+.+++.+||+.||++||+ +.|++.
T Consensus 246 ~~-~~--------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 246 KK-EV--------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred cC-Cc--------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 11 00 00001113456788999999999999999 666655
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=188.44 Aligned_cols=131 Identities=30% Similarity=0.456 Sum_probs=109.5
Q ss_pred CCceeEeeeccccccccc-------cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCC----CC
Q 046010 274 KGRKAIWIAIGTTIPTIY-------STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE----MN 342 (523)
Q Consensus 274 ~~~~~~~ia~g~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~----~~ 342 (523)
++.+.+|+...+..-.++ ..+.+.++...+..|+-||+.|+.|||++. |+||||||.|||+..+ |.
T Consensus 98 ~~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~ 174 (438)
T KOG0666|consen 98 SHDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGR 174 (438)
T ss_pred ccCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCe
Confidence 346788888887774333 344568999999999999999999999999 9999999999999877 89
Q ss_pred eeEeccccceeccCCCCCc-cccceeccCCCCchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCC
Q 046010 343 PKISDFGMARIFGGNQNES-NTSKVVGTYGYMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSG 407 (523)
Q Consensus 343 ~kL~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~ 407 (523)
+||+|||+++.+...-... .....+-|..|+|||++.+. .|+.+.|||+.|||+.||++-++.|.
T Consensus 175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 9999999999875433222 34456789999999999885 59999999999999999999887765
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-23 Score=211.71 Aligned_cols=180 Identities=23% Similarity=0.362 Sum_probs=143.8
Q ss_pred eEeeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCC
Q 046010 278 AIWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGN 357 (523)
Q Consensus 278 ~~~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 357 (523)
..||..|-+++++-.-.+..++-...+.++.||..||+||..++ +|||||-..|+|+.++..+|++|||+++.+..+
T Consensus 342 TEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred EecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 45566677777777778888999999999999999999999998 999999999999999999999999999987544
Q ss_pred CCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCc
Q 046010 358 QNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDP 436 (523)
Q Consensus 358 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (523)
.....- ...-.+.|.|||-+....++.|+|||+|||+|||+.| |..||.. .++ ..+ .+++..
T Consensus 419 TYTAHA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG------idl-SqV---------Y~LLEk 481 (1157)
T KOG4278|consen 419 TYTAHA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG------IDL-SQV---------YGLLEK 481 (1157)
T ss_pred ceeccc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC------ccH-HHH---------HHHHhc
Confidence 332221 1122568999999999999999999999999999998 6677642 222 122 233344
Q ss_pred cccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhcc
Q 046010 437 VLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 437 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
..+.+.+..++.++.+||+.||+++|.+||++.||-+.|+.
T Consensus 482 gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 482 GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 44555566778899999999999999999999999777654
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=198.14 Aligned_cols=163 Identities=28% Similarity=0.432 Sum_probs=122.6
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCc--cccceeccCCCC
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES--NTSKVVGTYGYM 373 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~ 373 (523)
..+++..++.++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||++.......... ......++..|+
T Consensus 97 ~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~ 173 (267)
T cd06610 97 GGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWM 173 (267)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhc
Confidence 56999999999999999999999998 9999999999999999999999999987664332221 223446788999
Q ss_pred chhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCc-cHHHHHHHH
Q 046010 374 APEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSC-MAAELLKCI 451 (523)
Q Consensus 374 aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~~~ 451 (523)
+||.+... .++.++|+||||+++|+|++|+.||...... ......... .. +.+.... .......+.
T Consensus 174 ~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~~~~~-~~-----~~~~~~~~~~~~~~~~~ 241 (267)
T cd06610 174 APEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM------KVLMLTLQN-DP-----PSLETGADYKKYSKSFR 241 (267)
T ss_pred ChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh------hhHHHHhcC-CC-----CCcCCccccccccHHHH
Confidence 99998876 7899999999999999999999998533221 111111111 00 0111100 012235677
Q ss_pred HHhhhcccCCCCCCCCHHHHHH
Q 046010 452 HIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+++.+||+.||++||++.+|++
T Consensus 242 ~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 242 KMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred HHHHHHcCCChhhCcCHHHHhh
Confidence 8999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.5e-23 Score=199.85 Aligned_cols=160 Identities=22% Similarity=0.324 Sum_probs=123.1
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.....+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||.+........ ......++..|
T Consensus 93 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~ 167 (256)
T cd08218 93 QRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYY 167 (256)
T ss_pred ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh--hhhhccCCccc
Confidence 34456899999999999999999999998 99999999999999999999999999976543211 12234578889
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
+|||.+.+...+.++|+||||+++++|++|+.||..... ....... ..+.... .+......+.+
T Consensus 168 ~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~-~~~~~~~---------~~~~~~~~~~~ 231 (256)
T cd08218 168 LSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKI-IRGSYPP---------VSSHYSYDLRN 231 (256)
T ss_pred cCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHH-hcCCCCC---------CcccCCHHHHH
Confidence 999999888899999999999999999999999753211 1111111 1111111 11122346778
Q ss_pred HhhhcccCCCCCCCCHHHHHH
Q 046010 453 IGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~ 473 (523)
++.+||+.+|++||++.+|++
T Consensus 232 li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 232 LVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred HHHHHhhCChhhCcCHHHHhh
Confidence 999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-22 Score=199.97 Aligned_cols=161 Identities=25% Similarity=0.293 Sum_probs=120.3
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........ ......++..|+
T Consensus 121 ~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~ 195 (291)
T cd06639 121 CGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWM 195 (291)
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccchhcccccc--cccCccCCcccc
Confidence 4567999999999999999999999998 99999999999999999999999999876532221 122345788999
Q ss_pred chhhhcCCC-----CCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 374 APEYALGGV-----ISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 374 aPE~l~~~~-----~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
|||.+.... ++.++||||||+++|+|++|+.||...... ..... +.......+.+ +.....
T Consensus 196 aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~------~~~~~-~~~~~~~~~~~-------~~~~~~ 261 (291)
T cd06639 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV------KTLFK-IPRNPPPTLLH-------PEKWCR 261 (291)
T ss_pred ChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH------HHHHH-HhcCCCCCCCc-------ccccCH
Confidence 999876433 678999999999999999999998532211 11111 11111111111 112234
Q ss_pred HHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 449 KCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+.+++.+||+.+|++||++.||++
T Consensus 262 ~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 262 SFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHHHHHHhhcChhhCcCHHHHhc
Confidence 5778999999999999999999876
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=198.66 Aligned_cols=161 Identities=28% Similarity=0.404 Sum_probs=122.0
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHh-cCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 296 AQLDWKRRISIINGIARGLLYLHE-DSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~-~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
..+++..+..++.||++||.|||+ .+ ++|+||||+||+++.++.+||+|||.+....... .....++..|+|
T Consensus 95 ~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~y~~ 167 (265)
T cd06605 95 GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL----AKTFVGTSSYMA 167 (265)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH----hhcccCChhccC
Confidence 679999999999999999999999 87 9999999999999999999999999987553211 112567889999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
||.+.+..++.++||||||+++|+|++|+.||...... .......... +....... +.. ......+.+++
T Consensus 168 PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~-~~~~~~~~-----~~~---~~~~~~~~~li 237 (265)
T cd06605 168 PERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQY-IVNEPPPR-----LPS---GKFSPDFQDFV 237 (265)
T ss_pred HHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHH-HhcCCCCC-----CCh---hhcCHHHHHHH
Confidence 99999889999999999999999999999998643221 1111111111 11111111 110 01334577889
Q ss_pred hhcccCCCCCCCCHHHHHH
Q 046010 455 LLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~ 473 (523)
.+||+.||++|||+.+++.
T Consensus 238 ~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 238 NLCLIKDPRERPSYKELLE 256 (265)
T ss_pred HHHcCCCchhCcCHHHHhh
Confidence 9999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-22 Score=209.88 Aligned_cols=165 Identities=20% Similarity=0.220 Sum_probs=117.0
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC------------
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE------------ 360 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~------------ 360 (523)
.+.+.+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 93 ~~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~ 169 (377)
T cd05629 93 IKYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSN 169 (377)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccccccccccccccccc
Confidence 34567999999999999999999999998 999999999999999999999999998643211000
Q ss_pred c---------------------------------cccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 046010 361 S---------------------------------NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSG 407 (523)
Q Consensus 361 ~---------------------------------~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~ 407 (523)
. ......||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~ 249 (377)
T cd05629 170 KNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFC 249 (377)
T ss_pred ccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCC
Confidence 0 0012468999999999998899999999999999999999999985
Q ss_pred CcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHhhhcccCCCCCC---CCHHHHHHH
Q 046010 408 FYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADR---PNMSSVAVM 474 (523)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~R---Ps~~ei~~~ 474 (523)
..... .. ............+.+. ......+.+++.+||+ +|.+| +++.|+++.
T Consensus 250 ~~~~~---~~---~~~i~~~~~~~~~p~~-------~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 250 SENSH---ET---YRKIINWRETLYFPDD-------IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred CCCHH---HH---HHHHHccCCccCCCCC-------CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 32211 11 1111110011111000 0112345677788887 67765 588887764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.1e-23 Score=199.30 Aligned_cols=164 Identities=28% Similarity=0.388 Sum_probs=122.6
Q ss_pred cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC-CeeEeccccceeccCCCCCccccce
Q 046010 288 PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM-NPKISDFGMARIFGGNQNESNTSKV 366 (523)
Q Consensus 288 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~ 366 (523)
.++.......+++..++.++.|++++|.|||+++ ++|+||||+||+++.++ .+||+|||.+....... .....
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~---~~~~~ 161 (256)
T cd08220 88 EYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS---KAYTV 161 (256)
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc---ccccc
Confidence 3333333556899999999999999999999998 99999999999998654 57999999998764322 12234
Q ss_pred eccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHH
Q 046010 367 VGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAE 446 (523)
Q Consensus 367 ~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 446 (523)
.++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .. .... ........ +...
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~---~~~~-~~~~~~~~---------~~~~ 225 (256)
T cd08220 162 VGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---AL---VLKI-MSGTFAPI---------SDRY 225 (256)
T ss_pred ccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HH---HHHH-HhcCCCCC---------CCCc
Confidence 6788999999998888899999999999999999999997532211 11 1111 11111111 1112
Q ss_pred HHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 447 LLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 447 ~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
...+.+++.+||+.+|++|||+.|+++
T Consensus 226 ~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 226 SPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 345778899999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.7e-23 Score=210.77 Aligned_cols=165 Identities=21% Similarity=0.258 Sum_probs=116.3
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCC-------------
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQN------------- 359 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~------------- 359 (523)
.+...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 93 ~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~ 169 (376)
T cd05598 93 IRLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQD 169 (376)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccc
Confidence 44567899999999999999999999998 99999999999999999999999999753210000
Q ss_pred ----------------------------CccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 046010 360 ----------------------------ESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLS 411 (523)
Q Consensus 360 ----------------------------~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~ 411 (523)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 249 (376)
T cd05598 170 SMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTP 249 (376)
T ss_pred cccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCH
Confidence 0001124689999999999999999999999999999999999999864322
Q ss_pred ccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCC---CHHHHHHH
Q 046010 412 EHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRP---NMSSVAVM 474 (523)
Q Consensus 412 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RP---s~~ei~~~ 474 (523)
.. .............. .. .. .....+.+++.+|+ .+|.+|+ ++.|+++.
T Consensus 250 ~~------~~~~i~~~~~~~~~-~~--~~----~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 250 AE------TQLKVINWETTLHI-PS--QA----KLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred HH------HHHHHhccCccccC-CC--CC----CCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 11 11111100000000 00 00 11223445666665 4999999 78888654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-23 Score=205.81 Aligned_cols=177 Identities=21% Similarity=0.284 Sum_probs=141.7
Q ss_pred CceeEeeeccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccc
Q 046010 275 GRKAIWIAIGTTI---PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA 351 (523)
Q Consensus 275 ~~~~~~ia~g~~~---~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 351 (523)
..+.+||-+..|. .|...++++.++.....-++..+++|++|||+++ ||+|||||+|++++.+|-+||.|||++
T Consensus 491 d~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFA 567 (732)
T KOG0614|consen 491 DSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFA 567 (732)
T ss_pred cchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhH
Confidence 3457888888888 5566889999999999999999999999999999 999999999999999999999999999
Q ss_pred eeccCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcc
Q 046010 352 RIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEAL 431 (523)
Q Consensus 352 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (523)
+.++. ...+..+.||+.|.|||++.+...+.++|.||||+++|||++|.+||...++....+++-.....+
T Consensus 568 Kki~~---g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i------ 638 (732)
T KOG0614|consen 568 KKIGS---GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI------ 638 (732)
T ss_pred HHhcc---CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh------
Confidence 98753 334567899999999999999999999999999999999999999997555443333222111111
Q ss_pred cccCccccCCccHHHHHHHHHHhhhcccCCCCCCCC-----HHHHH
Q 046010 432 ELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPN-----MSSVA 472 (523)
Q Consensus 432 ~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~ei~ 472 (523)
+ .+........+|+++....+|.+|.- +.+|.
T Consensus 639 ~---------~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIk 675 (732)
T KOG0614|consen 639 E---------FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIK 675 (732)
T ss_pred h---------cccccchhHHHHHHHHHhcCcHhhhccccCChHHHH
Confidence 1 11222345667888888999999976 55553
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=200.65 Aligned_cols=170 Identities=23% Similarity=0.265 Sum_probs=121.0
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
+...+++..++.++.||+.||+|||+++ ++|+||||+||+++. +.+||+|||.+....... ......++..|+
T Consensus 93 ~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~ 165 (282)
T cd07831 93 RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP---PYTEYISTRWYR 165 (282)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC---CcCCCCCCcccC
Confidence 3457999999999999999999999998 999999999999999 999999999998653222 112345688999
Q ss_pred chhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHH-----------HHhhhcCCcccccCccccC-
Q 046010 374 APEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYT-----------WKLWCNGEALELMDPVLKQ- 440 (523)
Q Consensus 374 aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~l~~- 440 (523)
|||.+.. ..++.++||||||+++|||++|..||....... ..... ..............+....
T Consensus 166 aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (282)
T cd07831 166 APECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGT 242 (282)
T ss_pred ChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhcccccccccCcccccc
Confidence 9997654 557889999999999999999999985432211 11111 0111111101100000000
Q ss_pred ---CccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 441 ---SCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 441 ---~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.........+.+++.+||+.+|++||+++++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 243 GLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 001123567889999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-23 Score=214.24 Aligned_cols=178 Identities=25% Similarity=0.316 Sum_probs=145.0
Q ss_pred eEeeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCC
Q 046010 278 AIWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGN 357 (523)
Q Consensus 278 ~~~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 357 (523)
..+..+|++++.+....+..|.......++.||+.||.||..+. +|||||-..|+++.....+||+|||+.+.++.+
T Consensus 189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 45667888888888878888999999999999999999999998 999999999999999999999999999988765
Q ss_pred CCCcc-ccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccC
Q 046010 358 QNESN-TSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMD 435 (523)
Q Consensus 358 ~~~~~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (523)
..... .....-.+.|.|||.++...++.++|||+|||++|||++ |..||..... ..+.+.+|
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g----------------~qIL~~iD 329 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG----------------IQILKNID 329 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH----------------HHHHHhcc
Confidence 54432 223344678999999999999999999999999999998 5667642221 12223334
Q ss_pred ccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 436 PVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 436 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
..-+...+..+.++++++|+.||..+|.+|||+..|.+.
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 333444566778899999999999999999999999743
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=199.82 Aligned_cols=158 Identities=27% Similarity=0.381 Sum_probs=123.1
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
.++++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ......++..|+||
T Consensus 96 ~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~ap 170 (277)
T cd06640 96 GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAP 170 (277)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--ccccccCcccccCH
Confidence 46899999999999999999999998 99999999999999999999999999976543221 22234577889999
Q ss_pred hhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHhh
Q 046010 376 EYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGL 455 (523)
Q Consensus 376 E~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~ 455 (523)
|.+.+..++.++|+||||+++|+|++|+.||....... .. . .... .............+.+++.
T Consensus 171 E~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~---~-~~~~---------~~~~~~~~~~~~~~~~li~ 234 (277)
T cd06640 171 EVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---VL---F-LIPK---------NNPPTLTGEFSKPFKEFID 234 (277)
T ss_pred hHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh---Hh---h-hhhc---------CCCCCCchhhhHHHHHHHH
Confidence 99988889999999999999999999999975322110 00 0 0000 0111122344567789999
Q ss_pred hcccCCCCCCCCHHHHHHH
Q 046010 456 LCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 456 ~cl~~dP~~RPs~~ei~~~ 474 (523)
+||+.+|++||++.++++.
T Consensus 235 ~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 235 ACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HHcccCcccCcCHHHHHhC
Confidence 9999999999999999654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=209.21 Aligned_cols=113 Identities=27% Similarity=0.371 Sum_probs=94.8
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCC-------------
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQN------------- 359 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~------------- 359 (523)
.+...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 93 ~~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~ 169 (382)
T cd05625 93 IRMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQD 169 (382)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccc
Confidence 34467899999999999999999999998 99999999999999999999999999753210000
Q ss_pred --------------------------------CccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 046010 360 --------------------------------ESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSG 407 (523)
Q Consensus 360 --------------------------------~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~ 407 (523)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~ 249 (382)
T cd05625 170 SMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFL 249 (382)
T ss_pred cccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCC
Confidence 000112468999999999999899999999999999999999999985
Q ss_pred C
Q 046010 408 F 408 (523)
Q Consensus 408 ~ 408 (523)
.
T Consensus 250 ~ 250 (382)
T cd05625 250 A 250 (382)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=197.45 Aligned_cols=164 Identities=26% Similarity=0.282 Sum_probs=122.1
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCC----Cccccceec
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQN----ESNTSKVVG 368 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~----~~~~~~~~g 368 (523)
.+...+++..+..++.||+.||+|||+.+ |+|+||+|+||+++.++.+||+|||.+........ ........+
T Consensus 94 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~ 170 (265)
T cd06631 94 NRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170 (265)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCC
Confidence 34457899999999999999999999998 99999999999999999999999999876432111 111223467
Q ss_pred cCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 369 TYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 369 t~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ............ .+.+ +.....
T Consensus 171 ~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~~~~~----~~~~----~~~~~~ 236 (265)
T cd06631 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL------AAMFYIGAHRGL----MPRL----PDSFSA 236 (265)
T ss_pred CccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH------HHHHHhhhccCC----CCCC----CCCCCH
Confidence 88999999999888999999999999999999999998532111 000000000000 0111 112234
Q ss_pred HHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 449 KCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+.+++.+||+.+|++||++.|+++
T Consensus 237 ~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 237 AAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhc
Confidence 5678899999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-22 Score=198.95 Aligned_cols=170 Identities=21% Similarity=0.260 Sum_probs=122.3
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||.+....... ......++..|+|
T Consensus 101 ~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~ 174 (287)
T cd07838 101 KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM---ALTSVVVTLWYRA 174 (287)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceeccCCc---ccccccccccccC
Confidence 346999999999999999999999998 9999999999999999999999999988764321 1123346788999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhc--------CCc--ccccCcccc---CC
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCN--------GEA--LELMDPVLK---QS 441 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~--~~~~~~~l~---~~ 441 (523)
||.+.+..++.++||||||+++|+|++|+.||....... ........... ... ......... ..
T Consensus 175 PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T cd07838 175 PEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD---QLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKS 251 (287)
T ss_pred hHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH---HHHHHHHHcCCCChHhcCCCcccchhhcccccccchhh
Confidence 999998889999999999999999999998875322211 11111110000 000 000000000 00
Q ss_pred ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 442 CMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 442 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
........+.+++.+||+.||++||++.+++.
T Consensus 252 ~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 252 FVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 11123356778999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=196.80 Aligned_cols=166 Identities=25% Similarity=0.358 Sum_probs=122.0
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
+...+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++................++..|+
T Consensus 101 ~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~ 177 (272)
T cd06629 101 TYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177 (272)
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCcccc
Confidence 3367999999999999999999999998 9999999999999999999999999987643222122223345788999
Q ss_pred chhhhcCCC--CCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 374 APEYALGGV--ISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 374 aPE~l~~~~--~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
+||.+.... ++.++|+||||+++|++++|..||..... .............. .+.... .......+.
T Consensus 178 ~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~ 246 (272)
T cd06629 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAMFKLGNKRSAP-PIPPDV----SMNLSPVAL 246 (272)
T ss_pred CHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHHHHhhccccCC-cCCccc----cccCCHHHH
Confidence 999987654 78999999999999999999999742111 11111111111111 111111 112345677
Q ss_pred HHhhhcccCCCCCCCCHHHHHH
Q 046010 452 HIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+++.+||+.+|++||++.+|++
T Consensus 247 ~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 247 DFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred HHHHHHhcCChhhCCCHHHHhh
Confidence 8899999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=206.42 Aligned_cols=163 Identities=20% Similarity=0.226 Sum_probs=117.2
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
+..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........ .......||+.|+|
T Consensus 136 ~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~a 211 (371)
T cd05622 136 NYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYIS 211 (371)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc-ccccCcccCccccC
Confidence 346899999999999999999999998 99999999999999999999999999987542211 12234578999999
Q ss_pred hhhhcCC----CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 375 PEYALGG----VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 375 PE~l~~~----~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
||++.+. .++.++|||||||++|||++|+.||.... ..................+. ......+
T Consensus 212 PE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i~~~~~~~~~~~~-------~~~s~~~ 278 (371)
T cd05622 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS------LVGTYSKIMNHKNSLTFPDD-------NDISKEA 278 (371)
T ss_pred HHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC------HHHHHHHHHcCCCcccCCCc-------CCCCHHH
Confidence 9998753 37889999999999999999999985322 11111222211111111110 1122345
Q ss_pred HHHhhhcccCCCCC--CCCHHHHHHH
Q 046010 451 IHIGLLCVQEDPAD--RPNMSSVAVM 474 (523)
Q Consensus 451 ~~li~~cl~~dP~~--RPs~~ei~~~ 474 (523)
.+++..||+.++.+ |+++.||++.
T Consensus 279 ~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 279 KNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 67778888744433 6788888774
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=201.88 Aligned_cols=170 Identities=24% Similarity=0.265 Sum_probs=118.9
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC-CCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH-EMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
...+++..++.++.||++||.|||+++ |+||||||+||+++. ++.+||+|||++..+..... ......+++.|+
T Consensus 104 ~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~ 178 (295)
T cd07837 104 GRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK--SYTHEIVTLWYR 178 (295)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecccceecCCCcc--ccCCcccccCCC
Confidence 356899999999999999999999998 999999999999998 88999999999876532211 112235678899
Q ss_pred chhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCC--c-------------ccccCcc
Q 046010 374 APEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGE--A-------------LELMDPV 437 (523)
Q Consensus 374 aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--~-------------~~~~~~~ 437 (523)
|||.+.+ ..++.++||||||+++|+|++|..||....... .... ......... . .......
T Consensus 179 aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (295)
T cd07837 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLH-IFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQD 255 (295)
T ss_pred ChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHH-HHHHhCCCChhhCcchhhccchhhcCcccchh
Confidence 9998865 457899999999999999999999985322110 0000 000000000 0 0000000
Q ss_pred ccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 438 LKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 438 l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+. .........+.+++.+||+.||.+||++.|++.
T Consensus 256 ~~-~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 256 LS-RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HH-HhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 000122355778999999999999999998875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=202.54 Aligned_cols=171 Identities=25% Similarity=0.285 Sum_probs=120.2
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++.+++.++.||++||.|||+.+ ++|+||||+||+++.++.+||+|||.+........ ......++..|+|
T Consensus 102 ~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~a 176 (309)
T cd07845 102 PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK--PMTPKVVTLWYRA 176 (309)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCccC--CCCcccccccccC
Confidence 467999999999999999999999998 99999999999999999999999999987643221 1122345778999
Q ss_pred hhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhc-----------CCcccccC---cccc
Q 046010 375 PEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCN-----------GEALELMD---PVLK 439 (523)
Q Consensus 375 PE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~---~~l~ 439 (523)
||.+.+ ..++.++||||||+++|+|++|+.||...... ............ ........ ....
T Consensus 177 PE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (309)
T cd07845 177 PELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI---EQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYN 253 (309)
T ss_pred hhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCChhhchhhhcccccccccccCCCCC
Confidence 998875 45789999999999999999999998532211 111111111000 00000000 0000
Q ss_pred C--CccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 440 Q--SCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 440 ~--~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
. .........+.+++.+||+.||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 254 NLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred chHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 000012345678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=194.23 Aligned_cols=163 Identities=28% Similarity=0.396 Sum_probs=126.1
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
+...+++..++.++.|++++|.|||+.+ ++|+||+|+||+++.++.++|+|||.+................++..|+
T Consensus 94 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~ 170 (260)
T cd06606 94 KFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170 (260)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCcccc
Confidence 3348999999999999999999999998 9999999999999999999999999998765433211233456788999
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
+||.+.+...+.++||||||+++++|++|..||.... ......+.......... .+......+.++
T Consensus 171 ~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~---------~~~~~~~~l~~~ 236 (260)
T cd06606 171 APEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEPPE---------IPEHLSEEAKDF 236 (260)
T ss_pred CHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCCcC---------CCcccCHHHHHH
Confidence 9999988889999999999999999999999986433 11112222111111111 111224567888
Q ss_pred hhhcccCCCCCCCCHHHHHH
Q 046010 454 GLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~ 473 (523)
+.+||+.+|++||++.+++.
T Consensus 237 i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 237 LRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHHhCcCChhhCCCHHHHhh
Confidence 99999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.2e-23 Score=202.00 Aligned_cols=172 Identities=24% Similarity=0.339 Sum_probs=120.8
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
....+++.+++.++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++....... .......++..|+
T Consensus 93 ~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~ 167 (286)
T cd07846 93 YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYTDYVATRWYR 167 (286)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--cccCcccceeecc
Confidence 3446999999999999999999999998 9999999999999999999999999988654322 1222345788999
Q ss_pred chhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHH-----------hhhcCCcc-cccCccccC
Q 046010 374 APEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWK-----------LWCNGEAL-ELMDPVLKQ 440 (523)
Q Consensus 374 aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~-----------~~~~~~~~-~~~~~~l~~ 440 (523)
|||++.+ ..++.++||||||+++|+|++|+.||...... ........ .+...... ....+....
T Consensus 168 aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (286)
T cd07846 168 APELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI---DQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKE 244 (286)
T ss_pred CcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH---HHHHHHHHHhCCCchhhHHHhccchHhhccccccccC
Confidence 9998875 44788999999999999999999888532211 00000000 00000000 000000000
Q ss_pred C-----ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 441 S-----CMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 441 ~-----~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
. ........+.+++.+||+.+|++||++.+|++
T Consensus 245 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 245 IEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0 00122456788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-22 Score=201.44 Aligned_cols=175 Identities=22% Similarity=0.281 Sum_probs=121.6
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCc---------cc
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES---------NT 363 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~---------~~ 363 (523)
.....+++..++.++.||++||.|||+++ |+|+||||+||++++++.+||+|||++.......... ..
T Consensus 107 ~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~ 183 (311)
T cd07866 107 NPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183 (311)
T ss_pred ccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCccccccc
Confidence 34567999999999999999999999998 9999999999999999999999999987653222111 11
Q ss_pred cceeccCCCCchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCC---------ccc-
Q 046010 364 SKVVGTYGYMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGE---------ALE- 432 (523)
Q Consensus 364 ~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~- 432 (523)
....++..|+|||.+.+. .++.++||||||+++|+|++|+.||....... .....+....... ...
T Consensus 184 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (311)
T cd07866 184 TNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID---QLHLIFKLCGTPTEETWPGWRSLPGC 260 (311)
T ss_pred ccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChhhchhhhhcccc
Confidence 233567889999987654 57899999999999999999999985322211 1111111110000 000
Q ss_pred ---ccCccccCCc---cHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 433 ---LMDPVLKQSC---MAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 433 ---~~~~~l~~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.......... .......+.+++.+||+.||++|||+.|++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 261 EGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred cccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000000000 0111246778999999999999999998874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.6e-23 Score=200.61 Aligned_cols=160 Identities=27% Similarity=0.356 Sum_probs=120.4
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
+..+++..++.++.||++||.|||+++ ++|+||+|+||+++.++.+||+|||.+....... .......++..|+|
T Consensus 107 ~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~a 181 (275)
T cd06608 107 GKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL--GRRNTFIGTPYWMA 181 (275)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccceecccch--hhhcCccccccccC
Confidence 567999999999999999999999998 9999999999999999999999999987653221 12234567889999
Q ss_pred hhhhcC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 375 PEYALG-----GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 375 PE~l~~-----~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
||.+.. ..++.++||||||+++|+|++|+.||...... . .... ........ +. .+......
T Consensus 182 PE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~----~~~~-~~~~~~~~-----~~--~~~~~~~~ 247 (275)
T cd06608 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--R----ALFK-IPRNPPPT-----LK--SPENWSKK 247 (275)
T ss_pred HhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--H----HHHH-hhccCCCC-----CC--chhhcCHH
Confidence 998753 34678999999999999999999998532111 1 1111 11111111 11 11123456
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHH
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+.+++.+||..||++|||+.+|++
T Consensus 248 ~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 248 FNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHHHHHHHhhcChhhCcCHHHHhc
Confidence 778999999999999999999976
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=199.36 Aligned_cols=161 Identities=25% Similarity=0.265 Sum_probs=121.9
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+...+++..++.++.|+++||.|||+.+ |+|+||||+||+++.++.+||+|||++..+... ......++..
T Consensus 88 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~ 160 (278)
T cd05606 88 LSQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHG 160 (278)
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc----CCcCcCCCcC
Confidence 345567999999999999999999999998 999999999999999999999999998755322 1223468899
Q ss_pred CCchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 372 YMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 372 y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
|+|||.+.++ .++.++||||+|+++|+|++|+.||........... ....... ...+ +......+
T Consensus 161 y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~~------~~~~----~~~~s~~~ 226 (278)
T cd05606 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTM------AVEL----PDSFSPEL 226 (278)
T ss_pred CcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHhhcc------CCCC----CCcCCHHH
Confidence 9999998754 588999999999999999999999864322111111 1111000 0111 11123467
Q ss_pred HHHhhhcccCCCCCCC-----CHHHHHH
Q 046010 451 IHIGLLCVQEDPADRP-----NMSSVAV 473 (523)
Q Consensus 451 ~~li~~cl~~dP~~RP-----s~~ei~~ 473 (523)
.+++.+||..+|.+|| ++.++++
T Consensus 227 ~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 227 RSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred HHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 7888899999999999 8989875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.2e-24 Score=229.89 Aligned_cols=181 Identities=25% Similarity=0.295 Sum_probs=132.5
Q ss_pred ceeEeeecccccccc---ccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccce
Q 046010 276 RKAIWIAIGTTIPTI---YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352 (523)
Q Consensus 276 ~~~~~ia~g~~~~~~---~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 352 (523)
+..++|-+.+|-..- ....++-.++.....+..|++.|+.|||+.| ||||||||.||+++.+|.+|++|||.+.
T Consensus 1306 Rekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeeccccee
Confidence 345555566665211 1234445777788889999999999999999 9999999999999999999999999999
Q ss_pred eccCCC--CCccccceeccCCCCchhhhcCCC---CCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHH-hhh
Q 046010 353 IFGGNQ--NESNTSKVVGTYGYMAPEYALGGV---ISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWK-LWC 426 (523)
Q Consensus 353 ~~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~---~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~-~~~ 426 (523)
.+.... .........||+.|||||++.+.. ...+.||||||||+.||+||++||...+.+ |+.. +..
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy~V~ 1455 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMYHVA 1455 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHhHHh
Confidence 875442 122345678999999999997633 456899999999999999999999755443 1111 111
Q ss_pred cCCcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHh
Q 046010 427 NGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVML 475 (523)
Q Consensus 427 ~~~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L 475 (523)
.++..++ +......-.+++.+||+.||++|.++.||++.=
T Consensus 1456 ~gh~Pq~---------P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1456 AGHKPQI---------PERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred ccCCCCC---------chhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 2222222 222233446788899999999999998887754
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=198.50 Aligned_cols=160 Identities=25% Similarity=0.336 Sum_probs=119.6
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhc-CCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHED-SRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~-g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.+..+++..++.++.||+.||+|||++ + ++||||||+||+++.++.+||+|||.+....... ......++..|
T Consensus 96 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y 169 (283)
T cd06617 96 KGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV---AKTIDAGCKPY 169 (283)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccccc---ccccccCCccc
Confidence 345799999999999999999999997 7 9999999999999999999999999987653221 12234678899
Q ss_pred CchhhhcC----CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 373 MAPEYALG----GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 373 ~aPE~l~~----~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
+|||.+.+ ..++.++|+||||+++|+|++|+.||...... ........ ......... .....
T Consensus 170 ~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~-~~~~~~~~~--------~~~~~ 235 (283)
T cd06617 170 MAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLKQVV-EEPSPQLPA--------EKFSP 235 (283)
T ss_pred cChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHHHHHHH-hcCCCCCCc--------cccCH
Confidence 99998864 44688999999999999999999998532211 11111111 111111100 01234
Q ss_pred HHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 449 KCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+.+++.+||+.+|++||++.+|++
T Consensus 236 ~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 236 EFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhc
Confidence 5778999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=201.08 Aligned_cols=160 Identities=24% Similarity=0.323 Sum_probs=121.1
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
+..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.+........ ......++..|++
T Consensus 109 ~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~a 183 (297)
T cd06656 109 ETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMA 183 (297)
T ss_pred hCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc--CcCcccCCccccC
Confidence 346899999999999999999999998 99999999999999999999999999876533221 1223467889999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
||.+.+..++.++||||||+++|++++|+.||........ .. .....+ ... + ..+......+.+++
T Consensus 184 PE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~~----~~~~~~-~~~-----~--~~~~~~~~~~~~li 249 (297)
T cd06656 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LY----LIATNG-TPE-----L--QNPERLSAVFRDFL 249 (297)
T ss_pred HHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--ee----eeccCC-CCC-----C--CCccccCHHHHHHH
Confidence 9999988899999999999999999999999853221110 00 000000 000 0 01112234567888
Q ss_pred hhcccCCCCCCCCHHHHHH
Q 046010 455 LLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~ 473 (523)
.+||+.+|++||++.+|++
T Consensus 250 ~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 250 NRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred HHHccCChhhCcCHHHHhc
Confidence 9999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=196.54 Aligned_cols=165 Identities=26% Similarity=0.394 Sum_probs=123.0
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC-CeeEeccccceeccCCCCC--ccccceeccC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM-NPKISDFGMARIFGGNQNE--SNTSKVVGTY 370 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~--~~~~~~~gt~ 370 (523)
+...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++ .+||+|||.+......... .......++.
T Consensus 96 ~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~ 172 (268)
T cd06630 96 KYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTI 172 (268)
T ss_pred HhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCcccccccccc
Confidence 4457899999999999999999999998 99999999999998776 5899999998766432111 1122346788
Q ss_pred CCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 371 GYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 371 ~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
.|+|||.+.+..++.++||||||+++|+|++|+.||........ ............ ....+......+
T Consensus 173 ~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~---------~~~~~~~~~~~~ 240 (268)
T cd06630 173 AFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFKIASATT---------APSIPEHLSPGL 240 (268)
T ss_pred ceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHHHHhccCC---------CCCCchhhCHHH
Confidence 99999999888899999999999999999999999853322111 111111110000 111222334567
Q ss_pred HHHhhhcccCCCCCCCCHHHHHH
Q 046010 451 IHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+++.+||+.+|++||++.++++
T Consensus 241 ~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 241 RDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHHHHHcCCCcccCcCHHHHhc
Confidence 78999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=192.95 Aligned_cols=158 Identities=26% Similarity=0.408 Sum_probs=122.1
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..+..++.|++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||.+........ .....++..|++|
T Consensus 93 ~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~P 166 (253)
T cd05122 93 QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAP 166 (253)
T ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCH
Confidence 67999999999999999999999998 99999999999999999999999999887643221 3345678899999
Q ss_pred hhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHhh
Q 046010 376 EYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGL 455 (523)
Q Consensus 376 E~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~ 455 (523)
|.+.+...+.++||||||+++|+|++|+.||...... ..... ............ ......+.+++.
T Consensus 167 E~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~~~~~~-------~~~~~~~~~~i~ 232 (253)
T cd05122 167 EVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM------KALFK-IATNGPPGLRNP-------EKWSDEFKDFLK 232 (253)
T ss_pred HHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH------HHHHH-HHhcCCCCcCcc-------cccCHHHHHHHH
Confidence 9998888999999999999999999999997532211 11111 111111111110 011346778899
Q ss_pred hcccCCCCCCCCHHHHHH
Q 046010 456 LCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 456 ~cl~~dP~~RPs~~ei~~ 473 (523)
+||+.||++|||+.++++
T Consensus 233 ~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 233 KCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HHccCChhhCCCHHHHhc
Confidence 999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=197.70 Aligned_cols=159 Identities=22% Similarity=0.327 Sum_probs=121.1
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
.++++..+..++.||+.||+|||+++ ++||||+|+||+++.++.++|+|||.+....... .......++..|+||
T Consensus 110 ~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~aP 184 (285)
T cd06648 110 TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAP 184 (285)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC--cccccccCCccccCH
Confidence 56899999999999999999999998 9999999999999999999999999877543221 112234578899999
Q ss_pred hhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHhh
Q 046010 376 EYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGL 455 (523)
Q Consensus 376 E~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~ 455 (523)
|.+.+..++.++||||||+++|+|++|+.||..... ...... ...... +.+.. .......+.+++.
T Consensus 185 E~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~-~~~~~~-----~~~~~--~~~~~~~l~~li~ 250 (285)
T cd06648 185 EVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKR-IRDNLP-----PKLKN--LHKVSPRLRSFLD 250 (285)
T ss_pred HHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHH-HHhcCC-----CCCcc--cccCCHHHHHHHH
Confidence 999888899999999999999999999999753211 111111 111110 01100 1112346788999
Q ss_pred hcccCCCCCCCCHHHHHH
Q 046010 456 LCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 456 ~cl~~dP~~RPs~~ei~~ 473 (523)
+||+.+|++||++.++++
T Consensus 251 ~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 251 RMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHcccChhhCcCHHHHcc
Confidence 999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=199.65 Aligned_cols=167 Identities=26% Similarity=0.382 Sum_probs=124.8
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHh-cCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHE-DSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~-~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
.+.+.+++..+..++.+++.+|.|||+ .+ ++|+||||+||++++++.++|+|||++...... ......++..
T Consensus 95 ~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~----~~~~~~~~~~ 167 (284)
T cd06620 95 KKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----IADTFVGTST 167 (284)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh----ccCccccCcc
Confidence 345679999999999999999999997 46 999999999999999999999999988654221 1223567899
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccc-----cchHHHHHHhhhcCCcccccCccccCCccHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHG-----QSLLAYTWKLWCNGEALELMDPVLKQSCMAAE 446 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 446 (523)
|+|||.+.+..++.++||||||+++|++++|+.||........ ............ .... .+. ....
T Consensus 168 ~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-----~~~---~~~~ 238 (284)
T cd06620 168 YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EPPP-----RLP---SSDF 238 (284)
T ss_pred cCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-ccCC-----CCC---chhc
Confidence 9999999888899999999999999999999999874333211 111111111111 1100 000 0113
Q ss_pred HHHHHHHhhhcccCCCCCCCCHHHHHHHh
Q 046010 447 LLKCIHIGLLCVQEDPADRPNMSSVAVML 475 (523)
Q Consensus 447 ~~~~~~li~~cl~~dP~~RPs~~ei~~~L 475 (523)
...+.+++.+||+.||++|||+.||+++.
T Consensus 239 ~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 239 PEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 34677899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.1e-23 Score=206.78 Aligned_cols=178 Identities=24% Similarity=0.306 Sum_probs=123.2
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC--ccccceeccC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE--SNTSKVVGTY 370 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~--~~~~~~~gt~ 370 (523)
..+..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++......... .......++.
T Consensus 99 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 175 (334)
T cd07855 99 HSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175 (334)
T ss_pred ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccc
Confidence 34566999999999999999999999998 999999999999999999999999999765432211 1112346788
Q ss_pred CCCchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHH--------HHHhhhcCCcccccCcc-ccC
Q 046010 371 GYMAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAY--------TWKLWCNGEALELMDPV-LKQ 440 (523)
Q Consensus 371 ~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~-l~~ 440 (523)
.|+|||.+.+ ..++.++||||||+++|+|++|+.||.............. .+.........+.++.. ...
T Consensus 176 ~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (334)
T cd07855 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQ 255 (334)
T ss_pred cccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCC
Confidence 9999998865 4588999999999999999999999854321110000000 00000000000000000 000
Q ss_pred Cc-----cHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 441 SC-----MAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 441 ~~-----~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.. .......+.+++.+||+.+|++||++.+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 256 PVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred CCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00 0122456889999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=199.58 Aligned_cols=167 Identities=25% Similarity=0.342 Sum_probs=121.5
Q ss_pred ccccccccccCHHHHHHHHHHHHHHHHHHHh-cCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcccccee
Q 046010 289 TIYSTRRAQLDWKRRISIINGIARGLLYLHE-DSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVV 367 (523)
Q Consensus 289 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 367 (523)
.++......+++..+..++.||++||.|||+ .+ |+||||+|+||++++++.+||+|||++..+..... .....
T Consensus 102 ~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~---~~~~~ 175 (296)
T cd06618 102 KLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA---KTRSA 175 (296)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCCc---ccCCC
Confidence 3334445589999999999999999999997 46 99999999999999999999999999876532221 12335
Q ss_pred ccCCCCchhhhcCCC----CCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCcc
Q 046010 368 GTYGYMAPEYALGGV----ISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCM 443 (523)
Q Consensus 368 gt~~y~aPE~l~~~~----~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 443 (523)
++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... .+....... ...... .. .
T Consensus 176 ~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~-~~~~~~-----~~--~ 242 (296)
T cd06618 176 GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQ-EEPPSL-----PP--N 242 (296)
T ss_pred CCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhc-CCCCCC-----CC--C
Confidence 678899999986543 788999999999999999999998532111 111111111 111111 00 0
Q ss_pred HHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 444 AAELLKCIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 444 ~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
.....++.+++.+||+.||++||++.+|++.
T Consensus 243 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 243 EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0123467889999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=208.40 Aligned_cols=113 Identities=26% Similarity=0.343 Sum_probs=96.6
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC------------
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE------------ 360 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~------------ 360 (523)
.++..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.........
T Consensus 93 ~~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~ 169 (360)
T cd05627 93 MKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPS 169 (360)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcc
Confidence 45667999999999999999999999998 999999999999999999999999998754221100
Q ss_pred ---------------------ccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 046010 361 ---------------------SNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGF 408 (523)
Q Consensus 361 ---------------------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~ 408 (523)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 170 DFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 001134689999999999999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=204.78 Aligned_cols=196 Identities=24% Similarity=0.285 Sum_probs=133.4
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCC-CccccceeccCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQN-ESNTSKVVGTYG 371 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~~gt~~ 371 (523)
.++..+++..++.++.||++||.|||+++ |+|+||||+||+++.++.++|+|||.+........ ........++..
T Consensus 95 ~~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~ 171 (330)
T cd07834 95 KSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171 (330)
T ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccC
Confidence 34458999999999999999999999998 99999999999999999999999999987643321 012233467888
Q ss_pred CCchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHH--------HHHhhhcCCcccccCccccC-C
Q 046010 372 YMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAY--------TWKLWCNGEALELMDPVLKQ-S 441 (523)
Q Consensus 372 y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~-~ 441 (523)
|+|||.+.+. .++.++||||||+++|+|++|+.||...........+.. .+.........+.+...... .
T Consensus 172 y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (330)
T cd07834 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPK 251 (330)
T ss_pred cCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCc
Confidence 9999999887 789999999999999999999999864332111000000 00000000001110000000 0
Q ss_pred -----ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH--hccCC-CCCCCCCCCCcc
Q 046010 442 -----CMAAELLKCIHIGLLCVQEDPADRPNMSSVAVM--LASDT-VSLPQPTQPAFS 491 (523)
Q Consensus 442 -----~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~--L~~~~-~~l~~p~~p~~~ 491 (523)
........+.+++.+||+.+|++||++.++++. |++.. .....++.+.+.
T Consensus 252 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~~ 309 (330)
T cd07834 252 KPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFD 309 (330)
T ss_pred chhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCccc
Confidence 001124567889999999999999999999873 55432 233445555553
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-22 Score=198.81 Aligned_cols=167 Identities=29% Similarity=0.321 Sum_probs=122.6
Q ss_pred cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcccccee
Q 046010 288 PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVV 367 (523)
Q Consensus 288 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 367 (523)
.++.......+++..++.++.||+.||.|||+++ ++|+||+|+||++++++.+||+|||.+...... .......
T Consensus 82 ~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~ 155 (277)
T cd05577 82 YHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGRA 155 (277)
T ss_pred HHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Ccccccc
Confidence 3444444457999999999999999999999998 999999999999999999999999998765321 1222345
Q ss_pred ccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHH
Q 046010 368 GTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAEL 447 (523)
Q Consensus 368 gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 447 (523)
++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+ ...... . .. ..+....
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~-~-----~~----~~~~~~~ 222 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL---KRRTLE-M-----AV----EYPDKFS 222 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH---Hhcccc-c-----cc----cCCccCC
Confidence 678999999998888999999999999999999999998543321111110 000000 0 00 0111123
Q ss_pred HHHHHHhhhcccCCCCCCC-----CHHHHHH
Q 046010 448 LKCIHIGLLCVQEDPADRP-----NMSSVAV 473 (523)
Q Consensus 448 ~~~~~li~~cl~~dP~~RP-----s~~ei~~ 473 (523)
..+.+++.+||+.||++|| ++.++++
T Consensus 223 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 223 PEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 4567889999999999999 5555653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=198.16 Aligned_cols=195 Identities=17% Similarity=0.191 Sum_probs=139.4
Q ss_pred eEeeeccccc-----cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccce
Q 046010 278 AIWIAIGTTI-----PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352 (523)
Q Consensus 278 ~~~ia~g~~~-----~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 352 (523)
...+.+.+|- .+...+.++.+++..++-++.+|+-||+|||..| ||+|||||+||||.++|.+.|+||.++.
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSL 227 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccc
Confidence 4455555555 4444666778999999999999999999999999 9999999999999999999999999874
Q ss_pred eccCC--------------------------------C-CC---------------------ccccceeccCCCCchhhh
Q 046010 353 IFGGN--------------------------------Q-NE---------------------SNTSKVVGTYGYMAPEYA 378 (523)
Q Consensus 353 ~~~~~--------------------------------~-~~---------------------~~~~~~~gt~~y~aPE~l 378 (523)
..... . .. .....++||-.|+|||++
T Consensus 228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI 307 (459)
T KOG0610|consen 228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI 307 (459)
T ss_pred cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence 32110 0 00 011235789999999999
Q ss_pred cCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHhhhcc
Q 046010 379 LGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCV 458 (523)
Q Consensus 379 ~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~~cl 458 (523)
.+...+.++|.|+|||++|||+.|..||.....+.. .. .++.+.+.-...+.....+.+||++.|
T Consensus 308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T-------l~--------NIv~~~l~Fp~~~~vs~~akDLIr~LL 372 (459)
T KOG0610|consen 308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET-------LR--------NIVGQPLKFPEEPEVSSAAKDLIRKLL 372 (459)
T ss_pred ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh-------HH--------HHhcCCCcCCCCCcchhHHHHHHHHHh
Confidence 999999999999999999999999999964332211 11 111111111111233456778999999
Q ss_pred cCCCCCCCC----HHHHHH--HhccCCCCCCCCCCCCc
Q 046010 459 QEDPADRPN----MSSVAV--MLASDTVSLPQPTQPAF 490 (523)
Q Consensus 459 ~~dP~~RPs----~~ei~~--~L~~~~~~l~~p~~p~~ 490 (523)
.+||++|.- +.||.+ ++++..=.+-.-.+|++
T Consensus 373 vKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~ 410 (459)
T KOG0610|consen 373 VKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPE 410 (459)
T ss_pred ccChhhhhccccchHHhhcCccccCCChhheeccCCCc
Confidence 999999998 778753 45554333433344444
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=194.95 Aligned_cols=163 Identities=23% Similarity=0.245 Sum_probs=124.1
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.+...+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||++..... .....++..|
T Consensus 89 ~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y 159 (260)
T cd05611 89 KTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDY 159 (260)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCCCcCc
Confidence 34457999999999999999999999998 99999999999999999999999999876432 2234577889
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
++||.+.+..++.++||||||+++|+|++|..||...... ..+......... ... .........+.+
T Consensus 160 ~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~--~~~----~~~~~~~~~~~~ 226 (260)
T cd05611 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-------AVFDNILSRRIN--WPE----EVKEFCSPEAVD 226 (260)
T ss_pred cChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhcccC--CCC----cccccCCHHHHH
Confidence 9999998888899999999999999999999998532211 111111111110 000 011122356778
Q ss_pred HhhhcccCCCCCCCCHHHHHHHhcc
Q 046010 453 IGLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
++.+||+.+|++||++.++.+.|+.
T Consensus 227 ~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 227 LINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred HHHHHccCCHHHccCCCcHHHHHcC
Confidence 9999999999999998877777755
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=197.53 Aligned_cols=175 Identities=22% Similarity=0.298 Sum_probs=122.3
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.....+++.+++.++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||.+........ .......++..|
T Consensus 91 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y 166 (286)
T cd07832 91 DEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWY 166 (286)
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-CccccccCcccc
Confidence 33467999999999999999999999998 99999999999999999999999999886543221 122345678899
Q ss_pred CchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCC------------cccccCcccc
Q 046010 373 MAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGE------------ALELMDPVLK 439 (523)
Q Consensus 373 ~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~l~ 439 (523)
+|||.+.+. .++.++||||||+++|+|++|.++|...... .............. ......+...
T Consensus 167 ~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (286)
T cd07832 167 RAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESK 243 (286)
T ss_pred cCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCC
Confidence 999988654 4689999999999999999997776432211 11111111110000 0000000000
Q ss_pred ----CCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 440 ----QSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 440 ----~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
..........+.+++.+||+.+|++||+++++++.
T Consensus 244 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 244 PIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00001223677899999999999999999998763
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-22 Score=203.65 Aligned_cols=185 Identities=23% Similarity=0.276 Sum_probs=122.4
Q ss_pred cccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCc--
Q 046010 284 GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES-- 361 (523)
Q Consensus 284 g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-- 361 (523)
|....++.......+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+|+.||+............
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 33333333333456999999999999999999999998 9999999999999999999999997654321111110
Q ss_pred ---cccceeccCCCCchhhhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHH--------------
Q 046010 362 ---NTSKVVGTYGYMAPEYALGG--VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTW-------------- 422 (523)
Q Consensus 362 ---~~~~~~gt~~y~aPE~l~~~--~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~-------------- 422 (523)
......++..|++||++.+. .++.++||||||+++|+|++|+.||........ ......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccch
Confidence 01112345679999998763 478999999999999999999999864321100 000000
Q ss_pred --Hhhhc----------------CCcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 423 --KLWCN----------------GEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 423 --~~~~~----------------~~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
..+.. ..........+...........+.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00000 0000011111111122334567889999999999999999999963
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=197.11 Aligned_cols=162 Identities=23% Similarity=0.289 Sum_probs=120.0
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.....+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||.+....... .......++..|
T Consensus 95 ~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y 169 (280)
T cd06611 95 ELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--QKRDTFIGTPYW 169 (280)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc--cccceeecchhh
Confidence 33457999999999999999999999998 9999999999999999999999999886543221 122345678899
Q ss_pred Cchhhhc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHH
Q 046010 373 MAPEYAL-----GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAEL 447 (523)
Q Consensus 373 ~aPE~l~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 447 (523)
++||.+. ...++.++||||||+++|+|++|+.||...... ... ..+.......+.. +....
T Consensus 170 ~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~-~~~~~~~~~~~~~-------~~~~~ 235 (280)
T cd06611 170 MAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVL-LKILKSEPPTLDQ-------PSKWS 235 (280)
T ss_pred cCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHH-HHHhcCCCCCcCC-------cccCC
Confidence 9999875 344678999999999999999999998532211 111 1111111111100 11122
Q ss_pred HHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 448 LKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 448 ~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
..+.+++.+||+.+|++||++.+|++
T Consensus 236 ~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 236 SSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHhc
Confidence 35678899999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-22 Score=199.26 Aligned_cols=173 Identities=22% Similarity=0.269 Sum_probs=120.3
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
...+..+++..++.++.||++||+|||+.+ ++|+||+|+||+++.++.+||+|||++....... .......++..
T Consensus 91 ~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~ 165 (284)
T cd07860 91 ASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLW 165 (284)
T ss_pred hCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc--ccccccccccc
Confidence 344567999999999999999999999998 9999999999999999999999999987653221 11223346788
Q ss_pred CCchhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcC----------------Cccccc
Q 046010 372 YMAPEYALGGV-ISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNG----------------EALELM 434 (523)
Q Consensus 372 y~aPE~l~~~~-~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~ 434 (523)
|+|||.+.+.. ++.++||||||+++|+|++|+.||....... ..... ....... ......
T Consensus 166 y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd07860 166 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRI-FRTLGTPDEVVWPGVTSLPDYKPSFPKWA 242 (284)
T ss_pred ccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHH-HHHhCCCChhhhhhhhHHHHHHhhccccc
Confidence 99999887644 5889999999999999999999985322110 11100 0000000 000000
Q ss_pred CccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 435 DPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 435 ~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
...+.. ........+.+++.+||+.||++||+++++++
T Consensus 243 ~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 243 RQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred ccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000 00011234678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.2e-23 Score=229.74 Aligned_cols=159 Identities=17% Similarity=0.193 Sum_probs=111.6
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCC-------------------CCeeEeccccceec
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE-------------------MNPKISDFGMARIF 354 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~-------------------~~~kL~Dfg~a~~~ 354 (523)
....+++.+++.++.||++||.|||++| |+||||||+||||+.. +.+|++|||+++..
T Consensus 73 ~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~ 149 (793)
T PLN00181 73 PDRSVDAFECFHVFRQIVEIVNAAHSQG---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRRE 149 (793)
T ss_pred ccccccHHHHHHHHHHHHHHHHHHHhCC---eeeccCCchhEEEcccCcEEEeeccccCcccccccCccccccccccccc
Confidence 3456999999999999999999999998 9999999999999653 45566666666532
Q ss_pred cCCCC--------------CccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHH
Q 046010 355 GGNQN--------------ESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAY 420 (523)
Q Consensus 355 ~~~~~--------------~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~ 420 (523)
..... ........+|+.|+|||++.+..++.++|||||||+||||++|..|+.... ...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~-- 222 (793)
T PLN00181 150 EILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTM-- 222 (793)
T ss_pred ccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHH--
Confidence 11000 000112357888999999999999999999999999999999887753110 000
Q ss_pred HHHhhhcCCcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 421 TWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 421 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
..+... .+.+.. .....+...++.+||+.+|.+||++.||++
T Consensus 223 --~~~~~~----~~~~~~-----~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 223 --SSLRHR----VLPPQI-----LLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred --HHHHHh----hcChhh-----hhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 000000 011100 112234567788999999999999999975
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.9e-22 Score=202.83 Aligned_cols=174 Identities=22% Similarity=0.265 Sum_probs=122.4
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
+..+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+||+|||+++.... ......++..|+|
T Consensus 111 ~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~-----~~~~~~~~~~y~a 182 (342)
T cd07879 111 GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRA 182 (342)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-----CCCCceeeecccC
Confidence 346899999999999999999999998 99999999999999999999999999875422 1223456788999
Q ss_pred hhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHh-----------hhcCCcccccC--ccc-c
Q 046010 375 PEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKL-----------WCNGEALELMD--PVL-K 439 (523)
Q Consensus 375 PE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~--~~l-~ 439 (523)
||.+.+ ..++.++||||||+++|+|++|+.||...... ......+.. +.......... +.. .
T Consensus 183 PE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (342)
T cd07879 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPR 259 (342)
T ss_pred hhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCccc
Confidence 999876 46889999999999999999999998632211 011100000 00000000000 000 0
Q ss_pred CCc---cHHHHHHHHHHhhhcccCCCCCCCCHHHHHH--HhccCC
Q 046010 440 QSC---MAAELLKCIHIGLLCVQEDPADRPNMSSVAV--MLASDT 479 (523)
Q Consensus 440 ~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~~~ 479 (523)
... .......+.+++.+||+.||++||++.+++. .++...
T Consensus 260 ~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 260 KDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred chHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 000 0012345778999999999999999999984 466543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.7e-22 Score=197.26 Aligned_cols=172 Identities=22% Similarity=0.275 Sum_probs=119.0
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.||++||.|||+++ |+|+||||+||+++.++.+||+|||.++....... ......++..|+|
T Consensus 97 ~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~a 171 (291)
T cd07844 97 GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--TYSNEVVTLWYRP 171 (291)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc--cccccccccccCC
Confidence 447899999999999999999999998 99999999999999999999999999875422111 1122345788999
Q ss_pred hhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCC------------ccccc-----Cc
Q 046010 375 PEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGE------------ALELM-----DP 436 (523)
Q Consensus 375 PE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~-----~~ 436 (523)
||.+.+ ..++.++||||||+++|+|++|+.||...... .......+....... ..... ..
T Consensus 172 PE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (291)
T cd07844 172 PDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPR 249 (291)
T ss_pred cHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhhhhhccccccccccccCCh
Confidence 998875 45789999999999999999999998533211 111111111110000 00000 00
Q ss_pred cccCCc-cHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 437 VLKQSC-MAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 437 ~l~~~~-~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+.... .......+.+++.+||+.+|++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 250 PLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000 0011256678999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-22 Score=199.85 Aligned_cols=169 Identities=20% Similarity=0.186 Sum_probs=123.9
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC------------
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE------------ 360 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~------------ 360 (523)
.....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+++........
T Consensus 93 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~ 169 (305)
T cd05609 93 KNIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169 (305)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchh
Confidence 34467999999999999999999999998 999999999999999999999999988642110000
Q ss_pred -ccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCcccc
Q 046010 361 -SNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLK 439 (523)
Q Consensus 361 -~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 439 (523)
.......++..|+|||.+.+..++.++||||||+++|+|++|..||..... .+. .......... .+...
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~------~~~-~~~~~~~~~~---~~~~~ 239 (305)
T cd05609 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP------EEL-FGQVISDDIE---WPEGD 239 (305)
T ss_pred hccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHH-HHHHHhcccC---CCCcc
Confidence 011123567889999999888899999999999999999999999852211 111 1111111110 01000
Q ss_pred CCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 440 QSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 440 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
......+.+++.+||+.||++||+..++.++|+..
T Consensus 240 ----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 240 ----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred ----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 01234567899999999999999988888888764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-22 Score=197.70 Aligned_cols=161 Identities=22% Similarity=0.288 Sum_probs=120.0
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC-ccccceeccCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE-SNTSKVVGTYGY 372 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~gt~~y 372 (523)
+...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||.+......... .......++..|
T Consensus 99 ~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y 175 (265)
T cd06652 99 SYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175 (265)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccc
Confidence 4456899999999999999999999998 999999999999999999999999998764321111 112234578899
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
+|||.+.+..++.++||||||+++|+|++|+.||..... . ........... . ...+......+.+
T Consensus 176 ~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~-~~~~~~~~~~~-----~----~~~~~~~~~~~~~ 240 (265)
T cd06652 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-----M-AAIFKIATQPT-----N----PVLPPHVSDHCRD 240 (265)
T ss_pred cChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-----H-HHHHHHhcCCC-----C----CCCchhhCHHHHH
Confidence 999999888899999999999999999999999853211 1 11111111110 1 1112233446667
Q ss_pred HhhhcccCCCCCCCCHHHHHH
Q 046010 453 IGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~ 473 (523)
++.+||. +|++||+++||++
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhc
Confidence 8888884 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.3e-22 Score=194.12 Aligned_cols=162 Identities=29% Similarity=0.412 Sum_probs=124.7
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHh-cCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHE-DSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~-~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
...+++..++.++.||++||.|||+ .+ ++|+||+|+||+++.++.++|+|||.+......... .....++..|+
T Consensus 93 ~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~ 167 (264)
T cd06623 93 VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--CNTFVGTVTYM 167 (264)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc--ccceeeccccc
Confidence 3679999999999999999999999 88 999999999999999999999999998876432221 22456788999
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHH-HHHHHHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAA-ELLKCIH 452 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~-~~~~~~~ 452 (523)
|||.+.+..++.++|+||||+++|+|++|+.||............ .......... + +.. ....+.+
T Consensus 168 ~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~----~~~~~~~~~~-----~----~~~~~~~~l~~ 234 (264)
T cd06623 168 SPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM----QAICDGPPPS-----L----PAEEFSPEFRD 234 (264)
T ss_pred CHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH----HHHhcCCCCC-----C----CcccCCHHHHH
Confidence 999999888999999999999999999999998543321111111 1111111111 1 111 3356778
Q ss_pred HhhhcccCCCCCCCCHHHHHHH
Q 046010 453 IGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~~ 474 (523)
++.+||+.+|++||++.++++.
T Consensus 235 li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 235 FISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHccCChhhCCCHHHHHhC
Confidence 8999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.6e-23 Score=210.10 Aligned_cols=168 Identities=30% Similarity=0.371 Sum_probs=127.0
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCchh
Q 046010 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPE 376 (523)
Q Consensus 297 ~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE 376 (523)
.++..+++.++.+.+.||+|||+++ +|||||-.+|+|++.++.+||+|||+++.-. ..........-+..|+|||
T Consensus 258 ~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~--~~~~~~~~~klPirWLAPE 332 (474)
T KOG0194|consen 258 SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGS--QYVMKKFLKKLPIRWLAPE 332 (474)
T ss_pred CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCc--ceeeccccccCcceecChh
Confidence 6999999999999999999999998 9999999999999999999999999987532 1111111223467899999
Q ss_pred hhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHhh
Q 046010 377 YALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGL 455 (523)
Q Consensus 377 ~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~ 455 (523)
.+..+.++.++|||||||++||+++ |..||...... +.......++... ..+...+..+..++.
T Consensus 333 tl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~v~~kI~~~~~r~---------~~~~~~p~~~~~~~~ 397 (474)
T KOG0194|consen 333 TLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------EVKAKIVKNGYRM---------PIPSKTPKELAKVMK 397 (474)
T ss_pred hhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------HHHHHHHhcCccC---------CCCCCCHHHHHHHHH
Confidence 9999999999999999999999999 77787432221 1111111221111 112233445566777
Q ss_pred hcccCCCCCCCCHHHHHHHhccCCCCCCC
Q 046010 456 LCVQEDPADRPNMSSVAVMLASDTVSLPQ 484 (523)
Q Consensus 456 ~cl~~dP~~RPs~~ei~~~L~~~~~~l~~ 484 (523)
+||..+|++||+|.+|.+.|+........
T Consensus 398 ~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 398 QCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred HhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 99999999999999999999887655443
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.3e-22 Score=193.44 Aligned_cols=160 Identities=26% Similarity=0.315 Sum_probs=121.9
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.+...+++..++.++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||.+....... ......++..|
T Consensus 94 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y 167 (258)
T cd06632 94 KKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYW 167 (258)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCCCcce
Confidence 34456899999999999999999999998 9999999999999999999999999987653322 22345678889
Q ss_pred CchhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 373 MAPEYALGGV-ISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 373 ~aPE~l~~~~-~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
++||.+.... ++.++|+||||+++|+|++|+.||..... ....+.......... .+......+.
T Consensus 168 ~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~---------~~~~~~~~~~ 232 (258)
T cd06632 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKELPP---------IPDHLSDEAK 232 (258)
T ss_pred eCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcccCCC---------cCCCcCHHHH
Confidence 9999987766 89999999999999999999999854321 111111111011111 1111234567
Q ss_pred HHhhhcccCCCCCCCCHHHHHH
Q 046010 452 HIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+++.+||+.+|++||++.++++
T Consensus 233 ~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 233 DFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHHHHhhcCcccCcCHHHHhc
Confidence 8899999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-22 Score=206.28 Aligned_cols=166 Identities=23% Similarity=0.336 Sum_probs=137.1
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..++..|+......++.||+.||.|||++. .|||||-..|||+.....+||+|||+++.+..+..... +...-+..
T Consensus 482 q~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYka-S~~kLPIK 557 (974)
T KOG4257|consen 482 QQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKA-SRGKLPIK 557 (974)
T ss_pred HhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccchhhc-ccccccee
Confidence 456677999999999999999999999997 99999999999999999999999999998764433322 23344678
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
|||||.+.-.+++.++|||-|||.+||++. |..||.... +..+.-.+...-+...++.++..+
T Consensus 558 WmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk----------------NsDVI~~iEnGeRlP~P~nCPp~L 621 (974)
T KOG4257|consen 558 WMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK----------------NSDVIGHIENGERLPCPPNCPPAL 621 (974)
T ss_pred ecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc----------------ccceEEEecCCCCCCCCCCCChHH
Confidence 999999999999999999999999999986 888975322 233333444455556677788899
Q ss_pred HHHhhhcccCCCCCCCCHHHHHHHhcc
Q 046010 451 IHIGLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
..||.+||.++|.+||.+.||.+.|+.
T Consensus 622 YslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 622 YSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred HHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 999999999999999999999887764
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-22 Score=205.34 Aligned_cols=175 Identities=23% Similarity=0.272 Sum_probs=121.7
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC---ccccceeccCCCC
Q 046010 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE---SNTSKVVGTYGYM 373 (523)
Q Consensus 297 ~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~---~~~~~~~gt~~y~ 373 (523)
.+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||.+......... .......++..|+
T Consensus 103 ~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~ 179 (337)
T cd07852 103 ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYR 179 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhccccccccc
Confidence 7899999999999999999999998 999999999999999999999999998865432221 1223456788999
Q ss_pred chhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHH--------HHHHhhhcCCcccccCccccC----
Q 046010 374 APEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLA--------YTWKLWCNGEALELMDPVLKQ---- 440 (523)
Q Consensus 374 aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~---- 440 (523)
|||.+.+ ..++.++||||||+++|+|++|+.||............. ..+..+......++++.....
T Consensus 180 aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (337)
T cd07852 180 APEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKP 259 (337)
T ss_pred CceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccc
Confidence 9998755 457889999999999999999999985322211000000 000000000000011000000
Q ss_pred --CccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 441 --SCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 441 --~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
.........+.+++.+||+.||++|||+.++++.
T Consensus 260 ~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 260 LDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0001123567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-22 Score=196.92 Aligned_cols=156 Identities=28% Similarity=0.388 Sum_probs=115.4
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC-CCCeeEeccccceeccCCCCCccccceeccCCCCchhh
Q 046010 299 DWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH-EMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEY 377 (523)
Q Consensus 299 ~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~ 377 (523)
++..+..++.||+.||.|||+++ |+||||||+||+++. ++.+||+|||.+........ ......++..|+|||.
T Consensus 106 ~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~ 180 (268)
T cd06624 106 NEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEV 180 (268)
T ss_pred cHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--ccccCCCCccccChhh
Confidence 88899999999999999999998 999999999999986 67899999999876532221 1223457889999999
Q ss_pred hcCCC--CCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHhh
Q 046010 378 ALGGV--ISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGL 455 (523)
Q Consensus 378 l~~~~--~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~ 455 (523)
+.... ++.++||||||+++|+|++|+.||........ ..+....... .+ ..+......+.+++.
T Consensus 181 ~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~-----~~----~~~~~~~~~~~~li~ 246 (268)
T cd06624 181 IDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-----AMFKVGMFKI-----HP----EIPESLSAEAKNFIL 246 (268)
T ss_pred hccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-----hHhhhhhhcc-----CC----CCCcccCHHHHHHHH
Confidence 86643 78899999999999999999999853221110 0011000000 00 111123345778899
Q ss_pred hcccCCCCCCCCHHHHHH
Q 046010 456 LCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 456 ~cl~~dP~~RPs~~ei~~ 473 (523)
+||+.+|++|||+.||++
T Consensus 247 ~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 247 RCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred HHcCCCchhCCCHHHHHh
Confidence 999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-22 Score=220.84 Aligned_cols=166 Identities=25% Similarity=0.329 Sum_probs=121.5
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC---------------
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE--------------- 360 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~--------------- 360 (523)
..+++..+++++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++........
T Consensus 108 ~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~ 184 (932)
T PRK13184 108 EKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184 (932)
T ss_pred cccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccc
Confidence 45778889999999999999999998 999999999999999999999999999865211100
Q ss_pred -ccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCcccc
Q 046010 361 -SNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLK 439 (523)
Q Consensus 361 -~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 439 (523)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .... ....... .+. .+
T Consensus 185 ~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~---ki~~--~~~i~~P--~~~-~p--- 253 (932)
T PRK13184 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR---KISY--RDVILSP--IEV-AP--- 253 (932)
T ss_pred cccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh---hhhh--hhhccCh--hhc-cc---
Confidence 0112346899999999999999999999999999999999999998542111 1100 0000000 000 00
Q ss_pred CCccHHHHHHHHHHhhhcccCCCCCCC-CHHHHHHHhccC
Q 046010 440 QSCMAAELLKCIHIGLLCVQEDPADRP-NMSSVAVMLASD 478 (523)
Q Consensus 440 ~~~~~~~~~~~~~li~~cl~~dP~~RP-s~~ei~~~L~~~ 478 (523)
....+..+.+++.+||+.||++|| +++++++.|+..
T Consensus 254 ---~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 254 ---YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred ---cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 012234567888999999999995 667777776654
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.9e-22 Score=201.21 Aligned_cols=110 Identities=25% Similarity=0.346 Sum_probs=94.2
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........ .......|++.|+
T Consensus 95 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~ 170 (331)
T cd05597 95 FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGTPDYI 170 (331)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCC-ccccceecccccc
Confidence 3567999999999999999999999998 99999999999999999999999999876543221 1122346899999
Q ss_pred chhhhcC-----CCCCcchhhHHHHHHHHHHHhCCCCCC
Q 046010 374 APEYALG-----GVISVKSDVFSFGVLLLEIISGKKNSG 407 (523)
Q Consensus 374 aPE~l~~-----~~~s~ksDVwSlGvvl~elltG~~p~~ 407 (523)
|||++.. ..++.++|||||||++|+|++|+.||.
T Consensus 171 aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 209 (331)
T cd05597 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred CHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence 9999863 457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-22 Score=205.06 Aligned_cols=171 Identities=27% Similarity=0.385 Sum_probs=132.3
Q ss_pred Eeeeccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceecc
Q 046010 279 IWIAIGTTI---PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFG 355 (523)
Q Consensus 279 ~~ia~g~~~---~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 355 (523)
-|+.+.+|+ ..+....+++|-+.++..|..+.+.||+|||+.+ .||||||..|||+++.|.|||+|||.+....
T Consensus 101 aWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 101 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA 177 (948)
T ss_pred HHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC
Confidence 477778887 3445667789999999999999999999999998 9999999999999999999999999987643
Q ss_pred CCCCCccccceeccCCCCchhhhc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCccc
Q 046010 356 GNQNESNTSKVVGTYGYMAPEYAL---GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALE 432 (523)
Q Consensus 356 ~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (523)
.-..++||+.|||||++. .++|+-|+||||||++..||...++|.-...-. .. .-++...+
T Consensus 178 ------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM------SA-LYHIAQNe--- 241 (948)
T KOG0577|consen 178 ------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SA-LYHIAQNE--- 241 (948)
T ss_pred ------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH------HH-HHHHHhcC---
Confidence 234689999999999885 478999999999999999999999885322111 10 11111111
Q ss_pred ccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 433 LMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 433 ~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.|.+.. .+-...+..++..||+.-|.+|||.++++.
T Consensus 242 --sPtLqs---~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 242 --SPTLQS---NEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred --CCCCCC---chhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 122222 233345667778999999999999998754
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-23 Score=193.75 Aligned_cols=177 Identities=24% Similarity=0.349 Sum_probs=139.5
Q ss_pred eEeeeccccc----cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 278 AIWIAIGTTI----PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 278 ~~~ia~g~~~----~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
-+||.+.+|- ..+...++++|++.++..+++..++||+|||... -||||||..|||++.+|..||+|||.+-.
T Consensus 102 DLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQ 178 (502)
T KOG0574|consen 102 DLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQ 178 (502)
T ss_pred ceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccch
Confidence 4688888887 4566788899999999999999999999999885 89999999999999999999999999977
Q ss_pred ccCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccc
Q 046010 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALEL 433 (523)
Q Consensus 354 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (523)
+.. +-.......||+.|||||++..-.|+.++||||||++..||..|++||..-.+......+ ...
T Consensus 179 LTD--TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI------------PT~ 244 (502)
T KOG0574|consen 179 LTD--TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI------------PTK 244 (502)
T ss_pred hhh--hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec------------cCC
Confidence 642 223345678999999999999999999999999999999999999997532222111000 000
Q ss_pred cCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 434 MDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 434 ~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
..+.++ .+..-...+-+++..||-.+|++|-|+.++++
T Consensus 245 PPPTF~--KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 245 PPPTFK--KPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCCCCC--ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 111111 23344557788999999999999999988765
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-22 Score=199.27 Aligned_cols=172 Identities=23% Similarity=0.297 Sum_probs=121.0
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
....+++..++.++.||+.||+|||+.+ |+|+||||+||++++++.+||+|||.+........ .......++..|+
T Consensus 109 ~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~ 184 (302)
T cd07864 109 GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES-RPYTNKVITLWYR 184 (302)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcccccccccCCcc-cccccceeccCcc
Confidence 3457999999999999999999999998 99999999999999999999999999886543221 1122234577899
Q ss_pred chhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCC---cccc--------cC------
Q 046010 374 APEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGE---ALEL--------MD------ 435 (523)
Q Consensus 374 aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~--------~~------ 435 (523)
|||.+.+ ..++.++||||||+++|+|++|+.||...... .............. ...+ .+
T Consensus 185 ~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (302)
T cd07864 185 PPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYR 261 (302)
T ss_pred ChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChhhcccccccccccccccccccc
Confidence 9998865 35788999999999999999999998532211 11111111110000 0000 00
Q ss_pred ccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 436 PVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 436 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
...... .......+.+++.+||+.||++||++.+|++
T Consensus 262 ~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 262 RRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred cchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000 0012356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.7e-22 Score=218.67 Aligned_cols=165 Identities=22% Similarity=0.288 Sum_probs=120.0
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCC----CcEEecCCCCCcEEeCC-----------------CCCeeEecccccee
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSR----LKVFHRDLKASNVLLDH-----------------EMNPKISDFGMARI 353 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~----~~ivH~Dlkp~NIll~~-----------------~~~~kL~Dfg~a~~ 353 (523)
...+++..++.|+.||+.||.|||+.+. ..||||||||+||||+. .+.+||+|||++..
T Consensus 112 ~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~ 191 (1021)
T PTZ00266 112 FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191 (1021)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccc
Confidence 4579999999999999999999998531 23999999999999964 23489999999986
Q ss_pred ccCCCCCccccceeccCCCCchhhhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcc
Q 046010 354 FGGNQNESNTSKVVGTYGYMAPEYALG--GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEAL 431 (523)
Q Consensus 354 ~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (523)
..... ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ... .........
T Consensus 192 l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~-----~~q-li~~lk~~p-- 260 (1021)
T PTZ00266 192 IGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN-----FSQ-LISELKRGP-- 260 (1021)
T ss_pred ccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc-----HHH-HHHHHhcCC--
Confidence 53221 1234568999999999864 4588999999999999999999999853211 111 111111111
Q ss_pred cccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHH--HHhccC
Q 046010 432 ELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVA--VMLASD 478 (523)
Q Consensus 432 ~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~--~~L~~~ 478 (523)
. +.. ......+.+||..||+.+|.+||++.|++ ..|...
T Consensus 261 ~-----lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 261 D-----LPI---KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred C-----CCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 0 000 01134577899999999999999999998 455433
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-23 Score=193.39 Aligned_cols=174 Identities=25% Similarity=0.335 Sum_probs=132.0
Q ss_pred cccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccc
Q 046010 286 TIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365 (523)
Q Consensus 286 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 365 (523)
.+..+|..++..+++...-+|..-.++||.||-+.- +||||||||+|||++..|.+||+|||.+-.+. .....+.
T Consensus 152 lYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv---~SiAkT~ 226 (361)
T KOG1006|consen 152 LYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV---DSIAKTV 226 (361)
T ss_pred HHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH---HHHHhhh
Confidence 336678899999999999999999999999998864 69999999999999999999999999987653 2223445
Q ss_pred eeccCCCCchhhhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCcc
Q 046010 366 VVGTYGYMAPEYALG--GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCM 443 (523)
Q Consensus 366 ~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 443 (523)
..|-..|||||.+.. ..|+.++||||||++|+|+.||+.|+..+.. ..+ .......+....+..+.- .
T Consensus 227 daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfe-ql~~Vv~gdpp~l~~~~~----~ 296 (361)
T KOG1006|consen 227 DAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFE-QLCQVVIGDPPILLFDKE----C 296 (361)
T ss_pred ccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHH-HHHHHHcCCCCeecCccc----c
Confidence 677789999998853 3489999999999999999999999854332 111 112222233222222111 1
Q ss_pred HHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 444 AAELLKCIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 444 ~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
......+.+++..||.+|.++||+..++.++
T Consensus 297 ~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 297 VHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 2234567788889999999999999998654
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-22 Score=205.39 Aligned_cols=173 Identities=26% Similarity=0.285 Sum_probs=121.5
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC--ccccceeccC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE--SNTSKVVGTY 370 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~--~~~~~~~gt~ 370 (523)
.....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++........ .......++.
T Consensus 97 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~ 173 (332)
T cd07857 97 RSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173 (332)
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCc
Confidence 35567999999999999999999999998 999999999999999999999999999865432211 1123356888
Q ss_pred CCCchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHH-----------HHhhhcCCccccc----
Q 046010 371 GYMAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYT-----------WKLWCNGEALELM---- 434 (523)
Q Consensus 371 ~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~---- 434 (523)
.|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ...... +..+.........
T Consensus 174 ~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (332)
T cd07857 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV---DQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLP 250 (332)
T ss_pred cccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH---HHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhcc
Confidence 9999998765 46889999999999999999999998542211 000000 0000000000000
Q ss_pred ---CccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 046010 435 ---DPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVA 472 (523)
Q Consensus 435 ---~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~ 472 (523)
...+.. ........+.+++.+||+.||++|||+.+++
T Consensus 251 ~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 251 NIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred ccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 000000 0001134677899999999999999999985
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.87 E-value=4e-22 Score=193.44 Aligned_cols=156 Identities=28% Similarity=0.309 Sum_probs=123.2
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
+..+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++...... ......++..|++
T Consensus 97 ~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~~~~ 169 (256)
T cd08530 97 RKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTPHYMA 169 (256)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC----CcccccCCccccC
Confidence 467899999999999999999999998 999999999999999999999999998876433 1223457789999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
||.+.+..++.++|+||||+++|+|++|+.||...... .. ........... .+......+.+++
T Consensus 170 Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~~-~~~~~~~~~~~---------~~~~~~~~~~~li 233 (256)
T cd08530 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ------DL-RYKVQRGKYPP---------IPPIYSQDLQNFI 233 (256)
T ss_pred HHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HH-HHHHhcCCCCC---------CchhhCHHHHHHH
Confidence 99999888999999999999999999999998532211 11 11111111111 1123445678899
Q ss_pred hhcccCCCCCCCCHHHHHH
Q 046010 455 LLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~ 473 (523)
.+||+.+|++||++.++++
T Consensus 234 ~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 234 RSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred HHHcCCCcccCCCHHHHhc
Confidence 9999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.9e-22 Score=201.99 Aligned_cols=164 Identities=18% Similarity=0.202 Sum_probs=116.1
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
+..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++........ .......||+.|+|
T Consensus 96 ~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~a 171 (332)
T cd05623 96 EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYIS 171 (332)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCc-ceecccccCccccC
Confidence 467999999999999999999999998 99999999999999999999999999876532221 12233568999999
Q ss_pred hhhhc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 375 PEYAL-----GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 375 PE~l~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
||++. ...++.++||||||+++|||++|+.||.... ................... . .......
T Consensus 172 PE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~------~~~~~~~i~~~~~~~~~p~-~-----~~~~s~~ 239 (332)
T cd05623 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKERFQFPA-Q-----VTDVSED 239 (332)
T ss_pred HHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC------HHHHHHHHhCCCccccCCC-c-----cccCCHH
Confidence 99986 3457899999999999999999999985321 1111122211111111100 0 0112234
Q ss_pred HHHHhhhcccCCC--CCCCCHHHHHHH
Q 046010 450 CIHIGLLCVQEDP--ADRPNMSSVAVM 474 (523)
Q Consensus 450 ~~~li~~cl~~dP--~~RPs~~ei~~~ 474 (523)
+.+++.+|+..++ ..|+++.|+++.
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 240 AKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 5567777775444 446888888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=194.50 Aligned_cols=173 Identities=27% Similarity=0.320 Sum_probs=125.8
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
+...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....++..|+
T Consensus 98 ~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~ 170 (287)
T cd06621 98 RGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL----AGTFTGTSFYM 170 (287)
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccccc----cccccCCcccc
Confidence 4566899999999999999999999998 9999999999999999999999999987543211 12345678899
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
+||.+.+..++.++||||||+++|+|++|+.||........ ...+.. ..........+.+. ... .......+.++
T Consensus 171 ~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~-~~~--~~~~~~~~~~l 245 (287)
T cd06621 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIELL-SYIVNMPNPELKDE-PGN--GIKWSEEFKDF 245 (287)
T ss_pred CHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC-ChHHHH-HHHhcCCchhhccC-CCC--CCchHHHHHHH
Confidence 99999988999999999999999999999999864432111 111111 11111111111111 100 01123467789
Q ss_pred hhhcccCCCCCCCCHHHHHH--HhccC
Q 046010 454 GLLCVQEDPADRPNMSSVAV--MLASD 478 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~--~L~~~ 478 (523)
+.+||+.+|++|||+.||++ .+.+.
T Consensus 246 i~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 246 IKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred HHHHcCCCcccCCCHHHHHhCcccccc
Confidence 99999999999999999987 44433
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.5e-22 Score=196.27 Aligned_cols=158 Identities=24% Similarity=0.366 Sum_probs=118.0
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhc-CCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 296 AQLDWKRRISIINGIARGLLYLHED-SRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~-g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
..+++..+..++.||+.||.|||+. + ++|+||||+||+++.++.+||+|||.+...... ......++..|+|
T Consensus 97 ~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~a 169 (286)
T cd06622 97 EGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS----LAKTNIGCQSYMA 169 (286)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC----ccccCCCccCccC
Confidence 4799999999999999999999974 6 999999999999999999999999998765322 1223457788999
Q ss_pred hhhhcCCC------CCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 375 PEYALGGV------ISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 375 PE~l~~~~------~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
||.+.+.. ++.++||||||+++|+|++|+.||...... ..... .......... ..+.....
T Consensus 170 PE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~-~~~~~~~~~~---------~~~~~~~~ 236 (286)
T cd06622 170 PERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFAQ-LSAIVDGDPP---------TLPSGYSD 236 (286)
T ss_pred cchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHHH-HHHHhhcCCC---------CCCcccCH
Confidence 99885543 578999999999999999999998532211 11111 1111111111 11122345
Q ss_pred HHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 449 KCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+.+++.+||+.+|++||++.+++.
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 237 DAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHHHHHHHHcccCcccCCCHHHHhc
Confidence 5678899999999999999999886
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=3e-22 Score=197.71 Aligned_cols=170 Identities=26% Similarity=0.310 Sum_probs=118.9
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..++.++.||++||.|||+++ ++|+||+|+||+++.++.++|+|||.+........ ......++..|+||
T Consensus 94 ~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aP 168 (283)
T cd07835 94 TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 168 (283)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--ccCccccccCCCCC
Confidence 47999999999999999999999998 99999999999999999999999999876532211 12223557889999
Q ss_pred hhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHH----------HHhhhc-CC----cccccCcccc
Q 046010 376 EYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYT----------WKLWCN-GE----ALELMDPVLK 439 (523)
Q Consensus 376 E~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~----------~~~~~~-~~----~~~~~~~~l~ 439 (523)
|.+.+. .++.++||||||+++|+|++|+.||...... ....... |..... .. ..........
T Consensus 169 E~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (283)
T cd07835 169 EILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI--DQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLS 246 (283)
T ss_pred ceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchh
Confidence 987664 5788999999999999999999998532211 0000000 000000 00 0000000000
Q ss_pred CCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 440 QSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 440 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.........+.+++.+||+.||++|||++|+++
T Consensus 247 -~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 247 -KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred -hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 001112246778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.3e-22 Score=196.42 Aligned_cols=172 Identities=23% Similarity=0.268 Sum_probs=119.1
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||+++....... ......++..|+|
T Consensus 97 ~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~a 171 (291)
T cd07870 97 PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ--TYSSEVVTLWYRP 171 (291)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCC--CCCCccccccccC
Confidence 456888999999999999999999998 99999999999999999999999999875432211 1223456889999
Q ss_pred hhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcC------------Cc-ccccCccccC
Q 046010 375 PEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNG------------EA-LELMDPVLKQ 440 (523)
Q Consensus 375 PE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~------------~~-~~~~~~~l~~ 440 (523)
||.+.+. .++.++||||||+++|+|++|+.||...... ...+...+..+... .. .+........
T Consensus 172 PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (291)
T cd07870 172 PDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQ 249 (291)
T ss_pred CceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCc
Confidence 9988753 4788999999999999999999998633221 11111111111000 00 0000000000
Q ss_pred Cc-----cHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 441 SC-----MAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 441 ~~-----~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.. .......+.+++.+|++.||++|||+.|++.
T Consensus 250 ~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 250 QLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred chhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00 0011345678899999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.5e-22 Score=192.69 Aligned_cols=165 Identities=24% Similarity=0.327 Sum_probs=123.1
Q ss_pred cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCC-eeEeccccceeccCCCCCccccce
Q 046010 288 PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMN-PKISDFGMARIFGGNQNESNTSKV 366 (523)
Q Consensus 288 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~-~kL~Dfg~a~~~~~~~~~~~~~~~ 366 (523)
.++.......+++..++.++.||++||.|||+.+ ++|+||||+||++++++. +||+|||.+........ .....
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 162 (257)
T cd08225 88 KRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTC 162 (257)
T ss_pred HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc--ccccc
Confidence 3343444556899999999999999999999998 999999999999998864 69999999876543221 12234
Q ss_pred eccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHH
Q 046010 367 VGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAE 446 (523)
Q Consensus 367 ~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 446 (523)
.+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.... ......... ...... +. ...
T Consensus 163 ~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~-~~~~~~-~~--------~~~ 226 (257)
T cd08225 163 VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKIC-QGYFAP-IS--------PNF 226 (257)
T ss_pred CCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHh-cccCCC-CC--------CCC
Confidence 57889999999988889999999999999999999999975321 111111111 111111 11 112
Q ss_pred HHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 447 LLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 447 ~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
...+.+++.+||+.+|++|||+.||++
T Consensus 227 ~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 227 SRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 245778899999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.2e-22 Score=196.86 Aligned_cols=158 Identities=28% Similarity=0.392 Sum_probs=120.3
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..++.++.||++||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .......++..|+||
T Consensus 96 ~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aP 170 (277)
T cd06917 96 GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAP 170 (277)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--cccccccCCcceeCH
Confidence 37999999999999999999999998 9999999999999999999999999998764332 122334678899999
Q ss_pred hhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 376 EYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 376 E~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
|.+.++ .++.++|+||||+++|+|++|..||...... ... ....... .+.+... .....+.+++
T Consensus 171 E~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~------~~~-~~~~~~~-----~~~~~~~---~~~~~~~~~i 235 (277)
T cd06917 171 EVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF------RAM-MLIPKSK-----PPRLEDN---GYSKLLREFV 235 (277)
T ss_pred HHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh------hhh-hccccCC-----CCCCCcc---cCCHHHHHHH
Confidence 988754 4688999999999999999999998532211 000 0000100 0111111 1234677899
Q ss_pred hhcccCCCCCCCCHHHHHH
Q 046010 455 LLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~ 473 (523)
.+||+.||++||++.++++
T Consensus 236 ~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 236 AACLDEEPKERLSAEELLK 254 (277)
T ss_pred HHHcCCCcccCcCHHHHhh
Confidence 9999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.9e-22 Score=192.09 Aligned_cols=161 Identities=24% Similarity=0.299 Sum_probs=122.2
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
+...+++..+..++.||++||.|||+++ ++|+||+|+||+++.++.++|+|||.+....... ......++..|+
T Consensus 86 ~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~ 159 (262)
T cd05572 86 DRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYV 159 (262)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcCcc
Confidence 3456899999999999999999999998 9999999999999999999999999998764322 122346788999
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
+||.+.+..++.++|+||||+++|+|++|..||.....+ .............. ...+......+.++
T Consensus 160 ~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~ 226 (262)
T cd05572 160 APEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDILKGNGK---------LEFPNYIDKAAKDL 226 (262)
T ss_pred ChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHhccCCC---------CCCCcccCHHHHHH
Confidence 999998888999999999999999999999998643321 11111111100110 01111124567889
Q ss_pred hhhcccCCCCCCCC-----HHHHHH
Q 046010 454 GLLCVQEDPADRPN-----MSSVAV 473 (523)
Q Consensus 454 i~~cl~~dP~~RPs-----~~ei~~ 473 (523)
+.+||+.+|++||+ ++|+++
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 227 IKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHccCChhhCcCCcccCHHHHhc
Confidence 99999999999999 677665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.3e-22 Score=200.20 Aligned_cols=157 Identities=28% Similarity=0.368 Sum_probs=119.4
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++...... ....++..|+
T Consensus 108 ~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~ 178 (307)
T cd06607 108 HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWM 178 (307)
T ss_pred cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC------CCccCCcccc
Confidence 3456999999999999999999999998 999999999999999999999999998764321 2345678899
Q ss_pred chhhhc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 374 APEYAL---GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 374 aPE~l~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
|||.+. ...++.++||||||+++|+|++|+.||...... ...... ....... +. .......+
T Consensus 179 aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------~~~~~~-~~~~~~~-----~~---~~~~~~~~ 243 (307)
T cd06607 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHI-AQNDSPT-----LS---SNDWSDYF 243 (307)
T ss_pred CceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH------HHHHHH-hcCCCCC-----CC---chhhCHHH
Confidence 999874 356889999999999999999999997432111 111111 1111000 00 11233467
Q ss_pred HHHhhhcccCCCCCCCCHHHHHHH
Q 046010 451 IHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
.+++.+||+.+|++||++.+|+..
T Consensus 244 ~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 244 RNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHHHHHhcCChhhCcCHHHHhcC
Confidence 889999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-22 Score=195.89 Aligned_cols=166 Identities=28% Similarity=0.342 Sum_probs=124.8
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCC------Cccccceec
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQN------ESNTSKVVG 368 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~------~~~~~~~~g 368 (523)
...+++..++.++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||++........ ........+
T Consensus 87 ~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (265)
T cd05579 87 VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVG 163 (265)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCccc
Confidence 347999999999999999999999998 99999999999999999999999999875432211 112233457
Q ss_pred cCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 369 TYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 369 t~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
+..|++||.......+.++||||||+++|++++|+.||...... ..... ...+.. ... . ......
T Consensus 164 ~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~-~~~~~~-~~~-----~--~~~~~~ 228 (265)
T cd05579 164 TPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQN-ILNGKI-EWP-----E--DVEVSD 228 (265)
T ss_pred CccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HhcCCc-CCC-----c--cccCCH
Confidence 78899999998888999999999999999999999998533211 11111 111110 000 0 000135
Q ss_pred HHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 449 KCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
.+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 229 ~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~ 258 (265)
T cd05579 229 EAIDLISKLLVPDPEKRLGAKSIEEIKNHP 258 (265)
T ss_pred HHHHHHHHHhcCCHhhcCCCccHHHHhcCc
Confidence 667899999999999999998888877654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=198.16 Aligned_cols=163 Identities=19% Similarity=0.225 Sum_probs=116.4
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
+..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++........ .......|++.|+|
T Consensus 96 ~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~a 171 (331)
T cd05624 96 EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYIS 171 (331)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCc-eeeccccCCcccCC
Confidence 467999999999999999999999998 99999999999999999999999999976543221 12233568999999
Q ss_pred hhhhcC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 375 PEYALG-----GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 375 PE~l~~-----~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
||++.+ +.++.++||||||+++|+|++|+.||..... ...............+ .... ......
T Consensus 172 PE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~~~-p~~~-----~~~~~~ 239 (331)
T cd05624 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHEERFQF-PSHI-----TDVSEE 239 (331)
T ss_pred HHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHHcCCCcccC-CCcc-----ccCCHH
Confidence 999875 4678899999999999999999999853221 1111111111111111 1111 112345
Q ss_pred HHHHhhhcccCCCCC--CCCHHHHHH
Q 046010 450 CIHIGLLCVQEDPAD--RPNMSSVAV 473 (523)
Q Consensus 450 ~~~li~~cl~~dP~~--RPs~~ei~~ 473 (523)
+.+++.+|+..++++ |++++++++
T Consensus 240 ~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 240 AKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred HHHHHHHHccCchhhcCCCCHHHHhc
Confidence 667788888765544 467777764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=6e-22 Score=195.48 Aligned_cols=174 Identities=22% Similarity=0.215 Sum_probs=121.1
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.||+++|.|||+++ ++|+||+|+||+++.++.++|+|||.+....... ......++..|+|
T Consensus 93 ~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~a 166 (283)
T cd07830 93 GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---PYTDYVSTRWYRA 166 (283)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC---CcCCCCCcccccC
Confidence 357899999999999999999999998 9999999999999999999999999998653221 1223457788999
Q ss_pred hhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccc-hH-------H--HHHHhhhcCCcccccCccccC---
Q 046010 375 PEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQS-LL-------A--YTWKLWCNGEALELMDPVLKQ--- 440 (523)
Q Consensus 375 PE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~-~~-------~--~~~~~~~~~~~~~~~~~~l~~--- 440 (523)
||.+.. ..++.++|+||||+++++|++|+.||.......... .. . +.............+......
T Consensus 167 PE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (283)
T cd07830 167 PEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLH 246 (283)
T ss_pred ceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHH
Confidence 998754 457899999999999999999999885432211000 00 0 000000000000000000000
Q ss_pred CccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 441 SCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 441 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
.........+.+++.+||+.+|++||+++||+..
T Consensus 247 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 247 QLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred HHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0001113568899999999999999999998753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.8e-22 Score=192.10 Aligned_cols=147 Identities=18% Similarity=0.132 Sum_probs=113.0
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
+...+++..+..++.|+++||.|||+++ |+||||||+||+++.++.++|+|||.+...... .....++..|+
T Consensus 78 ~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~ 149 (237)
T cd05576 78 KFLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYC 149 (237)
T ss_pred HhcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcccc
Confidence 4456999999999999999999999998 999999999999999999999999987654321 11234466799
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
|||.+.+..++.++||||+|+++|+|++|+.|+...... ..... . ...+......+.++
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------~~~~~--~-------~~~~~~~~~~~~~l 208 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------INTHT--T-------LNIPEWVSEEARSL 208 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------ccccc--c-------cCCcccCCHHHHHH
Confidence 999988888899999999999999999999876321110 00000 0 00111123456788
Q ss_pred hhhcccCCCCCCCCHH
Q 046010 454 GLLCVQEDPADRPNMS 469 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ 469 (523)
+.+||+.||++||++.
T Consensus 209 i~~~l~~dp~~R~~~~ 224 (237)
T cd05576 209 LQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHccCCHHHhcCCC
Confidence 9999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.4e-22 Score=192.97 Aligned_cols=158 Identities=23% Similarity=0.349 Sum_probs=123.7
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.+|++||.+||+++ ++|+||+|+||+++.++.++|+|||.+....... .......++..|+|
T Consensus 97 ~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~ 171 (258)
T cd08215 97 GKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLS 171 (258)
T ss_pred CCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc--ceecceeeeecccC
Confidence 477999999999999999999999998 9999999999999999999999999998764332 12234567889999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
||.+.+..++.++|+||+|+++++|++|+.||..... ...... ........+ +......+.+++
T Consensus 172 pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~-~~~~~~~~~---------~~~~~~~~~~~i 235 (258)
T cd08215 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALK-ILKGQYPPI---------PSQYSSELRNLV 235 (258)
T ss_pred hhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHH-HhcCCCCCC---------CCCCCHHHHHHH
Confidence 9999888899999999999999999999999753221 111111 111111111 112234677889
Q ss_pred hhcccCCCCCCCCHHHHHH
Q 046010 455 LLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~ 473 (523)
.+||..+|++||++.|+++
T Consensus 236 ~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 236 SSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred HHHcCCChhhCcCHHHHhc
Confidence 9999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=190.79 Aligned_cols=164 Identities=27% Similarity=0.407 Sum_probs=121.1
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcc--ccceeccCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN--TSKVVGTYG 371 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~--~~~~~gt~~ 371 (523)
++..+++..++.++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||.+........... .....++..
T Consensus 92 ~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
T cd06626 92 HGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPA 168 (264)
T ss_pred hcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcC
Confidence 3456899999999999999999999998 99999999999999999999999999887643322111 123456789
Q ss_pred CCchhhhcCCC---CCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 372 YMAPEYALGGV---ISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 372 y~aPE~l~~~~---~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
|+|||.+.+.. .+.++||||||+++|++++|+.||...... ....... ....... +.. ......
T Consensus 169 ~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~~~~~-~~~~~~~-----~~~--~~~~~~ 235 (264)
T cd06626 169 YMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIMFHV-GAGHKPP-----IPD--SLQLSP 235 (264)
T ss_pred ccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHHHHHH-hcCCCCC-----CCc--ccccCH
Confidence 99999988766 889999999999999999999998533211 0111110 1111111 100 011134
Q ss_pred HHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 449 KCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+.+++.+||+.+|++||++.+|+.
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 236 EGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhc
Confidence 5668899999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=199.04 Aligned_cols=167 Identities=25% Similarity=0.312 Sum_probs=119.6
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..++.++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||++...... .....++..|+||
T Consensus 113 ~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aP 184 (343)
T cd07851 113 QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 184 (343)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccccccccc-----ccCCcccccccCH
Confidence 57999999999999999999999998 999999999999999999999999998765322 2234567889999
Q ss_pred hhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHh-----------hhcCCcccccCccc---cC
Q 046010 376 EYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKL-----------WCNGEALELMDPVL---KQ 440 (523)
Q Consensus 376 E~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l---~~ 440 (523)
|.+.+ ..++.++||||||+++|++++|+.||....... ........ +........+.... ..
T Consensus 185 E~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (343)
T cd07851 185 EIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID---QLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKK 261 (343)
T ss_pred HHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCC
Confidence 98865 367899999999999999999999985322110 11100000 00000000000000 00
Q ss_pred Cc---cHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 441 SC---MAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 441 ~~---~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.. .......+.+++.+||+.||++|||+.||++
T Consensus 262 ~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 262 DFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00 0012456789999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=199.28 Aligned_cols=180 Identities=21% Similarity=0.235 Sum_probs=119.2
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC-CCCeeEeccccceeccCCCCC-ccccceeccCCC
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH-EMNPKISDFGMARIFGGNQNE-SNTSKVVGTYGY 372 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~gt~~y 372 (523)
...+++..++.++.||++||.|||+.+ ++||||||+||+++. ++.+||+|||.+......... .......++..|
T Consensus 108 ~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y 184 (342)
T cd07854 108 QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWY 184 (342)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccc
Confidence 346999999999999999999999998 999999999999975 457899999998765322111 112233568889
Q ss_pred CchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHH--------HHHhhhcCCcccccCccccCCcc
Q 046010 373 MAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAY--------TWKLWCNGEALELMDPVLKQSCM 443 (523)
Q Consensus 373 ~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~~~~ 443 (523)
+|||.+.. ..++.++||||||+++|+|++|+.||.............. .+....................+
T Consensus 185 ~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (342)
T cd07854 185 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRP 264 (342)
T ss_pred cCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCC
Confidence 99998754 4578899999999999999999999853221100000000 00000000000000000000000
Q ss_pred -----HHHHHHHHHHhhhcccCCCCCCCCHHHHH--HHhcc
Q 046010 444 -----AAELLKCIHIGLLCVQEDPADRPNMSSVA--VMLAS 477 (523)
Q Consensus 444 -----~~~~~~~~~li~~cl~~dP~~RPs~~ei~--~~L~~ 477 (523)
......+.+++.+||+.||++|||+.||+ .+|+.
T Consensus 265 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 265 LRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred HHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 01224577899999999999999999997 44543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-22 Score=199.83 Aligned_cols=160 Identities=29% Similarity=0.342 Sum_probs=121.0
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
..+.++++.++..++.||+.||.|||+++ ++|+||+|+||+++.++.+||+|||++..... .....++..|
T Consensus 117 ~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y 187 (317)
T cd06635 117 VHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYW 187 (317)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC------cccccCCccc
Confidence 34567999999999999999999999998 99999999999999999999999998865422 2234577889
Q ss_pred Cchhhhc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 373 MAPEYAL---GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 373 ~aPE~l~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
+|||.+. .+.++.++||||||+++|+|++|+.||...... .. ...+........ ........
T Consensus 188 ~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~-~~~~~~~~~~~~--------~~~~~~~~ 252 (317)
T cd06635 188 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SA-LYHIAQNESPTL--------QSNEWSDY 252 (317)
T ss_pred cChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH------HH-HHHHHhccCCCC--------CCccccHH
Confidence 9999874 456889999999999999999999997432111 11 111111111100 01122345
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHHHhc
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAVMLA 476 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~~L~ 476 (523)
+.+++.+||+.+|.+||++.+|++.+-
T Consensus 253 l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 253 FRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred HHHHHHHHccCCcccCcCHHHHHhChh
Confidence 678899999999999999999987553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.9e-22 Score=181.08 Aligned_cols=196 Identities=22% Similarity=0.365 Sum_probs=136.7
Q ss_pred CceeEeeeccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccc
Q 046010 275 GRKAIWIAIGTTI---PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA 351 (523)
Q Consensus 275 ~~~~~~ia~g~~~---~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 351 (523)
.+...|+....|. .-+..+.+.+++..++.+++.++..||.|+|... |+|||+|+.|+||+.++.+||+|||++
T Consensus 95 ~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 95 DRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence 3446677766666 3345677789999999999999999999999997 999999999999999999999999999
Q ss_pred eeccCCCC--CccccceeccCCCCchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHH--------H
Q 046010 352 RIFGGNQN--ESNTSKVVGTYGYMAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLA--------Y 420 (523)
Q Consensus 352 ~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~--------~ 420 (523)
+.+..... ....+..+-|+.|++||.+.+ .+++++.|||.-||++.||++|.+-+..........++. .
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 86643222 222345677999999999887 458999999999999999999998765322221111111 1
Q ss_pred HHHhhhcCCccccc--CccccCC--ccHHHH------HHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 421 TWKLWCNGEALELM--DPVLKQS--CMAAEL------LKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 421 ~~~~~~~~~~~~~~--~~~l~~~--~~~~~~------~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+|....+-...+.+ .|..... ...+.. ....+|+..++..||.+|+++++++.
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 12211111111111 1000000 001111 25678888999999999999998864
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.2e-22 Score=198.92 Aligned_cols=159 Identities=28% Similarity=0.335 Sum_probs=120.2
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
..+..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..... .....++..|
T Consensus 107 ~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y 177 (308)
T cd06634 107 VHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPYW 177 (308)
T ss_pred HcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC------cccccCCccc
Confidence 34556899999999999999999999998 99999999999999999999999999876532 1234577899
Q ss_pred Cchhhhc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 373 MAPEYAL---GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 373 ~aPE~l~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
+|||.+. ...++.++||||||+++|+|++|+.||...... ... ............ .......
T Consensus 178 ~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~-~~~~~~~~~~~~--------~~~~~~~ 242 (308)
T cd06634 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SAL-YHIAQNESPALQ--------SGHWSEY 242 (308)
T ss_pred cCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH------HHH-HHHhhcCCCCcC--------cccccHH
Confidence 9999874 356788999999999999999999997432111 000 111111111110 1122345
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHHHh
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAVML 475 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~~L 475 (523)
+.+++.+||+.+|++||++.+|++..
T Consensus 243 ~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 243 FRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred HHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 67889999999999999999998664
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=194.25 Aligned_cols=168 Identities=23% Similarity=0.322 Sum_probs=124.5
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
++..+++..++.++.|++++|.|||+.+ ++|+||||+||+++.++.++|+|||++......... ......++..|+
T Consensus 98 ~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~ 173 (288)
T cd05583 98 QREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYM 173 (288)
T ss_pred hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccccccccc-ccccccCCcccc
Confidence 4467999999999999999999999998 999999999999999999999999998765432211 122345788999
Q ss_pred chhhhcCCC--CCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 374 APEYALGGV--ISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 374 aPE~l~~~~--~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
+||.+.+.. .+.++||||||+++|+|++|..||........ ......... ... ... +......+.
T Consensus 174 aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~-~~~------~~~----~~~~~~~l~ 240 (288)
T cd05583 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRIL-KSK------PPF----PKTMSAEAR 240 (288)
T ss_pred CHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHH-ccC------CCC----CcccCHHHH
Confidence 999987655 78899999999999999999999853221111 111111111 100 001 111223566
Q ss_pred HHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 452 HIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+++.+||+.||++|||+.++.+.|+..
T Consensus 241 ~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 241 DFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred HHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 888999999999999999999888764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=199.45 Aligned_cols=173 Identities=24% Similarity=0.251 Sum_probs=132.2
Q ss_pred EeeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCC----CCeeEeccccceec
Q 046010 279 IWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE----MNPKISDFGMARIF 354 (523)
Q Consensus 279 ~~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~----~~~kL~Dfg~a~~~ 354 (523)
.++..|-.++.+... .+++..+..++.||+.+++|||+.| |+||||||+|+|+... +.+|++|||++...
T Consensus 116 EL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 116 ELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 334445555444444 3999999999999999999999999 9999999999999643 47999999999987
Q ss_pred cCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCccccc
Q 046010 355 GGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELM 434 (523)
Q Consensus 355 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (523)
.. ........||+.|+|||++....|+..+||||+|+++|.|++|..||........ . .....++. +
T Consensus 190 ~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~--~-----~~i~~~~~-~-- 256 (382)
T KOG0032|consen 190 KP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI--F-----LAILRGDF-D-- 256 (382)
T ss_pred cC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH--H-----HHHHcCCC-C--
Confidence 54 3445678999999999999999999999999999999999999999853322111 1 11122222 1
Q ss_pred CccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 435 DPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 435 ~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+....-......+.+++..++..||.+|+|+.++++
T Consensus 257 ---f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 257 ---FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred ---CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 111111233456678889999999999999999988
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-21 Score=193.12 Aligned_cols=156 Identities=23% Similarity=0.267 Sum_probs=120.5
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+...+++..++.++.||++||.|||+++ ++|+||+|+||+++.++.+||+|||++...... .....+++.
T Consensus 92 ~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~ 163 (290)
T cd05580 92 LRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPE 163 (290)
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCcc
Confidence 344578999999999999999999999998 999999999999999999999999998875432 223457889
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|++||.+.+...+.++||||||+++|+|++|+.||..... . ........+.. .+ +......+.
T Consensus 164 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~-~~~~~~~~~~~------~~----~~~~~~~l~ 226 (290)
T cd05580 164 YLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP------I-QIYEKILEGKV------RF----PSFFSPDAK 226 (290)
T ss_pred ccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------H-HHHHHHhcCCc------cC----CccCCHHHH
Confidence 9999999888889999999999999999999999853221 1 11111111110 01 111234667
Q ss_pred HHhhhcccCCCCCCC-----CHHHHH
Q 046010 452 HIGLLCVQEDPADRP-----NMSSVA 472 (523)
Q Consensus 452 ~li~~cl~~dP~~RP-----s~~ei~ 472 (523)
+++.+||+.||.+|+ +++|++
T Consensus 227 ~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 227 DLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred HHHHHHccCCHHHccCcccCCHHHHH
Confidence 888999999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.1e-22 Score=191.91 Aligned_cols=160 Identities=26% Similarity=0.268 Sum_probs=122.0
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.+...+++..+..++.||++||.|||+++ ++|+||+|+||++++++.++|+|||.+....... ......++..|
T Consensus 92 ~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y 165 (258)
T cd05578 92 SQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGY 165 (258)
T ss_pred HhcCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc---cccccCCChhh
Confidence 33468999999999999999999999998 9999999999999999999999999987654322 22234577889
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
+|||.+.+..++.++|+||||+++|+|++|+.||......... ........ .. ...+......+.+
T Consensus 166 ~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~--~~--------~~~~~~~~~~~~~ 231 (258)
T cd05578 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD----QIRAKQET--AD--------VLYPATWSTEAID 231 (258)
T ss_pred cCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH----HHHHHhcc--cc--------ccCcccCcHHHHH
Confidence 9999998888999999999999999999999998644332111 11111110 00 0111122357778
Q ss_pred HhhhcccCCCCCCCCH--HHHH
Q 046010 453 IGLLCVQEDPADRPNM--SSVA 472 (523)
Q Consensus 453 li~~cl~~dP~~RPs~--~ei~ 472 (523)
++.+||+.||.+||++ +|++
T Consensus 232 ~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 232 AINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHHHHccCChhHcCCccHHHHh
Confidence 9999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=193.86 Aligned_cols=170 Identities=28% Similarity=0.351 Sum_probs=119.9
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..++.++.||+.||.|||+++ ++|+||||+||++++++.+||+|||.+........ ......++..|++|
T Consensus 95 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~P 169 (284)
T cd07836 95 GALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAP 169 (284)
T ss_pred CCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--ccccccccccccCh
Confidence 46999999999999999999999998 99999999999999999999999999875532211 12234567889999
Q ss_pred hhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchH--------HHHHHhhhcCCcccccCcccc-------
Q 046010 376 EYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLL--------AYTWKLWCNGEALELMDPVLK------- 439 (523)
Q Consensus 376 E~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~l~------- 439 (523)
|.+.+. .++.++||||||+++|+|++|+.||............ ...+..+... ... .....
T Consensus 170 E~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~ 246 (284)
T cd07836 170 DVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL--PEY-KPTFPRYPPQDL 246 (284)
T ss_pred HHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcC--chh-cccccCCChHHH
Confidence 988664 4688999999999999999999998643221110000 0001111100 000 00000
Q ss_pred CCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 440 QSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 440 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
..........+.+++.+||+.||.+||++.+|++
T Consensus 247 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 247 QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0001122346778999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-21 Score=192.15 Aligned_cols=173 Identities=26% Similarity=0.297 Sum_probs=121.4
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..++.++.|+++||.+||+++ |+|+||+|+||++++++.+||+|||.+........ .......+..|+||
T Consensus 93 ~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aP 167 (282)
T cd07829 93 GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYTHEVVTLWYRAP 167 (282)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc--ccCccccCcCcCCh
Confidence 57999999999999999999999998 99999999999999999999999999876543221 12223456789999
Q ss_pred hhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccc-h-------HHHHHHhhhcCC-cccccCccccC---Cc
Q 046010 376 EYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQS-L-------LAYTWKLWCNGE-ALELMDPVLKQ---SC 442 (523)
Q Consensus 376 E~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~-~-------~~~~~~~~~~~~-~~~~~~~~l~~---~~ 442 (523)
|.+.+. .++.++||||||+++|+|++|+.||.......... + ....|..+..-. ........... ..
T Consensus 168 E~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (282)
T cd07829 168 EILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKV 247 (282)
T ss_pred HHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHh
Confidence 998776 78999999999999999999998885432111000 0 001111111100 00000000000 00
Q ss_pred cHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 443 MAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 443 ~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.......+.+++.+||+.||++||++.+++.
T Consensus 248 ~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 248 LPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0112456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.8e-22 Score=211.15 Aligned_cols=166 Identities=19% Similarity=0.216 Sum_probs=109.3
Q ss_pred cCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC-CCCeeEeccccceeccCCCCCccccceeccCCCCchh
Q 046010 298 LDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH-EMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPE 376 (523)
Q Consensus 298 l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE 376 (523)
..+..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++.+..... .......+++.|+|||
T Consensus 252 r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE 327 (566)
T PLN03225 252 RENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPE 327 (566)
T ss_pred hhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChH
Confidence 345567789999999999999998 999999999999986 57899999999986532221 2233567889999999
Q ss_pred hhcCC----------------------CCCcchhhHHHHHHHHHHHhCCCCCCCcccc-------cccchHHHHHHhhhc
Q 046010 377 YALGG----------------------VISVKSDVFSFGVLLLEIISGKKNSGFYLSE-------HGQSLLAYTWKLWCN 427 (523)
Q Consensus 377 ~l~~~----------------------~~s~ksDVwSlGvvl~elltG~~p~~~~~~~-------~~~~~~~~~~~~~~~ 427 (523)
.+... .++.++|||||||++|||+++..++...... ...... .|.....
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~--~~~~~~~ 405 (566)
T PLN03225 328 QYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLV--AWRKLVE 405 (566)
T ss_pred HhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHH--HHHHhhc
Confidence 66422 2345679999999999999977654311000 000000 1111100
Q ss_pred CCcccccCccccCCc--cHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 428 GEALELMDPVLKQSC--MAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 428 ~~~~~~~~~~l~~~~--~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.. ..+.+.... .........+|+.+||+.||++|||+.|+++
T Consensus 406 ~~----~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 406 PR----ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALA 449 (566)
T ss_pred cc----cchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhC
Confidence 00 000000000 0011223458999999999999999999986
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-21 Score=192.91 Aligned_cols=159 Identities=24% Similarity=0.340 Sum_probs=120.6
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........ ......++..|++|
T Consensus 111 ~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~P 185 (286)
T cd06614 111 VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAP 185 (286)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh--hhccccCCcccCCH
Confidence 47999999999999999999999998 99999999999999999999999998865432211 12233567889999
Q ss_pred hhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHhh
Q 046010 376 EYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGL 455 (523)
Q Consensus 376 E~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~ 455 (523)
|.+.+..++.++||||||+++|+|++|+.||...... ..... ........... .......+.+++.
T Consensus 186 E~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~~~~~-------~~~~~~~l~~li~ 251 (286)
T cd06614 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL------RALFL-ITTKGIPPLKN-------PEKWSPEFKDFLN 251 (286)
T ss_pred hHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HHhcCCCCCcc-------hhhCCHHHHHHHH
Confidence 9998888999999999999999999999997532211 11111 11111111100 1112346778999
Q ss_pred hcccCCCCCCCCHHHHHH
Q 046010 456 LCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 456 ~cl~~dP~~RPs~~ei~~ 473 (523)
+||+.+|.+||++.+|++
T Consensus 252 ~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 252 KCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HHhccChhhCcCHHHHhh
Confidence 999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-21 Score=192.44 Aligned_cols=160 Identities=22% Similarity=0.304 Sum_probs=120.4
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.|++.+|+|||+++ ++|+||+|+||++++++.++|+|||++....... .......++..|++
T Consensus 110 ~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~ 184 (292)
T cd06657 110 HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMA 184 (292)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccccCccccC
Confidence 346899999999999999999999998 9999999999999999999999999987653221 11223457889999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
||.+.+..++.++|+||||+++|+|++|+.||...... ......... .. +.+.. .......+.+++
T Consensus 185 pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~~~-----~~----~~~~~--~~~~~~~l~~li 250 (292)
T cd06657 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDN-----LP----PKLKN--LHKVSPSLKGFL 250 (292)
T ss_pred HHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhh-----CC----cccCC--cccCCHHHHHHH
Confidence 99998888899999999999999999999998532211 111111000 00 00000 011223566788
Q ss_pred hhcccCCCCCCCCHHHHHH
Q 046010 455 LLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~ 473 (523)
.+||+.+|.+||++.+|++
T Consensus 251 ~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 251 DRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHhCCcccCcCHHHHhc
Confidence 9999999999999999877
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-21 Score=194.46 Aligned_cols=160 Identities=23% Similarity=0.308 Sum_probs=121.3
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++.++..++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||++........ ......++..|++|
T Consensus 110 ~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~~P 184 (293)
T cd06647 110 TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAP 184 (293)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc--ccccccCChhhcCc
Confidence 45889999999999999999999998 99999999999999999999999998876543221 12234578889999
Q ss_pred hhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHhh
Q 046010 376 EYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGL 455 (523)
Q Consensus 376 E~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~ 455 (523)
|.+....++.++||||||+++|++++|+.||......... ......+. . .. .........+.+++.
T Consensus 185 E~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~------~~~~~~~~-~-----~~--~~~~~~~~~l~~li~ 250 (293)
T cd06647 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNGT-P-----EL--QNPEKLSAIFRDFLN 250 (293)
T ss_pred hhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe------eehhcCCC-C-----CC--CCccccCHHHHHHHH
Confidence 9998888999999999999999999999998543221110 00000000 0 00 011122345678899
Q ss_pred hcccCCCCCCCCHHHHHHH
Q 046010 456 LCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 456 ~cl~~dP~~RPs~~ei~~~ 474 (523)
+||+.+|++||++.+++..
T Consensus 251 ~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 251 RCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHccCChhhCcCHHHHhcC
Confidence 9999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=196.56 Aligned_cols=188 Identities=20% Similarity=0.247 Sum_probs=127.6
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++...... .....++..|++
T Consensus 112 ~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~a 183 (343)
T cd07880 112 HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRA 183 (343)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccccC-----ccccccCCcccC
Confidence 357999999999999999999999998 999999999999999999999999998764321 223456788999
Q ss_pred hhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCccccccc-chH-------HHHHHhhhcCCcccccCc--cccC---
Q 046010 375 PEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQ-SLL-------AYTWKLWCNGEALELMDP--VLKQ--- 440 (523)
Q Consensus 375 PE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~-~~~-------~~~~~~~~~~~~~~~~~~--~l~~--- 440 (523)
||.+.+ ..++.++|+||||+++|++++|+.||......... ... ...+..+........... ....
T Consensus 184 PE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (343)
T cd07880 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDF 263 (343)
T ss_pred HHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchH
Confidence 998876 45889999999999999999999998633211000 000 000000000000000000 0000
Q ss_pred -CccHHHHHHHHHHhhhcccCCCCCCCCHHHHH--HHhccCCCCCCCCCCCCc
Q 046010 441 -SCMAAELLKCIHIGLLCVQEDPADRPNMSSVA--VMLASDTVSLPQPTQPAF 490 (523)
Q Consensus 441 -~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~--~~L~~~~~~l~~p~~p~~ 490 (523)
.........+.+++.+|++.||++|||+.+++ ..++........+..|+|
T Consensus 264 ~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~~ 316 (343)
T cd07880 264 RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPPY 316 (343)
T ss_pred HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCCc
Confidence 00011233577899999999999999999998 556555444444444443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.4e-22 Score=200.51 Aligned_cols=171 Identities=26% Similarity=0.343 Sum_probs=133.9
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+.-+...+|+.||+.||+||.+.. +|||||.+.|+|++.++++||+|||+++.+-..+......+.+-++.|||+
T Consensus 632 pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmaw 708 (807)
T KOG1094|consen 632 PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAW 708 (807)
T ss_pred cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhH
Confidence 44566778889999999999999997 999999999999999999999999999966555555666677778999999
Q ss_pred hhhcCCCCCcchhhHHHHHHHHHHHh--CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 376 EYALGGVISVKSDVFSFGVLLLEIIS--GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 376 E~l~~~~~s~ksDVwSlGvvl~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
|.+..++++.++|||+||+++||+++ ..+||.....+ ...+........+.... -...+...+.++.++
T Consensus 709 EsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~~~~------~l~~P~~cp~~lyel 779 (807)
T KOG1094|consen 709 ESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQGRQV------VLSRPPACPQGLYEL 779 (807)
T ss_pred HHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCCcce------eccCCCcCcHHHHHH
Confidence 99999999999999999999999876 66776433222 22222222222211111 112244566788899
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
|++||..|-++||++++|...|.+.
T Consensus 780 ml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 780 MLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HHHHhchhhhcCCCHHHHHHHHHHh
Confidence 9999999999999999999999765
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-21 Score=193.90 Aligned_cols=159 Identities=27% Similarity=0.358 Sum_probs=119.3
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
......+++..++.++.||+.+|.|||+++ ++|+||+|+||+++.++.+||+|||++.... ......++..
T Consensus 112 ~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~------~~~~~~~~~~ 182 (313)
T cd06633 112 EVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS------PANSFVGTPY 182 (313)
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC------CCCCcccccc
Confidence 344567999999999999999999999998 9999999999999999999999999876432 1223567889
Q ss_pred CCchhhhc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 372 YMAPEYAL---GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 372 y~aPE~l~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
|+|||.+. ...++.++||||||+++|+|++|..||..... ......... ........ .....
T Consensus 183 y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~-~~~~~~~~--------~~~~~ 247 (313)
T cd06633 183 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQ-NDSPTLQS--------NEWTD 247 (313)
T ss_pred ccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHh-cCCCCCCc--------cccCH
Confidence 99999874 45688899999999999999999999743221 111111111 11111111 11123
Q ss_pred HHHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 449 KCIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
.+.+++.+||+.+|.+||++.+++..
T Consensus 248 ~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 248 SFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 46788999999999999999988743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.8e-22 Score=201.83 Aligned_cols=172 Identities=23% Similarity=0.261 Sum_probs=119.0
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++..... ......++..|+|
T Consensus 114 ~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~a 185 (345)
T cd07877 114 CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRA 185 (345)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEecccccccccc-----cccccccCCCccC
Confidence 346999999999999999999999998 99999999999999999999999999876422 1223467888999
Q ss_pred hhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHH--------HHHHhhhcCCcccc---cCccccCCc
Q 046010 375 PEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLA--------YTWKLWCNGEALEL---MDPVLKQSC 442 (523)
Q Consensus 375 PE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~---~~~~l~~~~ 442 (523)
||.+.+ ..++.++||||||+++|+|++|+.||............. .....+........ +........
T Consensus 186 PE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (345)
T cd07877 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNF 265 (345)
T ss_pred HHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcch
Confidence 998866 568899999999999999999999985322111000000 00000000000000 000000000
Q ss_pred ---cHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 443 ---MAAELLKCIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 443 ---~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
.......+.+++.+||+.||.+||++.++++.
T Consensus 266 ~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 266 ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00123456789999999999999999998653
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=198.93 Aligned_cols=175 Identities=23% Similarity=0.291 Sum_probs=122.1
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCC------------CC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ------------NE 360 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~------------~~ 360 (523)
..+..+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.+||+|||.+....... ..
T Consensus 111 ~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 187 (335)
T PTZ00024 111 DRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187 (335)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCccceeeccccccccccccccccccc
Confidence 44567999999999999999999999998 9999999999999999999999999997654111 01
Q ss_pred ccccceeccCCCCchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCc---cc----
Q 046010 361 SNTSKVVGTYGYMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEA---LE---- 432 (523)
Q Consensus 361 ~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~---- 432 (523)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...... ............... .+
T Consensus 188 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~ 264 (335)
T PTZ00024 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI---DQLGRIFELLGTPNEDNWPQAKKL 264 (335)
T ss_pred ccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCchhhCcchhhc
Confidence 111223457789999988764 4689999999999999999999998643221 111111111111000 00
Q ss_pred ----ccCccccC---CccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 433 ----LMDPVLKQ---SCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 433 ----~~~~~l~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
........ .........+.+++.+||+.+|++||+++|++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 265 PLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred ccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 00000000 000112356778999999999999999999986
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-22 Score=209.61 Aligned_cols=184 Identities=24% Similarity=0.340 Sum_probs=149.3
Q ss_pred eEeeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCC
Q 046010 278 AIWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGN 357 (523)
Q Consensus 278 ~~~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 357 (523)
.+|+++|++.+++.. .+..+-....+.|..||++||.|||++. +|||||-.+|+|+.+-..+||.|||+++....+
T Consensus 776 tq~mP~G~LlDyvr~-hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVRE-HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHhcccchHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 577888888877764 5667889999999999999999999987 999999999999999999999999999988766
Q ss_pred CCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCc
Q 046010 358 QNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDP 436 (523)
Q Consensus 358 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (523)
............+.|+|-|.+....++.++|||||||++||++| |..|+.....+ ++.+++..
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~----------------eI~dlle~ 915 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE----------------EIPDLLEK 915 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH----------------HhhHHHhc
Confidence 55554444455678999999999999999999999999999998 77886432222 22233333
Q ss_pred cccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCCC
Q 046010 437 VLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTVS 481 (523)
Q Consensus 437 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~ 481 (523)
..+.+.++.....+..+|.+||..|++.||+++++.+.+.+...+
T Consensus 916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 333444566778889999999999999999999999888765433
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=187.00 Aligned_cols=159 Identities=26% Similarity=0.377 Sum_probs=122.4
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
+...+++..++.++.|++.||.+||+++ |+|+||||+||+++.++.++|+|||.+......... .....++..|+
T Consensus 92 ~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~ 166 (254)
T cd06627 92 KFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWM 166 (254)
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccccccchhhc
Confidence 3367999999999999999999999998 999999999999999999999999999876433221 23346788999
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
+||.+.+...+.++|||+||+++|+|++|+.||..... ....+... ...... + +......+.++
T Consensus 167 ~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~------~~~~~~~~-~~~~~~-----~----~~~~~~~~~~~ 230 (254)
T cd06627 167 APEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP------MAALFRIV-QDDHPP-----L----PEGISPELKDF 230 (254)
T ss_pred CHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHh-ccCCCC-----C----CCCCCHHHHHH
Confidence 99999887889999999999999999999999753221 11111111 111111 1 11223466788
Q ss_pred hhhcccCCCCCCCCHHHHHH
Q 046010 454 GLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~ 473 (523)
+.+||+.+|++||++.+++.
T Consensus 231 i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 231 LMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHHHhCChhhCcCHHHHhc
Confidence 99999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.1e-22 Score=193.89 Aligned_cols=159 Identities=26% Similarity=0.359 Sum_probs=122.0
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
+..+++..+..++.|++.+|.+||+++ ++|+||||+||+++.++.++|+|||++....... .......++..|+|
T Consensus 95 ~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~ 169 (277)
T cd06641 95 PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMA 169 (277)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch--hhhccccCCccccC
Confidence 346899999999999999999999998 9999999999999999999999999987653221 11223457788999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
||.+.+...+.++|+||||+++|+|++|..||...... ..... ....... . ........+.+++
T Consensus 170 PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~-----~----~~~~~~~~~~~~i 233 (277)
T cd06641 170 PEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLFL-IPKNNPP-----T----LEGNYSKPLKEFV 233 (277)
T ss_pred hhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHHH-HhcCCCC-----C----CCcccCHHHHHHH
Confidence 99998888899999999999999999999997532111 11111 1111110 1 1112334577889
Q ss_pred hhcccCCCCCCCCHHHHHHH
Q 046010 455 LLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~~ 474 (523)
.+||+.+|.+||++.++++.
T Consensus 234 ~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 234 EACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHccCChhhCcCHHHHHhC
Confidence 99999999999999999884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-21 Score=194.75 Aligned_cols=169 Identities=25% Similarity=0.281 Sum_probs=116.9
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC-CCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH-EMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
..+++..++.++.||+.||+|||+++ ++|+||+|+||+++. ++.+||+|||++....... .......++..|+|
T Consensus 97 ~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~~ 171 (294)
T PLN00009 97 FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV--RTFTHEVVTLWYRA 171 (294)
T ss_pred CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc--cccccCceeecccC
Confidence 34688899999999999999999998 999999999999985 4578999999997653221 11223456789999
Q ss_pred hhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCccccc------------CccccCC
Q 046010 375 PEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELM------------DPVLKQS 441 (523)
Q Consensus 375 PE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~l~~~ 441 (523)
||.+.+ ..++.++||||||+++|+|++|+.||...... .........+... ..+.. .+.....
T Consensus 172 PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~---~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 247 (294)
T PLN00009 172 PEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI---DELFKIFRILGTP-NEETWPGVTSLPDYKSAFPKWPPK 247 (294)
T ss_pred HHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCC-ChhhccccccchhhhhhcccCCCC
Confidence 998866 45789999999999999999999998643221 1111111100000 00000 0000000
Q ss_pred ----ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 442 ----CMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 442 ----~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
........+.+++.+||+.+|++||++.++++
T Consensus 248 ~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 248 DLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred CHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00112345778999999999999999999986
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.3e-22 Score=213.67 Aligned_cols=164 Identities=30% Similarity=0.349 Sum_probs=127.8
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccc-cceeccCCCCch
Q 046010 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNT-SKVVGTYGYMAP 375 (523)
Q Consensus 297 ~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~-~~~~gt~~y~aP 375 (523)
.|+....+.++.||+.|++||+++. +|||||-.+|||+.++..+||+|||+++........... ....-...||||
T Consensus 414 ~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmAp 490 (609)
T KOG0200|consen 414 ALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAP 490 (609)
T ss_pred CcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCH
Confidence 4999999999999999999999997 999999999999999999999999999965443333211 111134569999
Q ss_pred hhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 376 EYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 376 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
|.+....++.|+||||||++||||++ |..|+.... .....++..+++.. ...+.....++.+||
T Consensus 491 Esl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~------~~~~l~~~l~~G~r---------~~~P~~c~~eiY~iM 555 (609)
T KOG0200|consen 491 ESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP------PTEELLEFLKEGNR---------MEQPEHCSDEIYDLM 555 (609)
T ss_pred HHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC------cHHHHHHHHhcCCC---------CCCCCCCCHHHHHHH
Confidence 99999999999999999999999998 666764211 01111223333332 233444566788999
Q ss_pred hhcccCCCCCCCCHHHHHHHhccC
Q 046010 455 LLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+.||+.+|++||++.++++.|+..
T Consensus 556 ~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 556 KSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHHhCCCcccCCCHHHHHHHHHHH
Confidence 999999999999999999999884
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-21 Score=191.69 Aligned_cols=161 Identities=24% Similarity=0.293 Sum_probs=119.9
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCC-CccccceeccCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQN-ESNTSKVVGTYGY 372 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~~gt~~y 372 (523)
+...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+++....... ........++..|
T Consensus 99 ~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y 175 (264)
T cd06653 99 AYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175 (264)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccc
Confidence 3456899999999999999999999998 99999999999999999999999999986532111 1112234578899
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
+|||.+.+...+.++|+||||+++|+|++|+.||..... ............. + ..+......+.+
T Consensus 176 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~-----~----~~p~~~~~~~~~ 240 (264)
T cd06653 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA------MAAIFKIATQPTK-----P----MLPDGVSDACRD 240 (264)
T ss_pred cCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH------HHHHHHHHcCCCC-----C----CCCcccCHHHHH
Confidence 999999888889999999999999999999999853211 1111111111110 1 112223345778
Q ss_pred HhhhcccCCCCCCCCHHHHHH
Q 046010 453 IGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~ 473 (523)
++.+||+ +|.+||++.+++.
T Consensus 241 ~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 241 FLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHhc-CcccCccHHHHhc
Confidence 8889999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.2e-21 Score=188.19 Aligned_cols=161 Identities=26% Similarity=0.332 Sum_probs=122.3
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC------------
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE------------ 360 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~------------ 360 (523)
.+...+++..++.++.||+.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 94 ~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~ 170 (280)
T cd05581 94 RKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170 (280)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccc
Confidence 44457999999999999999999999998 999999999999999999999999998865433211
Q ss_pred ------ccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCccccc
Q 046010 361 ------SNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELM 434 (523)
Q Consensus 361 ------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (523)
.......++..|++||.+....++.++||||||++++++++|+.||..... ........ ..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~-~~------ 237 (280)
T cd05581 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE------YLTFQKIL-KL------ 237 (280)
T ss_pred cccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHH-hc------
Confidence 122334577899999999888899999999999999999999999853321 11111111 00
Q ss_pred CccccCCccHHHHHHHHHHhhhcccCCCCCCCCH----HHHHH
Q 046010 435 DPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNM----SSVAV 473 (523)
Q Consensus 435 ~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~----~ei~~ 473 (523)
....+......+.+++.+||+.+|++||++ +++++
T Consensus 238 ----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 238 ----EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ----CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 001111124467789999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.4e-21 Score=187.77 Aligned_cols=159 Identities=25% Similarity=0.334 Sum_probs=121.2
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
..+..+++..++.++.|+++||.|||+++ ++|+||||+||+++. +.+||+|||.+........ ......++..|
T Consensus 98 ~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~ 171 (260)
T cd08222 98 HTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD--LATTFTGTPYY 171 (260)
T ss_pred hcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCCCcc--cccCCCCCcCc
Confidence 34567999999999999999999999998 999999999999975 5699999999876533221 12234567889
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
+|||.+.+..++.++|+||||+++|+|++|..||.... ........ ..+... ..+......+.+
T Consensus 172 ~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~-~~~~~~---------~~~~~~~~~~~~ 235 (260)
T cd08222 172 MSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRI-VEGPTP---------SLPETYSRQLNS 235 (260)
T ss_pred cCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHH-HcCCCC---------CCcchhcHHHHH
Confidence 99999988888999999999999999999999974211 11111111 111111 112233456778
Q ss_pred HhhhcccCCCCCCCCHHHHHH
Q 046010 453 IGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~ 473 (523)
++.+||+.+|++||++.||++
T Consensus 236 li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 236 IMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHHHHhcCChhhCcCHHHHhh
Confidence 999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.2e-21 Score=160.16 Aligned_cols=91 Identities=38% Similarity=0.720 Sum_probs=75.4
Q ss_pred CchhHHHHHHHHHHHHHHHhhcc-CCceeeeeeccCCCccEEEEEEecCCCChhchHHHHHHHHHhhhhhcCCCcceEEE
Q 046010 155 TGGLFNQQVRNLMNEAVNQALNT-TKMFGTVKKNYTASQTLYGLVQCTPDLSRHDCSTCLRLAISSFDECFSINIGGRMM 233 (523)
Q Consensus 155 ~~~~f~~~~~~ll~~l~~~a~~s-~~~~~~~~~~~~~~~~vyglaQC~~Dls~~~C~~CL~~~~~~~~~~c~~~~g~~v~ 233 (523)
++..|.+++..||..|++.|+.+ +.+|++++. ..+.++||||+||++||++.||..||+.++..+..+|+++.||+|+
T Consensus 15 ~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~-~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~~~~C~~~~g~~v~ 93 (106)
T PF01657_consen 15 DNSTFEQNLNSLLSSLVSNAASSSSKGFATGSA-GSGPDTVYGLAQCRGDLSPSDCRACLADAVANISSCCPGSRGGRVW 93 (106)
T ss_dssp TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE---ST---EEEEEEE-TTS-HHHHHHHHHHHHCCHHHHTTSBSSEEEE
T ss_pred CCchHHHHHHHHHHHHHHHHhhccccCcEEeec-CCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHHHHhCCCCceEEEE
Confidence 35569999999999999998764 579999986 3577899999999999999999999999999999999999999999
Q ss_pred cCCeeEEeecCCC
Q 046010 234 YPSCNFRYELYPF 246 (523)
Q Consensus 234 ~~~C~~Ry~~~~f 246 (523)
+++|+||||.|+|
T Consensus 94 ~~~C~lRY~~~~F 106 (106)
T PF01657_consen 94 YDSCFLRYENYPF 106 (106)
T ss_dssp ESSEEEEEESS--
T ss_pred CCCEEEEEECCCC
Confidence 9999999999998
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.1e-21 Score=184.09 Aligned_cols=156 Identities=28% Similarity=0.332 Sum_probs=119.9
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.+...+++..++.++.||++||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .......++..|
T Consensus 85 ~~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ 159 (250)
T cd05123 85 SKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPEY 159 (250)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCccc
Confidence 34457999999999999999999999998 9999999999999999999999999988754321 123345678899
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
++||...+...+.++|+||||+++|++++|+.||..... ....... .... . ..+......+.+
T Consensus 160 ~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~-~~~~-~---------~~~~~~~~~l~~ 222 (250)
T cd05123 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKI-LKDP-L---------RFPEFLSPEARD 222 (250)
T ss_pred cChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHH-hcCC-C---------CCCCCCCHHHHH
Confidence 999999888889999999999999999999999853221 1111111 1100 0 011111356678
Q ss_pred HhhhcccCCCCCCCCHHH
Q 046010 453 IGLLCVQEDPADRPNMSS 470 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~e 470 (523)
++.+||..||++||++.+
T Consensus 223 ~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 223 LISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHhcCCHhhCCCccc
Confidence 999999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.4e-21 Score=193.95 Aligned_cols=172 Identities=26% Similarity=0.333 Sum_probs=120.0
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
+..+++..+..++.||++||.|||+++ |+|+||+|+||+++.++.+||+|||.+..... ......++..|+|
T Consensus 102 ~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~-----~~~~~~~~~~y~a 173 (328)
T cd07856 102 SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDP-----QMTGYVSTRYYRA 173 (328)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCC-----CcCCCcccccccC
Confidence 456889999999999999999999998 99999999999999999999999999875422 1123456788999
Q ss_pred hhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHH--------HHHHhhhcCCcccccCcc-ccCCccH
Q 046010 375 PEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLA--------YTWKLWCNGEALELMDPV-LKQSCMA 444 (523)
Q Consensus 375 PE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~-l~~~~~~ 444 (523)
||.+.+ ..++.++||||||+++|+|++|+.||...........+. ..+..+......+.+... .....+.
T Consensus 174 PE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (328)
T cd07856 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPF 253 (328)
T ss_pred ceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcH
Confidence 998766 568999999999999999999999985432211100000 000000001111110000 0000011
Q ss_pred -----HHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 445 -----AELLKCIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 445 -----~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
.....+.+++.+||+.+|++||++.+++..
T Consensus 254 ~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 254 SEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 123567889999999999999999998654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.3e-21 Score=187.67 Aligned_cols=193 Identities=26% Similarity=0.344 Sum_probs=137.9
Q ss_pred ccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC------CCcEEecCCCCCcEEeCCCCCeeEeccccceeccC
Q 046010 283 IGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDS------RLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGG 356 (523)
Q Consensus 283 ~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g------~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 356 (523)
.|++.+++ +...++|....+|+..+++||+|||+.- +++|+|||||.+||||..|+...|+|||++..+..
T Consensus 292 kGsL~dyL---~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p 368 (534)
T KOG3653|consen 292 KGSLCDYL---KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEP 368 (534)
T ss_pred CCcHHHHH---HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecC
Confidence 56666555 4567999999999999999999999752 45799999999999999999999999999998876
Q ss_pred CCCCccccceeccCCCCchhhhcCCC-CC-----cchhhHHHHHHHHHHHhCCCCCCCcccccc----------cchHHH
Q 046010 357 NQNESNTSKVVGTYGYMAPEYALGGV-IS-----VKSDVFSFGVLLLEIISGKKNSGFYLSEHG----------QSLLAY 420 (523)
Q Consensus 357 ~~~~~~~~~~~gt~~y~aPE~l~~~~-~s-----~ksDVwSlGvvl~elltG~~p~~~~~~~~~----------~~~~~~ 420 (523)
..........+||.+|||||++.+.. +. .+.||||+|.|||||+++-.-+......+. ..-++.
T Consensus 369 ~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~ 448 (534)
T KOG3653|consen 369 GKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEE 448 (534)
T ss_pred CCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHH
Confidence 55555555689999999999997632 11 358999999999999987543311000000 011111
Q ss_pred HHHh-hhcCCcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCCCC
Q 046010 421 TWKL-WCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTVSL 482 (523)
Q Consensus 421 ~~~~-~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~l 482 (523)
.+.. ...+....+.+..... ..+..+.+.+..||..||+.|.|+.=+.+.+.+.....
T Consensus 449 mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 449 MQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred HHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 2222 1222222333332222 34556678888999999999999999999998875433
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.3e-21 Score=189.11 Aligned_cols=164 Identities=23% Similarity=0.316 Sum_probs=119.1
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.+...+++..+..++.||++||.|||+.+ ++||||+|+||+++.++.+||+|||++........ .......++..|
T Consensus 97 ~~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y 172 (290)
T cd05613 97 SQRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV-ERAYSFCGTIEY 172 (290)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceecccccc-cccccccCCccc
Confidence 44567999999999999999999999998 99999999999999999999999999876533221 112235578899
Q ss_pred CchhhhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 373 MAPEYALGG--VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 373 ~aPE~l~~~--~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
++||.+... .++.++||||||+++|+|++|+.||...... ............. . +. .+......+
T Consensus 173 ~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~-~------~~----~~~~~~~~~ 239 (290)
T cd05613 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKS-E------PP----YPQEMSALA 239 (290)
T ss_pred CChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhcc-C------CC----CCccCCHHH
Confidence 999988753 4678999999999999999999998532211 1111111111110 0 00 111123456
Q ss_pred HHHhhhcccCCCCCCC-----CHHHHHH
Q 046010 451 IHIGLLCVQEDPADRP-----NMSSVAV 473 (523)
Q Consensus 451 ~~li~~cl~~dP~~RP-----s~~ei~~ 473 (523)
.+++.+||+.||++|| ++.++++
T Consensus 240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 240 KDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 7888999999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-21 Score=186.83 Aligned_cols=168 Identities=20% Similarity=0.230 Sum_probs=131.9
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
.+..+.++..+...++.||+.|++|||+++ +||.||..+|++|++..++||+|=.+++.+-..+.+-.......+..
T Consensus 387 ~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvk 463 (563)
T KOG1024|consen 387 PSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVK 463 (563)
T ss_pred CccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCccc
Confidence 344566888899999999999999999999 99999999999999999999999988886544333333333345678
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
||+||.+.+..|+.++||||||+++|||+| |+.|+..-++.+ + .. .+....+...+.+++.++
T Consensus 464 WMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE---m----~~---------ylkdGyRlaQP~NCPDeL 527 (563)
T KOG1024|consen 464 WMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE---M----EH---------YLKDGYRLAQPFNCPDEL 527 (563)
T ss_pred ccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH---H----HH---------HHhccceecCCCCCcHHH
Confidence 999999999999999999999999999998 777864322211 1 11 112222333345677788
Q ss_pred HHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 451 IHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
..+|.-||...|++||++++++.-|.+-
T Consensus 528 f~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 528 FTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred HHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 8999999999999999999999988653
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-21 Score=171.91 Aligned_cols=128 Identities=28% Similarity=0.415 Sum_probs=103.0
Q ss_pred eEeeecc---ccccccc---cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccc
Q 046010 278 AIWIAIG---TTIPTIY---STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA 351 (523)
Q Consensus 278 ~~~ia~g---~~~~~~~---~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 351 (523)
-+||-+. .+.+-.| ..++..+++..+-+|+..|+.||.|||++- .+||||+||+||||+.+|++|++|||.+
T Consensus 119 dvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 119 DVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred cEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccc
Confidence 3566543 3333333 567888999999999999999999999974 6999999999999999999999999998
Q ss_pred eeccCCCCCccccceeccCCCCchhhhcC----CCCCcchhhHHHHHHHHHHHhCCCCCCCcc
Q 046010 352 RIFGGNQNESNTSKVVGTYGYMAPEYALG----GVISVKSDVFSFGVLLLEIISGKKNSGFYL 410 (523)
Q Consensus 352 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~s~ksDVwSlGvvl~elltG~~p~~~~~ 410 (523)
-.+.+. ...+...|-..|+|||.+.. ..|+.|+||||||+.+.||.+++.|++...
T Consensus 197 G~L~dS---iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 197 GYLVDS---IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred eeehhh---hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 776321 12223456678999998853 468999999999999999999999986433
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-21 Score=204.35 Aligned_cols=178 Identities=27% Similarity=0.409 Sum_probs=129.7
Q ss_pred ceeEeeeccccc----cccccc--cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC---C--CCee
Q 046010 276 RKAIWIAIGTTI----PTIYST--RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH---E--MNPK 344 (523)
Q Consensus 276 ~~~~~ia~g~~~----~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~---~--~~~k 344 (523)
+...||++.-|. +++... ..........+.++.|+++||++||+.+ ||||||||.||||+. + ..++
T Consensus 575 ~qF~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~ 651 (903)
T KOG1027|consen 575 RQFLYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAK 651 (903)
T ss_pred CceEEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEE
Confidence 447889887776 444442 1111222556889999999999999988 999999999999976 3 4689
Q ss_pred EeccccceeccCCCCCc-cccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhC-CCCCCCcccccccchHHHHH
Q 046010 345 ISDFGMARIFGGNQNES-NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISG-KKNSGFYLSEHGQSLLAYTW 422 (523)
Q Consensus 345 L~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG-~~p~~~~~~~~~~~~~~~~~ 422 (523)
|+|||+++.+..++... ......||.+|+|||++....-+.++|||||||++|+.++| .+||+.....+.
T Consensus 652 iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-------- 723 (903)
T KOG1027|consen 652 ISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-------- 723 (903)
T ss_pred ecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------
Confidence 99999999886554432 24567899999999999998888899999999999999997 899864332211
Q ss_pred HhhhcCCcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 046010 423 KLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVA 472 (523)
Q Consensus 423 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~ 472 (523)
...........+.+ ..++ ...+||.+|+..+|..||++.+|+
T Consensus 724 NIl~~~~~L~~L~~------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 724 NILTGNYTLVHLEP------LPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred hhhcCccceeeecc------CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 11111111111111 1111 667899999999999999999995
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.2e-21 Score=196.66 Aligned_cols=173 Identities=22% Similarity=0.316 Sum_probs=133.7
Q ss_pred eEeeeccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 278 AIWIAIGTTI---PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 278 ~~~ia~g~~~---~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
.+|..+.++. ...|..+..++.+..+..++.|+.+|++|||+++ |||||||++|||++.++++||+|||++..+
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceee
Confidence 4555555555 4557888889999999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCccccceeccCCCCchhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccc
Q 046010 355 GGNQNESNTSKVVGTYGYMAPEYALGGVI-SVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALEL 433 (523)
Q Consensus 355 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (523)
. .........|++.|.|||++.+..+ .++.|+||+|+++|.|+.|..||+...-. ... ...
T Consensus 206 ~---~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk------~Lr---------~rv 267 (596)
T KOG0586|consen 206 D---YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK------ELR---------PRV 267 (596)
T ss_pred c---ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc------ccc---------chh
Confidence 5 2334456789999999999998775 58899999999999999999998532111 100 001
Q ss_pred cCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 434 MDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 434 ~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+...++ .+......+-+|+.++|-.+|.+|+++++|.+
T Consensus 268 l~gk~r--Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 268 LRGKYR--IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eeeeec--ccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 111111 11122335667888999999999999999854
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.3e-20 Score=177.58 Aligned_cols=157 Identities=29% Similarity=0.317 Sum_probs=121.0
Q ss_pred cCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCchhh
Q 046010 298 LDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEY 377 (523)
Q Consensus 298 l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~ 377 (523)
+++..++.++.+++++|.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..|++||.
T Consensus 84 ~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~ 157 (244)
T smart00220 84 LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEV 157 (244)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHH
Confidence 899999999999999999999998 9999999999999999999999999998764332 2234557788999999
Q ss_pred hcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHhhhc
Q 046010 378 ALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLC 457 (523)
Q Consensus 378 l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~~c 457 (523)
+....++.++|||+||++++++++|..||..... .. .............. ... ......+.+++.+|
T Consensus 158 ~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~----~~~~~~~~~~~~~~-~~~------~~~~~~~~~~i~~~ 224 (244)
T smart00220 158 LLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LL----ELFKKIGKPKPPFP-PPE------WKISPEAKDLIRKL 224 (244)
T ss_pred HccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HH----HHHHHHhccCCCCc-ccc------ccCCHHHHHHHHHH
Confidence 9888899999999999999999999999753211 11 11111111111100 000 00234677899999
Q ss_pred ccCCCCCCCCHHHHHH
Q 046010 458 VQEDPADRPNMSSVAV 473 (523)
Q Consensus 458 l~~dP~~RPs~~ei~~ 473 (523)
|..+|++||++.++++
T Consensus 225 l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 225 LVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccCCchhccCHHHHhh
Confidence 9999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3e-21 Score=182.16 Aligned_cols=177 Identities=23% Similarity=0.253 Sum_probs=130.4
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
.++.+.+++...+-+-.+|+.||.|||+++ ||+||||.+|+++|++|.+||+|||+++.- .........+.||+.
T Consensus 259 Lsrer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I~~g~t~kTFCGTPE 333 (516)
T KOG0690|consen 259 LSRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE--IKYGDTTKTFCGTPE 333 (516)
T ss_pred hhhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc--ccccceeccccCChh
Confidence 456778999999999999999999999998 999999999999999999999999999753 223345667899999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||++....|..+.|.|.+||++|||++|+.||.....+.- .+.. ...+ -.+ +..-..+..
T Consensus 334 YLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL---FeLI----l~ed------~kF----Pr~ls~eAk 396 (516)
T KOG0690|consen 334 YLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL---FELI----LMED------LKF----PRTLSPEAK 396 (516)
T ss_pred hcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH---HHHH----Hhhh------ccC----CccCCHHHH
Confidence 9999999999999999999999999999999999864433311 1111 0000 001 111122445
Q ss_pred HHhhhcccCCCCCCC-----CHHHHHH--HhccC------CCCCCCCCCCCc
Q 046010 452 HIGLLCVQEDPADRP-----NMSSVAV--MLASD------TVSLPQPTQPAF 490 (523)
Q Consensus 452 ~li~~cl~~dP~~RP-----s~~ei~~--~L~~~------~~~l~~p~~p~~ 490 (523)
.|+...|..||.+|. .+.||.+ ++.+. .+++++|-.|..
T Consensus 397 tLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqV 448 (516)
T KOG0690|consen 397 TLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQV 448 (516)
T ss_pred HHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCc
Confidence 667788999999995 3444432 22222 245566666654
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-20 Score=181.62 Aligned_cols=182 Identities=25% Similarity=0.303 Sum_probs=135.1
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
+++-+++.+..+.-++.+|+-||-+||++| ||+||||.+||+++.+|.+||+|||+++.-- .....+..+.||+.
T Consensus 441 iQQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni--~~~~TTkTFCGTPd 515 (683)
T KOG0696|consen 441 IQQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI--FDGVTTKTFCGTPD 515 (683)
T ss_pred HHHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc--cCCcceeeecCCCc
Confidence 566778999999999999999999999999 9999999999999999999999999997532 22344567899999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||++...+|+..+|.||+||+||||+.|++||+..+.+ .+.+ .+.+.. ..++..-..+.+
T Consensus 516 YiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~---elF~----aI~ehn----------vsyPKslSkEAv 578 (683)
T KOG0696|consen 516 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQ----AIMEHN----------VSYPKSLSKEAV 578 (683)
T ss_pred ccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHH----HHHHcc----------CcCcccccHHHH
Confidence 99999999999999999999999999999999998643322 2221 111111 112222334566
Q ss_pred HHhhhcccCCCCCCCCH-----HHHH--------HHhccCCCCCCCCCCCCcccccc
Q 046010 452 HIGLLCVQEDPADRPNM-----SSVA--------VMLASDTVSLPQPTQPAFSVGRI 495 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~-----~ei~--------~~L~~~~~~l~~p~~p~~~~~~~ 495 (523)
.|....|..+|.+|.-. .+|. .+-+-+..++++|-+|....++.
T Consensus 579 ~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~r~ 635 (683)
T KOG0696|consen 579 AICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKCGRD 635 (683)
T ss_pred HHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccccCCc
Confidence 77778889999998532 1221 11122234567788888766554
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.4e-21 Score=176.53 Aligned_cols=184 Identities=22% Similarity=0.296 Sum_probs=129.3
Q ss_pred ccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccC
Q 046010 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTY 370 (523)
Q Consensus 291 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~ 370 (523)
.+.....|+.+.++-++.||++||+|||+.+ |.||||||.|+|++.|-.+||+|||+++....++. ...+..+-|.
T Consensus 146 IIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~-~hMTqEVVTQ 221 (449)
T KOG0664|consen 146 IIVSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR-LNMTHEVVTQ 221 (449)
T ss_pred eeccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhhh-hhhHHHHHHH
Confidence 3566778999999999999999999999998 99999999999999999999999999997643332 2344556788
Q ss_pred CCCchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHH--------HHHhhhcCCcccccCc-----
Q 046010 371 GYMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAY--------TWKLWCNGEALELMDP----- 436 (523)
Q Consensus 371 ~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~----- 436 (523)
.|+|||++++. .|+.+.||||.||++.|++-++..|.-..+.+...++.. ..+.--++....++..
T Consensus 222 YYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~P 301 (449)
T KOG0664|consen 222 YYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAP 301 (449)
T ss_pred HhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCC
Confidence 99999999985 499999999999999999988877653332221111110 0000001111111111
Q ss_pred ----cccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 437 ----VLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 437 ----~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
......+...-...+.+..+++..||++|.+..+.+..+-..
T Consensus 302 s~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 302 DTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE 347 (449)
T ss_pred CccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence 111112223334556777789999999999999988766443
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.1e-20 Score=181.54 Aligned_cols=189 Identities=22% Similarity=0.275 Sum_probs=139.0
Q ss_pred ccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-----cCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCC
Q 046010 283 IGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHE-----DSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGN 357 (523)
Q Consensus 283 ~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-----~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 357 (523)
.|++++++- +..++.+..++++..++.||++||. +|++.|.|||||..|||+.+++.+.|+|+|++......
T Consensus 293 ~GSL~DyL~---r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~ 369 (513)
T KOG2052|consen 293 HGSLYDYLN---RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSD 369 (513)
T ss_pred CCcHHHHHh---hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEeccc
Confidence 677776653 3779999999999999999999995 46778999999999999999999999999999876544
Q ss_pred CC--CccccceeccCCCCchhhhcCCC------CCcchhhHHHHHHHHHHHhC----------CCCCCCcccccccchHH
Q 046010 358 QN--ESNTSKVVGTYGYMAPEYALGGV------ISVKSDVFSFGVLLLEIISG----------KKNSGFYLSEHGQSLLA 419 (523)
Q Consensus 358 ~~--~~~~~~~~gt~~y~aPE~l~~~~------~s~ksDVwSlGvvl~elltG----------~~p~~~~~~~~~~~~~~ 419 (523)
.. .......+||-+|||||++...- --..+||||||+|+||+..+ +.||....+.+.. . +
T Consensus 370 t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs-~-e 447 (513)
T KOG2052|consen 370 TDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS-F-E 447 (513)
T ss_pred CCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC-H-H
Confidence 22 23456789999999999985421 12358999999999999863 2455433222211 1 1
Q ss_pred HHHHhhhcCCcccccCccccCCc-cHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCC
Q 046010 420 YTWKLWCNGEALELMDPVLKQSC-MAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTV 480 (523)
Q Consensus 420 ~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~ 480 (523)
.+..--..+.+.|.+.... ..+.+..+.+||..||..+|.-|.|+--|.+.|.+...
T Consensus 448 ----eMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 448 ----EMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred ----HHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 1112222333344443332 23567778899999999999999999999999987653
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.6e-20 Score=174.17 Aligned_cols=161 Identities=26% Similarity=0.343 Sum_probs=122.9
Q ss_pred ccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccC
Q 046010 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTY 370 (523)
Q Consensus 291 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~ 370 (523)
+.+++.+|+++.++-+..+|+-||.|||++| ||+||||.+|+|+|..|.+||.|+|+++.-- .....++.+.||+
T Consensus 341 hmqrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l--~~gd~tstfcgtp 415 (593)
T KOG0695|consen 341 HMQRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL--GPGDTTSTFCGTP 415 (593)
T ss_pred ehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC--CCCcccccccCCC
Confidence 3577788999999999999999999999999 9999999999999999999999999998532 2334566789999
Q ss_pred CCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccc-cccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 371 GYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSE-HGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 371 ~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
.|.|||++++..|....|.|+||++++||+.|+.||+....+ .+.+-..+..+.+.+.++. + +..-..+
T Consensus 416 nyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir-i---------prslsvk 485 (593)
T KOG0695|consen 416 NYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR-I---------PRSLSVK 485 (593)
T ss_pred cccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc-c---------cceeehh
Confidence 999999999999999999999999999999999999743222 1222222222222222111 0 1111123
Q ss_pred HHHHhhhcccCCCCCCC
Q 046010 450 CIHIGLLCVQEDPADRP 466 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RP 466 (523)
.-.++..-|.+||.+|.
T Consensus 486 as~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 486 ASHVLKGFLNKDPKERL 502 (593)
T ss_pred hHHHHHHhhcCCcHHhc
Confidence 34566677899999985
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.7e-20 Score=175.99 Aligned_cols=172 Identities=24% Similarity=0.241 Sum_probs=123.2
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
-.++.+.+..|+.|++.|++|||+.+ |+||||||+||++..+..+||.|||+++.-.. ....+..+.+..|.||
T Consensus 113 ~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~---~~~mtpyVvtRyyrap 186 (369)
T KOG0665|consen 113 MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDT---DFMMTPYVVTRYYRAP 186 (369)
T ss_pred HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCc---ccccCchhheeeccCc
Confidence 56888999999999999999999999 99999999999999999999999999986432 2345567788999999
Q ss_pred hhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccc------------c----chHHHHHHhhhcC------Ccccc
Q 046010 376 EYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHG------------Q----SLLAYTWKLWCNG------EALEL 433 (523)
Q Consensus 376 E~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~------------~----~~~~~~~~~~~~~------~~~~~ 433 (523)
|++.+..+.+.+||||+||++.||++|+.-|.....-+. . .+...+.....+. ...+.
T Consensus 187 evil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~ 266 (369)
T KOG0665|consen 187 EVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSEL 266 (369)
T ss_pred hheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhh
Confidence 999998899999999999999999999977652221100 0 0000000000000 00111
Q ss_pred c-CccccC--CccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 434 M-DPVLKQ--SCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 434 ~-~~~l~~--~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+ |..... +.+..+...+.+++.+||..||++|.++++++.
T Consensus 267 fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 267 FPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred CCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 1 111111 011123344567888999999999999999876
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-20 Score=184.31 Aligned_cols=173 Identities=29% Similarity=0.379 Sum_probs=127.9
Q ss_pred cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC---CCCeeEeccccceeccCCCCC----
Q 046010 288 PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH---EMNPKISDFGMARIFGGNQNE---- 360 (523)
Q Consensus 288 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~---~~~~kL~Dfg~a~~~~~~~~~---- 360 (523)
+..|..+.+.+++++++.|+.||+.||.||.+. .++|||-||||.|||+-. -|.+||.|||+++.+..+...
T Consensus 555 LDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdG 633 (775)
T KOG1151|consen 555 LDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDG 633 (775)
T ss_pred hhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccc
Confidence 455688889999999999999999999999998 478999999999999954 477999999999987644332
Q ss_pred -ccccceeccCCCCchhhhcCC----CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccC
Q 046010 361 -SNTSKVVGTYGYMAPEYALGG----VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMD 435 (523)
Q Consensus 361 -~~~~~~~gt~~y~aPE~l~~~----~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (523)
..++...||+.|+|||.+.-+ .++.|+||||+|||+|+.+.|+.||...... ++++++. ..+...++.-...
T Consensus 634 meLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdILqeN-TIlkAtEVqFP~K 710 (775)
T KOG1151|consen 634 MELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDILQEN-TILKATEVQFPPK 710 (775)
T ss_pred eeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHHHhhh-chhcceeccCCCC
Confidence 234567899999999977543 4788999999999999999999999754332 2222211 1111111111111
Q ss_pred ccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 046010 436 PVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVA 472 (523)
Q Consensus 436 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~ 472 (523)
+....+...+|++||++.-++|....++.
T Consensus 711 --------PvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 711 --------PVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred --------CccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 12233556788999999999998776653
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3e-20 Score=175.17 Aligned_cols=176 Identities=22% Similarity=0.247 Sum_probs=123.8
Q ss_pred ccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCC---eeEeccccceeccCCCC-----C
Q 046010 289 TIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMN---PKISDFGMARIFGGNQN-----E 360 (523)
Q Consensus 289 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~---~kL~Dfg~a~~~~~~~~-----~ 360 (523)
+-++.+++.+++.++.+++++|+.||.|||.+| |.||||||+|||-..... +||+||.+...+..+.. .
T Consensus 164 LshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spast 240 (463)
T KOG0607|consen 164 LSHIQKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAST 240 (463)
T ss_pred HHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCC
Confidence 445678888999999999999999999999999 999999999999976543 79999998765432211 1
Q ss_pred ccccceeccCCCCchhhhc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccc-----cchH---HHHHHhhhc
Q 046010 361 SNTSKVVGTYGYMAPEYAL-----GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHG-----QSLL---AYTWKLWCN 427 (523)
Q Consensus 361 ~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-----~~~~---~~~~~~~~~ 427 (523)
......+|+..|||||+.. ...|+.+.|.||||||+|-|++|.+||......+. ..-. +.....+.+
T Consensus 241 P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQE 320 (463)
T KOG0607|consen 241 PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQE 320 (463)
T ss_pred ccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhc
Confidence 2234567888999999763 23488899999999999999999999975443322 1111 111111122
Q ss_pred CCcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 428 GEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 428 ~~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+. .++.+... ........+++...+..|+.+|.++.+++.
T Consensus 321 Gk-YeFPdkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 321 GK-YEFPDKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cC-CcCChhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 21 11111100 122334557777888899999999998876
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.2e-20 Score=188.59 Aligned_cols=179 Identities=21% Similarity=0.263 Sum_probs=126.3
Q ss_pred eeecccccccc-ccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeC--CCC--CeeEeccccceec
Q 046010 280 WIAIGTTIPTI-YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLD--HEM--NPKISDFGMARIF 354 (523)
Q Consensus 280 ~ia~g~~~~~~-~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~--~~~--~~kL~Dfg~a~~~ 354 (523)
|.+.|...-.+ -..+...|++.+.+.++.++..||.|||+++ |+||||||.||++- .+| ..||+|||.++.+
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 33344444222 2566778999999999999999999999998 99999999999984 334 3699999999987
Q ss_pred cCCCCCccccceeccCCCCchhhhc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCC--cc
Q 046010 355 GGNQNESNTSKVVGTYGYMAPEYAL-GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGE--AL 431 (523)
Q Consensus 355 ~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~ 431 (523)
..+. ......||..|++||.+. ...|+..+|.|||||++|+.+||..||......... .+..|....... +.
T Consensus 175 ~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~--~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 175 DDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNN--KEIMWHIITKKPSGVA 249 (732)
T ss_pred CCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcccc--chhhhhhhccCCCcee
Confidence 5433 456789999999999998 488999999999999999999999999765544221 112222222111 00
Q ss_pred cccCcc----------c--cCCccHHHHHHHHHHhhhcccCCCCCCC
Q 046010 432 ELMDPV----------L--KQSCMAAELLKCIHIGLLCVQEDPADRP 466 (523)
Q Consensus 432 ~~~~~~----------l--~~~~~~~~~~~~~~li~~cl~~dP~~RP 466 (523)
-...+. + ..........++-+.+..+|..+|++|.
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 000000 0 1112233445566777778888999998
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-19 Score=195.34 Aligned_cols=159 Identities=26% Similarity=0.297 Sum_probs=120.4
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCchh
Q 046010 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPE 376 (523)
Q Consensus 297 ~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE 376 (523)
+++++.++-++..|+-||.-||+.| +|||||||+|||+|..|++||+|||.+-.+..++ .......+|||-|.+||
T Consensus 171 ~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG-~V~s~~aVGTPDYISPE 246 (1317)
T KOG0612|consen 171 RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG-TVRSSVAVGTPDYISPE 246 (1317)
T ss_pred CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCC-cEEeccccCCCCccCHH
Confidence 8999999999999999999999999 9999999999999999999999999987765333 33455679999999999
Q ss_pred hhc----C-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 377 YAL----G-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 377 ~l~----~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
++. + +.|++..|.||+||++|||+.|..||. ...+.....++....+...+.+.. +......
T Consensus 247 vLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY------adslveTY~KIm~hk~~l~FP~~~-------~VSeeak 313 (1317)
T KOG0612|consen 247 VLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY------ADSLVETYGKIMNHKESLSFPDET-------DVSEEAK 313 (1317)
T ss_pred HHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch------HHHHHHHHHHHhchhhhcCCCccc-------ccCHHHH
Confidence 985 2 679999999999999999999999984 233333333333333333332111 1223344
Q ss_pred HHhhhcccCCCCCCCC---HHHHHH
Q 046010 452 HIGLLCVQEDPADRPN---MSSVAV 473 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs---~~ei~~ 473 (523)
+||...+ -+|+.|.. +++|..
T Consensus 314 dLI~~ll-~~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 314 DLIEALL-CDREVRLGRNGIEDIKN 337 (1317)
T ss_pred HHHHHHh-cChhhhcccccHHHHHh
Confidence 5555544 48888888 888754
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.7e-20 Score=186.96 Aligned_cols=169 Identities=25% Similarity=0.290 Sum_probs=129.2
Q ss_pred ccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCC---CCeeEeccccceeccCCCC
Q 046010 283 IGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE---MNPKISDFGMARIFGGNQN 359 (523)
Q Consensus 283 ~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~---~~~kL~Dfg~a~~~~~~~~ 359 (523)
.|-.+..+....+++|++..-.-++.||+.||+|||-++ |+|.||||+|||+... -++||+|||+++.+++...
T Consensus 646 ~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 646 HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 355556667889999999999999999999999999998 9999999999999754 4689999999999875433
Q ss_pred CccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCcccc
Q 046010 360 ESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLK 439 (523)
Q Consensus 360 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 439 (523)
....+||+.|+|||+++...|+..-|+||.|+|+|--++|..||.... +..+.++. ....-...+
T Consensus 723 ---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQN-------AaFMyPp~P--- 787 (888)
T KOG4236|consen 723 ---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQN-------AAFMYPPNP--- 787 (888)
T ss_pred ---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhc-------cccccCCCc---
Confidence 335689999999999999999999999999999999999999985322 11111111 111111111
Q ss_pred CCccHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 046010 440 QSCMAAELLKCIHIGLLCVQEDPADRPNMSSVA 472 (523)
Q Consensus 440 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~ 472 (523)
-.+.....++||...||..=.+|-|.+.-+
T Consensus 788 ---W~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 788 ---WSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred ---hhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 112234567788888888888888877653
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-19 Score=191.29 Aligned_cols=177 Identities=24% Similarity=0.351 Sum_probs=138.1
Q ss_pred eEeeecccc-----ccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccce
Q 046010 278 AIWIAIGTT-----IPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352 (523)
Q Consensus 278 ~~~ia~g~~-----~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 352 (523)
-+|+.+.+| .++|-..++.++.|+.+..|++.++.||.+||.+- ++|||||-.|||++.++.+||.|||++.
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeee
Confidence 455555444 47888888999999999999999999999999996 9999999999999999999999999998
Q ss_pred eccCCCCCccccceeccCCCCchhhhcC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhc
Q 046010 353 IFGGNQNESNTSKVVGTYGYMAPEYALG-----GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCN 427 (523)
Q Consensus 353 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 427 (523)
.+.. +........||+.|||||++.- ..|+..+|+||||++..||--|.+|+-...+.. ..+.
T Consensus 172 Qlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr---------aLF~- 239 (953)
T KOG0587|consen 172 QLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR---------ALFL- 239 (953)
T ss_pred eeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---------hhcc-
Confidence 7743 3344556899999999998853 347788999999999999999999974332221 1110
Q ss_pred CCcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 428 GEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 428 ~~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+.. .|......+..-..++.++|..||..|-.+||++.++++
T Consensus 240 --IpR--NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 240 --IPR--NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred --CCC--CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 001 111222224456678999999999999999999988754
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=191.90 Aligned_cols=57 Identities=33% Similarity=0.571 Sum_probs=52.8
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccce
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 352 (523)
.....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 96 HIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 34456899999999999999999999998 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.8e-18 Score=181.70 Aligned_cols=166 Identities=17% Similarity=0.151 Sum_probs=110.9
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..++.++.||+++|.|||+++ |+||||||+||+++.++.+||+|||++....... ........+++.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeCh
Confidence 35788999999999999999999998 9999999999999999999999999987543221 1111223347899999
Q ss_pred hhhcCCCC----------------------CcchhhHHHHHHHHHHHhCCC-CCCCcccccc----cchHHHHHHhhhcC
Q 046010 376 EYALGGVI----------------------SVKSDVFSFGVLLLEIISGKK-NSGFYLSEHG----QSLLAYTWKLWCNG 428 (523)
Q Consensus 376 E~l~~~~~----------------------s~ksDVwSlGvvl~elltG~~-p~~~~~~~~~----~~~~~~~~~~~~~~ 428 (523)
|.+..... ..+.||||+||++++|++|.. |+........ .......|+.+...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 98754221 134799999999999999875 5532111000 00011112222211
Q ss_pred CcccccCccccCCccHHHHHHHHHHhhhcccCCC---CCCCCHHHHHH
Q 046010 429 EALELMDPVLKQSCMAAELLKCIHIGLLCVQEDP---ADRPNMSSVAV 473 (523)
Q Consensus 429 ~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP---~~RPs~~ei~~ 473 (523)
... + ...........+|+.++|..+| .+|+|++|+++
T Consensus 460 ~~~-~-------~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 460 KYD-F-------SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred CCC-c-------ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 110 0 0011123456778888888766 68999999875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.3e-18 Score=155.64 Aligned_cols=171 Identities=18% Similarity=0.214 Sum_probs=120.6
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCC-CCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE-MNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
..|+...+..++.++++||.|+|++| |.|||+||.|++||.. -.++|+|+|++.++.... .....+.+..|--
T Consensus 127 ~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~---eYnVRVASRyfKG 200 (338)
T KOG0668|consen 127 PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKG 200 (338)
T ss_pred hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCc---eeeeeeehhhcCC
Confidence 35777889999999999999999999 9999999999999975 468999999999875433 3344567778899
Q ss_pred hhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHH------------H--hhhcCCcccccCcccc
Q 046010 375 PEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTW------------K--LWCNGEALELMDPVLK 439 (523)
Q Consensus 375 PE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~------------~--~~~~~~~~~~~~~~l~ 439 (523)
||.+... .|+..-|+|||||++..|+..+.||-......+ .+...+. + ...+.+...++....+
T Consensus 201 PELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D-QLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~r 279 (338)
T KOG0668|consen 201 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSR 279 (338)
T ss_pred chheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH-HHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhcccc
Confidence 9998764 488899999999999999999999843322222 1221110 0 0011111121111111
Q ss_pred C--------CccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 440 Q--------SCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 440 ~--------~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
. +...-...+.++++...|..|..+|+|++|..+
T Consensus 280 k~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 280 KPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 1 111111356778888999999999999998753
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.2e-18 Score=172.60 Aligned_cols=116 Identities=25% Similarity=0.364 Sum_probs=96.9
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceecc---------CCCCCc--
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFG---------GNQNES-- 361 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~---------~~~~~~-- 361 (523)
-+.+-++|+.++-++.+|..|+++.|+.| +|||||||+|||||.+|.+||.|||++.-+. +.....
T Consensus 721 IrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqD 797 (1034)
T KOG0608|consen 721 IRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQD 797 (1034)
T ss_pred HHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccc
Confidence 34567899999999999999999999999 9999999999999999999999999986431 110000
Q ss_pred --c---------------------------ccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCccc
Q 046010 362 --N---------------------------TSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLS 411 (523)
Q Consensus 362 --~---------------------------~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~ 411 (523)
. ....+||..|+|||++....++...|.||.|||||||+.|+.||....+
T Consensus 798 Smep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 798 SMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTP 876 (1034)
T ss_pred cCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCC
Confidence 0 0023689999999999999999999999999999999999999965443
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.2e-18 Score=159.42 Aligned_cols=167 Identities=20% Similarity=0.283 Sum_probs=118.2
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC--CCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH--EMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~--~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
....+.+....+++.|+++||.|||+++ +||||||.+||||-. ..++||+|||..+..+. .......+..
T Consensus 114 ~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~-----tV~~~~~~~~ 185 (378)
T KOG1345|consen 114 EAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT-----TVKYLEYVNN 185 (378)
T ss_pred CcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc-----eehhhhhhcc
Confidence 3456888999999999999999999998 999999999999953 34799999999876432 1222334567
Q ss_pred CCchhhhcC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHH
Q 046010 372 YMAPEYALG-----GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAE 446 (523)
Q Consensus 372 y~aPE~l~~-----~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 446 (523)
|.+||.... ....+.+|||.||+++|.+++|+.||+.....+. .-+.|..|..+......+..- .-
T Consensus 186 y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~---~Y~~~~~w~~rk~~~~P~~F~------~f 256 (378)
T KOG1345|consen 186 YHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK---PYWEWEQWLKRKNPALPKKFN------PF 256 (378)
T ss_pred cCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc---hHHHHHHHhcccCccCchhhc------cc
Confidence 999997643 2356889999999999999999999974333222 223445555444332221111 11
Q ss_pred HHHHHHHhhhcccCCCCCCCCHHHHHHHhcc
Q 046010 447 LLKCIHIGLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 447 ~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
..+++++..+-|..+|++|=.+.++.++-..
T Consensus 257 s~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 257 SEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred CHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 2355667778899999999666666665543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-17 Score=154.67 Aligned_cols=127 Identities=36% Similarity=0.601 Sum_probs=109.9
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC-CCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH-EMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
..+++..++.++.+++++|.+||+.+ ++|+||+|.||+++. ++.++|+||+.+........ ......+...|++
T Consensus 87 ~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~ 161 (215)
T cd00180 87 GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMA 161 (215)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccC
Confidence 57899999999999999999999998 999999999999999 89999999999987543221 1233456788999
Q ss_pred hhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||..... ..+.+.|+|++|+++++| ..+.++
T Consensus 162 pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------~~~~~~ 193 (215)
T cd00180 162 PEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------PELKDL 193 (215)
T ss_pred hhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------HHHHHH
Confidence 9998877 788999999999999998 466788
Q ss_pred hhhcccCCCCCCCCHHHHHHHh
Q 046010 454 GLLCVQEDPADRPNMSSVAVML 475 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L 475 (523)
+..|++.+|++||++.++++.|
T Consensus 194 l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 194 IRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHhhCCcccCcCHHHHhhCC
Confidence 8899999999999999998643
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.5e-18 Score=173.03 Aligned_cols=124 Identities=25% Similarity=0.297 Sum_probs=100.2
Q ss_pred eEeeeccccccccc--cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC-CeeEeccccceec
Q 046010 278 AIWIAIGTTIPTIY--STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM-NPKISDFGMARIF 354 (523)
Q Consensus 278 ~~~ia~g~~~~~~~--~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~~~ 354 (523)
++|..+-.-+.-|. -.++..|....+..++.|+.-||..|-..| |+|.||||+|||+++.. .+||+|||.+...
T Consensus 511 lVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~ 587 (752)
T KOG0670|consen 511 LVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSASFA 587 (752)
T ss_pred EEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcccccc
Confidence 44444444443332 344556888899999999999999999999 99999999999998765 5799999999876
Q ss_pred cCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 046010 355 GGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGF 408 (523)
Q Consensus 355 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~ 408 (523)
..+. .+.+..+..|.|||++.+.+|+...|+||.||+||||.||+..|+.
T Consensus 588 ~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 588 SENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred cccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 5433 2234556789999999999999999999999999999999977753
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.1e-17 Score=145.82 Aligned_cols=123 Identities=28% Similarity=0.415 Sum_probs=101.6
Q ss_pred eEeeecccccccc---ccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 278 AIWIAIGTTIPTI---YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 278 ~~~ia~g~~~~~~---~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
.+.+...+|...+ +..-++.++.+.++.++.|+++||.|+|+++ +.|||+||.|++|+.+|.+||+|||+++.+
T Consensus 75 kltlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglaraf 151 (292)
T KOG0662|consen 75 KLTLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAF 151 (292)
T ss_pred eeEEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhc
Confidence 3444556666443 3566788999999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCccccceeccCCCCchhhhcCCC-CCcchhhHHHHHHHHHHHhCCCC
Q 046010 355 GGNQNESNTSKVVGTYGYMAPEYALGGV-ISVKSDVFSFGVLLLEIISGKKN 405 (523)
Q Consensus 355 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwSlGvvl~elltG~~p 405 (523)
+..- ...+..+-|..|.+|.++.+.. |+...|+||-||++.|+.....|
T Consensus 152 gipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrp 201 (292)
T KOG0662|consen 152 GIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201 (292)
T ss_pred CCce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCC
Confidence 5321 1234456789999999998754 88999999999999999975554
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.9e-17 Score=163.15 Aligned_cols=64 Identities=27% Similarity=0.416 Sum_probs=53.7
Q ss_pred CCCCceeEeeeccccccccc-cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEe
Q 046010 272 KGKGRKAIWIAIGTTIPTIY-STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLL 337 (523)
Q Consensus 272 ~~~~~~~~~ia~g~~~~~~~-~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll 337 (523)
.|.+-..++..+|..++-+. ...-+.|+...+++|++||+.||.|||.+. .|||.||||+|||+
T Consensus 157 NG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 45677788888888775444 444566999999999999999999999986 59999999999999
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.9e-17 Score=175.35 Aligned_cols=170 Identities=23% Similarity=0.290 Sum_probs=127.6
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC--ccccceeccC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE--SNTSKVVGTY 370 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~--~~~~~~~gt~ 370 (523)
.....++..++-.+++|++.|++|||+.| |.|||||++|+++..++.+||+|||.+..+...... .......|+-
T Consensus 412 ~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~ 488 (601)
T KOG0590|consen 412 MSNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSD 488 (601)
T ss_pred hcccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCC
Confidence 33457999999999999999999999999 999999999999999999999999999876544333 4456678999
Q ss_pred CCCchhhhcCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 371 GYMAPEYALGGVISVK-SDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 371 ~y~aPE~l~~~~~s~k-sDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
.|+|||.+.+.+|.+. .||||.|+++..|++|+.||......+... .. ....... ..... ........+..
T Consensus 489 pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~----~~~~~~~-~~~~~--~~~~~~~lp~~ 560 (601)
T KOG0590|consen 489 PYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KT----NNYSDQR-NIFEG--PNRLLSLLPRE 560 (601)
T ss_pred cCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hh----hcccccc-ccccC--hHHHHHhchhh
Confidence 9999999999998865 899999999999999999986443332211 00 0000000 00000 00111233445
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHH
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
...++.+||+.||.+|.|+++|++
T Consensus 561 ~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 561 TRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HHHHHHHHccCChhheecHHHHhh
Confidence 677888999999999999999975
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.1e-17 Score=166.96 Aligned_cols=112 Identities=27% Similarity=0.377 Sum_probs=100.0
Q ss_pred ccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceec
Q 046010 289 TIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVG 368 (523)
Q Consensus 289 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~g 368 (523)
.-|+..+..+++.++..|++||+.|+++||+.| |||||||-+|+.++.+|-+||+|||.+.... ......++|
T Consensus 658 Fd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa~~k----sgpfd~f~g 730 (772)
T KOG1152|consen 658 FDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAAYTK----SGPFDVFVG 730 (772)
T ss_pred hhhhhccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchhhhc----CCCcceeee
Confidence 335788999999999999999999999999999 9999999999999999999999999987653 234567899
Q ss_pred cCCCCchhhhcCCCCCc-chhhHHHHHHHHHHHhCCCCCC
Q 046010 369 TYGYMAPEYALGGVISV-KSDVFSFGVLLLEIISGKKNSG 407 (523)
Q Consensus 369 t~~y~aPE~l~~~~~s~-ksDVwSlGvvl~elltG~~p~~ 407 (523)
|..|.|||++.+..|-- ..|||+||++||.++....||.
T Consensus 731 tv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 731 TVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999999999988754 5899999999999999888863
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=8.6e-16 Score=157.95 Aligned_cols=188 Identities=22% Similarity=0.363 Sum_probs=134.4
Q ss_pred ccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcc
Q 046010 283 IGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN 362 (523)
Q Consensus 283 ~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 362 (523)
.|+..+.++. ...++++.....++++|++||.|||.-. . ..|+.+++.|.+++....+||+|||+............
T Consensus 31 rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~ 107 (484)
T KOG1023|consen 31 RGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEA 107 (484)
T ss_pred CccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeeeccccceeeeeEEEEechhhhcccccccccccc
Confidence 4555555544 7788999999999999999999999875 1 39999999999999999999999999877643111111
Q ss_pred ccceeccCCCCchhhhcCC-------CCCcchhhHHHHHHHHHHHhCCCCCCCccccccc-chHHHHHHhhhcCCccccc
Q 046010 363 TSKVVGTYGYMAPEYALGG-------VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQ-SLLAYTWKLWCNGEALELM 434 (523)
Q Consensus 363 ~~~~~gt~~y~aPE~l~~~-------~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 434 (523)
.........|.|||.+... ..+.+.||||||++++|+++.+.||......... .++..... .....+
T Consensus 108 ~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~-----~~~~~~ 182 (484)
T KOG1023|consen 108 HHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKK-----GGSNPF 182 (484)
T ss_pred cchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHh-----cCCCCc
Confidence 2222345679999998763 1467899999999999999999999764433322 22222211 112223
Q ss_pred CccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCC
Q 046010 435 DPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTV 480 (523)
Q Consensus 435 ~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~ 480 (523)
.|.+.... +....++.++..||.++|.+||++++|...++....
T Consensus 183 rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 183 RPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred Ccchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 33332111 222368889999999999999999999998877643
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.1e-16 Score=152.98 Aligned_cols=110 Identities=28% Similarity=0.431 Sum_probs=88.8
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCC-CCeeEeccccceeccCCC------C-------C-
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE-MNPKISDFGMARIFGGNQ------N-------E- 360 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~------~-------~- 360 (523)
..++..++..+++.++.||.++|.+| ||||||||+|++++.. +.-.|.|||++......+ . .
T Consensus 127 ~~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~ 203 (418)
T KOG1167|consen 127 RSLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPA 203 (418)
T ss_pred hcCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCcc
Confidence 45778999999999999999999999 9999999999999865 567899999987221100 0 0
Q ss_pred ----------------------------ccccceeccCCCCchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 046010 361 ----------------------------SNTSKVVGTYGYMAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGF 408 (523)
Q Consensus 361 ----------------------------~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~ 408 (523)
...-...||++|+|||++.. ..-+.+.||||.|+|++-+++++.||-.
T Consensus 204 ~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 204 MGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFK 280 (418)
T ss_pred ccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhcccccccc
Confidence 00112468999999999876 4478899999999999999999999853
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.62 E-value=9.5e-16 Score=148.44 Aligned_cols=141 Identities=21% Similarity=0.279 Sum_probs=97.2
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+....++.+..|+++.+++||..| ++|+||||+|++++.+|.++|+||+.....+.. ... ...+..|.||
T Consensus 140 ~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~--~~~~~~~~PP 211 (288)
T PF14531_consen 140 SPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR---YRC--SEFPVAFTPP 211 (288)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-TTS-EEE--GGGEEETTEE---EEG--GGS-TTTS-H
T ss_pred chhHHHHHHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcCCCCEEEcChHHHeecCce---eec--cCCCcccCCh
Confidence 34666677788899999999999999 999999999999999999999999887764321 111 2334779999
Q ss_pred hhhcC--------CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHH
Q 046010 376 EYALG--------GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAEL 447 (523)
Q Consensus 376 E~l~~--------~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 447 (523)
|.... -.++.+.|.|+||+++|.|++++.||........... .+ ..+. +.+
T Consensus 212 e~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-------------------~f-~~C~-~~P 270 (288)
T PF14531_consen 212 ELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW-------------------DF-SRCR-DMP 270 (288)
T ss_dssp HHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-------------------GG-TTSS----
T ss_pred hhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-------------------cc-hhcC-CcC
Confidence 97643 2478899999999999999999999875433322211 11 1233 556
Q ss_pred HHHHHHhhhcccCCCCCC
Q 046010 448 LKCIHIGLLCVQEDPADR 465 (523)
Q Consensus 448 ~~~~~li~~cl~~dP~~R 465 (523)
..+..||..+|+.||.+|
T Consensus 271 e~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 271 EPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHHccCCcccC
Confidence 677788999999999988
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.4e-16 Score=156.63 Aligned_cols=171 Identities=22% Similarity=0.317 Sum_probs=121.8
Q ss_pred CceeEeeeccccc-----cccc-cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEecc
Q 046010 275 GRKAIWIAIGTTI-----PTIY-STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDF 348 (523)
Q Consensus 275 ~~~~~~ia~g~~~-----~~~~-~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Df 348 (523)
+++..+|-+-.|- +|+. .......++...+.++.|++.|++| ++ .+|+|+||.||++..+..+||+||
T Consensus 327 ~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDF 400 (516)
T KOG1033|consen 327 KKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDF 400 (516)
T ss_pred cccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhh
Confidence 3456666665555 5554 4556678889999999999999999 66 999999999999999999999999
Q ss_pred ccceeccCCC----CCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHH
Q 046010 349 GMARIFGGNQ----NESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWK 423 (523)
Q Consensus 349 g~a~~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 423 (523)
|+........ .....+...||..||+||.+.+..|+.|+|||+||++|+|++. =...++ ......
T Consensus 401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----------r~~t~~ 470 (516)
T KOG1033|consen 401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----------RIATLT 470 (516)
T ss_pred hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----------HHHhhh
Confidence 9987654433 1223456789999999999999999999999999999999997 221111 001111
Q ss_pred hhhcCCcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 046010 424 LWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSS 470 (523)
Q Consensus 424 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~e 470 (523)
.++.+.+. +... .+...-..|+++++...|.+||++.+
T Consensus 471 d~r~g~ip----~~~~-----~d~p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 471 DIRDGIIP----PEFL-----QDYPEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred hhhcCCCC----hHHh-----hcCcHHHHHHHHhcCCCcccCchHHH
Confidence 12222222 1111 11122346778899999999995444
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.3e-15 Score=156.63 Aligned_cols=179 Identities=23% Similarity=0.310 Sum_probs=128.1
Q ss_pred ceeEeeeccccc----cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccc
Q 046010 276 RKAIWIAIGTTI----PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA 351 (523)
Q Consensus 276 ~~~~~ia~g~~~----~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 351 (523)
+..+||.+.+|- ..+| .--..|++.++..+.+..++||+|||++| -+|||||-.||++++.|.+||+|||.+
T Consensus 84 ~dklwicMEycgggslQdiy-~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvs 159 (829)
T KOG0576|consen 84 RDKLWICMEYCGGGSLQDIY-HVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVS 159 (829)
T ss_pred hcCcEEEEEecCCCccccee-eecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCch
Confidence 447888888877 3344 23457999999999999999999999998 899999999999999999999999998
Q ss_pred eeccCCCCCccccceeccCCCCchhhh---cCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcC
Q 046010 352 RIFGGNQNESNTSKVVGTYGYMAPEYA---LGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNG 428 (523)
Q Consensus 352 ~~~~~~~~~~~~~~~~gt~~y~aPE~l---~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 428 (523)
-.+.. .-.....+.||+.|||||+. +.+.|..++|||++|+...|+-.-++|.....+ . .+.... ..
T Consensus 160 aqita--ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp--m-----r~l~Lm-Tk 229 (829)
T KOG0576|consen 160 AQITA--TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP--M-----RALFLM-TK 229 (829)
T ss_pred hhhhh--hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch--H-----HHHHHh-hc
Confidence 76532 22334568899999999976 457799999999999999998776666311111 0 111111 11
Q ss_pred CcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 046010 429 EALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVA 472 (523)
Q Consensus 429 ~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~ 472 (523)
...+. +.++. ...-..-+-+++..++..+|++||+++.++
T Consensus 230 S~~qp--p~lkD--k~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 230 SGFQP--PTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred cCCCC--CcccC--CccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 11110 11111 111223455777889999999999998764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.58 E-value=6.3e-15 Score=139.56 Aligned_cols=106 Identities=33% Similarity=0.454 Sum_probs=92.3
Q ss_pred cCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCchhh
Q 046010 298 LDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEY 377 (523)
Q Consensus 298 l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~ 377 (523)
+++..++.++.+++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||.+........ .......++..|++||.
T Consensus 95 ~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~~pe~ 170 (225)
T smart00221 95 LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLKTVKGTPFYLAPEV 170 (225)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccccceeccCCcCCHhH
Confidence 899999999999999999999998 99999999999999999999999999987643321 12234567788999999
Q ss_pred h-cCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 046010 378 A-LGGVISVKSDVFSFGVLLLEIISGKKNSG 407 (523)
Q Consensus 378 l-~~~~~s~ksDVwSlGvvl~elltG~~p~~ 407 (523)
+ ....++.++|||+||+++++|++|+.||.
T Consensus 171 ~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 171 LLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred hcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 8 66678889999999999999999999984
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.8e-15 Score=138.05 Aligned_cols=176 Identities=17% Similarity=0.240 Sum_probs=131.3
Q ss_pred eEeeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeE--eccccceecc
Q 046010 278 AIWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKI--SDFGMARIFG 355 (523)
Q Consensus 278 ~~~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL--~Dfg~a~~~~ 355 (523)
..|++.|+.+..++...+..++..++.+++.+|++|++|||+..+ -|-.--|....++||++...+| +|-.++..
T Consensus 266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsfq-- 342 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSFQ-- 342 (448)
T ss_pred eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeeee--
Confidence 578889999999999999999999999999999999999999862 2334468889999999988766 34333221
Q ss_pred CCCCCccccceeccCCCCchhhhcCCCCC---cchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCccc
Q 046010 356 GNQNESNTSKVVGTYGYMAPEYALGGVIS---VKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALE 432 (523)
Q Consensus 356 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s---~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (523)
.......+.|++||.+...+-+ .++|+|||.+++||+.|...||....+.+....+
T Consensus 343 -------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki-------------- 401 (448)
T KOG0195|consen 343 -------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI-------------- 401 (448)
T ss_pred -------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh--------------
Confidence 1223457899999999765533 5789999999999999999998654443222111
Q ss_pred ccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 433 LMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 433 ~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
.-..++...++.....+.+||.-|+.+||.+||.+..|+-.|++.
T Consensus 402 -aleglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 402 -ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred -hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 112222333333444566788889999999999999999998764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.2e-14 Score=141.80 Aligned_cols=185 Identities=21% Similarity=0.211 Sum_probs=129.2
Q ss_pred cccccccccccc-ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCC-----CCeeEeccccce--ec
Q 046010 283 IGTTIPTIYSTR-RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE-----MNPKISDFGMAR--IF 354 (523)
Q Consensus 283 ~g~~~~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~-----~~~kL~Dfg~a~--~~ 354 (523)
+|..+..+.... .+.++...++.|+.|++.+|++||+.| ++||||||.|+++... ..+.|.|||+++ .+
T Consensus 103 ~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~ 179 (322)
T KOG1164|consen 103 LGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKY 179 (322)
T ss_pred cCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCCccccc
Confidence 566665555333 588999999999999999999999999 9999999999999865 358999999998 33
Q ss_pred cCCCCC----c-c-ccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcC
Q 046010 355 GGNQNE----S-N-TSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNG 428 (523)
Q Consensus 355 ~~~~~~----~-~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 428 (523)
...... . . .....||..|.+++...+.+.+.+.|+||++.++.+++.|..||............ .......
T Consensus 180 ~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~---~~~~~~~ 256 (322)
T KOG1164|consen 180 VGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF---EKDPRKL 256 (322)
T ss_pred cCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH---HHHhhhh
Confidence 222211 1 1 23456999999999999999999999999999999999999998543322111111 1111110
Q ss_pred CcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCCCC
Q 046010 429 EALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTVSL 482 (523)
Q Consensus 429 ~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~l 482 (523)
. ... .....+.+..++.. .+-..+..++|....+...|+......
T Consensus 257 ~----~~~--~~~~~~~~~~~~~~---~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 257 L----TDR--FGDLKPEEFAKILE---YIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred c----ccc--ccCCChHHHHHHHH---HhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 0 000 11122333434333 334479999999999999987664443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.2e-14 Score=153.74 Aligned_cols=167 Identities=20% Similarity=0.231 Sum_probs=113.3
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec-cCCCCCcccccee----
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF-GGNQNESNTSKVV---- 367 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~-~~~~~~~~~~~~~---- 367 (523)
..+.-|...+++.|+.||+.||..+|+.| |.|||||.+||||+.-..+.|+||..-+.. -..+.......+.
T Consensus 112 STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSr 188 (1431)
T KOG1240|consen 112 STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSR 188 (1431)
T ss_pred ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCC
Confidence 44555888899999999999999999999 999999999999999999999999765421 1111222222222
Q ss_pred ccCCCCchhhhcC----------C-CCCcchhhHHHHHHHHHHHhC-CCCCCCcccccccchHHHHHHhhhcCCcccccC
Q 046010 368 GTYGYMAPEYALG----------G-VISVKSDVFSFGVLLLEIISG-KKNSGFYLSEHGQSLLAYTWKLWCNGEALELMD 435 (523)
Q Consensus 368 gt~~y~aPE~l~~----------~-~~s~ksDVwSlGvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (523)
.-..|.|||.+.. . ..+++.||||+||++.||++- +++|.... +.. .+.+. .....
T Consensus 189 RRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~a-----Yr~~~-~~~~e 256 (1431)
T KOG1240|consen 189 RRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLA-----YRSGN-ADDPE 256 (1431)
T ss_pred ceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHh-----HhccC-ccCHH
Confidence 2347999997743 1 167899999999999999984 66664210 111 11111 00000
Q ss_pred ccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 436 PVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 436 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
..++. -+...+.++++.|++.||++|.++++.++.-++.
T Consensus 257 ~~Le~----Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 257 QLLEK----IEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred HHHHh----CcCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 00100 0111456788899999999999999998874443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.1e-13 Score=134.31 Aligned_cols=172 Identities=30% Similarity=0.358 Sum_probs=123.5
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC-CeeEeccccceeccCCCCCc----cccceeccC
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM-NPKISDFGMARIFGGNQNES----NTSKVVGTY 370 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~~----~~~~~~gt~ 370 (523)
..++......++.|++.++.|+|+.+ ++|||+||+||+++..+ .+++.|||.+.......... ......++.
T Consensus 96 ~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~ 172 (384)
T COG0515 96 GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172 (384)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccccccccccccccc
Confidence 37999999999999999999999998 99999999999999988 69999999998654333221 245678999
Q ss_pred CCCchhhhcC---CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHH
Q 046010 371 GYMAPEYALG---GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAEL 447 (523)
Q Consensus 371 ~y~aPE~l~~---~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 447 (523)
.|++||.+.+ .......|+|++|++++++++|..||...... ................ ...............
T Consensus 173 ~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 248 (384)
T COG0515 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP-SLASPLSPSNPELIS 248 (384)
T ss_pred ccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc-ccccccCccccchhh
Confidence 9999999987 57889999999999999999999996433321 0111111211111111 000001000002223
Q ss_pred HHHHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 448 LKCIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 448 ~~~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
..+.+++..++..+|..|.+..+....
T Consensus 249 ~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 249 KAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 456678888999999999999887653
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=4e-13 Score=130.93 Aligned_cols=161 Identities=23% Similarity=0.256 Sum_probs=107.7
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeC--CCC--CeeEeccccceeccCCCC----Cccccceec
Q 046010 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLD--HEM--NPKISDFGMARIFGGNQN----ESNTSKVVG 368 (523)
Q Consensus 297 ~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~--~~~--~~kL~Dfg~a~~~~~~~~----~~~~~~~~g 368 (523)
..+.....-++.|+++|+.|||++| |.|||+|.+|||+. +|+ .+.|+|||++-.-....- ....-..-|
T Consensus 337 ~~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GG 413 (598)
T KOG4158|consen 337 HRSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGG 413 (598)
T ss_pred CCchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCC
Confidence 4566778889999999999999999 99999999999994 333 468999998754221111 111223456
Q ss_pred cCCCCchhhhcCCC------CCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCc
Q 046010 369 TYGYMAPEYALGGV------ISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSC 442 (523)
Q Consensus 369 t~~y~aPE~l~~~~------~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 442 (523)
.-.-||||+....+ --.|+|.|+.|.+.||++....||.... +..++ .+...+.+... +
T Consensus 414 Na~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG----em~L~--~r~Yqe~qLPa-----l---- 478 (598)
T KOG4158|consen 414 NAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG----EMLLD--TRTYQESQLPA-----L---- 478 (598)
T ss_pred cceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc----hheec--hhhhhhhhCCC-----C----
Confidence 77789999875422 2368999999999999999999985311 11110 11111112111 1
Q ss_pred cHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHh
Q 046010 443 MAAELLKCIHIGLLCVQEDPADRPNMSSVAVML 475 (523)
Q Consensus 443 ~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L 475 (523)
+...+..+.+++...|+.||++|++..-....|
T Consensus 479 p~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 479 PSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred cccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 222333455677788999999999877655544
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=7.6e-13 Score=126.32 Aligned_cols=212 Identities=16% Similarity=0.216 Sum_probs=150.4
Q ss_pred CCCCceeEeeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC-----CeeEe
Q 046010 272 KGKGRKAIWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM-----NPKIS 346 (523)
Q Consensus 272 ~~~~~~~~~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~-----~~kL~ 346 (523)
.|++.-++.--+|.++..++.-.+.+++.+.+..++.|++.-++++|++. +|.|||||+|+||...+ .+.|+
T Consensus 95 eG~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~Ihii 171 (449)
T KOG1165|consen 95 EGKYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHII 171 (449)
T ss_pred ccchhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEE
Confidence 34556667777899999999999999999999999999999999999998 99999999999996543 48999
Q ss_pred ccccceeccCCCCCc-----cccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHH
Q 046010 347 DFGMARIFGGNQNES-----NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYT 421 (523)
Q Consensus 347 Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~ 421 (523)
|||+++.+....+.. +.....||..||+-....+.+-+.+.|+=|||-++...+-|..||....-..-... .
T Consensus 172 DFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k---Y 248 (449)
T KOG1165|consen 172 DFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK---Y 248 (449)
T ss_pred eccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH---H
Confidence 999999875443332 23346799999999988899999999999999999999999999975433222111 1
Q ss_pred HHhhhcCCcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCCCCCCCCCCCcccccc
Q 046010 422 WKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTVSLPQPTQPAFSVGRI 495 (523)
Q Consensus 422 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~l~~p~~p~~~~~~~ 495 (523)
.+ +.+.+....++..... -+++....++.++. .+-.+-|..+-+...+......+..-..-.|.|-..
T Consensus 249 eK-IGe~Kr~T~i~~Lc~g--~P~efa~Yl~yvR~---L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~l 316 (449)
T KOG1165|consen 249 EK-IGETKRSTPIEVLCEG--FPEEFATYLRYVRR---LDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGL 316 (449)
T ss_pred HH-hccccccCCHHHHHhc--CHHHHHHHHHHHHh---cCcccCCCHHHHHHHHHHHHHhcCCccccccccccc
Confidence 11 1111111111111111 23444444444443 366777888877777766655555555556665544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=9.2e-13 Score=142.49 Aligned_cols=140 Identities=25% Similarity=0.255 Sum_probs=100.2
Q ss_pred HHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC-------------ccccceeccCCCCchhh
Q 046010 311 ARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE-------------SNTSKVVGTYGYMAPEY 377 (523)
Q Consensus 311 ~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-------------~~~~~~~gt~~y~aPE~ 377 (523)
+.+++|||..| |+|||+||+|.+|..-|.+|+.|||+++........ .......||+.|.|||+
T Consensus 153 vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 78999999999 999999999999999999999999998754221111 11224579999999999
Q ss_pred hcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHhhhc
Q 046010 378 ALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLC 457 (523)
Q Consensus 378 l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~~c 457 (523)
+....|...+|.|++|+|+||.+.|..||....++ .++...... ...+.+- | .....++.+++.++
T Consensus 230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe---elfg~visd--~i~wpE~-d--------ea~p~Ea~dli~~L 295 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELFGQVISD--DIEWPEE-D--------EALPPEAQDLIEQL 295 (1205)
T ss_pred hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH---HHHhhhhhh--hcccccc-C--------cCCCHHHHHHHHHH
Confidence 99999999999999999999999999998533222 111111110 0011111 1 11223455677788
Q ss_pred ccCCCCCCCC
Q 046010 458 VQEDPADRPN 467 (523)
Q Consensus 458 l~~dP~~RPs 467 (523)
|+.+|..|--
T Consensus 296 L~qnp~~Rlg 305 (1205)
T KOG0606|consen 296 LRQNPLCRLG 305 (1205)
T ss_pred HHhChHhhcc
Confidence 9999999953
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.8e-12 Score=133.91 Aligned_cols=105 Identities=31% Similarity=0.369 Sum_probs=91.3
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.+...+++.....+...++-+++++|+.+ |+|||+|++||+++.+|.+|+.|||+++..-... ...||..|
T Consensus 89 ~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------~~cgt~ey 159 (612)
T KOG0603|consen 89 SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------IACGTYEY 159 (612)
T ss_pred ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh------hcccchhh
Confidence 34456778888889999999999999999 9999999999999999999999999998653221 22789999
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGF 408 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~ 408 (523)
||||++. ......|.||||++.+||++|..||..
T Consensus 160 mApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 160 RAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 9999988 457789999999999999999999864
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.9e-11 Score=133.27 Aligned_cols=120 Identities=20% Similarity=0.178 Sum_probs=99.2
Q ss_pred eeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC-------CCCeeEeccccce
Q 046010 280 WIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH-------EMNPKISDFGMAR 352 (523)
Q Consensus 280 ~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~-------~~~~kL~Dfg~a~ 352 (523)
|...|+.++++ +..+.++|...+.++.|+++-++.||..+ |||+||||+|++|.. +..++|+|||.+.
T Consensus 775 y~~~Gtlld~~--N~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 775 YSPYGTLLDLI--NTNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred ccccccHHHhh--ccCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 33345554443 57788999999999999999999999998 999999999999943 3458999999987
Q ss_pred eccCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCC
Q 046010 353 IFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKK 404 (523)
Q Consensus 353 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~ 404 (523)
.+..-.........++|-.+-.+|...+.+++.+.|.|.|+.+++-||.|+.
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 5432223334556788999999999999999999999999999999999984
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=9.6e-12 Score=113.96 Aligned_cols=206 Identities=14% Similarity=0.174 Sum_probs=140.1
Q ss_pred ceeEeeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCC---CCeeEeccccce
Q 046010 276 RKAIWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE---MNPKISDFGMAR 352 (523)
Q Consensus 276 ~~~~~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~---~~~kL~Dfg~a~ 352 (523)
..++---+|.++..++.--.+.++.+.++-++.|++.-++|+|.++ +|||||||+|+|..-. ..+.|+|||+++
T Consensus 86 nvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 86 NVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred ceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchh
Confidence 3444445899998888888889999999999999999999999998 9999999999999643 468899999998
Q ss_pred eccCCCCCc-----cccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhc
Q 046010 353 IFGGNQNES-----NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCN 427 (523)
Q Consensus 353 ~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 427 (523)
.+....+.. ......||..|.+-....+.+-+...|+=|+|.+|..+.-|..||+...........+ .+.+
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE----kI~E 238 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE----KISE 238 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH----HHHH
Confidence 775433322 2234578999999888877788889999999999999999999997544332221111 1111
Q ss_pred CCcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCCCCCCCCCCCcccc
Q 046010 428 GEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTVSLPQPTQPAFSVG 493 (523)
Q Consensus 428 ~~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~l~~p~~p~~~~~ 493 (523)
.+....+.. +-..+ +.++.-.+.-|-...-++-|...-+.++++-....+.....--|.|.
T Consensus 239 kK~s~~ie~-LC~G~----P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~ 299 (341)
T KOG1163|consen 239 KKMSTPIEV-LCKGF----PAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWT 299 (341)
T ss_pred hhcCCCHHH-HhCCC----cHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHH
Confidence 111111111 11112 22333344456666777778877777777665444444333333443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.2e-10 Score=117.97 Aligned_cols=75 Identities=21% Similarity=0.265 Sum_probs=60.8
Q ss_pred HHHHHHHHHHHHHHHhcCCCcEEecCC-CCCcEEeCCCCCeeEeccccceeccCCCCCcc------ccceeccCCCCchh
Q 046010 304 ISIINGIARGLLYLHEDSRLKVFHRDL-KASNVLLDHEMNPKISDFGMARIFGGNQNESN------TSKVVGTYGYMAPE 376 (523)
Q Consensus 304 ~~i~~qi~~aL~~LH~~g~~~ivH~Dl-kp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~------~~~~~gt~~y~aPE 376 (523)
..++.|++++|.|||++| |+|||| ||+|||++.++.+||+|||+++.+........ .....+++.|.+||
T Consensus 114 ~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe 190 (365)
T PRK09188 114 PAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPD 190 (365)
T ss_pred HHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcc
Confidence 467899999999999998 999999 99999999999999999999997654322111 13456778899999
Q ss_pred hhcCC
Q 046010 377 YALGG 381 (523)
Q Consensus 377 ~l~~~ 381 (523)
.+...
T Consensus 191 ~~~~~ 195 (365)
T PRK09188 191 ALTPR 195 (365)
T ss_pred cCChh
Confidence 88643
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.3e-10 Score=104.65 Aligned_cols=100 Identities=20% Similarity=0.187 Sum_probs=76.5
Q ss_pred HHHHHHHHHHHHHHHhcCCCcEEecCC-CCCcEEeCCCCCeeEeccccceeccCCCCC----c--c-----ccceeccCC
Q 046010 304 ISIINGIARGLLYLHEDSRLKVFHRDL-KASNVLLDHEMNPKISDFGMARIFGGNQNE----S--N-----TSKVVGTYG 371 (523)
Q Consensus 304 ~~i~~qi~~aL~~LH~~g~~~ivH~Dl-kp~NIll~~~~~~kL~Dfg~a~~~~~~~~~----~--~-----~~~~~gt~~ 371 (523)
..++.|++++|.++|++| |+|||| ||+||+++.++.++|+|||++......... . . ......++.
T Consensus 94 ~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~ 170 (218)
T PRK12274 94 LAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPA 170 (218)
T ss_pred HHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCC
Confidence 457889999999999999 999999 799999999999999999999865432211 0 0 112235778
Q ss_pred CCchhhhcCC-CCC-cchhhHHHHHHHHHHHhCCCCC
Q 046010 372 YMAPEYALGG-VIS-VKSDVFSFGVLLLEIISGKKNS 406 (523)
Q Consensus 372 y~aPE~l~~~-~~s-~ksDVwSlGvvl~elltG~~p~ 406 (523)
|+.|+...-. ..+ ...+.++.|..+|.++|++.++
T Consensus 171 ~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 171 ALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred CCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 8888854322 333 5678889999999999999874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.3e-11 Score=129.80 Aligned_cols=162 Identities=26% Similarity=0.362 Sum_probs=120.6
Q ss_pred ccCHHHHHHHHHHHHHHHHHHH-hcCCCcEEecCCCCCcEEeCCCC-CeeEeccccceeccC-CCCCccccceec-cCCC
Q 046010 297 QLDWKRRISIINGIARGLLYLH-EDSRLKVFHRDLKASNVLLDHEM-NPKISDFGMARIFGG-NQNESNTSKVVG-TYGY 372 (523)
Q Consensus 297 ~l~~~~~~~i~~qi~~aL~~LH-~~g~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~-~~~~~~~~~~~g-t~~y 372 (523)
..+...+-.++.|+..++.|+| ..+ +.|+||||+|.+++..+ .+|+.|||++..+.. +..........| ++.|
T Consensus 119 ~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y 195 (601)
T KOG0590|consen 119 GTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPY 195 (601)
T ss_pred CCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCC
Confidence 5777888899999999999999 888 99999999999999999 999999999998766 445555556778 9999
Q ss_pred CchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 373 MAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 373 ~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
++||...+. -..+..|+||.|+++.-+++|..||.......... ..|.......... ..........
T Consensus 196 ~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~------~~~~~~~~~~~~~------~~~~~~~~~~ 263 (601)
T KOG0590|consen 196 GAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY------SSWKSNKGRFTQL------PWNSISDQAH 263 (601)
T ss_pred CCcccccchhhcCCCcccccccccccccccCCCCccccccccccc------eeecccccccccC------ccccCChhhh
Confidence 999988774 45678999999999999999999987544433211 1111111000000 0011123455
Q ss_pred HHhhhcccCCCCCCCCHHHHHH
Q 046010 452 HIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+++..++..+|..|.+.+++..
T Consensus 264 ~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 264 DLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred hcccccccCCchhccccccccc
Confidence 6777888899999999988743
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=98.91 E-value=4.4e-10 Score=105.93 Aligned_cols=77 Identities=17% Similarity=0.228 Sum_probs=60.1
Q ss_pred HHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCchhhhcCCCCCc
Q 046010 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISV 385 (523)
Q Consensus 306 i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ 385 (523)
...+|+.+|..+|+.| ++|||+||+||+++.++ ++|+|||........... ..+.....+..
T Consensus 140 ~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~ 201 (232)
T PRK10359 140 VKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGI 201 (232)
T ss_pred HHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcc
Confidence 4669999999999999 99999999999999988 999999988654211110 11334445667
Q ss_pred chhhHHHHHHHHHHH
Q 046010 386 KSDVFSFGVLLLEII 400 (523)
Q Consensus 386 ksDVwSlGvvl~ell 400 (523)
++|+|+||+.+..+.
T Consensus 202 ~~di~~lg~~~~~~~ 216 (232)
T PRK10359 202 KNEIKDLGYYLLIYK 216 (232)
T ss_pred cccccceeEeehHHH
Confidence 999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.5e-09 Score=100.56 Aligned_cols=57 Identities=18% Similarity=0.172 Sum_probs=51.5
Q ss_pred cccccCHHHHHHHHHHHHHHHHHH-HhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 294 RRAQLDWKRRISIINGIARGLLYL-HEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~L-H~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
+...+++..+..++.||+.+|.+| |+.| |+||||||+||+++ ++.++|+|||++...
T Consensus 110 ~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 110 KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 346789999999999999999999 7888 99999999999998 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.7e-09 Score=98.93 Aligned_cols=57 Identities=19% Similarity=0.261 Sum_probs=52.4
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHh-cCCCcEEecCCCCCcEEeCCCCCeeEeccccceecc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHE-DSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFG 355 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~-~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 355 (523)
...++......++.|++.+|.+||+ +| |+||||||+||+++ ++.++|+|||++....
T Consensus 111 ~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 111 DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 4568889999999999999999999 88 99999999999999 8899999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=5e-09 Score=100.48 Aligned_cols=173 Identities=19% Similarity=0.220 Sum_probs=109.6
Q ss_pred eeeccccccccc--cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccce--ecc
Q 046010 280 WIAIGTTIPTIY--STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR--IFG 355 (523)
Q Consensus 280 ~ia~g~~~~~~~--~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~--~~~ 355 (523)
|+..|..-..+- ....+.+..+...+|+.||+.||.|||+.. ++|+|+++.-+.|++..++-+|++----.. ..-
T Consensus 153 ymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~ 231 (458)
T KOG1266|consen 153 YMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSV 231 (458)
T ss_pred cccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-CccccCCcchhheeecCCceEEecccCccccchhh
Confidence 333455443333 234556888899999999999999999985 679999999999999999988875422111 110
Q ss_pred CCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccC
Q 046010 356 GNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMD 435 (523)
Q Consensus 356 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (523)
............+-++|.+||.=.....+..+|||+||+..++|..+..-... .+.. ...+.... .....+.
T Consensus 232 ~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tn--seS~-~~~ee~ia-----~~i~~le 303 (458)
T KOG1266|consen 232 NSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTN--SESK-VEVEENIA-----NVIIGLE 303 (458)
T ss_pred hhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCC--Ccce-eehhhhhh-----hheeecc
Confidence 11111223344567889999976666778899999999999999887643111 0000 00000000 0011111
Q ss_pred ccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 046010 436 PVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVA 472 (523)
Q Consensus 436 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~ 472 (523)
..+.. .++..|++..|..||++++++
T Consensus 304 n~lqr-----------~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 304 NGLQR-----------GSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred Ccccc-----------CcCcccccCCCCCCcchhhhh
Confidence 11111 355679999999999999874
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.4e-07 Score=92.11 Aligned_cols=179 Identities=16% Similarity=0.183 Sum_probs=115.3
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
...+|...+++.+.|+.+.+.||..| .+-+|+.++|+|+++++.+.|.|=..-... .........+|...|.+|
T Consensus 112 P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~---~ng~~~~cpVg~~eftPP 185 (637)
T COG4248 112 PHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQIN---ANGTLHLCPVGVSEFTPP 185 (637)
T ss_pred CccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeec---cCCceEecccCccccCCH
Confidence 34789999999999999999999999 999999999999999999999885433322 122233456788999999
Q ss_pred hhhc-----CCCCCcchhhHHHHHHHHHHHhC-CCCCCCccc-ccccchHH--HHHHhhh--cCCcccccCccccCCccH
Q 046010 376 EYAL-----GGVISVKSDVFSFGVLLLEIISG-KKNSGFYLS-EHGQSLLA--YTWKLWC--NGEALELMDPVLKQSCMA 444 (523)
Q Consensus 376 E~l~-----~~~~s~ksDVwSlGvvl~elltG-~~p~~~~~~-~~~~~~~~--~~~~~~~--~~~~~~~~~~~l~~~~~~ 444 (523)
|... +..-+...|.|.||+++++++.| ++||..-.. .......+ .....+. .........+ ..+.+.
T Consensus 186 ElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~--P~~~P~ 263 (637)
T COG4248 186 ELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPP--PRSIPL 263 (637)
T ss_pred HHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCC--CCCCCh
Confidence 9764 34456789999999999999997 889853211 11111111 0000000 0000000000 011111
Q ss_pred H-HHHHHHHHhhhcccC--CCCCCCCHHHHHHHhccCCCCC
Q 046010 445 A-ELLKCIHIGLLCVQE--DPADRPNMSSVAVMLASDTVSL 482 (523)
Q Consensus 445 ~-~~~~~~~li~~cl~~--dP~~RPs~~ei~~~L~~~~~~l 482 (523)
. -...+..|..+|+.. ++.-|||++..+..|.....++
T Consensus 264 ~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 264 SMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred hhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 1 123444556677765 3668999999988887654444
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.2e-08 Score=107.23 Aligned_cols=157 Identities=21% Similarity=0.279 Sum_probs=101.8
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCc-------cccceeccCCCCc
Q 046010 302 RRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES-------NTSKVVGTYGYMA 374 (523)
Q Consensus 302 ~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-------~~~~~~gt~~y~a 374 (523)
....=+.+++.||.|+|..- .+||++|.|++|.++..+..||..|+++.......... ..........|.+
T Consensus 100 ~~f~nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~a 177 (700)
T KOG2137|consen 100 DGFANLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLA 177 (700)
T ss_pred HhhhhhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCccccc
Confidence 34444566779999999875 69999999999999999999999999887543311111 0111233567999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHhCCCC-CCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIISGKKN-SGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~elltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||++.+...+.++|+||+|+++|.+..|+.+ +........ .... ...+..-........+.++.+=
T Consensus 178 pE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-----~~~~--------~~~~~~~~~~~s~~~p~el~~~ 244 (700)
T KOG2137|consen 178 PEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-----YSFS--------RNLLNAGAFGYSNNLPSELRES 244 (700)
T ss_pred chhhccccccccccceeeeeEEEEEecCCcchhhccCCcch-----hhhh--------hcccccccccccccCcHHHHHH
Confidence 9999998889999999999999999855543 221111100 0000 0001111111112233455555
Q ss_pred hhhcccCCCCCCCCHHHHHH
Q 046010 454 GLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~ 473 (523)
+.+++..++..||++.++..
T Consensus 245 l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 245 LKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHHHhcCCcccCcchhhhhc
Confidence 66789999999998777643
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=98.52 E-value=2.1e-07 Score=89.26 Aligned_cols=57 Identities=16% Similarity=0.245 Sum_probs=50.1
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
+..+.......++.||+.+|.+||++| .++|+||||+||+++ ++.++|+|||.+...
T Consensus 142 ~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 142 DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 345666778899999999999999986 499999999999999 889999999998754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.7e-07 Score=97.22 Aligned_cols=175 Identities=21% Similarity=0.268 Sum_probs=118.7
Q ss_pred eEeeeccccc--ccccccc-ccccCHHHHHHHHHHHHH----HHHHHHhcCCCcEEecCCCCCcEEeCCC-CCeeEeccc
Q 046010 278 AIWIAIGTTI--PTIYSTR-RAQLDWKRRISIINGIAR----GLLYLHEDSRLKVFHRDLKASNVLLDHE-MNPKISDFG 349 (523)
Q Consensus 278 ~~~ia~g~~~--~~~~~~~-~~~l~~~~~~~i~~qi~~----aL~~LH~~g~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg 349 (523)
.+++-...|- ..-|... ...++....+..+.+... ||.++|..+ ++|-|+||.||+...+ ...+++|||
T Consensus 192 ~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 192 ILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred cceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 4555544444 2223333 334888899999999999 999999998 9999999999999999 889999999
Q ss_pred cceeccCCCCCccc---cceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhh
Q 046010 350 MARIFGGNQNESNT---SKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWC 426 (523)
Q Consensus 350 ~a~~~~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 426 (523)
+...+......... ....+...|++||... +.++.+.|||++|.++.+..++..+....... .|...+
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--------~W~~~r 339 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS--------SWSQLR 339 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC--------Cccccc
Confidence 99887654432221 2225677899999764 56788999999999999999987654221111 122111
Q ss_pred cCCcc-cccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 427 NGEAL-ELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 427 ~~~~~-~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+..+. ++.+. -..++-..+.++++.+|..|++...+..
T Consensus 340 ~~~ip~e~~~~---------~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 340 QGYIPLEFCEG---------GSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccCchhhhcC---------cchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11111 11111 1112223667899999999999888754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=98.42 E-value=3.1e-07 Score=85.68 Aligned_cols=51 Identities=18% Similarity=0.258 Sum_probs=46.5
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 301 KRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 301 ~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
.....++.++++++.++|+.+ |+|+||||+||++++++.++|+|||.+...
T Consensus 125 ~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 125 EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence 345678999999999999998 999999999999999999999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.38 E-value=3e-07 Score=88.38 Aligned_cols=45 Identities=29% Similarity=0.455 Sum_probs=41.8
Q ss_pred HHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 306 i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
.+.+|+.+|.+||++| |+|+||||.|||++.++.++|+|||.+..
T Consensus 147 ~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 147 QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 3678999999999999 99999999999999989999999998875
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.32 E-value=6.5e-07 Score=83.99 Aligned_cols=50 Identities=18% Similarity=0.306 Sum_probs=40.4
Q ss_pred ccCHHHHHHHHHHHHHHH-HHHHhcCCCcEEecCCCCCcEEeCCC----CCeeEeccccc
Q 046010 297 QLDWKRRISIINGIARGL-LYLHEDSRLKVFHRDLKASNVLLDHE----MNPKISDFGMA 351 (523)
Q Consensus 297 ~l~~~~~~~i~~qi~~aL-~~LH~~g~~~ivH~Dlkp~NIll~~~----~~~kL~Dfg~a 351 (523)
.+++. ..++.|++.++ +|||+++ |+||||||+||+++.. ..++|+||+.+
T Consensus 102 ~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 102 RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 46665 36688888888 9999998 9999999999999743 37999995443
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.31 E-value=5.9e-07 Score=82.80 Aligned_cols=50 Identities=22% Similarity=0.207 Sum_probs=46.5
Q ss_pred HHHHHHHHHHHHHHHHHHh-cCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 301 KRRISIINGIARGLLYLHE-DSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 301 ~~~~~i~~qi~~aL~~LH~-~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
.++..++.+++.++.++|. .+ |+|+||||+||+++ ++.++|+|||.+...
T Consensus 114 ~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 114 EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence 6788999999999999999 87 99999999999999 889999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.2e-06 Score=80.60 Aligned_cols=48 Identities=29% Similarity=0.458 Sum_probs=45.0
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 302 RRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 302 ~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
.+..++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++|+|||.+..
T Consensus 96 ~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 96 EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 77899999999999999998 99999999999999 78899999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.4e-06 Score=79.57 Aligned_cols=45 Identities=27% Similarity=0.507 Sum_probs=42.5
Q ss_pred HHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 305 ~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
.++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||.+..
T Consensus 94 ~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 94 ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 78999999999999998 99999999999999 88999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.5e-06 Score=90.29 Aligned_cols=157 Identities=22% Similarity=0.208 Sum_probs=105.1
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCC-CCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE-MNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
-...+++..++++..|++.++.++|++. ++|+|+||+||++..+ +..+++||+....+.-.. ......+..|
T Consensus 359 ~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~----~~~~~~~r~~ 431 (524)
T KOG0601|consen 359 TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS----GVFHHIDRLY 431 (524)
T ss_pred HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccceec----cccccccccc
Confidence 3445788899999999999999999998 9999999999999987 778999999886422111 1111222334
Q ss_pred -CchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 373 -MAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 373 -~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
.+++......+..+.|+++||..+.+.+++..--.. .. .|.....+.... + + ...+.+.
T Consensus 432 p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-----~~-----~~~~i~~~~~p~-----~----~-~~~~~~q 491 (524)
T KOG0601|consen 432 PIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-----GV-----QSLTIRSGDTPN-----L----P-GLKLQLQ 491 (524)
T ss_pred ccchhhccccccccccccccccccccccccCcccCcc-----cc-----cceeeecccccC-----C----C-chHHhhh
Confidence 356666677888999999999999999998753210 00 011111111111 1 1 1113444
Q ss_pred HHhhhcccCCCCCCCCHHHHHHHhcc
Q 046010 452 HIGLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
.+...+...++..||.+.++..+..-
T Consensus 492 ~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 492 VLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred hhhhhhcCCccccchhhhhhcccchh
Confidence 45556788999999999887665543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.4e-06 Score=92.19 Aligned_cols=47 Identities=21% Similarity=0.437 Sum_probs=43.8
Q ss_pred HHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 303 RISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 303 ~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
...++.+|+++|.+||+.+ ++||||||+||++ .++.++|+|||+++.
T Consensus 430 ~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 430 NPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred HHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 6789999999999999998 9999999999999 678899999999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.05 E-value=5.2e-06 Score=91.22 Aligned_cols=109 Identities=30% Similarity=0.358 Sum_probs=87.7
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCC-------------------
Q 046010 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGN------------------- 357 (523)
Q Consensus 297 ~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~------------------- 357 (523)
..+.+-....+..+..++++||... ++|+|++|.|+++..++..++.||+.....+..
T Consensus 900 ~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~ 976 (1205)
T KOG0606|consen 900 CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLS 976 (1205)
T ss_pred CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCcccccc
Confidence 4566677778889999999999886 899999999999999999999999843322110
Q ss_pred --CCC--------ccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 046010 358 --QNE--------SNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGF 408 (523)
Q Consensus 358 --~~~--------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~ 408 (523)
... .......+|..|.+||.+.+......+|.|++|++++|.++|..||..
T Consensus 977 ~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 977 RSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred ccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 000 011234688999999999999999999999999999999999999854
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.00 E-value=1e-05 Score=74.75 Aligned_cols=54 Identities=17% Similarity=0.091 Sum_probs=46.8
Q ss_pred ccCHHHHHHHHHHHHHHHHHH-HhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 297 QLDWKRRISIINGIARGLLYL-HEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 297 ~l~~~~~~~i~~qi~~aL~~L-H~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
.++.++...+..+++.+|..| |+.+ +||+||++.||+++ ++.+.|+|||.+...
T Consensus 120 ~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 120 KLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred ccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 355567778899999999998 8888 99999999999997 468999999998765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=97.95 E-value=1.4e-05 Score=69.94 Aligned_cols=55 Identities=27% Similarity=0.287 Sum_probs=48.1
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 299 DWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 299 ~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
+......++.+++++|.+||......++|+|++|+||++++.+.+++.||+.+..
T Consensus 84 ~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 84 SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 6677888999999999999986333499999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00014 Score=76.90 Aligned_cols=98 Identities=15% Similarity=0.202 Sum_probs=71.8
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCchhhhc
Q 046010 300 WKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYAL 379 (523)
Q Consensus 300 ~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~ 379 (523)
...+..-+.||+.||.|||+.+ .++|++|..+.|+|+..|.-||++|.++........ ......--..|..|+.+.
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEID 178 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcC
Confidence 5566677899999999999665 599999999999999999999999998765432111 111112223466676443
Q ss_pred CCCCCcchhhHHHHHHHHHHHhCC
Q 046010 380 GGVISVKSDVFSFGVLLLEIISGK 403 (523)
Q Consensus 380 ~~~~s~ksDVwSlGvvl~elltG~ 403 (523)
... -..|.|.||+++++++.|.
T Consensus 179 ~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 179 PSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred ccc--cchhhhhHHHHHHHHhCcc
Confidence 222 3469999999999999983
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=97.65 E-value=5.2e-05 Score=68.42 Aligned_cols=49 Identities=31% Similarity=0.331 Sum_probs=41.0
Q ss_pred HHHHHHHHHHHHHHHhcC--CCcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 304 ISIINGIARGLLYLHEDS--RLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 304 ~~i~~qi~~aL~~LH~~g--~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
..++.+++++|+.||+.+ ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 86 ~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 86 PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred HHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 346789999999999986 22369999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=97.60 E-value=4.5e-05 Score=52.68 Aligned_cols=45 Identities=49% Similarity=0.732 Sum_probs=34.0
Q ss_pred CCCCCCCCCCCCcccccccccCCCCCCCCC--cccccccccccccCCC
Q 046010 478 DTVSLPQPTQPAFSVGRIIARSGQSSSSYS--KICSVNEVTLSDVSPR 523 (523)
Q Consensus 478 ~~~~l~~p~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~r 523 (523)
+...||.|++|+|+..+...+.. ++++.. ...|+|++|+|-|++|
T Consensus 2 e~~~LP~PKqPgF~~~r~~~e~~-sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 2 ETATLPQPKQPGFFTGRSPSETD-SSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred CcccCCCCCCCCEEeEcCCCCcC-CCcccccCCCCCeeeEEEEeEecC
Confidence 34679999999999998754433 222222 5689999999999998
|
; GO: 0004674 protein serine/threonine kinase activity |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=97.60 E-value=8.3e-05 Score=72.47 Aligned_cols=55 Identities=22% Similarity=0.282 Sum_probs=48.5
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC-------CCCeeEecccccee
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH-------EMNPKISDFGMARI 353 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~-------~~~~kL~Dfg~a~~ 353 (523)
...+...+..++.+|+..+.-||+.| |+|+|++++|||++. +..+.|+||+.+..
T Consensus 133 ~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 133 NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 45667788899999999999999999 999999999999975 46789999998754
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.60 E-value=8.1e-05 Score=69.86 Aligned_cols=54 Identities=30% Similarity=0.467 Sum_probs=49.6
Q ss_pred cCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC---CeeEeccccceec
Q 046010 298 LDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM---NPKISDFGMARIF 354 (523)
Q Consensus 298 l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~---~~kL~Dfg~a~~~ 354 (523)
++......++.++++.+.-||+.| |+|+|+++.|||++.++ .+.|+||+.++..
T Consensus 115 ~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 115 LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 777888999999999999999999 99999999999999887 7899999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00016 Score=65.08 Aligned_cols=46 Identities=26% Similarity=0.444 Sum_probs=41.2
Q ss_pred HHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 304 ISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 304 ~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
..++..|-.-+.-||..| |+|+||.++||++.... +.++|||++..
T Consensus 95 ~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 95 PDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred hHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 568888888899999999 99999999999998664 99999999875
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0003 Score=73.74 Aligned_cols=50 Identities=26% Similarity=0.391 Sum_probs=42.3
Q ss_pred HHHHHHHHHH-HHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceecc
Q 046010 303 RISIINGIAR-GLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFG 355 (523)
Q Consensus 303 ~~~i~~qi~~-aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 355 (523)
..+++.+++. .+..+|..| ++|+|+||.||+++.++.++|.|||++..+.
T Consensus 258 ~~~ia~~~~~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 258 RKALAENLARSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHHHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 3456666666 467899998 9999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.00044 Score=62.11 Aligned_cols=53 Identities=28% Similarity=0.479 Sum_probs=44.4
Q ss_pred cCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCC---eeEecccccee
Q 046010 298 LDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMN---PKISDFGMARI 353 (523)
Q Consensus 298 l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~---~kL~Dfg~a~~ 353 (523)
........++.+|-+.|.-||.++ |+|+||..+||++..++. +.|+|||++..
T Consensus 110 ~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 110 SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 333444788999999999999999 999999999999976653 58999999865
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0023 Score=66.10 Aligned_cols=94 Identities=20% Similarity=0.347 Sum_probs=74.9
Q ss_pred cccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceecc
Q 046010 290 IYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369 (523)
Q Consensus 290 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt 369 (523)
.|..++.+++++.+|.++.||..||.++|+.| +.-+-|.+.+|+++.+.+++|...|....+..+...
T Consensus 382 ~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~~--------- 449 (655)
T KOG3741|consen 382 FYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPTE--------- 449 (655)
T ss_pred ccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCCCCc---------
Confidence 34456678999999999999999999999999 888999999999999999999988887665433211
Q ss_pred CCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCC
Q 046010 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKN 405 (523)
Q Consensus 370 ~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p 405 (523)
-+. --.+-|.=-||.+++.|.+|...
T Consensus 450 -------~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 450 -------PLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred -------chh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 011 12356888899999999999643
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.00051 Score=63.15 Aligned_cols=51 Identities=27% Similarity=0.387 Sum_probs=39.9
Q ss_pred HHHHHHHHHHHHHHHHH-HHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 300 WKRRISIINGIARGLLY-LHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 300 ~~~~~~i~~qi~~aL~~-LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
.+....++.+++..+.. +|+.| |+|+||.+.||+++++ .+.|+|||.+...
T Consensus 105 ~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 105 PEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp GSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred chhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEecCcceec
Confidence 45567788888886655 57888 9999999999999987 8999999988764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.00076 Score=62.68 Aligned_cols=56 Identities=13% Similarity=0.116 Sum_probs=50.0
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCC--eeEecccccee
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMN--PKISDFGMARI 353 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~a~~ 353 (523)
-.+.+..++..++.+|++.|.-||+.| +.|+|+-+.||+++.++. ++++||.-++.
T Consensus 122 ~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 122 VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 346788889999999999999999999 999999999999987777 89999987654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.0029 Score=67.59 Aligned_cols=48 Identities=19% Similarity=0.340 Sum_probs=37.0
Q ss_pred cCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC----CeeEeccccceecc
Q 046010 298 LDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM----NPKISDFGMARIFG 355 (523)
Q Consensus 298 l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~----~~kL~Dfg~a~~~~ 355 (523)
+.+..+..++.|| +..| ++|+|+||.||+++.++ .+++.|||+...+.
T Consensus 264 la~~~v~~~~~Qi-------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 264 LAERGVEVFFTQV-------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHHHHHHHHHHH-------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 4444444444444 4567 99999999999999988 89999999998764
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.0055 Score=57.32 Aligned_cols=44 Identities=23% Similarity=0.391 Sum_probs=37.6
Q ss_pred HHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 306 i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
+...|.++|.-||+.| ++|+|.+|.|++++++ .++++||+..+.
T Consensus 140 ~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 140 LAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GIRIIDTQGKRM 183 (229)
T ss_pred HHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cEEEEECccccc
Confidence 5567778899999999 9999999999999855 499999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.011 Score=54.58 Aligned_cols=58 Identities=17% Similarity=0.162 Sum_probs=51.2
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
..-+|..+.+|+.++++.+.+|+......+.-.|++++|+-+++++++|++|......
T Consensus 54 ~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 54 LQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 3468999999999999999999986444599999999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.015 Score=54.62 Aligned_cols=31 Identities=23% Similarity=0.349 Sum_probs=26.5
Q ss_pred CcEEecCCCCCcEEeCC--CCCeeEecccccee
Q 046010 323 LKVFHRDLKASNVLLDH--EMNPKISDFGMARI 353 (523)
Q Consensus 323 ~~ivH~Dlkp~NIll~~--~~~~kL~Dfg~a~~ 353 (523)
..++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 174 ~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 174 PGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 45899999999999998 56689999987754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.023 Score=54.59 Aligned_cols=52 Identities=19% Similarity=0.215 Sum_probs=42.1
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 299 DWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 299 ~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
+.+..-.++..|++-+..+-..| |||+|+++-||+++++|.+.++||-.+..
T Consensus 200 ~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 200 DVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred cccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCCEEEEeCccccc
Confidence 45556666677777676666777 99999999999999999999999976654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.77 E-value=0.055 Score=51.40 Aligned_cols=56 Identities=20% Similarity=0.293 Sum_probs=47.0
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHh-cCCCcEEecCCCCCcEEeCCCCCeeEeccccceecc
Q 046010 296 AQLDWKRRISIINGIARGLLYLHE-DSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFG 355 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~-~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 355 (523)
.++..++...+..++++.+.-|-. .+ +||+||+.=|||+. ++.+.++||+.+....
T Consensus 161 v~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 161 VPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred CCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 344555788889999999988877 55 99999999999999 8899999999887653
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=94.59 E-value=0.2 Score=57.18 Aligned_cols=152 Identities=21% Similarity=0.199 Sum_probs=96.2
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC---cEEeCCCCCeeEe--ccccceeccCCCCCcccccee
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKAS---NVLLDHEMNPKIS--DFGMARIFGGNQNESNTSKVV 367 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~---NIll~~~~~~kL~--Dfg~a~~~~~~~~~~~~~~~~ 367 (523)
..-..++.+..+.+..++.+||.++|+.. ..|.-+..+ +--.+.++...++ ||+..+......... ...
T Consensus 278 q~v~~i~~~~~r~~~~~~~~GL~~~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~ 351 (1351)
T KOG1035|consen 278 QSVGSIPLETLRILHQKLLEGLAYLHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDL 351 (1351)
T ss_pred hhccccCHHHHHHHHHHHhhhHHHHHHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhc
Confidence 34456788889999999999999999985 555555444 3344455556655 888877654332221 122
Q ss_pred ccCCCCchhhhcCCCCCc--chhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHH
Q 046010 368 GTYGYMAPEYALGGVISV--KSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAA 445 (523)
Q Consensus 368 gt~~y~aPE~l~~~~~s~--ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 445 (523)
.+..+.++|......... ..|+|.+|.....+..|..+-.... ....+++. ....
T Consensus 352 ~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~------------------~~~~~l~~----~~~~- 408 (1351)
T KOG1035|consen 352 LAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSA------------------VPVSLLDV----LSTS- 408 (1351)
T ss_pred CccccccccccccccchhhhhhHHHHHHHHHhhhhhcCccccccc------------------chhhhhcc----ccch-
Confidence 344577788766555444 4699999999999998876521100 00011111 0000
Q ss_pred HHHHHHHHhhhcccCCCCCCCCHHHHHHHhc
Q 046010 446 ELLKCIHIGLLCVQEDPADRPNMSSVAVMLA 476 (523)
Q Consensus 446 ~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~ 476 (523)
........|+..++++|++..+++...-
T Consensus 409 ---~~~d~~~~~~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 409 ---ELLDALPKCLDEDSEERLSALELLTHPF 436 (1351)
T ss_pred ---hhhhhhhhhcchhhhhccchhhhhhchh
Confidence 2334556799999999999999987653
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=92.84 E-value=0.22 Score=49.54 Aligned_cols=31 Identities=29% Similarity=0.391 Sum_probs=27.1
Q ss_pred CCcEEecCCCCCcEEeCCC----CCeeEeccccce
Q 046010 322 RLKVFHRDLKASNVLLDHE----MNPKISDFGMAR 352 (523)
Q Consensus 322 ~~~ivH~Dlkp~NIll~~~----~~~kL~Dfg~a~ 352 (523)
+..++|+|+.+.||+++++ +.++|+||..+.
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 4569999999999999985 789999998775
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=91.82 E-value=0.26 Score=49.47 Aligned_cols=54 Identities=26% Similarity=0.307 Sum_probs=47.7
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 297 ~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
...++++..++.+-+.-+.-+..+- +.-|||+...||+|+ +|++.|+||.+++.
T Consensus 317 ~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 317 ADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred cccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeec
Confidence 3568899999999888888887764 699999999999999 99999999999984
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=91.72 E-value=0.086 Score=56.25 Aligned_cols=98 Identities=23% Similarity=0.239 Sum_probs=76.0
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCchh
Q 046010 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPE 376 (523)
Q Consensus 297 ~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE 376 (523)
.+..-+...+.+.-.+++++||+.. -+|+| ||+..+ +..|+.+|+....+.... ......++..+++||
T Consensus 332 ~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pe 400 (829)
T KOG0576|consen 332 ALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPE 400 (829)
T ss_pred hhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCch
Confidence 3555566677777888999999875 58888 776654 678999999887664332 344567899999999
Q ss_pred hhcCCCCCcchhhHHHHHHHHHHHhCCCC
Q 046010 377 YALGGVISVKSDVFSFGVLLLEIISGKKN 405 (523)
Q Consensus 377 ~l~~~~~s~ksDVwSlGvvl~elltG~~p 405 (523)
......+..+.|+|++|.--.++--|-+|
T Consensus 401 v~~~~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 401 VIQENTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred hhcccccccCCCccCCCcchhhcCCCCCC
Confidence 99999999999999999876677666655
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=91.25 E-value=0.36 Score=45.40 Aligned_cols=32 Identities=31% Similarity=0.372 Sum_probs=21.8
Q ss_pred CCcEEecCCCCCcEEeC-CCCCeeEecccccee
Q 046010 322 RLKVFHRDLKASNVLLD-HEMNPKISDFGMARI 353 (523)
Q Consensus 322 ~~~ivH~Dlkp~NIll~-~~~~~kL~Dfg~a~~ 353 (523)
...++|+|+.|.||+++ +++.+.|+||+.+..
T Consensus 165 ~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 165 PPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp CEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred CcEEEEeccccccceeeeccceeEEEecccceE
Confidence 45699999999999999 556667999987754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=91.11 E-value=0.27 Score=46.72 Aligned_cols=31 Identities=23% Similarity=0.400 Sum_probs=26.7
Q ss_pred CcEEecCCCCCcEEeCC-CCCeeEecccccee
Q 046010 323 LKVFHRDLKASNVLLDH-EMNPKISDFGMARI 353 (523)
Q Consensus 323 ~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~a~~ 353 (523)
..++|+|+.+.||+++. ++.+.|+||..+..
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 45999999999999998 57899999987753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=91.02 E-value=0.21 Score=47.66 Aligned_cols=32 Identities=28% Similarity=0.421 Sum_probs=26.2
Q ss_pred CCcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 322 RLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 322 ~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
...++|+|+.+.||+++.+....|+||+.+..
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 34599999999999998765567999997753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=90.36 E-value=0.35 Score=48.22 Aligned_cols=30 Identities=37% Similarity=0.417 Sum_probs=26.4
Q ss_pred CcEEecCCCCCcEEeCCCCCeeEeccccce
Q 046010 323 LKVFHRDLKASNVLLDHEMNPKISDFGMAR 352 (523)
Q Consensus 323 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 352 (523)
..++|+|+++.||+++.++...|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 359999999999999988777899998774
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=89.40 E-value=0.65 Score=46.20 Aligned_cols=28 Identities=25% Similarity=0.375 Sum_probs=24.5
Q ss_pred cEEecCCCCCcEEeCCCCCeeEeccccce
Q 046010 324 KVFHRDLKASNVLLDHEMNPKISDFGMAR 352 (523)
Q Consensus 324 ~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 352 (523)
.++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 4999999999999987 678999998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.27 E-value=0.58 Score=46.82 Aligned_cols=29 Identities=34% Similarity=0.398 Sum_probs=25.1
Q ss_pred cEEecCCCCCcEEeCCCCCeeEeccccce
Q 046010 324 KVFHRDLKASNVLLDHEMNPKISDFGMAR 352 (523)
Q Consensus 324 ~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 352 (523)
.++|+|+++.||+++.+...-|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 49999999999999976556899998775
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=88.70 E-value=0.52 Score=46.55 Aligned_cols=29 Identities=38% Similarity=0.441 Sum_probs=25.9
Q ss_pred cEEecCCCCCcEEeCCCCCeeEeccccce
Q 046010 324 KVFHRDLKASNVLLDHEMNPKISDFGMAR 352 (523)
Q Consensus 324 ~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 352 (523)
.++|+|+.|.||++++++.+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 49999999999999988777899998765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=88.60 E-value=0.64 Score=46.14 Aligned_cols=41 Identities=24% Similarity=0.120 Sum_probs=27.5
Q ss_pred HHHHHHHHHHHHHHHHHHHhc-CCCcEEecCCCCCcEEeCCC
Q 046010 300 WKRRISIINGIARGLLYLHED-SRLKVFHRDLKASNVLLDHE 340 (523)
Q Consensus 300 ~~~~~~i~~qi~~aL~~LH~~-g~~~ivH~Dlkp~NIll~~~ 340 (523)
.+-++.++.||+--.-..-+. +-...+|-||||+|||+-+.
T Consensus 278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds 319 (444)
T PHA03111 278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS 319 (444)
T ss_pred HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence 345667788887655334222 12359999999999999544
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=88.47 E-value=0.69 Score=45.18 Aligned_cols=52 Identities=23% Similarity=0.276 Sum_probs=39.4
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 301 KRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 301 ~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
....+.+..+-..+.-.|... ..++|+|+.|.|++.++.+.++|+||..+..
T Consensus 132 ~~~~~~~~~l~~~l~~~~~~~-~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 132 HLLRKKLKELRRALEEVPKDD-LVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHHHHhhhcCCCc-eeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 344446666666666666541 3599999999999999999999999987753
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=88.46 E-value=0.38 Score=45.70 Aligned_cols=29 Identities=17% Similarity=0.210 Sum_probs=25.8
Q ss_pred CcEEecCCCCCcEEeCCCCCeeEeccccce
Q 046010 323 LKVFHRDLKASNVLLDHEMNPKISDFGMAR 352 (523)
Q Consensus 323 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 352 (523)
..++|+|+.|.||++++++ +.|+||+.+.
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 4589999999999999888 9999998765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=88.45 E-value=0.34 Score=46.40 Aligned_cols=31 Identities=26% Similarity=0.279 Sum_probs=26.8
Q ss_pred CCcEEecCCCCCcEEeCCCCCeeEeccccce
Q 046010 322 RLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352 (523)
Q Consensus 322 ~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 352 (523)
...++|+|+.|.||+++++..+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 3459999999999999997778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=88.26 E-value=0.37 Score=44.11 Aligned_cols=30 Identities=23% Similarity=0.293 Sum_probs=25.8
Q ss_pred CcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 323 LKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 323 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
...+|+|+.|.||++.+++ ++|+||+.+..
T Consensus 77 ~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 77 LAPLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 3589999999999998777 99999998753
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=88.09 E-value=1 Score=48.18 Aligned_cols=31 Identities=26% Similarity=0.473 Sum_probs=29.1
Q ss_pred EEecCCCCCcEEeCCCCCeeEeccccceecc
Q 046010 325 VFHRDLKASNVLLDHEMNPKISDFGMARIFG 355 (523)
Q Consensus 325 ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 355 (523)
+.|.|.+|.||+++.++.+.+.|||+...+.
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 9999999999999999999999999987654
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=87.71 E-value=0.41 Score=46.29 Aligned_cols=30 Identities=27% Similarity=0.330 Sum_probs=25.9
Q ss_pred CcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 323 LKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 323 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
..++|+|+.|.||++++++ ++|+||+.+..
T Consensus 146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 3599999999999999876 78999987753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=87.49 E-value=0.73 Score=43.07 Aligned_cols=31 Identities=32% Similarity=0.522 Sum_probs=21.9
Q ss_pred CcEEecCCCCCcEEe-CCCCCeeEecccccee
Q 046010 323 LKVFHRDLKASNVLL-DHEMNPKISDFGMARI 353 (523)
Q Consensus 323 ~~ivH~Dlkp~NIll-~~~~~~kL~Dfg~a~~ 353 (523)
..+.|+|+.+.||++ +.++.++|+||..+..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 459999999999999 8889999999988754
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=87.37 E-value=0.13 Score=60.10 Aligned_cols=110 Identities=13% Similarity=-0.029 Sum_probs=79.1
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcC--CCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDS--RLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g--~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
...++..-+.....+.+....-.|... .-..+|+++|+-|.+|..+.++|++++|+.+... ......+...+++.|
T Consensus 1329 ~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn--p~~sf~Gl~l~sp~~ 1406 (2724)
T KOG1826|consen 1329 SPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN--PVLSFFGLELCSPIY 1406 (2724)
T ss_pred CCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccC--chHhhhhhhhCCHHH
Confidence 334444444444444355555544432 2347999999999999999999999999998322 122233455677788
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKKNS 406 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~ 406 (523)
+.|++...-.++.++|+|..|+.+|+.--|..+|
T Consensus 1407 v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1407 VLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 8999888888898899999999999998888765
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=87.23 E-value=0.17 Score=52.92 Aligned_cols=88 Identities=22% Similarity=0.212 Sum_probs=45.9
Q ss_pred cchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHhhhcccCCCCC
Q 046010 385 VKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPAD 464 (523)
Q Consensus 385 ~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~ 464 (523)
+|+|||++|.++.++..|...+........ .....+..........+ ............+++++...|+-..|..
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~---l~~i~k~~~~d~~~~~~--a~e~~~~~~~d~~~~~~~~~c~~~~~~i 184 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEY---LEILLKYYTDDQELLST--AMEHLIQLLADKKRLPLLKKCLWLEPII 184 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHH---HHHHHHhccCchhHHHH--HHHHHHHHhhhHhHHHHhccCCcccccc
Confidence 599999999999999998755421111100 00001111000000000 0000112234456778888999999988
Q ss_pred CCCH---------HHHHHHhcc
Q 046010 465 RPNM---------SSVAVMLAS 477 (523)
Q Consensus 465 RPs~---------~ei~~~L~~ 477 (523)
||.. +|+.+++..
T Consensus 185 r~l~~~~~k~~i~~ev~~~~t~ 206 (725)
T KOG1093|consen 185 RPLPMELSKRCSFTEVYKDLTV 206 (725)
T ss_pred ccchhHHhcCccHHHHHhhhhH
Confidence 7754 455555554
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=86.97 E-value=0.62 Score=43.63 Aligned_cols=75 Identities=16% Similarity=0.162 Sum_probs=49.5
Q ss_pred HHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCchhhhcCCCCCcchhhH
Q 046010 311 ARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVF 390 (523)
Q Consensus 311 ~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVw 390 (523)
+++|.-.|+.. ...+|||..|+||+-|+.|.+||.|=+.-..- +..|.--| ....++++.+-
T Consensus 151 i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~--------------~V~~vN~~---Y~~lT~~aE~~ 212 (308)
T PF07387_consen 151 IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLEN--------------QVNMVNIE---YESLTQEAEVK 212 (308)
T ss_pred HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhhh--------------eeeEEeee---ccccChHHHHH
Confidence 46788889553 35999999999999999999999996543210 00111101 12346677777
Q ss_pred HHHHHHHHHHhCC
Q 046010 391 SFGVLLLEIISGK 403 (523)
Q Consensus 391 SlGvvl~elltG~ 403 (523)
+|=.-+++++...
T Consensus 213 ~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 213 VFVKSCLKLVEKQ 225 (308)
T ss_pred HHHHHHHHHHHHH
Confidence 7777777776643
|
The function of this family is unknown. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=86.05 E-value=1.5 Score=44.22 Aligned_cols=29 Identities=34% Similarity=0.598 Sum_probs=25.8
Q ss_pred cEEecCCCCCcEEeCCCCC-eeEeccccce
Q 046010 324 KVFHRDLKASNVLLDHEMN-PKISDFGMAR 352 (523)
Q Consensus 324 ~ivH~Dlkp~NIll~~~~~-~kL~Dfg~a~ 352 (523)
.+||+|+.|.||+++.+.. +.++||+-+.
T Consensus 198 ~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 198 QIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 3999999999999998875 8899998775
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=85.86 E-value=0.84 Score=45.56 Aligned_cols=54 Identities=22% Similarity=0.208 Sum_probs=33.7
Q ss_pred HHHHHHHHHHHHHHHHHHHhc-CCCcEEecCCCCCcEEeCCCC------------------CeeEecccccee
Q 046010 300 WKRRISIINGIARGLLYLHED-SRLKVFHRDLKASNVLLDHEM------------------NPKISDFGMARI 353 (523)
Q Consensus 300 ~~~~~~i~~qi~~aL~~LH~~-g~~~ivH~Dlkp~NIll~~~~------------------~~kL~Dfg~a~~ 353 (523)
.+-++.+..||+--.--.-+. +-...+|-||||+|||+-+.. ..+|.||.+++.
T Consensus 274 ~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 346 (434)
T PF05445_consen 274 VEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQV 346 (434)
T ss_pred HHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHh
Confidence 345566677775433112122 122499999999999995432 257778887765
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=85.76 E-value=0.97 Score=45.92 Aligned_cols=31 Identities=26% Similarity=0.444 Sum_probs=26.4
Q ss_pred CcEEecCCCCCcEEeCC-CCCeeEecccccee
Q 046010 323 LKVFHRDLKASNVLLDH-EMNPKISDFGMARI 353 (523)
Q Consensus 323 ~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~a~~ 353 (523)
..++|+|+++.||++++ ++.+.|+||..+..
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 45999999999999986 46799999987753
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=85.19 E-value=1.4 Score=43.89 Aligned_cols=31 Identities=23% Similarity=0.262 Sum_probs=27.5
Q ss_pred CcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 323 LKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 323 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
..++|+|+.++|++++.++.+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 3599999999999999999999999987753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=84.31 E-value=1.9 Score=39.86 Aligned_cols=30 Identities=23% Similarity=0.398 Sum_probs=25.1
Q ss_pred cEEecCCCCCcEEeCCCC-----CeeEecccccee
Q 046010 324 KVFHRDLKASNVLLDHEM-----NPKISDFGMARI 353 (523)
Q Consensus 324 ~ivH~Dlkp~NIll~~~~-----~~kL~Dfg~a~~ 353 (523)
.++|||+.+.||++..++ .+.|+||..+..
T Consensus 121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred EEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 599999999999998653 588999987753
|
subfamily of choline kinases |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=84.12 E-value=0.8 Score=44.95 Aligned_cols=31 Identities=23% Similarity=0.493 Sum_probs=25.7
Q ss_pred CcEEecCCCCCcEEeCCCCC-eeEecccccee
Q 046010 323 LKVFHRDLKASNVLLDHEMN-PKISDFGMARI 353 (523)
Q Consensus 323 ~~ivH~Dlkp~NIll~~~~~-~kL~Dfg~a~~ 353 (523)
..++|+|+++.||++++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35999999999999997555 46999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=81.82 E-value=1.2 Score=44.47 Aligned_cols=33 Identities=18% Similarity=0.377 Sum_probs=29.3
Q ss_pred CCCcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 321 SRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 321 g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
++..++|+|+++.||+++...-+-|.||+++..
T Consensus 196 ~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 196 GPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred CCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 455799999999999999988899999998865
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 523 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-29 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-28 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-23 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-23 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-21 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-21 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-20 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-11 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-09 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-08 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-07 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-07 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-07 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-07 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-07 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-07 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-07 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-07 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-07 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-07 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-07 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-07 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 9e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-07 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-07 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-06 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-06 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-06 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-06 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-06 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-06 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-06 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-06 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-06 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-06 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-06 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-06 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-06 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-06 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-06 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-06 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-06 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-06 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-06 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-06 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-06 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-06 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-06 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-05 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-05 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-05 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-05 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-05 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-05 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-05 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-05 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-05 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-05 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 9e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-04 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-04 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 266 bits (683), Expect = 8e-86
Identities = 65/189 (34%), Positives = 95/189 (50%), Gaps = 8/189 (4%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
L W R I G A G+ +LHE+ + HRD+K++N+LLD KISDFG+AR
Sbjct: 126 GTPPLSWHMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARA 182
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH 413
TS++VGT YMAPE L G I+ KSD++SFGV+LLEII+G +
Sbjct: 183 SEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP- 240
Query: 414 GQSLLAYTWKLWCNGEALE-LMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVA 472
Q LL ++ + +E +D + + + + C+ E RP++ V
Sbjct: 241 -QLLLDIKEEIEDEEKTIEDYIDKKMNDADS-TSVEAMYSVASQCLHEKKNKRPDIKKVQ 298
Query: 473 VMLASDTVS 481
+L T S
Sbjct: 299 QLLQEMTAS 307
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 7e-82
Identities = 71/188 (37%), Positives = 103/188 (54%), Gaps = 3/188 (1%)
Query: 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354
+ LDW +R I G ARGL YLH+ K+ HRD+KA+N+LLD E + DFG+A++
Sbjct: 125 QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184
Query: 355 GGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKN--SGFYLSE 412
T V GT G++APEY G S K+DVF +GV+LLE+I+G++ ++
Sbjct: 185 DYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243
Query: 413 HGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVA 472
LL + L + L+D L+ + E+ + I + LLC Q P +RP MS V
Sbjct: 244 DDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
Query: 473 VMLASDTV 480
ML D +
Sbjct: 304 RMLEGDGL 311
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 213 bits (546), Expect = 2e-65
Identities = 60/178 (33%), Positives = 94/178 (52%), Gaps = 3/178 (1%)
Query: 298 LDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGN 357
+ W++R+ I G ARGL YLH + + HRD+K+ N+LLD PKI+DFG+++
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTEL 192
Query: 358 QNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSL 417
++ V GT GY+ PEY + G ++ KSDV+SFGV+L E++ + L +L
Sbjct: 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252
Query: 418 LAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVML 475
+ + NG+ +++DP L L K + C+ DRP+M V L
Sbjct: 253 AEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 1e-59
Identities = 49/205 (23%), Positives = 87/205 (42%), Gaps = 24/205 (11%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHED-------SRLKVFHRDLKASNVLLDHEMNPKIS 346
+ + W I +ARGL YLHED + + HRD+K+ NVLL + + I+
Sbjct: 114 KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 347 DFGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVI-----SVKSDVFSFGVLLLEIIS 401
DFG+A F ++ +T VGT YMAPE G + ++ D+++ G++L E+ S
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233
Query: 402 GKKNSGFYLSEHGQSLLAYTWKLWCNGEALEL--------MDPVLKQSCMAAELLKCI-H 452
+ + E+ +L + ++ + ++ PVL+ + +
Sbjct: 234 RCTAADGPVDEY---MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCE 290
Query: 453 IGLLCVQEDPADRPNMSSVAVMLAS 477
C D R + V +
Sbjct: 291 TIEECWDHDAEARLSAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 4e-48
Identities = 43/225 (19%), Positives = 81/225 (36%), Gaps = 30/225 (13%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHED------SRLKVFHRDLKASNVLLDHEMNPKISD 347
DW + + + RGL YLH + + + HRDL + NVL+ ++ ISD
Sbjct: 104 SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163
Query: 348 FGMARIFGGN------QNESNTSKVVGTYGYMAPEYALGGV-------ISVKSDVFSFGV 394
FG++ GN + ++ VGT YMAPE G V + D+++ G+
Sbjct: 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223
Query: 395 LLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMD--------PVLKQSCMAAE 446
+ EI + + +A+ ++ + ++ P ++
Sbjct: 224 IYWEIFMRCTDLFPG-ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENS 282
Query: 447 LLKCIHIGLL--CVQEDPADRPNMSSVAVMLASDTVSLPQPTQPA 489
L + C +D R +A + + +
Sbjct: 283 LAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-37
Identities = 51/199 (25%), Positives = 82/199 (41%), Gaps = 26/199 (13%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMN-PKISDFGMAR 352
+S ++G+ YLH + HRDLK N+LL KI DFG A
Sbjct: 95 PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154
Query: 353 IFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSE 412
+++ + G+ +MAPE G S K DVFS+G++L E+I+ +K + E
Sbjct: 155 D-----IQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK---PF-DE 205
Query: 413 HGQSLLAYTWKLWCNGEALEL---MDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMS 469
G W + NG L + ++ L+ C +DP+ RP+M
Sbjct: 206 IGGPAFRIMWAV-HNGTRPPLIKNLPKPIE------SLMTR------CWSKDPSQRPSME 252
Query: 470 SVAVMLASDTVSLPQPTQP 488
+ ++ P +P
Sbjct: 253 EIVKIMTHLMRYFPGADEP 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 52/195 (26%), Positives = 77/195 (39%), Gaps = 29/195 (14%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
+ +Q W +R+S IA G+ YLH + + HRDL + N L+ N ++DFG+AR
Sbjct: 100 SMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLAR 156
Query: 353 IFGGNQNESNTSK------------VVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEII 400
+ + + + VVG +MAPE G K DVFSFG++L EII
Sbjct: 157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216
Query: 401 SGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQE 460
YL L +D +C + + C
Sbjct: 217 GRVNADPDYLPRTMDFGLNVR----------GFLDRYCPPNCPPS-FFPIT---VRCCDL 262
Query: 461 DPADRPNMSSVAVML 475
DP RP+ + L
Sbjct: 263 DPEKRPSFVKLEHWL 277
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-36
Identities = 52/203 (25%), Positives = 98/203 (48%), Gaps = 25/203 (12%)
Query: 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA 351
S R QLD +RR+S+ +A+G+ YLH + HR+LK+ N+L+D + K+ DFG++
Sbjct: 128 SGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186
Query: 352 RIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLS 411
R+ ++ GT +MAPE + KSDV+SFGV+L E+ + ++ +
Sbjct: 187 RLK--ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ---PW-- 239
Query: 412 EHGQSLLAYTWKLWCNGEALEL---MDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNM 468
+ + + LE+ ++P + A +++ C +P RP+
Sbjct: 240 -GNLNPAQVVAAVGFKCKRLEIPRNLNPQV------AAIIE------GCWTNEPWKRPSF 286
Query: 469 SSVAVMLAS-DTVSLPQPTQPAF 490
+++ +L ++P P +
Sbjct: 287 ATIMDLLRPLIKSAVPPPNRSDL 309
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-35
Identities = 43/188 (22%), Positives = 80/188 (42%), Gaps = 23/188 (12%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
+ + K+ I I ARG+ YLH + HRDLK++N+ L + KI DFG+A
Sbjct: 113 SETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169
Query: 354 FGGNQNESNTSKVVGTYGYMAPE---YALGGVISVKSDVFSFGVLLLEIISGKKNSGFYL 410
++ G+ +MAPE S +SDV++FG++L E+++G+ Y
Sbjct: 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP---Y- 225
Query: 411 SEHGQSLLAYTWKLWCNGEALELMDPVLKQSC---MAAELLKCIHIGLLCVQEDPADRPN 467
+ + + L ++ +C M + +C+ + +RP+
Sbjct: 226 -SNINNRDQIIEMVGRGS--LSPDLSKVRSNCPKRMKRLMAECLK-------KKRDERPS 275
Query: 468 MSSVAVML 475
+ +
Sbjct: 276 FPRILAEI 283
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-35
Identities = 53/193 (27%), Positives = 91/193 (47%), Gaps = 33/193 (17%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP--------KI 345
++ ++ IARG+ YLH+++ + + HRDLK+SN+L+ ++ KI
Sbjct: 98 SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157
Query: 346 SDFGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKN 405
+DFG+AR + + G Y +MAPE + S SDV+S+GVLL E+++G+
Sbjct: 158 TDFGLARE----WHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV- 212
Query: 406 SGFYLSEHGQSLLAYTWKLWCNGEALEL---MDPVLKQSCMAAELLKCIHIGLLCVQEDP 462
+ G LA + + N AL + A+L++ C DP
Sbjct: 213 --PF---RGIDGLAVAYGVAMNKLALPIPSTCPEPF------AKLME------DCWNPDP 255
Query: 463 ADRPNMSSVAVML 475
RP+ +++ L
Sbjct: 256 HSRPSFTNILDQL 268
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-34
Identities = 41/197 (20%), Positives = 85/197 (43%), Gaps = 42/197 (21%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLD-----HEMNPKISDF 348
+ + W ++ ++ IA G+ Y+ + + HRDL++ N+ L + K++DF
Sbjct: 115 KAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 349 GMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVI-------SVKSDVFSFGVLLLEIIS 401
G+++ + + S ++G + +MAPE I + K+D +SF ++L I++
Sbjct: 174 GLSQQ-----SVHSVSGLLGNFQWMAPE-----TIGAEEESYTEKADTYSFAMILYTILT 223
Query: 402 GKKNSGFYLSEHGQSLLAYTWKLWCNGEALEL---MDPVLKQSCMAAELLKCIHIGLLCV 458
G+ + E+ + + + G + P L +++ LC
Sbjct: 224 GEG---PF-DEYSYGKIKFINMIREEGLRPTIPEDCPPRL------RNVIE------LCW 267
Query: 459 QEDPADRPNMSSVAVML 475
DP RP+ S + L
Sbjct: 268 SGDPKKRPHFSYIVKEL 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-33
Identities = 39/193 (20%), Positives = 79/193 (40%), Gaps = 34/193 (17%)
Query: 290 IYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFG 349
++ +D + + +ARG+ +LH + L + +V++D +M +IS
Sbjct: 100 LHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMAD 158
Query: 350 MARIFGGNQNESNTSKVVGTYGYMAPEYALGG----VISVKSDVFSFGVLLLEIISGKKN 405
+ F + + ++APE AL +D++SF VLL E+++ +
Sbjct: 159 VKFSF-------QSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTREV- 209
Query: 406 SGFYLSEHGQSLLAYTWKLWCNGEALEL---MDPVLKQSCMAAELLKCIHIGLLCVQEDP 462
+ S + K+ G + + P + ++L+K +C+ EDP
Sbjct: 210 --PF---ADLSNMEIGMKVALEGLRPTIPPGISPHV------SKLMK------ICMNEDP 252
Query: 463 ADRPNMSSVAVML 475
A RP + +L
Sbjct: 253 AKRPKFDMIVPIL 265
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 51/208 (24%), Positives = 76/208 (36%), Gaps = 34/208 (16%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
+ LD + I I +G+ YLH + H+DLK+ NV D I+DFG+ I
Sbjct: 123 AKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSI 178
Query: 354 FGGNQNESNTSK---VVGTYGYMAPE---------YALGGVISVKSDVFSFGVLLLEIIS 401
G Q K G ++APE S SDVF+ G + E+ +
Sbjct: 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA 238
Query: 402 GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQED 461
+ + Q A W++ M P L Q M E+ + L C +
Sbjct: 239 REWP---F---KTQPAEAIIWQMGTG------MKPNLSQIGMGKEISDIL---LFCWAFE 283
Query: 462 PADRPNMSSVAVML---ASDTVSLPQPT 486
+RP + + ML L P
Sbjct: 284 QEERPTFTKLMDMLEKLPKRNRRLSHPG 311
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 47/213 (22%), Positives = 82/213 (38%), Gaps = 40/213 (18%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHED-----SRLKVFHRDLKASNVLLDHEMNPKISDF 348
+ LD K + + GL +LH + + + HRDLK+ N+L+ I+D
Sbjct: 127 KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186
Query: 349 GMARIF--GGNQNESNTSKVVGTYGYMAPEYALGGVISV-------KSDVFSFGVLLLEI 399
G+A F N+ + + VGT YM PE L ++ +D++SFG++L E+
Sbjct: 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEV 245
Query: 400 ISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQ-------------SCMA-- 444
+ G + L Y + + ++ + V + C+
Sbjct: 246 ARRCVSGG----IVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQM 301
Query: 445 AELLKCIHIGLLCVQEDPADRPNMSSVAVMLAS 477
+L+ C +PA R V LA
Sbjct: 302 GKLMT------ECWAHNPASRLTALRVKKTLAK 328
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-31
Identities = 49/209 (23%), Positives = 86/209 (41%), Gaps = 32/209 (15%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHED-----SRLKVFHRDLKASNVLLDHEMNPKISDF 348
+ LD + I+ IA GL +LH + + + HRDLK+ N+L+ I+D
Sbjct: 98 QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157
Query: 349 GMARIFGGNQNESNTSK--VVGTYGYMAPEYALGGVISV-------KSDVFSFGVLLLEI 399
G+A + + N+ + VGT YMAPE L I V + D+++FG++L E+
Sbjct: 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216
Query: 400 ISGKKNSG--------FYLSEHGQSLLAYTWKLWC-NGEALELMDPVLKQSCMA--AELL 448
++G FY K+ C + + + + + A+L+
Sbjct: 217 ARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLM 276
Query: 449 KCIHIGLLCVQEDPADRPNMSSVAVMLAS 477
K C ++P+ R + L
Sbjct: 277 K------ECWYQNPSARLTALRIKKTLTK 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 43/207 (20%), Positives = 79/207 (38%), Gaps = 28/207 (13%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHED-----SRLKVFHRDLKASNVLLDHEMNPKISDF 348
R + + I + A GL +LH + + + HRDLK+ N+L+ I+D
Sbjct: 132 NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191
Query: 349 GMARIFGGNQNESNTSK--VVGTYGYMAPEYALGGVISV-------KSDVFSFGVLLLEI 399
G+A + + + VGT YMAPE L I++ ++D+++ G++ EI
Sbjct: 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 250
Query: 400 ISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSC---MAAELLKCIHIGLL 456
G + L Y + + E+ V +Q + C + ++
Sbjct: 251 ARRCSIGGIHEDYQ----LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVM 306
Query: 457 ------CVQEDPADRPNMSSVAVMLAS 477
C + A R + L+
Sbjct: 307 AKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 34/110 (30%), Positives = 57/110 (51%), Gaps = 4/110 (3%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
L I+ N I G+ + H +++ HRD+K N+L+D KI DFG+A+
Sbjct: 104 SHGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKA 160
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
+ T+ V+GT Y +PE A G +D++S G++L E++ G+
Sbjct: 161 LSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-23
Identities = 39/162 (24%), Positives = 69/162 (42%), Gaps = 27/162 (16%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I +G+ Y+H K+ +RDLK SN+ L KI DFG+ +N+ ++ GT
Sbjct: 131 ITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRTRSKGT 184
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGE 429
YM+PE + D+++ G++L E++ + F S K + +
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-TAFETS-----------KFFTD-- 230
Query: 430 ALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSV 471
L D ++ + + + + P DRPN S +
Sbjct: 231 ---LRDGII-SDIFDKKEKTLLQ---KLLSKKPEDRPNTSEI 265
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 35/111 (31%), Positives = 62/111 (55%), Gaps = 4/111 (3%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
+ KR I +I + L + H + + HRD+K +N+++ K+ DFG+AR
Sbjct: 109 TEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA 165
Query: 354 FGGNQNE-SNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
+ N + T+ V+GT Y++PE A G + +SDV+S G +L E+++G+
Sbjct: 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 3e-23
Identities = 39/172 (22%), Positives = 62/172 (36%), Gaps = 31/172 (18%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTS----- 364
IA + +LH + HRDLK SN+ + K+ DFG+ ++ E
Sbjct: 173 IAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 229
Query: 365 -----KVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLA 419
VGT YM+PE G S K D+FS G++L E++ Q
Sbjct: 230 YATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS---------TQMERV 280
Query: 420 YTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSV 471
N + L Q +++ + P +RP + +
Sbjct: 281 RIITDVRNLKFPLLFTQKYPQ---EHMMVQ------DMLSPSPTERPEATDI 323
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 6e-23
Identities = 51/191 (26%), Positives = 69/191 (36%), Gaps = 34/191 (17%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
T A+L K + ++ A G+ YL HRDL A N L+ + KISDFGM+R
Sbjct: 205 TEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSR 261
Query: 353 IFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-------GKKN 405
++ + APE G S +SDV+SFG+LL E S N
Sbjct: 262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN 321
Query: 406 SGFYLS-EHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPAD 464
E G L C LM C +P
Sbjct: 322 QQTREFVEKGGRLPCPE---LCPDAVFRLM--------------------EQCWAYEPGQ 358
Query: 465 RPNMSSVAVML 475
RP+ S++ L
Sbjct: 359 RPSFSTIYQEL 369
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 6e-23
Identities = 36/98 (36%), Positives = 57/98 (58%), Gaps = 6/98 (6%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
+ + +GL YL E K+ HRD+K SN+L++ K+ DFG++ G +S +
Sbjct: 136 VSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANS 189
Query: 366 VVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
VGT YM+PE G SV+SD++S G+ L+E+ G+
Sbjct: 190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 29/110 (26%), Positives = 50/110 (45%), Gaps = 4/110 (3%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
R+ L R ++I+ I L H HRD+K N+L+ + + DFG+A
Sbjct: 127 RQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASA 183
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
+ + VGT YMAPE + ++D+++ +L E ++G
Sbjct: 184 TTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS 232
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-22
Identities = 41/173 (23%), Positives = 66/173 (38%), Gaps = 33/173 (19%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNT------ 363
IA + +LH + HRDLK SN+ + K+ DFG+ ++ E
Sbjct: 127 IAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 364 ----SKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLA 419
+ VGT YM+PE G S K D+FS G++L E++ F Q
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL-----YPFS----TQMERV 234
Query: 420 YTWKLWCNGEALELMDPVLKQ-SCMAAELLKCIHIGLLCVQEDPADRPNMSSV 471
T N + P+ Q +++ + P +RP ++
Sbjct: 235 RTLTDVRNLK----FPPLFTQKYPCEYVMVQ------DMLSPSPMERPEAINI 277
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 45/196 (22%), Positives = 80/196 (40%), Gaps = 28/196 (14%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
+ ++D + + + I +G+ YL + HRDL N+L+++E KI DFG+ +
Sbjct: 106 KHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTK 162
Query: 353 IFGGNQNESNTSKVVGTYG-----YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSG 407
+ ++ V G + APE SV SDV+SFGV+L E+ + + S
Sbjct: 163 VLPQDKEFF----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 218
Query: 408 FYLSEHGQSLLAYTWKLWCNGEALELMD-------PVLKQSCMAAELLKCIH-IGLLCVQ 459
+E + + +EL+ P C I+ I C
Sbjct: 219 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP---DGCPDE-----IYMIMTECWN 270
Query: 460 EDPADRPNMSSVAVML 475
+ RP+ +A+ +
Sbjct: 271 NNVNQRPSFRDLALRV 286
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 4e-22
Identities = 27/110 (24%), Positives = 45/110 (40%), Gaps = 11/110 (10%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
+ +L I+ + I L YLH + + + DLK N++L E K+ D G
Sbjct: 175 KGQKLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
+ GT G+ APE G +V +D+++ G L +
Sbjct: 231 INS------FGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDL 273
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 6e-22
Identities = 55/228 (24%), Positives = 89/228 (39%), Gaps = 52/228 (22%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
RA+LD R + + I +G+ YL + HRDL A N+L++ E + KI+DFG+A+
Sbjct: 119 RHRARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAK 175
Query: 353 IFGGNQNESNTSKVVGTYG-----YMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNS 406
+ +++ VV G + APE + S +SDV+SFGV+L E+ + K+
Sbjct: 176 LLPLDKDYY----VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS- 230
Query: 407 GFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG------------ 454
M + + LL+ + G
Sbjct: 231 ------------------CSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAE 272
Query: 455 -----LLCVQEDPADRPNMSSVAVML---ASDTVSLPQPTQPAFSVGR 494
LC P DRP+ S++ L S + A G+
Sbjct: 273 VHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGK 320
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 6e-22
Identities = 38/164 (23%), Positives = 56/164 (34%), Gaps = 39/164 (23%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
L +LH + H D+K +N+ L K+ DFG+ G G
Sbjct: 166 TLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGD 219
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGE 429
YMAPE L G +DVFS G+ +LE +A +L GE
Sbjct: 220 PRYMAPE-LLQGSYGTAADVFSLGLTILE-------------------VACNMELPHGGE 259
Query: 430 ALELM-----DPVLKQ--SCMAAELLKCIHIGLLCVQEDPADRP 466
+ + P S +L + ++ DP R
Sbjct: 260 GWQQLRQGYLPPEFTAGLSSELRSVLV------MMLEPDPKLRA 297
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 6e-22
Identities = 45/196 (22%), Positives = 80/196 (40%), Gaps = 28/196 (14%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
+ ++D + + + I +G+ YL + HRDL N+L+++E KI DFG+ +
Sbjct: 137 KHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTK 193
Query: 353 IFGGNQNESNTSKVVGTYG-----YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSG 407
+ ++ V G + APE SV SDV+SFGV+L E+ + + S
Sbjct: 194 VLPQDKEYY----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 249
Query: 408 FYLSEHGQSLLAYTWKLWCNGEALELMD-------PVLKQSCMAAELLKCIH-IGLLCVQ 459
+E + + +EL+ P C I+ I C
Sbjct: 250 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP---DGCPDE-----IYMIMTECWN 301
Query: 460 EDPADRPNMSSVAVML 475
+ RP+ +A+ +
Sbjct: 302 NNVNQRPSFRDLALRV 317
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 52/206 (25%), Positives = 83/206 (40%), Gaps = 37/206 (17%)
Query: 278 AIWIAI---GTTIPTIYSTRRAQLDWKRRIS------IINGIARGLLYLHEDSRLKVFHR 328
WI + T+ Y + I I + L +L E+ LK+ HR
Sbjct: 95 DCWICMELMSTSFDKFY--KYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHR 150
Query: 329 DLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPE----YALGGVIS 384
D+K SN+LLD N K+ DFG++ G + ++ G YMAPE A
Sbjct: 151 DIKPSNILLDRSGNIKLCDFGIS---GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYD 207
Query: 385 VKSDVFSFGVLLLEIISGKKNSGF-YLSEHGQ-SLLAYTWKLWCNGEALELMDPVLKQ-S 441
V+SDV+S G+ L E+ +G+ F Y + L G+ +L + ++ S
Sbjct: 208 VRSDVWSLGITLYELATGR----FPYPKWNSVFDQLTQV----VKGDPPQLSNSEEREFS 259
Query: 442 CMAAELLKCIHIGLLCVQEDPADRPN 467
+ C+ +D + RP
Sbjct: 260 PSFINFVNL------CLTKDESKRPK 279
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 46/198 (23%), Positives = 73/198 (36%), Gaps = 31/198 (15%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
R + + + I G+ YLH HRDL A NVLLD++ KI DFG+A+
Sbjct: 127 PRHSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183
Query: 354 FGGNQNESNTSKVVGTYG-----YMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSG 407
V G + APE SDV+SFGV L E+++ +
Sbjct: 184 VPEGHEYY----RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239
Query: 408 FYLSEHGQSLLAYTWKLWCNGEALELMD-------PVLKQSCMAAELLKCIH-IGLLCVQ 459
+A EL++ P C A ++ + C +
Sbjct: 240 PPTKFLELIGIAQ--GQMTVLRLTELLERGERLPRP---DKCPAE-----VYHLMKNCWE 289
Query: 460 EDPADRPNMSSVAVMLAS 477
+ + RP ++ +L +
Sbjct: 290 TEASFRPTFENLIPILKT 307
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 40/175 (22%), Positives = 66/175 (37%), Gaps = 31/175 (17%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF------------GGN 357
I L Y+H + HRDLK N+ +D N KI DFG+A+
Sbjct: 125 ILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 358 QNESNTSKVVGTYGYMAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQS 416
+ N + +GT Y+A E G G + K D++S G++ E+I E
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPF----STGMERVN- 236
Query: 417 LLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSV 471
K + D + + ++++ L + DP RP ++
Sbjct: 237 ----ILKKLRSVSIEFPPDFDDNKMKVEKKIIR------LLIDHDPNKRPGARTL 281
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 4e-21
Identities = 38/197 (19%), Positives = 75/197 (38%), Gaps = 31/197 (15%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
+ +++ K+++ I +G+ YL + HRDL A NVL++ E KI DFG+ +
Sbjct: 118 KNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 174
Query: 353 IFGGNQNESNTSKVVGTYG-----YMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNS 406
++ V + APE + + SDV+SFGV L E+++ +S
Sbjct: 175 AIETDKEYY----TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230
Query: 407 GFYLSEHGQSLLAYTWKLWCNGEALELMD-------PVLKQSCMAAELLKCIH-IGLLCV 458
+ + + P +C ++ + C
Sbjct: 231 SPMALFLKMIGPTHGQ--MTVTRLVNTLKEGKRLPCP---PNCPDE-----VYQLMRKCW 280
Query: 459 QEDPADRPNMSSVAVML 475
+ P++R + ++
Sbjct: 281 EFQPSNRTSFQNLIEGF 297
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 39/162 (24%), Positives = 74/162 (45%), Gaps = 21/162 (12%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I L ++H+ K+ HRD+K+ N+ L + ++ DFG+AR+ + +GT
Sbjct: 134 ICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGT 188
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGE 429
Y++PE + KSD+++ G +L E+ + K F S+ K+ +G
Sbjct: 189 PYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH--AFE----AGSMKNLVLKI-ISGS 241
Query: 430 ALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSV 471
PV + +L + + +P DRP+++S+
Sbjct: 242 ----FPPV--SLHYSYDLRSLVS---QLFKRNPRDRPSVNSI 274
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 5e-21
Identities = 42/144 (29%), Positives = 67/144 (46%), Gaps = 31/144 (21%)
Query: 278 AIWIAI---GTTIPTIYSTRRAQLDWKRRIS------IINGIARGLLYLHEDSRLKVFHR 328
+WI + T++ Y + +D + I I I + L +LH S+L V HR
Sbjct: 80 DVWICMELMDTSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLH--SKLSVIHR 134
Query: 329 DLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVI----- 383
D+K SNVL++ K+ DFG++ G ++ G YMAPE I
Sbjct: 135 DVKPSNVLINALGQVKMCDFGIS---GYLVDDVAKDIDAGCKPYMAPE-----RINPELN 186
Query: 384 ----SVKSDVFSFGVLLLEIISGK 403
SVKSD++S G+ ++E+ +
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILR 210
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 5e-21
Identities = 33/115 (28%), Positives = 54/115 (46%), Gaps = 14/115 (12%)
Query: 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA 351
R ++ + + I+ + YL + HRDL A N L+ K++DFG++
Sbjct: 102 ECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLS 158
Query: 352 RIFGGNQNESNTS-----KVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
R+ G+ ++ K + APE S+KSDV++FGVLL EI +
Sbjct: 159 RLMTGDTYTAHAGAKFPIK------WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 6e-21
Identities = 46/164 (28%), Positives = 69/164 (42%), Gaps = 20/164 (12%)
Query: 310 IARGLLYLHE--DSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVV 367
+ L H D V HRDLK +NV LD + N K+ DFG+ARI + + + T V
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FV 177
Query: 368 GTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCN 427
GT YM+PE + KSD++S G LL E+ + F S K+
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP--PFT----AFSQKELAGKI-RE 230
Query: 428 GEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSV 471
G+ + + EL + I + RP++ +
Sbjct: 231 GKFRRIP------YRYSDELNEIIT---RMLNLKDYHRPSVEEI 265
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 54/237 (22%), Positives = 99/237 (41%), Gaps = 46/237 (19%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
AQ + + ++ GIA G+ YL S + HRDL A N+L++ + K+SDFG+ R
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGR 195
Query: 353 IFGGNQNESNTSKVVGT---YGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGF 408
+ + + T++ G + +PE + SDV+S+G++L E++S G++
Sbjct: 196 VLEDDPEAAYTTR--GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER---- 249
Query: 409 YLSEHGQSLLAYTWKLWCNGEALELMD-------PVLKQSCMAAELLKCIH-IGLLCVQE 460
Y N + ++ +D P C AA ++ + L C Q+
Sbjct: 250 ----------PYWE--MSNQDVIKAVDEGYRLPPP---MDCPAA-----LYQLMLDCWQK 289
Query: 461 DPADRPNMSSVAVML---ASDTVSLPQPTQPAFSVGRIIARSGQSSSSYSKICSVNE 514
D +RP + +L + SL T + QS+ + + +
Sbjct: 290 DRNNRPKFEQIVSILDKLIRNPGSLKIITSA--AARPSNLLLDQSNVDITTFRTTGD 344
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 34/112 (30%), Positives = 62/112 (55%), Gaps = 8/112 (7%)
Query: 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA 351
+ +L + + + IA G+ ++ HRDL+A+N+L+ ++ KI+DFG+A
Sbjct: 100 TPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLA 156
Query: 352 RIFGGNQNESNTSKVVGTYGY--MAPEYALGGVISVKSDVFSFGVLLLEIIS 401
R+ ++ T++ + APE G ++KSDV+SFG+LL EI++
Sbjct: 157 RLI---EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 39/117 (33%), Positives = 64/117 (54%), Gaps = 14/117 (11%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
+ + + ++ IA+G+ YL ED RL HRDL A NVL+ + KI+DFG+A++
Sbjct: 110 HKDNIGSQYLLNWCVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKL 166
Query: 354 FGGNQNESNTSKVVGTYG-----YMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKK 404
G + E + G +MA E L + + +SDV+S+GV + E+++ G K
Sbjct: 167 LGAEEKEYHAEG-----GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 37/115 (32%), Positives = 60/115 (52%), Gaps = 14/115 (12%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
T Q + + ++ G+ G+ YL S L HRDL A NVL+D + K+SDFG++R
Sbjct: 143 THDGQFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199
Query: 353 IFGGNQNESNTSKVVGTYG------YMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+ + + + T+ G + APE S SDV+SFGV++ E+++
Sbjct: 200 VLEDDPDAAYTTT-----GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 43/162 (26%), Positives = 76/162 (46%), Gaps = 18/162 (11%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+ L ++H +V HRD+K +NV + K+ D G+ R F +++ +VGT
Sbjct: 145 LCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGE 429
YM+PE + KSD++S G LL E+ + + FY +L + K+ +
Sbjct: 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS--PFY--GDKMNLYSLCKKI-EQCD 254
Query: 430 ALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSV 471
P L + EL + ++ +C+ DP RP+++ V
Sbjct: 255 Y-----PPLPSDHYSEELRQLVN---MCINPDPEKRPDVTYV 288
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 31/115 (26%), Positives = 60/115 (52%), Gaps = 14/115 (12%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
+ + + + ++ GIA G+ YL + + HRDL A N+L++ + K+SDFG++R
Sbjct: 139 EKDGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195
Query: 353 IFGGNQNESNTSKVVGTYG------YMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+ + + T+ G + APE + SDV+SFG+++ E+++
Sbjct: 196 VLEDDPEATYTTS-----GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 47/183 (25%), Positives = 77/183 (42%), Gaps = 31/183 (16%)
Query: 301 KRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLL-----DHEMNPKISDFGMARIFG 355
I+++ GL +LH L + HRDLK N+L+ ++ ISDFG+ +
Sbjct: 118 LEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174
Query: 356 GNQNE-SNTSKVVGTYGYMAPEY---ALGGVISVKSDVFSFGVLLLEIISGKKNSG---F 408
++ S S V GT G++APE + D+FS G + +IS G F
Sbjct: 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE----GSHPF 230
Query: 409 YLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNM 468
S Q+ + +L+ + P + +A EL++ + DP RP+
Sbjct: 231 GKSLQRQANILL------GACSLDCLHPEKHEDVIARELIEK------MIAMDPQKRPSA 278
Query: 469 SSV 471
V
Sbjct: 279 KHV 281
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 36/113 (31%), Positives = 61/113 (53%), Gaps = 10/113 (8%)
Query: 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA 351
S ++ + I IA G+ ++ + HRDL+A+N+L+ + KI+DFG+A
Sbjct: 275 SDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLA 331
Query: 352 RIFGGNQNESNTSKVVGT---YGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
R+ N+ + G + APE G ++KSDV+SFG+LL+EI++
Sbjct: 332 RVIEDNEYTARE----GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 2e-20
Identities = 31/110 (28%), Positives = 53/110 (48%), Gaps = 4/110 (3%)
Query: 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA 351
R ++ + + I+ + YL + HR+L A N L+ K++DFG++
Sbjct: 309 ECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLS 365
Query: 352 RIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
R+ G+ ++ + APE S+KSDV++FGVLL EI +
Sbjct: 366 RLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 37/134 (27%), Positives = 63/134 (47%), Gaps = 13/134 (9%)
Query: 278 AIWIAI---GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASN 334
++IA+ GT + + + + + I + L YL E V HRD+K SN
Sbjct: 98 DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSN 155
Query: 335 VLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPE-----YALGGVISVKSDV 389
+LLD K+ DFG++ G ++ + G YMAPE +++DV
Sbjct: 156 ILLDERGQIKLCDFGIS---GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADV 212
Query: 390 FSFGVLLLEIISGK 403
+S G+ L+E+ +G+
Sbjct: 213 WSLGISLVELATGQ 226
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-20
Identities = 45/210 (21%), Positives = 79/210 (37%), Gaps = 47/210 (22%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
+R ++ +++ ++ G+ YL HRDL A NVLL + KISDFG+++
Sbjct: 102 GKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSK 158
Query: 353 IFGGNQNESNTSKVVGTYG------YMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKN 405
G + + + APE S +SDV+S+GV + E +S G+K
Sbjct: 159 ALGADDSYYTARS-----AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK- 212
Query: 406 SGFYLSEHGQSLLAYTWKLWCNGEALELMD-------PVLKQSCMAAELLKCIH-IGLLC 457
+K E + ++ P C ++ + C
Sbjct: 213 ---------------PYKKMKGPEVMAFIEQGKRMECP---PECPPE-----LYALMSDC 249
Query: 458 VQEDPADRPNMSSVAVMLASDTVSLPQPTQ 487
DRP+ +V + + SL +
Sbjct: 250 WIYKWEDRPDFLTVEQRMRACYYSLASKVE 279
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 4e-20
Identities = 36/158 (22%), Positives = 70/158 (44%), Gaps = 21/158 (13%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEM-NPKISDFGMARIFGGNQNESNTSKVVG 368
I +GL +LH + + HRDLK N+ + + KI D G+A + + ++ V+G
Sbjct: 138 ILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIG 192
Query: 369 TYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNG 428
T +MAPE DV++FG+ +LE+ + + Y + + ++ +G
Sbjct: 193 TPEFMAPEMYEEKY-DESVDVYAFGMCMLEMATSEYP---YSECQNAAQI---YRRVTSG 245
Query: 429 EALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRP 466
D V E+++ C++++ +R
Sbjct: 246 VKPASFDKVA--IPEVKEIIE------GCIRQNKDERY 275
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 90.5 bits (224), Expect = 6e-20
Identities = 19/183 (10%), Positives = 35/183 (19%), Gaps = 18/183 (9%)
Query: 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGM 350
R + + R L + H N+ + + + D
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSA 240
Query: 351 ARIFGGNQNESNTSKVVGTYGYMAPEYALGG--VISVKSDVFSFGVLLLEIISGKKNSGF 408
G + Y E+ + + + G+ + + F
Sbjct: 241 LWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF--LPF 293
Query: 409 YLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNM 468
L G L G L+ L D R
Sbjct: 294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG----RFLNF--DRRRRLLP 347
Query: 469 SSV 471
Sbjct: 348 LEA 350
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 7e-20
Identities = 37/114 (32%), Positives = 54/114 (47%), Gaps = 11/114 (9%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
+ + K IS +ARG+ YL + K HRDL A N +LD K++DFG+AR
Sbjct: 116 SPQRNPTVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172
Query: 353 IFGGNQNESNTSKVVGTYG-----YMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+ S + + A E + KSDV+SFGVLL E+++
Sbjct: 173 DI---LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 7e-20
Identities = 34/112 (30%), Positives = 54/112 (48%), Gaps = 10/112 (8%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
+ L+ + + + + G+ +L + HRDL A N L+D ++ K+SDFGM R
Sbjct: 96 SHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTR 152
Query: 353 IFGGNQNESNTSKVVGT---YGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+ VGT + APE S KSDV++FG+L+ E+ S
Sbjct: 153 YV----LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 8e-20
Identities = 33/112 (29%), Positives = 48/112 (42%), Gaps = 10/112 (8%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
R+ LD I ++ L YL + HRD+ A NVL+ K+ DFG++R
Sbjct: 108 VRKYSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164
Query: 353 IFGGNQNESNTSKVVGT---YGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+S K +MAPE + SDV+ FGV + EI+
Sbjct: 165 YM----EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 8e-20
Identities = 31/112 (27%), Positives = 55/112 (49%), Gaps = 10/112 (8%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
R + ++ + + + + YL + HRDL A N L++ + K+SDFG++R
Sbjct: 112 EMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 168
Query: 353 IFGGNQNESNTSKVVGT---YGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
++ S+ G+ + PE + S KSD+++FGVL+ EI S
Sbjct: 169 YVLDDEYTSSV----GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 8e-20
Identities = 26/101 (25%), Positives = 42/101 (41%), Gaps = 18/101 (17%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+ Y+H + + HRD+K SN+L+D K+SDFG + + GT
Sbjct: 160 VLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM----VDKKIKGSRGT 213
Query: 370 YGYMAPEYALGGVISVK-------SDVFSFGVLLLEIISGK 403
Y +M PE S + D++S G+ L +
Sbjct: 214 YEFMPPE-----FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 8e-20
Identities = 37/114 (32%), Positives = 52/114 (45%), Gaps = 13/114 (11%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
K I +A+G+ YL K HRDL A N +LD + K++DFG+AR
Sbjct: 121 ETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARD 177
Query: 354 FGGNQNESNTSKVVGTYG------YMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+ V G +MA E + KSDV+SFGVLL E+++
Sbjct: 178 M----YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 9e-20
Identities = 33/113 (29%), Positives = 60/113 (53%), Gaps = 13/113 (11%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
+ + + ++ IA+G+ YL ++ HRDL A NVL+ + KI+DFG+A++
Sbjct: 110 HKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166
Query: 354 FGGNQNESNTSKVVGTYG-----YMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
G + E + G +MA E L + + +SDV+S+GV + E+++
Sbjct: 167 LGAEEKEYHAEG-----GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 38/114 (33%), Positives = 53/114 (46%), Gaps = 14/114 (12%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
T+R + + + + G+ YL V HRDL A N L+ K+SDFGM R
Sbjct: 96 TQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTR 152
Query: 353 IFGGNQNESNTS-----KVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+Q S+T K + +PE S KSDV+SFGVL+ E+ S
Sbjct: 153 FVLDDQYTSSTGTKFPVK------WASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 36/112 (32%), Positives = 52/112 (46%), Gaps = 12/112 (10%)
Query: 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA 351
S R+ L + + + YL HRDL A NVL+ + K+SDFG+
Sbjct: 280 SRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336
Query: 352 RIFGGNQNESNTSKVVGTYGY--MAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+ E+++++ G APE S KSDV+SFG+LL EI S
Sbjct: 337 K-------EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 41/110 (37%), Positives = 57/110 (51%), Gaps = 13/110 (11%)
Query: 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGG 356
Q+ +K +S +ARG+ YL + K HRDL A NVL+ KI+DFG+AR
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 357 NQNESNTSKVVGTYG-----YMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
T+ G +MAPE V + +SDV+SFGVL+ EI +
Sbjct: 210 IDYYKKTTN-----GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 31/114 (27%), Positives = 55/114 (48%), Gaps = 13/114 (11%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
R L + ++ IA+G+ YL + HR+L A NVLL +++DFG+A
Sbjct: 107 QHRGALGPQLLLNWGVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVAD 163
Query: 353 IFGGNQNESNTSKVVGTYG-----YMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+ + + S+ +MA E G + +SDV+S+GV + E+++
Sbjct: 164 LLPPDDKQLLYSE-----AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 39/122 (31%), Positives = 56/122 (45%), Gaps = 13/122 (10%)
Query: 285 TTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPK 344
T P I LD + +S +A+G+ +L + HRDL A N+LL H K
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITK 185
Query: 345 ISDFGMARIFGGNQNESNTSKVVGTYG-----YMAPEYALGGVISVKSDVFSFGVLLLEI 399
I DFG+AR + N +MAPE V + +SDV+S+G+ L E+
Sbjct: 186 ICDFGLARDIKNDSNYVVKGN-----ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240
Query: 400 IS 401
S
Sbjct: 241 FS 242
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 17/118 (14%), Positives = 37/118 (31%), Gaps = 9/118 (7%)
Query: 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGM 350
+S+ L R+ + + R L LH + H L+ +++LD ++ F
Sbjct: 201 HSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEH 257
Query: 351 ARIFGGNQNESNTSKVVGTYGYMAPEYALG-----GVISVKSDVFSFGVLLLEIISGK 403
G + A +++ D ++ G+ + I
Sbjct: 258 LVRDGASAVSPIGR-GFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 48/196 (24%), Positives = 78/196 (39%), Gaps = 45/196 (22%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
+ + K I +++ ++ G+ YL HRDL A NVLL + KISDFG+++
Sbjct: 110 QNRHVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166
Query: 354 FGGNQNESNTSKVVGTYG------YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSG 407
++N + APE S KSDV+SFGVL+ E S
Sbjct: 167 LRADENYYKAQT-----HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS------ 215
Query: 408 FYLSEHGQSLLAYTWKLWCNGEALELMD-------PVLKQSCMAAELLKCIH-IGLLCVQ 459
+GQ ++ E +++ P C ++ + LC
Sbjct: 216 -----YGQK----PYRGMKGSEVTAMLEKGERMGCP---AGCPRE-----MYDLMNLCWT 258
Query: 460 EDPADRPNMSSVAVML 475
D +RP ++V + L
Sbjct: 259 YDVENRPGFAAVELRL 274
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 49/189 (25%), Positives = 83/189 (43%), Gaps = 33/189 (17%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
L + + + IA G+ Y+ R+ HRDL+A+N+L+ + K++DFG+AR+
Sbjct: 273 TGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARL 329
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH 413
N+ + + APE AL G ++KSDV+SFG+LL E+ +
Sbjct: 330 IEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT-----------K 377
Query: 414 GQSLLAYTWKLWCNGEALEL------MDPVLKQSCMAAELLKCIH-IGLLCVQEDPADRP 466
G+ Y N E L+ M C + +H + C +++P +RP
Sbjct: 378 GRV--PYPG--MVNREVLDQVERGYRMPC--PPECPES-----LHDLMCQCWRKEPEERP 426
Query: 467 NMSSVAVML 475
+ L
Sbjct: 427 TFEYLQAFL 435
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 40/114 (35%), Positives = 56/114 (49%), Gaps = 15/114 (13%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR- 352
+ L + I +A+G+ +L + K HRDL A N+LL + KI DFG+AR
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 353 IFGGNQNESNTS-----KVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
I+ K +MAPE V +++SDV+SFGVLL EI S
Sbjct: 198 IYKDPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 2e-19
Identities = 36/112 (32%), Positives = 52/112 (46%), Gaps = 12/112 (10%)
Query: 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA 351
S R+ L + + + YL HRDL A NVL+ + K+SDFG+
Sbjct: 108 SRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164
Query: 352 RIFGGNQNESNTSKVVGTYGY--MAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+ E+++++ G APE S KSDV+SFG+LL EI S
Sbjct: 165 K-------EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 41/110 (37%), Positives = 57/110 (51%), Gaps = 13/110 (11%)
Query: 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGG 356
Q+ +K +S +ARG+ YL + K HRDL A NVL+ KI+DFG+AR
Sbjct: 199 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 255
Query: 357 NQNESNTSKVVGTYG-----YMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
T+ G +MAPE V + +SDV+SFGVL+ EI +
Sbjct: 256 IDYYKKTTN-----GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 37/116 (31%), Positives = 58/116 (50%), Gaps = 13/116 (11%)
Query: 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGM 350
++ + + + + +A+G+ +L + HRD+ A NVLL + KI DFG+
Sbjct: 154 FAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGL 210
Query: 351 ARIFGGNQNESNTSKVVGTYG-----YMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
AR N+SN +MAPE V +V+SDV+S+G+LL EI S
Sbjct: 211 ARDI---MNDSNYIV--KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 33/116 (28%), Positives = 47/116 (40%), Gaps = 9/116 (7%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
+ +A G+ YL E R HRDL A N+LL KI DFG+ R
Sbjct: 113 KHQGHFLLGTLSRYAVQVAEGMGYL-ESKRF--IHRDLAARNLLLATRDLVKIGDFGLMR 169
Query: 353 IFGGNQNESNTSKVVGT---YGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKK 404
N + + + + APE S SD + FGV L E+ + G++
Sbjct: 170 ALPQNDDHYVMQE--HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 39/119 (32%), Positives = 59/119 (49%), Gaps = 16/119 (13%)
Query: 288 PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISD 347
I ++ + L ++ + +ARG+ YL S+ + HRDL A N+L+ KI+D
Sbjct: 129 FAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIAD 185
Query: 348 FGMARIFGGNQNESNTSKVVGTYG-----YMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
FG++R V T G +MA E V + SDV+S+GVLL EI+S
Sbjct: 186 FGLSR--------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 27/112 (24%), Positives = 46/112 (41%), Gaps = 10/112 (8%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
+ L + I + + YL + HRD+ N+L+ K+ DFG++R
Sbjct: 105 RNKNSLKVLTLVLYSLQICKAMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSR 161
Query: 353 IFGGNQNESNTSKVVGT---YGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+ + K T +M+PE + SDV+ F V + EI+S
Sbjct: 162 YI----EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 3e-19
Identities = 36/110 (32%), Positives = 60/110 (54%), Gaps = 4/110 (3%)
Query: 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA 351
L + + + IA G+ Y+ R+ HRDL+A+N+L+ + K++DFG+A
Sbjct: 354 GETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLA 410
Query: 352 RIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
R+ N+ + + APE AL G ++KSDV+SFG+LL E+ +
Sbjct: 411 RLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 36/114 (31%), Positives = 53/114 (46%), Gaps = 13/114 (11%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
K I +A+G+ +L + K HRDL A N +LD + K++DFG+AR
Sbjct: 185 ETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 241
Query: 354 FGGNQNESNTSKVVGTYG------YMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
+ V G +MA E + KSDV+SFGVLL E+++
Sbjct: 242 M----YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 39/138 (28%), Positives = 64/138 (46%), Gaps = 15/138 (10%)
Query: 270 SSKGKGRKAIWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRD 329
S+ G + ++ L IS I++G+ YL + +K+ HRD
Sbjct: 119 ESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRD 175
Query: 330 LKASNVLLDHEMNPKISDFGMAR-IFGGNQNESNTS-----KVVGTYGYMAPEYALGGVI 383
L A N+L+ KISDFG++R ++ + + K +MA E +
Sbjct: 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVK------WMAIESLFDHIY 229
Query: 384 SVKSDVFSFGVLLLEIIS 401
+ +SDV+SFGVLL EI++
Sbjct: 230 TTQSDVWSFGVLLWEIVT 247
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 42/112 (37%), Positives = 57/112 (50%), Gaps = 13/112 (11%)
Query: 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354
QL K +S +ARG+ YL + K HRDL A NVL+ + KI+DFG+AR
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 241
Query: 355 GGNQNESNTSKVVGTYG-----YMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
T+ G +MAPE + + +SDV+SFGVLL EI +
Sbjct: 242 HHIDYYKKTTN-----GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 5e-19
Identities = 44/208 (21%), Positives = 79/208 (37%), Gaps = 39/208 (18%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
+R ++ +++ ++ G+ YL HR+L A NVLL + KISDFG+++
Sbjct: 428 GKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSK 484
Query: 353 IFGGNQNESNTSKVVGT---YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFY 409
G + + + APE S +SDV+S+GV + E +S
Sbjct: 485 ALGADDSYYTAR--SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS-------- 534
Query: 410 LSEHGQSLLAYTWKLWCNGEALELMD-------PVLKQSCMAAELLKCIH-IGLLCVQED 461
+GQ +K E + ++ P C ++ + C
Sbjct: 535 ---YGQK----PYKKMKGPEVMAFIEQGKRMECP---PECPPE-----LYALMSDCWIYK 579
Query: 462 PADRPNMSSVAVMLASDTVSLPQPTQPA 489
DRP+ +V + + SL +
Sbjct: 580 WEDRPDFLTVEQRMRACYYSLASKVEGG 607
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 5e-19
Identities = 36/123 (29%), Positives = 58/123 (47%), Gaps = 13/123 (10%)
Query: 284 GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP 343
T ++ L+ + ++ IA G+ YL S V H+DL NVL+ ++N
Sbjct: 111 DVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNV 167
Query: 344 KISDFGMARIFGGNQNESNTSKVVGTYG-----YMAPEYALGGVISVKSDVFSFGVLLLE 398
KISD G+ R + + +MAPE + G S+ SD++S+GV+L E
Sbjct: 168 KISDLGLFREV-----YAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWE 222
Query: 399 IIS 401
+ S
Sbjct: 223 VFS 225
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 6e-19
Identities = 34/101 (33%), Positives = 52/101 (51%), Gaps = 12/101 (11%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
+I GI YLH K+ HRD+K SN+L+ + + KI+DFG++ F G+ + +
Sbjct: 146 LIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT- 197
Query: 366 VVGTYGYMAPE---YALGGVISVKSDVFSFGVLLLEIISGK 403
VGT +MAPE DV++ GV L + G+
Sbjct: 198 -VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 7e-19
Identities = 35/115 (30%), Positives = 57/115 (49%), Gaps = 13/115 (11%)
Query: 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA 351
L + +++ + +A G++YL + L HRDL N L+ + KI DFGM+
Sbjct: 149 DVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
Query: 352 RIFGGNQNESNTSKVVGTYG-----YMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
R + ++ + VG +M PE L + +SDV+SFGV+L EI +
Sbjct: 206 R----DIYSTDYYR-VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 87.4 bits (216), Expect = 7e-19
Identities = 19/124 (15%), Positives = 41/124 (33%), Gaps = 20/124 (16%)
Query: 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGM 350
+S+ L R+ + + R L LH + H L+ +++LD ++ F
Sbjct: 196 HSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEH 252
Query: 351 ARIFGGNQNESNTSKVVGTYGYMAPEYAL-----------GGVISVKSDVFSFGVLLLEI 399
G + G+ PE +++ D ++ G+++ I
Sbjct: 253 LVRDG------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306
Query: 400 ISGK 403
Sbjct: 307 WCAD 310
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 8e-19
Identities = 37/98 (37%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR-IFGGNQNESNTS---- 364
+A+G+ +L HRDL A NVL+ H KI DFG+AR I + +
Sbjct: 181 VAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 237
Query: 365 -KVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
K +MAPE G+ ++KSDV+S+G+LL EI S
Sbjct: 238 VK------WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 8e-19
Identities = 36/115 (31%), Positives = 55/115 (47%), Gaps = 13/115 (11%)
Query: 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA 351
+ +L + + I + IA G++YL + HRDL N L+ + KI DFGM+
Sbjct: 124 RQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
Query: 352 RIFGGNQNESNTSKVVGTYG-----YMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
R S VG + +M PE + + +SDV+SFGV+L EI +
Sbjct: 181 RDV-----YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 9e-19
Identities = 32/111 (28%), Positives = 49/111 (44%), Gaps = 8/111 (7%)
Query: 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
R+ LD I ++ L YL + HRD+ A NVL+ K+ DFG++R
Sbjct: 483 VRKFSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539
Query: 353 IFGGNQNESNTSKVVGTY--GYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
++ + G +MAPE + SDV+ FGV + EI+
Sbjct: 540 YM---EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 32/111 (28%), Positives = 53/111 (47%), Gaps = 15/111 (13%)
Query: 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR-IFG 355
+ + + + IA G+ YL S HRDL A N +L +M ++DFG+++ I+
Sbjct: 143 HIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYS 199
Query: 356 GNQNESNTS-----KVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
G+ K ++A E V + KSDV++FGV + EI +
Sbjct: 200 GDYYRQGRIAKMPVK------WIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 1e-18
Identities = 36/103 (34%), Positives = 56/103 (54%), Gaps = 18/103 (17%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
++ G+ YLH + + HRD+K N+LLD N KISDFG+A +F N E +K
Sbjct: 114 LMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 366 VVGTYGYMAPEYALGGVIS------VKSDVFSFGVLLLEIISG 402
+ GT Y+APE ++ DV+S G++L +++G
Sbjct: 167 MCGTLPYVAPE-----LLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 40/221 (18%), Positives = 74/221 (33%), Gaps = 47/221 (21%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
I R + ++H + + HRDLK N+LL ++ K+ DFG A + S +++
Sbjct: 141 IFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199
Query: 366 ----------VVGTYGYMAPE---YALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSE 412
T Y PE I K D+++ G +L + + F
Sbjct: 200 RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ--HPFE--- 254
Query: 413 HGQSLLA-----YTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPN 467
+ L Y+ P Q + L++ +Q +P +R +
Sbjct: 255 -DGAKLRIVNGKYSIP------------PHDTQYTVFHSLIRA------MLQVNPEERLS 295
Query: 468 MSSV----AVMLASDTVSLPQPTQPAFSVGRIIARSGQSSS 504
++ V + A+ V+ P + S
Sbjct: 296 IAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSATLSRG 336
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 30/105 (28%), Positives = 44/105 (41%), Gaps = 15/105 (14%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+ + +H+ + H DLK +N L+ + K+ DFG+A + VGT
Sbjct: 136 MLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 191
Query: 370 YGYMAPE-----------YALGGVISVKSDVFSFGVLLLEIISGK 403
YM PE IS KSDV+S G +L + GK
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 38/137 (27%), Positives = 59/137 (43%), Gaps = 13/137 (9%)
Query: 270 SSKGKGRKAIWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRD 329
S ++ + +T + S L ++ I +A G+ YL S K HRD
Sbjct: 143 SMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRD 199
Query: 330 LKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY-----MAPEYALGGVIS 384
L N L+ M KI+DFG++R N ++ K M PE +
Sbjct: 200 LATRNCLVGENMVVKIADFGLSR----NIYSADYYK-ADGNDAIPIRWMPPESIFYNRYT 254
Query: 385 VKSDVFSFGVLLLEIIS 401
+SDV+++GV+L EI S
Sbjct: 255 TESDVWAYGVVLWEIFS 271
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 38/119 (31%), Positives = 51/119 (42%), Gaps = 13/119 (10%)
Query: 288 PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISD 347
+ A + I + IA G+ YL+ K HRDL A N ++ + KI D
Sbjct: 125 AMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGD 181
Query: 348 FGMARIFGGNQNESNTSKVVGTYGY-----MAPEYALGGVISVKSDVFSFGVLLLEIIS 401
FGM R G G M+PE GV + SDV+SFGV+L EI +
Sbjct: 182 FGMTRDI-----YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 42/182 (23%), Positives = 67/182 (36%), Gaps = 39/182 (21%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
++ GI RGL +H HRDLK +N+LL E P + D G + S +
Sbjct: 139 LLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQAL 195
Query: 366 VV-------GTYGYMAPE---YALGGVISVKSDVFSFGVLLLEIISGKKNSGF-YLSEHG 414
+ T Y APE VI ++DV+S G +L ++ G+ + + + G
Sbjct: 196 TLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE--GPYDMVFQKG 253
Query: 415 QSLLA-----YTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMS 469
S+ + L Q LL + DP RP++
Sbjct: 254 DSVALAVQNQLSIPQSPR------HSSALWQ------LLNS------MMTVDPHQRPHIP 295
Query: 470 SV 471
+
Sbjct: 296 LL 297
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 38/111 (34%), Positives = 55/111 (49%), Gaps = 3/111 (2%)
Query: 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGM 350
+ L + I +A+G+ +L + K HRDL A N+LL + KI DFG+
Sbjct: 183 EDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGL 239
Query: 351 ARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
AR + + +MAPE V +++SDV+SFGVLL EI S
Sbjct: 240 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 36/103 (34%), Positives = 56/103 (54%), Gaps = 18/103 (17%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
++ G+ YLH + + HRD+K N+LLD N KISDFG+A +F N E +K
Sbjct: 114 LMAGVV----YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 366 VVGTYGYMAPEYALGGVIS------VKSDVFSFGVLLLEIISG 402
+ GT Y+APE ++ DV+S G++L +++G
Sbjct: 167 MCGTLPYVAPE-----LLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 33/121 (27%), Positives = 50/121 (41%), Gaps = 15/121 (12%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
++ +D R S + + +H+ + H DLK +N L+ + K+ DFG+A
Sbjct: 101 KKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 156
Query: 354 FGGNQNESNTSKVVGTYGYMAPE-----------YALGGVISVKSDVFSFGVLLLEIISG 402
+ VGT YM PE IS KSDV+S G +L + G
Sbjct: 157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 216
Query: 403 K 403
K
Sbjct: 217 K 217
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 33/116 (28%), Positives = 55/116 (47%), Gaps = 15/116 (12%)
Query: 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA 351
L + + + IA G+ YL S HRDL A N +L +M ++DFG++
Sbjct: 128 GENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184
Query: 352 R-IFGGNQNESNTS-----KVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
R I+ G+ + K ++A E + +V SDV++FGV + EI++
Sbjct: 185 RKIYSGDYYRQGCASKLPVK------WLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 3e-18
Identities = 29/105 (27%), Positives = 43/105 (40%), Gaps = 15/105 (14%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+ + +H+ + H DLK +N L+ + K+ DFG+A + VG
Sbjct: 164 MLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGA 219
Query: 370 YGYMAPE-----------YALGGVISVKSDVFSFGVLLLEIISGK 403
YM PE IS KSDV+S G +L + GK
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 87.4 bits (216), Expect = 3e-18
Identities = 34/97 (35%), Positives = 47/97 (48%), Gaps = 9/97 (9%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLD---HEMNPKISDFGMARIFGGNQNESNTSKV 366
I+ L YLHE ++ HRDLK N++L + KI D G A+ ++
Sbjct: 130 ISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEF 183
Query: 367 VGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
VGT Y+APE +V D +SFG L E I+G
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 3e-18
Identities = 36/97 (37%), Positives = 52/97 (53%), Gaps = 11/97 (11%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK---V 366
I G+LYLH + HRDL SN+LL MN KI+DFG+A Q + K +
Sbjct: 121 IITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLA-----TQLKMPHEKHYTL 172
Query: 367 VGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
GT Y++PE A ++SDV+S G + ++ G+
Sbjct: 173 CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 5e-18
Identities = 33/94 (35%), Positives = 47/94 (50%), Gaps = 5/94 (5%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I G YLH R +V HRDLK N+ L+ ++ KI DFG+A + GT
Sbjct: 124 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGT 178
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
Y+APE S + DV+S G ++ ++ GK
Sbjct: 179 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 6e-18
Identities = 29/103 (28%), Positives = 47/103 (45%), Gaps = 17/103 (16%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP-KISDFGMARIFGGNQNESNTSK--- 365
GL YLH ++ H D+KA NVLL + + + DFG A + +
Sbjct: 159 ALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215
Query: 366 VVGTYGYMAPEYALGGVI-----SVKSDVFSFGVLLLEIISGK 403
+ GT +MAPE V+ K D++S ++L +++G
Sbjct: 216 IPGTETHMAPE-----VVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 33/94 (35%), Positives = 47/94 (50%), Gaps = 5/94 (5%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I G YLH R +V HRDLK N+ L+ ++ KI DFG+A + GT
Sbjct: 150 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGT 204
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
Y+APE S + DV+S G ++ ++ GK
Sbjct: 205 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 1e-17
Identities = 35/137 (25%), Positives = 52/137 (37%), Gaps = 25/137 (18%)
Query: 288 PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP---- 343
+ IS++ IA G+ +LH LK+ HRDLK N+L+
Sbjct: 102 KNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQ 158
Query: 344 ---------KISDFGMARIFGGNQN--ESNTSKVVGTYGYMAPEYALGGVISV------- 385
ISDFG+ + Q+ +N + GT G+ APE
Sbjct: 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTR 218
Query: 386 KSDVFSFGVLLLEIISG 402
D+FS G + I+S
Sbjct: 219 SIDIFSMGCVFYYILSK 235
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 35/102 (34%), Positives = 54/102 (52%), Gaps = 18/102 (17%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLD-HEMNPKISDFGMARIFGGNQNESNTSKVVG 368
I GL YLH++ ++ HRD+K NVL++ + KISDFG ++ G + T G
Sbjct: 131 ILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTG 185
Query: 369 TYGYMAPEYALGGVI-------SVKSDVFSFGVLLLEIISGK 403
T YMAPE +I +D++S G ++E+ +GK
Sbjct: 186 TLQYMAPE-----IIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 3e-17
Identities = 33/95 (34%), Positives = 46/95 (48%), Gaps = 9/95 (9%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVV-G 368
+A L Y H +V HRD+K N+LL KI+DFG + S+ + G
Sbjct: 118 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTDLCG 169
Query: 369 TYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
T Y+ PE G + K D++S GVL E + GK
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 24/106 (22%), Positives = 45/106 (42%), Gaps = 18/106 (16%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLL----DHEMNPKISDFGMARIFGGNQNESNTSK 365
+ G+ +L E + HR++K N++ D + K++DFG AR +++
Sbjct: 121 VVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVS 174
Query: 366 VVGTYGYMAPEYALGGVI--------SVKSDVFSFGVLLLEIISGK 403
+ GT Y+ P+ V+ D++S GV +G
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 5e-17
Identities = 37/95 (38%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I GL ++H V +RDLK +N+LLD + +ISD G+A F + VGT
Sbjct: 301 IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGT 353
Query: 370 YGYMAPEYALGGVISVKS-DVFSFGVLLLEIISGK 403
+GYMAPE GV S D FS G +L +++ G
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 5e-17
Identities = 37/94 (39%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I GL +LH+ + +RDLK NVLLD + N +ISD G+A Q ++ GT
Sbjct: 298 IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY--AGT 352
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
G+MAPE LG D F+ GV L E+I+ +
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 7e-17
Identities = 29/100 (29%), Positives = 43/100 (43%), Gaps = 9/100 (9%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
+I+G+ YLH + H+D+K N+LL KIS G+A +
Sbjct: 118 LIDGLE----YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 366 VVGTYGYMAPEYALG--GVISVKSDVFSFGVLLLEIISGK 403
G+ + PE A G K D++S GV L I +G
Sbjct: 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 7e-17
Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 8/96 (8%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN---TSKVVG 368
GL Y+H + K+ HRD+KA+NVL+ + K++DFG+AR F +N T++VV
Sbjct: 135 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV- 190
Query: 369 TYGYMAPEYALGGVI-SVKSDVFSFGVLLLEIISGK 403
T Y PE LG D++ G ++ E+ +
Sbjct: 191 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 9e-17
Identities = 24/106 (22%), Positives = 45/106 (42%), Gaps = 18/106 (16%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLL----DHEMNPKISDFGMARIFGGNQNESNTSK 365
+ G+ +L E + HR++K N++ D + K++DFG AR +++
Sbjct: 121 VVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVS 174
Query: 366 VVGTYGYMAPEYALGGVI--------SVKSDVFSFGVLLLEIISGK 403
+ GT Y+ P+ V+ D++S GV +G
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 35/99 (35%), Positives = 50/99 (50%), Gaps = 11/99 (11%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
I++ + Y H + ++ HRDLKA N+LLD +MN KI+DFG + F
Sbjct: 123 IVSAVQ----YCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD-AF- 173
Query: 366 VVGTYGYMAPEYALG-GVISVKSDVFSFGVLLLEIISGK 403
G Y APE G + DV+S GV+L ++SG
Sbjct: 174 -CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 27/128 (21%), Positives = 47/128 (36%), Gaps = 30/128 (23%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+ + YL + HRD+K N+++ + K+ DFG A + GT
Sbjct: 139 LVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYTFCGT 192
Query: 370 YGYMAPEYALGGVISVKS------DVFSFGVLL-------------LEIISGKKNSGFYL 410
Y APE V+ +++S GV L E + + + +
Sbjct: 193 IEYCAPE-----VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLV 247
Query: 411 SEHGQSLL 418
S+ SL+
Sbjct: 248 SKELMSLV 255
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 38/119 (31%), Positives = 51/119 (42%), Gaps = 18/119 (15%)
Query: 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLD---HEMNPKISDF 348
++ + L + + IA G YL HRD+ A N LL KI DF
Sbjct: 131 PSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDF 187
Query: 349 GMAR-IFGGNQNESNTSKVVGTYGY-----MAPEYALGGVISVKSDVFSFGVLLLEIIS 401
GMAR I+ + G M PE + G+ + K+D +SFGVLL EI S
Sbjct: 188 GMARDIYRASYYR------KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 22/122 (18%), Positives = 45/122 (36%), Gaps = 28/122 (22%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP--------KI 345
+ ++ ++ + +A + +L + H ++ A N+LL E + K+
Sbjct: 106 NKNCINILWKLEVAKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162
Query: 346 SDFGMARIFGGNQNESNTSKVVGTYGY-----MAPEYAL-GGVISVKSDVFSFGVLLLEI 399
SD G++ + PE +++ +D +SFG L EI
Sbjct: 163 SDPGISITVLPKD-----------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEI 211
Query: 400 IS 401
S
Sbjct: 212 CS 213
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 5/98 (5%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
I+ I +GL YLH + K HRD+KA+NVLL K++DFG+A Q + NT
Sbjct: 124 ILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-- 178
Query: 366 VVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
VGT +MAPE K+D++S G+ +E+ G+
Sbjct: 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 30/99 (30%), Positives = 56/99 (56%), Gaps = 13/99 (13%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I L YLH + HRDLK N+LL+ +M+ +I+DFG A++ ++ + VGT
Sbjct: 139 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
Query: 370 YGYMAPEYALGGVISVK-----SDVFSFGVLLLEIISGK 403
Y++PE +++ K SD+++ G ++ ++++G
Sbjct: 196 AQYVSPE-----LLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 37/118 (31%), Positives = 48/118 (40%), Gaps = 16/118 (13%)
Query: 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLD---HEMNPKISDF 348
++ + L + + IA G YL HRD+ A N LL KI DF
Sbjct: 172 PSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDF 228
Query: 349 GMARIFGGNQNESNTSKVVGTYGY-----MAPEYALGGVISVKSDVFSFGVLLLEIIS 401
GMAR G M PE + G+ + K+D +SFGVLL EI S
Sbjct: 229 GMAR-----DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 41/130 (31%), Positives = 66/130 (50%), Gaps = 11/130 (8%)
Query: 279 IWIAI----GTTIPTIYSTRRAQLDWKRRISII-NGIARGLLYLHEDSRLKVFHRDLKAS 333
+WI + ++ I R L + I+ I +GL YLH + HRD+KA
Sbjct: 99 LWIVMEYCGAGSVSDIIRLRNKTLT-EDEIATILQSTLKGLEYLHFM---RKIHRDIKAG 154
Query: 334 NVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFG 393
N+LL+ E + K++DFG+A + NT V+GT +MAPE + +D++S G
Sbjct: 155 NILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNCVADIWSLG 212
Query: 394 VLLLEIISGK 403
+ +E+ GK
Sbjct: 213 ITAIEMAEGK 222
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 31/105 (29%), Positives = 46/105 (43%), Gaps = 9/105 (8%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLL--DHEMNPKISDFGMARIFGGNQNESN 362
+I+ I L YLH + HRD+K N L + K+ DFG+++ F N
Sbjct: 172 NIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY 228
Query: 363 T--SKVVGTYGYMAPE--YALGGVISVKSDVFSFGVLLLEIISGK 403
+ GT ++APE K D +S GVLL ++ G
Sbjct: 229 YGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 35/94 (37%), Positives = 48/94 (51%), Gaps = 6/94 (6%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I GL LH ++ +RDLK N+LLD + +ISD G+A Q VGT
Sbjct: 295 ICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGT 348
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
GYMAPE + D ++ G LL E+I+G+
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 38/108 (35%), Positives = 52/108 (48%), Gaps = 20/108 (18%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
I I RGL +LH+ KV HRD+K NVLL K+ DFG++ NT
Sbjct: 134 ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-- 188
Query: 366 VVGTYGYMAPEYALGGVISV----------KSDVFSFGVLLLEIISGK 403
+GT +MAPE VI+ KSD++S G+ +E+ G
Sbjct: 189 FIGTPYWMAPE-----VIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 30/96 (31%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP-KISDFGMARIFGGNQNESNTSKVVG 368
+ R + LH S + V HRD+K NVL++ K+ DFG A+ + +E N + +
Sbjct: 138 LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SPSEPNVAYICS 194
Query: 369 TYGYMAPEYALGGVI-SVKSDVFSFGVLLLEIISGK 403
Y Y APE G + D++S G + E++ G+
Sbjct: 195 RY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 35/102 (34%), Positives = 54/102 (52%), Gaps = 10/102 (9%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQNES 361
II + G+ YLH+ + HRDLK N+LL + + KI DFG++ +F +
Sbjct: 140 VIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK-- 194
Query: 362 NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
+ +GT Y+APE L K DV+S GV+L +++G
Sbjct: 195 -MKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 3e-16
Identities = 30/94 (31%), Positives = 44/94 (46%), Gaps = 7/94 (7%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+A L Y H KV HRD+K N+L+ ++ KI+DFG + + + GT
Sbjct: 123 LADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGT 175
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
Y+ PE G K D++ GVL E + G
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 37/101 (36%), Positives = 55/101 (54%), Gaps = 10/101 (9%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQNES 361
II + G+ Y+H+ K+ HRDLK N+LL + N +I DFG++ F ++
Sbjct: 130 RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-- 184
Query: 362 NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISG 402
+GT Y+APE L G K DV+S GV+L ++SG
Sbjct: 185 -MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 32/101 (31%), Positives = 57/101 (56%), Gaps = 6/101 (5%)
Query: 304 ISII-NGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN 362
I+ + + L +LH + +V HRD+K+ N+LL + + K++DFG Q++ +
Sbjct: 118 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174
Query: 363 TSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
T +VGT +MAPE K D++S G++ +E+I G+
Sbjct: 175 T--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 5e-16
Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 10/101 (9%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQNES 361
+I+ I G+ YLH+ + HRD+K N+LL + +N KI DFG++ F +
Sbjct: 150 NIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK-- 204
Query: 362 NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISG 402
+GT Y+APE L + K DV+S GV++ ++ G
Sbjct: 205 -LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 5e-16
Identities = 38/185 (20%), Positives = 60/185 (32%), Gaps = 62/185 (33%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP-------------------KISDFGM 350
+ RGL Y+H + H D+K SN+ + P KI D G
Sbjct: 124 VGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 351 ARIFGGNQNESNTSKVVGTYGYMAPEYALGGVI------SVKSDVFSFGVLLLEIISGKK 404
S+ G ++A E V+ K+D+F+ + ++ +
Sbjct: 181 VTRI------SSPQVEEGDSRFLANE-----VLQENYTHLPKADIFALALTVVCAAGAEP 229
Query: 405 NSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQ--SCMAAELLKCIHIGLLCVQEDP 462
L +G W G P + Q S ELLK + + DP
Sbjct: 230 -----LPRNGDQ-----WHEIRQGRL-----PRIPQVLSQEFTELLK------VMIHPDP 268
Query: 463 ADRPN 467
RP+
Sbjct: 269 ERRPS 273
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 9e-16
Identities = 30/98 (30%), Positives = 48/98 (48%), Gaps = 12/98 (12%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTS 364
I+ + + LH+ L + HRDLK N+LLD +MN K++DFG + +
Sbjct: 128 KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLR 181
Query: 365 KVVGTYGYMAPEYALGGVISVKS------DVFSFGVLL 396
+V GT Y+APE + D++S GV++
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 37/101 (36%), Positives = 54/101 (53%), Gaps = 10/101 (9%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQNES 361
II + G+ Y+H+ + HRDLK N+LL + + + KI DFG++ F N
Sbjct: 125 RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-- 179
Query: 362 NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISG 402
+GT Y+APE L G K DV+S GV+L ++SG
Sbjct: 180 -MKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 28/98 (28%), Positives = 54/98 (55%), Gaps = 5/98 (5%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
+ + + L YLH V HRD+K+ ++LL + K+SDFG + + +
Sbjct: 146 VCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-- 200
Query: 366 VVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
+VGT +MAPE + + + D++S G++++E++ G+
Sbjct: 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 2e-15
Identities = 35/93 (37%), Positives = 55/93 (59%), Gaps = 6/93 (6%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371
RG+ + H+ ++ HRDLK N+L++ + K++DFG+AR F G S T +VV T
Sbjct: 130 RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLW 184
Query: 372 YMAPEYALGGVI-SVKSDVFSFGVLLLEIISGK 403
Y AP+ +G S D++S G + E+I+GK
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 33/108 (30%), Positives = 59/108 (54%), Gaps = 17/108 (15%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTS 364
+I+ + GL YLH++ ++ HRD+KA N+LL + + +I+DFG++ + +
Sbjct: 125 TILREVLEGLEYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK 181
Query: 365 K---VVGTYGYMAPEYALGGVIS------VKSDVFSFGVLLLEIISGK 403
VGT +MAPE V+ K+D++SFG+ +E+ +G
Sbjct: 182 VRKTFVGTPCWMAPE-----VMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 29/108 (26%), Positives = 54/108 (50%), Gaps = 20/108 (18%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
+ + L +LH ++ HRDLKA NVL+ E + +++DFG++ + ++
Sbjct: 122 VCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-- 176
Query: 366 VVGTYGYMAPEYALGGVISV----------KSDVFSFGVLLLEIISGK 403
+GT +MAPE V+ K+D++S G+ L+E+ +
Sbjct: 177 FIGTPYWMAPE-----VVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 27/124 (21%), Positives = 48/124 (38%), Gaps = 22/124 (17%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP-KISDFGMARIFGGNQNESNTSKVVG 368
+ + + H V HRD+K N+L+D K+ DFG + G
Sbjct: 148 VVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT--DF--DG 200
Query: 369 TYGYMAPEYALGGV-ISVKSDVFSFGVLL-------------LEIISGKKNSGFYLSEHG 414
T Y PE+ ++ + V+S G+LL EI+ + + ++S
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDC 260
Query: 415 QSLL 418
+L+
Sbjct: 261 CALI 264
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 30/124 (24%), Positives = 45/124 (36%), Gaps = 22/124 (17%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHE-MNPKISDFGMARIFGGNQNESNTSKVVG 368
+ + + H V HRD+K N+L+D K+ DFG + G
Sbjct: 158 VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT--DF--DG 210
Query: 369 TYGYMAPEYALGGV-ISVKSDVFSFGVLL-------------LEIISGKKNSGFYLSEHG 414
T Y PE+ + V+S G+LL EII G+ +S
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSEC 270
Query: 415 QSLL 418
Q L+
Sbjct: 271 QHLI 274
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 35/92 (38%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371
RGL +LH +V HRDLK N+L+ K++DFG+ARI+ TS VV T
Sbjct: 131 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVV-TLW 184
Query: 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
Y APE L + D++S G + E+ K
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 23/110 (20%), Positives = 43/110 (39%), Gaps = 20/110 (18%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNT-- 363
I+ G+ + L Y+H HR +KAS++L+ + +S +
Sbjct: 133 ILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVH 189
Query: 364 ---SKVVGTYGYMAPEYALGGVIS-------VKSDVFSFGVLLLEIISGK 403
V +++PE V+ KSD++S G+ E+ +G
Sbjct: 190 DFPKYSVKVLPWLSPE-----VLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 33/92 (35%), Positives = 47/92 (51%), Gaps = 6/92 (6%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371
RGL +LH + + HRDLK N+L+ K++DFG+ARI+ T VV T
Sbjct: 131 RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTPVVV-TLW 184
Query: 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
Y APE L + D++S G + E+ K
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 75.2 bits (186), Expect = 3e-15
Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371
+GL + H V HRDLK N+L++ K+++FG+AR F G +++VV T
Sbjct: 112 KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLW 166
Query: 372 YMAPEYALGGVI-SVKSDVFSFGVLLLEIISGKK 404
Y P+ G + S D++S G + E+ + +
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 29/96 (30%), Positives = 51/96 (53%), Gaps = 8/96 (8%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP-KISDFGMARIFGGNQNESNTSKVVG 368
+ R + ++H L + HRD+K N+L++ + N K+ DFG A+ +E + + +
Sbjct: 150 LFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYICS 204
Query: 369 TYGYMAPEYALGGVI-SVKSDVFSFGVLLLEIISGK 403
+ Y APE LG + D++S G + E+I GK
Sbjct: 205 RF-YRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 36/106 (33%), Positives = 50/106 (47%), Gaps = 22/106 (20%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
+ +G +GL YLH + HRD+KA N+LL K+ DFG A +N+
Sbjct: 159 VTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANS-- 209
Query: 366 VVGTYGYMAPEYALGGVISV--------KSDVFSFGVLLLEIISGK 403
VGT +MAPE VI K DV+S G+ +E+ K
Sbjct: 210 FVGTPYWMAPE-----VILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 5e-15
Identities = 38/104 (36%), Positives = 52/104 (50%), Gaps = 21/104 (20%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
I++ + Y H R V HRDLK NVLLD MN KI+DFG++ + TS
Sbjct: 120 ILSAVD----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTS- 170
Query: 366 VVGTYGYMAPEYALGGVIS------VKSDVFSFGVLLLEIISGK 403
G+ Y APE VIS + D++S GV+L ++ G
Sbjct: 171 -CGSPNYAAPE-----VISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 5e-15
Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 6/93 (6%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371
RGL Y H KV HRDLK N+L++ K++DFG+AR ++ ++VV T
Sbjct: 111 RGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLW 165
Query: 372 YMAPEYALGGVI-SVKSDVFSFGVLLLEIISGK 403
Y P+ LG S + D++ G + E+ +G+
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 38/104 (36%), Positives = 53/104 (50%), Gaps = 21/104 (20%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
II I Y H R K+ HRDLK N+LLD +N KI+DFG++ I TS
Sbjct: 117 IICAIE----YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-LKTS- 167
Query: 366 VVGTYGYMAPEYALGGVIS------VKSDVFSFGVLLLEIISGK 403
G+ Y APE VI+ + DV+S G++L ++ G+
Sbjct: 168 -CGSPNYAAPE-----VINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 5e-15
Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 10/95 (10%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQNES 361
++ + L Y H V H+DLK N+L KI DFG+A +F ++
Sbjct: 128 ELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--- 181
Query: 362 NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLL 396
+++ GT YMAPE ++ K D++S GV++
Sbjct: 182 HSTNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVM 215
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP-KISDFGMARIFGGNQNESNTSKVVG 368
+ R L Y+H + + HRD+K N+LLD K+ DFG A+I E N S +
Sbjct: 150 LLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICS 204
Query: 369 TYGYMAPEYALGGVI-SVKSDVFSFGVLLLEIISGK 403
Y Y APE G + D++S G ++ E++ G+
Sbjct: 205 RY-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 6e-15
Identities = 37/93 (39%), Positives = 56/93 (60%), Gaps = 6/93 (6%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371
+GL + HE+ K+ HRDLK N+L++ K+ DFG+AR F G + +S+VV T
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-TLW 173
Query: 372 YMAPEYALGGVI-SVKSDVFSFGVLLLEIISGK 403
Y AP+ +G S D++S G +L E+I+GK
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 6e-15
Identities = 29/98 (29%), Positives = 48/98 (48%), Gaps = 12/98 (12%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTS 364
SI+ + + +LH + HRDLK N+LLD M ++SDFG + +
Sbjct: 204 SIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLR 257
Query: 365 KVVGTYGYMAPEYALGGVISV------KSDVFSFGVLL 396
++ GT GY+APE + + D+++ GV+L
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 7e-15
Identities = 29/95 (30%), Positives = 41/95 (43%), Gaps = 8/95 (8%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP---KISDFGMARIFGGNQNES 361
+ I L Y H+ + HRD+K VLL + N K+ FG+A G + +
Sbjct: 134 HYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA 190
Query: 362 NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLL 396
VGT +MAPE DV+ GV+L
Sbjct: 191 GG--RVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 7e-15
Identities = 34/93 (36%), Positives = 52/93 (55%), Gaps = 6/93 (6%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371
G+ Y H+ +V HRDLK N+L++ E KI+DFG+AR F G T ++V T
Sbjct: 111 NGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLW 165
Query: 372 YMAPEYALGGVI-SVKSDVFSFGVLLLEIISGK 403
Y AP+ +G S D++S G + E+++G
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 9e-15
Identities = 28/97 (28%), Positives = 45/97 (46%), Gaps = 10/97 (10%)
Query: 304 ISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP----KISDFGMARIFGGNQN 359
+ I G+ YLH L++ H DLK N++L P KI DFG+A
Sbjct: 117 TEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 360 ESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLL 396
+ GT ++APE + +++D++S GV+
Sbjct: 174 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 9e-15
Identities = 26/97 (26%), Positives = 45/97 (46%), Gaps = 10/97 (10%)
Query: 304 ISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP----KISDFGMARIFGGNQN 359
+ I G+ YLH ++ H DLK N++L + P K+ DFG+A
Sbjct: 111 TQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE 167
Query: 360 ESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLL 396
+ GT ++APE + +++D++S GV+
Sbjct: 168 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 36/93 (38%), Positives = 55/93 (59%), Gaps = 6/93 (6%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371
+GL YLH+ + HRDLK +N+LLD K++DFG+A+ F G+ N + T +VV T
Sbjct: 123 QGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV-TRW 177
Query: 372 YMAPEYALGGVI-SVKSDVFSFGVLLLEIISGK 403
Y APE G + V D+++ G +L E++
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 29/97 (29%), Positives = 46/97 (47%), Gaps = 10/97 (10%)
Query: 304 ISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP----KISDFGMARIFGGNQN 359
S I I G+ YLH K+ H DLK N++L + P K+ DFG+A
Sbjct: 118 TSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 360 ESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLL 396
+ GT ++APE + +++D++S GV+
Sbjct: 175 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 9/98 (9%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP----KISDFGMARIFGG-NQNESNTSKV 366
G+ YLH + V HRDLK +N+L+ E KI+D G AR+F + ++ V
Sbjct: 139 DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 367 VGTYGYMAPEYALGGVI-SVKSDVFSFGVLLLEIISGK 403
V T+ Y APE LG + D+++ G + E+++ +
Sbjct: 196 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 29/97 (29%), Positives = 46/97 (47%), Gaps = 10/97 (10%)
Query: 304 ISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP----KISDFGMARIFGGNQN 359
S I I G+ YLH K+ H DLK N++L + P K+ DFG+A
Sbjct: 118 TSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 360 ESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLL 396
+ GT ++APE + +++D++S GV+
Sbjct: 175 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 33/96 (34%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP-KISDFGMARIFGGNQNESNTSKVVG 368
+ R L Y+H + HRD+K N+LLD + K+ DFG A+ + E N S +
Sbjct: 165 LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICS 219
Query: 369 TYGYMAPEYALGGVI-SVKSDVFSFGVLLLEIISGK 403
Y Y APE G + DV+S G +L E++ G+
Sbjct: 220 RY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 8/95 (8%)
Query: 304 ISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP--KISDFGMARIFGGNQNES 361
I + I G+ ++H+ + + H DLK N+L + KI DFG+AR + +
Sbjct: 190 ILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244
Query: 362 NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLL 396
GT ++APE +S +D++S GV+
Sbjct: 245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 1e-14
Identities = 35/95 (36%), Positives = 50/95 (52%), Gaps = 10/95 (10%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQNES 361
II + G+ Y+H+ + HRDLK N+LL + + + KI DFG++ F N
Sbjct: 125 RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--- 178
Query: 362 NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLL 396
+GT Y+APE L G K DV+S GV+L
Sbjct: 179 KMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 23/95 (24%), Positives = 42/95 (44%), Gaps = 8/95 (8%)
Query: 304 ISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP--KISDFGMARIFGGNQNES 361
I+ + GL ++HE + H D+K N++ + + KI DFG+A ++
Sbjct: 152 INYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-- 206
Query: 362 NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLL 396
T + APE + +D+++ GVL
Sbjct: 207 -VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 2e-14
Identities = 29/95 (30%), Positives = 45/95 (47%), Gaps = 10/95 (10%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQNES 361
I+ + + Y H+ L V HRDLK N L + K+ DFG+A F +
Sbjct: 110 RIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--- 163
Query: 362 NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLL 396
VGT Y++P+ L G+ + D +S GV++
Sbjct: 164 MMRTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMM 197
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 39/104 (37%), Positives = 53/104 (50%), Gaps = 21/104 (20%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
I++G+ Y H R V HRDLK NVLLD MN KI+DFG++ + TS
Sbjct: 125 ILSGVD----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTS- 175
Query: 366 VVGTYGYMAPEYALGGVIS------VKSDVFSFGVLLLEIISGK 403
G+ Y APE VIS + D++S GV+L ++ G
Sbjct: 176 -CGSPNYAAPE-----VISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 30/102 (29%), Positives = 48/102 (47%), Gaps = 19/102 (18%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+ L YL ++ HRD+K N+LLD + I+DF +A + E+ + + GT
Sbjct: 124 LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAML---PRETQITTMAGT 177
Query: 370 YGYMAPEYALGGVISVKS--------DVFSFGVLLLEIISGK 403
YMAPE + S + D +S GV E++ G+
Sbjct: 178 KPYMAPE-----MFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 24/95 (25%), Positives = 42/95 (44%), Gaps = 8/95 (8%)
Query: 304 ISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP--KISDFGMARIFGGNQNES 361
+S ++ + L +LH + H D++ N++ + KI +FG AR N
Sbjct: 105 VSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-- 159
Query: 362 NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLL 396
+ Y APE V+S +D++S G L+
Sbjct: 160 -FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 33/98 (33%), Positives = 46/98 (46%), Gaps = 22/98 (22%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQNESNTSKV 366
+ + YLHE + HRDLK NVLL + + KI+DFG ++I G S +
Sbjct: 123 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTL 176
Query: 367 VGTYGYMAPEYALGGVISVKS--------DVFSFGVLL 396
GT Y+APE V+ D +S GV+L
Sbjct: 177 CGTPTYLAPE-----VLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 9/96 (9%)
Query: 304 ISIINGIARGLLYLHEDSRLKVFHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQNE 360
I +I I G+ YLH+ + H DLK N+LL + KI DFGM+R G
Sbjct: 134 IRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE- 189
Query: 361 SNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLL 396
+++GT Y+APE I+ +D+++ G++
Sbjct: 190 --LREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 4e-14
Identities = 29/102 (28%), Positives = 48/102 (47%), Gaps = 10/102 (9%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTS 364
SI + + + H + HRD+K N+L+ K+ DFG AR+ G ++
Sbjct: 106 SITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDD 161
Query: 365 KVVGTYGYMAPEYALGGVI---SVKSDVFSFGVLLLEIISGK 403
+V T Y +PE +G V DV++ G + E++SG
Sbjct: 162 EVA-TRWYRSPELLVGDTQYGPPV--DVWAIGCVFAELLSGV 200
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 5e-14
Identities = 29/94 (30%), Positives = 43/94 (45%), Gaps = 10/94 (10%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQNESN 362
+I + + YLHE + HRDLK N+L + I+DFG++++
Sbjct: 111 VIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME----QNGI 163
Query: 363 TSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLL 396
S GT GY+APE S D +S GV+
Sbjct: 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 6e-14
Identities = 33/101 (32%), Positives = 47/101 (46%), Gaps = 19/101 (18%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLL-DHEMNP---KISDFGMARIFGGNQNE 360
+++ I + + YLH V HRDLK SN+L D NP +I DFG A+
Sbjct: 120 AVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176
Query: 361 SNTSKVVGTYGYMAPEYALGGVISVKS-----DVFSFGVLL 396
T T ++APE V+ + D++S GVLL
Sbjct: 177 LMT--PCYTANFVAPE-----VLERQGYDAACDIWSLGVLL 210
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 7e-14
Identities = 27/95 (28%), Positives = 43/95 (45%), Gaps = 9/95 (9%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP---KISDFGMARIFGGNQNES 361
I I + Y H + HR+LK N+LL + K++DFG+A ++
Sbjct: 109 HCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-- 163
Query: 362 NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLL 396
GT GY++PE S D+++ GV+L
Sbjct: 164 -WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 9e-14
Identities = 32/99 (32%), Positives = 46/99 (46%), Gaps = 23/99 (23%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH--EMNPKISDFGMARIFGGNQNESNT 363
+++G++ Y H +++ HRDLK N LLD KI DFG ++ S
Sbjct: 125 LLSGVS----YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS---VLHSQP 174
Query: 364 SKVVGTYGYMAPEYALGGVIS------VKSDVFSFGVLL 396
VGT Y+APE V+ +DV+S GV L
Sbjct: 175 KSTVGTPAYIAPE-----VLLRQEYDGKIADVWSCGVTL 208
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 9e-14
Identities = 31/97 (31%), Positives = 46/97 (47%), Gaps = 10/97 (10%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I G+ + H + HRD+K N+L+ K+ DFG AR E +V T
Sbjct: 133 IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA-T 187
Query: 370 YGYMAPEYALGGVI---SVKSDVFSFGVLLLEIISGK 403
Y APE +G V +V DV++ G L+ E+ G+
Sbjct: 188 RWYRAPELLVGDVKYGKAV--DVWAIGCLVTEMFMGE 222
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 33/98 (33%), Positives = 45/98 (45%), Gaps = 22/98 (22%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP---KISDFGMARIFGGNQNESNTSKV 366
+ + YLHE + HRDLK NVLL + KI+DFG ++I G S +
Sbjct: 248 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTL 301
Query: 367 VGTYGYMAPEYALGGVISVKS--------DVFSFGVLL 396
GT Y+APE V+ D +S GV+L
Sbjct: 302 CGTPTYLAPE-----VLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 27/95 (28%), Positives = 43/95 (45%), Gaps = 9/95 (9%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP---KISDFGMARIFGGNQNES 361
I I + Y H + HR+LK N+LL + K++DFG+A ++
Sbjct: 132 HCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-- 186
Query: 362 NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLL 396
GT GY++PE S D+++ GV+L
Sbjct: 187 -WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 28/95 (29%), Positives = 43/95 (45%), Gaps = 8/95 (8%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQNES 361
I+ + + ++H+ + V HRDLK N+L + + KI DFG AR+ +
Sbjct: 110 YIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166
Query: 362 NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLL 396
T T Y APE D++S GV+L
Sbjct: 167 KT--PCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 46/168 (27%), Positives = 75/168 (44%), Gaps = 39/168 (23%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I L +LH+ L + +RD+K N+LLD + ++DFG+++ F ++ E GT
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGT 223
Query: 370 YGYMAPE----YALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLW 425
YMAP+ G +V D +S GVL+ E+++G S F + S
Sbjct: 224 IEYMAPDIVRGGDSGHDKAV--DWWSLGVLMYELLTGA--SPFTVDGEKNS--------- 270
Query: 426 CNGEALELMDPVLKQ--------SCMAAELLKCIHIGLLCVQEDPADR 465
E+ +LK S +A +L++ LL +DP R
Sbjct: 271 ----QAEISRRILKSEPPYPQEMSALAKDLIQ----RLL--MKDPKKR 308
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 30/95 (31%), Positives = 44/95 (46%), Gaps = 9/95 (9%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQNES 361
+ I + YLHE + HRDLK N+L + KI+DFG+++I
Sbjct: 152 DAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-- 206
Query: 362 NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLL 396
V GT GY APE G + D++S G++
Sbjct: 207 -MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 26/95 (27%), Positives = 44/95 (46%), Gaps = 8/95 (8%)
Query: 304 ISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP--KISDFGMARIFGGNQNES 361
+ + + +GL ++HE H DLK N++ + + K+ DFG+ Q+
Sbjct: 258 VEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-- 312
Query: 362 NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLL 396
GT + APE A G + +D++S GVL
Sbjct: 313 -VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 35/109 (32%), Positives = 55/109 (50%), Gaps = 6/109 (5%)
Query: 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354
+ +LD +R ++ + G+ +LH + HRDLK SN+++ + KI DFG+AR
Sbjct: 121 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 177
Query: 355 GGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
G + V T Y APE LG D++S G ++ E+I G
Sbjct: 178 G---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 46/198 (23%), Positives = 67/198 (33%), Gaps = 50/198 (25%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP---KISDFGMARIFGGNQNES 361
++ +A L +LH + HRDLK N+L +H KI DF + N + S
Sbjct: 115 VVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171
Query: 362 NTSK-----VVGTYGYMAPEYALGGVISVKS-----DVFSFGVL---LLEIISGKKNSG- 407
S G+ YMAPE D++S GV+ LL SG
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILL--------SGY 223
Query: 408 --FYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQ------------SCMAAELLKCIHI 453
F S + C L + + + SC A +L+
Sbjct: 224 PPFV--GRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLIS---- 277
Query: 454 GLLCVQEDPADRPNMSSV 471
LL D R + + V
Sbjct: 278 KLLVR--DAKQRLSAAQV 293
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 30/100 (30%), Positives = 44/100 (44%), Gaps = 11/100 (11%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP-----KISDFGMARIFGGNQNESNTS 364
+ G+ + H + HRDLK N+LL KI DFG+AR F G T
Sbjct: 141 LINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTH 196
Query: 365 KVVGTYGYMAPEYALGGVI-SVKSDVFSFGVLLLEIISGK 403
+++ T Y PE LG S D++S + E++
Sbjct: 197 EII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 29/95 (30%), Positives = 46/95 (48%), Gaps = 8/95 (8%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP---KISDFGMARIFGGNQNES 361
I I +L+ H+ + V HR+LK N+LL ++ K++DFG+A G Q
Sbjct: 114 HCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--Q 168
Query: 362 NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLL 396
GT GY++PE D+++ GV+L
Sbjct: 169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 25/95 (26%), Positives = 41/95 (43%), Gaps = 10/95 (10%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQNES 361
I+ I + +LH + HRD+K N+L + + K++DFG A+ N
Sbjct: 132 EIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--- 185
Query: 362 NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLL 396
T Y+APE D++S GV++
Sbjct: 186 -LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 33/100 (33%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I L YLH S V +RDLK N++LD + + KI+DFG+ + G ++ + GT
Sbjct: 257 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGT 312
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFY 409
Y+APE D + GV++ E++ G+ FY
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFY 350
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 7e-13
Identities = 16/117 (13%), Positives = 36/117 (30%), Gaps = 14/117 (11%)
Query: 298 LDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP-----------KIS 346
+ IS + + +H+ ++ H D+K N +L + +
Sbjct: 169 MPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALI 225
Query: 347 DFGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
D G + + + T G+ E + + D F + ++ G
Sbjct: 226 DLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I+ L YLHE + +RDLK NVLLD E + K++D+GM + G + TS GT
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGT 173
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
Y+APE G D ++ GVL+ E+++G+
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 32/102 (31%), Positives = 48/102 (47%), Gaps = 11/102 (10%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR--IFGGNQNESNTSKVV 367
I L YLH V +RD+K N++LD + + KI+DFG+ + I G
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT----MKTFC 166
Query: 368 GTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFY 409
GT Y+APE D + GV++ E++ G+ FY
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFY 206
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 40/97 (41%), Positives = 55/97 (56%), Gaps = 7/97 (7%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN--TSKVV 367
I RGL Y+H S V HRDLK SN+LL+ + KI DFG+AR+ + + + T V
Sbjct: 137 ILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 368 GTYGYMAPEYALGGVISVKS-DVFSFGVLLLEIISGK 403
T Y APE L KS D++S G +L E++S +
Sbjct: 194 -TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 6/109 (5%)
Query: 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354
+ +LD +R ++ + G+ +LH + HRDLK SN+++ + KI DFG+AR
Sbjct: 158 QMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214
Query: 355 GGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
G + V T Y APE LG D++S G ++ E++ K
Sbjct: 215 G---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 28/94 (29%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I+ L +LH+ + +RDLK N++L+H+ + K++DFG+ + + ++T GT
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGT 184
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
YMAPE + + D +S G L+ ++++G
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 35/105 (33%), Positives = 59/105 (56%), Gaps = 17/105 (16%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+A L +LH L + +RDLK N+LLD E + K++DFG+++ ++ ++ + GT
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 189
Query: 370 YGYMAPEYALGGVISVKS-----DVFSFGVLLLEIISGKKNSGFY 409
YMAPE V++ + D +SFGVL+ E+++G F
Sbjct: 190 VEYMAPE-----VVNRRGHTQSADWWSFGVLMFEMLTGT--LPFQ 227
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 39/100 (39%), Positives = 57/100 (57%), Gaps = 7/100 (7%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I GL +LH + +RDLK N+LLD + + KI+DFGM + ++ T+ GT
Sbjct: 127 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE--NMLGDAKTNTFCGT 181
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFY 409
Y+APE LG + D +SFGVLL E++ G+ S F+
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ--SPFH 219
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I+ L YLHE + +RDLK NVLLD E + K++D+GM + G + TS GT
Sbjct: 162 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGT 216
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
Y+APE G D ++ GVL+ E+++G+
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 34/100 (34%), Positives = 50/100 (50%), Gaps = 7/100 (7%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
IA L YLH L + +RDLK N+LLD + + ++DFG+ + ++ S TS GT
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNSTTSTFCGT 202
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFY 409
Y+APE D + G +L E++ G FY
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL--PPFY 240
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 37/96 (38%), Positives = 52/96 (54%), Gaps = 9/96 (9%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR--IFGGNQNESNTSKVV 367
IA GL +L + +RDLK NV+LD E + KI+DFGM + I+ G T
Sbjct: 130 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT----TKTFC 182
Query: 368 GTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
GT Y+APE D ++FGVLL E+++G+
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 36/94 (38%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I L++LH+ + +RDLK NVLLDHE + K++DFGM + G N T+ GT
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE--GICNGVTTATFCGT 187
Query: 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
Y+APE + D ++ GVLL E++ G
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 27/95 (28%), Positives = 47/95 (49%), Gaps = 8/95 (8%)
Query: 312 RGLLYLHEDSRLKVFHRDLKASNVLLDHE-MNPKISDFGMARIFGGNQNESNTSKVVGTY 370
+ L Y H S + HRD+K NV++DHE ++ D+G+A + + +V Y
Sbjct: 141 KALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY 195
Query: 371 GYMAPEYALGGVISVKS-DVFSFGVLLLEIISGKK 404
+ PE + + S D++S G +L +I K+
Sbjct: 196 -FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 27/101 (26%), Positives = 47/101 (46%), Gaps = 21/101 (20%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP----KISDFGMARIFGGNQNE 360
I+ I + YLH + + HRD+K N+L + P K++DFG A+ +
Sbjct: 165 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHN-- 218
Query: 361 SNTSKVVGTYGYMAPEYALGGVISVKS-----DVFSFGVLL 396
+ + T Y+APE V+ + D++S GV++
Sbjct: 219 -SLTTPCYTPYYVAPE-----VLGPEKYDKSCDMWSLGVIM 253
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 38/102 (37%), Positives = 54/102 (52%), Gaps = 11/102 (10%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR--IFGGNQNESNTSKVV 367
IA GL +L + +RDLK NV+LD E + KI+DFGM + I+ G T
Sbjct: 451 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT----TKTFC 503
Query: 368 GTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFY 409
GT Y+APE D ++FGVLL E+++G+ + F
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ--APFE 543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 7e-12
Identities = 32/103 (31%), Positives = 50/103 (48%), Gaps = 12/103 (11%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKV--- 366
R + LH + V HRDLK SN+L++ + K+ DFG+ARI + +++
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 367 -----VGTYGYMAPEYALGGVISVKS-DVFSFGVLLLEIISGK 403
V T Y APE L ++ DV+S G +L E+ +
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 8e-12
Identities = 31/95 (32%), Positives = 45/95 (47%), Gaps = 7/95 (7%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I GL LHE V HRDL N+LL + I DF +AR + ++N + V
Sbjct: 143 ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTH 196
Query: 370 YGYMAPEYALGGVISVKS-DVFSFGVLLLEIISGK 403
Y APE + K D++S G ++ E+ + K
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 8e-12
Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHE-MNPKISDFGMARIFGGNQNESN--TSKV 366
+ RGL Y+H + V HRDLK +N+ ++ E + KI DFG+ARI + + + +
Sbjct: 129 LLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185
Query: 367 VGTYGYMAPEYALGGVI-SVKSDVFSFGVLLLEIISGK 403
V T Y +P L + D+++ G + E+++GK
Sbjct: 186 V-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 9/95 (9%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+ +GL Y+H + HRDLK N+ ++ + KI DFG+AR V T
Sbjct: 137 MLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY-----VVT 188
Query: 370 YGYMAPEYALGGVISVKS-DVFSFGVLLLEIISGK 403
Y APE L + ++ D++S G ++ E+I+GK
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 25/98 (25%), Positives = 44/98 (44%), Gaps = 9/98 (9%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+ + +H+ L HRD+K N+L+D + +++DFG + +S VGT
Sbjct: 184 MVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQSSVAVGT 239
Query: 370 YGYMAPEYALGGVISVKS-----DVFSFGVLLLEIISG 402
Y++PE D +S GV + E++ G
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 29/100 (29%), Positives = 45/100 (45%), Gaps = 11/100 (11%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I + +H L HRD+K N+LLD + +++DFG + + VGT
Sbjct: 171 IVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD-GTVRSLVAVGT 226
Query: 370 YGYMAPE--YALGGVISVKS-----DVFSFGVLLLEIISG 402
Y++PE A+GG S D ++ GV E+ G
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 31/110 (28%), Positives = 54/110 (49%), Gaps = 9/110 (8%)
Query: 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354
+ ++ ++ + +GL Y+H V HRDLK N+ ++ + KI DFG+AR
Sbjct: 120 GLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA 176
Query: 355 GGNQNESNTSKVVGTYGYMAPEYALGGVISVKS-DVFSFGVLLLEIISGK 403
V T Y APE L + ++ D++S G ++ E+++GK
Sbjct: 177 DAEMTG-----YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 2e-11
Identities = 35/98 (35%), Positives = 51/98 (52%), Gaps = 18/98 (18%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+ L YLH + +RDLK N+LLD + KI+DFG A+ T + GT
Sbjct: 115 VCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGT 166
Query: 370 YGYMAPEYALGGVISVKS-----DVFSFGVLLLEIISG 402
Y+APE V+S K D +SFG+L+ E+++G
Sbjct: 167 PDYIAPE-----VVSTKPYNKSIDWWSFGILIYEMLAG 199
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I RGL Y+H S + HRDLK SN+ ++ + KI DFG+AR V T
Sbjct: 141 ILRGLKYIH--SA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG-----YVAT 192
Query: 370 YGYMAPEYALGGVISVKS-DVFSFGVLLLEIISGK 403
Y APE L + ++ D++S G ++ E+++G+
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 18/98 (18%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
I YLH L + +RDLK N+L+D + +++DFG A+ + + T + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGT 201
Query: 370 YGYMAPEYALGGVISVKS-----DVFSFGVLLLEIISG 402
+APE +I K D ++ GVL+ E+ +G
Sbjct: 202 PEALAPE-----IILSKGYNKAVDWWALGVLIYEMAAG 234
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 28/102 (27%), Positives = 43/102 (42%), Gaps = 18/102 (17%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+ L +H + HRD+K N+LLD + K++DFG VGT
Sbjct: 177 VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGT 232
Query: 370 YGYMAPEYALGGVISVKS---------DVFSFGVLLLEIISG 402
Y++PE V+ + D +S GV L E++ G
Sbjct: 233 PDYISPE-----VLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 37/114 (32%), Positives = 56/114 (49%), Gaps = 23/114 (20%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKV--- 366
+ + + YLH S + HRD+K SN+LL+ E + K++DFG++R F + +N +
Sbjct: 118 LIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 367 ----------------VGTYGYMAPEYALGGVISVKS-DVFSFGVLLLEIISGK 403
V T Y APE LG K D++S G +L EI+ GK
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 18/69 (26%), Positives = 33/69 (47%), Gaps = 3/69 (4%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369
+ G+ Y+H + HRDLK +N L++ + + K+ DFG+AR +N ++ +
Sbjct: 165 LLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 370 YGYMAPEYA 378
M
Sbjct: 222 EDDMNLVTF 230
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 30/110 (27%), Positives = 52/110 (47%), Gaps = 17/110 (15%)
Query: 304 ISIINGIAR----GLLYLHEDSRLKVFHRDLKASNVLLDHEMNP------KISDFGMARI 353
+ + I++ GL Y+H R + H D+K NVL++ +P KI+D G A
Sbjct: 130 LIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-C 186
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
+ + + + T Y +PE LG +D++S L+ E+I+G
Sbjct: 187 WYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 30/118 (25%), Positives = 53/118 (44%), Gaps = 24/118 (20%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKV--- 366
+ G ++HE + HRDLK +N LL+ + + K+ DFG+AR ++ + + +
Sbjct: 138 LLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 367 -----------------VGTYGYMAPEYALGGVISVKS-DVFSFGVLLLEIISGKKNS 406
V T Y APE L KS D++S G + E+++ ++
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 25/200 (12%), Positives = 48/200 (24%), Gaps = 43/200 (21%)
Query: 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354
I + +A H R V S V +S G
Sbjct: 123 DTSPSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVR--------VSIDGDV--- 168
Query: 355 GGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHG 414
V+ M + + D+ G L ++ +
Sbjct: 169 -----------VLAYPATMPDA-------NPQDDIRGIGASLYALLVNRWP---LPEAGV 207
Query: 415 QSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVM 474
+S LA + A + ++P + ++ VQ D R S++ +
Sbjct: 208 RSGLAPAER----DTAGQPIEPADIDRDIPFQISAVA---ARSVQGDGGIRSA-STLLNL 259
Query: 475 LASDTVSLPQPTQPAFSVGR 494
+ T +
Sbjct: 260 MQQATAVADRTEVLGPIDEA 279
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 27/148 (18%), Positives = 49/148 (33%), Gaps = 56/148 (37%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLL--------------------------- 337
II + +GL YLH ++ ++ H D+K N+LL
Sbjct: 150 KIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 338 ----------------------DHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375
++ KI+D G A + E + T Y +
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTED-----IQTRQYRSL 262
Query: 376 EYALGGVISVKSDVFSFGVLLLEIISGK 403
E +G + +D++S + E+ +G
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP--KISDFGMARIFGGNQNESNTSKVV 367
+ LL+L L + H DLK N+LL + KI DFG + G + + +
Sbjct: 166 MCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQR----IYQYI 219
Query: 368 GTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
+ Y +PE LG + D++S G +L+E+ +G+
Sbjct: 220 QSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 27/96 (28%), Positives = 48/96 (50%), Gaps = 10/96 (10%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP--KISDFGMARIFGGNQNESNTSKVV 367
I + L LH + ++ H DLK N+LL + K+ DFG + +++ + +
Sbjct: 209 ILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY----EHQRVYTYIQ 261
Query: 368 GTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
+ Y APE LG + D++S G +L E+++G
Sbjct: 262 SRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 1e-05
Identities = 20/113 (17%), Positives = 35/113 (30%), Gaps = 15/113 (13%)
Query: 298 LDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGN 357
SI++ + L L+ HRDL NVLL K+ +
Sbjct: 158 SSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSST-- 213
Query: 358 QNESNTSKVVGTYGYMAP--EYALGGVISVKSDVFSFGVLLLEIISGKKNSGF 408
+ + G +Y L + VF + ++ +G + F
Sbjct: 214 ---------IPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQF 257
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 16/50 (32%), Positives = 25/50 (50%), Gaps = 6/50 (12%)
Query: 305 SIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE---MNPKISDFGMA 351
I+ I + YLH + + HRD+K N+L + K++DFG A
Sbjct: 121 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 1e-04
Identities = 49/397 (12%), Positives = 102/397 (25%), Gaps = 121/397 (30%)
Query: 91 RGDVSAETCKDCVNFATSDITQRCPLQKETVIWYDHCLLRY--SGIS-FFSTMDTKP--- 144
+ +S E + + D + W LL + F +
Sbjct: 43 KSILSKEEIDHIIM--SKDAVSGTLR----LFW---TLLSKQEEMVQKFVEEVLRINYKF 93
Query: 145 -AKAWQNRQNSTGG---LFNQQVRNLMNEAVNQALNTTKMFGTVKKNYTASQT-LYGLVQ 199
+ Q ++ +Q L N+ NQ K + + Y + L L +
Sbjct: 94 LMSPIKTEQRQPSMMTRMYIEQRDRLYND--NQVF--AKYNVSRLQPYLKLRQALLEL-R 148
Query: 200 CTPDLSRHD---CS-TCLRLAISSFDECFSINIGGRMMYPSCNFRYELYPFYDDPSIVTP 255
++ T + A+ C S + +M F
Sbjct: 149 PAKNVLIDGVLGSGKTWV--ALDV---CLSYKVQCKM------------DF--------- 182
Query: 256 PPVFLSPPSPGSVTSSKGKGRKAIWIAIG-----TTIPTIYSTRRAQLD--WKRRISIIN 308
+F W+ + T+ + Q+D W R +
Sbjct: 183 -KIF--------------------WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSS 221
Query: 309 GIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVG 368
I + + + R + + + ++L + N K F + K++
Sbjct: 222 NIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKA-----WNAFNLS------CKIL- 269
Query: 369 TYGYMAPEYALGGVISVKSDVFSF--GVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWC 426
+ + V F I + E +SLL +
Sbjct: 270 -------------LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE-VKSLLL----KYL 311
Query: 427 NGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPA 463
+ +L P ++ I I +++ A
Sbjct: 312 DCRPQDL--P--REVLTTNPRRLSI-IAES-IRDGLA 342
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 30/113 (26%), Positives = 46/113 (40%), Gaps = 27/113 (23%)
Query: 310 IARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP-------------------KISDFGM 350
+ L +LHE ++ H DLK N+L + +++DFG
Sbjct: 132 LCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188
Query: 351 ARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
A F +E +T+ +V T Y PE L + DV+S G +L E G
Sbjct: 189 A-TF---DHEHHTT-IVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 523 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 99.98 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.98 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 99.98 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.97 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.97 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.97 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.97 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.96 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.96 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.96 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.96 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.96 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.95 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.95 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.95 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.95 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.95 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.95 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.95 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.95 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.95 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.95 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.95 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.95 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.95 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.95 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.95 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.95 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.94 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.94 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.94 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.94 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.94 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.94 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.94 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.94 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.94 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.94 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.94 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.94 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.94 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.94 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.94 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.94 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.94 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.94 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.94 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.94 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.94 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.94 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.94 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.94 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.94 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.94 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.94 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.94 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.94 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.94 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.94 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.94 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.94 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.94 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.93 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.93 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.93 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.93 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.93 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.93 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.93 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.93 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.93 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.93 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.93 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.93 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.93 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.93 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.93 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.93 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.93 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.93 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.93 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.93 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.93 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.93 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.93 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.93 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.93 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.93 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.93 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.93 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.93 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.93 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.93 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.93 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.93 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.93 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.93 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.93 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.93 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.93 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.93 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.93 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.93 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.93 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.93 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.93 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.93 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.93 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.93 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.93 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.93 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.93 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.93 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.93 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.93 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.93 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.93 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.93 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.93 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.93 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.93 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.93 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.93 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.93 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.93 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.93 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.93 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.93 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.93 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.93 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.93 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.93 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.93 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.93 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.93 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.93 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.93 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.93 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.93 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.93 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.93 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.93 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.93 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.92 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.92 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.92 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.92 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.92 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.92 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.92 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.92 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.92 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.92 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.92 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.92 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.92 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.92 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.92 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.92 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.92 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.92 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.92 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.92 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.92 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.92 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.92 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.92 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.92 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.92 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.92 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.92 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.92 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.92 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.92 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.92 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.92 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.92 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.92 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.92 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.92 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.92 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.92 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.92 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.92 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.92 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.92 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.92 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.92 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.92 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.92 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.92 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.92 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.92 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.92 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.92 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.92 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.92 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.92 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.92 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.92 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.92 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.92 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.92 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.92 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.92 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.92 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.92 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.92 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.92 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.92 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.92 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.91 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.91 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.91 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.91 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.91 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.91 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.91 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.91 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.91 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.91 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.91 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.91 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.91 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.91 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.91 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.91 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.91 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.91 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.91 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.91 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.9 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.9 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.9 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.9 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.9 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.9 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.9 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.9 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.89 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.89 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.88 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.87 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.87 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.84 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.82 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.7 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.39 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.08 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 98.74 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 98.17 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 97.43 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.91 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 96.85 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 96.59 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 96.58 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 94.51 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 94.37 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 93.53 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 92.14 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 91.82 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 90.48 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 88.5 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 88.26 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 86.5 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 86.14 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 84.69 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 84.24 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 83.99 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 83.37 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 83.29 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 82.45 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 81.63 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=291.07 Aligned_cols=192 Identities=22% Similarity=0.343 Sum_probs=136.6
Q ss_pred eEeeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCC
Q 046010 278 AIWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGN 357 (523)
Q Consensus 278 ~~~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 357 (523)
..|+..|.+..++. ..+.++++.+++.|+.||++||+|||+++ ||||||||+|||+++++.+||+|||+++.....
T Consensus 110 mEy~~gGsL~~~l~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 110 TQWCEGSSLYKHLH-VQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp EECCSSCBHHHHHH-TSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEcCCCCCHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 34444555555444 34567999999999999999999999998 999999999999999999999999999876443
Q ss_pred CCCccccceeccCCCCchhhhcC---CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCccccc
Q 046010 358 QNESNTSKVVGTYGYMAPEYALG---GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELM 434 (523)
Q Consensus 358 ~~~~~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (523)
..........||+.|+|||++.+ +.++.++|||||||++|||+||+.||...... .........+.....+
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------~~~~~~~~~~~~~p~~ 259 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------DQIIFMVGRGYASPDL 259 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHTTCCCCCS
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCCCCCCc
Confidence 33333455689999999999864 46899999999999999999999998532211 1111111111111100
Q ss_pred CccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCCCCCC
Q 046010 435 DPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTVSLPQ 484 (523)
Q Consensus 435 ~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~l~~ 484 (523)
. ..+......+.+|+.+||+.||++|||+.||++.|+....++|.
T Consensus 260 ~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 260 S-----KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp T-----TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred c-----cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 0 11122345677899999999999999999999998876555543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=291.49 Aligned_cols=165 Identities=28% Similarity=0.407 Sum_probs=133.1
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
+..|+|.++++|+.||++||+|||+++ ||||||||+|||+++++.+||+|||+++...............||+.|+|
T Consensus 139 ~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymA 215 (308)
T 4gt4_A 139 KSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMA 215 (308)
T ss_dssp ECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCC
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccC
Confidence 456999999999999999999999998 99999999999999999999999999987644333333445678999999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||++.++.++.++|||||||++|||+| |+.||..... ..+. .....+.... .+...+..+.+|
T Consensus 216 PE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~----~~i~~~~~~~---------~p~~~~~~~~~l 279 (308)
T 4gt4_A 216 PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVV----EMIRNRQVLP---------CPDDCPAWVYAL 279 (308)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHH----HHHHTTCCCC---------CCTTCCHHHHHH
T ss_pred HHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHH----HHHHcCCCCC---------CcccchHHHHHH
Confidence 999999999999999999999999998 8899853321 1121 2222222221 122334567889
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+.+||+.||++|||+.||++.|+..
T Consensus 280 i~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 280 MIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHcCCChhHCcCHHHHHHHHHhc
Confidence 9999999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=292.75 Aligned_cols=166 Identities=26% Similarity=0.372 Sum_probs=133.0
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...|+|.++++|+.||++||.|||+++ ||||||||+|||++.++.+||+|||+++...............||+.|+|
T Consensus 122 ~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymA 198 (299)
T 4asz_A 122 PTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP 198 (299)
T ss_dssp CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcC
Confidence 467999999999999999999999998 99999999999999999999999999987643333333345678999999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||++.+..++.++|||||||++|||+| |+.||..... ..+. .....+..... +...+..+.+|
T Consensus 199 PE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~----~~i~~~~~~~~---------p~~~~~~~~~l 262 (299)
T 4asz_A 199 PESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVI----ECITQGRVLQR---------PRTCPQEVYEL 262 (299)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHH----HHHHHTCCCCC---------CTTCCHHHHHH
T ss_pred HHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHH----HHHHcCCCCCC---------CccchHHHHHH
Confidence 999999999999999999999999998 8999854321 1111 12222222111 11233567889
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
+.+||+.||++|||++||+++|++..
T Consensus 263 i~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 263 MLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 99999999999999999999998754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=292.60 Aligned_cols=166 Identities=27% Similarity=0.354 Sum_probs=124.3
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
..+|+|.+++.|+.||++||+|||+++ ||||||||+|||+++++.+||+|||+++...............||+.|+|
T Consensus 152 ~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymA 228 (329)
T 4aoj_A 152 PGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMP 228 (329)
T ss_dssp CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccC
Confidence 457999999999999999999999998 99999999999999999999999999987654433334445678999999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||++.+..++.++|||||||++|||+| |+.||...... .++ .....+...+ .+......+.+|
T Consensus 229 PE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~----~~i~~g~~~~---------~p~~~~~~~~~l 292 (329)
T 4aoj_A 229 PESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---EAI----DCITQGRELE---------RPRACPPEVYAI 292 (329)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---HHH----HHHHHTCCCC---------CCTTCCHHHHHH
T ss_pred hhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---HHH----HHHHcCCCCC---------CcccccHHHHHH
Confidence 999999999999999999999999999 89998543211 111 1122222111 111223467789
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
+.+||+.||++|||++||+++|+...
T Consensus 293 i~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 293 MRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp HHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 99999999999999999999998764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=290.36 Aligned_cols=166 Identities=28% Similarity=0.366 Sum_probs=133.6
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
+..|++.+++.++.||++||+|||+++ ||||||||+|||+++++.+||+|||+++...............||+.|+|
T Consensus 179 ~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymA 255 (353)
T 4ase_A 179 KDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 255 (353)
T ss_dssp TTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCC
T ss_pred cccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccC
Confidence 356999999999999999999999998 99999999999999999999999999997755544444556789999999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||++.+..++.++|||||||++|||+| |+.||...... . ........+..... +.....++.+|
T Consensus 256 PE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~--~----~~~~~i~~g~~~~~---------p~~~~~~~~~l 320 (353)
T 4ase_A 256 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--E----EFCRRLKEGTRMRA---------PDYTTPEMYQT 320 (353)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--H----HHHHHHHHTCCCCC---------CTTCCHHHHHH
T ss_pred HHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH--H----HHHHHHHcCCCCCC---------CccCCHHHHHH
Confidence 999999999999999999999999998 89998543211 1 11222222222111 11223467789
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
|.+||+.||++|||+.||++.|++.
T Consensus 321 i~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 321 MLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHcCcChhHCcCHHHHHHHHHHH
Confidence 9999999999999999999998764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=281.61 Aligned_cols=184 Identities=20% Similarity=0.214 Sum_probs=135.4
Q ss_pred eEeeeccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC-CeeEecccccee
Q 046010 278 AIWIAIGTTI---PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM-NPKISDFGMARI 353 (523)
Q Consensus 278 ~~~ia~g~~~---~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~~ 353 (523)
.+|+.+.+|- +.-+..+.+.|++.+++.++.||+.||+|||+++ ||||||||+|||++.++ .+||+|||+++.
T Consensus 124 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~ 200 (336)
T 4g3f_A 124 WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALC 200 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEE
T ss_pred EEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeE
Confidence 4566665554 1122355678999999999999999999999998 99999999999999988 599999999997
Q ss_pred ccCCCCCc---cccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCc
Q 046010 354 FGGNQNES---NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEA 430 (523)
Q Consensus 354 ~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (523)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+..... .....
T Consensus 201 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~i~---~~~~~ 274 (336)
T 4g3f_A 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG---PLCLKIA---SEPPP 274 (336)
T ss_dssp C------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS---CCHHHHH---HSCCG
T ss_pred ccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHHHHHH---cCCCC
Confidence 65332211 223457999999999999999999999999999999999999999643222 1211111 11110
Q ss_pred ccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 431 LELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 431 ~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
... .+......+.+|+.+||+.||++|||+.||++.|...
T Consensus 275 ~~~--------~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 275 IRE--------IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp GGG--------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred chh--------cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 000 1112234567889999999999999999999887654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-33 Score=272.52 Aligned_cols=176 Identities=23% Similarity=0.322 Sum_probs=130.3
Q ss_pred eEeeeccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC-CCCeeEecccccee
Q 046010 278 AIWIAIGTTI---PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH-EMNPKISDFGMARI 353 (523)
Q Consensus 278 ~~~ia~g~~~---~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~a~~ 353 (523)
.+++.+.+|- +.-+..+...+++..++.|+.||++||+|||+++ .+||||||||+|||++. ++.+||+|||+++.
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 4555555554 1223456678999999999999999999999985 35999999999999974 78999999999975
Q ss_pred ccCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccc
Q 046010 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALEL 433 (523)
Q Consensus 354 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (523)
... .......||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ..........+.....
T Consensus 182 ~~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~------~~~~~~~i~~~~~~~~ 250 (290)
T 3fpq_A 182 KRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYRRVTSGVKPAS 250 (290)
T ss_dssp CCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHHHHHHHTTTCCCGG
T ss_pred CCC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc------HHHHHHHHHcCCCCCC
Confidence 422 22345689999999998864 699999999999999999999999853211 1111222222221111
Q ss_pred cCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 434 MDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 434 ~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
++ .. ....+.+|+.+||+.||++|||+.|+++
T Consensus 251 ~~----~~----~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 251 FD----KV----AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GG----GC----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CC----cc----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 11 1235678899999999999999999976
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=276.51 Aligned_cols=177 Identities=19% Similarity=0.288 Sum_probs=133.3
Q ss_pred eEeeecccccc-cc-ccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceecc
Q 046010 278 AIWIAIGTTIP-TI-YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFG 355 (523)
Q Consensus 278 ~~~ia~g~~~~-~~-~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 355 (523)
.+|+.+.+|-. .+ ...++.++++.+++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.+.
T Consensus 145 ~~~ivmEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 221 (346)
T 4fih_A 145 ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 221 (346)
T ss_dssp EEEEEECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecC
Confidence 45666666551 11 1123467999999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccC
Q 046010 356 GNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMD 435 (523)
Q Consensus 356 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (523)
... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||..... ..... .......... .
T Consensus 222 ~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~----~i~~~~~~~~-~ 291 (346)
T 4fih_A 222 KEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMK----MIRDNLPPRL-K 291 (346)
T ss_dssp SSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHH----HHHHSSCCCC-S
T ss_pred CCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHH----HHHcCCCCCC-C
Confidence 322 223457899999999999999999999999999999999999999853221 11111 1111111111 0
Q ss_pred ccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 436 PVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 436 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
........+.+|+.+||+.||++|||+.|+++
T Consensus 292 ------~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 292 ------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp ------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01112245678899999999999999999876
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.8e-33 Score=281.09 Aligned_cols=175 Identities=20% Similarity=0.330 Sum_probs=133.8
Q ss_pred eEeeecccc-----ccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccce
Q 046010 278 AIWIAIGTT-----IPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352 (523)
Q Consensus 278 ~~~ia~g~~-----~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 352 (523)
.+|+.+.+| ..++...++..+++.+++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++
T Consensus 97 ~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~ 173 (350)
T 4b9d_A 97 SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIAR 173 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEES
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccce
Confidence 345555444 34444556667899999999999999999999999 9999999999999999999999999998
Q ss_pred eccCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCccc
Q 046010 353 IFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALE 432 (523)
Q Consensus 353 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (523)
..... ........||+.|+|||++.+..|+.++|||||||++|||++|+.||.... ..+...... .+....
T Consensus 174 ~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~-~~~~~~ 244 (350)
T 4b9d_A 174 VLNST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS------MKNLVLKII-SGSFPP 244 (350)
T ss_dssp CCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHH-HTCCCC
T ss_pred eecCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHH-cCCCCC
Confidence 65311 112334679999999999999999999999999999999999999995321 122222222 222111
Q ss_pred ccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 433 LMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 433 ~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
. .. .....+.+|+.+||+.||++|||+.|+++
T Consensus 245 ~-----~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 V-----SL----HYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp C-----CT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C-----Cc----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 11 12245778899999999999999999976
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.9e-33 Score=274.42 Aligned_cols=189 Identities=22% Similarity=0.276 Sum_probs=132.9
Q ss_pred ccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC-----CCcEEecCCCCCcEEeCCCCCeeEeccccceeccCC
Q 046010 283 IGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDS-----RLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGN 357 (523)
Q Consensus 283 ~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g-----~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 357 (523)
.|.+..++ ++.+++|+.+++++.|+++||+|||++. .++||||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~gsL~~~l---~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 161 (303)
T 3hmm_A 85 HGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 161 (303)
T ss_dssp TCBHHHHH---HHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred CCcHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCC
Confidence 44444444 3457999999999999999999999871 223999999999999999999999999999876543
Q ss_pred CCCc--cccceeccCCCCchhhhcCC------CCCcchhhHHHHHHHHHHHhCCCCCCCccccc--------ccchHHHH
Q 046010 358 QNES--NTSKVVGTYGYMAPEYALGG------VISVKSDVFSFGVLLLEIISGKKNSGFYLSEH--------GQSLLAYT 421 (523)
Q Consensus 358 ~~~~--~~~~~~gt~~y~aPE~l~~~------~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~--------~~~~~~~~ 421 (523)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|..||....... ........
T Consensus 162 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~ 241 (303)
T 3hmm_A 162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241 (303)
T ss_dssp TTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred CCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHH
Confidence 3221 22346799999999998754 36789999999999999999988765322111 01111122
Q ss_pred HHhhhcCCcccccCccccCC-ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 422 WKLWCNGEALELMDPVLKQS-CMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 422 ~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
........ +++.+... ...+....+.+|+.+||+.||++|||+.||++.|++.
T Consensus 242 ~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 242 RKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp HHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 22221111 12222111 1234566788999999999999999999999999865
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=6.8e-33 Score=273.80 Aligned_cols=174 Identities=21% Similarity=0.319 Sum_probs=136.2
Q ss_pred eEeeecccccc---ccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 278 AIWIAIGTTIP---TIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 278 ~~~ia~g~~~~---~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
.+|+.+.+|-. .-+..+.+.+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 106 ~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~ 182 (311)
T 4aw0_A 106 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL 182 (311)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceec
Confidence 46677666652 223456778999999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCccccc
Q 046010 355 GGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELM 434 (523)
Q Consensus 355 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (523)
.............||+.|+|||++.+..|+.++|||||||++|||++|+.||.... ...+. .. ...... ++
T Consensus 183 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~---~~-i~~~~~-~~- 253 (311)
T 4aw0_A 183 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EGLIF---AK-IIKLEY-DF- 253 (311)
T ss_dssp CTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH---HH-HHHTCC-CC-
T ss_pred CCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHH---HH-HHcCCC-CC-
Confidence 54444444556789999999999999999999999999999999999999985321 11111 11 111111 11
Q ss_pred CccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 046010 435 DPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSV 471 (523)
Q Consensus 435 ~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei 471 (523)
... ...++.+|+.+||+.||++|||++|+
T Consensus 254 ----p~~----~s~~~~dli~~lL~~dp~~R~t~~e~ 282 (311)
T 4aw0_A 254 ----PEK----FFPKARDLVEKLLVLDATKRLGCEEM 282 (311)
T ss_dssp ----CTT----CCHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred ----Ccc----cCHHHHHHHHHHccCCHhHCcChHHH
Confidence 111 12356789999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-32 Score=277.42 Aligned_cols=181 Identities=21% Similarity=0.292 Sum_probs=134.8
Q ss_pred eEeeecccccc--ccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceecc
Q 046010 278 AIWIAIGTTIP--TIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFG 355 (523)
Q Consensus 278 ~~~ia~g~~~~--~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 355 (523)
.+|+.+.+|-. +-...+..++++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.+.
T Consensus 222 ~~~iVmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~ 298 (423)
T 4fie_A 222 ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 298 (423)
T ss_dssp EEEEEEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECC
Confidence 45666655541 111123467999999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccC
Q 046010 356 GNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMD 435 (523)
Q Consensus 356 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (523)
... .......||+.|||||++.+..|+.++|||||||++|||++|+.||..... ..... .+.......+
T Consensus 299 ~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~-~i~~~~~~~~-- 367 (423)
T 4fie_A 299 KEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAMK-MIRDNLPPRL-- 367 (423)
T ss_dssp SSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHH-HHHHSCCCCC--
T ss_pred CCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHH-HHHcCCCCCC--
Confidence 322 233457899999999999999999999999999999999999999853211 11111 1111111111
Q ss_pred ccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH--Hhcc
Q 046010 436 PVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV--MLAS 477 (523)
Q Consensus 436 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~ 477 (523)
.. .......+.+|+.+||+.||++|||+.|+++ +|++
T Consensus 368 ---~~--~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~ 406 (423)
T 4fie_A 368 ---KN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 406 (423)
T ss_dssp ---SC--TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred ---cc--cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcC
Confidence 00 0111235678899999999999999999876 4543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-32 Score=263.43 Aligned_cols=176 Identities=24% Similarity=0.320 Sum_probs=125.9
Q ss_pred eEeeecccccccc--ccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceecc
Q 046010 278 AIWIAIGTTIPTI--YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFG 355 (523)
Q Consensus 278 ~~~ia~g~~~~~~--~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 355 (523)
.+|+.+.+|-..+ +..++.++++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 87 ~~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 87 EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp EEEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 4566666554322 3456778999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCCccccceeccCCCCchhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCccccc
Q 046010 356 GNQNESNTSKVVGTYGYMAPEYALGGVI-SVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELM 434 (523)
Q Consensus 356 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (523)
.. .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.... ...+ .....++...
T Consensus 164 ~~---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~---~~~~----~~~i~~~~~~--- 230 (275)
T 3hyh_A 164 DG---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES---IPVL----FKNISNGVYT--- 230 (275)
T ss_dssp --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHH----HHHHHHTCCC---
T ss_pred CC---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC---HHHH----HHHHHcCCCC---
Confidence 22 22335689999999999998776 579999999999999999999985321 1111 1122222111
Q ss_pred CccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH--Hhc
Q 046010 435 DPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV--MLA 476 (523)
Q Consensus 435 ~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~ 476 (523)
+... ....+.+|+.+||+.||++|||++|+++ +++
T Consensus 231 ---~p~~----~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k 267 (275)
T 3hyh_A 231 ---LPKF----LSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 267 (275)
T ss_dssp ---CCTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHH
T ss_pred ---CCCC----CCHHHHHHHHHHccCChhHCcCHHHHHcCcccc
Confidence 1111 1235678899999999999999999987 454
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-32 Score=267.30 Aligned_cols=174 Identities=21% Similarity=0.235 Sum_probs=130.9
Q ss_pred eEeeeccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 278 AIWIAIGTTI---PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 278 ~~~ia~g~~~---~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
.+|+.+.+|- +.-+..+...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 4666666665 1223456678999999999999999999999999 999999999999999999999999999865
Q ss_pred cCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCccccc
Q 046010 355 GGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELM 434 (523)
Q Consensus 355 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (523)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+...... +... .
T Consensus 177 ~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~-~~~~-~-- 244 (304)
T 3ubd_A 177 IDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD------RKETMTMIL-KAKL-G-- 244 (304)
T ss_dssp ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHH-HCCC-C--
T ss_pred cCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC------HHHHHHHHH-cCCC-C--
Confidence 3222 22335689999999999999999999999999999999999999985322 111111111 1111 1
Q ss_pred CccccCCccHHHHHHHHHHhhhcccCCCCCCCCH-----HHHHH
Q 046010 435 DPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNM-----SSVAV 473 (523)
Q Consensus 435 ~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~-----~ei~~ 473 (523)
+.. .....+.+|+.+||+.||++|||+ +|+++
T Consensus 245 ---~p~----~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 245 ---MPQ----FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ---CCT----TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ---CCC----cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 111 112356789999999999999984 56653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-30 Score=255.76 Aligned_cols=193 Identities=32% Similarity=0.547 Sum_probs=159.6
Q ss_pred cccccccccccc--ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC
Q 046010 283 IGTTIPTIYSTR--RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE 360 (523)
Q Consensus 283 ~g~~~~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 360 (523)
.|....++.... ...+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++........
T Consensus 119 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 195 (321)
T 2qkw_B 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQT 195 (321)
T ss_dssp TCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCC
T ss_pred CCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 344444444332 346999999999999999999999998 999999999999999999999999999875433333
Q ss_pred ccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccC
Q 046010 361 SNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQ 440 (523)
Q Consensus 361 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 440 (523)
.......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.............+.......+...+.+++.+..
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (321)
T 2qkw_B 196 HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLAD 275 (321)
T ss_dssp CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTT
T ss_pred ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhcc
Confidence 33345578999999999998999999999999999999999999997666555555666655666666777777777777
Q ss_pred CccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 441 SCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 441 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
.........+.+++.+||+.||++|||+.||++.|+..
T Consensus 276 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 276 KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 77788889999999999999999999999999999865
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-30 Score=255.55 Aligned_cols=179 Identities=22% Similarity=0.300 Sum_probs=121.5
Q ss_pred eEeeeccccc-----ccccccc-ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccc
Q 046010 278 AIWIAIGTTI-----PTIYSTR-RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA 351 (523)
Q Consensus 278 ~~~ia~g~~~-----~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 351 (523)
.+|+.+.+|. .++.... -...++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 89 ~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFGla 165 (299)
T 4g31_A 89 YLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLV 165 (299)
T ss_dssp EEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCCCC
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCccc
Confidence 5666666664 2222211 233566779999999999999999998 999999999999999999999999999
Q ss_pred eeccCCCCCc----------cccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHH
Q 046010 352 RIFGGNQNES----------NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYT 421 (523)
Q Consensus 352 ~~~~~~~~~~----------~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~ 421 (523)
+......... ......||+.|+|||++.+..|+.++|||||||++|||++ ||.... ... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~~~-~~ 236 (299)
T 4g31_A 166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----ERV-RT 236 (299)
T ss_dssp --------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HHH-HH
T ss_pred eecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----HHH-HH
Confidence 8765332211 1233579999999999999999999999999999999996 653211 011 11
Q ss_pred HHhhhcCCcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH--Hhcc
Q 046010 422 WKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV--MLAS 477 (523)
Q Consensus 422 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~ 477 (523)
........... ........+.+|+.+||+.||++|||+.||++ ++++
T Consensus 237 ~~~~~~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 237 LTDVRNLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp HHHHHTTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred HHHHhcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 11112211111 11122334567999999999999999999987 4543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8e-30 Score=261.84 Aligned_cols=195 Identities=21% Similarity=0.254 Sum_probs=135.6
Q ss_pred eEeeecccccccc--ccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceecc
Q 046010 278 AIWIAIGTTIPTI--YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFG 355 (523)
Q Consensus 278 ~~~ia~g~~~~~~--~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 355 (523)
.+|+.+.+|-..+ +..+++.+++.+++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++.+.
T Consensus 133 ~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 133 SVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 4566666655322 3456778999999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCC--CccccceeccCCCCchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCccc
Q 046010 356 GNQN--ESNTSKVVGTYGYMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALE 432 (523)
Q Consensus 356 ~~~~--~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (523)
.... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+..............
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~---~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV---HQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH---HHHHHHHHHHCCCCGGG
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH---HHHHHHHHhcCCCChHH
Confidence 3221 2233457899999999998875 4689999999999999999999999543211 11111111111100000
Q ss_pred c--cC--------ccc--cCCccH-----HHHHHHHHHhhhcccCCCCCCCCHHHHHH--HhccC
Q 046010 433 L--MD--------PVL--KQSCMA-----AELLKCIHIGLLCVQEDPADRPNMSSVAV--MLASD 478 (523)
Q Consensus 433 ~--~~--------~~l--~~~~~~-----~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~~ 478 (523)
. +. ..+ ....+. .....+++|+.+||+.||++|||+.|+++ +|++.
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 0 00 000 000000 11245778999999999999999999976 56544
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-29 Score=254.63 Aligned_cols=110 Identities=25% Similarity=0.365 Sum_probs=93.0
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCC-CCeeEeccccceeccCCCCC--------------
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE-MNPKISDFGMARIFGGNQNE-------------- 360 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~~~-------------- 360 (523)
+.+++.+++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++........
T Consensus 112 ~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~ 188 (361)
T 4f9c_A 112 NSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERC 188 (361)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC---------
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccccccccccccccc
Confidence 46999999999999999999999999 9999999999999877 79999999999865432211
Q ss_pred ------------ccccceeccCCCCchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCC
Q 046010 361 ------------SNTSKVVGTYGYMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGF 408 (523)
Q Consensus 361 ------------~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~ 408 (523)
.......||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 189 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 189 SQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp -----------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred ccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 112235799999999999875 489999999999999999999999853
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-29 Score=250.70 Aligned_cols=182 Identities=38% Similarity=0.646 Sum_probs=152.1
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhc---CCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHED---SRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~---g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
...+++..++.++.||+.||.|||++ + |+||||||+||+++.++.+||+|||++........ .......||+.
T Consensus 125 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~ 200 (326)
T 3uim_A 125 QPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIG 200 (326)
T ss_dssp CCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGG
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCCEEeccCccccccCcccc-cccccccCCcC
Confidence 44599999999999999999999999 7 99999999999999999999999999987643322 22334568999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc--cccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYL--SEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
|+|||.+.+..++.++||||||+++|+|++|+.||.... .........+..............+..+...........
T Consensus 201 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (326)
T 3uim_A 201 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQ 280 (326)
T ss_dssp GCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHH
T ss_pred ccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHH
Confidence 999999988889999999999999999999999986322 223334445555555666666777777777778888999
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHHHhccCCC
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAVMLASDTV 480 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~ 480 (523)
+.+++.+||+.||.+|||+.||+++|++...
T Consensus 281 l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 281 LIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp HHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred HHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 9999999999999999999999999987643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=243.50 Aligned_cols=190 Identities=15% Similarity=0.135 Sum_probs=142.3
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCC-----eeEeccccceeccCCCCC-----c
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMN-----PKISDFGMARIFGGNQNE-----S 361 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~-----~kL~Dfg~a~~~~~~~~~-----~ 361 (523)
...+.++++..++.++.||++||+|||+++ |+||||||+||+++.++. +||+|||+++........ .
T Consensus 97 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 173 (298)
T 1csn_A 97 DLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 173 (298)
T ss_dssp HHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCC
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccccccccccc
Confidence 334557999999999999999999999998 999999999999987776 999999999876543322 1
Q ss_pred cccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCC
Q 046010 362 NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQS 441 (523)
Q Consensus 362 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 441 (523)
......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.........................+. ..
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~- 247 (298)
T 1csn_A 174 EKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL-----CA- 247 (298)
T ss_dssp CCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH-----TT-
T ss_pred CccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHH-----Hh-
Confidence 234567899999999999999999999999999999999999999754333222222221111111111111 01
Q ss_pred ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCCCCCCCCCCCcccc
Q 046010 442 CMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTVSLPQPTQPAFSVG 493 (523)
Q Consensus 442 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~l~~p~~p~~~~~ 493 (523)
.....+.+++.+||+.||++||++++|++.|++....+.....-+|.|.
T Consensus 248 ---~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 296 (298)
T 1csn_A 248 ---GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN 296 (298)
T ss_dssp ---TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred ---hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccC
Confidence 1234677899999999999999999999999987666655555555553
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.95 E-value=7.7e-29 Score=266.03 Aligned_cols=175 Identities=23% Similarity=0.215 Sum_probs=131.4
Q ss_pred eEeeeccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 278 AIWIAIGTTI---PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 278 ~~~ia~g~~~---~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
.+|+.+.+|. +.-+..+...+++..++.++.||+.||+|||++| ||||||||+||||+.+|.+||+|||+++.+
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 4566665555 1223456678999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCccccceeccCCCCchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccc
Q 046010 355 GGNQNESNTSKVVGTYGYMAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALEL 433 (523)
Q Consensus 355 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (523)
.... .....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||........ ......... ... .
T Consensus 343 ~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~---~~i~~~i~~-~~~-~- 412 (689)
T 3v5w_A 343 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMTLT-MAV-E- 412 (689)
T ss_dssp SSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH---HHHHHHHHH-CCC-C-
T ss_pred CCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHhhcC-CCC-C-
Confidence 4332 334689999999999975 5799999999999999999999999964322221 111111111 111 0
Q ss_pred cCccccCCccHHHHHHHHHHhhhcccCCCCCCCC-----HHHHHH
Q 046010 434 MDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPN-----MSSVAV 473 (523)
Q Consensus 434 ~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~ei~~ 473 (523)
+.. .....+.+|+.+||+.||.+|++ ++||++
T Consensus 413 ----~p~----~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 413 ----LPD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ----CCT----TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ----CCc----cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 111 11235678899999999999998 577753
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-28 Score=239.37 Aligned_cols=191 Identities=17% Similarity=0.163 Sum_probs=144.0
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeC---CCCCeeEeccccceeccCCCCCc-----cc
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLD---HEMNPKISDFGMARIFGGNQNES-----NT 363 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~---~~~~~kL~Dfg~a~~~~~~~~~~-----~~ 363 (523)
...+..+++..++.++.||+.||+|||+++ |+||||||+||+++ .++.+||+|||++.......... ..
T Consensus 96 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 172 (296)
T 3uzp_A 96 NFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172 (296)
T ss_dssp HHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCS
T ss_pred HhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccc
Confidence 334567999999999999999999999998 99999999999994 78899999999998765433211 12
Q ss_pred cceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCcc
Q 046010 364 SKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCM 443 (523)
Q Consensus 364 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 443 (523)
....|+..|+|||.+.+..++.++||||||+++|+|++|+.||......................... .+..
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~--- 244 (296)
T 3uzp_A 173 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-----VLCK--- 244 (296)
T ss_dssp CCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-----HHTT---
T ss_pred cccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH-----HHHh---
Confidence 35678999999999999999999999999999999999999997644333333332222211111100 0011
Q ss_pred HHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCCCCCCCCCCCccccc
Q 046010 444 AAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTVSLPQPTQPAFSVGR 494 (523)
Q Consensus 444 ~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~l~~p~~p~~~~~~ 494 (523)
.....+.+++.+||+.||++|||+.+|++.|++.......+..-+|.|..
T Consensus 245 -~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~ 294 (296)
T 3uzp_A 245 -GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 294 (296)
T ss_dssp -TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGG
T ss_pred -hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccccc
Confidence 11245778999999999999999999999999876666655555565543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-28 Score=240.31 Aligned_cols=189 Identities=16% Similarity=0.158 Sum_probs=142.0
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEe---CCCCCeeEeccccceeccCCCCCc-----cc
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQNES-----NT 363 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~-----~~ 363 (523)
...+..+++..++.++.||+.||.|||+++ |+||||||+||++ +.++.+||+|||+++......... ..
T Consensus 96 ~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~ 172 (296)
T 4hgt_A 96 NFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172 (296)
T ss_dssp HHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCS
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcc
Confidence 334567999999999999999999999998 9999999999999 788999999999998765433211 22
Q ss_pred cceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCcc
Q 046010 364 SKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCM 443 (523)
Q Consensus 364 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 443 (523)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||.......................... +..
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~--- 244 (296)
T 4hgt_A 173 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV-----LCK--- 244 (296)
T ss_dssp CCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH-----HTT---
T ss_pred cccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh-----hhc---
Confidence 356789999999999999999999999999999999999999976444333333322222111111000 001
Q ss_pred HHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCCCCCCCCCCCccc
Q 046010 444 AAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTVSLPQPTQPAFSV 492 (523)
Q Consensus 444 ~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~l~~p~~p~~~~ 492 (523)
.....+.+|+.+||+.||++|||+.+|+++|++.......+..-+|.|
T Consensus 245 -~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw 292 (296)
T 4hgt_A 245 -GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW 292 (296)
T ss_dssp -TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGG
T ss_pred -cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccch
Confidence 112467789999999999999999999999998765554444444443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=249.89 Aligned_cols=197 Identities=17% Similarity=0.192 Sum_probs=145.5
Q ss_pred cccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeC--CCCCeeEeccccceeccCCCCCc-----c
Q 046010 290 IYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLD--HEMNPKISDFGMARIFGGNQNES-----N 362 (523)
Q Consensus 290 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~--~~~~~kL~Dfg~a~~~~~~~~~~-----~ 362 (523)
++......+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++.+....... .
T Consensus 141 ~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 217 (364)
T 3op5_A 141 IYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADP 217 (364)
T ss_dssp HHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCS
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCc
Confidence 33445578999999999999999999999998 99999999999999 88999999999998764322111 1
Q ss_pred ccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCc
Q 046010 363 TSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSC 442 (523)
Q Consensus 363 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 442 (523)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ........... .....+++++.+...
T Consensus 218 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~- 293 (364)
T 3op5_A 218 KRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD--PKYVRDSKIRY-RENIASLMDKCFPAA- 293 (364)
T ss_dssp SCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC--HHHHHHHHHHH-HHCHHHHHHHHSCTT-
T ss_pred ccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC--HHHHHHHHHHh-hhhHHHHHHHhcccc-
Confidence 13345899999999999999999999999999999999999998642221 11111111111 112222322222111
Q ss_pred cHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCCCCCCCCCCCcccccc
Q 046010 443 MAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTVSLPQPTQPAFSVGRI 495 (523)
Q Consensus 443 ~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~l~~p~~p~~~~~~~ 495 (523)
.....+.+++..||+.||++||++.+|+++|++.......+....|.+...
T Consensus 294 --~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 344 (364)
T 3op5_A 294 --NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVV 344 (364)
T ss_dssp --CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC---
T ss_pred --cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEec
Confidence 123467788889999999999999999999998877777777777777654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-29 Score=251.42 Aligned_cols=167 Identities=25% Similarity=0.392 Sum_probs=128.8
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
..+..+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...............+|..|
T Consensus 109 ~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y 185 (327)
T 3poz_A 109 EHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185 (327)
T ss_dssp HSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGG
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccc
Confidence 34567999999999999999999999998 999999999999999999999999999877544443334445667899
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
+|||.+.+..++.++||||||+++|||++ |+.||....... +.. ......... .+......+.
T Consensus 186 ~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~----~~~~~~~~~---------~~~~~~~~~~ 249 (327)
T 3poz_A 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGERLP---------QPPICTIDVY 249 (327)
T ss_dssp SCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----HHHTTCCCC---------CCTTBCHHHH
T ss_pred cChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHH----HHHcCCCCC---------CCccCCHHHH
Confidence 99999999999999999999999999999 999986432221 111 111111111 1112234677
Q ss_pred HHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 452 HIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+|+.+||+.||++||++.||++.|+..
T Consensus 250 ~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 250 MIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp HHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 899999999999999999999998764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-28 Score=243.41 Aligned_cols=188 Identities=15% Similarity=0.130 Sum_probs=139.7
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCC-----eeEeccccceeccCCCCCc-----c
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMN-----PKISDFGMARIFGGNQNES-----N 362 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~-----~kL~Dfg~a~~~~~~~~~~-----~ 362 (523)
..+..+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++......... .
T Consensus 97 ~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~ 173 (330)
T 2izr_A 97 LCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYRE 173 (330)
T ss_dssp HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCC
T ss_pred HcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccc
Confidence 33578999999999999999999999998 999999999999998887 9999999998764433221 1
Q ss_pred ccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCc
Q 046010 363 TSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSC 442 (523)
Q Consensus 363 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 442 (523)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||....................... . ..+...
T Consensus 174 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~-~----~~~~~~- 247 (330)
T 2izr_A 174 HKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP-I----EVLCEN- 247 (330)
T ss_dssp CCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC-H----HHHTTT-
T ss_pred cCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC-H----HHHhcc-
Confidence 2456789999999999999999999999999999999999999975433222222111111100000 0 000111
Q ss_pred cHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCCCCCCCCCCCcccc
Q 046010 443 MAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTVSLPQPTQPAFSVG 493 (523)
Q Consensus 443 ~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~l~~p~~p~~~~~ 493 (523)
.+ .+.+|+..||+.||.+||++.+|++.|+........+....|.+.
T Consensus 248 ---~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 248 ---FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp ---CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred ---Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence 12 678899999999999999999999999876555544444445444
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.6e-29 Score=248.93 Aligned_cols=178 Identities=26% Similarity=0.369 Sum_probs=133.5
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhc----------CCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcccc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHED----------SRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTS 364 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~----------g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 364 (523)
+..+++..++.++.||++||.|||+. + |+||||||+|||++.++.+||+|||+++............
T Consensus 115 ~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~ 191 (322)
T 3soc_A 115 ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTH 191 (322)
T ss_dssp HCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCT
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCcccccccccCccccc
Confidence 35699999999999999999999998 7 9999999999999999999999999998775544433344
Q ss_pred ceeccCCCCchhhhcCC-----CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchH---------HHHHHhhhcCCc
Q 046010 365 KVVGTYGYMAPEYALGG-----VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLL---------AYTWKLWCNGEA 430 (523)
Q Consensus 365 ~~~gt~~y~aPE~l~~~-----~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~---------~~~~~~~~~~~~ 430 (523)
...||+.|+|||++.+. .++.++||||||+++|||++|+.||............ ............
T Consensus 192 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (322)
T 3soc_A 192 GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKK 271 (322)
T ss_dssp TCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCC
T ss_pred cCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccC
Confidence 56789999999999863 4567899999999999999999998654332211111 111111111111
Q ss_pred ccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 431 LELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 431 ~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
...+..... .......+.+|+.+||+.||++|||+.||++.|++.
T Consensus 272 ~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 272 RPVLRDYWQ---KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CCCCCGGGG---SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcccccc---ccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111111111 124456688999999999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.6e-28 Score=239.12 Aligned_cols=176 Identities=24% Similarity=0.312 Sum_probs=130.9
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHH--------hcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCc--cc
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLH--------EDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES--NT 363 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH--------~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~--~~ 363 (523)
++..+++..++.++.||++||+||| +++ |+||||||+|||++.++.+||+|||+++......... ..
T Consensus 98 ~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 174 (301)
T 3q4u_A 98 QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174 (301)
T ss_dssp TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCC
T ss_pred hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccc
Confidence 4457999999999999999999999 777 9999999999999999999999999998764333221 12
Q ss_pred cceeccCCCCchhhhcCC------CCCcchhhHHHHHHHHHHHhC----------CCCCCCcccccccchHHHHHHhhh-
Q 046010 364 SKVVGTYGYMAPEYALGG------VISVKSDVFSFGVLLLEIISG----------KKNSGFYLSEHGQSLLAYTWKLWC- 426 (523)
Q Consensus 364 ~~~~gt~~y~aPE~l~~~------~~s~ksDVwSlGvvl~elltG----------~~p~~~~~~~~~~~~~~~~~~~~~- 426 (523)
....||+.|+|||.+.+. .++.++||||||+++|||++| +.||......... .........
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~--~~~~~~~~~~ 252 (301)
T 3q4u_A 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS--FEDMRKVVCV 252 (301)
T ss_dssp CCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC--HHHHHHHHTT
T ss_pred cccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc--hhhhhHHHhc
Confidence 234789999999999876 455799999999999999999 7776533322211 111122111
Q ss_pred cCCcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 427 NGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 427 ~~~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
.......... .........+.+|+.+||+.||++|||+.||++.|++.
T Consensus 253 ~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 253 DQQRPNIPNR----WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCCCCCCCGG----GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCCChh----hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 1111111111 11234567888999999999999999999999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=240.72 Aligned_cols=181 Identities=18% Similarity=0.201 Sum_probs=133.2
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC--CeeEeccccceeccCCCCC-----cccc
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM--NPKISDFGMARIFGGNQNE-----SNTS 364 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~--~~kL~Dfg~a~~~~~~~~~-----~~~~ 364 (523)
..+...+++.+++.++.||+.||+|||+++ |+||||||+||+++.++ .+||+|||+++.+...... ....
T Consensus 142 l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~ 218 (345)
T 2v62_A 142 SGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRK 218 (345)
T ss_dssp CBGGGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGG
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhcccc
Confidence 344458999999999999999999999998 99999999999998887 9999999999876422111 1123
Q ss_pred ceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccH
Q 046010 365 KVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMA 444 (523)
Q Consensus 365 ~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 444 (523)
...|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ............ .....+...... .
T Consensus 219 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~---~ 292 (345)
T 2v62_A 219 GHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP--VAVQTAKTNLLD-ELPQSVLKWAPS---G 292 (345)
T ss_dssp CSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH--HHHHHHHHHHHH-TTTHHHHHHSCT---T
T ss_pred ccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc--HHHHHHHHhhcc-cccHHHHhhccc---c
Confidence 4578999999999999999999999999999999999999985322111 111111111111 111111110000 0
Q ss_pred HHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCCC
Q 046010 445 AELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTVS 481 (523)
Q Consensus 445 ~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~ 481 (523)
.....+.+++.+||+.||++||++.+|++.|++....
T Consensus 293 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 329 (345)
T 2v62_A 293 SSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP 329 (345)
T ss_dssp SCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred ccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence 1234677889999999999999999999999987553
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-28 Score=247.27 Aligned_cols=164 Identities=30% Similarity=0.382 Sum_probs=129.8
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++.+++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...............+++.|+||
T Consensus 198 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP 274 (370)
T 2psq_A 198 EQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 274 (370)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCH
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECH
Confidence 46899999999999999999999998 999999999999999999999999999876544333333345567889999
Q ss_pred hhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 376 EYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 376 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
|++.+..++.++||||||+++|||++ |+.||...... .+.. ....+.... .+......+.+++
T Consensus 275 E~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---~~~~----~~~~~~~~~---------~~~~~~~~l~~li 338 (370)
T 2psq_A 275 EALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---ELFK----LLKEGHRMD---------KPANCTNELYMMM 338 (370)
T ss_dssp HHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHH----HHHTTCCCC---------CCTTSCHHHHHHH
T ss_pred hHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHhcCCCCC---------CCCCCCHHHHHHH
Confidence 99999999999999999999999999 99998543221 1111 111211111 1112234677899
Q ss_pred hhcccCCCCCCCCHHHHHHHhccC
Q 046010 455 LLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
.+||+.||++||++.||++.|++.
T Consensus 339 ~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 339 RDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHcCCChhhCcCHHHHHHHHHHH
Confidence 999999999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=256.16 Aligned_cols=162 Identities=20% Similarity=0.247 Sum_probs=125.8
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCC--CCeeEeccccceeccCCCCCccccceeccC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE--MNPKISDFGMARIFGGNQNESNTSKVVGTY 370 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~--~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~ 370 (523)
.+...|++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++.+... .......||+
T Consensus 247 ~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~---~~~~~~~GT~ 320 (573)
T 3uto_A 247 DEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK---QSVKVTTGTA 320 (573)
T ss_dssp CTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT---SEEEEECSSG
T ss_pred HhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC---CceeeeEECc
Confidence 45568999999999999999999999999 9999999999999854 78999999999986432 2234567999
Q ss_pred CCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 371 GYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 371 ~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
.|+|||++.+..|+.++|||||||++|||++|+.||..... ... ......... .+... ... .....+
T Consensus 321 ~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~------~~~-~~~i~~~~~-~~~~~-~~~----~~s~~~ 387 (573)
T 3uto_A 321 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DET-LRNVKSCDW-NMDDS-AFS----GISEDG 387 (573)
T ss_dssp GGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHH-HHHHHTTCC-CCCSG-GGT----TSCHHH
T ss_pred cccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHH-HHHHHhCCC-CCCcc-ccc----CCCHHH
Confidence 99999999999999999999999999999999999853221 111 111111111 01011 111 112356
Q ss_pred HHHhhhcccCCCCCCCCHHHHHH
Q 046010 451 IHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+|+.+||+.||.+|||+.|+++
T Consensus 388 ~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 388 KDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHhc
Confidence 78999999999999999999987
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=198.21 Aligned_cols=106 Identities=21% Similarity=0.449 Sum_probs=95.0
Q ss_pred CCccccCCCCCCccccCCchHHHHHHHHHHHHHhhcCCCCCCCcccCeeeeeccC-CCCeEEEEEEecCCCChhhHHHHH
Q 046010 25 DLFYIYHFCNNTVNFTRNSTYQSNLNLLLSTLRSNATHGSSDKFSEGFYNATASQ-DPDKVYGLFLCRGDVSAETCKDCV 103 (523)
Q Consensus 25 ~~~~~~~~C~~~~~~~~~s~f~~nl~~ll~~l~~~a~~~~~~~~~~~~~~~~~g~-~~~~vyg~~qC~~D~~~~~C~~Cl 103 (523)
++.++++.|++ ++|+++++|++||+.||+.|+++++.++ .+|++...|. ++++||||+|||||+++++|+.||
T Consensus 2 ~t~~v~~~Cn~-~~~t~~s~f~~nl~~ll~~L~~~a~~s~-----~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl 75 (108)
T 3a2e_A 2 NTAFVSSACNT-QKIPSGSPFNRNLRAMLADLRQNTAFSG-----YDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACL 75 (108)
T ss_dssp CCCEEEEEECS-SBCCTTCTHHHHHHHHHHHHHHHGGGTT-----SEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHH
T ss_pred CcceeeeecCC-CccCCCChHHHHHHHHHHHHHhhCcccc-----CCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHH
Confidence 34578999965 6999999999999999999999987653 4566666554 458999999999999999999999
Q ss_pred HHHHHhhhhcCCCcccceEecccceeeecCCcc
Q 046010 104 NFATSDITQRCPLQKETVIWYDHCLLRYSGISF 136 (523)
Q Consensus 104 ~~a~~~~~~~C~~~~~a~i~~~~C~lry~~~~f 136 (523)
+.|+.++.++|++++||+||+++|+||||+++|
T Consensus 76 ~~a~~~~~~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 76 SNLVNRIFSICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp HHHHTTHHHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred HHHHHHHHHHCCCCceEEEECCCEEEEEeCCcC
Confidence 999999999999999999999999999999998
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=251.95 Aligned_cols=177 Identities=18% Similarity=0.225 Sum_probs=135.0
Q ss_pred cccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEe---CCCCCeeEeccccceeccCCCCCc-----
Q 046010 290 IYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQNES----- 361 (523)
Q Consensus 290 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~----- 361 (523)
++......+++..++.|+.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++.+.......
T Consensus 92 ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 168 (483)
T 3sv0_A 92 LFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168 (483)
T ss_dssp HHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCC
T ss_pred HHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccc
Confidence 33344667999999999999999999999998 9999999999999 578899999999998765433221
Q ss_pred cccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCC
Q 046010 362 NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQS 441 (523)
Q Consensus 362 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 441 (523)
......||..|+|||.+.+..++.++||||||+++|||++|+.||..........................+ ..
T Consensus 169 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l-----~~- 242 (483)
T 3sv0_A 169 ENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL-----CR- 242 (483)
T ss_dssp CCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH-----HT-
T ss_pred cccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH-----hc-
Confidence 123567899999999999999999999999999999999999999754433222222221111111111110 01
Q ss_pred ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 442 CMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 442 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
....++.+|+..||+.||++||++.+|+++|+..
T Consensus 243 ---~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 243 ---GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp ---TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ---CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1134678899999999999999999999998865
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.8e-28 Score=239.04 Aligned_cols=169 Identities=29% Similarity=0.413 Sum_probs=121.0
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..++.++.||++||+|||+++ .+|+||||||+||+++.++.+||+|||+++..... ........||+.|+||
T Consensus 132 ~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aP 208 (309)
T 3p86_A 132 EQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST--FLSSKSAAGTPEWMAP 208 (309)
T ss_dssp HHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-------------------CCTTSCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc--ccccccCCCCccccCh
Confidence 34999999999999999999999985 34999999999999999999999999999754322 1223346789999999
Q ss_pred hhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHhh
Q 046010 376 EYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGL 455 (523)
Q Consensus 376 E~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~ 455 (523)
|.+.+..++.++||||||+++|+|++|+.||...... .............+. +......+.+|+.
T Consensus 209 E~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~------~~~~~~~~~~~~~~~---------~~~~~~~l~~li~ 273 (309)
T 3p86_A 209 EVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA------QVVAAVGFKCKRLEI---------PRNLNPQVAAIIE 273 (309)
T ss_dssp HHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHHSCCCCCC---------CTTSCHHHHHHHH
T ss_pred hhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcCCCCCC---------CccCCHHHHHHHH
Confidence 9999999999999999999999999999998543221 111111111111111 1112245778999
Q ss_pred hcccCCCCCCCCHHHHHHHhccCCCCC
Q 046010 456 LCVQEDPADRPNMSSVAVMLASDTVSL 482 (523)
Q Consensus 456 ~cl~~dP~~RPs~~ei~~~L~~~~~~l 482 (523)
+||+.||++|||+.+|++.|+......
T Consensus 274 ~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 274 GCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred HHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 999999999999999999998875443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=245.68 Aligned_cols=168 Identities=25% Similarity=0.319 Sum_probs=129.5
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
..+..+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...............++..|
T Consensus 107 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y 183 (325)
T 3kex_A 107 QHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183 (325)
T ss_dssp SSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTT
T ss_pred HccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccc
Confidence 33568999999999999999999999998 999999999999999999999999999877554444444556778899
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
+|||.+.+..++.++||||||+++|+|++ |+.||...... .. .............. .....+.
T Consensus 184 ~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~----~~~~~~~~~~~~~~---------~~~~~~~ 247 (325)
T 3kex_A 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA---EV----PDLLEKGERLAQPQ---------ICTIDVY 247 (325)
T ss_dssp SCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT---HH----HHHHHTTCBCCCCT---------TBCTTTT
T ss_pred cChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH---HH----HHHHHcCCCCCCCC---------cCcHHHH
Confidence 99999999999999999999999999999 99998643221 11 11111111111100 1122456
Q ss_pred HHhhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 452 HIGLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
+++.+||+.||.+|||+.||++.|+...
T Consensus 248 ~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 248 MVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 7889999999999999999999998764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-27 Score=233.73 Aligned_cols=179 Identities=34% Similarity=0.521 Sum_probs=137.7
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
....+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||++................|+..|+
T Consensus 126 ~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~ 202 (307)
T 2nru_A 126 GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYM 202 (307)
T ss_dssp GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGC
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcC
Confidence 3456999999999999999999999998 9999999999999999999999999998765433333334567899999
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhh-hcCCcccccCccccCCccHHHHHHHHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLW-CNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
|||.+.+ .++.++||||||+++|+|++|+.||........ ......... ......+.+++.+. ..+......+.+
T Consensus 203 aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 278 (307)
T 2nru_A 203 APEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYS 278 (307)
T ss_dssp CHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--TTHHHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHH
T ss_pred ChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--HHHHHHHhhhhhhhhhhhcccccc-ccchHHHHHHHH
Confidence 9998764 588999999999999999999999865433221 111111111 11222233333332 345566778899
Q ss_pred HhhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 453 IGLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
++.+||+.||.+|||+.+|++.|++..
T Consensus 279 li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 279 VASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 999999999999999999999998753
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=243.06 Aligned_cols=196 Identities=14% Similarity=0.172 Sum_probs=141.5
Q ss_pred ccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC--CeeEeccccceeccCCCCC-----c
Q 046010 289 TIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM--NPKISDFGMARIFGGNQNE-----S 361 (523)
Q Consensus 289 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~--~~kL~Dfg~a~~~~~~~~~-----~ 361 (523)
++....+..+++..++.++.||++||.|||+++ |+||||||+||+++.++ .+||+|||+++........ .
T Consensus 147 ~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 223 (352)
T 2jii_A 147 ALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEG 223 (352)
T ss_dssp HHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTT
T ss_pred HHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCcccccccc
Confidence 333333578999999999999999999999998 99999999999999998 8999999999865432211 1
Q ss_pred cccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCC
Q 046010 362 NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQS 441 (523)
Q Consensus 362 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 441 (523)
......|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ..+.. ....+.. ....+.......
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~-~~~~~~~-~~~~~~~~~~~~- 299 (352)
T 2jii_A 224 SRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT-EDIMK-QKQKFVD-KPGPFVGPCGHW- 299 (352)
T ss_dssp SSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH-HHHHH-HHHHHHH-SCCCEECTTSCE-
T ss_pred ccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH-HHHHH-HHHhccC-Chhhhhhhcccc-
Confidence 1233478999999999999999999999999999999999999986433211 11111 1111111 111111111100
Q ss_pred ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCCCCCCCCCCCcccc
Q 046010 442 CMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTVSLPQPTQPAFSVG 493 (523)
Q Consensus 442 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~l~~p~~p~~~~~ 493 (523)
......+.+|+.+||+.||++|||+.+|+++|++.......+...++.+.
T Consensus 300 --~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw~ 349 (352)
T 2jii_A 300 --IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGLP 349 (352)
T ss_dssp --ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCCC
T ss_pred --CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccCc
Confidence 01124677888999999999999999999999987666655544445443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=234.57 Aligned_cols=173 Identities=24% Similarity=0.404 Sum_probs=120.7
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++................|+..|
T Consensus 112 ~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 188 (289)
T 3og7_A 112 ASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 188 (289)
T ss_dssp TC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------------------CCCTT
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccc
Confidence 45677999999999999999999999998 999999999999999999999999999865433333334456789999
Q ss_pred Cchhhhc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 373 MAPEYAL---GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 373 ~aPE~l~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
+|||.+. +..++.++||||||+++|+|++|+.||...... ... ......+.....+.. + .......
T Consensus 189 ~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~----~~~~~~~~~~~~~~~-~----~~~~~~~ 257 (289)
T 3og7_A 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQI----IEMVGRGSLSPDLSK-V----RSNCPKR 257 (289)
T ss_dssp CCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HHH----HHHHHHTSCCCCTTS-S----CTTSCHH
T ss_pred cCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HHH----HHHhcccccCcchhh-c----cccCCHH
Confidence 9999986 567889999999999999999999998543221 111 111111111111111 1 1122356
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
+.+|+.+||+.||++|||+.+|+++|++..
T Consensus 258 l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 258 MKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 788999999999999999999999998864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-28 Score=243.95 Aligned_cols=168 Identities=25% Similarity=0.383 Sum_probs=123.8
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
..+..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++...............++..|
T Consensus 109 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y 185 (327)
T 3lzb_A 109 EHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185 (327)
T ss_dssp HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGG
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccc
Confidence 34567999999999999999999999998 999999999999999999999999999876543333333345567789
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
+|||.+.+..++.++||||||+++|+|++ |+.||....... ... ......... .+......+.
T Consensus 186 ~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~----~~~~~~~~~---------~~~~~~~~l~ 249 (327)
T 3lzb_A 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGERLP---------QPPICTIDVY 249 (327)
T ss_dssp SCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----HHHTTCCCC---------CCTTBCHHHH
T ss_pred cCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHcCCCCC---------CCccCCHHHH
Confidence 99999999999999999999999999999 999986432221 111 111111111 0111233577
Q ss_pred HHhhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 452 HIGLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
+|+.+||+.||.+||++.||++.|+...
T Consensus 250 ~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 250 MIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 8999999999999999999999998764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-27 Score=238.17 Aligned_cols=168 Identities=30% Similarity=0.485 Sum_probs=128.9
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCc------------
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES------------ 361 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~------------ 361 (523)
....+++.+++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++.........
T Consensus 101 ~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~ 177 (310)
T 3s95_A 101 MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177 (310)
T ss_dssp CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC------------------
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccc
Confidence 3567999999999999999999999998 9999999999999999999999999998764332211
Q ss_pred cccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccc--hHHHHHHhhhcCCcccccCcccc
Q 046010 362 NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQS--LLAYTWKLWCNGEALELMDPVLK 439 (523)
Q Consensus 362 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~ 439 (523)
......||+.|+|||.+.+..++.++||||||+++|+|++|..|+.......... .........
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~-------------- 243 (310)
T 3s95_A 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY-------------- 243 (310)
T ss_dssp --CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT--------------
T ss_pred cccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc--------------
Confidence 1114568999999999999999999999999999999999999986543322211 111100000
Q ss_pred CCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCC
Q 046010 440 QSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTV 480 (523)
Q Consensus 440 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~ 480 (523)
.+......+.+|+.+||+.||++|||+.+|+++|+....
T Consensus 244 --~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 244 --CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp --CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 011112356788999999999999999999999987643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-27 Score=240.50 Aligned_cols=166 Identities=28% Similarity=0.366 Sum_probs=130.0
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
+..+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++...............+|..|+|
T Consensus 187 ~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~a 263 (359)
T 3vhe_A 187 KDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 263 (359)
T ss_dssp TTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCC
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEC
Confidence 344999999999999999999999998 99999999999999999999999999987654444444455678899999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||++.+..++.++||||||+++|+|++ |+.||...... . .............. +......+.++
T Consensus 264 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~----~~~~~~~~~~~~~~---------~~~~~~~l~~l 328 (359)
T 3vhe_A 264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--E----EFCRRLKEGTRMRA---------PDYTTPEMYQT 328 (359)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--H----HHHHHHHHTCCCCC---------CTTCCHHHHHH
T ss_pred hhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh--H----HHHHHHHcCCCCCC---------CCCCCHHHHHH
Confidence 999999999999999999999999998 99998543221 1 11111222111111 11122457788
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+.+||+.||++|||+.||++.|+..
T Consensus 329 i~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 329 MLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHccCChhhCCCHHHHHHHHHHH
Confidence 9999999999999999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.4e-27 Score=230.90 Aligned_cols=160 Identities=24% Similarity=0.320 Sum_probs=124.6
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
+..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++........ ......||+.|+|
T Consensus 110 ~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~a 184 (297)
T 3fxz_A 110 ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMA 184 (297)
T ss_dssp HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCC
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--ccCCccCCcCccC
Confidence 346999999999999999999999998 99999999999999999999999999987643322 2334678999999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
||.+.+..++.++||||||+++|+|++|+.||...... ............ ... .+......+.+++
T Consensus 185 PE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~-~~~-------~~~~~~~~~~~li 250 (297)
T 3fxz_A 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTP-ELQ-------NPEKLSAIFRDFL 250 (297)
T ss_dssp HHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSC-CCS-------CGGGSCHHHHHHH
T ss_pred hhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC-CCC-------CccccCHHHHHHH
Confidence 99999999999999999999999999999998532211 111111111111 110 0112234567889
Q ss_pred hhcccCCCCCCCCHHHHHH
Q 046010 455 LLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~ 473 (523)
.+||+.||++|||+.|+++
T Consensus 251 ~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 251 NRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHHSCSSTTTSCCHHHHTT
T ss_pred HHHccCChhHCcCHHHHhh
Confidence 9999999999999999975
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=232.98 Aligned_cols=166 Identities=25% Similarity=0.353 Sum_probs=126.8
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
...+..+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||++..+.............||+.
T Consensus 96 l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~ 172 (323)
T 3tki_A 96 IEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172 (323)
T ss_dssp SBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGG
T ss_pred HhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcC
Confidence 455667999999999999999999999998 99999999999999999999999999987643333333445678999
Q ss_pred CCchhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 372 YMAPEYALGGVI-SVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 372 y~aPE~l~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
|+|||++.+..+ +.++||||||+++|+|++|+.||........ . ...+...... ..+ .......+
T Consensus 173 y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~---~~~~~~~~~~--~~~------~~~~~~~~ 238 (323)
T 3tki_A 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---E---YSDWKEKKTY--LNP------WKKIDSAP 238 (323)
T ss_dssp GSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH---H---HHHHHTTCTT--STT------GGGSCHHH
T ss_pred ccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH---H---HHHHhccccc--CCc------cccCCHHH
Confidence 999999988775 7899999999999999999999864322111 1 1111111110 010 01122456
Q ss_pred HHHhhhcccCCCCCCCCHHHHHHH
Q 046010 451 IHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
.+|+.+||+.||++|||+.||++.
T Consensus 239 ~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 239 LALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHccCChhhCcCHHHHhhC
Confidence 788999999999999999998763
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=9.1e-28 Score=242.59 Aligned_cols=169 Identities=29% Similarity=0.383 Sum_probs=130.5
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||++................+++.|+||
T Consensus 167 ~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP 243 (344)
T 1rjb_A 167 NVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP 243 (344)
T ss_dssp --CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCH
Confidence 45899999999999999999999998 999999999999999999999999999876544433344456778899999
Q ss_pred hhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 376 EYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 376 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
|.+.+..++.++||||||+++|+|++ |..||...... . ........+.... .+......+.+|+
T Consensus 244 E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~----~~~~~~~~~~~~~---------~~~~~~~~l~~li 308 (344)
T 1rjb_A 244 ESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD--A----NFYKLIQNGFKMD---------QPFYATEEIYIIM 308 (344)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--H----HHHHHHHTTCCCC---------CCTTCCHHHHHHH
T ss_pred HHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH--H----HHHHHHhcCCCCC---------CCCCCCHHHHHHH
Confidence 99999999999999999999999998 99998543221 1 1111122211111 1111234677899
Q ss_pred hhcccCCCCCCCCHHHHHHHhccCCCCC
Q 046010 455 LLCVQEDPADRPNMSSVAVMLASDTVSL 482 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~~L~~~~~~l 482 (523)
.+||+.||.+|||+.||++.|+......
T Consensus 309 ~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 309 QSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred HHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 9999999999999999999998865443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=240.01 Aligned_cols=174 Identities=18% Similarity=0.222 Sum_probs=123.1
Q ss_pred cccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC---CCCeeEeccccceeccCCCCC
Q 046010 284 GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH---EMNPKISDFGMARIFGGNQNE 360 (523)
Q Consensus 284 g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~---~~~~kL~Dfg~a~~~~~~~~~ 360 (523)
|.+..++.......+++.+++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 144 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~--- 217 (400)
T 1nxk_A 144 GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--- 217 (400)
T ss_dssp EEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----
T ss_pred CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCCC---
Confidence 33334444444567999999999999999999999998 999999999999998 788999999999865322
Q ss_pred ccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCccccccc-chHHHHHHhhhcCCcccccCcccc
Q 046010 361 SNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQ-SLLAYTWKLWCNGEALELMDPVLK 439 (523)
Q Consensus 361 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~ 439 (523)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ...... ..+... ...+..
T Consensus 218 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i----~~~~~~-~~~~~~- 291 (400)
T 1nxk_A 218 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQYE-FPNPEW- 291 (400)
T ss_dssp ---------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH----HHTCCC-CCTTTT-
T ss_pred CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH----HcCccc-CCCccc-
Confidence 2233567899999999999999999999999999999999999998644332211 111111 111110 000000
Q ss_pred CCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 440 QSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 440 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
......+.+|+.+||+.||++|||+.||++
T Consensus 292 ----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 292 ----SEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp ----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 112345778999999999999999999987
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.4e-28 Score=246.39 Aligned_cols=169 Identities=30% Similarity=0.345 Sum_probs=133.0
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...............++..|+|
T Consensus 185 ~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~a 261 (382)
T 3tt0_A 185 EEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMA 261 (382)
T ss_dssp CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSC
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeC
Confidence 356999999999999999999999998 99999999999999999999999999987654433333445567888999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||++.+..++.++||||||+++|+|++ |..||...... ........+..... +......+.+|
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~-------~~~~~~~~~~~~~~---------~~~~~~~l~~l 325 (382)
T 3tt0_A 262 PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-------ELFKLLKEGHRMDK---------PSNCTNELYMM 325 (382)
T ss_dssp HHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------HHHHHHHTTCCCCC---------CSSCCHHHHHH
T ss_pred HHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCCC---------CccCCHHHHHH
Confidence 999999999999999999999999999 99998532211 11222222221111 11123467789
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccCCCCC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASDTVSL 482 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~~~~l 482 (523)
+.+||+.||++|||+.||++.|++.....
T Consensus 326 i~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 326 MRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 99999999999999999999998875433
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.1e-27 Score=232.98 Aligned_cols=178 Identities=22% Similarity=0.294 Sum_probs=127.6
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
...+..+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++...... .......+|..
T Consensus 110 ~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~ 184 (311)
T 3niz_A 110 DENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV--RSYTHEVVTLW 184 (311)
T ss_dssp HTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC--C---CCCCCCT
T ss_pred HhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc--ccccCCcccCC
Confidence 445567999999999999999999999998 9999999999999999999999999998764222 22334567999
Q ss_pred CCchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcc---c-------------cc
Q 046010 372 YMAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEAL---E-------------LM 434 (523)
Q Consensus 372 y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~-------------~~ 434 (523)
|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ............... . ..
T Consensus 185 y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (311)
T 3niz_A 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD---QLPKIFSILGTPNPREWPQVQELPLWKQRTFQVF 261 (311)
T ss_dssp TCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT---HHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCC
T ss_pred cCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHHCCCChHHhhhhhccchhhhcccccc
Confidence 999999876 568999999999999999999999986433221 122211111111000 0 00
Q ss_pred CccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH--Hhcc
Q 046010 435 DPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV--MLAS 477 (523)
Q Consensus 435 ~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~ 477 (523)
..............++.+|+.+||+.||++|||++|+++ ++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 262 EKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp CCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred cCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 000000000112246778999999999999999999987 4544
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=7.7e-28 Score=252.56 Aligned_cols=183 Identities=25% Similarity=0.394 Sum_probs=132.5
Q ss_pred cccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccc
Q 046010 284 GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNT 363 (523)
Q Consensus 284 g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 363 (523)
|....++....+..+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++....... ...
T Consensus 263 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~ 338 (452)
T 1fmk_A 263 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TAR 338 (452)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce-ecc
Confidence 44444444344567999999999999999999999998 99999999999999999999999999987543221 112
Q ss_pred cceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCc
Q 046010 364 SKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSC 442 (523)
Q Consensus 364 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 442 (523)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .. ......+... ..
T Consensus 339 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~----~~~i~~~~~~---------~~ 402 (452)
T 1fmk_A 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EV----LDQVERGYRM---------PC 402 (452)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HH----HHHHHTTCCC---------CC
T ss_pred cCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHcCCCC---------CC
Confidence 23446778999999999999999999999999999999 89998532211 11 1111221111 11
Q ss_pred cHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCCCCCCCC
Q 046010 443 MAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTVSLPQPT 486 (523)
Q Consensus 443 ~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~l~~p~ 486 (523)
+......+.+|+.+||+.||++|||+++|+++|+..........
T Consensus 403 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~ 446 (452)
T 1fmk_A 403 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 446 (452)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccc
Confidence 12233567789999999999999999999999998765544333
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=8.9e-29 Score=244.51 Aligned_cols=176 Identities=24% Similarity=0.331 Sum_probs=126.8
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC-ccccceeccCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE-SNTSKVVGTYG 371 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~gt~~ 371 (523)
..+..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++......... .......++..
T Consensus 106 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~ 182 (295)
T 3ugc_A 106 KHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182 (295)
T ss_dssp HCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGG
T ss_pred hcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccc
Confidence 33456999999999999999999999998 999999999999999999999999999876433221 11223345667
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccc---------cccchHHHHHHhhhcCCcccccCccccCCc
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSE---------HGQSLLAYTWKLWCNGEALELMDPVLKQSC 442 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 442 (523)
|+|||.+.+..++.++||||||+++|+|++|..|+...... ................... ..
T Consensus 183 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~ 253 (295)
T 3ugc_A 183 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL---------PR 253 (295)
T ss_dssp GCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCC---------CC
T ss_pred eeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcC---------CC
Confidence 99999999999999999999999999999999987532211 0001111111111111111 11
Q ss_pred cHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCC
Q 046010 443 MAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTV 480 (523)
Q Consensus 443 ~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~ 480 (523)
+......+.+|+.+||+.||++|||+.||++.|+....
T Consensus 254 ~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 254 PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 12233567889999999999999999999999987643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.3e-28 Score=246.80 Aligned_cols=167 Identities=30% Similarity=0.359 Sum_probs=128.1
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
..+..+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...............++..|
T Consensus 205 ~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y 281 (377)
T 3cbl_A 205 TEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKW 281 (377)
T ss_dssp HHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGG
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCc
Confidence 34557999999999999999999999998 999999999999999999999999999864322111112223456789
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
+|||.+.+..++.++||||||+++|||++ |..||...... ........+.... .+......+.
T Consensus 282 ~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~---------~~~~~~~~l~ 345 (377)
T 3cbl_A 282 TAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-------QTREFVEKGGRLP---------CPELCPDAVF 345 (377)
T ss_dssp SCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-------HHHHHHHTTCCCC---------CCTTCCHHHH
T ss_pred CCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCC---------CCCCCCHHHH
Confidence 99999998899999999999999999998 99998543221 1111122211111 1112234677
Q ss_pred HHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 452 HIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+|+.+||+.||++|||+.+|++.|+..
T Consensus 346 ~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 346 RLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 899999999999999999999999764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=236.51 Aligned_cols=173 Identities=22% Similarity=0.237 Sum_probs=126.1
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
......+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++..... .......+|+.
T Consensus 111 ~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~ 184 (308)
T 3g33_A 111 KAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALTPVVVTLW 184 (308)
T ss_dssp TCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSCSCTTTSTTC---CCSGGGGCCCS
T ss_pred hccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeCccccccCCC---cccCCcccccc
Confidence 334445999999999999999999999999 999999999999999999999999999765322 22344678999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCC---ccccc---CccccC--Cc-
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGE---ALELM---DPVLKQ--SC- 442 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~---~~~l~~--~~- 442 (523)
|+|||++.+..++.++||||||+++|+|++|+.||...... .............. ..... ...+.. ..
T Consensus 185 y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (308)
T 3g33_A 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA---DQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRP 261 (308)
T ss_dssp SCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCC
T ss_pred ccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChhhccchhhccccccCCCCCCc
Confidence 99999999999999999999999999999999998543221 11111111111100 00000 000000 00
Q ss_pred ----cHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 443 ----MAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 443 ----~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.......+.+|+.+||+.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 262 VQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0112346778999999999999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-27 Score=237.55 Aligned_cols=180 Identities=24% Similarity=0.275 Sum_probs=128.2
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhc---------CCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC-----
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHED---------SRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE----- 360 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~---------g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~----- 360 (523)
...+++..++.++.||++||.|||++ + |+||||||+|||++.++.+||+|||+++........
T Consensus 105 ~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~ 181 (336)
T 3g2f_A 105 LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181 (336)
T ss_dssp HCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC-----
T ss_pred hcccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEeeccceeecccccccCcccc
Confidence 44569999999999999999999998 8 999999999999999999999999999876432211
Q ss_pred -ccccceeccCCCCchhhhcC-------CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccc-cchH----------HHH
Q 046010 361 -SNTSKVVGTYGYMAPEYALG-------GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHG-QSLL----------AYT 421 (523)
Q Consensus 361 -~~~~~~~gt~~y~aPE~l~~-------~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~-~~~~----------~~~ 421 (523)
.......||..|+|||++.+ ..++.++||||||+++|||++|..||........ .... ...
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (336)
T 3g2f_A 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDM 261 (336)
T ss_dssp ----CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHH
T ss_pred ccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHH
Confidence 11223468999999999976 3566789999999999999999877643222111 1110 111
Q ss_pred HHhhhcCCcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 422 WKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 422 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
............+..... ........+.+|+.+||+.||++|||+.||++.|+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 262 QVLVSREKQRPKFPEAWK--ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp HHHHTTSCCCCCCCTTCC--CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhhhcccccCCCCCcccc--cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 111111111111111111 12235567889999999999999999999999998764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-26 Score=230.39 Aligned_cols=177 Identities=16% Similarity=0.174 Sum_probs=131.5
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEe----CCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLL----DHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 297 ~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll----~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.+++..++.++.||++||.|||+++ |+||||||+||++ +.++.+||+|||+++...... ......||..|
T Consensus 108 ~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y 181 (319)
T 4euu_A 108 GLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEY 181 (319)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC---CBCCCCSCGGG
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCC---ceeecccCCCc
Confidence 3999999999999999999999998 9999999999999 777889999999998764332 22345689999
Q ss_pred Cchhhhc--------CCCCCcchhhHHHHHHHHHHHhCCCCCCCccccccc-chHHHHHHhhhcCCccccc---------
Q 046010 373 MAPEYAL--------GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQ-SLLAYTWKLWCNGEALELM--------- 434 (523)
Q Consensus 373 ~aPE~l~--------~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~--------- 434 (523)
+|||++. +..++.++||||||+++|||++|+.||......... ...................
T Consensus 182 ~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 261 (319)
T 4euu_A 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDW 261 (319)
T ss_dssp CCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEE
T ss_pred cCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCcccc
Confidence 9999886 577899999999999999999999998643332221 1111111111110000000
Q ss_pred --CccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 435 --DPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 435 --~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
.-.............+.+++.+||+.||++|||++|+++....+.
T Consensus 262 ~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 262 SGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp ESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 000111334566677889999999999999999999999988654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=236.91 Aligned_cols=165 Identities=30% Similarity=0.382 Sum_probs=129.6
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++.+++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||++................+++.|+|
T Consensus 144 ~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 220 (314)
T 2ivs_A 144 ERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMA 220 (314)
T ss_dssp -CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCC
T ss_pred ccCcCHHHHHHHHHHHHHHHHHHHHCC---CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccC
Confidence 456999999999999999999999998 99999999999999999999999999987654433333344556788999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||.+.+..++.++||||||+++|+|++ |+.||...... ... ........... +......+.+|
T Consensus 221 PE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~----~~~~~~~~~~~---------~~~~~~~~~~l 284 (314)
T 2ivs_A 221 IESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE---RLF----NLLKTGHRMER---------PDNCSEEMYRL 284 (314)
T ss_dssp HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHH----HHHHTTCCCCC---------CTTCCHHHHHH
T ss_pred hhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHhhcCCcCCC---------CccCCHHHHHH
Confidence 999998889999999999999999999 99998543221 111 11111111111 11223467789
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+.+||+.||++|||+.||++.|++.
T Consensus 285 i~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 285 MLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.94 E-value=9.5e-28 Score=252.05 Aligned_cols=179 Identities=25% Similarity=0.386 Sum_probs=134.8
Q ss_pred ccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcc
Q 046010 283 IGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN 362 (523)
Q Consensus 283 ~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 362 (523)
.|....++.......+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 266 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~ 341 (454)
T 1qcf_A 266 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTA 341 (454)
T ss_dssp TCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-HHT
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-eec
Confidence 344444554445567999999999999999999999998 9999999999999999999999999998653211 111
Q ss_pred ccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCC
Q 046010 363 TSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQS 441 (523)
Q Consensus 363 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 441 (523)
.....++..|+|||.+....++.++||||||+++|||++ |+.||...... .... ....+... .
T Consensus 342 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~----~i~~~~~~---------~ 405 (454)
T 1qcf_A 342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIR----ALERGYRM---------P 405 (454)
T ss_dssp TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHH----HHHHTCCC---------C
T ss_pred cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCC---------C
Confidence 122345678999999998999999999999999999999 99998532211 1111 11111111 0
Q ss_pred ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCCC
Q 046010 442 CMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTVS 481 (523)
Q Consensus 442 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~ 481 (523)
.+......+.+|+.+||+.||++|||+.+|+++|+.....
T Consensus 406 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 406 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 1112235677899999999999999999999999987543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.7e-27 Score=247.22 Aligned_cols=172 Identities=25% Similarity=0.297 Sum_probs=130.9
Q ss_pred ccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcc
Q 046010 283 IGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN 362 (523)
Q Consensus 283 ~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 362 (523)
.|....++.......+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 271 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----- 342 (450)
T 1k9a_A 271 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----- 342 (450)
T ss_dssp TCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-----
Confidence 344444444444445899999999999999999999998 999999999999999999999999999864321
Q ss_pred ccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCC
Q 046010 363 TSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQS 441 (523)
Q Consensus 363 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 441 (523)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... ...+... .
T Consensus 343 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~~----i~~~~~~---------~ 406 (450)
T 1k9a_A 343 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPR----VEKGYKM---------D 406 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT---THHHH----HHTTCCC---------C
T ss_pred ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCCCC---------C
Confidence 122356789999999999999999999999999999998 99998643222 12111 1111111 1
Q ss_pred ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 442 CMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 442 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
.+......+.+||.+||+.||++|||+.+|++.|+..
T Consensus 407 ~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 407 APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1122345677899999999999999999999999764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-27 Score=236.85 Aligned_cols=164 Identities=23% Similarity=0.366 Sum_probs=120.8
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCchh
Q 046010 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPE 376 (523)
Q Consensus 297 ~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE 376 (523)
.+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++...............+++.|+|||
T Consensus 133 ~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE 209 (323)
T 3qup_A 133 NLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALE 209 (323)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHH
T ss_pred ccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCch
Confidence 6999999999999999999999998 9999999999999999999999999998764433333333445677899999
Q ss_pred hhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHhh
Q 046010 377 YALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGL 455 (523)
Q Consensus 377 ~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~ 455 (523)
.+.+..++.++||||||+++|+|++ |+.||...... .... .......... +......+.+|+.
T Consensus 210 ~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~----~~~~~~~~~~---------~~~~~~~l~~li~ 273 (323)
T 3qup_A 210 SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EIYN----YLIGGNRLKQ---------PPECMEEVYDLMY 273 (323)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHH----HHHTTCCCCC---------CTTCCHHHHHHHH
T ss_pred hhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---HHHH----HHhcCCCCCC---------CCccCHHHHHHHH
Confidence 9999999999999999999999999 89988543221 1111 1111111111 1122346778999
Q ss_pred hcccCCCCCCCCHHHHHHHhccCC
Q 046010 456 LCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 456 ~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
+||+.||++|||+.++++.|++..
T Consensus 274 ~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 274 QCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp HTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHccCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999998764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=240.68 Aligned_cols=166 Identities=23% Similarity=0.322 Sum_probs=119.1
Q ss_pred ccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccC
Q 046010 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTY 370 (523)
Q Consensus 291 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~ 370 (523)
+..++..+++.+++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+++...............||+
T Consensus 98 ~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~ 173 (343)
T 3dbq_A 98 WLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 173 (343)
T ss_dssp HHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCC
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCc
Confidence 3455678999999999999999999999998 99999999999997 6789999999998765433333344567999
Q ss_pred CCCchhhhcC-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCcccc
Q 046010 371 GYMAPEYALG-----------GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLK 439 (523)
Q Consensus 371 ~y~aPE~l~~-----------~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 439 (523)
.|+|||++.+ ..++.++||||||+++|+|++|+.||..... ...............+
T Consensus 174 ~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~~~~~~~~------- 241 (343)
T 3dbq_A 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDPNHEIE------- 241 (343)
T ss_dssp SSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHCTTSCCC-------
T ss_pred CcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHHHhcCCcccC-------
Confidence 9999999865 6788999999999999999999999853221 1111111111111111
Q ss_pred CCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 440 QSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 440 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
.+......+.+|+.+||+.||.+|||+.|+++.
T Consensus 242 --~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 242 --FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp --CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 111112356788999999999999999999753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=232.38 Aligned_cols=178 Identities=24% Similarity=0.290 Sum_probs=128.4
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhc--------CCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCc--ccc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHED--------SRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES--NTS 364 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~--------g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~--~~~ 364 (523)
+..+++..++.++.||+.||.|||++ + |+||||||+||+++.++.+||+|||++.......... ...
T Consensus 128 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 204 (337)
T 3mdy_A 128 STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204 (337)
T ss_dssp HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEECCCTTCEECC---------CC
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCC
Confidence 45799999999999999999999998 7 9999999999999999999999999998764332221 122
Q ss_pred ceeccCCCCchhhhcCCCCCcc------hhhHHHHHHHHHHHhC----------CCCCCCcccccccchHHHHHHhhhcC
Q 046010 365 KVVGTYGYMAPEYALGGVISVK------SDVFSFGVLLLEIISG----------KKNSGFYLSEHGQSLLAYTWKLWCNG 428 (523)
Q Consensus 365 ~~~gt~~y~aPE~l~~~~~s~k------sDVwSlGvvl~elltG----------~~p~~~~~~~~~~~~~~~~~~~~~~~ 428 (523)
...||..|+|||.+.+.....+ +||||||+++|||++| +.||........ ............
T Consensus 205 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~--~~~~~~~~~~~~ 282 (337)
T 3mdy_A 205 TRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP--SYEDMREIVCIK 282 (337)
T ss_dssp SSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC--CHHHHHHHHTTS
T ss_pred CCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC--chhhhHHHHhhh
Confidence 4578999999999987766655 9999999999999999 555543222211 111111111111
Q ss_pred CcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCC
Q 046010 429 EALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTV 480 (523)
Q Consensus 429 ~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~ 480 (523)
.....+.... ........+.+|+.+||+.||++|||+.||++.|++...
T Consensus 283 ~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 283 KLRPSFPNRW---SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp CCCCCCCGGG---GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCccccccc---hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 1111111111 122556778899999999999999999999999987643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-27 Score=236.65 Aligned_cols=171 Identities=26% Similarity=0.344 Sum_probs=125.3
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.....+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||++................+++.|
T Consensus 139 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y 215 (313)
T 3brb_A 139 TGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215 (313)
T ss_dssp TSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGG
T ss_pred cCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccc
Confidence 34567999999999999999999999998 999999999999999999999999999876433322233345567889
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
+|||.+.+..++.++||||||+++|+|++ |..||...... .... ....+..... +......+.
T Consensus 216 ~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~----~~~~~~~~~~---------~~~~~~~l~ 279 (313)
T 3brb_A 216 IAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMYD----YLLHGHRLKQ---------PEDCLDELY 279 (313)
T ss_dssp SCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHH----HHHTTCCCCC---------BTTCCHHHH
T ss_pred cCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHH----HHHcCCCCCC---------CccccHHHH
Confidence 99999999999999999999999999999 88887543221 1111 1111111111 112234677
Q ss_pred HHhhhcccCCCCCCCCHHHHHHHhccCCCCC
Q 046010 452 HIGLLCVQEDPADRPNMSSVAVMLASDTVSL 482 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~~L~~~~~~l 482 (523)
+++.+||+.||++|||+.+|++.|+.....+
T Consensus 280 ~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 280 EIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 8999999999999999999999998765443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-27 Score=235.48 Aligned_cols=167 Identities=28% Similarity=0.428 Sum_probs=130.3
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||++................+++.|+|
T Consensus 139 ~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 215 (313)
T 1t46_A 139 ELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMA 215 (313)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCC
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeC
Confidence 346999999999999999999999998 99999999999999999999999999987654443333445567889999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||.+.+..++.++||||||+++|+|++ |+.||...... ... .......... . . +......+.+|
T Consensus 216 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~----~~~~~~~~~~-~----~----~~~~~~~l~~l 280 (313)
T 1t46_A 216 PESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--SKF----YKMIKEGFRM-L----S----PEHAPAEMYDI 280 (313)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--HHH----HHHHHHTCCC-C----C----CTTSCHHHHHH
T ss_pred hHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch--hHH----HHHhccCCCC-C----C----cccCCHHHHHH
Confidence 999999999999999999999999999 99998543221 111 1111111100 0 0 11123467789
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
+.+||+.||.+|||+.||++.|++..
T Consensus 281 i~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 281 MKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 99999999999999999999998753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=226.96 Aligned_cols=170 Identities=24% Similarity=0.308 Sum_probs=131.3
Q ss_pred cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcccccee
Q 046010 288 PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVV 367 (523)
Q Consensus 288 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 367 (523)
.++.......+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++....... ......
T Consensus 109 ~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~ 182 (284)
T 2a19_B 109 QWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG---KRTRSK 182 (284)
T ss_dssp HHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEESSCCS---CCCCCC
T ss_pred HHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECcchhheeccccc---cccccC
Confidence 4444445578999999999999999999999998 9999999999999999999999999998764332 223456
Q ss_pred ccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHH
Q 046010 368 GTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAEL 447 (523)
Q Consensus 368 gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 447 (523)
+++.|+|||.+.+..++.++||||||+++|+|++|..|+... .............. . ..
T Consensus 183 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~~~~~~~~~~~~--------~----~~ 241 (284)
T 2a19_B 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SKFFTDLRDGIISD--------I----FD 241 (284)
T ss_dssp SCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHHHHHHHTTCCCT--------T----SC
T ss_pred CcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HHHHHHhhcccccc--------c----CC
Confidence 899999999999999999999999999999999999885210 11111222222111 1 12
Q ss_pred HHHHHHhhhcccCCCCCCCCHHHHHHHhccCCCCCCC
Q 046010 448 LKCIHIGLLCVQEDPADRPNMSSVAVMLASDTVSLPQ 484 (523)
Q Consensus 448 ~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~l~~ 484 (523)
..+.+++.+||+.||++|||+.|+++.|.........
T Consensus 242 ~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 242 KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 3466888999999999999999999999887655443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-27 Score=237.80 Aligned_cols=168 Identities=27% Similarity=0.393 Sum_probs=127.6
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCc-cccceeccCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES-NTSKVVGTYG 371 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~gt~~ 371 (523)
.....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++......... ......+|+.
T Consensus 143 ~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~ 219 (325)
T 3kul_A 143 THDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR 219 (325)
T ss_dssp TTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGG
T ss_pred hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCccc
Confidence 44567999999999999999999999998 9999999999999999999999999998764332221 2223345678
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
|+|||.+.+..++.++||||||+++|+|++ |+.||...... .. ........... .+......+
T Consensus 220 y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~----~~~~~~~~~~~---------~~~~~~~~l 283 (325)
T 3kul_A 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DV----ISSVEEGYRLP---------APMGCPHAL 283 (325)
T ss_dssp GSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HH----HHHHHTTCCCC---------CCTTCCHHH
T ss_pred ccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HH----HHHHHcCCCCC---------CCCCcCHHH
Confidence 999999998899999999999999999999 99998532211 11 11111111111 111223467
Q ss_pred HHHhhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 451 IHIGLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
.+|+.+||+.||++|||+.+|+++|+...
T Consensus 284 ~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 284 HQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 78999999999999999999999998764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=242.70 Aligned_cols=187 Identities=22% Similarity=0.222 Sum_probs=128.7
Q ss_pred eEeeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCC
Q 046010 278 AIWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGN 357 (523)
Q Consensus 278 ~~~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 357 (523)
.+++.+.++-..++..-...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 141 ~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217 (464)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred eEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence 45555555553333333456999999999999999999999998 999999999999999999999999999875422
Q ss_pred CCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHh-------------
Q 046010 358 QNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKL------------- 424 (523)
Q Consensus 358 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~------------- 424 (523)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+......
T Consensus 218 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~---~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 218 ---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID---QWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCSCCHHHHTTSC
T ss_pred ---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHHHHHHcc
Confidence 22345678999999999999999999999999999999999999986432111 11000000
Q ss_pred ------hhcC-C-----cccccCccccC-C--ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 425 ------WCNG-E-----ALELMDPVLKQ-S--CMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 425 ------~~~~-~-----~~~~~~~~l~~-~--~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.... . ....+...+.. . ........+.+|+.+||+.||++|||++|+++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 0 00000110000 0 01122456889999999999999999999976
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-27 Score=250.62 Aligned_cols=176 Identities=23% Similarity=0.323 Sum_probs=133.8
Q ss_pred cccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccc
Q 046010 284 GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNT 363 (523)
Q Consensus 284 g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 363 (523)
|....++....+..+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 301 g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~ 376 (495)
T 1opk_A 301 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAH 376 (495)
T ss_dssp CBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-EECC
T ss_pred CCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc-eeec
Confidence 33334444445567999999999999999999999998 9999999999999999999999999998764322 1122
Q ss_pred cceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCc
Q 046010 364 SKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSC 442 (523)
Q Consensus 364 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 442 (523)
....++..|+|||.+.+..++.++||||||+++|||++ |..||...... .... ....+... ..
T Consensus 377 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~~~---------~~ 440 (495)
T 1opk_A 377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYE----LLEKDYRM---------ER 440 (495)
T ss_dssp TTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHH----HHHTTCCC---------CC
T ss_pred CCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCC---------CC
Confidence 23445678999999998899999999999999999999 88888543221 1111 11111111 11
Q ss_pred cHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 443 MAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 443 ~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
+......+.+|+.+||+.||++|||+.+|+++|+...
T Consensus 441 ~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 441 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 1223356778999999999999999999999998864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-27 Score=233.25 Aligned_cols=176 Identities=26% Similarity=0.396 Sum_probs=132.3
Q ss_pred ccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcccc
Q 046010 285 TTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTS 364 (523)
Q Consensus 285 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 364 (523)
....++.......+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||.+........ ....
T Consensus 93 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 168 (279)
T 1qpc_A 93 SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TARE 168 (279)
T ss_dssp BHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECCT
T ss_pred CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc-cccc
Confidence 3334443333447999999999999999999999998 99999999999999999999999999987643221 1222
Q ss_pred ceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCcc
Q 046010 365 KVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCM 443 (523)
Q Consensus 365 ~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 443 (523)
...++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... .. ......+.... . +
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~----~~~~~~~~~~~-----~----~ 232 (279)
T 1qpc_A 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EV----IQNLERGYRMV-----R----P 232 (279)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HH----HHHHHTTCCCC-----C----C
T ss_pred CCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HH----HHHHhcccCCC-----C----c
Confidence 3456778999999998889999999999999999999 88887532211 11 11111111110 0 1
Q ss_pred HHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCC
Q 046010 444 AAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTV 480 (523)
Q Consensus 444 ~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~ 480 (523)
......+.+++.+||+.||++|||+.+|++.|+....
T Consensus 233 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 1223467789999999999999999999999987643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=240.05 Aligned_cols=169 Identities=27% Similarity=0.356 Sum_probs=129.5
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++.+++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++...............+++.|+|
T Consensus 168 ~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~a 244 (343)
T 1luf_A 168 PPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMP 244 (343)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecC
Confidence 367999999999999999999999998 99999999999999999999999999986543322223334567889999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||.+.+..++.++||||||+++|+|++ |..||...... ........+..... +......+.+|
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~~---------~~~~~~~l~~l 308 (343)
T 1luf_A 245 PESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE-------EVIYYVRDGNILAC---------PENCPLELYNL 308 (343)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HHHHHHHTTCCCCC---------CTTCCHHHHHH
T ss_pred hhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChH-------HHHHHHhCCCcCCC---------CCCCCHHHHHH
Confidence 999999999999999999999999999 99998532211 11112222222111 11223467789
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccCCCCC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASDTVSL 482 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~~~~l 482 (523)
+.+||+.||++|||+.+|++.|++.....
T Consensus 309 i~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 309 MRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred HHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 99999999999999999999999875443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-27 Score=235.61 Aligned_cols=157 Identities=22% Similarity=0.296 Sum_probs=120.3
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
...+..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....... ......||+.
T Consensus 148 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~ 221 (311)
T 3p1a_A 148 EAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG---AGEVQEGDPR 221 (311)
T ss_dssp HHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGG
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccCC---CCcccCCCcc
Confidence 344567999999999999999999999998 9999999999999999999999999998754322 2334568999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||++.+ .++.++||||||+++|||++|..|+... ..+.....+.. .+.+.. .....+.
T Consensus 222 y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~~~~~~~~~----~~~~~~----~~~~~l~ 282 (311)
T 3p1a_A 222 YMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----------EGWQQLRQGYL----PPEFTA----GLSSELR 282 (311)
T ss_dssp GCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHHHHHTTTCC----CHHHHT----TSCHHHH
T ss_pred ccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHHHHHhccCC----Cccccc----CCCHHHH
Confidence 999998875 7899999999999999999997765321 11222222111 111111 1234678
Q ss_pred HHhhhcccCCCCCCCCHHHHHH
Q 046010 452 HIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+++.+||+.||++|||+.|+++
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 283 SVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHcCCChhhCcCHHHHHh
Confidence 8999999999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4e-27 Score=229.16 Aligned_cols=168 Identities=26% Similarity=0.372 Sum_probs=129.0
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
..+..+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||.+........ .......++..|
T Consensus 96 ~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y 171 (268)
T 3sxs_A 96 SHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VSSVGTKFPVKW 171 (268)
T ss_dssp HHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-EECCSCCCCGGG
T ss_pred HcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh-hcccCCCcCccc
Confidence 34556999999999999999999999998 99999999999999999999999999987643322 122234456679
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
+|||.+.+..++.++||||||+++|+|++ |+.||...... .... ........ ..+ ......+.
T Consensus 172 ~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~-~~~~~~~~--~~~-------~~~~~~l~ 235 (268)
T 3sxs_A 172 SAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------EVVL-KVSQGHRL--YRP-------HLASDTIY 235 (268)
T ss_dssp CCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHH-HHHTTCCC--CCC-------TTSCHHHH
T ss_pred CCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH------HHHH-HHHcCCCC--CCC-------CcChHHHH
Confidence 99999998889999999999999999999 99998533221 1111 11111111 011 11123577
Q ss_pred HHhhhcccCCCCCCCCHHHHHHHhccCCC
Q 046010 452 HIGLLCVQEDPADRPNMSSVAVMLASDTV 480 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~~L~~~~~ 480 (523)
+++.+||+.||++|||+.||++.|+....
T Consensus 236 ~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 236 QIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 88999999999999999999999988643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-27 Score=242.77 Aligned_cols=165 Identities=29% Similarity=0.363 Sum_probs=127.1
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC---CeeEeccccceeccCCCCCccccceeccCCC
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM---NPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~---~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
..+++..++.++.||++||.|||+++ |+||||||+|||++.++ .+||+|||+++...............+|+.|
T Consensus 176 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y 252 (367)
T 3l9p_A 176 SSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252 (367)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGG
T ss_pred ccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccE
Confidence 56999999999999999999999998 99999999999999655 4999999999865332222333445678899
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
+|||++.+..++.++||||||+++|||++ |..||...... . .......+..... +......+.
T Consensus 253 ~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~----~~~~i~~~~~~~~---------~~~~~~~l~ 316 (367)
T 3l9p_A 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---E----VLEFVTSGGRMDP---------PKNCPGPVY 316 (367)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H----HHHHHHTTCCCCC---------CTTCCHHHH
T ss_pred ECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---H----HHHHHHcCCCCCC---------CccCCHHHH
Confidence 99999999999999999999999999998 99998532211 1 1111222111111 112234577
Q ss_pred HHhhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 452 HIGLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
+|+.+||+.||++|||+.+|++.|+...
T Consensus 317 ~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 317 RIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 8999999999999999999999997653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=227.92 Aligned_cols=171 Identities=24% Similarity=0.349 Sum_probs=126.5
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.+...+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||++....... ........||+.|
T Consensus 103 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y 178 (294)
T 4eqm_A 103 ESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-LTQTNHVLGTVQY 178 (294)
T ss_dssp HHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--------------CCSS
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccccc-ccccCccccCccc
Confidence 45567999999999999999999999998 9999999999999999999999999997653222 1223345789999
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
+|||.+.+..++.++||||||+++|+|++|+.||..... .......... ..... ..... ......+.+
T Consensus 179 ~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~-~~~~~-~~~~~----~~~~~~l~~ 246 (294)
T 4eqm_A 179 FSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQD-SVPNV-TTDVR----KDIPQSLSN 246 (294)
T ss_dssp CCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSS-CCCCH-HHHSC----TTSCHHHHH
T ss_pred cCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhc-cCCCc-chhcc----cCCCHHHHH
Confidence 999999999999999999999999999999999853221 1111222211 11110 00111 122346778
Q ss_pred HhhhcccCCCCCCC-CHHHHHHHhccCC
Q 046010 453 IGLLCVQEDPADRP-NMSSVAVMLASDT 479 (523)
Q Consensus 453 li~~cl~~dP~~RP-s~~ei~~~L~~~~ 479 (523)
++.+||+.||++|| ++.++.+.|+...
T Consensus 247 li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 247 VILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred HHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 99999999999998 9999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-26 Score=230.43 Aligned_cols=159 Identities=26% Similarity=0.343 Sum_probs=124.4
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+...+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||++...... .......||+.
T Consensus 105 l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~ 178 (328)
T 3fe3_A 105 LVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDAFCGAPP 178 (328)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS---CGGGTTSSSGG
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC---CccccccCCcc
Confidence 345567999999999999999999999998 999999999999999999999999999765432 22345678999
Q ss_pred CCchhhhcCCCCC-cchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 372 YMAPEYALGGVIS-VKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 372 y~aPE~l~~~~~s-~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
|+|||++.+..+. .++||||||+++|+|++|+.||..... ....... ..+... + +......+
T Consensus 179 y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i-~~~~~~------~----p~~~s~~~ 241 (328)
T 3fe3_A 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL------KELRERV-LRGKYR------I----PFYMSTDC 241 (328)
T ss_dssp GCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHH-HHCCCC------C----CTTSCHHH
T ss_pred eeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH------HHHHHHH-HhCCCC------C----CCCCCHHH
Confidence 9999999887765 799999999999999999999853221 1111111 111110 0 11122456
Q ss_pred HHHhhhcccCCCCCCCCHHHHHH
Q 046010 451 IHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+|+.+||+.||.+|||++|+++
T Consensus 242 ~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 242 ENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp HHHHHHHCCSSTTTSCCHHHHTT
T ss_pred HHHHHHHCCCChhHCcCHHHHhc
Confidence 78899999999999999999976
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-26 Score=226.57 Aligned_cols=175 Identities=21% Similarity=0.233 Sum_probs=126.0
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
...+..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++...... .......+|..
T Consensus 92 ~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~ 166 (292)
T 3o0g_A 92 DSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCYSAEVVTLW 166 (292)
T ss_dssp HHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--SCCCSCCSCGG
T ss_pred HhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc--ccccCCccccC
Confidence 444678999999999999999999999998 9999999999999999999999999998764222 22334577899
Q ss_pred CCchhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCccccc------C---------
Q 046010 372 YMAPEYALGGV-ISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELM------D--------- 435 (523)
Q Consensus 372 y~aPE~l~~~~-~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~--------- 435 (523)
|+|||.+.+.. ++.++||||||+++|+|++|+.||.... ...................... +
T Consensus 167 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (292)
T 3o0g_A 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPA 244 (292)
T ss_dssp GCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCT
T ss_pred CcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC--CHHHHHHHHHHHhCCCChhhhhhhcccccccccccccC
Confidence 99999998766 7999999999999999999998863221 1112222222211111100000 0
Q ss_pred ccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 436 PVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 436 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
..............+.+|+.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 245 TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000011122346678999999999999999999976
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-26 Score=229.14 Aligned_cols=183 Identities=26% Similarity=0.312 Sum_probs=122.4
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCC---CCccccceecc
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ---NESNTSKVVGT 369 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~---~~~~~~~~~gt 369 (523)
..+..+++..++.++.||++||+|||+++ |+||||||+||+++ ++.+||+|||++....... .........|+
T Consensus 122 ~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~ 197 (319)
T 2y4i_B 122 DAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGW 197 (319)
T ss_dssp SSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGG
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCc
Confidence 34457999999999999999999999998 99999999999998 6799999999987543211 11222345688
Q ss_pred CCCCchhhhcC---------CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccC
Q 046010 370 YGYMAPEYALG---------GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQ 440 (523)
Q Consensus 370 ~~y~aPE~l~~---------~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 440 (523)
..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ...+. ...+.........
T Consensus 198 ~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~-~~~~~~~~~~~~~--- 267 (319)
T 2y4i_B 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE------AIIWQ-MGTGMKPNLSQIG--- 267 (319)
T ss_dssp GGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH------HHHHH-HHTTCCCCCCCSS---
T ss_pred ccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-hccCCCCCCCcCC---
Confidence 99999999874 45788999999999999999999998532211 11111 1111111111111
Q ss_pred CccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCCCCCCCCCCCccccc
Q 046010 441 SCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTVSLPQPTQPAFSVGR 494 (523)
Q Consensus 441 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~l~~p~~p~~~~~~ 494 (523)
....+.+|+.+||+.||++|||+.+|+++|+...........|..++..
T Consensus 268 -----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~~ 316 (319)
T 2y4i_B 268 -----MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKS 316 (319)
T ss_dssp -----CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----------------
T ss_pred -----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccccc
Confidence 1234678899999999999999999999999987777666666666543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-27 Score=237.00 Aligned_cols=175 Identities=20% Similarity=0.205 Sum_probs=115.4
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCc----------cc
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES----------NT 363 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~----------~~ 363 (523)
.+..+++..++.++.||+.||.|||+++ .+|+||||||+|||++.++.+||+|||++.......... ..
T Consensus 129 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~ 207 (337)
T 3ll6_A 129 SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207 (337)
T ss_dssp TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC---------------
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhh
Confidence 4567999999999999999999999884 349999999999999999999999999998764322211 11
Q ss_pred cceeccCCCCchhhh---cCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccC
Q 046010 364 SKVVGTYGYMAPEYA---LGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQ 440 (523)
Q Consensus 364 ~~~~gt~~y~aPE~l---~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 440 (523)
....+++.|+|||++ .+..++.++||||||+++|+|++|+.||....... .. ........
T Consensus 208 ~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~-----~~~~~~~~------ 270 (337)
T 3ll6_A 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR------IV-----NGKYSIPP------ 270 (337)
T ss_dssp ----------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------------------CCCCT------
T ss_pred ccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH------hh-----cCcccCCc------
Confidence 234588999999998 56678999999999999999999999985321110 00 00000000
Q ss_pred CccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCCCCCCCCCC
Q 046010 441 SCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTVSLPQPTQP 488 (523)
Q Consensus 441 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~l~~p~~p 488 (523)
.......+.+|+.+||+.||++|||+.|+++.|+........++.+
T Consensus 271 --~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~ 316 (337)
T 3ll6_A 271 --HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKS 316 (337)
T ss_dssp --TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred --ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCc
Confidence 0011123567889999999999999999999998875544443333
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-27 Score=242.25 Aligned_cols=165 Identities=22% Similarity=0.328 Sum_probs=119.8
Q ss_pred ccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccC
Q 046010 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTY 370 (523)
Q Consensus 291 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~ 370 (523)
+..+...+++.+++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+++.+.............||+
T Consensus 145 ~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~ 220 (390)
T 2zmd_A 145 WLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAV 220 (390)
T ss_dssp HHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCG
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCC
Confidence 3445568999999999999999999999998 99999999999995 5889999999998764433332334567999
Q ss_pred CCCchhhhcC-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCcccc
Q 046010 371 GYMAPEYALG-----------GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLK 439 (523)
Q Consensus 371 ~y~aPE~l~~-----------~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 439 (523)
.|+|||++.+ ..++.++|||||||++|+|++|+.||..... .................
T Consensus 221 ~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~~~~~~~~~~------ 289 (390)
T 2zmd_A 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDPNHEIEF------ 289 (390)
T ss_dssp GGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHHCTTSCCCC------
T ss_pred CccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHHhCccccCCC------
Confidence 9999999865 3688999999999999999999999853221 11111111111111110
Q ss_pred CCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 440 QSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 440 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+......+.+|+.+||+.||++|||+.||++
T Consensus 290 ---~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 290 ---PDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp ---CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---CccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 1111235678899999999999999999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=230.74 Aligned_cols=171 Identities=28% Similarity=0.404 Sum_probs=125.4
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHh---cCCCcEEecCCCCCcEEeCCCCC-eeEeccccceeccCCCCCccccceeccCCC
Q 046010 297 QLDWKRRISIINGIARGLLYLHE---DSRLKVFHRDLKASNVLLDHEMN-PKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 297 ~l~~~~~~~i~~qi~~aL~~LH~---~g~~~ivH~Dlkp~NIll~~~~~-~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.+++..++.++.||++||.|||+ ++ |+||||||+||+++.++. +||+|||++...... .....|+..|
T Consensus 98 ~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y 169 (307)
T 2eva_A 98 YYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAW 169 (307)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTS
T ss_pred ccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEcccccccccccc-----cccCCCCCce
Confidence 48899999999999999999999 66 999999999999998887 799999999764321 2234689999
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
+|||.+.+..++.++||||||+++|+|++|+.||...... .....+... .+..... .. .....+.+
T Consensus 170 ~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~-~~~~~~~-----~~----~~~~~l~~ 235 (307)
T 2eva_A 170 MAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP----AFRIMWAVH-NGTRPPL-----IK----NLPKPIES 235 (307)
T ss_dssp SCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS----HHHHHHHHH-TTCCCCC-----BT----TCCHHHHH
T ss_pred EChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc----HHHHHHHHh-cCCCCCc-----cc----ccCHHHHH
Confidence 9999999999999999999999999999999998643221 111112111 1111111 11 12245678
Q ss_pred HhhhcccCCCCCCCCHHHHHHHhccCCCCCCCCCCCC
Q 046010 453 IGLLCVQEDPADRPNMSSVAVMLASDTVSLPQPTQPA 489 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~~L~~~~~~l~~p~~p~ 489 (523)
|+.+||+.||++|||+.||++.|+......+.+..|.
T Consensus 236 li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~ 272 (307)
T 2eva_A 236 LMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 272 (307)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCC
T ss_pred HHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcc
Confidence 9999999999999999999999998766555544443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-26 Score=231.23 Aligned_cols=164 Identities=28% Similarity=0.365 Sum_probs=129.6
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCchh
Q 046010 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPE 376 (523)
Q Consensus 297 ~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE 376 (523)
.+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++...............+++.|+|||
T Consensus 144 ~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE 220 (316)
T 2xir_A 144 FLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 220 (316)
T ss_dssp CEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHH
T ss_pred ccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCch
Confidence 3899999999999999999999998 9999999999999999999999999998765444333444567788999999
Q ss_pred hhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHhh
Q 046010 377 YALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGL 455 (523)
Q Consensus 377 ~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~ 455 (523)
.+.+..++.++||||||+++|+|++ |..||...... . ........+..... +......+.+++.
T Consensus 221 ~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~----~~~~~~~~~~~~~~---------~~~~~~~l~~li~ 285 (316)
T 2xir_A 221 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--E----EFCRRLKEGTRMRA---------PDYTTPEMYQTML 285 (316)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--H----HHHHHHHHTCCCCC---------CTTCCHHHHHHHH
T ss_pred hhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh--H----HHHHHhccCccCCC---------CCCCCHHHHHHHH
Confidence 9999999999999999999999998 99998543221 1 11111221111111 1112345778899
Q ss_pred hcccCCCCCCCCHHHHHHHhccC
Q 046010 456 LCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 456 ~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+||+.||.+|||+.||++.|+..
T Consensus 286 ~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 286 DCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999865
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-27 Score=233.88 Aligned_cols=173 Identities=27% Similarity=0.304 Sum_probs=129.4
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCC--Cccccceecc
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQN--ESNTSKVVGT 369 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~~~gt 369 (523)
......+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++....... ........++
T Consensus 115 ~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 191 (298)
T 3pls_A 115 RSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP 191 (298)
T ss_dssp HCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCG
T ss_pred hccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCC
Confidence 344677999999999999999999999998 99999999999999999999999999976532211 1122334567
Q ss_pred CCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 370 ~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
..|+|||.+.+..++.++||||||+++|+|++|+.|+..... ........ ........ +......
T Consensus 192 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~~~~~----~~~~~~~~---------~~~~~~~ 256 (298)
T 3pls_A 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDLTHFL----AQGRRLPQ---------PEYCPDS 256 (298)
T ss_dssp GGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGHHHHH----HTTCCCCC---------CTTCCHH
T ss_pred ccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHHHHHh----hcCCCCCC---------CccchHH
Confidence 889999999999999999999999999999997666432211 11111111 11111100 1112246
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHHHhccCCCCC
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAVMLASDTVSL 482 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~l 482 (523)
+.+++.+||+.||.+|||+.+|+++|++....+
T Consensus 257 l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 257 LYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 778999999999999999999999998764433
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-27 Score=240.83 Aligned_cols=167 Identities=25% Similarity=0.391 Sum_probs=117.9
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCc-cccceeccCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES-NTSKVVGTYG 371 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~gt~~ 371 (523)
..+..+++.+++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++......... ......++..
T Consensus 139 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~ 215 (373)
T 2qol_A 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215 (373)
T ss_dssp TTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------------------CT
T ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCC
Confidence 44567999999999999999999999998 9999999999999999999999999998764332211 1222345678
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
|+|||.+.+..++.++||||||+++|||++ |+.||...... ... .....+. ....+......+
T Consensus 216 y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~~----~~i~~~~---------~~~~~~~~~~~l 279 (373)
T 2qol_A 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DVI----KAVDEGY---------RLPPPMDCPAAL 279 (373)
T ss_dssp TSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HHH----HHHHTTE---------ECCCCTTCBHHH
T ss_pred ccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCC---------CCCCCccccHHH
Confidence 999999999999999999999999999998 99998532211 111 1111111 111111234567
Q ss_pred HHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 451 IHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
.+|+.+||+.||++||++.+|+++|++.
T Consensus 280 ~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 280 YQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 8899999999999999999999999865
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=227.45 Aligned_cols=167 Identities=23% Similarity=0.417 Sum_probs=126.8
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCC-----eeEeccccceeccCCCCCccccce
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMN-----PKISDFGMARIFGGNQNESNTSKV 366 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~-----~kL~Dfg~a~~~~~~~~~~~~~~~ 366 (523)
..+...+++..++.++.||+.||+|||+++ .+|+||||||+||+++.++. +||+|||+++.... .....
T Consensus 113 ~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~ 186 (287)
T 4f0f_A 113 LDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGL 186 (287)
T ss_dssp HCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS-----CEECC
T ss_pred hcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc-----ccccc
Confidence 345568999999999999999999999985 34999999999999988776 99999999975322 23346
Q ss_pred eccCCCCchhhhc--CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccH
Q 046010 367 VGTYGYMAPEYAL--GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMA 444 (523)
Q Consensus 367 ~gt~~y~aPE~l~--~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 444 (523)
.+++.|+|||.+. ...++.++||||||+++|+|++|+.||....... ............... + +.
T Consensus 187 ~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~-----~----~~ 253 (287)
T 4f0f_A 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIREEGLRPT-----I----PE 253 (287)
T ss_dssp CCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----HHHHHHHHHSCCCCC-----C----CT
T ss_pred CCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----HHHHHHHhccCCCCC-----C----Cc
Confidence 7899999999984 4557899999999999999999999986433221 111111111111111 1 11
Q ss_pred HHHHHHHHHhhhcccCCCCCCCCHHHHHHHhcc
Q 046010 445 AELLKCIHIGLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 445 ~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
.....+.+++.+||+.||++|||+.||++.|++
T Consensus 254 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 254 DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 223467789999999999999999999999976
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-26 Score=236.36 Aligned_cols=175 Identities=21% Similarity=0.229 Sum_probs=129.3
Q ss_pred ccccccccCHHHHHHHHHHHHHHHHHHHhc-CCCcEEecCCCCCcEEeCCCC----------------------------
Q 046010 291 YSTRRAQLDWKRRISIINGIARGLLYLHED-SRLKVFHRDLKASNVLLDHEM---------------------------- 341 (523)
Q Consensus 291 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-g~~~ivH~Dlkp~NIll~~~~---------------------------- 341 (523)
.......+++..++.++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 136 ~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (397)
T 1wak_A 136 IKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212 (397)
T ss_dssp HHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHHHHHC-----------------
T ss_pred HhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCcccc
Confidence 334446799999999999999999999998 8 99999999999999775
Q ss_pred ---------------------CeeEeccccceeccCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHH
Q 046010 342 ---------------------NPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEII 400 (523)
Q Consensus 342 ---------------------~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ell 400 (523)
.+||+|||++...... .....||..|+|||++.+..++.++|||||||++|+|+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 287 (397)
T 1wak_A 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELA 287 (397)
T ss_dssp ----CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHH
T ss_pred CCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHh
Confidence 7999999999875322 23457899999999999999999999999999999999
Q ss_pred hCCCCCCCcccccccch---HHHHHHhhhc--------CCc-ccccCc---------c----------ccCCccHHHHHH
Q 046010 401 SGKKNSGFYLSEHGQSL---LAYTWKLWCN--------GEA-LELMDP---------V----------LKQSCMAAELLK 449 (523)
Q Consensus 401 tG~~p~~~~~~~~~~~~---~~~~~~~~~~--------~~~-~~~~~~---------~----------l~~~~~~~~~~~ 449 (523)
+|+.||........... .......... ... .+.+.. . -....+......
T Consensus 288 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (397)
T 1wak_A 288 TGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAG 367 (397)
T ss_dssp HSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHH
T ss_pred hCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHH
Confidence 99999975443322111 1111111000 000 000000 0 001224566678
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHH
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+.+|+.+||+.||++|||+.||++
T Consensus 368 ~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 368 FTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHhccChhhcCCHHHHhh
Confidence 899999999999999999999985
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.6e-26 Score=224.27 Aligned_cols=160 Identities=23% Similarity=0.290 Sum_probs=122.1
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
....+++.+++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||++....... .......||+.|+
T Consensus 130 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~ 204 (298)
T 2zv2_A 130 TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFM 204 (298)
T ss_dssp CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCcccc
Confidence 4567999999999999999999999998 9999999999999999999999999998764322 2233457899999
Q ss_pred chhhhcCCC---CCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 374 APEYALGGV---ISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 374 aPE~l~~~~---~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
|||.+.+.. ++.++||||||+++|+|++|+.||.... ..... ......... ... .. .....+
T Consensus 205 aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~~~-~~~~~~~~~-~~~---~~----~~~~~l 269 (298)
T 2zv2_A 205 APESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER------IMCLH-SKIKSQALE-FPD---QP----DIAEDL 269 (298)
T ss_dssp CGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHH-HHHHHCCCC-CCS---SS----CCCHHH
T ss_pred ChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc------HHHHH-HHHhcccCC-CCC---cc----ccCHHH
Confidence 999987655 4788999999999999999999985321 11111 111111111 000 01 122457
Q ss_pred HHHhhhcccCCCCCCCCHHHHHH
Q 046010 451 IHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+|+.+||+.||++|||+.||++
T Consensus 270 ~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 270 KDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHHhhcChhhCCCHHHHhc
Confidence 78899999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.93 E-value=4.2e-26 Score=222.25 Aligned_cols=165 Identities=30% Similarity=0.435 Sum_probs=121.9
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC--------CCCeeEeccccceeccCCCCCccccc
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH--------EMNPKISDFGMARIFGGNQNESNTSK 365 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~--------~~~~kL~Dfg~a~~~~~~~~~~~~~~ 365 (523)
++..+++..++.++.||++||.|||+++..+|+||||||+||+++. ++.+||+|||.+....... ...
T Consensus 98 ~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~ 173 (271)
T 3dtc_A 98 SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMS 173 (271)
T ss_dssp TSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---------------
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc----ccC
Confidence 3567999999999999999999999997555889999999999986 6779999999998653222 224
Q ss_pred eeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHH
Q 046010 366 VVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAA 445 (523)
Q Consensus 366 ~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 445 (523)
..++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ............... .+..
T Consensus 174 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~---------~~~~ 238 (271)
T 3dtc_A 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG------LAVAYGVAMNKLALP---------IPST 238 (271)
T ss_dssp --CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH------HHHHHHHHTSCCCCC---------CCTT
T ss_pred CCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHhhhcCCCCCC---------CCcc
Confidence 5688999999999999999999999999999999999999853221 111111111111111 1112
Q ss_pred HHHHHHHHhhhcccCCCCCCCCHHHHHHHhcc
Q 046010 446 ELLKCIHIGLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 446 ~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
....+.+++.+||+.||++|||+.||++.|++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 23467789999999999999999999999975
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.4e-26 Score=226.69 Aligned_cols=160 Identities=21% Similarity=0.331 Sum_probs=124.3
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
+..+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||++....... .......||+.|+|
T Consensus 135 ~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~a 209 (321)
T 2c30_A 135 QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMA 209 (321)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCC
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCc--cccccccCCccccC
Confidence 457999999999999999999999998 9999999999999999999999999998764322 12334678999999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
||.+.+..++.++||||||+++|+|++|+.||..... .... ............. .......+.+++
T Consensus 210 PE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~------~~~~-~~~~~~~~~~~~~-------~~~~~~~l~~li 275 (321)
T 2c30_A 210 PEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP------VQAM-KRLRDSPPPKLKN-------SHKVSPVLRDFL 275 (321)
T ss_dssp HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHH-HHHHHSSCCCCTT-------GGGSCHHHHHHH
T ss_pred HhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHH-HHHhcCCCCCcCc-------cccCCHHHHHHH
Confidence 9999999999999999999999999999999853221 1111 1111111111100 011223567888
Q ss_pred hhcccCCCCCCCCHHHHHH
Q 046010 455 LLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~ 473 (523)
.+||+.||++|||+.||++
T Consensus 276 ~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 276 ERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHSCSSTTTSCCHHHHHT
T ss_pred HHHccCChhhCcCHHHHhc
Confidence 9999999999999999986
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-26 Score=236.91 Aligned_cols=162 Identities=27% Similarity=0.358 Sum_probs=122.7
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ........||+.
T Consensus 144 l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~--~~~~~~~~gt~~ 218 (396)
T 4dc2_A 144 MQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGTPN 218 (396)
T ss_dssp HHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--TCCBCCCCBCGG
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccC--CCccccccCCcc
Confidence 445678999999999999999999999998 999999999999999999999999999753221 223445689999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCccccc--ccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH--GQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
|+|||++.+..++.++||||||+++|||++|+.||....... .................. + +......
T Consensus 219 Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~------~----p~~~s~~ 288 (396)
T 4dc2_A 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR------I----PRSLSVK 288 (396)
T ss_dssp GCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC------C----CTTSCHH
T ss_pred cCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC------C----CCcCCHH
Confidence 999999999999999999999999999999999996432211 111111122222221110 1 1112235
Q ss_pred HHHHhhhcccCCCCCCCCH
Q 046010 450 CIHIGLLCVQEDPADRPNM 468 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~ 468 (523)
+.+|+.+||+.||++||++
T Consensus 289 ~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 289 AASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHHHHHTCSCTTTSTTC
T ss_pred HHHHHHHHhcCCHhHcCCC
Confidence 6788999999999999996
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-27 Score=238.68 Aligned_cols=166 Identities=28% Similarity=0.403 Sum_probs=128.9
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++................+++.|+|
T Consensus 158 ~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 234 (333)
T 2i1m_A 158 NSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMA 234 (333)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSC
T ss_pred ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccC
Confidence 456899999999999999999999998 99999999999999999999999999987654433333445567889999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||.+.+..++.++||||||+++|+|++ |..||....... .. ........... .+......+.+|
T Consensus 235 PE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~----~~~~~~~~~~~---------~~~~~~~~l~~l 299 (333)
T 2i1m_A 235 PESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--KF----YKLVKDGYQMA---------QPAFAPKNIYSI 299 (333)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--HH----HHHHHHTCCCC---------CCTTCCHHHHHH
T ss_pred HHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--HH----HHHHhcCCCCC---------CCCCCCHHHHHH
Confidence 999999999999999999999999998 888885432211 11 11111111100 011113467789
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+.+||+.||.+|||+.||++.|+..
T Consensus 300 i~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 300 MQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhccChhhCcCHHHHHHHHHHH
Confidence 9999999999999999999999764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=6.5e-26 Score=228.55 Aligned_cols=160 Identities=22% Similarity=0.236 Sum_probs=125.0
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ........||+.
T Consensus 96 l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~~~~~~~~gt~~ 170 (337)
T 1o6l_A 96 LSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPE 170 (337)
T ss_dssp HHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT--TCCBCCCEECGG
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC--CCcccccccChh
Confidence 445678999999999999999999999998 999999999999999999999999999864222 122345689999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||++.+..++.++||||||+++|||++|+.||..... ........ .... . +.. .....+.
T Consensus 171 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~-~~~~-~-----~p~----~~s~~~~ 233 (337)
T 1o6l_A 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELIL-MEEI-R-----FPR----TLSPEAK 233 (337)
T ss_dssp GCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HCCC-C-----CCT----TSCHHHH
T ss_pred hCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH------HHHHHHHH-cCCC-C-----CCC----CCCHHHH
Confidence 9999999999999999999999999999999999853221 11111111 1111 0 111 1224567
Q ss_pred HHhhhcccCCCCCCC-----CHHHHHH
Q 046010 452 HIGLLCVQEDPADRP-----NMSSVAV 473 (523)
Q Consensus 452 ~li~~cl~~dP~~RP-----s~~ei~~ 473 (523)
+|+.+||+.||++|| ++.||++
T Consensus 234 ~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 234 SLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 889999999999999 8999865
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9e-27 Score=238.09 Aligned_cols=163 Identities=9% Similarity=0.004 Sum_probs=119.4
Q ss_pred ccccCHHHH------HHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceec
Q 046010 295 RAQLDWKRR------ISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVG 368 (523)
Q Consensus 295 ~~~l~~~~~------~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~g 368 (523)
+..+++..+ +.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.... ......+
T Consensus 182 ~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~ 253 (371)
T 3q60_A 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSV 253 (371)
T ss_dssp HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGS
T ss_pred ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccC
Confidence 445566666 788899999999999998 99999999999999999999999999987532 1113456
Q ss_pred cCCCCchhhhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHH
Q 046010 369 TYGYMAPEYALG--GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAE 446 (523)
Q Consensus 369 t~~y~aPE~l~~--~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 446 (523)
++.|+|||++.+ ..++.++||||||+++|+|++|+.||.......... +.....................
T Consensus 254 t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~ 325 (371)
T 3q60_A 254 PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPL 325 (371)
T ss_dssp CGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCC
T ss_pred CcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccc--------hhhhhhhhccccccchhhccCC
Confidence 699999999987 679999999999999999999999986543221110 0000000000111111111122
Q ss_pred HHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 447 LLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 447 ~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
...+.+|+.+||+.||++|||+.|+++
T Consensus 326 ~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 326 PDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 356778999999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.6e-27 Score=238.39 Aligned_cols=109 Identities=30% Similarity=0.372 Sum_probs=96.4
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC-------------------------CCCeeEe
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH-------------------------EMNPKIS 346 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~-------------------------~~~~kL~ 346 (523)
......+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+
T Consensus 128 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 204 (360)
T 3llt_A 128 RNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204 (360)
T ss_dssp HTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEEC
T ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEE
Confidence 344456999999999999999999999998 999999999999975 7889999
Q ss_pred ccccceeccCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 046010 347 DFGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGF 408 (523)
Q Consensus 347 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~ 408 (523)
|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus 205 DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 205 DFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp CCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred eccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 99999864321 2345789999999999999999999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-26 Score=232.81 Aligned_cols=170 Identities=22% Similarity=0.230 Sum_probs=108.3
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC---CeeEeccccceeccCCCCCccccceec
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM---NPKISDFGMARIFGGNQNESNTSKVVG 368 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~---~~kL~Dfg~a~~~~~~~~~~~~~~~~g 368 (523)
..++..+++.+++.++.||+.||+|||+++ |+||||||+||+++.++ .+||+|||+++...... .......+
T Consensus 97 l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~ 171 (325)
T 3kn6_A 97 IKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCF 171 (325)
T ss_dssp HHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------------
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--CcccccCC
Confidence 345678999999999999999999999998 99999999999997765 79999999998654322 22334567
Q ss_pred cCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 369 TYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 369 t~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
|+.|+|||++.+..++.++||||||+++|+|++|+.||..................+..+... .... .......
T Consensus 172 t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~-----~~~~~s~ 245 (325)
T 3kn6_A 172 TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS-FEGE-----AWKNVSQ 245 (325)
T ss_dssp ------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC-CCSH-----HHHTSCH
T ss_pred CcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC-CCcc-----cccCCCH
Confidence 999999999999999999999999999999999999996543322111112222222222211 0000 0011234
Q ss_pred HHHHHhhhcccCCCCCCCCHHHHH
Q 046010 449 KCIHIGLLCVQEDPADRPNMSSVA 472 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~RPs~~ei~ 472 (523)
.+.+|+.+||+.||++|||+.|++
T Consensus 246 ~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 246 EAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp HHHHHHHHHHCCCTTTCCCTTTST
T ss_pred HHHHHHHHHCCCChhHCCCHHHHh
Confidence 677899999999999999999986
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.7e-26 Score=225.03 Aligned_cols=174 Identities=24% Similarity=0.334 Sum_probs=121.7
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
......+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||++....... .......+|+.
T Consensus 91 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~ 165 (288)
T 1ob3_A 91 DVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKYTHEIVTLW 165 (288)
T ss_dssp HTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCT
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc--ccccccccccc
Confidence 344567999999999999999999999998 9999999999999999999999999998654221 12234567999
Q ss_pred CCchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcc--------cccCcccc---
Q 046010 372 YMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEAL--------ELMDPVLK--- 439 (523)
Q Consensus 372 y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~l~--- 439 (523)
|+|||.+.+. .++.++||||||+++|+|++|+.||...... ................ ...++.+.
T Consensus 166 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T 1ob3_A 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242 (288)
T ss_dssp TCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCC
T ss_pred ccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHHCCCChhhchhhhccccccccccccc
Confidence 9999998764 5899999999999999999999998643211 1111111111110000 00000000
Q ss_pred ----CCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 440 ----QSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 440 ----~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
..........+.+|+.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000112346678999999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.2e-27 Score=230.89 Aligned_cols=165 Identities=27% Similarity=0.334 Sum_probs=118.3
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
++..+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++....... .......+++.|+
T Consensus 109 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~ 184 (281)
T 1mp8_A 109 RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWM 184 (281)
T ss_dssp TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------------------CCGGGC
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCcccc-cccccCCCccccc
Confidence 4457999999999999999999999998 99999999999999999999999999987643221 1222345677899
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
|||.+.+..++.++||||||+++|+|++ |..||...... ..... ........ .+......+.+
T Consensus 185 aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~~----i~~~~~~~---------~~~~~~~~l~~ 248 (281)
T 1mp8_A 185 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGR----IENGERLP---------MPPNCPPTLYS 248 (281)
T ss_dssp CHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH----HHTTCCCC---------CCTTCCHHHHH
T ss_pred ChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHHH----HHcCCCCC---------CCCCCCHHHHH
Confidence 9999998899999999999999999997 88898643221 11111 11111111 11122346778
Q ss_pred HhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 453 IGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
++.+||+.||++|||+.||++.|+..
T Consensus 249 li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 249 LMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=5.8e-27 Score=230.40 Aligned_cols=175 Identities=24% Similarity=0.332 Sum_probs=134.0
Q ss_pred cccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccc
Q 046010 284 GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNT 363 (523)
Q Consensus 284 g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 363 (523)
|....++.......+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||.+....... ....
T Consensus 94 ~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~ 169 (288)
T 3kfa_A 94 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAH 169 (288)
T ss_dssp EEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-SEEE
T ss_pred CcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc-cccc
Confidence 34444444445677999999999999999999999998 9999999999999999999999999998654322 2223
Q ss_pred cceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCc
Q 046010 364 SKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSC 442 (523)
Q Consensus 364 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 442 (523)
....++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ..... ........ .
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~~~~----~~~~~~~~---------~ 233 (288)
T 3kfa_A 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYEL----LEKDYRME---------R 233 (288)
T ss_dssp TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHH----HHTTCCCC---------C
T ss_pred cCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HhccCCCC---------C
Confidence 34567788999999999999999999999999999999 88888543222 11111 11111110 1
Q ss_pred cHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 443 MAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 443 ~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+......+.+|+.+||+.||.+|||+.+|++.|+..
T Consensus 234 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 234 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 112234677899999999999999999999999865
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.7e-28 Score=240.68 Aligned_cols=176 Identities=26% Similarity=0.318 Sum_probs=130.5
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC-ccccceeccCCCC
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE-SNTSKVVGTYGYM 373 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~ 373 (523)
+..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++......... .......++..|+
T Consensus 128 ~~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~ 204 (318)
T 3lxp_A 128 RHSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 204 (318)
T ss_dssp GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGC
T ss_pred hCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceee
Confidence 345999999999999999999999998 999999999999999999999999999876543221 1223445777899
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCccccc--------ccchHHHHHHhhhcCCcccccCccccCCccHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH--------GQSLLAYTWKLWCNGEALELMDPVLKQSCMAA 445 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 445 (523)
|||.+.+..++.++||||||+++|+|++|+.||....... ................ ....+..
T Consensus 205 aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~ 275 (318)
T 3lxp_A 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE---------RLPRPDK 275 (318)
T ss_dssp CHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC---------CCCCCTT
T ss_pred ChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc---------CCCCCcc
Confidence 9999999899999999999999999999999975322110 0000001111111111 1111222
Q ss_pred HHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCCCC
Q 046010 446 ELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTVSL 482 (523)
Q Consensus 446 ~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~l 482 (523)
....+.+|+.+||+.||++|||+.||+++|+.....+
T Consensus 276 ~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 276 CPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 3356788999999999999999999999998764433
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.93 E-value=7.2e-27 Score=240.28 Aligned_cols=111 Identities=32% Similarity=0.465 Sum_probs=94.6
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCC---------------
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQN--------------- 359 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~--------------- 359 (523)
...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 103 ~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~ 179 (388)
T 3oz6_A 103 ANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179 (388)
T ss_dssp HTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC-----
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccc
Confidence 357999999999999999999999998 99999999999999999999999999987532110
Q ss_pred ----CccccceeccCCCCchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 046010 360 ----ESNTSKVVGTYGYMAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGF 408 (523)
Q Consensus 360 ----~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~ 408 (523)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 180 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp ----------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 112234578999999999986 6789999999999999999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.9e-27 Score=228.87 Aligned_cols=167 Identities=25% Similarity=0.287 Sum_probs=123.2
Q ss_pred cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcccccee
Q 046010 288 PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVV 367 (523)
Q Consensus 288 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 367 (523)
.++.......+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||++...... .....
T Consensus 104 ~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-----~~~~~ 175 (278)
T 1byg_A 104 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGK 175 (278)
T ss_dssp HHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------
T ss_pred HHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc-----ccCCC
Confidence 3333333345899999999999999999999998 999999999999999999999999998764322 12335
Q ss_pred ccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHH
Q 046010 368 GTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAE 446 (523)
Q Consensus 368 gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 446 (523)
++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... ... .....+.... .+...
T Consensus 176 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~----~~~~~~~~~~---------~~~~~ 239 (278)
T 1byg_A 176 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVV----PRVEKGYKMD---------APDGC 239 (278)
T ss_dssp CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHH----HHHTTTCCCC---------CCTTC
T ss_pred ccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHhcCCCCC---------CcccC
Confidence 6789999999999999999999999999999998 99998643221 111 1111111111 11122
Q ss_pred HHHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 447 LLKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 447 ~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
...+.+++.+||+.||++|||+.||++.|+..
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 240 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 34677889999999999999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-27 Score=232.70 Aligned_cols=172 Identities=27% Similarity=0.367 Sum_probs=132.7
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC-ccccceeccCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE-SNTSKVVGTYG 371 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~gt~~ 371 (523)
.++..+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||++......... .......+++.
T Consensus 102 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~ 178 (287)
T 1u59_A 102 GKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178 (287)
T ss_dssp TCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGG
T ss_pred hCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecccccccccc
Confidence 45567999999999999999999999998 999999999999999999999999999876433221 11223456788
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
|+|||.+.+..++.++||||||+++|+|++ |+.||...... .. ......+.... .+......+
T Consensus 179 y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~----~~~i~~~~~~~---------~~~~~~~~l 242 (287)
T 1u59_A 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EV----MAFIEQGKRME---------CPPECPPEL 242 (287)
T ss_dssp GCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HH----HHHHHTTCCCC---------CCTTCCHHH
T ss_pred ccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HH----HHHHhcCCcCC---------CCCCcCHHH
Confidence 999999988889999999999999999998 99998543221 11 11122221111 111223467
Q ss_pred HHHhhhcccCCCCCCCCHHHHHHHhccCCCCCC
Q 046010 451 IHIGLLCVQEDPADRPNMSSVAVMLASDTVSLP 483 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~l~ 483 (523)
.+++.+||+.||++||++.+|++.|+....+..
T Consensus 243 ~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 243 YALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 789999999999999999999999988654443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-27 Score=239.87 Aligned_cols=178 Identities=28% Similarity=0.359 Sum_probs=131.4
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCc-cccceeccCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES-NTSKVVGTYG 371 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~gt~~ 371 (523)
..+..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++.......... ......++..
T Consensus 119 ~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~ 195 (327)
T 3lxl_A 119 RHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 195 (327)
T ss_dssp HHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGG
T ss_pred hcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCcccc
Confidence 33457999999999999999999999998 9999999999999999999999999998764332221 2233457778
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccc--------cccchHHHHHHhhhcCCcccccCccccCCcc
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSE--------HGQSLLAYTWKLWCNGEALELMDPVLKQSCM 443 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 443 (523)
|+|||.+.+..++.++||||||+++|+|++|+.||...... ...............+.. ...+
T Consensus 196 y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~ 266 (327)
T 3lxl_A 196 WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQR---------LPAP 266 (327)
T ss_dssp GSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCC---------CCCC
T ss_pred ccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccC---------CCCC
Confidence 99999999988999999999999999999999997532211 000111111111111111 1112
Q ss_pred HHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCCCC
Q 046010 444 AAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTVSL 482 (523)
Q Consensus 444 ~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~l 482 (523)
......+.+|+.+||+.||++|||+.||++.|+......
T Consensus 267 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 267 PACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred CcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 223456778999999999999999999999999875544
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-27 Score=253.77 Aligned_cols=176 Identities=25% Similarity=0.392 Sum_probs=132.3
Q ss_pred cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcccccee
Q 046010 288 PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVV 367 (523)
Q Consensus 288 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 367 (523)
.++....+..+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...... ........
T Consensus 350 ~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~ 425 (535)
T 2h8h_A 350 DFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAK 425 (535)
T ss_dssp HHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HHTTCSTT
T ss_pred HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-eecccCCc
Confidence 3333334466999999999999999999999998 9999999999999999999999999997653211 11112234
Q ss_pred ccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHH
Q 046010 368 GTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAE 446 (523)
Q Consensus 368 gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 446 (523)
++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .. ......+.... .+...
T Consensus 426 ~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~----~~~i~~~~~~~---------~~~~~ 489 (535)
T 2h8h_A 426 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EV----LDQVERGYRMP---------CPPEC 489 (535)
T ss_dssp SCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HH----HHHHHTTCCCC---------CCTTC
T ss_pred CcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHcCCCCC---------CCCCC
Confidence 5678999999999999999999999999999999 89898532211 11 11112211111 11122
Q ss_pred HHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCCCCC
Q 046010 447 LLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTVSLP 483 (523)
Q Consensus 447 ~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~l~ 483 (523)
...+.+||.+||+.||++|||+.+|+++|+.......
T Consensus 490 ~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 490 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 3467789999999999999999999999998765443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.93 E-value=9.7e-27 Score=234.26 Aligned_cols=164 Identities=31% Similarity=0.394 Sum_probs=128.2
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||++................+++.|+||
T Consensus 152 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 228 (334)
T 2pvf_A 152 EQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 228 (334)
T ss_dssp -CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCH
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeCh
Confidence 45999999999999999999999998 999999999999999999999999999876543332233344567889999
Q ss_pred hhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 376 EYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 376 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
|.+.+..++.++||||||+++|+|++ |+.||...... .. ......+..... +......+.+++
T Consensus 229 E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~----~~~~~~~~~~~~---------~~~~~~~l~~li 292 (334)
T 2pvf_A 229 EALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---EL----FKLLKEGHRMDK---------PANCTNELYMMM 292 (334)
T ss_dssp HHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HH----HHHHHHTCCCCC---------CTTCCHHHHHHH
T ss_pred HHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH---HH----HHHHhcCCCCCC---------CccCCHHHHHHH
Confidence 99998889999999999999999999 99998532211 11 111111111111 112234577889
Q ss_pred hhcccCCCCCCCCHHHHHHHhccC
Q 046010 455 LLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
.+||+.||.+|||+.||++.|++.
T Consensus 293 ~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 293 RDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHccCChhhCcCHHHHHHHHHHH
Confidence 999999999999999999999876
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.9e-26 Score=226.20 Aligned_cols=170 Identities=24% Similarity=0.396 Sum_probs=119.0
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC-ccccceeccCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE-SNTSKVVGTYG 371 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~gt~~ 371 (523)
.....+++.+++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++........ .......|++.
T Consensus 108 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~ 184 (311)
T 3ork_A 108 HTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184 (311)
T ss_dssp HHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC------------------CCT
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcc
Confidence 44567999999999999999999999998 999999999999999999999999999876433222 22334568999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||.+.+..++.++||||||+++|+|++|+.||..... .............. +... .......+.
T Consensus 185 y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~----~~~~---~~~~~~~l~ 251 (311)
T 3ork_A 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIP----PSAR---HEGLSADLD 251 (311)
T ss_dssp TCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCC----HHHH---STTCCHHHH
T ss_pred cCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCCCC----cccc---cCCCCHHHH
Confidence 9999999999999999999999999999999999853221 11222222221111 0000 001234577
Q ss_pred HHhhhcccCCCCCCCCHHHH-HHHhccC
Q 046010 452 HIGLLCVQEDPADRPNMSSV-AVMLASD 478 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei-~~~L~~~ 478 (523)
+|+.+||+.||++||+..++ ...|...
T Consensus 252 ~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 252 AVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 88999999999999966554 4555443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-26 Score=231.28 Aligned_cols=159 Identities=21% Similarity=0.304 Sum_probs=123.6
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..++..+++.+++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++...... .......||+.
T Consensus 99 l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~---~~~~~~~gt~~ 172 (336)
T 3h4j_B 99 IVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG---NFLKTSCGSPN 172 (336)
T ss_dssp HHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS---BTTCCCTTSTT
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC---cccccccCCcC
Confidence 345678999999999999999999999998 999999999999999999999999999865422 22334578999
Q ss_pred CCchhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 372 YMAPEYALGGVI-SVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 372 y~aPE~l~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
|+|||.+.+..+ +.++||||||+++|+|++|+.||......... +.+.... ...+......+
T Consensus 173 y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------------~~i~~~~-~~~p~~~s~~~ 235 (336)
T 3h4j_B 173 YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------------KKVNSCV-YVMPDFLSPGA 235 (336)
T ss_dssp TSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------------CCCCSSC-CCCCTTSCHHH
T ss_pred cCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------------HHHHcCC-CCCcccCCHHH
Confidence 999999988776 68999999999999999999998643221110 0000000 00111123456
Q ss_pred HHHhhhcccCCCCCCCCHHHHHH
Q 046010 451 IHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+|+.+||+.||.+|||+.||++
T Consensus 236 ~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 236 QSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHcCCChhHCcCHHHHHh
Confidence 78999999999999999999965
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-26 Score=232.16 Aligned_cols=166 Identities=27% Similarity=0.371 Sum_probs=129.4
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++................+++.|+||
T Consensus 133 ~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 209 (322)
T 1p4o_A 133 APPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209 (322)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCH
T ss_pred CCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccCh
Confidence 46799999999999999999999998 999999999999999999999999999865433222233345678889999
Q ss_pred hhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 376 EYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 376 E~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
|.+.+..++.++||||||+++|+|++ |+.||...... ........+..... +......+.+|+
T Consensus 210 E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~---------~~~~~~~l~~li 273 (322)
T 1p4o_A 210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-------QVLRFVMEGGLLDK---------PDNCPDMLFELM 273 (322)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-------HHHHHHHTTCCCCC---------CTTCCHHHHHHH
T ss_pred hhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH-------HHHHHHHcCCcCCC---------CCCCCHHHHHHH
Confidence 99999999999999999999999999 88887532211 11112222221111 112234577899
Q ss_pred hhcccCCCCCCCCHHHHHHHhccCCC
Q 046010 455 LLCVQEDPADRPNMSSVAVMLASDTV 480 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~~L~~~~~ 480 (523)
.+||+.||++|||+.||++.|++...
T Consensus 274 ~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 274 RMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 99999999999999999999988643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8e-26 Score=226.98 Aligned_cols=172 Identities=20% Similarity=0.301 Sum_probs=125.9
Q ss_pred ccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC---CCCeeEeccccceeccCCCC
Q 046010 283 IGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH---EMNPKISDFGMARIFGGNQN 359 (523)
Q Consensus 283 ~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~---~~~~kL~Dfg~a~~~~~~~~ 359 (523)
.|....++.......+++..++.++.||+.||+|||+++ |+||||||+||+++. ++.+||+|||+++......
T Consensus 113 ~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~- 188 (327)
T 3lm5_A 113 GGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC- 188 (327)
T ss_dssp TEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-----
T ss_pred CCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc-
Confidence 344445555555678999999999999999999999998 999999999999998 7899999999998764222
Q ss_pred CccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCcccc
Q 046010 360 ESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLK 439 (523)
Q Consensus 360 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 439 (523)
......+++.|+|||++.+..++.++||||||+++|+|++|+.||...... ... ... ..... ....+
T Consensus 189 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~---~~i-~~~~~-~~~~~--- 255 (327)
T 3lm5_A 189 --ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ---ETY---LNI-SQVNV-DYSEE--- 255 (327)
T ss_dssp -------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHH-HHTCC-CCCTT---
T ss_pred --ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHH---HHH-Hhccc-ccCch---
Confidence 223457899999999999999999999999999999999999998532211 111 111 11000 00000
Q ss_pred CCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 440 QSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 440 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
........+.+|+.+||+.||++|||++|+++
T Consensus 256 --~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 256 --TFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp --TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --hhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 01112345778899999999999999999976
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4e-27 Score=229.39 Aligned_cols=167 Identities=30% Similarity=0.366 Sum_probs=127.6
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
......+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||++....... ........++..
T Consensus 97 ~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~ 172 (269)
T 4hcu_A 97 RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVK 172 (269)
T ss_dssp HTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGG
T ss_pred HhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc-cccccCcccccc
Confidence 345567999999999999999999999998 9999999999999999999999999997653221 111223445678
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
|+|||.+.+..++.++||||||+++|+|++ |+.||...... .. .......... .. +......+
T Consensus 173 y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~~----~~~~~~~~~~--~~-------~~~~~~~~ 236 (269)
T 4hcu_A 173 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EV----VEDISTGFRL--YK-------PRLASTHV 236 (269)
T ss_dssp GCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH----HHHHHTTCCC--CC-------CTTSCHHH
T ss_pred cCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---HH----HHHHhcCccC--CC-------CCcCCHHH
Confidence 999999998999999999999999999999 89998532211 11 1111111100 00 11113457
Q ss_pred HHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 451 IHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
.+++.+||+.||++|||+.|+++.|++.
T Consensus 237 ~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 237 YQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 7889999999999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-26 Score=228.99 Aligned_cols=170 Identities=26% Similarity=0.312 Sum_probs=122.9
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||++....... .......+|+.|+||
T Consensus 103 ~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aP 177 (317)
T 2pmi_A 103 RGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV--NTFSSEVVTLWYRAP 177 (317)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTSCC--CCCCCCCSCCTTCCH
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCCCc--ccCCCCcccccccCc
Confidence 46999999999999999999999998 9999999999999999999999999998764322 122345789999999
Q ss_pred hhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcC--Cccc------ccCc----------
Q 046010 376 EYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNG--EALE------LMDP---------- 436 (523)
Q Consensus 376 E~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~------~~~~---------- 436 (523)
|++.+ ..++.++||||||+++|+|++|+.||...... ............. .... ...+
T Consensus 178 E~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (317)
T 2pmi_A 178 DVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE---EQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDL 254 (317)
T ss_dssp HHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCS
T ss_pred hHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhH
Confidence 99876 46899999999999999999999998643221 1111111111000 0000 0000
Q ss_pred --cccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 437 --VLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 437 --~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+...........+.+|+.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 255 RQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp HHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000000112346788999999999999999999875
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.2e-26 Score=231.17 Aligned_cols=190 Identities=23% Similarity=0.291 Sum_probs=131.5
Q ss_pred eEeeeccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 278 AIWIAIGTTI---PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 278 ~~~ia~g~~~---~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
..++.+.++. ...+......+++.+++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 98 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 98 SIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp EEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred eEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 3445544444 2233445567999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCC--ccccceeccCCCCchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhc---C
Q 046010 355 GGNQNE--SNTSKVVGTYGYMAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCN---G 428 (523)
Q Consensus 355 ~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~ 428 (523)
...... .......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||....... ........... .
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH---QLALISQLCGSITPE 251 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTT
T ss_pred cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChh
Confidence 432221 22334577999999999876 458999999999999999999999986432211 11111111100 0
Q ss_pred C--------cccccCccccCC-ccHHH------HHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 429 E--------ALELMDPVLKQS-CMAAE------LLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 429 ~--------~~~~~~~~l~~~-~~~~~------~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
. ..+.+....... ..... ...+.+|+.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0 000000000000 01111 234778999999999999999999876
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-26 Score=239.95 Aligned_cols=110 Identities=25% Similarity=0.307 Sum_probs=96.9
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCC--eeEeccccceeccCCCCCccccceecc
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMN--PKISDFGMARIFGGNQNESNTSKVVGT 369 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~~~gt 369 (523)
......+++..++.++.||++||+|||+++ |+||||||+|||++.++. +||+|||++...... .....+|
T Consensus 191 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~-----~~~~~gt 262 (429)
T 3kvw_A 191 KNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQS 262 (429)
T ss_dssp HTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSC
T ss_pred hccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccceecCCc-----ccccCCC
Confidence 344456999999999999999999999998 999999999999999987 999999999764321 2245788
Q ss_pred CCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Q 046010 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFY 409 (523)
Q Consensus 370 ~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~ 409 (523)
+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 263 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 263 RFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp GGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999999999999999998643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.9e-27 Score=236.39 Aligned_cols=173 Identities=24% Similarity=0.273 Sum_probs=125.8
Q ss_pred Eeeeccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceecc
Q 046010 279 IWIAIGTTI---PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFG 355 (523)
Q Consensus 279 ~~ia~g~~~---~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 355 (523)
+++.+.++. +..+..+...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 444444443 1223455678999999999999999999999998 9999999999999999999999999997532
Q ss_pred CCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccC
Q 046010 356 GNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMD 435 (523)
Q Consensus 356 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (523)
.. ........||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..... .......
T Consensus 176 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~-i~~~~~~---- 242 (353)
T 3txo_A 176 CN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------DLFEA-ILNDEVV---- 242 (353)
T ss_dssp C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-HHHCCCC----
T ss_pred cC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH------HHHHH-HHcCCCC----
Confidence 21 22334567999999999999888999999999999999999999998532211 11111 1111110
Q ss_pred ccccCCccHHHHHHHHHHhhhcccCCCCCCCCH------HHHHH
Q 046010 436 PVLKQSCMAAELLKCIHIGLLCVQEDPADRPNM------SSVAV 473 (523)
Q Consensus 436 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~------~ei~~ 473 (523)
+ +......+.+|+.+||+.||++||++ .||++
T Consensus 243 --~----p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 243 --Y----PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --C----CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --C----CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 0 11122356788999999999999998 67754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=9.6e-27 Score=230.14 Aligned_cols=169 Identities=25% Similarity=0.297 Sum_probs=125.9
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC--ccccceeccC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE--SNTSKVVGTY 370 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~--~~~~~~~gt~ 370 (523)
.....+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++........ .......+++
T Consensus 120 ~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~ 196 (298)
T 3f66_A 120 NETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196 (298)
T ss_dssp CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCG
T ss_pred hcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCc
Confidence 45567999999999999999999999998 999999999999999999999999999865432211 1223345678
Q ss_pred CCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCC-CCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 371 GYMAPEYALGGVISVKSDVFSFGVLLLEIISGKK-NSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 371 ~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
.|+|||.+.+..++.++||||||+++|+|++|.. ||..... ....... ....... . +......
T Consensus 197 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~~~~~~~----~~~~~~~--~-------~~~~~~~ 260 (298)
T 3f66_A 197 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYL----LQGRRLL--Q-------PEYCPDP 260 (298)
T ss_dssp GGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT---TTHHHHH----HTTCCCC--C-------CTTCCHH
T ss_pred cccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH---HHHHHHH----hcCCCCC--C-------CccCCHH
Confidence 8999999999999999999999999999999554 4432211 1111111 1111100 0 0111235
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHHHhccCCC
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAVMLASDTV 480 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~ 480 (523)
+.+++.+||+.||++|||+.||++.|+....
T Consensus 261 l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 261 LYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 7788999999999999999999999987643
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-26 Score=235.12 Aligned_cols=188 Identities=19% Similarity=0.220 Sum_probs=132.8
Q ss_pred eeEeeecccccccc------ccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeC-CCCCeeEeccc
Q 046010 277 KAIWIAIGTTIPTI------YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLD-HEMNPKISDFG 349 (523)
Q Consensus 277 ~~~~ia~g~~~~~~------~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~-~~~~~kL~Dfg 349 (523)
..+++.+.++...+ +...+..+++..++.++.||++||+|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 34556666655322 2334678999999999999999999999998 99999999999998 78999999999
Q ss_pred cceeccCCCCCccccceeccCCCCchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhh---
Q 046010 350 MARIFGGNQNESNTSKVVGTYGYMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLW--- 425 (523)
Q Consensus 350 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~--- 425 (523)
+++...... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+.......
T Consensus 188 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~p 261 (394)
T 4e7w_A 188 SAKILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID---QLVEIIKVLGTP 261 (394)
T ss_dssp TCEECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCC
T ss_pred CcccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCC
Confidence 998764322 22345678999999998765 58999999999999999999999986432211 111111110
Q ss_pred ------------hcCCcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 426 ------------CNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 426 ------------~~~~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
............+...........+.+|+.+||+.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 000110100000000011112346889999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=219.98 Aligned_cols=165 Identities=25% Similarity=0.361 Sum_probs=125.3
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..++..+++..++.++.||++||.|||+++ |+|+||||+||+++.++.+||+|||.+................++..
T Consensus 96 l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 172 (276)
T 2yex_A 96 IEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172 (276)
T ss_dssp SBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGG
T ss_pred HhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccC
Confidence 345567999999999999999999999998 99999999999999999999999999986543322223345678899
Q ss_pred CCchhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 372 YMAPEYALGGVI-SVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 372 y~aPE~l~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
|+|||.+.+..+ +.++||||||+++|+|++|+.||........ . ...+...... ... .......+
T Consensus 173 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~~~~~~~--~~~------~~~~~~~~ 238 (276)
T 2yex_A 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--E----YSDWKEKKTY--LNP------WKKIDSAP 238 (276)
T ss_dssp GCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--H----HHHHHTTCTT--STT------GGGSCHHH
T ss_pred ccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--H----HHHhhhcccc--cCc------hhhcCHHH
Confidence 999999987665 7899999999999999999999864332111 1 1111111110 000 01122356
Q ss_pred HHHhhhcccCCCCCCCCHHHHHH
Q 046010 451 IHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+|+.+||+.||++|||+.||++
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 239 LALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHCCCCchhCCCHHHHhc
Confidence 78899999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.5e-27 Score=229.00 Aligned_cols=166 Identities=22% Similarity=0.300 Sum_probs=125.7
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
..+..+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||++........ .......++..|
T Consensus 105 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y 180 (281)
T 3cc6_A 105 RNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKW 180 (281)
T ss_dssp HHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGG
T ss_pred hccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccccccc-cccccCCCCcce
Confidence 34566999999999999999999999998 99999999999999999999999999986543221 122334567789
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
+|||.+.+..++.++||||||+++|+|++ |+.||...... ...... ........ +......+.
T Consensus 181 ~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~~~~~----~~~~~~~~---------~~~~~~~l~ 244 (281)
T 3cc6_A 181 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DVIGVL----EKGDRLPK---------PDLCPPVLY 244 (281)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GHHHHH----HHTCCCCC---------CTTCCHHHH
T ss_pred eCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HHHHHH----hcCCCCCC---------CCCCCHHHH
Confidence 99999998899999999999999999998 99998533222 111111 11111110 111224577
Q ss_pred HHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 452 HIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+++.+||+.||++|||+.||++.|+..
T Consensus 245 ~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 245 TLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 889999999999999999999999764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=237.05 Aligned_cols=171 Identities=26% Similarity=0.320 Sum_probs=120.5
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCc--cccceeccC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES--NTSKVVGTY 370 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~--~~~~~~gt~ 370 (523)
.....+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++......... ......++.
T Consensus 184 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~ 260 (373)
T 3c1x_A 184 NETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 260 (373)
T ss_dssp CTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------------------CCG
T ss_pred hcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcc
Confidence 44567899999999999999999999998 9999999999999999999999999998654322111 122345677
Q ss_pred CCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 371 GYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 371 ~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
.|+|||.+.+..++.++||||||+++|||++ |..||...... ...... ..+.... . +......
T Consensus 261 ~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~---~~~~~~----~~~~~~~--~-------p~~~~~~ 324 (373)
T 3c1x_A 261 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVYL----LQGRRLL--Q-------PEYCPDP 324 (373)
T ss_dssp GGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS---CHHHHH----HTTCCCC--C-------CTTCCHH
T ss_pred cccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH---HHHHHH----HcCCCCC--C-------CCCCCHH
Confidence 8999999999999999999999999999999 56666432221 121111 1111110 0 1112346
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHHHhccCCCCC
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAVMLASDTVSL 482 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~l 482 (523)
+.+++.+||+.||++|||+.||++.|+.....+
T Consensus 325 l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 325 LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 778999999999999999999999998764433
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.9e-26 Score=230.95 Aligned_cols=161 Identities=12% Similarity=0.056 Sum_probs=126.2
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC-----------CCCeeEeccccceeccCCCCCcc
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH-----------EMNPKISDFGMARIFGGNQNESN 362 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~-----------~~~~kL~Dfg~a~~~~~~~~~~~ 362 (523)
....+++..++.++.||++||+|||+++ |+||||||+|||++. ++.+||+|||+++..........
T Consensus 165 ~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~ 241 (365)
T 3e7e_A 165 PEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI 241 (365)
T ss_dssp TTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEE
T ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCce
Confidence 3567999999999999999999999998 999999999999998 89999999999987543333334
Q ss_pred ccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCc
Q 046010 363 TSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSC 442 (523)
Q Consensus 363 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 442 (523)
.....||..|+|||++.+..++.++||||||+++|||++|+.||........ .+...+....
T Consensus 242 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------------------~~~~~~~~~~ 303 (365)
T 3e7e_A 242 FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC------------------KPEGLFRRLP 303 (365)
T ss_dssp ECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE------------------EECSCCTTCS
T ss_pred eeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce------------------eechhccccC
Confidence 4556799999999999999999999999999999999999999843221100 0111111111
Q ss_pred cHHHHHHHHHHhhhcccCCCCCC-CCHHHHHHHhccC
Q 046010 443 MAAELLKCIHIGLLCVQEDPADR-PNMSSVAVMLASD 478 (523)
Q Consensus 443 ~~~~~~~~~~li~~cl~~dP~~R-Ps~~ei~~~L~~~ 478 (523)
. ...+.+++..|++.+|.+| |++.++.+.|++.
T Consensus 304 ~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 304 H---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp S---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred c---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 2 2344567778999999999 6888888887764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.93 E-value=7.1e-27 Score=229.29 Aligned_cols=166 Identities=23% Similarity=0.329 Sum_probs=127.0
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
..+..+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||++....... ........++..|
T Consensus 112 ~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y 187 (283)
T 3gen_A 112 EMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRW 187 (283)
T ss_dssp CGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HHSTTSTTSCGGG
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc-cccccCCccCccc
Confidence 33567999999999999999999999998 9999999999999999999999999997653211 1112233456789
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
+|||.+.+..++.++||||||+++|+|++ |+.||...... .. ........... . +......+.
T Consensus 188 ~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~------~~-~~~~~~~~~~~--~-------~~~~~~~l~ 251 (283)
T 3gen_A 188 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ET-AEHIAQGLRLY--R-------PHLASEKVY 251 (283)
T ss_dssp CCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HH-HHHHHTTCCCC--C-------CTTCCHHHH
T ss_pred CCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh------HH-HHHHhcccCCC--C-------CCcCCHHHH
Confidence 99999998899999999999999999998 99998543221 11 11111111000 0 111124577
Q ss_pred HHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 452 HIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+|+.+||+.||++|||+.+|++.|+..
T Consensus 252 ~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 252 TIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 899999999999999999999999764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=225.13 Aligned_cols=162 Identities=22% Similarity=0.255 Sum_probs=124.4
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC----CeeEeccccceeccCCCCCccccceec
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM----NPKISDFGMARIFGGNQNESNTSKVVG 368 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~----~~kL~Dfg~a~~~~~~~~~~~~~~~~g 368 (523)
.++..+++..++.++.||+.||.|||+++ |+||||||+||+++.++ .+||+|||+++...... ......|
T Consensus 106 ~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~g 179 (326)
T 2y0a_A 106 AEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFG 179 (326)
T ss_dssp TTSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS---CCCCCCS
T ss_pred HhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC---ccccccC
Confidence 45677999999999999999999999998 99999999999999887 79999999998764322 2234578
Q ss_pred cCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 369 TYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 369 t~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
|+.|+|||++.+..++.++||||||+++|+|++|+.||...... .... ....... .. ...... ....
T Consensus 180 t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~----~~~~~~~-~~-~~~~~~----~~~~ 246 (326)
T 2y0a_A 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLA----NVSAVNY-EF-EDEYFS----NTSA 246 (326)
T ss_dssp CTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHH----HHHHTCC-CC-CHHHHT----TSCH
T ss_pred CcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHHH----HHHhcCC-Cc-Cccccc----cCCH
Confidence 99999999999899999999999999999999999998532211 1111 1111100 00 000001 1124
Q ss_pred HHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 449 KCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 247 LAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhhCCCHHHHhc
Confidence 5678899999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-26 Score=229.33 Aligned_cols=168 Identities=29% Similarity=0.362 Sum_probs=129.0
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCc-cccceeccCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES-NTSKVVGTYG 371 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~gt~~ 371 (523)
.+...+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||++.......... ......++..
T Consensus 109 ~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~ 185 (291)
T 1xbb_A 109 QQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 185 (291)
T ss_dssp HHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGG
T ss_pred HhCcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCce
Confidence 44567999999999999999999999998 9999999999999999999999999998764332221 1222345678
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
|+|||.+.+..++.++||||||+++|+|++ |+.||...... .............. +......+
T Consensus 186 y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~---------~~~~~~~l 249 (291)
T 1xbb_A 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGERMGC---------PAGCPREM 249 (291)
T ss_dssp GCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCCCCC---------CTTCCHHH
T ss_pred eeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCCCCC---------CCCCCHHH
Confidence 999999998889999999999999999999 99998543221 11112222211111 11223467
Q ss_pred HHHhhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 451 IHIGLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
.+++.+||+.||++||++.+|++.|++..
T Consensus 250 ~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 250 YDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 78999999999999999999999998753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.8e-26 Score=227.60 Aligned_cols=177 Identities=21% Similarity=0.238 Sum_probs=130.2
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHH--------hcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCc--ccc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLH--------EDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES--NTS 364 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH--------~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~--~~~ 364 (523)
+..+++.+++.++.||+.||.||| +++ |+||||||+||+++.++.+||+|||++.......... ...
T Consensus 133 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~ 209 (342)
T 1b6c_B 133 RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 209 (342)
T ss_dssp HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCC
T ss_pred ccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccc
Confidence 357999999999999999999999 777 9999999999999999999999999998765433221 223
Q ss_pred ceeccCCCCchhhhcCC------CCCcchhhHHHHHHHHHHHhC----------CCCCCCcccccccchHHHHHHhhhcC
Q 046010 365 KVVGTYGYMAPEYALGG------VISVKSDVFSFGVLLLEIISG----------KKNSGFYLSEHGQSLLAYTWKLWCNG 428 (523)
Q Consensus 365 ~~~gt~~y~aPE~l~~~------~~s~ksDVwSlGvvl~elltG----------~~p~~~~~~~~~~~~~~~~~~~~~~~ 428 (523)
...++..|+|||.+.+. .++.++||||||+++|+|++| +.||........ ............
T Consensus 210 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~--~~~~~~~~~~~~ 287 (342)
T 1b6c_B 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP--SVEEMRKVVCEQ 287 (342)
T ss_dssp SCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC--CHHHHHHHHTTS
T ss_pred cCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcc--cHHHHHHHHHHH
Confidence 45789999999998765 234789999999999999999 667643322111 111122222221
Q ss_pred CcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 429 EALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 429 ~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
.....+.... ........+.+|+.+||+.||++|||+.||++.|++..
T Consensus 288 ~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 288 KLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp CCCCCCCGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhCCCCcccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 1111111111 12355677889999999999999999999999998753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.1e-26 Score=229.58 Aligned_cols=162 Identities=27% Similarity=0.358 Sum_probs=121.9
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ........||+.
T Consensus 101 l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~--~~~~~~~~gt~~ 175 (345)
T 3a8x_A 101 MQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGTPN 175 (345)
T ss_dssp HHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT--TCCBCCCCSCGG
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCC--CCcccccCCCcc
Confidence 345567999999999999999999999998 999999999999999999999999999853221 122345678999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccc--cchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHG--QSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
|+|||++.+..++.++||||||+++|||++|+.||........ ................. + +......
T Consensus 176 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~------~----p~~~s~~ 245 (345)
T 3a8x_A 176 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR------I----PRSLSVK 245 (345)
T ss_dssp GCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC------C----CTTSCHH
T ss_pred ccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC------C----CCCCCHH
Confidence 9999999999999999999999999999999999964222111 11111112222221110 1 1112345
Q ss_pred HHHHhhhcccCCCCCCCCH
Q 046010 450 CIHIGLLCVQEDPADRPNM 468 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~ 468 (523)
+.+|+.+||+.||++||++
T Consensus 246 ~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 246 AASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHHHHHHTCSSTTTSTTC
T ss_pred HHHHHHHHhcCCHhHCCCC
Confidence 6788999999999999996
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.7e-26 Score=227.55 Aligned_cols=155 Identities=20% Similarity=0.287 Sum_probs=124.2
Q ss_pred ccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccC
Q 046010 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTY 370 (523)
Q Consensus 291 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~ 370 (523)
+..+...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++....... ......||+
T Consensus 120 ~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~ 193 (335)
T 3dls_A 120 FIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK---LFYTFCGTI 193 (335)
T ss_dssp HHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTC---CBCEECSCG
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceECCCCC---ceeccCCCc
Confidence 4456668999999999999999999999998 9999999999999999999999999998764322 233467899
Q ss_pred CCCchhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 371 GYMAPEYALGGVI-SVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 371 ~y~aPE~l~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
.|+|||++.+..+ +.++||||||+++|+|++|+.||....... . ..... +......
T Consensus 194 ~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------------~----~~~~~------~~~~~~~ 250 (335)
T 3dls_A 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-------------E----AAIHP------PYLVSKE 250 (335)
T ss_dssp GGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-------------T----TCCCC------SSCCCHH
T ss_pred cccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-------------h----hccCC------CcccCHH
Confidence 9999999988776 789999999999999999999985311100 0 00000 0011235
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
+.+|+.+||+.||++|||+.||++.
T Consensus 251 l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 251 LMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcC
Confidence 7788999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-26 Score=229.24 Aligned_cols=174 Identities=21% Similarity=0.221 Sum_probs=125.5
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC-------------------CCCeeEeccccce
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH-------------------EMNPKISDFGMAR 352 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~-------------------~~~~kL~Dfg~a~ 352 (523)
......+++..++.++.||++||+|||+++ |+||||||+||+++. ++.+||+|||++.
T Consensus 109 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 185 (339)
T 1z57_A 109 ENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185 (339)
T ss_dssp HTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCE
T ss_pred hcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccc
Confidence 334457999999999999999999999998 999999999999987 6679999999998
Q ss_pred eccCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHH--------HHh
Q 046010 353 IFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYT--------WKL 424 (523)
Q Consensus 353 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~ 424 (523)
..... .....+|..|+|||.+.+..++.++||||||+++|||++|+.||...........+... +..
T Consensus 186 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 260 (339)
T 1z57_A 186 YDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQK 260 (339)
T ss_dssp ETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHH
T ss_pred cCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Confidence 74322 23456899999999999999999999999999999999999998643322111111000 000
Q ss_pred hhcCCcc-----c-------------ccCccc-cCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 425 WCNGEAL-----E-------------LMDPVL-KQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 425 ~~~~~~~-----~-------------~~~~~l-~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
....... . ...+.. ...........+.+|+.+||+.||++|||+.||++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 261 TRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp CSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 0000000 0 000000 00112244567889999999999999999999974
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=238.05 Aligned_cols=147 Identities=15% Similarity=0.124 Sum_probs=114.9
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCchh
Q 046010 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPE 376 (523)
Q Consensus 297 ~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE 376 (523)
.+++..++.|+.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.... ......| +.|+|||
T Consensus 202 ~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE 272 (377)
T 3byv_A 202 SLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPE 272 (377)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHH
T ss_pred cccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChh
Confidence 4445899999999999999999998 99999999999999999999999999986321 2334566 8999999
Q ss_pred hhcCC-----------CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHH
Q 046010 377 YALGG-----------VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAA 445 (523)
Q Consensus 377 ~l~~~-----------~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 445 (523)
++.+. .++.++||||||+++|||++|+.||......... ...... . . .
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~---------------~~~~~~-~-~----~ 331 (377)
T 3byv_A 273 LEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGS---------------EWIFRS-C-K----N 331 (377)
T ss_dssp HHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCS---------------GGGGSS-C-C----C
T ss_pred hhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccch---------------hhhhhh-c-c----C
Confidence 99887 7999999999999999999999998532221110 000000 0 1 1
Q ss_pred HHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 446 ELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 446 ~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
....+.+|+.+||+.||++|||+.|+++
T Consensus 332 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 332 IPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp CCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred CCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 1245778899999999999999999985
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=5e-26 Score=234.00 Aligned_cols=122 Identities=20% Similarity=0.243 Sum_probs=100.2
Q ss_pred cccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCC----
Q 046010 284 GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQN---- 359 (523)
Q Consensus 284 g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~---- 359 (523)
|....++.......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||.+........
T Consensus 111 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~ 187 (389)
T 3gni_B 111 GSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRV 187 (389)
T ss_dssp CBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSC
T ss_pred CCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeeccccccccc
Confidence 33334444444577999999999999999999999998 99999999999999999999999998865422111
Q ss_pred -CccccceeccCCCCchhhhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 046010 360 -ESNTSKVVGTYGYMAPEYALG--GVISVKSDVFSFGVLLLEIISGKKNSGF 408 (523)
Q Consensus 360 -~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwSlGvvl~elltG~~p~~~ 408 (523)
........||..|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 188 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 188 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp BCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 111223467888999999987 6799999999999999999999999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.8e-26 Score=226.17 Aligned_cols=174 Identities=23% Similarity=0.356 Sum_probs=130.6
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC-ccccceeccCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE-SNTSKVVGTYG 371 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~gt~~ 371 (523)
.....+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++......... .......++..
T Consensus 118 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~ 194 (302)
T 4e5w_A 118 KNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF 194 (302)
T ss_dssp HHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGG
T ss_pred hccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCcc
Confidence 44567999999999999999999999998 999999999999999999999999999876543321 12234456778
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcc--------cccccchHHHHHHhhhcCCcccccCccccCCcc
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYL--------SEHGQSLLAYTWKLWCNGEALELMDPVLKQSCM 443 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 443 (523)
|+|||.+.+..++.++||||||+++|+|++|..|+.... ...................... .+
T Consensus 195 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~ 265 (302)
T 4e5w_A 195 WYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLP---------CP 265 (302)
T ss_dssp GCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCC---------CC
T ss_pred ccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCC---------CC
Confidence 999999999999999999999999999999998854211 0011111111112222211111 11
Q ss_pred HHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 444 AAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 444 ~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
......+.+|+.+||+.||.+|||+.+|+++|+..
T Consensus 266 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 266 PNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 12235677899999999999999999999999763
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-26 Score=230.04 Aligned_cols=179 Identities=20% Similarity=0.236 Sum_probs=123.6
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
..+..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++...... ........+|..|
T Consensus 92 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y 166 (324)
T 3mtl_A 92 DCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP--TKTYDNEVVTLWY 166 (324)
T ss_dssp HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--------------CGGG
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC--ccccccccCcccc
Confidence 44567999999999999999999999998 999999999999999999999999999865322 1223345679999
Q ss_pred CchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCC---cccccCc---------ccc
Q 046010 373 MAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGE---ALELMDP---------VLK 439 (523)
Q Consensus 373 ~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~---------~l~ 439 (523)
+|||++.+ ..++.++||||||+++|+|++|+.||...... .............. ....... ...
T Consensus 167 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (324)
T 3mtl_A 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE---EQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYR 243 (324)
T ss_dssp CCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCC
T ss_pred cChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChHhchhhhcchhhccccccccc
Confidence 99999876 56899999999999999999999998643221 11122222111110 0000000 000
Q ss_pred CC----ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH--HhccCC
Q 046010 440 QS----CMAAELLKCIHIGLLCVQEDPADRPNMSSVAV--MLASDT 479 (523)
Q Consensus 440 ~~----~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~~~ 479 (523)
.. ........+.+|+.+||+.||++|||++|+++ ++.+..
T Consensus 244 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 244 AEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp CCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred chhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 00 00112345678999999999999999999987 565543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.5e-25 Score=232.16 Aligned_cols=166 Identities=29% Similarity=0.425 Sum_probs=128.6
Q ss_pred ccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccC
Q 046010 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTY 370 (523)
Q Consensus 291 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~ 370 (523)
+..++..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++....... ......||+
T Consensus 106 ~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~ 179 (476)
T 2y94_A 106 YICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSP 179 (476)
T ss_dssp HTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTC---CBCCCCSCS
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccccc---cccccCCCc
Confidence 3456678999999999999999999999998 9999999999999999999999999998764322 233457899
Q ss_pred CCCchhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 371 GYMAPEYALGGVI-SVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 371 ~y~aPE~l~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
.|+|||++.+..+ +.++||||||+++|+|++|+.||..... ..+ ......+... . +......
T Consensus 180 ~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~----~~~i~~~~~~------~----p~~~s~~ 242 (476)
T 2y94_A 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---PTL----FKKICDGIFY------T----PQYLNPS 242 (476)
T ss_dssp TTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---HHH----HHHHHTTCCC------C----CTTCCHH
T ss_pred CeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---HHH----HHHHhcCCcC------C----CccCCHH
Confidence 9999999988765 6899999999999999999999853221 111 1111121110 0 0111235
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHH--HhccCC
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAV--MLASDT 479 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~--~L~~~~ 479 (523)
+.+|+.+||+.||++|||+.||++ ++++..
T Consensus 243 ~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 274 (476)
T 2y94_A 243 VISLLKHMLQVDPMKRATIKDIREHEWFKQDL 274 (476)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred HHHHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence 678899999999999999999987 566543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=251.44 Aligned_cols=168 Identities=26% Similarity=0.353 Sum_probs=127.2
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCc-cccceeccCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES-NTSKVVGTYG 371 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~gt~~ 371 (523)
.++..+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++......... ......+++.
T Consensus 428 ~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~ 504 (613)
T 2ozo_A 428 GKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 504 (613)
T ss_dssp TCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCT
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccc
Confidence 34667999999999999999999999998 9999999999999999999999999998654322211 1223345688
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
|+|||++.+..++.++||||||+++|||++ |+.||...... .. ......+.... .+......+
T Consensus 505 y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~----~~~i~~~~~~~---------~p~~~~~~l 568 (613)
T 2ozo_A 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EV----MAFIEQGKRME---------CPPECPPEL 568 (613)
T ss_dssp TSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HH----HHHHHTTCCCC---------CCTTCCHHH
T ss_pred eeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HH----HHHHHcCCCCC---------CCCcCCHHH
Confidence 999999999999999999999999999998 99998643221 11 12222222111 112234567
Q ss_pred HHHhhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 451 IHIGLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
.+||.+||+.||++||++.+|++.|+...
T Consensus 569 ~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 569 YALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp HHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 78999999999999999999999998753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-25 Score=222.23 Aligned_cols=157 Identities=24% Similarity=0.259 Sum_probs=124.1
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.... ......||+.
T Consensus 97 l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-----~~~~~~gt~~ 168 (318)
T 1fot_A 97 LRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPD 168 (318)
T ss_dssp HHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS-----CBCCCCSCTT
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC-----ccccccCCcc
Confidence 345667999999999999999999999998 99999999999999999999999999987532 1234578999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||++.+..++.++||||||+++|||++|+.||..... ......... ... . +.. .....+.
T Consensus 169 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~-~~~-~-----~p~----~~~~~~~ 231 (318)
T 1fot_A 169 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILN-AEL-R-----FPP----FFNEDVK 231 (318)
T ss_dssp TCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHH-CCC-C-----CCT----TSCHHHH
T ss_pred ccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHh-CCC-C-----CCC----CCCHHHH
Confidence 9999999999999999999999999999999999853221 111112111 111 0 011 1123567
Q ss_pred HHhhhcccCCCCCCC-----CHHHHHH
Q 046010 452 HIGLLCVQEDPADRP-----NMSSVAV 473 (523)
Q Consensus 452 ~li~~cl~~dP~~RP-----s~~ei~~ 473 (523)
+++.+||+.||++|| +++||++
T Consensus 232 ~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 232 DLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 888999999999999 8899873
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=9.1e-26 Score=226.04 Aligned_cols=167 Identities=20% Similarity=0.274 Sum_probs=127.2
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC--CCCeeEeccccceeccCCCCCccccceeccC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH--EMNPKISDFGMARIFGGNQNESNTSKVVGTY 370 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~--~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~ 370 (523)
.....+++..++.++.||+.||.|||+++ |+||||||+||+++. ++.+||+|||++...... .......+++
T Consensus 94 ~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~ 167 (321)
T 1tki_A 94 TSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAP 167 (321)
T ss_dssp SSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT---CEEEEEESCG
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC---CccccccCCh
Confidence 34457999999999999999999999998 999999999999987 789999999999876432 2234567899
Q ss_pred CCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 371 GYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 371 ~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
.|+|||++.+..++.++||||||+++|+|++|..||...... ... ......... ....... .....+
T Consensus 168 ~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~----~~i~~~~~~--~~~~~~~----~~s~~~ 234 (321)
T 1tki_A 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QII----ENIMNAEYT--FDEEAFK----EISIEA 234 (321)
T ss_dssp GGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH----HHHHHTCCC--CCHHHHT----TSCHHH
T ss_pred hhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---HHH----HHHHcCCCC--CChhhhc----cCCHHH
Confidence 999999999888999999999999999999999998532211 111 111111110 0000000 113467
Q ss_pred HHHhhhcccCCCCCCCCHHHHHH--HhccC
Q 046010 451 IHIGLLCVQEDPADRPNMSSVAV--MLASD 478 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~~--~L~~~ 478 (523)
.+|+.+||+.||++|||+.|+++ ++.+.
T Consensus 235 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 235 MDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 78999999999999999999987 44443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-26 Score=229.22 Aligned_cols=171 Identities=23% Similarity=0.266 Sum_probs=126.8
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCc-------cccce
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES-------NTSKV 366 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-------~~~~~ 366 (523)
.+..+++.+++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||.+.......... .....
T Consensus 127 ~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 203 (317)
T 2buj_A 127 KGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203 (317)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHH
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccc
Confidence 4577999999999999999999999998 9999999999999999999999999987642111110 01234
Q ss_pred eccCCCCchhhhcCCC---CCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCcc
Q 046010 367 VGTYGYMAPEYALGGV---ISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCM 443 (523)
Q Consensus 367 ~gt~~y~aPE~l~~~~---~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 443 (523)
.|+..|+|||.+.+.. ++.++||||||+++|+|++|+.||........ ...... .... .. ...
T Consensus 204 ~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~----~~~~--~~-------~~~ 269 (317)
T 2buj_A 204 RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALAV----QNQL--SI-------PQS 269 (317)
T ss_dssp HSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHHH----HCC----C-------CCC
T ss_pred cCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHHh----hccC--CC-------Ccc
Confidence 5688999999987554 68899999999999999999999853211111 111111 1100 00 001
Q ss_pred HHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCCC
Q 046010 444 AAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTVS 481 (523)
Q Consensus 444 ~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~ 481 (523)
......+.+++.+||+.||.+|||+.+|++.|+.....
T Consensus 270 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 270 PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 11234677899999999999999999999999987533
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=228.02 Aligned_cols=163 Identities=20% Similarity=0.234 Sum_probs=125.0
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC----CeeEeccccceeccCCCCCcccccee
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM----NPKISDFGMARIFGGNQNESNTSKVV 367 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~----~~kL~Dfg~a~~~~~~~~~~~~~~~~ 367 (523)
..++..+++..++.++.||+.||.|||+++ |+||||||+||+++.++ .+||+|||++....... ......
T Consensus 106 l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~ 179 (361)
T 2yab_A 106 LAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIF 179 (361)
T ss_dssp HTTCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC---CCCCCC
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC---ccccCC
Confidence 345668999999999999999999999998 99999999999998877 79999999998764322 233467
Q ss_pred ccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHH
Q 046010 368 GTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAEL 447 (523)
Q Consensus 368 gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 447 (523)
||+.|+|||++.+..++.++||||||+++|+|++|..||..... ... ...+..... . +++.... ...
T Consensus 180 gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~---~~~----~~~i~~~~~-~-~~~~~~~----~~s 246 (361)
T 2yab_A 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QET----LANITAVSY-D-FDEEFFS----QTS 246 (361)
T ss_dssp SCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHH----HHHHHTTCC-C-CCHHHHT----TSC
T ss_pred CCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHH----HHHHHhcCC-C-CCchhcc----CCC
Confidence 89999999999998999999999999999999999999853221 111 111111111 0 0111101 112
Q ss_pred HHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 448 LKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 448 ~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
..+.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 247 ELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 45678999999999999999999874
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-25 Score=232.93 Aligned_cols=164 Identities=22% Similarity=0.237 Sum_probs=125.1
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeC---CCCCeeEeccccceeccCCCCCccccceec
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLD---HEMNPKISDFGMARIFGGNQNESNTSKVVG 368 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~---~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~g 368 (523)
..++..+++..++.++.||++||.|||+++ |+||||||+|||++ .++.+||+|||++....... .......|
T Consensus 101 i~~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~--~~~~~~~g 175 (444)
T 3soa_A 101 IVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAWFGFAG 175 (444)
T ss_dssp HHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC--CBCCCSCS
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC--ceeecccC
Confidence 345567999999999999999999999998 99999999999998 45789999999998764322 22234678
Q ss_pred cCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 369 TYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 369 t~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
|+.|+|||++.+..++.++||||||+++|+|++|..||..... ... ......+... ...+.. .....
T Consensus 176 t~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~---~~~----~~~i~~~~~~-~~~~~~-----~~~s~ 242 (444)
T 3soa_A 176 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ---HRL----YQQIKAGAYD-FPSPEW-----DTVTP 242 (444)
T ss_dssp CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHH----HHHHHHTCCC-CCTTTT-----TTSCH
T ss_pred CcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH---HHH----HHHHHhCCCC-CCcccc-----ccCCH
Confidence 9999999999999999999999999999999999999853221 111 1112211111 111100 01124
Q ss_pred HHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 449 KCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+.+|+.+||+.||++|||+.|+++
T Consensus 243 ~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 243 EAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhHCCCHHHHhc
Confidence 5778899999999999999999986
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=9.1e-26 Score=231.22 Aligned_cols=162 Identities=22% Similarity=0.321 Sum_probs=124.7
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..++..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++...... .......||+.
T Consensus 106 l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~---~~~~~~~gt~~ 179 (384)
T 4fr4_A 106 LQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE---TQITTMAGTKP 179 (384)
T ss_dssp HHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT---CCBCCCCSCGG
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC---CceeccCCCcc
Confidence 345667999999999999999999999999 999999999999999999999999999876432 22345679999
Q ss_pred CCchhhhcC---CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 372 YMAPEYALG---GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 372 y~aPE~l~~---~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
|+|||++.. ..++.++||||||+++|+|++|+.||.............. ...... . .+.....
T Consensus 180 Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~----~~~~~~-~---------~p~~~s~ 245 (384)
T 4fr4_A 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT----FETTVV-T---------YPSAWSQ 245 (384)
T ss_dssp GCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH----HHHCCC-C---------CCTTSCH
T ss_pred ccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH----Hhhccc-C---------CCCcCCH
Confidence 999999864 4589999999999999999999999864333222222111 111110 0 0111234
Q ss_pred HHHHHhhhcccCCCCCCCC-HHHHHH
Q 046010 449 KCIHIGLLCVQEDPADRPN-MSSVAV 473 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~RPs-~~ei~~ 473 (523)
.+.+|+.+||+.||.+||+ +++|++
T Consensus 246 ~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 246 EMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 6778999999999999998 777764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-26 Score=236.72 Aligned_cols=172 Identities=23% Similarity=0.247 Sum_probs=124.5
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCC-CCeeEeccccceeccCCCCCccccceeccCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE-MNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+..+++..++.++.||++||.|||+++ |+||||||+|||++.+ +.+||+|||+++...... ......+|+.
T Consensus 148 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~---~~~~~~~t~~ 221 (420)
T 1j1b_A 148 RAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PNVSYICSRY 221 (420)
T ss_dssp HTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSCCSCTT
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhcccCC---CceeeeeCCC
Confidence 45678999999999999999999999998 9999999999999965 568999999998764322 2234578999
Q ss_pred CCchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhh----------hcCCcccccCccccC
Q 046010 372 YMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLW----------CNGEALELMDPVLKQ 440 (523)
Q Consensus 372 y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~ 440 (523)
|+|||++.+. .++.++|||||||++|||++|+.||...... ..+....... ......+..-+.+..
T Consensus 222 y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~---~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~ 298 (420)
T 1j1b_A 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKA 298 (420)
T ss_dssp SCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCC
T ss_pred cCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCC
Confidence 9999998765 6899999999999999999999998643211 1111111110 011111111111110
Q ss_pred C-----ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 441 S-----CMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 441 ~-----~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
. ........+.+|+.+||+.||++|||+.|+++
T Consensus 299 ~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 299 HPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0 01112356789999999999999999999975
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-26 Score=231.84 Aligned_cols=168 Identities=24% Similarity=0.384 Sum_probs=122.8
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC-ccccceeccCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE-SNTSKVVGTYG 371 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~gt~~ 371 (523)
.....+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||++......... .......++..
T Consensus 139 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~ 215 (333)
T 1mqb_A 139 EKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 215 (333)
T ss_dssp HTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGG
T ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCcccc
Confidence 34567999999999999999999999998 999999999999999999999999999876432221 11223345678
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
|+|||.+.+..++.++||||||+++|+|++ |+.||...... .. ......+.... .+......+
T Consensus 216 y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~----~~~~~~~~~~~---------~~~~~~~~l 279 (333)
T 1mqb_A 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EV----MKAINDGFRLP---------TPMDCPSAI 279 (333)
T ss_dssp GSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH----HHHHHTTCCCC---------CCTTCBHHH
T ss_pred ccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HH----HHHHHCCCcCC---------CcccCCHHH
Confidence 999999999999999999999999999999 99998532211 11 11122211111 011223467
Q ss_pred HHHhhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 451 IHIGLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
.+|+.+||+.||++||++.+|++.|++..
T Consensus 280 ~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 280 YQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 78999999999999999999999998753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=218.52 Aligned_cols=174 Identities=20% Similarity=0.281 Sum_probs=130.2
Q ss_pred ccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcc
Q 046010 283 IGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN 362 (523)
Q Consensus 283 ~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 362 (523)
.|....++....+..+++..++.++.||++||.|||+++ .+|+||||||+||+++.++.++|.|||+.....
T Consensus 93 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~------- 164 (271)
T 3kmu_A 93 YGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------- 164 (271)
T ss_dssp TCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-------
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec-------
Confidence 345545555555557999999999999999999999874 359999999999999999999999998875432
Q ss_pred ccceeccCCCCchhhhcCCCCCc---chhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCcccc
Q 046010 363 TSKVVGTYGYMAPEYALGGVISV---KSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLK 439 (523)
Q Consensus 363 ~~~~~gt~~y~aPE~l~~~~~s~---ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 439 (523)
.....+|+.|+|||.+.+..++. ++||||||+++|+|++|+.||..... ................
T Consensus 165 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~~------ 232 (271)
T 3kmu_A 165 SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------MEIGMKVALEGLRPTI------ 232 (271)
T ss_dssp CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------HHHHHHHHHSCCCCCC------
T ss_pred ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------HHHHHHHHhcCCCCCC------
Confidence 12346788999999998765544 79999999999999999999853221 1111222222111111
Q ss_pred CCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 440 QSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 440 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
+......+.+++.+||+.||++|||+.||++.|+...
T Consensus 233 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 233 ---PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1122345778899999999999999999999998753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.6e-26 Score=228.75 Aligned_cols=160 Identities=24% Similarity=0.270 Sum_probs=123.4
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ........||+.
T Consensus 112 l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~~~~~~~~gt~~ 186 (353)
T 2i0e_A 112 IQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKTFCGTPD 186 (353)
T ss_dssp HHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--TCCBCCCCSCGG
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccC--CcccccccCCcc
Confidence 345567999999999999999999999998 999999999999999999999999999854221 122345678999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||++.+..++.++||||||+++|||++|+.||..... ....... ...... + +......+.
T Consensus 187 y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i-~~~~~~------~----p~~~s~~~~ 249 (353)
T 2i0e_A 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSI-MEHNVA------Y----PKSMSKEAV 249 (353)
T ss_dssp GCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHH-HHCCCC------C----CTTSCHHHH
T ss_pred ccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH------HHHHHHH-HhCCCC------C----CCCCCHHHH
Confidence 9999999999999999999999999999999999853221 1111111 111110 1 111224677
Q ss_pred HHhhhcccCCCCCCCC-----HHHHHH
Q 046010 452 HIGLLCVQEDPADRPN-----MSSVAV 473 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs-----~~ei~~ 473 (523)
+|+.+||+.||++||+ +++|++
T Consensus 250 ~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 250 AICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 8899999999999995 466653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-25 Score=243.82 Aligned_cols=160 Identities=24% Similarity=0.264 Sum_probs=125.5
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...... .......||+.
T Consensus 433 l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~--~~~~~~~GT~~ 507 (674)
T 3pfq_A 433 IQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPD 507 (674)
T ss_dssp HHHHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCTT--CCBCCCCSCSS
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccCC--cccccccCCCc
Confidence 345568999999999999999999999998 9999999999999999999999999998643222 23445689999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||++.+..++.++||||||+++|||++|+.||..... ...... +..... . + +......+.
T Consensus 508 Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~~-i~~~~~-~-----~----p~~~s~~~~ 570 (674)
T 3pfq_A 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQS-IMEHNV-A-----Y----PKSMSKEAV 570 (674)
T ss_dssp SCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH-HHSSCC-C-----C----CTTSCHHHH
T ss_pred ccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHHH-HHhCCC-C-----C----CccCCHHHH
Confidence 9999999999999999999999999999999999853221 111111 122111 0 1 111234677
Q ss_pred HHhhhcccCCCCCCCCH-----HHHHH
Q 046010 452 HIGLLCVQEDPADRPNM-----SSVAV 473 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~-----~ei~~ 473 (523)
+|+.+||+.||++||++ +||++
T Consensus 571 ~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 571 AICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 89999999999999998 67753
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=232.32 Aligned_cols=174 Identities=17% Similarity=0.203 Sum_probs=129.5
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEe----CCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 297 QLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLL----DHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 297 ~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll----~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.+++..++.++.||+.||.|||+++ |+||||||+||++ +.++.+||+|||+++..... .......||..|
T Consensus 108 ~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~---~~~~~~~gt~~y 181 (396)
T 4eut_A 108 GLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQFVSLYGTEEY 181 (396)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG---GGSSCSSSCCTT
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC---CccccccCCccc
Confidence 3999999999999999999999998 9999999999999 77778999999999876432 222345689999
Q ss_pred CchhhhcC--------CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCC--ccccc--------
Q 046010 373 MAPEYALG--------GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGE--ALELM-------- 434 (523)
Q Consensus 373 ~aPE~l~~--------~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-------- 434 (523)
+|||++.+ ..++.++||||||+++|||++|+.||......... ............ ....+
T Consensus 182 ~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~~~~~p~~~~~~~~~~~~~~~ 259 (396)
T 4eut_A 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIITGKPSGAISGVQKAENGPI 259 (396)
T ss_dssp CCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHHHHSCCTTCCEEEECSTTCCE
T ss_pred cCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHHhcCCCcccchhheeccCCCc
Confidence 99998865 56788999999999999999999998643332221 111112111110 00000
Q ss_pred ----CccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 435 ----DPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 435 ----~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+..............+.+++.+||+.||++||++.|+++.|+..
T Consensus 260 ~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 260 DWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp EEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred ccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 00011123356667788999999999999999999999988765
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.5e-26 Score=229.95 Aligned_cols=171 Identities=20% Similarity=0.217 Sum_probs=124.7
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEe-------------------CCCCCeeEeccccce
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLL-------------------DHEMNPKISDFGMAR 352 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll-------------------~~~~~~kL~Dfg~a~ 352 (523)
......+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 114 ~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 190 (355)
T 2eu9_A 114 ENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190 (355)
T ss_dssp HTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCE
T ss_pred hccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccc
Confidence 344457999999999999999999999998 9999999999999 567889999999998
Q ss_pred eccCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhc-----
Q 046010 353 IFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCN----- 427 (523)
Q Consensus 353 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----- 427 (523)
..... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||........ ..........
T Consensus 191 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~p~~~ 262 (355)
T 2eu9_A 191 FDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH---LVMMEKILGPIPSHM 262 (355)
T ss_dssp ETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCHHH
T ss_pred ccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCcHHH
Confidence 64322 2345789999999999999999999999999999999999999864332111 1111111000
Q ss_pred ---CCccc-ccCcc---------------------ccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 428 ---GEALE-LMDPV---------------------LKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 428 ---~~~~~-~~~~~---------------------l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
..... ..... ............+.+|+.+||+.||++|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 263 IHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 00000 000111233557889999999999999999999973
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-26 Score=227.03 Aligned_cols=177 Identities=20% Similarity=0.270 Sum_probs=120.8
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
......+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||.+....... .......++..
T Consensus 93 ~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~ 167 (311)
T 4agu_A 93 DRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS--DYYDDEVATRW 167 (311)
T ss_dssp HHTSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--------------GG
T ss_pred HhhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc--cccCCCcCCcc
Confidence 345667999999999999999999999998 9999999999999999999999999998764222 12234578899
Q ss_pred CCchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHH--------HHHhhhcCCccc---ccCcccc
Q 046010 372 YMAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAY--------TWKLWCNGEALE---LMDPVLK 439 (523)
Q Consensus 372 y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~---~~~~~l~ 439 (523)
|+|||.+.+ ..++.++||||||+++|+|++|+.||.............. .+..+....... ..++...
T Consensus 168 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (311)
T 4agu_A 168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDM 247 (311)
T ss_dssp GCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSC
T ss_pred ccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCcccc
Confidence 999999876 6689999999999999999999999864332211111100 011111111000 0000000
Q ss_pred CCc---cHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 440 QSC---MAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 440 ~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
... .......+.+|+.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 248 EPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred chhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 0112345778999999999999999999975
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.4e-26 Score=222.60 Aligned_cols=162 Identities=19% Similarity=0.233 Sum_probs=122.2
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCC--------eeEeccccceeccCCCCCcccc
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMN--------PKISDFGMARIFGGNQNESNTS 364 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~--------~kL~Dfg~a~~~~~~~~~~~~~ 364 (523)
.....+++..++.++.||++||.|||+++ |+||||||+||+++.++. +||+|||++.... ...
T Consensus 105 ~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~------~~~ 175 (289)
T 4fvq_A 105 KNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL------PKD 175 (289)
T ss_dssp HTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTS------CHH
T ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeeccCccccccc------Ccc
Confidence 34445999999999999999999999998 999999999999998887 9999999986532 122
Q ss_pred ceeccCCCCchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCcc
Q 046010 365 KVVGTYGYMAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCM 443 (523)
Q Consensus 365 ~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 443 (523)
...++..|+|||.+.+ ..++.++||||||+++|+|++|..|+...... .................
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~--------- 241 (289)
T 4fvq_A 176 ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-----QRKLQFYEDRHQLPAPK--------- 241 (289)
T ss_dssp HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----HHHHHHHHTTCCCCCCS---------
T ss_pred ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-----HHHHHHhhccCCCCCCC---------
Confidence 3467889999999987 67899999999999999999966554221111 11111111111111111
Q ss_pred HHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCC
Q 046010 444 AAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTV 480 (523)
Q Consensus 444 ~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~ 480 (523)
...+.+|+.+||+.||++|||+.||++.|++...
T Consensus 242 ---~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 242 ---AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp ---SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred ---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1246688899999999999999999999988743
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=8.2e-26 Score=221.32 Aligned_cols=157 Identities=27% Similarity=0.372 Sum_probs=120.5
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.+...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++...... ......++..|
T Consensus 101 ~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~~y 173 (279)
T 3fdn_A 101 QKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDY 173 (279)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC------------CCCCTT
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc----cccccCCCCCc
Confidence 44567999999999999999999999998 999999999999999999999999988654322 22345789999
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
+|||.+.+..++.++||||||+++|+|++|+.||...... . .......... .. +......+.+
T Consensus 174 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~-~~~~~~~~~~------~~----~~~~~~~~~~ 236 (279)
T 3fdn_A 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------E-TYKRISRVEF------TF----PDFVTEGARD 236 (279)
T ss_dssp CCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------H-HHHHHHHTCC------CC----CTTSCHHHHH
T ss_pred cCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH------H-HHHHHHhCCC------CC----CCcCCHHHHH
Confidence 9999999999999999999999999999999998532211 1 1111111110 00 1112245678
Q ss_pred HhhhcccCCCCCCCCHHHHHH
Q 046010 453 IGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~ 473 (523)
|+.+||+.||++|||+.||++
T Consensus 237 li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 237 LISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp HHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHHhccChhhCCCHHHHhh
Confidence 899999999999999999986
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-25 Score=226.82 Aligned_cols=164 Identities=21% Similarity=0.244 Sum_probs=124.3
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC---CeeEeccccceeccCCCCCccccceec
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM---NPKISDFGMARIFGGNQNESNTSKVVG 368 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~---~~kL~Dfg~a~~~~~~~~~~~~~~~~g 368 (523)
..++..+++..++.++.||++||.|||+++ |+||||||+||+++.++ .+||+|||++....... ......|
T Consensus 119 l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~g 192 (362)
T 2bdw_A 119 IVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAG 192 (362)
T ss_dssp HTTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC---SCCCSCS
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc---ccccCCC
Confidence 345567999999999999999999999998 99999999999998654 59999999998764322 2234678
Q ss_pred cCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 369 TYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 369 t~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
|+.|+|||++.+..++.++||||||+++|+|++|+.||..... ..+ ......+... ...+.. .....
T Consensus 193 t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~----~~~i~~~~~~-~~~~~~-----~~~~~ 259 (362)
T 2bdw_A 193 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRL----YAQIKAGAYD-YPSPEW-----DTVTP 259 (362)
T ss_dssp CTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH----HHHHHHTCCC-CCTTGG-----GGSCH
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHH----HHHHHhCCCC-CCcccc-----cCCCH
Confidence 9999999999998999999999999999999999999853221 111 1111111111 001100 11234
Q ss_pred HHHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 449 KCIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
.+.+|+.+||+.||++|||+.|+++.
T Consensus 260 ~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 260 EAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 56789999999999999999998753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-26 Score=252.27 Aligned_cols=168 Identities=29% Similarity=0.365 Sum_probs=127.6
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC-ccccceeccC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE-SNTSKVVGTY 370 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~gt~ 370 (523)
..++..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...... .......++.
T Consensus 460 l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~ 536 (635)
T 4fl3_A 460 LQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 536 (635)
T ss_dssp HHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CG
T ss_pred HhhCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCce
Confidence 345678999999999999999999999998 999999999999999999999999999876433221 1222345677
Q ss_pred CCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 371 GYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 371 ~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
.|+|||++.+..++.++||||||+++|||++ |+.||...... ........+..... +......
T Consensus 537 ~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-------~~~~~i~~~~~~~~---------p~~~~~~ 600 (635)
T 4fl3_A 537 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGERMGC---------PAGCPRE 600 (635)
T ss_dssp GGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCCCCC---------CTTCCHH
T ss_pred eeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCCC---------CCCCCHH
Confidence 8999999999999999999999999999998 99998543221 11222222221111 1123356
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+.+||.+||+.||++||++.+|+++|+..
T Consensus 601 l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 601 MYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 78899999999999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-25 Score=233.70 Aligned_cols=108 Identities=28% Similarity=0.417 Sum_probs=89.4
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC-----------
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE----------- 360 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~----------- 360 (523)
..+...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 147 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~ 223 (458)
T 3rp9_A 147 FRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223 (458)
T ss_dssp HHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC------
T ss_pred cccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCcccc
Confidence 355667999999999999999999999998 999999999999999999999999999876422111
Q ss_pred --------------ccccceeccCCCCchhhh-cCCCCCcchhhHHHHHHHHHHHhC
Q 046010 361 --------------SNTSKVVGTYGYMAPEYA-LGGVISVKSDVFSFGVLLLEIISG 402 (523)
Q Consensus 361 --------------~~~~~~~gt~~y~aPE~l-~~~~~s~ksDVwSlGvvl~elltG 402 (523)
.......||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp ---------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 122345789999999976 456799999999999999999994
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-25 Score=219.78 Aligned_cols=169 Identities=20% Similarity=0.214 Sum_probs=128.4
Q ss_pred cccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceecc
Q 046010 290 IYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369 (523)
Q Consensus 290 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt 369 (523)
+.......+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||.+................++
T Consensus 98 ~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 174 (305)
T 2wtk_C 98 LDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGS 174 (305)
T ss_dssp HHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSC
T ss_pred HHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCC
Confidence 33445677999999999999999999999998 999999999999999999999999999876533333333456689
Q ss_pred CCCCchhhhcCCC--CCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHH
Q 046010 370 YGYMAPEYALGGV--ISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAEL 447 (523)
Q Consensus 370 ~~y~aPE~l~~~~--~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 447 (523)
..|+|||.+.+.. .+.++||||||+++|+|++|+.||..... .. .......... . +.. ...
T Consensus 175 ~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~-~~~~i~~~~~-~-----~~~----~~~ 237 (305)
T 2wtk_C 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------YK-LFENIGKGSY-A-----IPG----DCG 237 (305)
T ss_dssp GGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------HH-HHHHHHHCCC-C-----CCS----SSC
T ss_pred CCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------HH-HHHHHhcCCC-C-----CCC----ccC
Confidence 9999999987644 47799999999999999999999853221 11 1111111111 0 111 122
Q ss_pred HHHHHHhhhcccCCCCCCCCHHHHHH--HhccC
Q 046010 448 LKCIHIGLLCVQEDPADRPNMSSVAV--MLASD 478 (523)
Q Consensus 448 ~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~~ 478 (523)
..+.+++.+||+.||++|||+.|+++ ++++.
T Consensus 238 ~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 238 PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 45678899999999999999999985 45544
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.3e-26 Score=228.49 Aligned_cols=159 Identities=26% Similarity=0.339 Sum_probs=123.7
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .......||+.
T Consensus 109 l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~ 183 (345)
T 1xjd_A 109 IQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPD 183 (345)
T ss_dssp HHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGG
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcccCC--CcccCCCCCcc
Confidence 345567999999999999999999999998 9999999999999999999999999997543211 22345678999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||++.+..++.++||||||+++|||++|+.||..... ..+ ......... .+.. .....+.
T Consensus 184 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~----~~~i~~~~~------~~p~----~~s~~~~ 246 (345)
T 1xjd_A 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EEL----FHSIRMDNP------FYPR----WLEKEAK 246 (345)
T ss_dssp GCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH----HHHHHHCCC------CCCT----TSCHHHH
T ss_pred cCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH---HHH----HHHHHhCCC------CCCc----ccCHHHH
Confidence 9999999999999999999999999999999999853221 111 111111111 0111 1124567
Q ss_pred HHhhhcccCCCCCCCCHH-HHH
Q 046010 452 HIGLLCVQEDPADRPNMS-SVA 472 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~-ei~ 472 (523)
+|+.+||+.||++||++. +|+
T Consensus 247 ~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 247 DLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHHHHHSCSSGGGSBTTBSCGG
T ss_pred HHHHHHhcCCHhHcCCChHHHH
Confidence 889999999999999997 664
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=2.4e-25 Score=227.24 Aligned_cols=181 Identities=23% Similarity=0.250 Sum_probs=127.4
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++..... .....+|..|+||
T Consensus 123 ~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aP 194 (367)
T 1cm8_A 123 EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAP 194 (367)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCT
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccccccc-----cCcCcCCCCcCCH
Confidence 57999999999999999999999998 999999999999999999999999999875322 2345778999999
Q ss_pred hhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCC------------------cccccCc
Q 046010 376 EYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGE------------------ALELMDP 436 (523)
Q Consensus 376 E~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~ 436 (523)
|++.+ ..++.++|||||||++|+|++|+.||....... .+........... .......
T Consensus 195 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (367)
T 1cm8_A 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD---QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKK 271 (367)
T ss_dssp HHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCC
T ss_pred HHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCC
Confidence 99887 679999999999999999999999986432211 1111110000000 0000000
Q ss_pred cccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH--HhccCCCCCCCCCCC
Q 046010 437 VLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV--MLASDTVSLPQPTQP 488 (523)
Q Consensus 437 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~~~~~l~~p~~p 488 (523)
.+. .........+.+|+.+||+.||++|||+.|+++ .+++.......|..+
T Consensus 272 ~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~ 324 (367)
T 1cm8_A 272 DFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ 324 (367)
T ss_dssp CGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC
T ss_pred CHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCCC
Confidence 000 001122346778999999999999999999988 566554333333333
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.92 E-value=6.4e-26 Score=229.15 Aligned_cols=181 Identities=20% Similarity=0.230 Sum_probs=129.9
Q ss_pred eEeeecccccc---ccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCC-C---CeeEecccc
Q 046010 278 AIWIAIGTTIP---TIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE-M---NPKISDFGM 350 (523)
Q Consensus 278 ~~~ia~g~~~~---~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~-~---~~kL~Dfg~ 350 (523)
..++.+.++.. .-+..++..+++..++.++.||+.||+|||+++ |+||||||+||++..+ + .+||+|||+
T Consensus 90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~ 166 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGF 166 (342)
T ss_dssp EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence 34555444431 223345567999999999999999999999998 9999999999998543 3 499999999
Q ss_pred ceeccCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCc
Q 046010 351 ARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEA 430 (523)
Q Consensus 351 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (523)
++....... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||..........+. .....+..
T Consensus 167 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~----~~i~~~~~ 240 (342)
T 2qr7_A 167 AKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL----ARIGSGKF 240 (342)
T ss_dssp CEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH----HHHHHCCC
T ss_pred cccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH----HHHccCCc
Confidence 987643322 233457899999999998888999999999999999999999998643222222221 22222221
Q ss_pred ccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 431 LELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 431 ~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.. .. .........+.+|+.+||+.||++|||+.|+++
T Consensus 241 ~~-~~-----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 241 SL-SG-----GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CC-CS-----TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cc-Cc-----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 10 00 001112345678899999999999999999975
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-26 Score=237.93 Aligned_cols=149 Identities=15% Similarity=0.155 Sum_probs=117.3
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
..+..+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..... .....| +.|
T Consensus 203 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y 273 (413)
T 3dzo_A 203 STHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGF 273 (413)
T ss_dssp TTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTT
T ss_pred ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-Cce
Confidence 44667999999999999999999999998 999999999999999999999999998865321 334566 999
Q ss_pred Cchhhh----------cCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCc
Q 046010 373 MAPEYA----------LGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSC 442 (523)
Q Consensus 373 ~aPE~l----------~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 442 (523)
+|||++ .+..++.++|||||||++|||++|+.||.......... ..+... ...
T Consensus 274 ~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~---------------~~~~~~--~~~ 336 (413)
T 3dzo_A 274 APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE---------------WIFRSC--KNI 336 (413)
T ss_dssp CCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG---------------GGGSSC--CCC
T ss_pred eCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHH---------------HHHhhc--ccC
Confidence 999999 55568889999999999999999999986432211110 011100 011
Q ss_pred cHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 046010 443 MAAELLKCIHIGLLCVQEDPADRPNMSSV 471 (523)
Q Consensus 443 ~~~~~~~~~~li~~cl~~dP~~RPs~~ei 471 (523)
...+.+|+.+||+.||++||++.++
T Consensus 337 ----~~~~~~li~~~l~~dP~~Rpt~~~~ 361 (413)
T 3dzo_A 337 ----PQPVRALLEGFLRYPKEDRLLPLQA 361 (413)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ----CHHHHHHHHHHccCChhhCcCHHHH
Confidence 2457788999999999999996655
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.1e-26 Score=230.56 Aligned_cols=172 Identities=23% Similarity=0.207 Sum_probs=128.0
Q ss_pred eEeeeccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 278 AIWIAIGTTI---PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 278 ~~~ia~g~~~---~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
.+++.+.++. +.-+..+...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 3445544443 1223345667999999999999999999999998 999999999999999999999999999864
Q ss_pred cCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCccccc
Q 046010 355 GGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELM 434 (523)
Q Consensus 355 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (523)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ........ .... .
T Consensus 190 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~-~~~~-~-- 257 (373)
T 2r5t_A 190 IEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNIL-NKPL-Q-- 257 (373)
T ss_dssp BCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHHH-HSCC-C--
T ss_pred ccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHH-hccc-C--
Confidence 3221 223456789999999999999999999999999999999999999853221 11111111 1111 0
Q ss_pred CccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 046010 435 DPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSV 471 (523)
Q Consensus 435 ~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei 471 (523)
+... ....+.+|+.+||+.||.+||++.+.
T Consensus 258 ---~~~~----~~~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 258 ---LKPN----ITNSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp ---CCSS----SCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred ---CCCC----CCHHHHHHHHHHcccCHHhCCCCCCC
Confidence 1111 12356788999999999999998543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=226.72 Aligned_cols=157 Identities=22% Similarity=0.241 Sum_probs=124.2
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .....||+.
T Consensus 132 l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-----~~~~~gt~~ 203 (350)
T 1rdq_E 132 LRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPE 203 (350)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGG
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC-----cccccCCcc
Confidence 344567999999999999999999999998 999999999999999999999999999875322 234678999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||++.+..++.++||||||+++|+|++|+.||..... ... ...+..+.. . +.. .....+.
T Consensus 204 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~-~~~i~~~~~-~-----~p~----~~~~~~~ 266 (350)
T 1rdq_E 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQI-YEKIVSGKV-R-----FPS----HFSSDLK 266 (350)
T ss_dssp GCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHH-HHHHHHCCC-C-----CCT----TCCHHHH
T ss_pred ccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHH-HHHHHcCCC-C-----CCC----CCCHHHH
Confidence 9999999999999999999999999999999999853221 111 111222111 0 111 1224577
Q ss_pred HHhhhcccCCCCCCCC-----HHHHHH
Q 046010 452 HIGLLCVQEDPADRPN-----MSSVAV 473 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs-----~~ei~~ 473 (523)
+|+.+||+.||.+||+ ++||++
T Consensus 267 ~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 267 DLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 8899999999999998 888864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.1e-26 Score=224.48 Aligned_cols=168 Identities=23% Similarity=0.298 Sum_probs=119.8
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
.+..+++..++.++.||++||.|||+++ |+|+||||+||+++.++.+||+|||++....... .......++..|+
T Consensus 129 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~ 203 (310)
T 2wqm_A 129 QKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYM 203 (310)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------------------CCSSC
T ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC--ccccccCCCeeEe
Confidence 4567999999999999999999999998 9999999999999999999999999987654322 1223456889999
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
|||.+.+..++.++||||||+++|+|++|+.||..... ...... ............. . .....+.+|
T Consensus 204 aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~-~~~~~~~~~~~~~----~----~~~~~l~~l 270 (310)
T 2wqm_A 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLC-KKIEQCDYPPLPS----D----HYSEELRQL 270 (310)
T ss_dssp CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHH-HHHHTTCSCCCCT----T----TSCHHHHHH
T ss_pred ChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHH-HHhhcccCCCCcc----c----ccCHHHHHH
Confidence 99999999999999999999999999999999853221 111111 1112211111111 1 122457788
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
+.+||+.||++|||+.+|++.|++..
T Consensus 271 i~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 271 VNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 99999999999999999999998864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-25 Score=221.85 Aligned_cols=171 Identities=19% Similarity=0.218 Sum_probs=120.0
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.+...+++..++.++.||++||.|||+++ |+|+||||+||+++.++.+||+|||++........ .......++..|
T Consensus 126 ~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y 201 (309)
T 2h34_A 126 RRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-TQLGNTVGTLYY 201 (309)
T ss_dssp HHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----------------CCGGG
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccccc-ccccccCCCcCc
Confidence 44567999999999999999999999998 99999999999999999999999999876543221 122345688999
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCC-cccccCccccCCccHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGE-ALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
+|||.+.+..++.++||||||+++|+|++|+.||...... .......... ...... ......+.
T Consensus 202 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~--------~~~~~~l~ 266 (309)
T 2h34_A 202 MAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIPRPSTVR--------PGIPVAFD 266 (309)
T ss_dssp CCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCCCGGGTS--------TTCCTHHH
T ss_pred cCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCCCccccC--------CCCCHHHH
Confidence 9999999989999999999999999999999998532211 1111111111 011111 11223567
Q ss_pred HHhhhcccCCCCCCC-CHHHHHHHhccCCCCC
Q 046010 452 HIGLLCVQEDPADRP-NMSSVAVMLASDTVSL 482 (523)
Q Consensus 452 ~li~~cl~~dP~~RP-s~~ei~~~L~~~~~~l 482 (523)
+++.+||+.||++|| +++++++.|+......
T Consensus 267 ~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 267 AVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred HHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 889999999999999 9999999999875444
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-26 Score=229.72 Aligned_cols=165 Identities=27% Similarity=0.322 Sum_probs=125.8
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++.+++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++.... ........++..|+|
T Consensus 136 ~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~a 209 (327)
T 1fvr_A 136 ASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMA 209 (327)
T ss_dssp SCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCE---ECCC----CCTTTCC
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeEEEcccCcCccccc---cccccCCCCCccccC
Confidence 357999999999999999999999998 99999999999999999999999999874321 112223456788999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||.+.+..++.++||||||+++|+|++ |+.||..... .. .......+.... .+......+.+|
T Consensus 210 PE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~~-~~~~~~~~~~~~---------~~~~~~~~l~~l 273 (327)
T 1fvr_A 210 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AE-LYEKLPQGYRLE---------KPLNCDDEVYDL 273 (327)
T ss_dssp HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HH-HHHHGGGTCCCC---------CCTTBCHHHHHH
T ss_pred hhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH------HH-HHHHhhcCCCCC---------CCCCCCHHHHHH
Confidence 999998889999999999999999998 9999853221 11 111121111111 111223467789
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccCCCC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASDTVS 481 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~~~~ 481 (523)
+.+||+.||++|||+.|+++.|+.....
T Consensus 274 i~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 274 MRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999876433
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-25 Score=227.18 Aligned_cols=187 Identities=22% Similarity=0.228 Sum_probs=123.4
Q ss_pred eEeeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCC
Q 046010 278 AIWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGN 357 (523)
Q Consensus 278 ~~~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 357 (523)
..++.+.++-..+...-...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 104 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180 (371)
T ss_dssp EEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred ceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence 34455444443333222356999999999999999999999998 999999999999999999999999999865322
Q ss_pred CCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHH---------------
Q 046010 358 QNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTW--------------- 422 (523)
Q Consensus 358 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~--------------- 422 (523)
.......+|+.|+|||++.+..++.++||||||+++|+|++|+.||....... ......
T Consensus 181 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 181 ---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID---QWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHC-CCCCCHHHHTTSC
T ss_pred ---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHHHhh
Confidence 12334678999999999999999999999999999999999999986432110 000000
Q ss_pred ----HhhhcC-C-----cccccCccccC---CccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 423 ----KLWCNG-E-----ALELMDPVLKQ---SCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 423 ----~~~~~~-~-----~~~~~~~~l~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
...... . ..+.+...... .........+.+|+.+||+.||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000000 0 00000000000 011223567889999999999999999999976
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-25 Score=228.36 Aligned_cols=109 Identities=27% Similarity=0.361 Sum_probs=94.7
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHh--cCCCcEEecCCCCCcEEeC--CCCCeeEeccccceeccCCCCCcccccee
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHE--DSRLKVFHRDLKASNVLLD--HEMNPKISDFGMARIFGGNQNESNTSKVV 367 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~g~~~ivH~Dlkp~NIll~--~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 367 (523)
......+++..++.++.||+.||.|||. .+ |+||||||+|||++ .++.+||+|||+++..... .....
T Consensus 148 ~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~-----~~~~~ 219 (382)
T 2vx3_A 148 NTNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYI 219 (382)
T ss_dssp HTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSC
T ss_pred hcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEeccCceecccc-----ccccc
Confidence 3334569999999999999999999994 56 99999999999995 4778999999999876422 23457
Q ss_pred ccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 046010 368 GTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGF 408 (523)
Q Consensus 368 gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~ 408 (523)
+|+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 220 ~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 220 QSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp SCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 88999999999999999999999999999999999999864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.4e-26 Score=222.35 Aligned_cols=168 Identities=24% Similarity=0.304 Sum_probs=127.5
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCc-cccceeccCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES-NTSKVVGTYGY 372 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~gt~~y 372 (523)
.+..+++..++.++.||++||.|||+++ |+|+||||+||+++.++.+||+|||++.......... ......++..|
T Consensus 114 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y 190 (291)
T 1u46_A 114 HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190 (291)
T ss_dssp HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGG
T ss_pred ccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCcee
Confidence 3467999999999999999999999998 9999999999999999999999999998764333221 22334567789
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
+|||.+.+..++.++||||||+++|+|++ |+.||...... .............. .+......+.
T Consensus 191 ~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~~~---------~~~~~~~~l~ 255 (291)
T 1u46_A 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGERLP---------RPEDCPQDIY 255 (291)
T ss_dssp CCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCCCCC---------CCTTCCHHHH
T ss_pred eCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHHccCCCCC---------CCcCcCHHHH
Confidence 99999998889999999999999999999 99998533211 11111111111110 0112234677
Q ss_pred HHhhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 452 HIGLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
+++.+||+.||++|||+.+|++.|++..
T Consensus 256 ~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 256 NVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 8999999999999999999999998763
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-25 Score=224.01 Aligned_cols=171 Identities=18% Similarity=0.202 Sum_probs=122.8
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC-CeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM-NPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
..+++..++.++.||++||+|||+++ |+||||||+|||++.++ .+||+|||+++...... ......++..|+|
T Consensus 125 ~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~~~y~a 198 (330)
T 3nsz_A 125 QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKG 198 (330)
T ss_dssp GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSCCSCGGGCC
T ss_pred HhCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC---ccccccccccccC
Confidence 45999999999999999999999998 99999999999999777 89999999998764322 2334568889999
Q ss_pred hhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHH--------HHHhhhcC--------------Ccc
Q 046010 375 PEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAY--------TWKLWCNG--------------EAL 431 (523)
Q Consensus 375 PE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~--------~~~~~~~~--------------~~~ 431 (523)
||.+.+ ..++.++||||||+++|+|++|+.||......... +... ....+... ...
T Consensus 199 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (330)
T 3nsz_A 199 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSR 277 (330)
T ss_dssp HHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCC
T ss_pred hhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCchhhhHHHHhccccccchhhhhhhccc
Confidence 999887 67899999999999999999999998432221110 0000 00000000 000
Q ss_pred cccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 432 ELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 432 ~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
..................+.+|+.+||+.||++|||++|+++
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 278 KRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000111111111123456788999999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=228.20 Aligned_cols=178 Identities=21% Similarity=0.250 Sum_probs=126.4
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhc-CCCcEEecCCCCCcEEeC------CCCCeeEeccccceeccCCCCCcccc
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHED-SRLKVFHRDLKASNVLLD------HEMNPKISDFGMARIFGGNQNESNTS 364 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-g~~~ivH~Dlkp~NIll~------~~~~~kL~Dfg~a~~~~~~~~~~~~~ 364 (523)
......+++..++.++.||+.||+|||++ + |+||||||+|||++ ..+.+||+|||++...... ..
T Consensus 122 ~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~ 193 (373)
T 1q8y_A 122 KYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YT 193 (373)
T ss_dssp HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CC
T ss_pred HhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC-----CC
Confidence 33456699999999999999999999998 8 99999999999994 4447999999999875422 23
Q ss_pred ceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccc---hHHHHHHhhh---------------
Q 046010 365 KVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQS---LLAYTWKLWC--------------- 426 (523)
Q Consensus 365 ~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~---~~~~~~~~~~--------------- 426 (523)
...+|+.|+|||++.+..++.++||||||+++|+|++|+.||.......... .+........
T Consensus 194 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 273 (373)
T 1q8y_A 194 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRT 273 (373)
T ss_dssp SCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHH
T ss_pred CCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhh
Confidence 3468999999999999999999999999999999999999996433221111 1111111000
Q ss_pred ---cCCcccccCc----------cccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH--Hhcc
Q 046010 427 ---NGEALELMDP----------VLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV--MLAS 477 (523)
Q Consensus 427 ---~~~~~~~~~~----------~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~ 477 (523)
.......+.. ......+......+.+|+.+||+.||++|||+.||++ ++++
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 339 (373)
T 1q8y_A 274 FFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339 (373)
T ss_dssp HBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTT
T ss_pred hcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhc
Confidence 0000000000 0011234566778889999999999999999999987 5554
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.7e-27 Score=236.52 Aligned_cols=174 Identities=25% Similarity=0.339 Sum_probs=129.0
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCc-cccceeccCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES-NTSKVVGTYG 371 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~gt~~ 371 (523)
..+..+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||++.......... ......++..
T Consensus 137 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~ 213 (326)
T 2w1i_A 137 KHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF 213 (326)
T ss_dssp HSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGG
T ss_pred hcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCcee
Confidence 33456999999999999999999999998 9999999999999999999999999998765332211 1223446677
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccc---------cccchHHHHHHhhhcCCcccccCccccCCc
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSE---------HGQSLLAYTWKLWCNGEALELMDPVLKQSC 442 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 442 (523)
|+|||.+.+..++.++||||||+++|+|++|..|+...... ................... ..
T Consensus 214 y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~ 284 (326)
T 2w1i_A 214 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL---------PR 284 (326)
T ss_dssp GCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCC---------CC
T ss_pred EECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCC---------CC
Confidence 99999999888999999999999999999999887532110 0000011111111111111 11
Q ss_pred cHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 443 MAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 443 ~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+......+.+|+.+||+.||++|||+.||++.|++.
T Consensus 285 ~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 285 PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 112235677899999999999999999999999865
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-25 Score=221.54 Aligned_cols=161 Identities=23% Similarity=0.286 Sum_probs=114.3
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhc-CCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHED-SRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~-g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
.++..+++..++.++.||+.||.|||++ + |+||||||+||+++.++.+||+|||++....... ......+++.
T Consensus 101 ~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~ 174 (290)
T 3fme_A 101 DKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV---AKDIDAGCKP 174 (290)
T ss_dssp HTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------------------CCCCC
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccccccc---cccccCCCcc
Confidence 3567899999999999999999999998 8 9999999999999999999999999998654322 2233468999
Q ss_pred CCchhhh----cCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHH
Q 046010 372 YMAPEYA----LGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAEL 447 (523)
Q Consensus 372 y~aPE~l----~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 447 (523)
|+|||.+ .+..++.++||||||+++|+|++|+.||...... ............ ...... ...
T Consensus 175 y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~-~~~~~~--------~~~ 240 (290)
T 3fme_A 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQLKQVVEEPS-PQLPAD--------KFS 240 (290)
T ss_dssp CSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHHHHHHHHSCC-CCCCTT--------TSC
T ss_pred ccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHHHHHHhccCC-CCcccc--------cCC
Confidence 9999996 4567899999999999999999999998532211 111111111111 111111 112
Q ss_pred HHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 448 LKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 448 ~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
..+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 241 AEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 45778899999999999999999976
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-25 Score=225.09 Aligned_cols=164 Identities=23% Similarity=0.336 Sum_probs=116.9
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC---CCCeeEeccccceeccCCCCCccccceec
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH---EMNPKISDFGMARIFGGNQNESNTSKVVG 368 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~---~~~~kL~Dfg~a~~~~~~~~~~~~~~~~g 368 (523)
..++..+++.+++.++.||++||.|||+++ |+||||||+||+++. ++.+||+|||+++..... .......|
T Consensus 139 l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~g 212 (349)
T 2w4o_A 139 IVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ---VLMKTVCG 212 (349)
T ss_dssp HTTCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------------------
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCcc---cccccccC
Confidence 345567999999999999999999999998 999999999999975 889999999999865322 12234578
Q ss_pred cCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 369 TYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 369 t~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
|+.|+|||++.+..++.++||||||+++|+|++|+.||...... ............. ...+. ......
T Consensus 213 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~i~~~~~~-~~~~~-----~~~~~~ 280 (349)
T 2w4o_A 213 TPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD------QFMFRRILNCEYY-FISPW-----WDEVSL 280 (349)
T ss_dssp CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH------HHHHHHHHTTCCC-CCTTT-----TTTSCH
T ss_pred CCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc------HHHHHHHHhCCCc-cCCch-----hhhCCH
Confidence 99999999999999999999999999999999999998532211 1111122221111 11111 111234
Q ss_pred HHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 449 KCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+.+|+.+||+.||++|||+.|+++
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHhc
Confidence 6778999999999999999999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-25 Score=225.26 Aligned_cols=160 Identities=24% Similarity=0.255 Sum_probs=122.5
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCC---eeEeccccceeccCCCCCccccceeccCC
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMN---PKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~---~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
+..+++..++.++.||++||.|||+++ |+||||||+||+++.++. +||+|||++....... .......||+.
T Consensus 124 ~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~ 198 (351)
T 3c0i_A 124 GFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LVAGGRVGTPH 198 (351)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTS--CBCCCCCSCGG
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcceeEecCCC--eeecCCcCCcC
Confidence 345899999999999999999999998 999999999999987654 9999999998764322 22334578999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||++.+..++.++||||||+++|+|++|+.||.... ... ......+... ..+.... .....+.
T Consensus 199 y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~----~~~i~~~~~~--~~~~~~~----~~s~~~~ 264 (351)
T 3c0i_A 199 FMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERL----FEGIIKGKYK--MNPRQWS----HISESAK 264 (351)
T ss_dssp GCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHH----HHHHHHTCCC--CCHHHHT----TSCHHHH
T ss_pred ccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHH----HHHHHcCCCC--CCccccc----cCCHHHH
Confidence 999999999999999999999999999999999985421 111 1111111110 0000000 1134677
Q ss_pred HHhhhcccCCCCCCCCHHHHHH
Q 046010 452 HIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+|+.+||+.||++|||+.|+++
T Consensus 265 ~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 265 DLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHCCCChhHCcCHHHHhc
Confidence 8999999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-25 Score=227.28 Aligned_cols=185 Identities=23% Similarity=0.270 Sum_probs=120.8
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..++.++.||++||.|||++| |+||||||+||+++.++.+||+|||+++.... ......+|..|+||
T Consensus 127 ~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aP 198 (367)
T 2fst_X 127 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGYVATRWYRAP 198 (367)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--------------------CCCTTCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccccccc-----cCCCcCcCcCccCh
Confidence 57999999999999999999999998 99999999999999999999999999986532 12345789999999
Q ss_pred hhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCc-----------ccc---cCccccC
Q 046010 376 EYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEA-----------LEL---MDPVLKQ 440 (523)
Q Consensus 376 E~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~---~~~~l~~ 440 (523)
|++.+ ..++.++|||||||++|+|++|+.||...... ..+............ ... +......
T Consensus 199 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (367)
T 2fst_X 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKM 275 (367)
T ss_dssp HHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCC
T ss_pred HHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCC
Confidence 99887 67899999999999999999999998643221 111111111100000 000 0000000
Q ss_pred Cc---cHHHHHHHHHHhhhcccCCCCCCCCHHHHHH--HhccCCCCCCCCCCCCcc
Q 046010 441 SC---MAAELLKCIHIGLLCVQEDPADRPNMSSVAV--MLASDTVSLPQPTQPAFS 491 (523)
Q Consensus 441 ~~---~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~~~~~l~~p~~p~~~ 491 (523)
.. .......+.+|+.+||+.||++|||+.|+++ .++........|..++|.
T Consensus 276 ~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~~~~ 331 (367)
T 2fst_X 276 NFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYD 331 (367)
T ss_dssp CHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCCCCCC
T ss_pred CHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCCCCCC
Confidence 00 0011245788999999999999999999986 455443333334444443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.3e-26 Score=227.03 Aligned_cols=174 Identities=21% Similarity=0.230 Sum_probs=118.3
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeC-----CCCCeeEeccccceeccCCCCCccccce
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLD-----HEMNPKISDFGMARIFGGNQNESNTSKV 366 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~-----~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 366 (523)
..+...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....... ......
T Consensus 123 ~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~ 197 (329)
T 3gbz_A 123 MDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI--RQFTHE 197 (329)
T ss_dssp HHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------
T ss_pred HhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc--cccCCC
Confidence 455667999999999999999999999998 99999999999994 45569999999998764221 223345
Q ss_pred eccCCCCchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCC----------------
Q 046010 367 VGTYGYMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGE---------------- 429 (523)
Q Consensus 367 ~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------- 429 (523)
.+|..|+|||++.+. .++.++||||||+++|+|++|+.||...... ..............
T Consensus 198 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (329)
T 3gbz_A 198 IITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI---DQLFKIFEVLGLPDDTTWPGVTALPDWKQS 274 (329)
T ss_dssp --CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred cCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH---HHHHHHHHHhCCCchhhhhhhhhhhhhhhh
Confidence 679999999999874 4899999999999999999999998543221 11111111110000
Q ss_pred cccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 430 ALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 430 ~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
..+.....+...........+.+|+.+||+.||++|||+.|+++
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 275 FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000000000000012346778999999999999999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-25 Score=233.52 Aligned_cols=161 Identities=22% Similarity=0.239 Sum_probs=124.2
Q ss_pred ccccccccCHHHHHHHHHHHHHHHHHHHh-cCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceecc
Q 046010 291 YSTRRAQLDWKRRISIINGIARGLLYLHE-DSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369 (523)
Q Consensus 291 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt 369 (523)
+..+...+++..++.++.||+.||+|||+ ++ |+||||||+|||++.++.+||+|||+++..... ........||
T Consensus 238 ~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~~~~~~~~gt 312 (446)
T 4ejn_A 238 HLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGT 312 (446)
T ss_dssp HHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSC
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCC--CcccccccCC
Confidence 34556789999999999999999999998 88 999999999999999999999999999754222 1223456789
Q ss_pred CCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 370 ~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
+.|+|||++.+..++.++||||||+++|||++|+.||...... ........ ... . +.. .....
T Consensus 313 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~-~~~-~-----~p~----~~~~~ 375 (446)
T 4ejn_A 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILM-EEI-R-----FPR----TLGPE 375 (446)
T ss_dssp GGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-CCC-C-----CCT----TSCHH
T ss_pred ccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHHh-CCC-C-----CCc----cCCHH
Confidence 9999999999999999999999999999999999998532211 11111111 111 0 111 12245
Q ss_pred HHHHhhhcccCCCCCCC-----CHHHHHH
Q 046010 450 CIHIGLLCVQEDPADRP-----NMSSVAV 473 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RP-----s~~ei~~ 473 (523)
+.+|+.+||+.||.+|| +++|+++
T Consensus 376 ~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 376 AKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 77889999999999999 9999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.1e-26 Score=228.70 Aligned_cols=177 Identities=22% Similarity=0.281 Sum_probs=121.4
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
......+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++....... .......++..
T Consensus 115 ~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~ 189 (331)
T 4aaa_A 115 ELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYDDEVATRW 189 (331)
T ss_dssp HHSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC--------------CCCCCT
T ss_pred HhhccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc--cccCCCcCCcc
Confidence 344567999999999999999999999998 9999999999999999999999999997654322 22334568999
Q ss_pred CCchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchH--------HHHHHhhhcCC-cccccCccccCC
Q 046010 372 YMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLL--------AYTWKLWCNGE-ALELMDPVLKQS 441 (523)
Q Consensus 372 y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~--------~~~~~~~~~~~-~~~~~~~~l~~~ 441 (523)
|+|||.+.+. .++.++||||||+++|+|++|+.||...........+ ...+..+.... ......+.+...
T Consensus 190 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (331)
T 4aaa_A 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKER 269 (331)
T ss_dssp TCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSC
T ss_pred ccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCcccccc
Confidence 9999999875 6899999999999999999999998643321110000 00011111100 000111111111
Q ss_pred cc-----HHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 442 CM-----AAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 442 ~~-----~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+ ......+.+|+.+||+.||++|||+.||++
T Consensus 270 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 270 EPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred chhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11 122456789999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-26 Score=224.63 Aligned_cols=166 Identities=30% Similarity=0.359 Sum_probs=126.7
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
..+..+++..++.++.||++||.|||+++ ++|+||||+||+++.++.+||+|||++....... ........++..|
T Consensus 96 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y 171 (267)
T 3t9t_A 96 TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKW 171 (267)
T ss_dssp HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGG
T ss_pred hCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc-ccccccccccccc
Confidence 34467999999999999999999999998 9999999999999999999999999987653211 1112233456789
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
+|||.+.+..++.++||||||+++|+|++ |+.||...... . .......+.... . +......+.
T Consensus 172 ~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~-~~~~i~~~~~~~--~-------~~~~~~~l~ 235 (267)
T 3t9t_A 172 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------E-VVEDISTGFRLY--K-------PRLASTHVY 235 (267)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------H-HHHHHHTTCCCC--C-------CTTSCHHHH
T ss_pred cChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH------H-HHHHHhcCCcCC--C-------CccCcHHHH
Confidence 99999998899999999999999999999 89888532211 1 111111111100 0 111234577
Q ss_pred HHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 452 HIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+++.+||+.||++|||+.++++.|++.
T Consensus 236 ~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 236 QIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 889999999999999999999999865
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=5.5e-25 Score=216.02 Aligned_cols=162 Identities=22% Similarity=0.286 Sum_probs=126.2
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.+...+++..++.++.||++||.|||+++ |+|+||||+||+++.++.+||+|||++...... ......++..|
T Consensus 106 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y 178 (284)
T 2vgo_A 106 QKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL----RRRTMCGTLDY 178 (284)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS----CBCCCCSCGGG
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc----ccccccCCCCc
Confidence 44567999999999999999999999998 999999999999999999999999998765322 22345688999
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
+|||.+.+..++.++||||||+++|+|++|+.||...... .. ......... .+.. .....+.+
T Consensus 179 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~-~~~~~~~~~------~~~~----~~~~~~~~ 241 (284)
T 2vgo_A 179 LPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------ET-HRRIVNVDL------KFPP----FLSDGSKD 241 (284)
T ss_dssp CCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HH-HHHHHTTCC------CCCT----TSCHHHHH
T ss_pred CCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------HH-HHHHhcccc------CCCC----cCCHHHHH
Confidence 9999999999999999999999999999999998532211 11 111111111 0111 12245678
Q ss_pred HhhhcccCCCCCCCCHHHHHH--HhccC
Q 046010 453 IGLLCVQEDPADRPNMSSVAV--MLASD 478 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~--~L~~~ 478 (523)
++.+||+.||.+||++.+|++ +++..
T Consensus 242 li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 242 LISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 899999999999999999986 55543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=226.79 Aligned_cols=178 Identities=19% Similarity=0.227 Sum_probs=109.5
Q ss_pred ccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCC---CCeeEeccccceeccCCCCCc
Q 046010 285 TTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE---MNPKISDFGMARIFGGNQNES 361 (523)
Q Consensus 285 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~---~~~kL~Dfg~a~~~~~~~~~~ 361 (523)
....++....+..+++.+++.++.||++||.|||+++ |+||||||+||+++.+ +.+||+|||++......
T Consensus 112 ~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~---- 184 (336)
T 3fhr_A 112 ELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN---- 184 (336)
T ss_dssp EHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-------
T ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccceecccc----
Confidence 3334444444567999999999999999999999998 9999999999999864 45999999999865322
Q ss_pred cccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCC
Q 046010 362 NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQS 441 (523)
Q Consensus 362 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 441 (523)
......+++.|+|||++.+..++.++||||||+++|+|++|+.||........... ......... .....+
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~-~~~~~~----- 255 (336)
T 3fhr_A 185 ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---MKRRIRLGQ-YGFPNP----- 255 (336)
T ss_dssp -------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------CCCTT-----
T ss_pred ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh---HHHhhhccc-cccCch-----
Confidence 22345679999999999888899999999999999999999999854322211000 000000000 000000
Q ss_pred ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH--HhccC
Q 046010 442 CMAAELLKCIHIGLLCVQEDPADRPNMSSVAV--MLASD 478 (523)
Q Consensus 442 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~~ 478 (523)
........+.+|+.+||+.||++|||+.|+++ ++++.
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 00122346778999999999999999999997 56554
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.4e-25 Score=231.91 Aligned_cols=168 Identities=15% Similarity=0.141 Sum_probs=124.5
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
.+..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....... .......||+.|+
T Consensus 168 ~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~ 243 (437)
T 4aw2_A 168 FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYI 243 (437)
T ss_dssp TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-EECCSCCSCGGGC
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC-cccccccCCcCee
Confidence 3567999999999999999999999998 99999999999999999999999999987643222 2233467999999
Q ss_pred chhhhc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 374 APEYAL-----GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 374 aPE~l~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
|||++. ...++.++|||||||++|||++|+.||...... ................... . ....
T Consensus 244 APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~---~~~~~i~~~~~~~~~p~~~-----~----~~s~ 311 (437)
T 4aw2_A 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMNHKERFQFPTQV-----T----DVSE 311 (437)
T ss_dssp CHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTHHHHCCCCSSC-----C----CSCH
T ss_pred ChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh---HHHHhhhhccccccCCccc-----c----cCCH
Confidence 999987 566899999999999999999999998532211 1111111100001111110 0 1123
Q ss_pred HHHHHhhhcccCCCCC--CCCHHHHHH--Hhcc
Q 046010 449 KCIHIGLLCVQEDPAD--RPNMSSVAV--MLAS 477 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~--RPs~~ei~~--~L~~ 477 (523)
.+.+|+.+||..+|++ ||+++||++ ++++
T Consensus 312 ~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 312 NAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp HHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred HHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 5678888999888888 999999976 4544
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-25 Score=226.47 Aligned_cols=164 Identities=24% Similarity=0.270 Sum_probs=114.1
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCC--eeEeccccceeccCCCCCccccceeccC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMN--PKISDFGMARIFGGNQNESNTSKVVGTY 370 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~~~gt~ 370 (523)
.+...+++..++.++.||+.||.|||+++ |+||||||+||+++.++. +||+|||+++.... ........||+
T Consensus 108 ~~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~ 181 (361)
T 3uc3_A 108 CNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTP 181 (361)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------------------C
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc---cCCCCCCcCCC
Confidence 44567999999999999999999999998 999999999999987765 99999999874321 12233457899
Q ss_pred CCCchhhhcCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 371 GYMAPEYALGGVISVK-SDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 371 ~y~aPE~l~~~~~s~k-sDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
.|+|||++.+..++.+ +||||||+++|+|++|+.||....... ........... .... . ... ......
T Consensus 182 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~-~~~~-~-~~~------~~~s~~ 250 (361)
T 3uc3_A 182 AYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILS-VKYS-I-PDD------IRISPE 250 (361)
T ss_dssp TTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHT-TCCC-C-CTT------SCCCHH
T ss_pred CcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhc-CCCC-C-CCc------CCCCHH
Confidence 9999999988877655 899999999999999999986433221 11111111111 1110 0 000 011245
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHH
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+.+|+.+||+.||++|||+.||++
T Consensus 251 ~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 251 CCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp HHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHccCChhHCcCHHHHHh
Confidence 678999999999999999999976
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-25 Score=227.58 Aligned_cols=175 Identities=22% Similarity=0.230 Sum_probs=126.0
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
......+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++...... .......+|+.
T Consensus 103 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~ 177 (346)
T 1ua2_A 103 KDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYTHQVVTRW 177 (346)
T ss_dssp TTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--CCCCCSCCCCT
T ss_pred HhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccCCc--ccCCccccccc
Confidence 445567999999999999999999999998 9999999999999999999999999998764322 22334578999
Q ss_pred CCchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCc---cc------ccCccccCC
Q 046010 372 YMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEA---LE------LMDPVLKQS 441 (523)
Q Consensus 372 y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~------~~~~~l~~~ 441 (523)
|+|||.+.+. .++.++||||||+++|+|++|..||..... ...+............ .+ .+.......
T Consensus 178 y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (346)
T 1ua2_A 178 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 254 (346)
T ss_dssp TCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCC
T ss_pred ccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHcCCCChhhhhhhccCcccccccccCC
Confidence 9999998764 488999999999999999999998753321 1111111111111100 00 000000000
Q ss_pred cc-----HHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 442 CM-----AAELLKCIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 442 ~~-----~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
.+ ......+.+|+.+||+.||++|||+.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 255 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 11 1123567889999999999999999999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-25 Score=226.98 Aligned_cols=158 Identities=29% Similarity=0.374 Sum_probs=122.5
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
..+..+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||++..... .....||+.|
T Consensus 146 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------~~~~~gt~~y 216 (348)
T 1u5q_A 146 VHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYW 216 (348)
T ss_dssp HHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGG
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC------CCcccCCcce
Confidence 44578999999999999999999999998 99999999999999999999999999976532 2245689999
Q ss_pred Cchhhhc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 373 MAPEYAL---GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 373 ~aPE~l~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
+|||++. ...++.++||||||+++|||++|+.||..... .......... ....... . .....
T Consensus 217 ~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~~-~~~~~~~----~----~~~~~ 281 (348)
T 1u5q_A 217 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQN-ESPALQS----G----HWSEY 281 (348)
T ss_dssp CCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHS-CCCCCCC----T----TSCHH
T ss_pred eCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhc-CCCCCCC----C----CCCHH
Confidence 9999985 56789999999999999999999999853221 1111121111 1111111 1 11235
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHHH
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAVM 474 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~~ 474 (523)
+.+|+.+||+.||++|||+.+|++.
T Consensus 282 l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 282 FRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHHcccChhhCcCHHHHhhC
Confidence 6788899999999999999999753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.4e-25 Score=230.22 Aligned_cols=113 Identities=27% Similarity=0.403 Sum_probs=92.5
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC-----------
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE----------- 360 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~----------- 360 (523)
..++..+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 120 ~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~ 196 (432)
T 3n9x_A 120 FKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196 (432)
T ss_dssp HHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC-----------------
T ss_pred HhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccccccccccccccccccccc
Confidence 455667999999999999999999999999 999999999999999999999999999876432211
Q ss_pred ---------ccccceeccCCCCchhhh-cCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 046010 361 ---------SNTSKVVGTYGYMAPEYA-LGGVISVKSDVFSFGVLLLEIISGKKNSG 407 (523)
Q Consensus 361 ---------~~~~~~~gt~~y~aPE~l-~~~~~s~ksDVwSlGvvl~elltG~~p~~ 407 (523)
.......||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 197 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp --------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 122456789999999986 45669999999999999999998765553
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-25 Score=223.19 Aligned_cols=160 Identities=21% Similarity=0.234 Sum_probs=119.8
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++...... .......||+.
T Consensus 112 l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~ 186 (327)
T 3a62_A 112 LEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG--TVTHTFCGTIE 186 (327)
T ss_dssp HHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC------------CTTSSCCT
T ss_pred HHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccccCC--ccccccCCCcC
Confidence 345567999999999999999999999998 9999999999999999999999999987543221 12234578999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||.+.+..++.++||||||+++|+|++|+.||..... ......... ... . + +......+.
T Consensus 187 y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~-~~~-~-----~----p~~~~~~~~ 249 (327)
T 3a62_A 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR------KKTIDKILK-CKL-N-----L----PPYLTQEAR 249 (327)
T ss_dssp TSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHH-TCC-C-----C----CTTSCHHHH
T ss_pred ccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHh-CCC-C-----C----CCCCCHHHH
Confidence 9999999998999999999999999999999999853221 111111111 110 0 1 111234567
Q ss_pred HHhhhcccCCCCCCC-----CHHHHHH
Q 046010 452 HIGLLCVQEDPADRP-----NMSSVAV 473 (523)
Q Consensus 452 ~li~~cl~~dP~~RP-----s~~ei~~ 473 (523)
+++.+||+.||++|| ++.|+++
T Consensus 250 ~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 250 DLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 889999999999999 6777765
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.6e-25 Score=228.89 Aligned_cols=110 Identities=32% Similarity=0.505 Sum_probs=88.0
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEe----CCCCCeeEeccccceeccCCCCC-ccccceeccC
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLL----DHEMNPKISDFGMARIFGGNQNE-SNTSKVVGTY 370 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll----~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~gt~ 370 (523)
..+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++........ .......||+
T Consensus 123 ~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~ 199 (405)
T 3rgf_A 123 VQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199 (405)
T ss_dssp --CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCC
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecC
Confidence 35999999999999999999999998 9999999999999 67789999999999876432111 2234467899
Q ss_pred CCCchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCC
Q 046010 371 GYMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGF 408 (523)
Q Consensus 371 ~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~ 408 (523)
.|+|||++.+. .++.++|||||||++|+|++|+.||..
T Consensus 200 ~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 238 (405)
T 3rgf_A 200 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 238 (405)
T ss_dssp TTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred cccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence 99999999874 589999999999999999999999964
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=239.05 Aligned_cols=171 Identities=27% Similarity=0.308 Sum_probs=129.3
Q ss_pred cccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccc
Q 046010 284 GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNT 363 (523)
Q Consensus 284 g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 363 (523)
|....++.......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 269 g~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~---~~ 342 (576)
T 2acx_A 269 GDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TI 342 (576)
T ss_dssp CBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTC---CE
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccCc---cc
Confidence 33334455555566999999999999999999999998 9999999999999999999999999998764322 22
Q ss_pred cceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCcc
Q 046010 364 SKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCM 443 (523)
Q Consensus 364 ~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 443 (523)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ........... . + +
T Consensus 343 ~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~---~i~~~i~~~~~-~-----~----p 409 (576)
T 2acx_A 343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE---EVERLVKEVPE-E-----Y----S 409 (576)
T ss_dssp ECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH---HHHHHHHHCCC-C-----C----C
T ss_pred cccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH---HHHHHhhcccc-c-----C----C
Confidence 34578999999999999899999999999999999999999996433221111 11111111110 0 0 1
Q ss_pred HHHHHHHHHHhhhcccCCCCCCC-----CHHHHHH
Q 046010 444 AAELLKCIHIGLLCVQEDPADRP-----NMSSVAV 473 (523)
Q Consensus 444 ~~~~~~~~~li~~cl~~dP~~RP-----s~~ei~~ 473 (523)
......+.+|+.+||+.||.+|| ++.||++
T Consensus 410 ~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 410 ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 11224677889999999999999 7788864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-25 Score=225.96 Aligned_cols=166 Identities=22% Similarity=0.322 Sum_probs=123.5
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.++..+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++....... .......||+.|
T Consensus 151 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y 226 (355)
T 1vzo_A 151 SQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEY 226 (355)
T ss_dssp HHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG-GGGCGGGSCCTT
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecccCCC-CcccCcccCcCc
Confidence 44567999999999999999999999998 99999999999999999999999999986532211 123345789999
Q ss_pred CchhhhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 373 MAPEYALG--GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 373 ~aPE~l~~--~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
+|||++.+ ..++.++||||||+++|+|++|+.||......... .......... . +.. +......+
T Consensus 227 ~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~-~------~~~----~~~~~~~~ 293 (355)
T 1vzo_A 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKS-E------PPY----PQEMSALA 293 (355)
T ss_dssp CCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHC-C------CCC----CTTSCHHH
T ss_pred cChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhcc-C------CCC----CcccCHHH
Confidence 99999986 34789999999999999999999998643322211 1111111111 0 001 11122456
Q ss_pred HHHhhhcccCCCCCCC-----CHHHHHHHh
Q 046010 451 IHIGLLCVQEDPADRP-----NMSSVAVML 475 (523)
Q Consensus 451 ~~li~~cl~~dP~~RP-----s~~ei~~~L 475 (523)
.+|+.+||+.||++|| ++.|+++..
T Consensus 294 ~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 294 KDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp HHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred HHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 7899999999999999 899997643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-25 Score=228.84 Aligned_cols=188 Identities=20% Similarity=0.206 Sum_probs=131.9
Q ss_pred eeEeeecccccccc------ccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeC-CCCCeeEeccc
Q 046010 277 KAIWIAIGTTIPTI------YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLD-HEMNPKISDFG 349 (523)
Q Consensus 277 ~~~~ia~g~~~~~~------~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~-~~~~~kL~Dfg 349 (523)
...++.+.++-..+ +...+..+++..++.++.||++||.|||++| |+||||||+||+++ .++.+||+|||
T Consensus 111 ~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg 187 (383)
T 3eb0_A 111 KYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFG 187 (383)
T ss_dssp CEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECC
Confidence 34555555554321 2355678999999999999999999999998 99999999999997 68899999999
Q ss_pred cceeccCCCCCccccceeccCCCCchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhh--
Q 046010 350 MARIFGGNQNESNTSKVVGTYGYMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWC-- 426 (523)
Q Consensus 350 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~-- 426 (523)
+++...... ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||....... .+........
T Consensus 188 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~g~p 261 (383)
T 3eb0_A 188 SAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSID---QLVRIIQIMGTP 261 (383)
T ss_dssp TCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCC
T ss_pred CCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCC
Confidence 998764322 22345678999999998875 48999999999999999999999986432211 1111111000
Q ss_pred --------cCCccc-----ccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 427 --------NGEALE-----LMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 427 --------~~~~~~-----~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+....+ ..........+......+.+|+.+||+.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 262 TKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp CHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000001 00111111111123346789999999999999999999973
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-25 Score=226.88 Aligned_cols=162 Identities=22% Similarity=0.219 Sum_probs=124.2
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEe--CCCCCeeEeccccceeccCCCCCccccceeccC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLL--DHEMNPKISDFGMARIFGGNQNESNTSKVVGTY 370 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll--~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~ 370 (523)
.....+++..++.++.||++||.|||+++ |+||||||+|||+ +.++.+||+|||+++...... ......||+
T Consensus 179 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~ 252 (373)
T 2x4f_A 179 DESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTP 252 (373)
T ss_dssp HTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BCCCCCSSC
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---ccccccCCC
Confidence 44567999999999999999999999998 9999999999999 567789999999998764322 223456899
Q ss_pred CCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 371 GYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 371 ~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
.|+|||++.+..++.++||||||+++|+|++|+.||...... ..+ .... .... ....... ......+
T Consensus 253 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~---~~i~-~~~~-~~~~~~~-----~~~~~~~ 319 (373)
T 2x4f_A 253 EFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA---ETL---NNIL-ACRW-DLEDEEF-----QDISEEA 319 (373)
T ss_dssp TTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH---HHHH-HTCC-CSCSGGG-----TTSCHHH
T ss_pred cEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHH-hccC-CCChhhh-----ccCCHHH
Confidence 999999999888999999999999999999999998532211 111 1111 1110 0101100 1123467
Q ss_pred HHHhhhcccCCCCCCCCHHHHHH
Q 046010 451 IHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+|+.+||+.||.+|||+.|+++
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhhCCCHHHHhc
Confidence 78999999999999999999987
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=4.6e-25 Score=226.46 Aligned_cols=162 Identities=19% Similarity=0.220 Sum_probs=123.7
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC--CCCeeEeccccceeccCCCCCccccceeccC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH--EMNPKISDFGMARIFGGNQNESNTSKVVGTY 370 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~--~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~ 370 (523)
..+..+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++....... ......||+
T Consensus 141 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~ 214 (387)
T 1kob_A 141 AEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATA 214 (387)
T ss_dssp CTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---CEEEECSSG
T ss_pred hhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCc---ceeeeccCC
Confidence 34457999999999999999999999998 999999999999974 4679999999998764322 223457899
Q ss_pred CCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 371 GYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 371 ~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
.|+|||++.+..++.++||||||+++|+|++|+.||..... ..... . ....... ..... .......+
T Consensus 215 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~---~-i~~~~~~--~~~~~----~~~~s~~~ 281 (387)
T 1kob_A 215 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQ---N-VKRCDWE--FDEDA----FSSVSPEA 281 (387)
T ss_dssp GGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHH---H-HHHCCCC--CCSST----TTTSCHHH
T ss_pred CccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH---HHHHH---H-HHhCCCC--CCccc----cccCCHHH
Confidence 99999999999999999999999999999999999853221 11111 1 1111110 00100 11123467
Q ss_pred HHHhhhcccCCCCCCCCHHHHHH
Q 046010 451 IHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+|+.+||+.||++|||+.|+++
T Consensus 282 ~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 282 KDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHcCCChhHCcCHHHHhh
Confidence 78999999999999999999987
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.92 E-value=6.3e-25 Score=216.25 Aligned_cols=162 Identities=23% Similarity=0.333 Sum_probs=122.3
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeC-CCCCeeEeccccceeccCCCCCccccceeccC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLD-HEMNPKISDFGMARIFGGNQNESNTSKVVGTY 370 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~ 370 (523)
..+...+++..++.++.||+.||.|||+++ .+|+|+||||+||+++ .++.+||+|||++...... ......+++
T Consensus 120 l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~t~ 194 (290)
T 1t4h_A 120 LKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTP 194 (290)
T ss_dssp HHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSC
T ss_pred HHHccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc----ccccccCCc
Confidence 345577999999999999999999999985 3499999999999998 7889999999999754321 223456899
Q ss_pred CCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 371 GYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 371 ~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
.|+|||.+. +.++.++||||||+++|+|++|+.||...... . ........+....... . .....+
T Consensus 195 ~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~-~~~~~~~~~~~~~~~~----~----~~~~~l 259 (290)
T 1t4h_A 195 EFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA-----A-QIYRRVTSGVKPASFD----K----VAIPEV 259 (290)
T ss_dssp CCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----H-HHHHHHTTTCCCGGGG----G----CCCHHH
T ss_pred CcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----H-HHHHHHhccCCccccC----C----CCCHHH
Confidence 999999876 45899999999999999999999998532211 1 1112222211111111 1 112357
Q ss_pred HHHhhhcccCCCCCCCCHHHHHH
Q 046010 451 IHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+|+.+||+.||++|||+.||++
T Consensus 260 ~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 260 KEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHccCChhhCCCHHHHhh
Confidence 78999999999999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7e-25 Score=215.04 Aligned_cols=163 Identities=21% Similarity=0.243 Sum_probs=123.8
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCC---eeEeccccceeccCCCCCccccceec
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMN---PKISDFGMARIFGGNQNESNTSKVVG 368 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~---~kL~Dfg~a~~~~~~~~~~~~~~~~g 368 (523)
..++..+++..++.++.||+.||.|||+++ |+||||||+||+++.++. +||+|||.+....... ......+
T Consensus 96 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~ 169 (284)
T 3kk8_A 96 IVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAG 169 (284)
T ss_dssp HHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC---BCCCSCS
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc---cccCCCC
Confidence 344567999999999999999999999998 999999999999987655 9999999998754322 2234578
Q ss_pred cCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 369 TYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 369 t~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
++.|+|||.+.+..++.++||||||+++|+|++|+.||...... .. ......+... ...+.. .....
T Consensus 170 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~----~~~~~~~~~~-~~~~~~-----~~~~~ 236 (284)
T 3kk8_A 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RL----YAQIKAGAYD-YPSPEW-----DTVTP 236 (284)
T ss_dssp CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHTCCC-CCTTTT-----TTSCH
T ss_pred CcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HH----HHHHHhcccc-CCchhh-----cccCH
Confidence 99999999999999999999999999999999999998532211 11 1111111111 101100 11124
Q ss_pred HHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 449 KCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 237 EAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHcccChhhCCCHHHHhc
Confidence 5678899999999999999999976
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-25 Score=225.09 Aligned_cols=157 Identities=24% Similarity=0.324 Sum_probs=118.9
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC----------ccccc
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE----------SNTSK 365 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~----------~~~~~ 365 (523)
...++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++........ .....
T Consensus 159 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T 3qd2_B 159 EDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG 235 (332)
T ss_dssp GGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCS
T ss_pred cchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccc
Confidence 44677789999999999999999998 999999999999999999999999999876543211 12234
Q ss_pred eeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHH
Q 046010 366 VVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAA 445 (523)
Q Consensus 366 ~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 445 (523)
..||+.|+|||.+.+..++.++||||||+++|+|++|..|+.. . ............. .....
T Consensus 236 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~-~~~~~~~~~~~~~---------~~~~~ 297 (332)
T 3qd2_B 236 QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------R-VRIITDVRNLKFP---------LLFTQ 297 (332)
T ss_dssp CC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------H-HHHHHHHHTTCCC---------HHHHH
T ss_pred cCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------H-HHHHHHhhccCCC---------ccccc
Confidence 5689999999999999999999999999999999998766310 0 0111111111111 01123
Q ss_pred HHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 446 ELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 446 ~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
....+.+|+.+||+.||++|||+.|+++
T Consensus 298 ~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 298 KYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred CChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 3345678999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3e-25 Score=229.50 Aligned_cols=166 Identities=17% Similarity=0.193 Sum_probs=121.9
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
+..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....... .......||+.|+|
T Consensus 156 ~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~A 231 (412)
T 2vd5_A 156 GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLS 231 (412)
T ss_dssp SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-EECSSCCSCGGGCC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCCCc-cccceeccccCcCC
Confidence 457999999999999999999999998 99999999999999999999999999987643221 12234579999999
Q ss_pred hhhhc-------CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHH
Q 046010 375 PEYAL-------GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAEL 447 (523)
Q Consensus 375 PE~l~-------~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 447 (523)
||++. ...++.++|||||||++|||++|+.||...... ............... +... ....
T Consensus 232 PE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i~~~~~~~~~-----p~~~----~~~s 299 (412)
T 2vd5_A 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA---ETYGKIVHYKEHLSL-----PLVD----EGVP 299 (412)
T ss_dssp HHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTHHHHCCC-----C--------CCC
T ss_pred HHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH---HHHHHHHhcccCcCC-----Cccc----cCCC
Confidence 99987 356899999999999999999999998532211 111111100000000 1010 1122
Q ss_pred HHHHHHhhhcccCCCCCC---CCHHHHHH--Hhcc
Q 046010 448 LKCIHIGLLCVQEDPADR---PNMSSVAV--MLAS 477 (523)
Q Consensus 448 ~~~~~li~~cl~~dP~~R---Ps~~ei~~--~L~~ 477 (523)
..+.+|+.+||+ +|.+| |+++||++ ++++
T Consensus 300 ~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 300 EEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp HHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 467788999999 99998 58999865 3444
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-25 Score=220.69 Aligned_cols=164 Identities=23% Similarity=0.332 Sum_probs=116.9
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..++..+++..++.++.||++||.|||+++ |+||||||+||+++ ++.+||+|||++................++..
T Consensus 118 l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~ 193 (313)
T 3cek_A 118 LKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 193 (313)
T ss_dssp HHHCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCC--------------CCGG
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-CCeEEEeeccccccccCccccccccCCCCCCC
Confidence 345568999999999999999999999998 99999999999996 48899999999987644333223345578999
Q ss_pred CCchhhhcC-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccC
Q 046010 372 YMAPEYALG-----------GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQ 440 (523)
Q Consensus 372 y~aPE~l~~-----------~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 440 (523)
|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ................
T Consensus 194 y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~------- 261 (313)
T 3cek_A 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAIIDPNHEIEF------- 261 (313)
T ss_dssp GCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHCTTSCCCC-------
T ss_pred cCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----HHHHHHHHhcccccCC-------
Confidence 999999875 46888999999999999999999998532211 1111111111111111
Q ss_pred CccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 441 SCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 441 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+......+.+++.+||+.||++||++.||++
T Consensus 262 --~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 262 --PDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp --CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --cccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 1111245678889999999999999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.5e-25 Score=221.63 Aligned_cols=165 Identities=25% Similarity=0.350 Sum_probs=127.8
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..++..+++.+++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||++....... .......++..
T Consensus 132 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~ 206 (335)
T 2owb_A 132 HKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPN 206 (335)
T ss_dssp HHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCCS
T ss_pred HhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCc--ccccccCCCcc
Confidence 344567999999999999999999999998 9999999999999999999999999998764222 22334578999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||.+.+..++.++||||||+++|+|++|+.||...... .. ......... . +.. .....+.
T Consensus 207 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~-~~~~~~~~~-~-----~~~----~~~~~~~ 269 (335)
T 2owb_A 207 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ET-YLRIKKNEY-S-----IPK----HINPVAA 269 (335)
T ss_dssp SCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HH-HHHHHHTCC-C-----CCT----TSCHHHH
T ss_pred ccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH------HH-HHHHhcCCC-C-----CCc----cCCHHHH
Confidence 99999999989999999999999999999999998532211 11 111111111 0 111 1123567
Q ss_pred HHhhhcccCCCCCCCCHHHHHH--HhccC
Q 046010 452 HIGLLCVQEDPADRPNMSSVAV--MLASD 478 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~--~L~~~ 478 (523)
+|+.+||+.||++|||+.||++ ++.+.
T Consensus 270 ~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 270 SLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp HHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 8899999999999999999986 45543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=223.96 Aligned_cols=177 Identities=23% Similarity=0.243 Sum_probs=127.4
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.....+++..++.++.||++||.|||++| |+||||||+||+++.++.+||+|||++..... ........++..|
T Consensus 112 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~~~~y 185 (326)
T 1blx_A 112 VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWY 185 (326)
T ss_dssp SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCG---GGGGCCCCCCCTT
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCcccccccC---CCCccccccccce
Confidence 33456999999999999999999999998 99999999999999999999999999976532 1223346789999
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccc----------cCc---ccc
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALEL----------MDP---VLK 439 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~---~l~ 439 (523)
+|||.+.+..++.++||||||+++|+|++|+.||...... .................. +.. ...
T Consensus 186 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (326)
T 1blx_A 186 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPI 262 (326)
T ss_dssp CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCG
T ss_pred eCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHcCCCCcccCccccccchhhhcccCcchh
Confidence 9999999999999999999999999999999998643221 111111111110000000 000 000
Q ss_pred CCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH--HhccC
Q 046010 440 QSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV--MLASD 478 (523)
Q Consensus 440 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~~ 478 (523)
..........+.+|+.+||+.||++|||+.|+++ +++..
T Consensus 263 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 263 EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred hhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 0011122345678999999999999999999984 45443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.7e-26 Score=227.86 Aligned_cols=164 Identities=29% Similarity=0.370 Sum_probs=124.3
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCC---CCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE---MNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~---~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
..+++..++.++.||++||.|||+++ |+||||||+||+++.+ ..+||+|||++................+++.|
T Consensus 135 ~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y 211 (327)
T 2yfx_A 135 SSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211 (327)
T ss_dssp TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGG
T ss_pred ccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcce
Confidence 55999999999999999999999998 9999999999999854 46999999999765433332333345678899
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
+|||.+.+..++.++||||||+++|+|++ |+.||...... .. ............ +......+.
T Consensus 212 ~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~----~~~~~~~~~~~~---------~~~~~~~l~ 275 (327)
T 2yfx_A 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EV----LEFVTSGGRMDP---------PKNCPGPVY 275 (327)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HH----HHHHHTTCCCCC---------CTTCCHHHH
T ss_pred eCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HH----HHHHhcCCCCCC---------CCCCCHHHH
Confidence 99999999999999999999999999998 88887532211 11 111222111111 111234677
Q ss_pred HHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 452 HIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+|+.+||+.||.+||++.+|++.|...
T Consensus 276 ~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 276 RIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 899999999999999999999999865
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4e-26 Score=227.60 Aligned_cols=173 Identities=21% Similarity=0.249 Sum_probs=119.8
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCC---eeEeccccceeccCCCC-----Cccc
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMN---PKISDFGMARIFGGNQN-----ESNT 363 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~---~kL~Dfg~a~~~~~~~~-----~~~~ 363 (523)
..++..+++..++.++.||++||+|||+++ |+||||||+||+++.++. +||+|||++........ ....
T Consensus 102 l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 178 (316)
T 2ac3_A 102 IHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178 (316)
T ss_dssp HHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC----------------
T ss_pred HhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccccccccc
Confidence 344567999999999999999999999998 999999999999998776 99999999876532211 1112
Q ss_pred cceeccCCCCchhhhcC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccc--------hHHHHHHhhhcCCc
Q 046010 364 SKVVGTYGYMAPEYALG-----GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQS--------LLAYTWKLWCNGEA 430 (523)
Q Consensus 364 ~~~~gt~~y~aPE~l~~-----~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~ 430 (523)
....||..|+|||++.+ ..++.++||||||+++|+|++|+.||.......... ...........+..
T Consensus 179 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 258 (316)
T 2ac3_A 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKY 258 (316)
T ss_dssp ---CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCC
T ss_pred ccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCc
Confidence 23458999999999875 457899999999999999999999996543221100 00111111111111
Q ss_pred ccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 431 LELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 431 ~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
..... ... .....+.+|+.+||+.||++|||+.|+++
T Consensus 259 -~~~~~-~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 259 -EFPDK-DWA----HISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp -CCCHH-HHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -ccCch-hcc----cCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 00000 000 11346778999999999999999999987
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-25 Score=218.67 Aligned_cols=159 Identities=28% Similarity=0.399 Sum_probs=103.1
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.....+++..++.++.||++||.|||+++ |+|+||||+||+++.++.+||+|||++....... .......+++.|
T Consensus 104 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y 178 (278)
T 3cok_A 104 NRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH--EKHYTLCGTPNY 178 (278)
T ss_dssp TCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-----------------
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC--CcceeccCCCCc
Confidence 34467999999999999999999999998 9999999999999999999999999998754221 122245688999
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
+|||.+.+..++.++||||||+++|+|++|+.||........ . .. ... .. ... +......+.+
T Consensus 179 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~---~~-~~~---~~---~~~----~~~~~~~~~~ 241 (278)
T 3cok_A 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---L---NK-VVL---AD---YEM----PSFLSIEAKD 241 (278)
T ss_dssp -------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCS---SC---CCC----CTTSCHHHHH
T ss_pred CCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH---H---HH-Hhh---cc---cCC----ccccCHHHHH
Confidence 999999988899999999999999999999999864322111 0 00 000 00 001 1112345678
Q ss_pred HhhhcccCCCCCCCCHHHHHH
Q 046010 453 IGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~ 473 (523)
++.+||+.||++|||+.+|++
T Consensus 242 li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 242 LIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp HHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHcccCHhhCCCHHHHhc
Confidence 999999999999999999875
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.92 E-value=7.5e-25 Score=219.16 Aligned_cols=162 Identities=20% Similarity=0.225 Sum_probs=124.8
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC----CeeEeccccceeccCCCCCccccceec
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM----NPKISDFGMARIFGGNQNESNTSKVVG 368 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~----~~kL~Dfg~a~~~~~~~~~~~~~~~~g 368 (523)
.++..+++..++.++.||+.||.|||+++ |+||||||+||+++.++ .+||+|||++....... ......|
T Consensus 107 ~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g 180 (321)
T 2a2a_A 107 AQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFG 180 (321)
T ss_dssp HTCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTC---CCCCCCS
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccceecCccc---cccccCC
Confidence 45667999999999999999999999998 99999999999999888 79999999998764322 2234568
Q ss_pred cCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 369 TYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 369 t~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
++.|+|||.+.+..++.++||||||+++|+|++|+.||...... .. ......... ...+.... ....
T Consensus 181 t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~----~~~i~~~~~--~~~~~~~~----~~~~ 247 (321)
T 2a2a_A 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ET----LANITSVSY--DFDEEFFS----HTSE 247 (321)
T ss_dssp CGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HH----HHHHHTTCC--CCCHHHHT----TCCH
T ss_pred CCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH---HH----HHHHHhccc--ccChhhhc----ccCH
Confidence 99999999999999999999999999999999999998532211 11 111111110 01111111 1124
Q ss_pred HHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 449 KCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+.+|+.+||+.||++|||+.|+++
T Consensus 248 ~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 248 LAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhc
Confidence 5778999999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.92 E-value=9e-25 Score=220.56 Aligned_cols=168 Identities=20% Similarity=0.184 Sum_probs=122.3
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC--CeeEeccccceeccCCCCC--ccccceeccC
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM--NPKISDFGMARIFGGNQNE--SNTSKVVGTY 370 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~--~~kL~Dfg~a~~~~~~~~~--~~~~~~~gt~ 370 (523)
...+++..++.++.||++||+|||+++ |+||||||+||+++.++ .+||+|||++..+...... .......||+
T Consensus 162 ~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~ 238 (345)
T 3hko_A 162 DFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTP 238 (345)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCG
T ss_pred cccccHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCc
Confidence 445678899999999999999999998 99999999999998776 8999999999876432221 1234567899
Q ss_pred CCCchhhhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 371 GYMAPEYALG--GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 371 ~y~aPE~l~~--~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
.|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ............. ..+.. .....
T Consensus 239 ~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~~--~~~~~-----~~~~~ 305 (345)
T 3hko_A 239 YFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLCF--ENPNY-----NVLSP 305 (345)
T ss_dssp GGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCT--TSGGG-----GGSCH
T ss_pred cccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhccccc--CCccc-----ccCCH
Confidence 9999999875 67899999999999999999999998532211 1112222211111 11111 11234
Q ss_pred HHHHHhhhcccCCCCCCCCHHHHHH--HhccC
Q 046010 449 KCIHIGLLCVQEDPADRPNMSSVAV--MLASD 478 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~RPs~~ei~~--~L~~~ 478 (523)
.+.+|+.+||+.||++||++.|+++ +|++.
T Consensus 306 ~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 306 LARDLLSNLLNRNVDERFDAMRALQHPWISQF 337 (345)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence 5778999999999999999999976 45544
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-25 Score=221.00 Aligned_cols=170 Identities=26% Similarity=0.392 Sum_probs=119.5
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCC---CccccceeccC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQN---ESNTSKVVGTY 370 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~gt~ 370 (523)
....+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||++........ ........+++
T Consensus 114 ~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 190 (303)
T 2vwi_A 114 KSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190 (303)
T ss_dssp TTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCC
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCc
Confidence 3566999999999999999999999998 99999999999999999999999999876532211 11123457899
Q ss_pred CCCchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 371 GYMAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 371 ~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
.|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ..................+..... .....
T Consensus 191 ~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~ 263 (303)
T 2vwi_A 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VLMLTLQNDPPSLETGVQDKEMLK----KYGKS 263 (303)
T ss_dssp TTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHHHHHTSSCCCTTC-----CCCC----CCCHH
T ss_pred cccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HHHHHhccCCCccccccccchhhh----hhhHH
Confidence 9999999875 568999999999999999999999986433221 111111100000000001111111 12245
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHH
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+.+|+.+||+.||.+|||+.||++
T Consensus 264 ~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 264 FRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHccCChhhCcCHHHHhh
Confidence 778899999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-25 Score=225.20 Aligned_cols=176 Identities=26% Similarity=0.267 Sum_probs=123.6
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCc--------ccccee
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES--------NTSKVV 367 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~--------~~~~~~ 367 (523)
..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.......... ......
T Consensus 107 ~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~ 183 (353)
T 2b9h_A 107 QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183 (353)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCC
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhcc
Confidence 57999999999999999999999998 9999999999999999999999999998764322111 122346
Q ss_pred ccCCCCchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcc---ccc---------
Q 046010 368 GTYGYMAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEAL---ELM--------- 434 (523)
Q Consensus 368 gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~--------- 434 (523)
||..|+|||++.+ ..++.++||||||+++|+|++|+.||....... ............... ..+
T Consensus 184 gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (353)
T 2b9h_A 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---QLLLIFGIIGTPHSDNDLRCIESPRAREYI 260 (353)
T ss_dssp CCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCSTTTTTTCCCHHHHHHH
T ss_pred ccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCCCchhccccccccchhhHHh
Confidence 7899999998765 678999999999999999999999986432211 111111111100000 000
Q ss_pred -------CccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH--HhccC
Q 046010 435 -------DPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV--MLASD 478 (523)
Q Consensus 435 -------~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~~ 478 (523)
...+. .........+.+|+.+||+.||++|||+.|+++ .|+..
T Consensus 261 ~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 261 KSLPMYPAAPLE-KMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp HTSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hcccCCCCcchh-hhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 00000 000112346778999999999999999999987 55543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.5e-25 Score=215.84 Aligned_cols=159 Identities=25% Similarity=0.352 Sum_probs=115.8
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEe---CCCCCeeEeccccceeccCCCCCccccceeccC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQNESNTSKVVGTY 370 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~ 370 (523)
++..+++..++.++.||++||+|||+++ |+||||||+||++ +.++.+||+|||++...... .......++.
T Consensus 117 ~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~ 190 (285)
T 3is5_A 117 RGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD---EHSTNAAGTA 190 (285)
T ss_dssp HTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CTTG
T ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc---ccCcCccccc
Confidence 3477999999999999999999999998 9999999999999 45678999999999765432 2233456899
Q ss_pred CCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 371 GYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 371 ~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
.|+|||.+. ..++.++||||||+++|+|++|+.||...... ............... . ... ....+
T Consensus 191 ~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~~~-~---~~~----~~~~~ 255 (285)
T 3is5_A 191 LYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE------EVQQKATYKEPNYAV-E---CRP----LTPQA 255 (285)
T ss_dssp GGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCCCC------CC----CCHHH
T ss_pred CcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH------HHHhhhccCCccccc-c---cCc----CCHHH
Confidence 999999875 56899999999999999999999998532211 111111111110000 0 000 12356
Q ss_pred HHHhhhcccCCCCCCCCHHHHHH
Q 046010 451 IHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+|+.+||+.||++|||+.||++
T Consensus 256 ~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 256 VDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHHHHccCChhhCcCHHHHhc
Confidence 78899999999999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.1e-25 Score=215.92 Aligned_cols=160 Identities=26% Similarity=0.357 Sum_probs=125.4
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..++..+++.+++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||++....... .......++..
T Consensus 106 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~ 180 (294)
T 2rku_A 106 HKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPN 180 (294)
T ss_dssp HHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCCS
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCc--cccccccCCCC
Confidence 345568999999999999999999999998 9999999999999999999999999998764222 12334568999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||.+.+..++.++||||||+++|+|++|+.||...... . .......... . +.. .....+.
T Consensus 181 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~-~~~~~~~~~~-~-----~~~----~~~~~~~ 243 (294)
T 2rku_A 181 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------E-TYLRIKKNEY-S-----IPK----HINPVAA 243 (294)
T ss_dssp SCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------H-HHHHHHTTCC-C-----CCT----TSCHHHH
T ss_pred cCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHhhccC-C-----Ccc----ccCHHHH
Confidence 99999999888999999999999999999999998532211 1 1111111111 0 111 1123567
Q ss_pred HHhhhcccCCCCCCCCHHHHHH
Q 046010 452 HIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+++.+||+.||++|||+.|+++
T Consensus 244 ~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 244 SLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp HHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHHHHHcccChhhCcCHHHHhh
Confidence 8899999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.92 E-value=5.6e-25 Score=224.79 Aligned_cols=182 Identities=20% Similarity=0.241 Sum_probs=124.8
Q ss_pred eeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCC
Q 046010 280 WIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQN 359 (523)
Q Consensus 280 ~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 359 (523)
++.+.++...+...-+..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 123 ~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-- 197 (371)
T 4exu_A 123 YLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-- 197 (371)
T ss_dssp EEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC--------
T ss_pred EEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccccccC--
Confidence 344444443333333556999999999999999999999998 999999999999999999999999999865322
Q ss_pred CccccceeccCCCCchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccc-----
Q 046010 360 ESNTSKVVGTYGYMAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALEL----- 433 (523)
Q Consensus 360 ~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 433 (523)
.....+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ............. ..+.
T Consensus 198 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~-~~~~~~~~~ 270 (371)
T 4exu_A 198 ---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVP-GTEFVQKLN 270 (371)
T ss_dssp -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCC-CHHHHTTCS
T ss_pred ---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCC-cHHHHHHhh
Confidence 233567899999999987 67899999999999999999999998643211 1111111100000 0000
Q ss_pred ----------cCccccCC---ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 434 ----------MDPVLKQS---CMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 434 ----------~~~~l~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+....... ........+.+|+.+||+.||++|||+.|+++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00000000 00112356788999999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-25 Score=229.66 Aligned_cols=179 Identities=25% Similarity=0.298 Sum_probs=126.2
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC-ccccceeccCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE-SNTSKVVGTYGY 372 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~gt~~y 372 (523)
+...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++......... .......||+.|
T Consensus 121 ~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y 197 (364)
T 3qyz_A 121 KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197 (364)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGG
T ss_pred HhCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCC
Confidence 3456999999999999999999999998 999999999999999999999999999876432211 112345789999
Q ss_pred CchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccc---c--------Ccc-cc
Q 046010 373 MAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALEL---M--------DPV-LK 439 (523)
Q Consensus 373 ~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~--------~~~-l~ 439 (523)
+|||++.+ ..++.++||||||+++|+|++|+.||....... ................. . ... ..
T Consensus 198 ~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (364)
T 3qyz_A 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHK 274 (364)
T ss_dssp CCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG---HHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCC
T ss_pred CCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH---HHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCc
Confidence 99998765 458999999999999999999999986433221 11111111100000000 0 000 00
Q ss_pred CCcc-----HHHHHHHHHHhhhcccCCCCCCCCHHHHHH--HhccC
Q 046010 440 QSCM-----AAELLKCIHIGLLCVQEDPADRPNMSSVAV--MLASD 478 (523)
Q Consensus 440 ~~~~-----~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~~ 478 (523)
...+ ......+.+|+.+||+.||++|||+.|+++ ++++.
T Consensus 275 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 275 NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp CCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred cCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 0000 112345788999999999999999999986 44443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.92 E-value=6e-25 Score=234.09 Aligned_cols=160 Identities=28% Similarity=0.324 Sum_probs=123.2
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
+..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....... ......||+.|+|
T Consensus 283 ~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~GT~~Y~A 357 (543)
T 3c4z_A 283 NPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFMA 357 (543)
T ss_dssp SCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC--CBCCCCSCTTTSC
T ss_pred cccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCCCc--ccccccCCccccC
Confidence 557999999999999999999999998 99999999999999999999999999987643221 2234579999999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
||++.+..++.++|||||||++|||++|+.||........ .......... ... . .+......+.+|+
T Consensus 358 PE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~~-~~~-~---------~p~~~s~~~~~li 424 (543)
T 3c4z_A 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVLE-QAV-T---------YPDKFSPASKDFC 424 (543)
T ss_dssp HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHHH-CCC-C---------CCTTSCHHHHHHH
T ss_pred hhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHhh-ccc-C---------CCcccCHHHHHHH
Confidence 9999999999999999999999999999999864322111 1111111111 111 0 0111234567889
Q ss_pred hhcccCCCCCCCCH-----HHHH
Q 046010 455 LLCVQEDPADRPNM-----SSVA 472 (523)
Q Consensus 455 ~~cl~~dP~~RPs~-----~ei~ 472 (523)
.+||+.||++||++ .+|+
T Consensus 425 ~~lL~~dP~~R~~~~~~~a~ei~ 447 (543)
T 3c4z_A 425 EALLQKDPEKRLGFRDGSCDGLR 447 (543)
T ss_dssp HHHSCSSGGGSCCCBTTBSHHHH
T ss_pred HHhccCCHhHCCCCcccCHHHHH
Confidence 99999999999975 5565
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-25 Score=222.03 Aligned_cols=166 Identities=26% Similarity=0.315 Sum_probs=118.6
Q ss_pred cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcccccee
Q 046010 288 PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVV 367 (523)
Q Consensus 288 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 367 (523)
.++...+...+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++....... .......
T Consensus 116 ~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~ 190 (326)
T 2x7f_A 116 DLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFI 190 (326)
T ss_dssp HHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC---------------
T ss_pred HHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc--ccccccc
Confidence 4444445578999999999999999999999998 9999999999999999999999999987653221 1223456
Q ss_pred ccCCCCchhhhc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCc
Q 046010 368 GTYGYMAPEYAL-----GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSC 442 (523)
Q Consensus 368 gt~~y~aPE~l~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 442 (523)
++..|+|||.+. +..++.++||||||+++|+|++|+.||...... ......... ........
T Consensus 191 ~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~-~~~~~~~~------ 257 (326)
T 2x7f_A 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RALFLIPRN-PAPRLKSK------ 257 (326)
T ss_dssp CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHS-CCCCCSCS------
T ss_pred CCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHHHHhhcC-ccccCCcc------
Confidence 889999999987 566889999999999999999999998532211 111111111 11111111
Q ss_pred cHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 443 MAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 443 ~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.....+.+++.+||+.||.+||++.+|++
T Consensus 258 --~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 258 --KWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp --CSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --ccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11245678899999999999999999987
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=212.86 Aligned_cols=162 Identities=19% Similarity=0.193 Sum_probs=122.5
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEe---CCCCCeeEeccccceeccCCCCCccccceec
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQNESNTSKVVG 368 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~g 368 (523)
...+..+++..++.++.||+.||.|||+++ |+||||||+||++ +.++.+||+|||++....... ......+
T Consensus 97 ~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~ 170 (277)
T 3f3z_A 97 VVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVG 170 (277)
T ss_dssp HHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS---CBCCCCS
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc---chhccCC
Confidence 345567999999999999999999999998 9999999999999 788899999999998764322 2334578
Q ss_pred cCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 369 TYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 369 t~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
++.|+|||.+.+ .++.++||||||+++|+|++|+.||...... .. ......+.... ...... ....
T Consensus 171 t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~-~~~~~~~~~~~--~~~~~~----~~~~ 236 (277)
T 3f3z_A 171 TPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS------EV-MLKIREGTFTF--PEKDWL----NVSP 236 (277)
T ss_dssp CTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HH-HHHHHHCCCCC--CHHHHT----TSCH
T ss_pred CCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH------HH-HHHHHhCCCCC--Cchhhh----cCCH
Confidence 999999998865 4899999999999999999999998532211 11 11111111100 000000 1134
Q ss_pred HHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 449 KCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+.+++.+||+.||++|||+.++++
T Consensus 237 ~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 237 QAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHccCChhhCcCHHHHhc
Confidence 6778999999999999999999974
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=217.10 Aligned_cols=162 Identities=24% Similarity=0.316 Sum_probs=125.1
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.....+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||++....... .......++..|
T Consensus 117 ~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y 191 (314)
T 3com_A 117 LRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVIGTPFW 191 (314)
T ss_dssp HHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--SCBCCCCSCGGG
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--cccCccCCCCCc
Confidence 34678999999999999999999999998 9999999999999999999999999998764322 122345688999
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
+|||.+.+..++.++||||||+++|+|++|+.||...... ......... ....... +......+.+
T Consensus 192 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~-~~~~~~~-------~~~~~~~l~~ 257 (314)
T 3com_A 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIFMIPTN-PPPTFRK-------PELWSDNFTD 257 (314)
T ss_dssp CCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHS-CCCCCSS-------GGGSCHHHHH
T ss_pred cChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcC-CCcccCC-------cccCCHHHHH
Confidence 9999999999999999999999999999999998532211 111111111 1111100 1112346778
Q ss_pred HhhhcccCCCCCCCCHHHHHH
Q 046010 453 IGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~ 473 (523)
|+.+||+.||.+|||+.++++
T Consensus 258 li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 258 FVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHccCChhhCcCHHHHHh
Confidence 999999999999999999975
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.1e-25 Score=228.33 Aligned_cols=162 Identities=20% Similarity=0.206 Sum_probs=122.0
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
+..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ........||+.|+|
T Consensus 162 ~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~A 237 (410)
T 3v8s_A 162 NYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYIS 237 (410)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-EEECCSCCSCGGGCC
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCC-cccccCCcCCccccC
Confidence 456999999999999999999999998 9999999999999999999999999998764322 112335679999999
Q ss_pred hhhhcCCC----CCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 375 PEYALGGV----ISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 375 PE~l~~~~----~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
||++.+.. ++.++||||||+++|||++|+.||...... .................. ......+
T Consensus 238 PE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~~~p~~-------~~~s~~~ 304 (410)
T 3v8s_A 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNHKNSLTFPDD-------NDISKEA 304 (410)
T ss_dssp HHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTHHHHCCCCTT-------CCCCHHH
T ss_pred HHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh------hHHHHHHhccccccCCCc-------ccccHHH
Confidence 99998655 789999999999999999999998532211 111111110000000000 0112356
Q ss_pred HHHhhhcccCCCCC--CCCHHHHHH
Q 046010 451 IHIGLLCVQEDPAD--RPNMSSVAV 473 (523)
Q Consensus 451 ~~li~~cl~~dP~~--RPs~~ei~~ 473 (523)
.+|+.+||+.+|.+ ||+++||++
T Consensus 305 ~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 305 KNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred HHHHHHHccChhhhCCCCCHHHHhc
Confidence 78888999999988 999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.9e-25 Score=228.92 Aligned_cols=164 Identities=26% Similarity=0.319 Sum_probs=117.2
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC---CeeEeccccceeccCCCCCccccceec
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM---NPKISDFGMARIFGGNQNESNTSKVVG 368 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~---~~kL~Dfg~a~~~~~~~~~~~~~~~~g 368 (523)
..++..+++..++.++.||++||+|||+++ |+||||||+|||++.++ .+||+|||+++..... .......|
T Consensus 230 l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~---~~~~~~~g 303 (419)
T 3i6u_A 230 VVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTLCG 303 (419)
T ss_dssp TSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-------------
T ss_pred HhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeecccceecCCC---ccccccCC
Confidence 455678999999999999999999999998 99999999999997554 5999999999875422 22334678
Q ss_pred cCCCCchhhhcC---CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHH
Q 046010 369 TYGYMAPEYALG---GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAA 445 (523)
Q Consensus 369 t~~y~aPE~l~~---~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 445 (523)
|+.|+|||++.+ ..++.++||||||+++|+|++|+.||...... ..+... ...+... .. +.... .
T Consensus 304 t~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~~----i~~~~~~-~~-~~~~~----~ 371 (419)
T 3i6u_A 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKDQ----ITSGKYN-FI-PEVWA----E 371 (419)
T ss_dssp -CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS--CCHHHH----HHTTCCC-CC-HHHHT----T
T ss_pred CCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch--HHHHHH----HhcCCCC-CC-chhhc----c
Confidence 999999999853 66889999999999999999999998643221 111111 1111110 00 00000 1
Q ss_pred HHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 446 ELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 446 ~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
....+.+|+.+||+.||++|||+.|+++
T Consensus 372 ~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 372 VSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 2346778999999999999999999886
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=8e-25 Score=218.14 Aligned_cols=171 Identities=24% Similarity=0.324 Sum_probs=118.1
Q ss_pred cccccccccccccccCHHHHHHHHHHHHHHHHHHHhc-CCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcc
Q 046010 284 GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHED-SRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN 362 (523)
Q Consensus 284 g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 362 (523)
|.+...+.......+++..++.++.||++||.|||++ + |+|+||||+||+++.++.+||+|||++....... .
T Consensus 107 ~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~ 180 (318)
T 2dyl_A 107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK---A 180 (318)
T ss_dssp SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCc---c
Confidence 3333444445567899999999999999999999995 8 9999999999999999999999999997653321 2
Q ss_pred ccceeccCCCCchhhhc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCcc
Q 046010 363 TSKVVGTYGYMAPEYAL-----GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPV 437 (523)
Q Consensus 363 ~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (523)
.....+++.|+|||.+. ...++.++||||||+++|+|++|+.||...... ......... .........
T Consensus 181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~-~~~~~~~~~- 253 (318)
T 2dyl_A 181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQ-EEPPLLPGH- 253 (318)
T ss_dssp ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHH-SCCCCCCSS-
T ss_pred ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhc-cCCCCCCcc-
Confidence 23456899999999984 456889999999999999999999998632211 111111111 111111000
Q ss_pred ccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 438 LKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 438 l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
. .....+.+++.+||+.||.+||++.||++
T Consensus 254 --~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 254 --M----GFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp --S----CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --C----CCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 11235678899999999999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=3.6e-25 Score=225.10 Aligned_cols=109 Identities=30% Similarity=0.483 Sum_probs=95.0
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhc-CCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHED-SRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~-g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
.+...+++..++.++.||+.||.|||++ + |+||||||+||+++.++.+||+|||++...... ......|++.
T Consensus 123 ~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~gt~~ 195 (360)
T 3eqc_A 123 KKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRS 195 (360)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----C----CCCCT
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc----cccCCCCCCC
Confidence 4456799999999999999999999996 7 999999999999999999999999998754321 2234578999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGF 408 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~ 408 (523)
|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus 196 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 196 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp TCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred eECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999999999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.91 E-value=8.3e-25 Score=222.15 Aligned_cols=187 Identities=19% Similarity=0.204 Sum_probs=131.7
Q ss_pred eEeeecccccccc------ccccccccCHHHHHHHHHHHHHHHHHHH--hcCCCcEEecCCCCCcEEeCC-CCCeeEecc
Q 046010 278 AIWIAIGTTIPTI------YSTRRAQLDWKRRISIINGIARGLLYLH--EDSRLKVFHRDLKASNVLLDH-EMNPKISDF 348 (523)
Q Consensus 278 ~~~ia~g~~~~~~------~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~g~~~ivH~Dlkp~NIll~~-~~~~kL~Df 348 (523)
..++.+.++...+ +..+...+++..++.++.||+.||.||| +++ |+||||||+|||++. ++.+||+||
T Consensus 100 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Df 176 (360)
T 3e3p_A 100 YLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCDF 176 (360)
T ss_dssp EEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECCC
T ss_pred eEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEeeC
Confidence 4555555554322 2346778999999999999999999999 888 999999999999997 899999999
Q ss_pred ccceeccCCCCCccccceeccCCCCchhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHH----
Q 046010 349 GMARIFGGNQNESNTSKVVGTYGYMAPEYALGGV-ISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWK---- 423 (523)
Q Consensus 349 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~---- 423 (523)
|+++...... ......+|..|+|||++.+.. ++.++||||||+++|+|++|+.||....... .......
T Consensus 177 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~ 250 (360)
T 3e3p_A 177 GSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG---QLHEIVRVLGC 250 (360)
T ss_dssp TTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCC
T ss_pred CCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH---HHHHHHHHcCC
Confidence 9998764322 222456789999999987654 8999999999999999999999986432211 1111111
Q ss_pred -------hhhcCC-cccccCc------cccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 424 -------LWCNGE-ALELMDP------VLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 424 -------~~~~~~-~~~~~~~------~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+.... ....... .............+.+|+.+||+.||.+|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 110000 0000000 0000111123457889999999999999999999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.7e-25 Score=223.67 Aligned_cols=167 Identities=21% Similarity=0.225 Sum_probs=119.7
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
+..+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||++..... ......++..|+|
T Consensus 120 ~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~t~~y~a 191 (353)
T 3coi_A 120 GLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRA 191 (353)
T ss_dssp TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSC
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCCC-----CccccccCcCcCC
Confidence 446999999999999999999999998 99999999999999999999999999976432 1234567899999
Q ss_pred hhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcC------------------CcccccC
Q 046010 375 PEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNG------------------EALELMD 435 (523)
Q Consensus 375 PE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~ 435 (523)
||.+.+ ..++.++||||||+++|+|++|+.||...... ..+.......... .......
T Consensus 192 PE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (353)
T 3coi_A 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPR 268 (353)
T ss_dssp HHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH---HHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSS
T ss_pred HHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCC
Confidence 999887 67899999999999999999999998643211 1111111100000 0000000
Q ss_pred ccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 436 PVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 436 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
..+. .........+.+|+.+||+.||++|||+.|+++
T Consensus 269 ~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 269 KDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 011123456788999999999999999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-25 Score=220.68 Aligned_cols=158 Identities=27% Similarity=0.394 Sum_probs=123.9
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
+..+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++....... .......++..|+|
T Consensus 113 ~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~a 187 (303)
T 3a7i_A 113 PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMA 187 (303)
T ss_dssp TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--CCBCCCCSCGGGCC
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc--cccCccCCCcCccC
Confidence 457999999999999999999999998 9999999999999999999999999998764322 12234578899999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
||.+.+..++.++||||||+++|+|++|+.||...... .... ........ .+... ....+.+|+
T Consensus 188 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~-~~~~~~~~-----~~~~~----~~~~l~~li 251 (303)
T 3a7i_A 188 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM------KVLF-LIPKNNPP-----TLEGN----YSKPLKEFV 251 (303)
T ss_dssp HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHH-HHHHSCCC-----CCCSS----CCHHHHHHH
T ss_pred HHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH------HHHH-HhhcCCCC-----CCccc----cCHHHHHHH
Confidence 99999999999999999999999999999998532211 1111 11111111 11111 123577889
Q ss_pred hhcccCCCCCCCCHHHHHH
Q 046010 455 LLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~ 473 (523)
.+||+.||++|||+.||++
T Consensus 252 ~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 252 EACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp HHHCCSSGGGSCCHHHHTT
T ss_pred HHHcCCChhhCcCHHHHhh
Confidence 9999999999999999976
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.7e-24 Score=219.26 Aligned_cols=162 Identities=24% Similarity=0.379 Sum_probs=123.0
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.++..+++..++.++.||+.||.|||+.| |+|+||||+||+++.++.+||+|||++....... ......||+.|
T Consensus 192 ~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y 265 (365)
T 2y7j_A 192 TEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGY 265 (365)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGG
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccccCCCc---ccccCCCCCCc
Confidence 34567999999999999999999999998 9999999999999999999999999998764322 23346789999
Q ss_pred CchhhhcC------CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHH
Q 046010 373 MAPEYALG------GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAE 446 (523)
Q Consensus 373 ~aPE~l~~------~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 446 (523)
+|||++.+ ..++.++||||||+++|+|++|+.||..... ... ......+... ...+.. . ..
T Consensus 266 ~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~~----~~~i~~~~~~-~~~~~~-~----~~ 332 (365)
T 2y7j_A 266 LAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ---ILM----LRMIMEGQYQ-FSSPEW-D----DR 332 (365)
T ss_dssp CCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHH----HHHHHHTCCC-CCHHHH-S----SS
T ss_pred cChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH---HHH----HHHHHhCCCC-CCCccc-c----cC
Confidence 99998863 3588999999999999999999999853211 111 1111111110 000000 0 11
Q ss_pred HHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 447 LLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 447 ~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
...+.+++.+||+.||++|||+.|+++
T Consensus 333 ~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 333 SSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 245778999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-25 Score=226.76 Aligned_cols=172 Identities=20% Similarity=0.190 Sum_probs=117.6
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..++..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++...... .......++..
T Consensus 125 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~ 198 (362)
T 3pg1_A 125 HDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTAD---ANKTHYVTHRW 198 (362)
T ss_dssp HCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCTTC------------------CGG
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEEecCcccccccc---cccceecccce
Confidence 355567999999999999999999999998 999999999999999999999999999754322 22334578889
Q ss_pred CCchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcC-------------------Ccc
Q 046010 372 YMAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNG-------------------EAL 431 (523)
Q Consensus 372 y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~ 431 (523)
|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ............. ...
T Consensus 199 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (362)
T 3pg1_A 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY---NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLS 275 (362)
T ss_dssp GCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCC
T ss_pred ecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcc
Confidence 999999877 67899999999999999999999998643211 1111111111000 000
Q ss_pred cccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 432 ELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 432 ~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
....... ..........+.+|+.+||+.||++|||+.|+++
T Consensus 276 ~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 276 NVPARAW-TAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp CCCCCCH-HHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCChhhH-HhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 0000000 0001112345778999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-25 Score=218.86 Aligned_cols=150 Identities=19% Similarity=0.285 Sum_probs=115.4
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCC-------------------CCeeEeccccceeccC
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE-------------------MNPKISDFGMARIFGG 356 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~-------------------~~~kL~Dfg~a~~~~~ 356 (523)
..+++..++.++.||++||.|||+++ |+||||||+||+++.+ ..+||+|||.+.....
T Consensus 110 ~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~ 186 (289)
T 1x8b_A 110 SYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186 (289)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTC
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCC
Confidence 66999999999999999999999998 9999999999999844 4789999999987643
Q ss_pred CCCCccccceeccCCCCchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccC
Q 046010 357 NQNESNTSKVVGTYGYMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMD 435 (523)
Q Consensus 357 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (523)
.. ...++..|+|||.+.+. .++.++||||||+++|+|++|.+++... . .+.....+.....
T Consensus 187 ~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------~----~~~~~~~~~~~~~-- 248 (289)
T 1x8b_A 187 PQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG------D----QWHEIRQGRLPRI-- 248 (289)
T ss_dssp SC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS------H----HHHHHHTTCCCCC--
T ss_pred cc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch------h----HHHHHHcCCCCCC--
Confidence 22 23588999999999765 5678999999999999999998765321 1 1112222222111
Q ss_pred ccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 436 PVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 436 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.. .....+.+++.+||+.||++|||+.|+++
T Consensus 249 ---~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 249 ---PQ----VLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ---SS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---Cc----ccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 11 12245778899999999999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=217.76 Aligned_cols=166 Identities=21% Similarity=0.292 Sum_probs=123.9
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHh-cCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHE-DSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~-~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
...+++..++.++.||+.||.|||+ ++ |+|+||||+||+++.++.+||+|||.+...... ......++..|+
T Consensus 145 ~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~ 217 (348)
T 2pml_X 145 TCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFM 217 (348)
T ss_dssp CCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGC
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCcc
Confidence 6789999999999999999999999 88 999999999999999999999999999875432 233457889999
Q ss_pred chhhhcCC-CCCc-chhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCccccc------Ccccc---CCc
Q 046010 374 APEYALGG-VISV-KSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELM------DPVLK---QSC 442 (523)
Q Consensus 374 aPE~l~~~-~~s~-ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~l~---~~~ 442 (523)
|||.+.+. .++. ++||||||+++|+|++|+.||...... .. .............. .+... ...
T Consensus 218 aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (348)
T 2pml_X 218 PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VE----LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCS 291 (348)
T ss_dssp CGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HH----HHHHHTSCCCCCCCSSSSSTTTTCC------
T ss_pred CchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HH----HHHHHhccCcCCccchhhhhccccccccccc
Confidence 99999877 6666 999999999999999999998643221 11 11112221111000 00000 000
Q ss_pred cHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 443 MAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 443 ~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.......+.+|+.+||+.||.+|||+.|+++
T Consensus 292 ~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 292 NNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp --CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0122356788999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=217.87 Aligned_cols=164 Identities=26% Similarity=0.313 Sum_probs=122.6
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCC---eeEeccccceeccCCCCCccccceec
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMN---PKISDFGMARIFGGNQNESNTSKVVG 368 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~---~kL~Dfg~a~~~~~~~~~~~~~~~~g 368 (523)
..+...+++..++.++.||++||.|||+++ |+||||||+||+++.++. +||+|||++...... .......|
T Consensus 105 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~g 178 (322)
T 2ycf_A 105 VVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTLCG 178 (322)
T ss_dssp HSTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCC---HHHHHHHS
T ss_pred HhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCccceecccc---cccccccC
Confidence 345678999999999999999999999998 999999999999987664 999999999875321 12234568
Q ss_pred cCCCCchhhhc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHH
Q 046010 369 TYGYMAPEYAL---GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAA 445 (523)
Q Consensus 369 t~~y~aPE~l~---~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 445 (523)
+..|+|||++. ...++.++||||||+++|+|++|+.||....... .+.... ..+... . .+.... .
T Consensus 179 t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~----~~~~~~-~-~~~~~~----~ 246 (322)
T 2ycf_A 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI----TSGKYN-F-IPEVWA----E 246 (322)
T ss_dssp CCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHH----HHTCCC-C-CHHHHT----T
T ss_pred CcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHH----HhCccc-c-Cchhhh----h
Confidence 99999999874 4668899999999999999999999986432221 111111 111110 0 010101 1
Q ss_pred HHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 446 ELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 446 ~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
....+.+|+.+||+.||++||++.|+++
T Consensus 247 ~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 247 VSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 2346778999999999999999999874
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=212.68 Aligned_cols=162 Identities=20% Similarity=0.238 Sum_probs=121.7
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC----CeeEeccccceeccCCCCCccccceec
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM----NPKISDFGMARIFGGNQNESNTSKVVG 368 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~----~~kL~Dfg~a~~~~~~~~~~~~~~~~g 368 (523)
.++..+++..++.++.||++||.|||+++ |+|+||||+||+++.++ .+||+|||.+....... ......+
T Consensus 100 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~ 173 (283)
T 3bhy_A 100 AEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFG 173 (283)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-----------CC
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC---cccccCC
Confidence 45567999999999999999999999998 99999999999998877 79999999998754322 2234568
Q ss_pred cCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 369 TYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 369 t~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
++.|+|||.+.+..++.++||||||+++|+|++|+.||...... .....+...... ....... ....
T Consensus 174 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~--~~~~~~~----~~~~ 240 (283)
T 3bhy_A 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ-------ETLTNISAVNYD--FDEEYFS----NTSE 240 (283)
T ss_dssp CGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTTCCC--CCHHHHT----TCCH
T ss_pred CcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-------HHHHHhHhcccC--Ccchhcc----cCCH
Confidence 89999999999999999999999999999999999998532211 111111111100 0111101 1234
Q ss_pred HHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 449 KCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 241 LAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHh
Confidence 5778999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-25 Score=224.15 Aligned_cols=152 Identities=24% Similarity=0.385 Sum_probs=121.0
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeC-CCCCeeEeccccceeccCCCCCccccceeccC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLD-HEMNPKISDFGMARIFGGNQNESNTSKVVGTY 370 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~ 370 (523)
..++..+++..++.++.||++||+|||+++ |+||||||+||+++ +++.+||+|||++...... ......++.
T Consensus 140 l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~----~~~~~~gt~ 212 (320)
T 3a99_A 140 ITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTR 212 (320)
T ss_dssp HHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCSS----CBCCCCSCG
T ss_pred HhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCccccccccc----cccCCCCCc
Confidence 345678999999999999999999999998 99999999999999 7789999999999876432 223456899
Q ss_pred CCCchhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 371 GYMAPEYALGGVI-SVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 371 ~y~aPE~l~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
.|+|||++.+..+ +.++||||||+++|+|++|+.||..... ... ... . .... ....
T Consensus 213 ~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------------~~~-~~~--~----~~~~----~~~~ 269 (320)
T 3a99_A 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIR-GQV--F----FRQR----VSSE 269 (320)
T ss_dssp GGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHH-CCC--C----CSSC----CCHH
T ss_pred cCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------------hhc-ccc--c----cccc----CCHH
Confidence 9999999887665 6889999999999999999999853110 000 100 0 0111 1235
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHH
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+.+|+.+||+.||++|||+.||++
T Consensus 270 ~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 270 CQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHccCChhhCcCHHHHhc
Confidence 678999999999999999999987
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-25 Score=219.41 Aligned_cols=165 Identities=27% Similarity=0.289 Sum_probs=123.0
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcC--CCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDS--RLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g--~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
+..+++..++.++.||+.||.|||+++ ..+|+|+||||+||+++.++.+||+|||.+....... .......++..|
T Consensus 105 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y 182 (279)
T 2w5a_A 105 RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKTFVGTPYY 182 (279)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---C--HHHHHHHSCCTT
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccc--ccccccCCCccc
Confidence 345999999999999999999999985 1239999999999999999999999999997653221 112345688999
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
+|||.+.+..++.++||||||+++|+|++|+.||...... .. ......+....+ . ......+.+
T Consensus 183 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~----~~~i~~~~~~~~-----~----~~~~~~l~~ 246 (279)
T 2w5a_A 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---EL----AGKIREGKFRRI-----P----YRYSDELNE 246 (279)
T ss_dssp CCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHTCCCCC-----C----TTSCHHHHH
T ss_pred cChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HH----HHHHhhcccccC-----C----cccCHHHHH
Confidence 9999999989999999999999999999999998643211 11 111222221111 1 112346778
Q ss_pred HhhhcccCCCCCCCCHHHHHHHhcc
Q 046010 453 IGLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
++.+||+.||++|||+.||++.+..
T Consensus 247 li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 247 IITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHcCCCcccCCCHHHHHhChhh
Confidence 8999999999999999999987643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4e-25 Score=221.65 Aligned_cols=163 Identities=26% Similarity=0.327 Sum_probs=104.8
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhc-CCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHED-SRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~-g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.+..+++..++.++.|++.||.|||++ + |+||||||+||+++.++.+||+|||++....... ......|+..|
T Consensus 118 ~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y 191 (327)
T 3aln_A 118 LDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI---AKTRDAGCRPY 191 (327)
T ss_dssp TCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-------------------
T ss_pred hcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceeccccc---ccccCCCCccc
Confidence 467899999999999999999999998 8 9999999999999999999999999997654221 22334689999
Q ss_pred Cchhhh----cCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 373 MAPEYA----LGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 373 ~aPE~l----~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
+|||.+ .+..++.++||||||+++|+|++|+.||........ . ......+... .+..........
T Consensus 192 ~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~-~~~~~~~~~~-----~~~~~~~~~~~~ 260 (327)
T 3aln_A 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----Q-LTQVVKGDPP-----QLSNSEEREFSP 260 (327)
T ss_dssp --------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCCC-----CCCCCSSCCCCH
T ss_pred cCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----H-HHHHhcCCCC-----CCCCcccccCCH
Confidence 999998 456689999999999999999999999863221100 0 0000011111 111111112234
Q ss_pred HHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 449 KCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+.+|+.+||+.||++|||+.||++
T Consensus 261 ~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 261 SFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHhhCChhhCcCHHHHHh
Confidence 6778999999999999999999965
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.5e-24 Score=214.28 Aligned_cols=151 Identities=22% Similarity=0.369 Sum_probs=120.4
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeC-CCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLD-HEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
.++..+++..++.++.||++||.|||+++ |+||||||+||+++ .++.+||+|||++...... ......++..
T Consensus 131 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~ 203 (312)
T 2iwi_A 131 TEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE----PYTDFDGTRV 203 (312)
T ss_dssp HHHCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCSSCEECCSS----CBCCCCSCTT
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcchhhhcccC----cccccCCccc
Confidence 44567999999999999999999999998 99999999999999 7899999999999876432 2234568999
Q ss_pred CCchhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 372 YMAPEYALGGVI-SVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 372 y~aPE~l~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
|+|||.+.+..+ +.++||||||+++|+|++|+.||.... . . . .... . + +......+
T Consensus 204 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~-~---~-~~~~-~-----~----~~~~~~~~ 260 (312)
T 2iwi_A 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------E-I---L-EAEL-H-----F----PAHVSPDC 260 (312)
T ss_dssp TSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H-H---H-HTCC-C-----C----CTTSCHHH
T ss_pred ccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------H-H---h-hhcc-C-----C----cccCCHHH
Confidence 999999887666 458999999999999999999985311 0 0 0 0000 0 0 11122356
Q ss_pred HHHhhhcccCCCCCCCCHHHHHH
Q 046010 451 IHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+++.+||+.||++|||+.|+++
T Consensus 261 ~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 261 CALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHhc
Confidence 78899999999999999999987
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=214.43 Aligned_cols=159 Identities=27% Similarity=0.373 Sum_probs=118.5
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC-CCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH-EMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
..+++..++.++.||+.||.|||+++ |+|+||||+||+++. ++.+||+|||++....... .......++..|+|
T Consensus 117 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~a 191 (295)
T 2clq_A 117 LKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--PCTETFTGTLQYMA 191 (295)
T ss_dssp CTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCC
T ss_pred CCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC--CcccccCCCccccC
Confidence 45779999999999999999999998 999999999999987 8999999999998754321 12234568899999
Q ss_pred hhhhcCCC--CCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 375 PEYALGGV--ISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 375 PE~l~~~~--~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
||.+.+.. ++.++||||||+++|+|++|+.||........ .......... .+.+. ......+.+
T Consensus 192 PE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~-----~~~~~----~~~~~~~~~ 257 (295)
T 2clq_A 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-----AMFKVGMFKV-----HPEIP----ESMSAEAKA 257 (295)
T ss_dssp HHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH-----HHHHHHHHCC-----CCCCC----TTSCHHHHH
T ss_pred hhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH-----HHHhhccccc-----ccccc----ccCCHHHHH
Confidence 99987644 78999999999999999999999853221110 0111100000 01111 112346678
Q ss_pred HhhhcccCCCCCCCCHHHHHH
Q 046010 453 IGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~ 473 (523)
++.+||+.||++||++.|+++
T Consensus 258 li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 258 FILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHHHTTCSSTTTSCCHHHHHT
T ss_pred HHHHHccCChhhCCCHHHHhc
Confidence 899999999999999999975
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-24 Score=213.80 Aligned_cols=166 Identities=23% Similarity=0.307 Sum_probs=125.9
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEe---CCCCCeeEeccccceeccCCCCCccccceecc
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt 369 (523)
.+...+++..++.++.||+.||.|||+++ |+|+||||+||++ +.++.+||+|||++..... .......++
T Consensus 98 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~~~~ 170 (304)
T 2jam_A 98 LERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN----GIMSTACGT 170 (304)
T ss_dssp HHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC----BTTHHHHSC
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC----CccccccCC
Confidence 44567999999999999999999999998 9999999999999 7788999999999875422 122345689
Q ss_pred CCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 370 ~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ... ......+.. .. .... .......
T Consensus 171 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~----~~~i~~~~~-~~-~~~~----~~~~~~~ 237 (304)
T 2jam_A 171 PGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---SKL----FEKIKEGYY-EF-ESPF----WDDISES 237 (304)
T ss_dssp CCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---HHH----HHHHHHCCC-CC-CTTT----TTTSCHH
T ss_pred CCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHH----HHHHHcCCC-CC-Cccc----cccCCHH
Confidence 999999999999999999999999999999999999853221 111 111111111 00 0000 1112346
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHH--HhccC
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAV--MLASD 478 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~--~L~~~ 478 (523)
+.+++.+||+.||++|||+.|+++ ++++.
T Consensus 238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 238 AKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 778999999999999999999986 45543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8e-25 Score=216.60 Aligned_cols=162 Identities=21% Similarity=0.287 Sum_probs=119.1
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.....+++..++.++.||++||.|||+++ ++|+||||+||+++.++.+||+|||++...... ........++..|
T Consensus 109 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y 183 (302)
T 2j7t_A 109 ELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQKRDSFIGTPYW 183 (302)
T ss_dssp HHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--HHC-----CCGGG
T ss_pred hhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc--ccccccccCChhh
Confidence 34567999999999999999999999998 999999999999999999999999987543111 1112235688999
Q ss_pred Cchhhhc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHH
Q 046010 373 MAPEYAL-----GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAEL 447 (523)
Q Consensus 373 ~aPE~l~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 447 (523)
+|||.+. +..++.++||||||+++|+|++|+.||...... ......... ....... +....
T Consensus 184 ~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~-~~~~~~~-------~~~~~ 249 (302)
T 2j7t_A 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKS-DPPTLLT-------PSKWS 249 (302)
T ss_dssp CCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHS-CCCCCSS-------GGGSC
T ss_pred cCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHHHhcc-CCcccCC-------ccccC
Confidence 9999883 667899999999999999999999998543211 111111111 1111111 11123
Q ss_pred HHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 448 LKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 448 ~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
..+.+++.+||+.||++|||+.+|++
T Consensus 250 ~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 250 VEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhc
Confidence 45778899999999999999999865
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.2e-24 Score=209.47 Aligned_cols=158 Identities=25% Similarity=0.357 Sum_probs=115.0
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.+...+++..++.++.||++||.|||+++ |+|+||||+||+++.++.+||+|||++....... ......+++.|
T Consensus 103 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y 176 (276)
T 2h6d_A 103 CKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNY 176 (276)
T ss_dssp HHHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----------------
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc---ceecccCCccc
Confidence 44567999999999999999999999998 9999999999999999999999999997654321 22345688999
Q ss_pred CchhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 373 MAPEYALGGVI-SVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 373 ~aPE~l~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
+|||.+.+..+ +.++||||||+++|+|++|+.||...... ........... . +.. .....+.
T Consensus 177 ~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~-~-----~~~----~~~~~l~ 239 (276)
T 2h6d_A 177 AAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP-------TLFKKIRGGVF-Y-----IPE----YLNRSVA 239 (276)
T ss_dssp CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCC-C-----CCT----TSCHHHH
T ss_pred cCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-------HHHHHhhcCcc-c-----Cch----hcCHHHH
Confidence 99999987765 68999999999999999999998532211 11111111110 0 011 1123567
Q ss_pred HHhhhcccCCCCCCCCHHHHHH
Q 046010 452 HIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+++.+||+.||++|||+.||++
T Consensus 240 ~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 240 TLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhhCCCHHHHHh
Confidence 8899999999999999999987
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-24 Score=227.46 Aligned_cols=162 Identities=26% Similarity=0.332 Sum_probs=123.0
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEe---CCCCCeeEeccccceeccCCCCCccccceec
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLL---DHEMNPKISDFGMARIFGGNQNESNTSKVVG 368 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~g 368 (523)
...+..+++..++.++.||+.||.|||+++ |+||||||+||++ +.++.+||+|||++....... ......|
T Consensus 117 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~g 190 (484)
T 3nyv_A 117 IISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIG 190 (484)
T ss_dssp HHTCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC---SHHHHTT
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc---ccccCCC
Confidence 345567999999999999999999999998 9999999999999 567889999999998764322 2334568
Q ss_pred cCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 369 TYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 369 t~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
|+.|+|||++.+ .++.++||||||+++|+|++|+.||...... ... .....+...... +.. .....
T Consensus 191 t~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~----~~i~~~~~~~~~-~~~-----~~~s~ 256 (484)
T 3nyv_A 191 TAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DIL----KKVEKGKYTFEL-PQW-----KKVSE 256 (484)
T ss_dssp GGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHCCCCCCS-GGG-----GGSCH
T ss_pred CccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HHH----HHHHcCCCCCCC-ccc-----ccCCH
Confidence 999999999876 6899999999999999999999998532211 111 111111111100 000 11234
Q ss_pred HHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 449 KCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+.+|+.+||+.||++|||+.|+++
T Consensus 257 ~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 257 SAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhh
Confidence 5778999999999999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3e-24 Score=213.89 Aligned_cols=178 Identities=19% Similarity=0.234 Sum_probs=122.4
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeC-CCCCeeEeccccceeccCCCC-CccccceeccCCC
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLD-HEMNPKISDFGMARIFGGNQN-ESNTSKVVGTYGY 372 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~~gt~~y 372 (523)
+.++++..++.++.||++||+|||+++ |+||||||+||+++ +++.+||+|||+++....... ........++..|
T Consensus 114 ~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y 190 (320)
T 2i6l_A 114 QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWY 190 (320)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTT
T ss_pred cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccc
Confidence 467999999999999999999999998 99999999999997 567899999999986542211 1122344568899
Q ss_pred CchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhc----------CCcccccCcccc-C
Q 046010 373 MAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCN----------GEALELMDPVLK-Q 440 (523)
Q Consensus 373 ~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~-~ 440 (523)
+|||.+.+ ..++.++||||||+++|+|++|+.||....... ........... ......+..... .
T Consensus 191 ~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (320)
T 2i6l_A 191 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE---QMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEP 267 (320)
T ss_dssp CCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSC
T ss_pred cCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCchhhhhhhhhcCcccccccccCC
Confidence 99998865 678999999999999999999999986432211 11110000000 000000000000 0
Q ss_pred Ccc-----HHHHHHHHHHhhhcccCCCCCCCCHHHHHH--HhccC
Q 046010 441 SCM-----AAELLKCIHIGLLCVQEDPADRPNMSSVAV--MLASD 478 (523)
Q Consensus 441 ~~~-----~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~~ 478 (523)
..+ ......+.+++.+||+.||++|||+.|+++ +++..
T Consensus 268 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 268 HKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp CCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred CCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 000 112356788999999999999999999976 55543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6e-24 Score=225.03 Aligned_cols=166 Identities=26% Similarity=0.338 Sum_probs=122.8
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeC---CCCCeeEeccccceeccCCCCCccccceecc
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLD---HEMNPKISDFGMARIFGGNQNESNTSKVVGT 369 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~---~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt 369 (523)
.+...+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||+++...... ......||
T Consensus 113 ~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt 186 (486)
T 3mwu_A 113 IKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGT 186 (486)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTG
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC---ccCCCcCC
Confidence 44567999999999999999999999998 99999999999995 45679999999997654321 23345789
Q ss_pred CCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 370 ~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
+.|+|||++.+ .++.++||||||+++|+|++|+.||..... .... .....+...... +.. ......
T Consensus 187 ~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~----~~i~~~~~~~~~-~~~-----~~~s~~ 252 (486)
T 3mwu_A 187 AYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDIL----KRVETGKYAFDL-PQW-----RTISDD 252 (486)
T ss_dssp GGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH----HHHHHTCCCSCS-GGG-----GGSCHH
T ss_pred CCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHH----HHHHhCCCCCCC-ccc-----CCCCHH
Confidence 99999999875 589999999999999999999999853221 1111 111111111100 000 112245
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHH--HhccC
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAV--MLASD 478 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~--~L~~~ 478 (523)
+.+|+.+||+.||++|||+.|+++ ++++.
T Consensus 253 ~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 678999999999999999999987 35544
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-24 Score=228.84 Aligned_cols=162 Identities=26% Similarity=0.356 Sum_probs=122.2
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCC---CCeeEeccccceeccCCCCCccccceec
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE---MNPKISDFGMARIFGGNQNESNTSKVVG 368 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~---~~~kL~Dfg~a~~~~~~~~~~~~~~~~g 368 (523)
..++..+++..++.++.||+.||.|||+++ |+||||||+|||++.. +.+||+|||++....... ......|
T Consensus 127 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~g 200 (494)
T 3lij_A 127 IIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLG 200 (494)
T ss_dssp HHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB---CBCCCCS
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc---cccccCC
Confidence 345567999999999999999999999998 9999999999999764 459999999998764322 2334678
Q ss_pred cCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 369 TYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 369 t~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
|+.|+|||++. ..++.++||||||+++|+|++|..||..... ..+ ......+... ...+.. . ....
T Consensus 201 t~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~----~~~i~~~~~~-~~~~~~-~----~~s~ 266 (494)
T 3lij_A 201 TAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD---QEI----LRKVEKGKYT-FDSPEW-K----NVSE 266 (494)
T ss_dssp CTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH----HHHHHHTCCC-CCSGGG-T----TSCH
T ss_pred CcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHH----HHHHHhCCCC-CCchhc-c----cCCH
Confidence 99999999876 5699999999999999999999999853221 111 1111111111 111111 0 1124
Q ss_pred HHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 449 KCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+.+|+.+||+.||.+|||+.|+++
T Consensus 267 ~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 267 GAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHCCCChhhCccHHHHhc
Confidence 5678899999999999999999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.8e-25 Score=241.97 Aligned_cols=165 Identities=27% Similarity=0.338 Sum_probs=125.0
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
++..+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++....... .......+++.|+
T Consensus 484 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~~t~~y~ 559 (656)
T 2j0j_A 484 RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWM 559 (656)
T ss_dssp TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGC
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCCCcc-eeccCCCCCccee
Confidence 4457999999999999999999999998 99999999999999999999999999987543221 1222345677899
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
|||.+.+..++.++||||||+++|||++ |..||...... ... .....+..... +......+.+
T Consensus 560 aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~----~~i~~~~~~~~---------~~~~~~~l~~ 623 (656)
T 2j0j_A 560 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVI----GRIENGERLPM---------PPNCPPTLYS 623 (656)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH----HHHHHTCCCCC---------CTTCCHHHHH
T ss_pred CHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHH----HHHHcCCCCCC---------CccccHHHHH
Confidence 9999998899999999999999999997 88898532211 111 11111111111 1122346778
Q ss_pred HhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 453 IGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
|+.+||+.||++|||+.||++.|+..
T Consensus 624 li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 624 LMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 99999999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=9.1e-24 Score=208.59 Aligned_cols=162 Identities=23% Similarity=0.318 Sum_probs=123.5
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.++..+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++....... ......++..|
T Consensus 116 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y 189 (298)
T 1phk_A 116 TEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSY 189 (298)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGG
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhhcCCCc---ccccccCCccc
Confidence 45568999999999999999999999998 9999999999999999999999999998764322 22345688999
Q ss_pred Cchhhhc------CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHH
Q 046010 373 MAPEYAL------GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAE 446 (523)
Q Consensus 373 ~aPE~l~------~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 446 (523)
+|||.+. ...++.++||||||+++|+|++|+.||..... ... ......+... ...+. ....
T Consensus 190 ~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~-~~~~~~~~~~-~~~~~-----~~~~ 256 (298)
T 1phk_A 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLM-LRMIMSGNYQ-FGSPE-----WDDY 256 (298)
T ss_dssp CCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHH-HHHHHHTCCC-CCTTT-----GGGS
T ss_pred cCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------HHH-HHHHhcCCcc-cCccc-----cccc
Confidence 9999885 45688999999999999999999999853221 111 1111111111 00010 1122
Q ss_pred HHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 447 LLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 447 ~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
...+.+++.+||+.||++|||+.|+++
T Consensus 257 ~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 257 SDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 346778999999999999999999975
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-24 Score=224.93 Aligned_cols=160 Identities=28% Similarity=0.368 Sum_probs=112.4
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCC-------------CCeeEeccccceeccCCCCCc--cc
Q 046010 299 DWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE-------------MNPKISDFGMARIFGGNQNES--NT 363 (523)
Q Consensus 299 ~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~-------------~~~kL~Dfg~a~~~~~~~~~~--~~ 363 (523)
++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++......... ..
T Consensus 113 ~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~ 189 (434)
T 2rio_A 113 KEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189 (434)
T ss_dssp --CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC---------
T ss_pred cchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeee
Confidence 34456789999999999999998 9999999999999754 479999999998765432211 22
Q ss_pred cceeccCCCCchhhhcC-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccC
Q 046010 364 SKVVGTYGYMAPEYALG-------GVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMD 435 (523)
Q Consensus 364 ~~~~gt~~y~aPE~l~~-------~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (523)
....||+.|+|||++.+ ..++.++|||||||++|||++ |+.||....... . ..........
T Consensus 190 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~----~----~i~~~~~~~~--- 258 (434)
T 2rio_A 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE----S----NIIRGIFSLD--- 258 (434)
T ss_dssp -----CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH----H----HHHHTCCCCC---
T ss_pred cCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH----H----HHhcCCCCcc---
Confidence 34578999999999975 568999999999999999999 899985322111 0 1111100000
Q ss_pred ccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 436 PVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 436 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.............+.+|+.+||+.||++|||+.||++
T Consensus 259 -~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 259 -EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 0111112345567889999999999999999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-24 Score=213.28 Aligned_cols=163 Identities=23% Similarity=0.340 Sum_probs=114.8
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCC------------C
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQN------------E 360 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~------------~ 360 (523)
..+..+++..++.++.||++||+|||+++ |+|+||||+||+++.++.+||+|||++........ .
T Consensus 108 ~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 184 (303)
T 1zy4_A 108 SENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184 (303)
T ss_dssp HSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC----------------
T ss_pred ccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccc
Confidence 34567899999999999999999999998 99999999999999999999999999976542211 1
Q ss_pred ccccceeccCCCCchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCcccc
Q 046010 361 SNTSKVVGTYGYMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLK 439 (523)
Q Consensus 361 ~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 439 (523)
.......++..|+|||.+.+. .++.++||||||+++|+|++ ||.... ... ........... .+.
T Consensus 185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-----~~~-~~~~~~~~~~~------~~~ 249 (303)
T 1zy4_A 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-----ERV-NILKKLRSVSI------EFP 249 (303)
T ss_dssp ---------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HHH-HHHHHHHSTTC------CCC
T ss_pred cccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-----hHH-HHHHhcccccc------ccC
Confidence 122345688999999999764 68999999999999999998 442111 001 11111111110 111
Q ss_pred CCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 440 QSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 440 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
..........+.+++.+||+.||++|||+.++++
T Consensus 250 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 250 PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 1122233445778999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=223.82 Aligned_cols=167 Identities=25% Similarity=0.304 Sum_probs=125.4
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC---CeeEeccccceeccCCCCCccccceec
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM---NPKISDFGMARIFGGNQNESNTSKVVG 368 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~---~~kL~Dfg~a~~~~~~~~~~~~~~~~g 368 (523)
..++..+++..++.++.||+.||.|||+++ |+||||||+||+++.++ .+||+|||++....... ......|
T Consensus 137 l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~g 210 (504)
T 3q5i_A 137 IINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLG 210 (504)
T ss_dssp HHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTS---CBCCCCS
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCC---ccccccC
Confidence 345567999999999999999999999998 99999999999998776 69999999998764322 2334578
Q ss_pred cCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 369 TYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 369 t~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
|+.|+|||++. +.++.++||||||+++|+|++|..||...... .. ......+.... ...... ....
T Consensus 211 t~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~----~~~i~~~~~~~--~~~~~~----~~s~ 276 (504)
T 3q5i_A 211 TAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---DI----IKKVEKGKYYF--DFNDWK----NISD 276 (504)
T ss_dssp CTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHCCCCC--CHHHHT----TSCH
T ss_pred CcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HH----HHHHHcCCCCC--CccccC----CCCH
Confidence 99999999886 56999999999999999999999998532211 11 11111111110 000000 1124
Q ss_pred HHHHHhhhcccCCCCCCCCHHHHHH--HhccC
Q 046010 449 KCIHIGLLCVQEDPADRPNMSSVAV--MLASD 478 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~RPs~~ei~~--~L~~~ 478 (523)
.+.+|+.+||+.||.+|||+.|+++ ++++.
T Consensus 277 ~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 277 EAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred HHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 5778999999999999999999975 45444
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=5.6e-24 Score=221.62 Aligned_cols=164 Identities=26% Similarity=0.373 Sum_probs=113.8
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC-----CCCeeEeccccceeccCCCCC-ccccce
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH-----EMNPKISDFGMARIFGGNQNE-SNTSKV 366 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~-----~~~~kL~Dfg~a~~~~~~~~~-~~~~~~ 366 (523)
.....+.+..++.++.||++||.|||+++ |+||||||+|||++. ...+||+|||+++........ ......
T Consensus 110 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~ 186 (432)
T 3p23_A 110 QKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186 (432)
T ss_dssp SSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------C
T ss_pred hcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeecccc
Confidence 34445666678899999999999999998 999999999999953 235789999999876433211 223346
Q ss_pred eccCCCCchhhhc---CCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCc
Q 046010 367 VGTYGYMAPEYAL---GGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSC 442 (523)
Q Consensus 367 ~gt~~y~aPE~l~---~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 442 (523)
.||+.|+|||++. ...++.++|||||||++|||++ |..||...... .. .............+
T Consensus 187 ~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------~~-~~~~~~~~~~~~~~------ 252 (432)
T 3p23_A 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------QA-NILLGACSLDCLHP------ 252 (432)
T ss_dssp CSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------HH-HHHTTCCCCTTSCT------
T ss_pred CCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------HH-HHHhccCCccccCc------
Confidence 7899999999987 4567889999999999999999 88887432111 11 11111111111111
Q ss_pred cHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 443 MAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 443 ~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.......+.+|+.+||+.||++|||+.||++
T Consensus 253 ~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 253 EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1123445678999999999999999999983
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.4e-23 Score=204.72 Aligned_cols=161 Identities=26% Similarity=0.334 Sum_probs=120.3
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCC---CCeeEeccccceeccCCCCCccccceecc
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE---MNPKISDFGMARIFGGNQNESNTSKVVGT 369 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~---~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt 369 (523)
.+...+++..++.++.||++||.|||+++ |+|+||||+||+++.+ +.+||+|||++....... ......++
T Consensus 113 ~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~ 186 (287)
T 2wei_A 113 IKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGT 186 (287)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS---SCSCHHHH
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCCC---ccccccCc
Confidence 34567999999999999999999999998 9999999999999764 469999999988654322 12234578
Q ss_pred CCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 370 ~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
..|+|||.+.+ .++.++||||||+++|+|++|+.||...... .. ......+...... +.. ......
T Consensus 187 ~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~----~~~~~~~~~~~~~-~~~-----~~~~~~ 252 (287)
T 2wei_A 187 AYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DI----LKRVETGKYAFDL-PQW-----RTISDD 252 (287)
T ss_dssp HTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHCCCCCCS-GGG-----TTSCHH
T ss_pred ccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HH----HHHHHcCCCCCCc-hhh-----hhcCHH
Confidence 89999998865 4899999999999999999999998532211 11 1112222111100 000 111245
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHH
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+.+++.+||+.||++|||+.|+++
T Consensus 253 ~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 253 AKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcccChhhCcCHHHHhc
Confidence 778999999999999999999987
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.4e-23 Score=171.40 Aligned_cols=105 Identities=23% Similarity=0.407 Sum_probs=94.9
Q ss_pred CCCceeeeccCCC-CchhHHHHHHHHHHHHHHHhhccCCceeeeeeccCCCccEEEEEEecCCCChhchHHHHHHHHHhh
Q 046010 142 TKPAKAWQNRQNS-TGGLFNQQVRNLMNEAVNQALNTTKMFGTVKKNYTASQTLYGLVQCTPDLSRHDCSTCLRLAISSF 220 (523)
Q Consensus 142 ~~~~~~~~~~~~~-~~~~f~~~~~~ll~~l~~~a~~s~~~~~~~~~~~~~~~~vyglaQC~~Dls~~~C~~CL~~~~~~~ 220 (523)
+......|+..+. .++.|+++++.||..|+..|+.+..+|+++..+..+.++||||+||++|+++.+|+.||+.++.++
T Consensus 3 t~~v~~~Cn~~~~t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~ 82 (108)
T 3a2e_A 3 TAFVSSACNTQKIPSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRI 82 (108)
T ss_dssp CCEEEEEECSSBCCTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTH
T ss_pred cceeeeecCCCccCCCChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHH
Confidence 3445567887776 678899999999999999998888888888777666789999999999999999999999999999
Q ss_pred hhhcCCCcceEEEcCCeeEEeecCCC
Q 046010 221 DECFSINIGGRMMYPSCNFRYELYPF 246 (523)
Q Consensus 221 ~~~c~~~~g~~v~~~~C~~Ry~~~~f 246 (523)
.++|++++||+|++++|++|||.++|
T Consensus 83 ~~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 83 FSICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp HHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred HHHCCCCceEEEECCCEEEEEeCCcC
Confidence 99999999999999999999999998
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=8e-23 Score=202.30 Aligned_cols=151 Identities=17% Similarity=0.219 Sum_probs=109.4
Q ss_pred cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC---CCCeeEeccccceeccCCCCCcccc
Q 046010 288 PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH---EMNPKISDFGMARIFGGNQNESNTS 364 (523)
Q Consensus 288 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~---~~~~kL~Dfg~a~~~~~~~~~~~~~ 364 (523)
.++.......+++..++.++.||+.||.|||+++ |+||||||+||+++. ++.+||+|||++....
T Consensus 104 ~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--------- 171 (299)
T 3m2w_A 104 SRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--------- 171 (299)
T ss_dssp HHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---------
T ss_pred HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccccc---------
Confidence 3333444557999999999999999999999998 999999999999998 7889999999987542
Q ss_pred ceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCcc-
Q 046010 365 KVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCM- 443 (523)
Q Consensus 365 ~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~- 443 (523)
+..++.++||||||+++|+|++|+.||......... ............ ..+
T Consensus 172 ---------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~~~~~~~~~--~~~~ 223 (299)
T 3m2w_A 172 ---------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKTRIRMGQY--EFPN 223 (299)
T ss_dssp ---------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCSSCTTCC--SSCH
T ss_pred ---------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHHHHHhhccc--cCCc
Confidence 134678999999999999999999998532211100 000000000000 011
Q ss_pred ---HHHHHHHHHHhhhcccCCCCCCCCHHHHHH--HhccC
Q 046010 444 ---AAELLKCIHIGLLCVQEDPADRPNMSSVAV--MLASD 478 (523)
Q Consensus 444 ---~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~~ 478 (523)
......+.+|+.+||+.||++|||+.|+++ ++.+.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred hhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 112356788999999999999999999987 45444
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.87 E-value=2e-22 Score=221.93 Aligned_cols=148 Identities=21% Similarity=0.271 Sum_probs=116.1
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++.+++.++.||++||.|||+++ |+||||||+|||++.+ .+||+|||+++..... ....||+.|+||
T Consensus 177 ~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aP 246 (681)
T 2pzi_A 177 QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAP 246 (681)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCT
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcccC------CccCCCccccCH
Confidence 37999999999999999999999998 9999999999999975 8999999999876422 345789999999
Q ss_pred hhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHhh
Q 046010 376 EYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGL 455 (523)
Q Consensus 376 E~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~ 455 (523)
|++.+.. +.++||||||+++|+|++|..||....... .. ...........+.+|+.
T Consensus 247 E~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------------~~-------~~~~~~~~~~~l~~li~ 302 (681)
T 2pzi_A 247 EIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----------------LP-------EDDPVLKTYDSYGRLLR 302 (681)
T ss_dssp THHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS----------------CC-------TTCHHHHHCHHHHHHHH
T ss_pred HHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc----------------cc-------ccccccccCHHHHHHHh
Confidence 9987654 889999999999999999988764211100 00 00011122346778999
Q ss_pred hcccCCCCCCCC-HHHHHHHhcc
Q 046010 456 LCVQEDPADRPN-MSSVAVMLAS 477 (523)
Q Consensus 456 ~cl~~dP~~RPs-~~ei~~~L~~ 477 (523)
+||+.||++||+ ++++...|..
T Consensus 303 ~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 303 RAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHTCSSGGGSCSSHHHHHHHHHH
T ss_pred hhccCChhhCCCHHHHHHHHHHH
Confidence 999999999995 5566655543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=6.1e-23 Score=221.79 Aligned_cols=169 Identities=22% Similarity=0.228 Sum_probs=117.8
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCC---eeEeccccceeccCCCCCccccceeccCCC
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMN---PKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~---~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
..+++..++.++.||+.||.|||+++ |+||||||+||+++.++. +||+|||.+....... ......++..|
T Consensus 116 ~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~---~~~~~~gt~~Y 189 (676)
T 3qa8_A 116 CGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQY 189 (676)
T ss_dssp TCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC---CCCCCCSCCTT
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccccccccccc---ccccccCCccc
Confidence 46999999999999999999999998 999999999999997765 8999999998764322 22346789999
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccc--cchHHHHHHh-hhcCCccc--ccCcc--ccCCccHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHG--QSLLAYTWKL-WCNGEALE--LMDPV--LKQSCMAA 445 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~--~~~~~~~~~~-~~~~~~~~--~~~~~--l~~~~~~~ 445 (523)
+|||.+.+..++.++||||||+++|+|++|+.||........ .......... ........ ..... ........
T Consensus 190 ~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ 269 (676)
T 3qa8_A 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGI 269 (676)
T ss_dssp CSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGG
T ss_pred CChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchh
Confidence 999999999999999999999999999999999854211100 0000000000 00000000 00000 01112234
Q ss_pred HHHHHHHHhhhcccCCCCCCCCHHH
Q 046010 446 ELLKCIHIGLLCVQEDPADRPNMSS 470 (523)
Q Consensus 446 ~~~~~~~li~~cl~~dP~~RPs~~e 470 (523)
....+.+++.+||+.||++|||+.|
T Consensus 270 ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 270 LAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp GHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhHHHHHHHHHHccCCHhhCcCHHH
Confidence 5567889999999999999999966
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.84 E-value=3.4e-21 Score=193.79 Aligned_cols=153 Identities=15% Similarity=0.055 Sum_probs=112.2
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHH-hcCCCcEEecCCCCCcEEeCCCC--------------------CeeEecccccee
Q 046010 295 RAQLDWKRRISIINGIARGLLYLH-EDSRLKVFHRDLKASNVLLDHEM--------------------NPKISDFGMARI 353 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH-~~g~~~ivH~Dlkp~NIll~~~~--------------------~~kL~Dfg~a~~ 353 (523)
+..+++..++.++.||+.||.||| +++ |+||||||+|||++.++ .+||+|||+++.
T Consensus 155 ~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~ 231 (336)
T 2vuw_A 155 TKLSSLATAKSILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRL 231 (336)
T ss_dssp TTCCCHHHHHHHHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBE
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEe
Confidence 367899999999999999999999 898 99999999999999887 899999999987
Q ss_pred ccCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHH-HHHHHhCCCCCCCcccccccchHHHHHHhhhcCCccc
Q 046010 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVL-LLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALE 432 (523)
Q Consensus 354 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvv-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (523)
... ....||+.|+|||++.+.. +.++|||||+++ .++++.|..||... ................
T Consensus 232 ~~~-------~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~~~- 296 (336)
T 2vuw_A 232 ERD-------GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQMTF- 296 (336)
T ss_dssp EET-------TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTCCC-
T ss_pred cCC-------CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhhcc-
Confidence 642 2457899999999998766 889999998776 77788898886310 0000011111100000
Q ss_pred ccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 046010 433 LMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVA 472 (523)
Q Consensus 433 ~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~ 472 (523)
...............+.+|+.+||+.| |+.|++
T Consensus 297 --~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 297 --KTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp --SSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred --CcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 011111122345667889999999976 888887
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.82 E-value=1.5e-20 Score=184.94 Aligned_cols=139 Identities=14% Similarity=0.043 Sum_probs=101.0
Q ss_pred cCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCchhh
Q 046010 298 LDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEY 377 (523)
Q Consensus 298 l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~ 377 (523)
....++.+++.||++||+|||++| |+||||||+||+++.++.+||++++ |++
T Consensus 126 ~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~----------------------~~~--- 177 (286)
T 3uqc_A 126 PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA----------------------TMP--- 177 (286)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC----------------------CCT---
T ss_pred CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc----------------------ccC---
Confidence 466678999999999999999999 9999999999999999999998543 233
Q ss_pred hcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHhhhc
Q 046010 378 ALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLC 457 (523)
Q Consensus 378 l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li~~c 457 (523)
.++.++||||||+++|+|++|+.||............ .... ... ..... .........+.+|+.+|
T Consensus 178 ----~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~~~~-~~~---~~~~~---~~~~~~~~~l~~li~~~ 243 (286)
T 3uqc_A 178 ----DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---ERDT-AGQ---PIEPA---DIDRDIPFQISAVAARS 243 (286)
T ss_dssp ----TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---CBCT-TSC---BCCHH---HHCTTSCHHHHHHHHHH
T ss_pred ----CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---HHHh-ccC---CCChh---hcccCCCHHHHHHHHHH
Confidence 3688999999999999999999998643322110000 0000 000 00000 00011234577899999
Q ss_pred ccCCCCCCCCHHHHHHHhccCC
Q 046010 458 VQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 458 l~~dP~~RPs~~ei~~~L~~~~ 479 (523)
|+.||++| |+.|+++.|+...
T Consensus 244 l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 244 VQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp HCTTSSCC-CHHHHHHHHHHHH
T ss_pred cccCCccC-CHHHHHHHHHHHh
Confidence 99999999 9999999998753
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=1e-18 Score=187.68 Aligned_cols=119 Identities=18% Similarity=0.200 Sum_probs=77.7
Q ss_pred eEeeecccccc---ccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 278 AIWIAIGTTIP---TIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 278 ~~~ia~g~~~~---~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
..|+.+.++-+ .-+..++.++++. +|+.||+.||+|||++| ||||||||+|||++.++.+||+|||+++..
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 45666655541 1123556678765 47899999999999999 999999999999999999999999999876
Q ss_pred cCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCC
Q 046010 355 GGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKN 405 (523)
Q Consensus 355 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p 405 (523)
.... .......||+.|+|||++.+ .+..++|+|++|++++++.++..+
T Consensus 390 ~~~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 390 PQDC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C-----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 4332 22345679999999998865 567789999999998877665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=3.9e-14 Score=151.19 Aligned_cols=99 Identities=21% Similarity=0.236 Sum_probs=83.0
Q ss_pred HHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCc-----cccceeccCCCCchhh
Q 046010 303 RISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES-----NTSKVVGTYGYMAPEY 377 (523)
Q Consensus 303 ~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~ 377 (523)
++.++.||++||+|||+++ |+||||||+|||++. .+||+|||+++......... ......||+.|+|||+
T Consensus 433 ~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv 507 (540)
T 3en9_A 433 NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEI 507 (540)
T ss_dssp CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHH
T ss_pred HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHH
Confidence 6689999999999999998 999999999999998 99999999999864321111 1235679999999999
Q ss_pred hcC--CCCCcchhhHHHHHHHHHHHhCCCCC
Q 046010 378 ALG--GVISVKSDVFSFGVLLLEIISGKKNS 406 (523)
Q Consensus 378 l~~--~~~s~ksDVwSlGvvl~elltG~~p~ 406 (523)
+.. ..|+.+.|+|+..+-..+.+.++.+|
T Consensus 508 ~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 508 WERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred HHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 976 56788899999999998888877664
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=3.6e-11 Score=117.46 Aligned_cols=60 Identities=20% Similarity=0.104 Sum_probs=52.8
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCchhhhc
Q 046010 301 KRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYAL 379 (523)
Q Consensus 301 ~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~ 379 (523)
.....++.||++||.|||++| |+||||||+|||++ ++.+||+|||+++.. ..+.|||++.
T Consensus 193 ~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DFG~a~~~---------------~~~~a~e~l~ 252 (282)
T 1zar_A 193 ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEV---------------GEEGWREILE 252 (282)
T ss_dssp SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCCTTCEET---------------TSTTHHHHHH
T ss_pred hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEECCCCeEC---------------CCCCHHHHHH
Confidence 345679999999999999999 99999999999999 999999999998743 3568999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=98.74 E-value=6.6e-09 Score=99.88 Aligned_cols=51 Identities=22% Similarity=0.236 Sum_probs=46.7
Q ss_pred CHHHHHHHHHHHHHHHHHHH-hcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 299 DWKRRISIINGIARGLLYLH-EDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 299 ~~~~~~~i~~qi~~aL~~LH-~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
++..+..++.||+.+|.||| +.+ |+||||||+|||++. .++|+|||++...
T Consensus 168 ~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 168 KELDVEGIFNDVVENVKRLYQEAE---LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp GGSCHHHHHHHHHHHHHHHHHTSC---EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred ChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 35578899999999999999 888 999999999999998 8999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=98.17 E-value=8.1e-07 Score=89.66 Aligned_cols=51 Identities=22% Similarity=0.322 Sum_probs=44.4
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCC----------eeEeccccceec
Q 046010 301 KRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMN----------PKISDFGMARIF 354 (523)
Q Consensus 301 ~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~----------~kL~Dfg~a~~~ 354 (523)
.....++.||+.+|.+||+.| ||||||||.|||+++++. +.|+||+.+...
T Consensus 205 ~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 205 PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 345678999999999999998 999999999999988763 789999987653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=97.43 E-value=6.4e-05 Score=73.54 Aligned_cols=82 Identities=22% Similarity=0.273 Sum_probs=48.9
Q ss_pred CcEEecCCCCCcEEeCC--CCCeeEeccccceeccCCCCCccc------------cceeccCCCCc-hhhhcCCCCCcch
Q 046010 323 LKVFHRDLKASNVLLDH--EMNPKISDFGMARIFGGNQNESNT------------SKVVGTYGYMA-PEYALGGVISVKS 387 (523)
Q Consensus 323 ~~ivH~Dlkp~NIll~~--~~~~kL~Dfg~a~~~~~~~~~~~~------------~~~~gt~~y~a-PE~l~~~~~s~ks 387 (523)
..++|+|+++.||+++. ...+.|+||+.+..-......... ......+.... |+.... .....
T Consensus 191 ~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r--~~~~~ 268 (304)
T 3sg8_A 191 PCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEK--YRMKE 268 (304)
T ss_dssp CEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHH--HHHHH
T ss_pred ceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHH--HHHHH
Confidence 35899999999999998 456789999988653210000000 00000111122 222111 11236
Q ss_pred hhHHHHHHHHHHHhCCCCC
Q 046010 388 DVFSFGVLLLEIISGKKNS 406 (523)
Q Consensus 388 DVwSlGvvl~elltG~~p~ 406 (523)
+.|+++.++|.+.+|..+|
T Consensus 269 ~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 269 KYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHHHHcCCHHH
Confidence 8999999999999998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0022 Score=58.57 Aligned_cols=99 Identities=9% Similarity=0.042 Sum_probs=64.2
Q ss_pred cccccccccccCHHHHHHHHHHHHHHHHHHH-hcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccce
Q 046010 288 PTIYSTRRAQLDWKRRISIINGIARGLLYLH-EDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKV 366 (523)
Q Consensus 288 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 366 (523)
..|....+.+|+++++|.++.|.+++|.-+- ++. -..+=+.|..|++..+|.+.+.+ ..+.
T Consensus 36 ~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~---~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------- 97 (229)
T 2yle_A 36 EEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ---PRHRVRSAAQIRVWRDGAVTLAP-AADD-------------- 97 (229)
T ss_dssp HHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred HHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc---CCceecCCcceEEecCCceeccc-cccc--------------
Confidence 4455677889999999999999999987762 221 11233457899999999887764 1110
Q ss_pred eccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCC
Q 046010 367 VGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKN 405 (523)
Q Consensus 367 ~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p 405 (523)
.....+.|||... ...+.+.-|||||+++|.-+--..|
T Consensus 98 ~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ---------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122456787653 3456788999999999999865544
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=96.85 E-value=0.002 Score=64.36 Aligned_cols=58 Identities=14% Similarity=0.273 Sum_probs=48.6
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcC------------------------------------------------------
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDS------------------------------------------------------ 321 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g------------------------------------------------------ 321 (523)
..++..++..++.++++.|..||+..
T Consensus 134 ~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 213 (359)
T 3dxp_A 134 PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDA 213 (359)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTS
T ss_pred ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccC
Confidence 34778899999999999999999731
Q ss_pred -CCcEEecCCCCCcEEeCCCCC--eeEecccccee
Q 046010 322 -RLKVFHRDLKASNVLLDHEMN--PKISDFGMARI 353 (523)
Q Consensus 322 -~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~a~~ 353 (523)
...++|+|+++.||+++.++. +.|+||+.+..
T Consensus 214 ~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 214 DLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp SCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999998864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0013 Score=62.05 Aligned_cols=30 Identities=20% Similarity=0.251 Sum_probs=25.8
Q ss_pred cEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 324 KVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 324 ~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
.++|+|++|.||+++.++.++|+||+.+..
T Consensus 185 ~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 185 VVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred EEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 399999999999998776677999998754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0011 Score=62.80 Aligned_cols=31 Identities=26% Similarity=0.314 Sum_probs=25.6
Q ss_pred CcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 323 LKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 323 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
..++|+|++|.||+++.+..+.|+||+.+..
T Consensus 183 ~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 183 LVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp EEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 3599999999999998765567999987753
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=94.37 E-value=0.039 Score=54.07 Aligned_cols=46 Identities=17% Similarity=0.130 Sum_probs=34.4
Q ss_pred HHHHHHHHHHHh----------cCCCcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 308 NGIARGLLYLHE----------DSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 308 ~qi~~aL~~LH~----------~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
.++.+++.+|++ ..+..++|+|+++.||+++.++.+.|+||+.+..
T Consensus 197 ~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 197 EDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 344556666653 1134599999999999998888899999997753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=93.53 E-value=0.12 Score=50.06 Aligned_cols=31 Identities=32% Similarity=0.455 Sum_probs=25.8
Q ss_pred CcEEecCCCCCcEEeCC---CCCe-eEecccccee
Q 046010 323 LKVFHRDLKASNVLLDH---EMNP-KISDFGMARI 353 (523)
Q Consensus 323 ~~ivH~Dlkp~NIll~~---~~~~-kL~Dfg~a~~ 353 (523)
..++|+|+++.||+++. ++.+ .|+||+.+..
T Consensus 190 ~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 190 PRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp CEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred CeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 35899999999999987 4554 8999998765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=92.14 E-value=0.12 Score=52.49 Aligned_cols=77 Identities=10% Similarity=0.092 Sum_probs=45.2
Q ss_pred CcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceec--cCCCCchhhhcCC---CCCcchhhHHHHHHHH
Q 046010 323 LKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVG--TYGYMAPEYALGG---VISVKSDVFSFGVLLL 397 (523)
Q Consensus 323 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~l~~~---~~s~ksDVwSlGvvl~ 397 (523)
..++|+|+++.||+++.++ ++|+||+.+..-.. ......... ...|.+|+..... ......++......+|
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p---~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPM---GFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECH---HHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCch---HHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 4599999999999998776 99999998875310 000011110 1234555543211 1122345557777777
Q ss_pred HHHhCC
Q 046010 398 EIISGK 403 (523)
Q Consensus 398 elltG~ 403 (523)
+.+.+.
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=91.82 E-value=0.18 Score=49.66 Aligned_cols=32 Identities=19% Similarity=0.246 Sum_probs=26.4
Q ss_pred CCcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 322 RLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 322 ~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
+..++|+|+++.||+++++..+.|+||+.+..
T Consensus 221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred CceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 34699999999999999644578999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=90.48 E-value=0.32 Score=47.43 Aligned_cols=32 Identities=31% Similarity=0.445 Sum_probs=27.4
Q ss_pred CCcEEecCCCCCcEEeCCC----CCeeEecccccee
Q 046010 322 RLKVFHRDLKASNVLLDHE----MNPKISDFGMARI 353 (523)
Q Consensus 322 ~~~ivH~Dlkp~NIll~~~----~~~kL~Dfg~a~~ 353 (523)
...++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3469999999999999874 6789999998865
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=88.50 E-value=0.44 Score=46.18 Aligned_cols=29 Identities=31% Similarity=0.445 Sum_probs=25.1
Q ss_pred CcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 323 LKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 323 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
..++|+|+++.||+++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 4589999999999999 4 889999987754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=88.26 E-value=0.18 Score=47.40 Aligned_cols=31 Identities=26% Similarity=0.270 Sum_probs=26.5
Q ss_pred CcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 323 LKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 323 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
..++|+|+++.||+++.++.+-|+||+.+..
T Consensus 193 ~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 193 SVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp EEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 4599999999999999877677999988754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=86.50 E-value=0.23 Score=48.07 Aligned_cols=31 Identities=29% Similarity=0.256 Sum_probs=26.0
Q ss_pred CcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 323 LKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 323 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
..++|+|+++.||+++.+..+.|+||+.+..
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 4599999999999998776568999987653
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=84.69 E-value=0.64 Score=45.60 Aligned_cols=32 Identities=28% Similarity=0.426 Sum_probs=27.9
Q ss_pred CCcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 322 RLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 322 ~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
+..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 34699999999999999888899999987764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=84.24 E-value=0.97 Score=44.69 Aligned_cols=30 Identities=20% Similarity=0.437 Sum_probs=24.7
Q ss_pred CcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 323 LKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 323 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
..++|+|+++.||+++.+. +.|+||..+..
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 4599999999999998654 89999987753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=83.99 E-value=0.95 Score=46.46 Aligned_cols=17 Identities=29% Similarity=0.425 Sum_probs=15.2
Q ss_pred CCcEEecCCCCCcEEeC
Q 046010 322 RLKVFHRDLKASNVLLD 338 (523)
Q Consensus 322 ~~~ivH~Dlkp~NIll~ 338 (523)
+..++|+|+.+.|||++
T Consensus 289 ~~v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 289 PIVLCHCDLLSSNIINT 305 (458)
T ss_dssp CEEEECSCCCGGGEEEC
T ss_pred CeeEEecCCCCCcEEee
Confidence 34699999999999998
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=83.37 E-value=1 Score=45.06 Aligned_cols=30 Identities=20% Similarity=0.304 Sum_probs=25.5
Q ss_pred CcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 323 LKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 323 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
..++|||+.+.||+++.+ .++|+||..+..
T Consensus 227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp CEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 359999999999999875 489999987764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=82.45 E-value=1 Score=45.73 Aligned_cols=32 Identities=28% Similarity=0.408 Sum_probs=25.4
Q ss_pred CCcEEecCCCCCcEEeCCC----------------------------CCeeEecccccee
Q 046010 322 RLKVFHRDLKASNVLLDHE----------------------------MNPKISDFGMARI 353 (523)
Q Consensus 322 ~~~ivH~Dlkp~NIll~~~----------------------------~~~kL~Dfg~a~~ 353 (523)
+..++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 248 ~~v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~ 307 (429)
T 1nw1_A 248 PVTFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY 307 (429)
T ss_dssp CEEEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred CeEEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence 3469999999999999875 6789999987653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=81.63 E-value=1.1 Score=42.85 Aligned_cols=31 Identities=26% Similarity=0.255 Sum_probs=26.0
Q ss_pred CCcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 322 RLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 322 ~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
+..++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 446999999999999 5566789999988764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 523 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-43 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-40 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-39 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-38 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-38 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-38 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-36 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-36 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-35 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-35 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-35 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-35 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-35 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-35 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-35 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-34 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-34 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-34 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-34 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-33 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-33 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-33 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-33 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-32 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-32 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-32 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-31 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-31 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-31 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-31 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-29 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-25 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-25 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-25 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-25 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-24 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-24 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-23 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-23 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-23 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-22 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-22 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-22 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-21 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-21 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-20 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-20 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-20 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-20 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-20 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-19 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-19 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-18 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-18 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-18 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-18 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-18 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-15 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-14 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-14 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-14 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-13 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-08 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-43
Identities = 41/194 (21%), Positives = 85/194 (43%), Gaps = 17/194 (8%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
+ + + I I A+G+ YLH + HRDLK++N+ L ++ KI DFG+A +
Sbjct: 97 IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATV 153
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALG---GVISVKSDVFSFGVLLLEIISGKKNSGFYL 410
++ G+ +MAPE S +SDV++FG++L E+++G+ +
Sbjct: 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP--YSN 211
Query: 411 SEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSS 470
+ ++ + + + + ++ K + C+++ +RP
Sbjct: 212 INNRDQIIFMVGRGYLSPDLSKVRSNCPK---------AMKRLMAECLKKKRDERPLFPQ 262
Query: 471 VAVMLASDTVSLPQ 484
+ + SLP+
Sbjct: 263 ILASIELLARSLPK 276
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 9e-40
Identities = 39/200 (19%), Positives = 74/200 (37%), Gaps = 18/200 (9%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHED-----SRLKVFHRDLKASNVLLDHEMNPKISDF 348
R + + I + A GL +LH + + + HRDLK+ N+L+ I+D
Sbjct: 93 NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152
Query: 349 GMARIF--GGNQNESNTSKVVGTYGYMAPEYALGGV------ISVKSDVFSFGVLLLEII 400
G+A + + + VGT YMAPE + ++D+++ G++ EI
Sbjct: 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212
Query: 401 SGKKNSGFYLSE----HGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH-IGL 455
G + + + + + + P + + E L+ + I
Sbjct: 213 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR 272
Query: 456 LCVQEDPADRPNMSSVAVML 475
C + A R + L
Sbjct: 273 ECWYANGAARLTALRIKKTL 292
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 8e-39
Identities = 47/192 (24%), Positives = 87/192 (45%), Gaps = 19/192 (9%)
Query: 284 GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP 343
G+ + + + +L + + + IA G+ ++ E HRDL+A+N+L+ ++
Sbjct: 92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSC 148
Query: 344 KISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
KI+DFG+AR+ N+ + + APE G ++KSDV+SFG+LL EI++
Sbjct: 149 KIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 207
Query: 404 KNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPA 463
+ Y ++ + G + D ++ + LC +E P
Sbjct: 208 RI--PYPGMTNPEVI----QNLERGYRMVRPDNCPEE---------LYQLMRLCWKERPE 252
Query: 464 DRPNMSSVAVML 475
DRP + +L
Sbjct: 253 DRPTFDYLRSVL 264
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (353), Expect = 3e-38
Identities = 46/184 (25%), Positives = 73/184 (39%), Gaps = 18/184 (9%)
Query: 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA 351
S L ++ I +A G+ YL E K HRDL N L+ M KI+DFG++
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS 187
Query: 352 RIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLS 411
R +M PE + +SDV+++GV+L EI S Y
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ--PYYG 245
Query: 412 EHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSV 471
+ ++ +G L + + ++ LC + PADRP+ S+
Sbjct: 246 MAHEEVI----YYVRDGNILACPENCPLE---------LYNLMRLCWSKLPADRPSFCSI 292
Query: 472 AVML 475
+L
Sbjct: 293 HRIL 296
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 5e-38
Identities = 40/193 (20%), Positives = 83/193 (43%), Gaps = 19/193 (9%)
Query: 284 GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP 343
+ + + + + ++ GIA G+ YL + HRDL A N+L++ +
Sbjct: 93 NGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVC 149
Query: 344 KISDFGMARIFGGNQNESNTSK-VVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISG 402
K+SDFG++R+ + + T+ + APE + SDV+SFG+++ E+++
Sbjct: 150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTY 209
Query: 403 KKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDP 462
+ + LS H E ++ ++ + + + C Q++
Sbjct: 210 GERPYWELSNH---------------EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQER 254
Query: 463 ADRPNMSSVAVML 475
A RP + + +L
Sbjct: 255 ARRPKFADIVSIL 267
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 9e-38
Identities = 47/190 (24%), Positives = 83/190 (43%), Gaps = 19/190 (10%)
Query: 300 WKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQN 359
+ + + IA G+ Y+ R+ HRDL+A+N+L+ + K++DFG+AR+ N+
Sbjct: 112 LPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168
Query: 360 ESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLA 419
+ + APE AL G ++KSDV+SFG+LL E+ + +
Sbjct: 169 TARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV-------------- 213
Query: 420 YTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDT 479
+ N E L+ ++ + C + C +++P +RP + L
Sbjct: 214 -PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272
Query: 480 VSLPQPTQPA 489
S QP
Sbjct: 273 TSTEPQYQPG 282
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 3e-36
Identities = 52/207 (25%), Positives = 79/207 (38%), Gaps = 17/207 (8%)
Query: 271 SKGKGRKAIWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDL 330
SK + I L ++ + +A+G+ +L HRDL
Sbjct: 134 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDL 190
Query: 331 KASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVF 390
A NVL+ H KI DFG+AR + N +MAPE G+ ++KSDV+
Sbjct: 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 250
Query: 391 SFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450
S+G+LL EI S G + A +KL NG ++ ++
Sbjct: 251 SYGILLWEIFSLGV-----NPYPGIPVDANFYKLIQNGFKMDQPFYATEE---------I 296
Query: 451 IHIGLLCVQEDPADRPNMSSVAVMLAS 477
I C D RP+ ++ L
Sbjct: 297 YIIMQSCWAFDSRKRPSFPNLTSFLGC 323
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 5e-36
Identities = 48/184 (26%), Positives = 71/184 (38%), Gaps = 17/184 (9%)
Query: 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA 351
+ L + I +A+G+ +L K HRDL A N+LL + KI DFG+A
Sbjct: 125 DLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLA 181
Query: 352 RIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLS 411
R + + +MAPE V +++SDV+SFGVLL EI S
Sbjct: 182 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF-----SLGASP 236
Query: 412 EHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSV 471
G + + G + D + L C +P+ RP S +
Sbjct: 237 YPGVKIDEEFCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSEL 287
Query: 472 AVML 475
L
Sbjct: 288 VEHL 291
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (332), Expect = 2e-35
Identities = 42/192 (21%), Positives = 77/192 (40%), Gaps = 19/192 (9%)
Query: 284 GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP 343
G + + R ++ + + I+ + YL + HRDL A N L+
Sbjct: 98 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLV 154
Query: 344 KISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
K++DFG++R+ G+ ++ + APE S+KSDV++FGVLL EI +
Sbjct: 155 KVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 213
Query: 404 KNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPA 463
+ + + EL++ + K + C Q +P+
Sbjct: 214 MS---------------PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPS 258
Query: 464 DRPNMSSVAVML 475
DRP+ + +
Sbjct: 259 DRPSFAEIHQAF 270
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-35
Identities = 48/186 (25%), Positives = 76/186 (40%), Gaps = 19/186 (10%)
Query: 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGM 350
Y + + K I +++ ++ G+ YL HRDL A NVLL + KISDFG+
Sbjct: 97 YLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGL 153
Query: 351 ARIFGGNQNESNTSK-VVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFY 409
++ ++N + APE S KSDV+SFGVL+ E S + Y
Sbjct: 154 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK--PY 211
Query: 410 LSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMS 469
G + + GE + ++ + LC D +RP +
Sbjct: 212 RGMKGSEVT----AMLEKGERMGCPAGCPRE---------MYDLMNLCWTYDVENRPGFA 258
Query: 470 SVAVML 475
+V + L
Sbjct: 259 AVELRL 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-35
Identities = 46/212 (21%), Positives = 80/212 (37%), Gaps = 32/212 (15%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
+ + + ++ IA+G+ YL ++ HRDL A NVL+ + KI+DFG+A++
Sbjct: 104 HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 160
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH 413
G + E + +MA E L + + +SDV+S+GV + E+++ Y
Sbjct: 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK--PYDGIP 218
Query: 414 GQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473
+ + GE L I + C D RP + +
Sbjct: 219 ASEIS----SILEKGERLPQPPICTID---------VYMIMVKCWMIDADSRPKFRELII 265
Query: 474 ML--------------ASDTVSLPQPTQPAFS 491
+ + LP PT F
Sbjct: 266 EFSKMARDPQRYLVIQGDERMHLPSPTDSNFY 297
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-35
Identities = 45/208 (21%), Positives = 79/208 (37%), Gaps = 19/208 (9%)
Query: 284 GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP 343
G + +R ++ +++ ++ G+ YL HRDL A NVLL +
Sbjct: 92 GGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYA 148
Query: 344 KISDFGMARIFGGNQNESN-TSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISG 402
KISDFG+++ G + + S + APE S +SDV+S+GV + E +S
Sbjct: 149 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSY 208
Query: 403 KKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDP 462
+ Y G ++ G+ +E + + C
Sbjct: 209 GQK--PYKKMKGPEVM----AFIEQGKRMECPPECPPE---------LYALMSDCWIYKW 253
Query: 463 ADRPNMSSVAVMLASDTVSLPQPTQPAF 490
DRP+ +V + + SL +
Sbjct: 254 EDRPDFLTVEQRMRACYYSLASKVEGHH 281
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 3e-35
Identities = 49/200 (24%), Positives = 76/200 (38%), Gaps = 17/200 (8%)
Query: 276 RKAIWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNV 335
RK T P I LD + +S +A+G+ +L HRDL A N+
Sbjct: 120 RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNI 176
Query: 336 LLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVL 395
LL H KI DFG+AR + N +MAPE V + +SDV+S+G+
Sbjct: 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236
Query: 396 LLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGL 455
L E+ S + + + +K+ G + + + I
Sbjct: 237 LWELFSLGSSPYPGMPVDSK-----FYKMIKEGFRMLSPEHAPAE---------MYDIMK 282
Query: 456 LCVQEDPADRPNMSSVAVML 475
C DP RP + ++
Sbjct: 283 TCWDADPLKRPTFKQIVQLI 302
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 4e-35
Identities = 44/186 (23%), Positives = 66/186 (35%), Gaps = 23/186 (12%)
Query: 290 IYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFG 349
+ S R+ L + + + YL HRDL A NVL+ + K+SDFG
Sbjct: 92 LRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFG 148
Query: 350 MARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFY 409
+ + S + APE S KSDV+SFG+LL EI S + Y
Sbjct: 149 LTKEA-----SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV--PY 201
Query: 410 LSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMS 469
+ ++ G ++ D + C D A RP+
Sbjct: 202 PRIPLKDVV----PRVEKGYKMDAPDGCPPA---------VYEVMKNCWHLDAAMRPSFL 248
Query: 470 SVAVML 475
+ L
Sbjct: 249 QLREQL 254
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 7e-35
Identities = 45/179 (25%), Positives = 76/179 (42%), Gaps = 18/179 (10%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
+ + + G++YLH + + HRD+K N+LLD N KISDFG+A +
Sbjct: 96 PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATV 152
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSE 412
F N E +K+ GT Y+APE + DV+S G++L +++G+
Sbjct: 153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW------ 206
Query: 413 HGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSV 471
S + W + ++P K LL + E+P+ R + +
Sbjct: 207 DQPSDSCQEYSDWKEKK--TYLNPWKKIDSAPLALLHK------ILVENPSARITIPDI 257
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 1e-34
Identities = 47/211 (22%), Positives = 87/211 (41%), Gaps = 39/211 (18%)
Query: 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGM 350
+ ++ + + + +GL YL + K+ HRD+K SN+L++ K+ DFG+
Sbjct: 94 VLKKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGV 151
Query: 351 ARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK------- 403
+ +S + VGT YM+PE G SV+SD++S G+ L+E+ G+
Sbjct: 152 SGQL----IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207
Query: 404 ----------------KNSGFYLSEHGQSLLAYTWKLWCNGEALELMD-------PVLKQ 440
+ G+ L +Y EL+D P L
Sbjct: 208 AKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS 267
Query: 441 SCMAAELLKCIHIGLLCVQEDPADRPNMSSV 471
+ E ++ C+ ++PA+R ++ +
Sbjct: 268 GVFSLEFQDFVN---KCLIKNPAERADLKQL 295
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (326), Expect = 1e-34
Identities = 39/195 (20%), Positives = 79/195 (40%), Gaps = 21/195 (10%)
Query: 284 GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP 343
++ + Q + + ++ GIA G+ YL + HRDL A N+L++ +
Sbjct: 111 NGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVC 167
Query: 344 KISDFGMARIFGGNQNESNTSKVVG---TYGYMAPEYALGGVISVKSDVFSFGVLLLEII 400
K+SDFG++R + ++ + +G + APE + SDV+S+G+++ E++
Sbjct: 168 KVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 227
Query: 401 SGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQE 460
S + + N + + ++ + + L C Q+
Sbjct: 228 SYGE---------------RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQK 272
Query: 461 DPADRPNMSSVAVML 475
D RP + L
Sbjct: 273 DRNHRPKFGQIVNTL 287
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 5e-34
Identities = 49/186 (26%), Positives = 74/186 (39%), Gaps = 19/186 (10%)
Query: 290 IYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFG 349
T+R + + + + G+ YL E V HRDL A N L+ K+SDFG
Sbjct: 90 YLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFG 146
Query: 350 MARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFY 409
M R +Q ++++ + +PE S KSDV+SFGVL+ E+ S K
Sbjct: 147 MTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK----- 200
Query: 410 LSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMS 469
++ N E +E + + I C +E P DRP S
Sbjct: 201 ----------IPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFS 250
Query: 470 SVAVML 475
+ L
Sbjct: 251 RLLRQL 256
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 7e-34
Identities = 47/183 (25%), Positives = 75/183 (40%), Gaps = 20/183 (10%)
Query: 291 YSTRRAQLDWKRRISIINGIARGLLYLHE--DSRLKVFHRDLKASNVLLDHEMNPKISDF 348
+ R LD + + ++ + L H D V HRDLK +NV LD + N K+ DF
Sbjct: 99 GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 158
Query: 349 GMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGF 408
G+ARI N + S VGT YM+PE + KSD++S G LL E+ +
Sbjct: 159 GLARIL--NHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP---P 213
Query: 409 YLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNM 468
+ + + L G+ + S E++ + RP++
Sbjct: 214 FTAFSQKELA----GKIREGKFRRIPYRY---SDELNEIITR------MLNLKDYHRPSV 260
Query: 469 SSV 471
+
Sbjct: 261 EEI 263
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 1e-33
Identities = 47/184 (25%), Positives = 78/184 (42%), Gaps = 21/184 (11%)
Query: 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMA 351
++ + L ++ + +ARG+ YL + + HRDL A N+L+ KI+DFG++
Sbjct: 118 NSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS 174
Query: 352 RIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLS 411
R G + + +MA E V + SDV+S+GVLL EI+S Y
Sbjct: 175 R---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCG 229
Query: 412 EHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSV 471
L ++ G LE + + C +E P +RP+ + +
Sbjct: 230 MTCAEL----YEKLPQGYRLEKPLNCDDE---------VYDLMRQCWREKPYERPSFAQI 276
Query: 472 AVML 475
V L
Sbjct: 277 LVSL 280
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 1e-33
Identities = 44/188 (23%), Positives = 70/188 (37%), Gaps = 20/188 (10%)
Query: 290 IYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFG 349
K I +A+G+ + K HRDL A N +LD + K++DFG
Sbjct: 119 FIRNETHNPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFG 175
Query: 350 MARIFGGNQNESNTSK--VVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSG 407
+AR + +S +K +MA E + KSDV+SFGVLL E+++
Sbjct: 176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-- 233
Query: 408 FYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPN 467
Y + + Y + G L + + L C RP+
Sbjct: 234 PYPDVNTFDITVYLLQ----GRRLLQPEYCPDP---------LYEVMLKCWHPKAEMRPS 280
Query: 468 MSSVAVML 475
S + +
Sbjct: 281 FSELVSRI 288
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-33
Identities = 40/182 (21%), Positives = 77/182 (42%), Gaps = 21/182 (11%)
Query: 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE-MNPKISDFG 349
Y R + K S I +GL +LH + + HRDLK N+ + + KI D G
Sbjct: 102 YLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLG 160
Query: 350 MARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFY 409
+A + S V+GT +MAPE DV++FG+ +LE+ + + +
Sbjct: 161 LATLK----RASFAKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP--YS 213
Query: 410 LSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMS 469
++ + ++ +G D V E+++ C++++ +R ++
Sbjct: 214 ECQNAAQI----YRRVTSGVKPASFDKVA--IPEVKEIIEG------CIRQNKDERYSIK 261
Query: 470 SV 471
+
Sbjct: 262 DL 263
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 6e-33
Identities = 41/186 (22%), Positives = 72/186 (38%), Gaps = 19/186 (10%)
Query: 290 IYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFG 349
R + ++ + + + + YL + HRDL A N L++ + K+SDFG
Sbjct: 89 YLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFG 145
Query: 350 MARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFY 409
++R ++ S+ + PE + S KSD+++FGVL+ EI S K
Sbjct: 146 LSRYVLDDEYTSSVG-SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK----- 199
Query: 410 LSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMS 469
++ + N E E + L+ K I C E +RP
Sbjct: 200 ----------MPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFK 249
Query: 470 SVAVML 475
+ +
Sbjct: 250 ILLSNI 255
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 5e-32
Identities = 42/193 (21%), Positives = 76/193 (39%), Gaps = 24/193 (12%)
Query: 284 GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP 343
G + + L + + L YLH+ K+ HRDLKA N+L + +
Sbjct: 93 GGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDI 149
Query: 344 KISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYALG-----GVISVKSDVFSFGVLLLE 398
K++DFG++ ++ +GT +MAPE + K+DV+S G+ L+E
Sbjct: 150 KLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIE 207
Query: 399 IISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCV 458
+ + + + +L E L P + S + LK C+
Sbjct: 208 MAEIEP---PHHELNPMRVL----LKIAKSEPPTLAQPS-RWSSNFKDFLKK------CL 253
Query: 459 QEDPADRPNMSSV 471
+++ R S +
Sbjct: 254 EKNVDARWTTSQL 266
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 5e-32
Identities = 51/181 (28%), Positives = 74/181 (40%), Gaps = 18/181 (9%)
Query: 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354
QL K +S +ARG+ YL K HRDL A NVL+ + KI+DFG+AR
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 355 GGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHG 414
T+ +MAPE + + +SDV+SFGVLL EI + + Y
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVPV 243
Query: 415 QSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVM 474
+ L +KL G ++ + + C P+ RP +
Sbjct: 244 EEL----FKLLKEGHRMDKPSNCTNE---------LYMMMRDCWHAVPSQRPTFKQLVED 290
Query: 475 L 475
L
Sbjct: 291 L 291
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 7e-32
Identities = 42/193 (21%), Positives = 69/193 (35%), Gaps = 18/193 (9%)
Query: 284 GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP 343
++ + +A G+ YL + HRDL A N+LL
Sbjct: 94 LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLV 150
Query: 344 KISDFGMARIFGGNQNES-NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISG 402
KI DFG+ R N + + + APE S SD + FGV L E+ +
Sbjct: 151 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTY 210
Query: 403 KKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDP 462
+ ++ +G +L K+ GE L + + ++ + C P
Sbjct: 211 GQE--PWIGLNGSQIL---HKIDKEGERLPRPEDCPQ---------DIYNVMVQCWAHKP 256
Query: 463 ADRPNMSSVAVML 475
DRP ++ L
Sbjct: 257 EDRPTFVALRDFL 269
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 2e-31
Identities = 49/198 (24%), Positives = 78/198 (39%), Gaps = 20/198 (10%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
A + I + IA G+ YL+ + K HRDL A N ++ + KI DFGM R
Sbjct: 126 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 182
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH 413
K + +M+PE GV + SDV+SFGV+L EI + + Y
Sbjct: 183 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGLS 240
Query: 414 GQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473
+ +L + G L+ D + +C Q +P RP+ +
Sbjct: 241 NEQVL----RFVMEGGLLDKPDNCPDM---------LFELMRMCWQYNPKMRPSFLEIIS 287
Query: 474 MLASDTVSLPQPTQPAFS 491
+ + P + +F
Sbjct: 288 SIKEEM--EPGFREVSFY 303
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 120 bits (303), Expect = 3e-31
Identities = 47/181 (25%), Positives = 72/181 (39%), Gaps = 27/181 (14%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
+ L ++ +G +GL YLH + HRD+KA N+LL K+ DFG A I
Sbjct: 108 HKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALG---GVISVKSDVFSFGVLLLEIISGKKNSGFYL 410
+ + VGT +MAPE L G K DV+S G+ +E+ K
Sbjct: 165 M------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP---PLF 215
Query: 411 SEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSS 470
+ + S L + P L+ + + C+Q+ P DRP
Sbjct: 216 NMNAMSALY---------HIAQNESPALQSGHWSEYFRNFV---DSCLQKIPQDRPTSEV 263
Query: 471 V 471
+
Sbjct: 264 L 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 3e-31
Identities = 43/178 (24%), Positives = 72/178 (40%), Gaps = 24/178 (13%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
+ ++ D +R + I +A L Y H +V HRD+K N+LL KI+DFG +
Sbjct: 99 KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV- 154
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH 413
+ S + + GT Y+ PE G + K D++S GVL E + GK E
Sbjct: 155 ---HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK-----PPFEA 206
Query: 414 GQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSV 471
Y + + + +L+ ++ +P+ RP + V
Sbjct: 207 NTYQETYKRISRVEFTFPDFVTEGAR------DLISR------LLKHNPSQRPMLREV 252
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 4e-31
Identities = 43/194 (22%), Positives = 69/194 (35%), Gaps = 19/194 (9%)
Query: 284 GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP 343
+ + R+ LD I ++ L YL + HRD+ A NVL+
Sbjct: 91 LGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCV 147
Query: 344 KISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
K+ DFG++R + SK +MAPE + SDV+ FGV + EI+
Sbjct: 148 KLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 206
Query: 404 KNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPA 463
+ + NGE L + + C DP+
Sbjct: 207 VKPFQGVKNND------VIGRIENGERLPMPPNCPPT---------LYSLMTKCWAYDPS 251
Query: 464 DRPNMSSVAVMLAS 477
RP + + L++
Sbjct: 252 RRPRFTELKAQLST 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 4e-29
Identities = 46/173 (26%), Positives = 77/173 (44%), Gaps = 19/173 (10%)
Query: 299 DWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ 358
D + ++ + L +LH +V HRD+K+ N+LL + + K++DFG
Sbjct: 114 DEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TP 168
Query: 359 NESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLL 418
+S S +VGT +MAPE K D++S G++ +E+I G+ YL+E+ L
Sbjct: 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP---PYLNENPLRAL 225
Query: 419 AYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSV 471
L EL +P K S + + L C+ D R + +
Sbjct: 226 ----YLIATNGTPELQNPE-KLSAIFRDFLNR------CLDMDVEKRGSAKEL 267
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 104 bits (260), Expect = 1e-25
Identities = 41/187 (21%), Positives = 71/187 (37%), Gaps = 25/187 (13%)
Query: 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGM 350
Y T + L K I+ + + LH+ L + HRDLK N+LLD +MN K++DFG
Sbjct: 100 YLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF 156
Query: 351 ARIFGGNQNESNTSKVVGTYGYMAPEYALGGV------ISVKSDVFSFGVLLLEIISGKK 404
+ +V GT Y+APE + + D++S GV++ +++G
Sbjct: 157 SCQL---DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 213
Query: 405 NSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPAD 464
+ +L ++ +G S +L+ + P
Sbjct: 214 ---PFWHRKQMLML----RMIMSGNYQFGSPEWDDYSDTVKDLVSR------FLVVQPQK 260
Query: 465 RPNMSSV 471
R
Sbjct: 261 RYTAEEA 267
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 2e-25
Identities = 44/192 (22%), Positives = 75/192 (39%), Gaps = 16/192 (8%)
Query: 290 IYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFG 349
+ + + ++ + RGL +LH +V HRDLK N+L+ K++DFG
Sbjct: 105 LDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG 161
Query: 350 MARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK-----K 404
+ARI+ ++ VV T Y APE L + D++S G + E+ K
Sbjct: 162 LARIYSFQMALTS---VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 218
Query: 405 NSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLL-----CVQ 459
+ L + + + W AL K + + + I C+
Sbjct: 219 SDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLT 278
Query: 460 EDPADRPNMSSV 471
+PA R + S
Sbjct: 279 FNPAKRISAYSA 290
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 102 bits (255), Expect = 7e-25
Identities = 33/205 (16%), Positives = 67/205 (32%), Gaps = 20/205 (9%)
Query: 279 IWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVL-- 336
+ +G ++ +++ + K + + + + + Y+H HRD+K N L
Sbjct: 81 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMG 137
Query: 337 -LDHEMNPKISDFGMARIFGGNQNESN-----TSKVVGTYGYMAPEYALGGVISVKSDVF 390
I DFG+A+ + + + + GT Y + LG S + D+
Sbjct: 138 LGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLE 197
Query: 391 SFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450
S G +L+ G + + + + L A L
Sbjct: 198 SLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY---PSEFATYLNF 254
Query: 451 IHIGLLCVQEDPADRPNMSSVAVML 475
C D+P+ S + +
Sbjct: 255 ------CRSLRFDDKPDYSYLRQLF 273
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 102 bits (254), Expect = 7e-25
Identities = 31/203 (15%), Positives = 62/203 (30%), Gaps = 22/203 (10%)
Query: 283 IGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMN 342
+G ++ + + K + + +HE + +RD+K N L+ +
Sbjct: 83 LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNS 139
Query: 343 P-----KISDFGMARIF-----GGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSF 392
+ DFGM + + + + GT YM+ LG S + D+ +
Sbjct: 140 KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEAL 199
Query: 393 GVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452
G + + + G G K GE + + E K +H
Sbjct: 200 GHVFMYFLRGSLPW------QGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMH 253
Query: 453 IGLLCVQEDPADRPNMSSVAVML 475
P+ + +
Sbjct: 254 ---YARNLAFDATPDYDYLQGLF 273
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 3e-24
Identities = 31/113 (27%), Positives = 55/113 (48%), Gaps = 3/113 (2%)
Query: 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGM 350
Y + D I L YLH + HRDLK N+LL+ +M+ +I+DFG
Sbjct: 98 YIRKIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGT 154
Query: 351 ARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
A++ ++ + VGT Y++PE SD+++ G ++ ++++G
Sbjct: 155 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 101 bits (252), Expect = 4e-24
Identities = 35/190 (18%), Positives = 69/190 (36%), Gaps = 21/190 (11%)
Query: 284 GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP 343
G + + ++ + + + +GL ++HE H DLK N++ + +
Sbjct: 107 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSN 163
Query: 344 --KISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
K+ DFG+ Q+ GT + APE A G + +D++S GVL ++S
Sbjct: 164 ELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS 220
Query: 402 GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQED 461
G + E+ L + + + S + ++ + D
Sbjct: 221 GLS---PFGGENDDETL----RNVKSCDWNMDDSAFSGISEDGKDFIRK------LLLAD 267
Query: 462 PADRPNMSSV 471
P R +
Sbjct: 268 PNTRMTIHQA 277
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 98.7 bits (245), Expect = 1e-23
Identities = 45/180 (25%), Positives = 88/180 (48%), Gaps = 19/180 (10%)
Query: 298 LDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGN 357
+ KR I +I + L + H+ + HRD+K +N+++ K+ DFG+AR +
Sbjct: 108 MTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164
Query: 358 QNE-SNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQS 416
N + T+ V+GT Y++PE A G + +SDV+S G +L E+++G+ + + S
Sbjct: 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP---PFTGDSPVS 221
Query: 417 LLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLA 476
+ + + + P + ++A+L + L + ++P +R + A M A
Sbjct: 222 VAYQHVR-------EDPIPPSARHEGLSADLDAVV---LKALAKNPENRY--QTAAEMRA 269
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 99.4 bits (247), Expect = 2e-23
Identities = 35/190 (18%), Positives = 69/190 (36%), Gaps = 21/190 (11%)
Query: 284 GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP 343
G + + ++ I+ + GL ++HE + H D+K N++ + +
Sbjct: 110 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKAS 166
Query: 344 --KISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
KI DFG+A + T + APE + +D+++ GVL ++S
Sbjct: 167 SVKIIDFGLATKL---NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 223
Query: 402 GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQED 461
G F + + T + + D S A + +K +Q++
Sbjct: 224 GLSP--FAGEDDLE-----TLQNVKRCDWEFDEDAFSSVSPEAKDFIKN------LLQKE 270
Query: 462 PADRPNMSSV 471
P R +
Sbjct: 271 PRKRLTVHDA 280
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.2 bits (244), Expect = 3e-23
Identities = 39/190 (20%), Positives = 75/190 (39%), Gaps = 21/190 (11%)
Query: 284 GTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP 343
G I +T +L+ + +S ++ + L +LH + H D++ N++ +
Sbjct: 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSS 141
Query: 344 --KISDFGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS 401
KI +FG AR N + Y APE V+S +D++S G L+ ++S
Sbjct: 142 TIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS 198
Query: 402 GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQED 461
G +L+E Q ++ + N E + + S A + + + ++
Sbjct: 199 GIN---PFLAETNQQII----ENIMNAEYTFDEEAFKEISIEAMDFVDR------LLVKE 245
Query: 462 PADRPNMSSV 471
R S
Sbjct: 246 RKSRMTASEA 255
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.9 bits (238), Expect = 2e-22
Identities = 37/186 (19%), Positives = 71/186 (38%), Gaps = 20/186 (10%)
Query: 290 IYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP---KIS 346
I + I+ I + YLH + + HRD+K N+L + K++
Sbjct: 100 IQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLT 156
Query: 347 DFGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNS 406
DFG A+ + + + T Y+APE D++S GV++ ++ G
Sbjct: 157 DFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP-- 211
Query: 407 GFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQ-SCMAAELLKCIHIGLLCVQEDPADR 465
+ S HG ++ G+ E +P + S L++ ++ +P R
Sbjct: 212 -PFYSNHGLAISPGMKTRIRMGQ-YEFPNPEWSEVSEEVKMLIRN------LLKTEPTQR 263
Query: 466 PNMSSV 471
++
Sbjct: 264 MTITEF 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.8 bits (235), Expect = 4e-22
Identities = 48/177 (27%), Positives = 74/177 (41%), Gaps = 22/177 (12%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
+ D R I GL +LH + +RDLK N+LLD + + KI+DFGM +
Sbjct: 96 SCHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE 152
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH 413
++NT GT Y+APE LG + D +SFGVLL E++ G+ S F+ +
Sbjct: 153 NMLGDAKTNT--FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ--SPFHGQDE 208
Query: 414 GQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSS 470
+ + N ++ K +LL +P R +
Sbjct: 209 EE---LFHSIRMDNPFYPRWLEKEAK------DLLVK------LFVREPEKRLGVRG 250
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.5 bits (234), Expect = 8e-22
Identities = 47/194 (24%), Positives = 79/194 (40%), Gaps = 19/194 (9%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
+ L + I RGL Y+H V HRDLK SN+LL+ + KI DFG+AR+
Sbjct: 102 KTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 158
Query: 354 FGGNQNESNT-SKVVGTYGYMAPEYALGGVISVKS-DVFSFGVLLLEIISGK-----KNS 406
+ + + ++ V T Y APE L KS D++S G +L E++S + K+
Sbjct: 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 218
Query: 407 GFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL---------KCIHIGLLC 457
L+ L + + + L+ + +L K + +
Sbjct: 219 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 278
Query: 458 VQEDPADRPNMSSV 471
+ +P R +
Sbjct: 279 LTFNPHKRIEVEQA 292
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 94.4 bits (234), Expect = 1e-21
Identities = 46/176 (26%), Positives = 68/176 (38%), Gaps = 22/176 (12%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
+ I GL ++H V +RDLK +N+LLD + +ISD G+A
Sbjct: 100 QHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACD 156
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGGV-ISVKSDVFSFGVLLLEIISGKKNSGFYLSE 412
F + VGT+GYMAPE GV +D FS G +L +++ G +
Sbjct: 157 FS----KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH----SPFRQ 208
Query: 413 HGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNM 468
H ++ +EL D S LL+ +Q D R
Sbjct: 209 HKTKDKHEIDRMTLTMA-VELPDSF---SPELRSLLEG------LLQRDVNRRLGC 254
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.1 bits (228), Expect = 2e-21
Identities = 37/183 (20%), Positives = 66/183 (36%), Gaps = 32/183 (17%)
Query: 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE-MNPKISDFG 349
+ T R L + S + + + H V HRD+K N+L+D K+ DFG
Sbjct: 100 FITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG 156
Query: 350 MARIFGGNQNESNTSKVVGTYGYMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGF 408
+ ++ + GT Y PE+ + V+S G+LL +++ G
Sbjct: 157 SGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD----- 207
Query: 409 YLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNM 468
+ + E + +Q + C H+ C+ P+DRP
Sbjct: 208 --------------IPFEHDEEIIRGQVFFRQRVSSE----CQHLIRWCLALRPSDRPTF 249
Query: 469 SSV 471
+
Sbjct: 250 EEI 252
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (223), Expect = 1e-20
Identities = 48/221 (21%), Positives = 81/221 (36%), Gaps = 36/221 (16%)
Query: 290 IYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFG 349
I L + + +GL YLH+ + HRDLK +N+LLD K++DFG
Sbjct: 89 IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFG 145
Query: 350 MARIFGGNQNESNTSKVVGTYGYMAPEYALG-GVISVKSDVFSFGVLLLEIISGK----- 403
+A+ FG + V T Y APE G + V D+++ G +L E++
Sbjct: 146 LAKSFG--SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 203
Query: 404 KNSGFYLSEHGQSLLAYTWKLWCNGEAL------------ELMDPVLKQSCMAAELLKCI 451
+ L+ ++L T + W + +L L +L++
Sbjct: 204 DSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQG- 262
Query: 452 HIGLLCVQEDPADRPNMSSVAVM-------LASDTVSLPQP 485
+P R + M + LP+P
Sbjct: 263 -----LFLFNPCARITATQALKMKYFSNRPGPTPGCQLPRP 298
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 90.2 bits (223), Expect = 1e-20
Identities = 32/106 (30%), Positives = 48/106 (45%), Gaps = 8/106 (7%)
Query: 299 DWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ 358
+ L YLH + +RDLK N+LLD + KI+DFG A+
Sbjct: 102 PNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV---- 154
Query: 359 NESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKK 404
T + GT Y+APE + D +SFG+L+ E+++G
Sbjct: 155 -PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (223), Expect = 2e-20
Identities = 43/200 (21%), Positives = 79/200 (39%), Gaps = 21/200 (10%)
Query: 290 IYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFG 349
+ S + ++ + GL Y+H + K+ HRD+KA+NVL+ + K++DFG
Sbjct: 106 LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162
Query: 350 MARIFGGNQNESNT--SKVVGTYGYMAPEYALGG-VISVKSDVFSFGVLLLEIISGK--- 403
+AR F +N + V T Y PE LG D++ G ++ E+ +
Sbjct: 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 222
Query: 404 --KNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLL----- 456
L+ Q + T ++W N + EL + + ++ + +
Sbjct: 223 QGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYAL 282
Query: 457 -----CVQEDPADRPNMSSV 471
+ DPA R +
Sbjct: 283 DLIDKLLVLDPAQRIDSDDA 302
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.5 bits (221), Expect = 2e-20
Identities = 41/201 (20%), Positives = 73/201 (36%), Gaps = 30/201 (14%)
Query: 290 IYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFG 349
+ ++ + S + + +GL + H +V HRDLK N+L++ E K++DFG
Sbjct: 91 MDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFG 147
Query: 350 MARIFGGNQNESNTSKVVGTYGYMAPE-YALGGVISVKSDVFSFGVLLLEIISGK----- 403
+AR FG V T Y APE S D++S G + E+++ +
Sbjct: 148 LARAFGVPVRTYTH--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 205
Query: 404 KNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQ-------------SCMAAELLKC 450
+ L ++L +W ++ P + LL
Sbjct: 206 DSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQ 265
Query: 451 IHIGLLCVQEDPADRPNMSSV 471
+ DP R + +
Sbjct: 266 ------MLHYDPNKRISAKAA 280
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 88.0 bits (217), Expect = 6e-20
Identities = 47/195 (24%), Positives = 77/195 (39%), Gaps = 18/195 (9%)
Query: 290 IYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFG 349
+ L+ S + + G+ Y H+ +V HRDLK N+L++ E KI+DFG
Sbjct: 89 LLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFG 145
Query: 350 MARIFGGNQNESNTSKVVGTYGYMAPEYALG-GVISVKSDVFSFGVLLLEIISGK----- 403
+AR FG + + T Y AP+ +G S D++S G + E+++G
Sbjct: 146 LARAFGIPVRKYTH--EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203
Query: 404 KNSGFYLSEHGQSLLAYTWKLWCNGEALELMDP--VLKQSCMAAELLKCIHIGLL----- 456
+ L + L K W N L DP + + LK + +
Sbjct: 204 VSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSK 263
Query: 457 CVQEDPADRPNMSSV 471
++ DP R
Sbjct: 264 MLKLDPNQRITAKQA 278
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 87.4 bits (216), Expect = 1e-19
Identities = 36/179 (20%), Positives = 62/179 (34%), Gaps = 18/179 (10%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
+ + +I + + YLH+ + + LD + ISDFG++++
Sbjct: 100 EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH 413
S S GT GY+APE S D +S GV+ ++ G + E+
Sbjct: 160 EDPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP---PFYDEN 213
Query: 414 GQSLLAYTWKLWCNGEALELMDPVLKQ-SCMAAELLKCIHIGLLCVQEDPADRPNMSSV 471
L K E P S A + ++ +++DP R
Sbjct: 214 DAKLFEQILK-----AEYEFDSPYWDDISDSAKDFIRH------LMEKDPEKRFTCEQA 261
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.2 bits (210), Expect = 6e-19
Identities = 42/186 (22%), Positives = 75/186 (40%), Gaps = 25/186 (13%)
Query: 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNP----KIS 346
+ + L + + I G+ YLH L++ H DLK N++L P KI
Sbjct: 103 FLAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKII 159
Query: 347 DFGMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNS 406
DFG+A + + GT ++APE + +++D++S GV+ ++SG
Sbjct: 160 DFGLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS-- 214
Query: 407 GFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQ-SCMAAELLKCIHIGLLCVQEDPADR 465
+L + Q LA + E D S +A + ++ + +DP R
Sbjct: 215 -PFLGDTKQETLANVSAV-----NYEFEDEYFSNTSALAKDFIRR------LLVKDPKKR 262
Query: 466 PNMSSV 471
+
Sbjct: 263 MTIQDS 268
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.8 bits (206), Expect = 1e-18
Identities = 40/186 (21%), Positives = 70/186 (37%), Gaps = 19/186 (10%)
Query: 300 WKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQN 359
+ S + + +GL + H V HRDLK N+L++ K+++FG+AR FG
Sbjct: 100 PEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFG--IP 154
Query: 360 ESNTSKVVGTYGYMAPEYALG-GVISVKSDVFSFGVLLLEIISGK------KNSGFYLSE 412
S V T Y P+ G + S D++S G + E+ + + L
Sbjct: 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 214
Query: 413 HGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG-----LL--CVQEDPADR 465
+ L T + W + L P + + + LL ++ +P R
Sbjct: 215 IFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQR 274
Query: 466 PNMSSV 471
+
Sbjct: 275 ISAEEA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.1 bits (207), Expect = 2e-18
Identities = 40/178 (22%), Positives = 70/178 (39%), Gaps = 22/178 (12%)
Query: 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGM 350
+ +R +R I L YLH V +RD+K N++LD + + KI+DFG+
Sbjct: 95 HLSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGL 151
Query: 351 ARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYL 410
+ G + + GT Y+APE D + GV++ E++ G+ +
Sbjct: 152 CKE--GISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL---PFY 206
Query: 411 SEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNM 468
++ + L E + + S A LL +++DP R
Sbjct: 207 NQDHERLFELILM-----EEIRFPRTL---SPEAKSLLAG------LLKKDPKQRLGG 250
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.1 bits (207), Expect = 3e-18
Identities = 43/199 (21%), Positives = 73/199 (36%), Gaps = 35/199 (17%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
+ +L R ++ + +GL Y+H + HRDLK N+ ++ + KI DFG+AR
Sbjct: 114 KHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR- 169
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGGV-ISVKSDVFSFGVLLLEIISGK--------- 403
Q +S + V T Y APE L + + D++S G ++ E+I+GK
Sbjct: 170 ----QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 225
Query: 404 -----------KNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452
++ K E + + S +A LL+
Sbjct: 226 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEK-- 283
Query: 453 IGLLCVQEDPADRPNMSSV 471
+ D R
Sbjct: 284 ----MLVLDAEQRVTAGEA 298
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.7 bits (206), Expect = 3e-18
Identities = 42/195 (21%), Positives = 69/195 (35%), Gaps = 20/195 (10%)
Query: 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE-MNPKISDFG 349
YS + L + + R L Y+H + HRD+K N+LLD + K+ DFG
Sbjct: 112 YSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFG 168
Query: 350 MARIFGGNQNESNTSKVVGTYGYMAPEYALGGV-ISVKSDVFSFGVLLLEIISGK----- 403
A+ + + + + Y APE G + DV+S G +L E++ G+
Sbjct: 169 SAKQLVRGEPNVSY---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225
Query: 404 KNSGFYLSEHGQSLLAYTWKLW--CNGEALELMDPVLKQSCMAAELLKCIHIGLL----- 456
+ L E + L T + N E P +K +
Sbjct: 226 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 285
Query: 457 CVQEDPADRPNMSSV 471
++ P R
Sbjct: 286 LLEYTPTARLTPLEA 300
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 82.5 bits (203), Expect = 9e-18
Identities = 36/174 (20%), Positives = 62/174 (35%), Gaps = 25/174 (14%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
R + I YLH L + +RDLK N+L+D + +++DFG A+
Sbjct: 134 RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEH 413
G + GT +APE L + D ++ GVL+ E+ +G + ++
Sbjct: 191 VKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP---PFFADQ 242
Query: 414 GQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPN 467
+ + S +LL+ +Q D R
Sbjct: 243 PIQIYEKIVSGK--------VRFPSHFSSDLKDLLRN------LLQVDLTKRFG 282
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.2 bits (181), Expect = 5e-15
Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGM 350
+ +LD +R ++ + G+ +LH HRDLK SN+++ + KI DFG+
Sbjct: 109 CQVIQMELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGL 165
Query: 351 ARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
AR G + + V T Y APE LG D++S G ++ E++ K
Sbjct: 166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 73.1 bits (178), Expect = 1e-14
Identities = 26/115 (22%), Positives = 47/115 (40%), Gaps = 3/115 (2%)
Query: 290 IYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE-MNPKISDF 348
I + I + GL Y+H R + H D+K NVL++ +
Sbjct: 114 IKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQI 171
Query: 349 GMARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGK 403
+A + + + + + T Y +PE LG +D++S L+ E+I+G
Sbjct: 172 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.6 bits (177), Expect = 1e-14
Identities = 39/164 (23%), Positives = 74/164 (45%), Gaps = 18/164 (10%)
Query: 306 IINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSK 365
+ + +L L +L + +RD+K N+LLD + ++DFG+++ F ++ E
Sbjct: 131 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYD 189
Query: 366 VVGTYGYMAPEYALGGV--ISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWK 423
GT YMAP+ GG D +S GVL+ E+++G + + ++ A +
Sbjct: 190 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS---PFTVDGEKNSQAEISR 246
Query: 424 LWCNGEALELMDPVLKQ-SCMAAELLKCIHIGLLCVQEDPADRP 466
E P ++ S +A +L++ + +DP R
Sbjct: 247 RILKSE-----PPYPQEMSALAKDLIQR------LLMKDPKKRL 279
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 71.4 bits (174), Expect = 4e-14
Identities = 27/108 (25%), Positives = 48/108 (44%), Gaps = 8/108 (7%)
Query: 298 LDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE-MNPKISDFGMARIFGG 356
L + I + L Y H + + HRD+K NV++DHE ++ D+G+A +
Sbjct: 126 LTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182
Query: 357 NQNESNTSKVVGTYGYMAPEYALG-GVISVKSDVFSFGVLLLEIISGK 403
Q + V + + PE + + D++S G +L +I K
Sbjct: 183 GQEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.2 bits (163), Expect = 9e-13
Identities = 42/191 (21%), Positives = 73/191 (38%), Gaps = 23/191 (12%)
Query: 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353
+ +L +I I RGL Y+H + HRDLK SN+ ++ + KI DFG+AR
Sbjct: 114 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH 170
Query: 354 FGGNQNESNTSKVVGTYGYMAPEYALGGV-ISVKSDVFSFGVLLLEIISGK-----KNSG 407
T Y APE L + + D++S G ++ E+++G+ +
Sbjct: 171 TDDEMTGYVA-----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 225
Query: 408 FYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG-------LL--CV 458
L + + +L + + + + M + IG LL +
Sbjct: 226 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML 285
Query: 459 QEDPADRPNMS 469
D R +
Sbjct: 286 VLDSDKRITAA 296
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 52.5 bits (125), Expect = 2e-08
Identities = 11/53 (20%), Positives = 20/53 (37%), Gaps = 4/53 (7%)
Query: 300 WKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMAR 352
+ +++ I + + + H DL NVL+ E I DF +
Sbjct: 102 VENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 523 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.98 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.97 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.97 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.97 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.97 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.97 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.97 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.97 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.97 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.97 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.97 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.97 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.97 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.97 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.97 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.97 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.97 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.97 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.96 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.96 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.96 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.96 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.96 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.96 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.96 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.96 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.96 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.96 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.96 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.96 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.96 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.96 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.96 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.96 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.96 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.96 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.96 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.96 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.96 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.96 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.96 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.95 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.95 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.95 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.95 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.95 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.95 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.95 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.94 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.94 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.94 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.93 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.93 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.93 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.92 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.18 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 89.86 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 88.28 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 87.17 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 84.2 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 82.52 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-34 Score=277.47 Aligned_cols=188 Identities=22% Similarity=0.354 Sum_probs=133.4
Q ss_pred eeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC
Q 046010 281 IAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE 360 (523)
Q Consensus 281 ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 360 (523)
+..|....++. ..+.++++..++.++.||++||+|||+++ ||||||||+|||++.++.+||+|||+++........
T Consensus 85 ~~~g~L~~~l~-~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 85 CEGSSLYHHLH-IIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCEEEHHHHHH-TSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CCCCCHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 33444444443 34567999999999999999999999998 999999999999999999999999999876544333
Q ss_pred ccccceeccCCCCchhhhcC---CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCcc
Q 046010 361 SNTSKVVGTYGYMAPEYALG---GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPV 437 (523)
Q Consensus 361 ~~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (523)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+..............+
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~--~~~~~~~~~~~~~p~~~~----- 233 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIFMVGRGYLSPDLSK----- 233 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHHTSCCCCGGG-----
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCCCCCcchh-----
Confidence 34455678999999999864 45889999999999999999999998532211 111111111111111111
Q ss_pred ccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCCCCC
Q 046010 438 LKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTVSLP 483 (523)
Q Consensus 438 l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~l~ 483 (523)
+ +......+.+|+.+||+.||++|||++||++.|+.....+|
T Consensus 234 ~----~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 234 V----RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp S----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred c----cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 1 11223467789999999999999999999999987655444
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1e-32 Score=266.89 Aligned_cols=179 Identities=22% Similarity=0.262 Sum_probs=132.7
Q ss_pred eEeeeccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 278 AIWIAIGTTI---PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 278 ~~~ia~g~~~---~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
..|+.+.+|. +.-+..++..+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~ 153 (271)
T d1nvra_ 77 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVF 153 (271)
T ss_dssp EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheee
Confidence 3455555443 1223456778999999999999999999999998 999999999999999999999999999976
Q ss_pred cCCCCCccccceeccCCCCchhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccc
Q 046010 355 GGNQNESNTSKVVGTYGYMAPEYALGGVI-SVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALEL 433 (523)
Q Consensus 355 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (523)
.............||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... ... ...........
T Consensus 154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~----~~~~~~~~~~~ 227 (271)
T d1nvra_ 154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEY----SDWKEKKTYLN 227 (271)
T ss_dssp EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--HHH----HHHHTTCTTST
T ss_pred ccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH--HHH----HHHhcCCCCCC
Confidence 54433333455789999999999988776 678999999999999999999985432211 111 11111111110
Q ss_pred cCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 434 MDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 434 ~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.. ......+.+|+.+||+.||++|||++||++
T Consensus 228 ~~--------~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 PW--------KKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TG--------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cc--------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 111235668899999999999999999854
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.3e-33 Score=273.84 Aligned_cols=180 Identities=25% Similarity=0.403 Sum_probs=137.2
Q ss_pred EeeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCC
Q 046010 279 IWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ 358 (523)
Q Consensus 279 ~~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 358 (523)
.|+..|....++......++++.++++++.||++||.|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 3444555555566666678999999999999999999999998 9999999999999999999999999999765332
Q ss_pred CCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccc
Q 046010 359 NESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVL 438 (523)
Q Consensus 359 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 438 (523)
. .......+++.|+|||++.++.++.++|||||||++|||+||+.|+..... .... ......+.....
T Consensus 164 ~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~----~~~i~~~~~~~~----- 231 (272)
T d1qpca_ 164 Y-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEV----IQNLERGYRMVR----- 231 (272)
T ss_dssp E-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHH----HHHHHTTCCCCC-----
T ss_pred c-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHH----HHHHHhcCCCCC-----
Confidence 2 223345788999999999999999999999999999999997766532211 1111 122222211111
Q ss_pred cCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhcc
Q 046010 439 KQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 439 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
+......+.+|+.+||+.||++|||++||+++|+.
T Consensus 232 ----p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 232 ----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 11223467789999999999999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.7e-33 Score=278.75 Aligned_cols=164 Identities=30% Similarity=0.405 Sum_probs=129.6
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++..++.++.||++||+|||+++ ||||||||+||+++.++.+||+|||+++...............||+.|+|
T Consensus 158 ~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 234 (325)
T d1rjba_ 158 LNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMA 234 (325)
T ss_dssp ---CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCC
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCC
Confidence 356999999999999999999999998 99999999999999999999999999987655444444456778999999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||++.++.++.++|||||||++|||++ |+.||...... ..+ ......+...+ .+......+.+|
T Consensus 235 PE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~--~~~----~~~~~~~~~~~---------~p~~~~~~l~~l 299 (325)
T d1rjba_ 235 PESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD--ANF----YKLIQNGFKMD---------QPFYATEEIYII 299 (325)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--HHH----HHHHHTTCCCC---------CCTTCCHHHHHH
T ss_pred hHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH--HHH----HHHHhcCCCCC---------CCCcCCHHHHHH
Confidence 999999999999999999999999998 89998533221 111 12222221111 111223467789
Q ss_pred hhhcccCCCCCCCCHHHHHHHhc
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLA 476 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~ 476 (523)
+.+||+.||++|||++||+++|.
T Consensus 300 i~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 300 MQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHHHh
Confidence 99999999999999999999995
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=2.2e-33 Score=274.28 Aligned_cols=182 Identities=23% Similarity=0.323 Sum_probs=139.9
Q ss_pred EeeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCC
Q 046010 279 IWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQ 358 (523)
Q Consensus 279 ~~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 358 (523)
.|+..|....++.......+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 3444555556666667788999999999999999999999998 9999999999999999999999999998764332
Q ss_pred CCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccc
Q 046010 359 NESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVL 438 (523)
Q Consensus 359 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 438 (523)
. .......|++.|+|||++.+..++.++|||||||++|||++|+.|+..... . .........+...+
T Consensus 170 ~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~----~~~~~~i~~~~~~~------ 236 (287)
T d1opja_ 170 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--L----SQVYELLEKDYRME------ 236 (287)
T ss_dssp S-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--H----HHHHHHHHTTCCCC------
T ss_pred c-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--H----HHHHHHHhcCCCCC------
Confidence 2 223345688999999999999999999999999999999998777532211 1 11122222221111
Q ss_pred cCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 439 KQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 439 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
.+......+.+|+.+||+.||++|||+.||+++|+...
T Consensus 237 ---~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 237 ---RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11122346788999999999999999999999998764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=8.6e-33 Score=271.64 Aligned_cols=168 Identities=23% Similarity=0.346 Sum_probs=120.9
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcc---ccceec
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESN---TSKVVG 368 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~---~~~~~g 368 (523)
......+++.+++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.......... .....+
T Consensus 119 ~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~ 195 (299)
T d1jpaa_ 119 RQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKI 195 (299)
T ss_dssp HTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----------------------
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccC
Confidence 344567999999999999999999999998 99999999999999999999999999987654332221 122457
Q ss_pred cCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHH
Q 046010 369 TYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAEL 447 (523)
Q Consensus 369 t~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 447 (523)
|+.|+|||.+.++.++.++|||||||++|||++ |+.||...... .+.. ....+... ..+....
T Consensus 196 t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~----~i~~~~~~---------~~~~~~~ 259 (299)
T d1jpaa_ 196 PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVIN----AIEQDYRL---------PPPMDCP 259 (299)
T ss_dssp CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH----HHHTTCCC---------CCCTTCC
T ss_pred CccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCC---------CCCccch
Confidence 889999999999999999999999999999998 89998533211 1111 11121111 1112234
Q ss_pred HHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 448 LKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 448 ~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
..+.+|+.+||+.||++|||+.||++.|++.
T Consensus 260 ~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 260 SALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 5677899999999999999999999999764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.7e-33 Score=273.07 Aligned_cols=189 Identities=24% Similarity=0.367 Sum_probs=136.0
Q ss_pred eeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC
Q 046010 281 IAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE 360 (523)
Q Consensus 281 ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 360 (523)
+..|.+...+.......++|.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~- 168 (285)
T d1fmka3 93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 168 (285)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence 33454445555566678999999999999999999999998 99999999999999999999999999987643322
Q ss_pred ccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccC
Q 046010 361 SNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQ 440 (523)
Q Consensus 361 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 440 (523)
.......+|+.|+|||++.++.++.++||||||+++|||++|+.|+..... ....+. ....+.... .
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~----~i~~~~~~~-----~-- 235 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLD----QVERGYRMP-----C-- 235 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHH----HHHTTCCCC-----C--
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHHH----HHHhcCCCC-----C--
Confidence 223345789999999999999999999999999999999998777543221 111111 122211111 1
Q ss_pred CccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCCCCCCCCCC
Q 046010 441 SCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTVSLPQPTQP 488 (523)
Q Consensus 441 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~l~~p~~p 488 (523)
+.....++.+|+.+||+.||++|||+++|+++|+......+.+.+|
T Consensus 236 --~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p 281 (285)
T d1fmka3 236 --PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281 (285)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred --CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCC
Confidence 1122346778999999999999999999999999876554433333
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6e-33 Score=270.81 Aligned_cols=170 Identities=25% Similarity=0.387 Sum_probs=124.9
Q ss_pred ccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC-ccccceecc
Q 046010 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE-SNTSKVVGT 369 (523)
Q Consensus 291 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~gt 369 (523)
+......+++.++++++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........ .......||
T Consensus 100 ~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt 176 (283)
T d1mqba_ 100 LREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176 (283)
T ss_dssp HHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCC
T ss_pred hhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCC
Confidence 3456678999999999999999999999998 999999999999999999999999999876433222 223345678
Q ss_pred CCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 370 ~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
+.|+|||++.++.++.++|||||||++|||++|+.|+..... ...+ ......+... ..+......
T Consensus 177 ~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~~----~~~i~~~~~~---------~~~~~~~~~ 241 (283)
T d1mqba_ 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEV----MKAINDGFRL---------PTPMDCPSA 241 (283)
T ss_dssp GGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHH----HHHHHTTCCC---------CCCTTCBHH
T ss_pred ccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--HHHH----HHHHhccCCC---------CCchhhHHH
Confidence 999999999999999999999999999999997766532221 1111 2222222111 111223356
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+.+|+.+||+.||++|||+.||+++|++.
T Consensus 242 l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 242 IYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 78899999999999999999999999764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.1e-32 Score=263.79 Aligned_cols=176 Identities=24% Similarity=0.329 Sum_probs=131.8
Q ss_pred Eeeeccccc--cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccC
Q 046010 279 IWIAIGTTI--PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGG 356 (523)
Q Consensus 279 ~~ia~g~~~--~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 356 (523)
+|+.+.+|. .+.....+..+++.+++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.+..
T Consensus 92 ~~ivmEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 92 LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp EEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 455555444 1111233457999999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCc
Q 046010 357 NQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDP 436 (523)
Q Consensus 357 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (523)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ............. ...
T Consensus 169 ~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~~~~~~~~-~~~-- 237 (293)
T d1yhwa1 169 EQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGTP-ELQ-- 237 (293)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCSC-CCS--
T ss_pred cc--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH------HHHHHHHHhCCCC-CCC--
Confidence 22 233456799999999999999999999999999999999999999853221 1111222111111 110
Q ss_pred cccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 437 VLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 437 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+......+.+|+.+||+.||++|||+.|+++
T Consensus 238 -----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 238 -----NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -----SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -----CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01112245778999999999999999999864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.1e-32 Score=268.05 Aligned_cols=166 Identities=27% Similarity=0.341 Sum_probs=124.3
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
+..+++.+++.++.||++||.|||+++ ||||||||+|||++.++.+||+|||+++...............||+.|+|
T Consensus 128 ~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~A 204 (299)
T d1ywna1 128 KDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 204 (299)
T ss_dssp --CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCC
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccc
Confidence 456999999999999999999999998 99999999999999999999999999987654444444556689999999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHhCCC-CCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIISGKK-NSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~elltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||.+.+..++.++|||||||++|||++|.. ||...... . ........+...... .....++.+|
T Consensus 205 PE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--~----~~~~~~~~~~~~~~~---------~~~~~~l~~l 269 (299)
T d1ywna1 205 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--E----EFCRRLKEGTRMRAP---------DYTTPEMYQT 269 (299)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--H----HHHHHHHHTCCCCCC---------TTCCHHHHHH
T ss_pred hhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH--H----HHHHHHhcCCCCCCC---------ccCCHHHHHH
Confidence 999999999999999999999999999754 55422211 1 111222222222111 1123457789
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+.+||+.||++|||+.||++.|++.
T Consensus 270 i~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 270 MLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHHHHHH
Confidence 9999999999999999999999764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.4e-32 Score=260.20 Aligned_cols=172 Identities=24% Similarity=0.321 Sum_probs=132.5
Q ss_pred eEeeecccccc---ccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 278 AIWIAIGTTIP---TIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 278 ~~~ia~g~~~~---~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
..|+.+.+|.. .-+..+...+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~ 156 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 156 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred EEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeec
Confidence 34555555541 223456678999999999999999999999998 999999999999999999999999999865
Q ss_pred cCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCccccc
Q 046010 355 GGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELM 434 (523)
Q Consensus 355 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (523)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... . .......+....
T Consensus 157 ~~~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~-~~~~~i~~~~~~--- 222 (263)
T d2j4za1 157 PSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------Q-ETYKRISRVEFT--- 222 (263)
T ss_dssp CCC----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------H-HHHHHHHTTCCC---
T ss_pred CCC----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH------H-HHHHHHHcCCCC---
Confidence 422 22345789999999999999999999999999999999999999853221 1 111222222111
Q ss_pred CccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 435 DPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 435 ~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+.. .....+.+|+.+||+.||++|||++||++
T Consensus 223 ---~p~----~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 ---FPD----FVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ---CCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCc----cCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 111 12245678899999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.1e-32 Score=267.84 Aligned_cols=169 Identities=30% Similarity=0.380 Sum_probs=131.3
Q ss_pred ccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCc-cccceecc
Q 046010 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES-NTSKVVGT 369 (523)
Q Consensus 291 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~gt 369 (523)
+..+...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++......... ......||
T Consensus 97 ~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt 173 (277)
T d1xbba_ 97 YLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173 (277)
T ss_dssp HHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCC
T ss_pred HHhhccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCC
Confidence 3456678999999999999999999999998 9999999999999999999999999998765433222 23345688
Q ss_pred CCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 370 YGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 370 ~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
+.|+|||.+.+..++.++|||||||++|||++ |+.||...... . .......+...+. +.....
T Consensus 174 ~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~----~~~~i~~~~~~~~---------p~~~~~ 237 (277)
T d1xbba_ 174 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---E----VTAMLEKGERMGC---------PAGCPR 237 (277)
T ss_dssp GGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---H----HHHHHHTTCCCCC---------CTTCCH
T ss_pred ceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---H----HHHHHHcCCCCCC---------CcccCH
Confidence 99999999999999999999999999999998 89998532211 1 1222222222111 112234
Q ss_pred HHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 449 KCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
.+.+|+.+||+.||++|||+++|+++|+..
T Consensus 238 ~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 238 EMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 677899999999999999999999998753
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.2e-33 Score=266.91 Aligned_cols=168 Identities=29% Similarity=0.349 Sum_probs=119.6
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
...+..++++.++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++........ ......||+.
T Consensus 92 ~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~gt~~ 167 (263)
T d1sm2a_ 92 RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVK 167 (263)
T ss_dssp HTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------------------CTT
T ss_pred hccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-eecceecCcc
Confidence 345577999999999999999999999998 999999999999999999999999999876433222 2334578999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||++.+..++.++|||||||++|||++++.|+.... ....+.. ....+... .. +.....++.
T Consensus 168 y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~--~~~~~~~----~i~~~~~~--~~-------p~~~~~~l~ 232 (263)
T d1sm2a_ 168 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVE----DISTGFRL--YK-------PRLASTHVY 232 (263)
T ss_dssp SCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC--CHHHHHH----HHHHTCCC--CC-------CTTSCHHHH
T ss_pred cCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC--CHHHHHH----HHHhcCCC--CC-------ccccCHHHH
Confidence 999999999999999999999999999999655542211 1111211 11111111 11 111234677
Q ss_pred HHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 452 HIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+|+.+||+.||++|||++||++.|++.
T Consensus 233 ~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 233 QIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 899999999999999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.8e-31 Score=258.00 Aligned_cols=176 Identities=23% Similarity=0.325 Sum_probs=130.3
Q ss_pred eEeeeccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeC-CCCCeeEecccccee
Q 046010 278 AIWIAIGTTI---PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLD-HEMNPKISDFGMARI 353 (523)
Q Consensus 278 ~~~ia~g~~~---~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~-~~~~~kL~Dfg~a~~ 353 (523)
.+|+.+.+|- +.-+..+...+++..++.++.||++||+|||+++ .+|+||||||+|||++ +++.+||+|||+++.
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 4555555554 2234456678999999999999999999999985 3599999999999996 578999999999976
Q ss_pred ccCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccc
Q 046010 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALEL 433 (523)
Q Consensus 354 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (523)
... .......||+.|+|||++.+ .++.++|||||||++|||++|+.||...... .........+.....
T Consensus 165 ~~~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~------~~~~~~i~~~~~~~~ 233 (270)
T d1t4ha_ 165 KRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPAS 233 (270)
T ss_dssp CCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGG
T ss_pred ccC----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH------HHHHHHHHcCCCCcc
Confidence 422 12335679999999998865 6999999999999999999999998532211 111222222221111
Q ss_pred cCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 434 MDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 434 ~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
++ .. ...++.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~----~~----~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 FD----KV----AIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GG----GC----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cC----cc----CCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11 11 1234678899999999999999999976
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.3e-32 Score=266.53 Aligned_cols=168 Identities=26% Similarity=0.341 Sum_probs=133.0
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC-ccccceeccC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE-SNTSKVVGTY 370 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~gt~ 370 (523)
...+..+++.+++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++........ .......||+
T Consensus 100 ~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~ 176 (285)
T d1u59a_ 100 VGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176 (285)
T ss_dssp TTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCG
T ss_pred hccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCc
Confidence 445678999999999999999999999998 999999999999999999999999999977543322 2233456789
Q ss_pred CCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 371 GYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 371 ~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
.|+|||++.++.++.++|||||||++|||++ |+.||...... .+ ......+...+. +...+..
T Consensus 177 ~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~----~~~i~~~~~~~~---------p~~~~~~ 240 (285)
T d1u59a_ 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EV----MAFIEQGKRMEC---------PPECPPE 240 (285)
T ss_dssp GGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HH----HHHHHTTCCCCC---------CTTCCHH
T ss_pred cccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HH----HHHHHcCCCCCC---------CCcCCHH
Confidence 9999999999999999999999999999998 89998643211 11 122222222221 1122346
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 241 l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 241 LYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 77899999999999999999999999754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.8e-32 Score=269.47 Aligned_cols=169 Identities=25% Similarity=0.378 Sum_probs=129.6
Q ss_pred ccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccC
Q 046010 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTY 370 (523)
Q Consensus 291 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~ 370 (523)
+..+...+++..+++++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...............||+
T Consensus 101 ~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 177 (317)
T d1xkka_ 101 VREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177 (317)
T ss_dssp HHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCT
T ss_pred ccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCc
Confidence 3455678999999999999999999999998 9999999999999999999999999998775544444444567899
Q ss_pred CCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 371 GYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 371 ~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
.|+|||.+.++.++.++|||||||++|||+| |+.||...... .+... ...+.... .+......
T Consensus 178 ~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~~~~~----i~~~~~~~---------~p~~~~~~ 241 (317)
T d1xkka_ 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSI----LEKGERLP---------QPPICTID 241 (317)
T ss_dssp TTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---GHHHH----HHHTCCCC---------CCTTBCHH
T ss_pred cccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---HHHHH----HHcCCCCC---------CCcccCHH
Confidence 9999999999999999999999999999998 77887533221 12211 11221111 11122346
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+.+|+.+||+.||++|||+.||++.|...
T Consensus 242 ~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 242 VYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 77899999999999999999999988654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.4e-32 Score=264.18 Aligned_cols=163 Identities=28% Similarity=0.311 Sum_probs=116.6
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCC--CcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSR--LKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTY 370 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~--~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~ 370 (523)
..+..+++..++.++.||+.||+|||+++. .+|+||||||+|||++.++.+||+|||+++...... .......||+
T Consensus 101 ~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~ 178 (269)
T d2java1 101 KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTP 178 (269)
T ss_dssp HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-------------CCC
T ss_pred ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC--CccccCCCCc
Confidence 345679999999999999999999998641 249999999999999999999999999998764322 2233567899
Q ss_pred CCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 371 GYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 371 ~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
.|+|||++.+..++.++|||||||++|||++|+.||..... ..+ ......+....+ ... ....+
T Consensus 179 ~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~~~----~~~i~~~~~~~~-----~~~----~s~~l 242 (269)
T d2java1 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KEL----AGKIREGKFRRI-----PYR----YSDEL 242 (269)
T ss_dssp SCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHH----HHHHHHTCCCCC-----CTT----SCHHH
T ss_pred ccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---HHH----HHHHHcCCCCCC-----Ccc----cCHHH
Confidence 99999999999999999999999999999999999853221 111 122222222211 111 12357
Q ss_pred HHHhhhcccCCCCCCCCHHHHHH
Q 046010 451 IHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+|+.+||+.||++|||+.||++
T Consensus 243 ~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 243 NEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHcCCChhHCcCHHHHHh
Confidence 78899999999999999999874
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.8e-31 Score=259.04 Aligned_cols=175 Identities=20% Similarity=0.312 Sum_probs=131.1
Q ss_pred eEeeecccccc---ccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 278 AIWIAIGTTIP---TIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 278 ~~~ia~g~~~~---~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
.+|+.+.+|-. .-+..+.+.+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+
T Consensus 82 ~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 158 (288)
T d1uu3a_ 82 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL 158 (288)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceec
Confidence 45666666551 224566778999999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCccccc
Q 046010 355 GGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELM 434 (523)
Q Consensus 355 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (523)
.............||+.|+|||++.+..++.++|||||||++|||++|+.||.... .... ......... .
T Consensus 159 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~~~~-~~~i~~~~~-~-- 228 (288)
T d1uu3a_ 159 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN------EYLI-FQKIIKLEY-D-- 228 (288)
T ss_dssp C----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHH-HHHHHTTCC-C--
T ss_pred ccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC------HHHH-HHHHHcCCC-C--
Confidence 54433334445679999999999999999999999999999999999999985321 1111 111122211 1
Q ss_pred CccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 046010 435 DPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVA 472 (523)
Q Consensus 435 ~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~ 472 (523)
+.. .....+.+|+.+||+.||++|||++|++
T Consensus 229 ---~p~----~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 229 ---FPE----KFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp ---CCT----TCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred ---CCc----cCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 111 1223567899999999999999999863
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.4e-31 Score=265.83 Aligned_cols=123 Identities=28% Similarity=0.415 Sum_probs=102.3
Q ss_pred Eeeeccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhc-CCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 279 IWIAIGTTI---PTIYSTRRAQLDWKRRISIINGIARGLLYLHED-SRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 279 ~~ia~g~~~---~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
+++.+.++. +.-+..+...+++..++.++.||++||.|||++ + |+||||||+|||++.++.+||+|||+++..
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 455555444 122234567899999999999999999999974 7 999999999999999999999999999865
Q ss_pred cCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 046010 355 GGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGF 408 (523)
Q Consensus 355 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~ 408 (523)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 156 ~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 156 IDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp HHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred CCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 321 22346899999999999999999999999999999999999999964
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.4e-31 Score=258.55 Aligned_cols=177 Identities=23% Similarity=0.298 Sum_probs=129.9
Q ss_pred eEeeeccccc----cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 278 AIWIAIGTTI----PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 278 ~~~ia~g~~~----~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
.+++.+.+|. ..+....+..+++.++..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 83 ~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~ 159 (288)
T d2jfla1 83 NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAK 159 (288)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhc
Confidence 3455555544 1122344567999999999999999999999998 99999999999999999999999999976
Q ss_pred ccCCCCCccccceeccCCCCchhhhc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcC
Q 046010 354 FGGNQNESNTSKVVGTYGYMAPEYAL-----GGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNG 428 (523)
Q Consensus 354 ~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 428 (523)
.... ........||+.|+|||++. +..++.++|||||||++|||++|+.||...... .... ... ..
T Consensus 160 ~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~---~~~~---~i~-~~ 230 (288)
T d2jfla1 160 NTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---RVLL---KIA-KS 230 (288)
T ss_dssp CHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG---GHHH---HHH-HS
T ss_pred cCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH---HHHH---HHH-cC
Confidence 4311 11233567999999999984 455889999999999999999999998543221 1111 111 11
Q ss_pred CcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 429 EALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 429 ~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
....+.. +......+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~-------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 231 EPPTLAQ-------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CCCCCSS-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCc-------cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111 1122346778899999999999999999876
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=5.6e-32 Score=266.29 Aligned_cols=167 Identities=26% Similarity=0.353 Sum_probs=128.8
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
....+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++...............+++.|+
T Consensus 133 ~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~ 209 (301)
T d1lufa_ 133 GPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWM 209 (301)
T ss_dssp --CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGC
T ss_pred CCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcC
Confidence 3456999999999999999999999998 9999999999999999999999999998664333333344567888999
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHhCCC-CCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIISGKK-NSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIH 452 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~elltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 452 (523)
|||.+.+..++.++|||||||++|||++|.. ||..... ..+. .....+..... +.....++.+
T Consensus 210 aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~---~e~~----~~v~~~~~~~~---------p~~~~~~~~~ 273 (301)
T d1lufa_ 210 PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH---EEVI----YYVRDGNILAC---------PENCPLELYN 273 (301)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHH----HHHHTTCCCCC---------CTTCCHHHHH
T ss_pred CHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH---HHHH----HHHHcCCCCCC---------CccchHHHHH
Confidence 9999999999999999999999999999964 5543221 1111 12223322221 1122346788
Q ss_pred HhhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 453 IGLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 453 li~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
|+.+||+.||++|||+.||+++|++..
T Consensus 274 li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 274 LMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 999999999999999999999998764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.5e-31 Score=255.42 Aligned_cols=166 Identities=23% Similarity=0.339 Sum_probs=130.5
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
......+++..+++++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++....... .......+|+.
T Consensus 91 ~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~t~~ 166 (258)
T d1k2pa_ 91 REMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVR 166 (258)
T ss_dssp HSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CCCCCSCCCGG
T ss_pred hccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc-eeecccCCCCC
Confidence 455667999999999999999999999998 99999999999999999999999999987643322 22334568899
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
|+|||.+.+..++.++||||||+++|||++ |+.||...... .+ ......+.... . +......+
T Consensus 167 y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~----~~~i~~~~~~~--~-------p~~~~~~l 230 (258)
T d1k2pa_ 167 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ET----AEHIAQGLRLY--R-------PHLASEKV 230 (258)
T ss_dssp GCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HH----HHHHHTTCCCC--C-------CTTCCHHH
T ss_pred cCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HH----HHHHHhCCCCC--C-------cccccHHH
Confidence 999999999999999999999999999998 78888543221 11 11222221111 1 11223467
Q ss_pred HHHhhhcccCCCCCCCCHHHHHHHhcc
Q 046010 451 IHIGLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
.+|+.+||+.||++|||++||++.|..
T Consensus 231 ~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 231 YTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 789999999999999999999999854
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1e-31 Score=264.06 Aligned_cols=165 Identities=30% Similarity=0.353 Sum_probs=133.2
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
...+++.+++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++...............+++.|+|
T Consensus 129 ~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 205 (299)
T d1fgka_ 129 EEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMA 205 (299)
T ss_dssp CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSC
T ss_pred cccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhh
Confidence 456999999999999999999999998 99999999999999999999999999998765544444556778999999
Q ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 375 PEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 375 PE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
||.+.++.++.++||||||+++|||++ |..||..... ......+..+...+.. ......+.+|
T Consensus 206 PE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~-------~~~~~~i~~~~~~~~p---------~~~~~~l~~l 269 (299)
T d1fgka_ 206 PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-------EELFKLLKEGHRMDKP---------SNCTNELYMM 269 (299)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHHHTTCCCCCC---------SSCCHHHHHH
T ss_pred hhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-------HHHHHHHHcCCCCCCC---------ccchHHHHHH
Confidence 999999999999999999999999998 6777643221 1222333333222211 1123457789
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+.+||+.||++|||+.||+++|++.
T Consensus 270 i~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 270 MRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHccCCHhHCcCHHHHHHHHHHH
Confidence 9999999999999999999999765
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=5e-31 Score=259.86 Aligned_cols=171 Identities=27% Similarity=0.388 Sum_probs=130.5
Q ss_pred Eeeeccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceecc
Q 046010 279 IWIAIGTTI---PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFG 355 (523)
Q Consensus 279 ~~ia~g~~~---~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 355 (523)
.|+.+.+|. ...+...+..+++.+++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp EEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccC
Confidence 455555554 2334566778999999999999999999999999 9999999999999999999999999998653
Q ss_pred CCCCCccccceeccCCCCchhhhcC---CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCccc
Q 046010 356 GNQNESNTSKVVGTYGYMAPEYALG---GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALE 432 (523)
Q Consensus 356 ~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (523)
. .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ........... ....
T Consensus 167 ~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~------~~~~~~~i~~~-~~~~ 233 (309)
T d1u5ra_ 167 P------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQN-ESPA 233 (309)
T ss_dssp S------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHS-CCCC
T ss_pred C------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC------HHHHHHHHHhC-CCCC
Confidence 2 234579999999999864 468999999999999999999999985321 11111222211 1111
Q ss_pred ccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 433 LMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 433 ~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.... .....+.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~--------~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 234 LQSG--------HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CSCT--------TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCC--------CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1111 11235778899999999999999999976
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1e-30 Score=253.37 Aligned_cols=168 Identities=24% Similarity=0.290 Sum_probs=129.3
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCc-cccceeccC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES-NTSKVVGTY 370 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~gt~ 370 (523)
..+...+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++......... ......++.
T Consensus 102 ~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~ 178 (273)
T d1u46a_ 102 RKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178 (273)
T ss_dssp HHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCG
T ss_pred hcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCc
Confidence 445667999999999999999999999998 9999999999999999999999999999875443322 223445778
Q ss_pred CCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHH
Q 046010 371 GYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLK 449 (523)
Q Consensus 371 ~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 449 (523)
.|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+........+...+. +......
T Consensus 179 ~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~------~~~~~~~i~~~~~~~~~---------~~~~~~~ 243 (273)
T d1u46a_ 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN------GSQILHKIDKEGERLPR---------PEDCPQD 243 (273)
T ss_dssp GGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHTSCCCCCC---------CTTCCHH
T ss_pred ccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC------HHHHHHHHHhCCCCCCC---------cccccHH
Confidence 9999999999999999999999999999998 899985322 11222222222221111 1112245
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHHHhcc
Q 046010 450 CIHIGLLCVQEDPADRPNMSSVAVMLAS 477 (523)
Q Consensus 450 ~~~li~~cl~~dP~~RPs~~ei~~~L~~ 477 (523)
+.+|+.+||+.||++|||+.||+++|++
T Consensus 244 l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 244 IYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 7789999999999999999999999975
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.7e-31 Score=257.76 Aligned_cols=167 Identities=27% Similarity=0.338 Sum_probs=121.1
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
......+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++....... .......+|+.
T Consensus 99 ~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~-~~~~~~~gt~~ 174 (273)
T d1mp8a_ 99 QVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIK 174 (273)
T ss_dssp HHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------------------CCGG
T ss_pred hccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCCcc-eeccceecCcc
Confidence 455678999999999999999999999998 99999999999999999999999999987543222 22334567899
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
|+|||.+.+..++.++|||||||++|||++ |..||...... .+... ..++..... +......+
T Consensus 175 y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~----i~~~~~~~~---------~~~~~~~~ 238 (273)
T d1mp8a_ 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGR----IENGERLPM---------PPNCPPTL 238 (273)
T ss_dssp GCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH----HHTTCCCCC---------CTTCCHHH
T ss_pred cchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHHH----HHcCCCCCC---------CCCCCHHH
Confidence 999999999999999999999999999998 78887543221 22221 222222111 11223467
Q ss_pred HHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 451 IHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
.+|+.+||+.||++|||+.||++.|+..
T Consensus 239 ~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 239 YSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 7899999999999999999999998764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.2e-31 Score=255.13 Aligned_cols=175 Identities=25% Similarity=0.305 Sum_probs=129.8
Q ss_pred eeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCC
Q 046010 280 WIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQN 359 (523)
Q Consensus 280 ~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 359 (523)
|+..|.+..++.......+++..+++|+.||++||.|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC--
Confidence 444555556666566667999999999999999999999998 999999999999999999999999999865322
Q ss_pred CccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcccccccchHHHHHHhhhcCCcccccCccc
Q 046010 360 ESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIIS-GKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVL 438 (523)
Q Consensus 360 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 438 (523)
.....++..|+|||++.++.++.++||||||+++|||++ |+.||..... ..+... ..++...+.
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~----i~~~~~~~~----- 221 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPR----VEKGYKMDA----- 221 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHH----HTTTCCCCC-----
T ss_pred ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHHH----HHcCCCCCC-----
Confidence 223467889999999999999999999999999999998 6776643221 122221 122222211
Q ss_pred cCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 439 KQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 439 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+......+.+|+.+||+.||++|||+.||+++|++.
T Consensus 222 ----~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 222 ----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 112234677899999999999999999999999764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=3.5e-30 Score=253.62 Aligned_cols=181 Identities=20% Similarity=0.217 Sum_probs=123.8
Q ss_pred eEeeeccccc-cc--cccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeC---CCCCeeEeccccc
Q 046010 278 AIWIAIGTTI-PT--IYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLD---HEMNPKISDFGMA 351 (523)
Q Consensus 278 ~~~ia~g~~~-~~--~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~---~~~~~kL~Dfg~a 351 (523)
.+|+.+.+|. .. -+..++..+++.++..++.||+.||+|||+++ |+||||||+||++. +++.+||+|||++
T Consensus 81 ~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 81 HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred EEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEecccee
Confidence 4566666554 11 23456678999999999999999999999998 99999999999995 5788999999999
Q ss_pred eeccCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcc
Q 046010 352 RIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEAL 431 (523)
Q Consensus 352 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (523)
+...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ... ..........
T Consensus 158 ~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~-~~~i~~~~~~ 227 (307)
T d1a06a_ 158 KMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND------AKL-FEQILKAEYE 227 (307)
T ss_dssp ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHH-HHHHHTTCCC
T ss_pred EEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH------HHH-HHHHhccCCC
Confidence 8654222 23346799999999999999999999999999999999999999853221 111 1112221111
Q ss_pred cccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH--Hhcc
Q 046010 432 ELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV--MLAS 477 (523)
Q Consensus 432 ~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~ 477 (523)
. .... .......+.+|+.+||+.||++|||++|+++ +|++
T Consensus 228 -~-~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 228 -F-DSPY----WDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp -C-CTTT----TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred -C-CCcc----ccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 0 0001 1112245778999999999999999999988 4654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.8e-30 Score=255.20 Aligned_cols=180 Identities=21% Similarity=0.203 Sum_probs=129.6
Q ss_pred ccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccC
Q 046010 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTY 370 (523)
Q Consensus 291 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~ 370 (523)
+...+..+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .......||+
T Consensus 90 ~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~~~~~~~gt~ 164 (299)
T d1ua2a_ 90 IKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYTHQVVTR 164 (299)
T ss_dssp HTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--CCCCCSCCCC
T ss_pred hhhcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc--ccccceecCh
Confidence 4556778999999999999999999999999 9999999999999999999999999998654322 2233457899
Q ss_pred CCCchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCccccc---------CccccC
Q 046010 371 GYMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELM---------DPVLKQ 440 (523)
Q Consensus 371 ~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~l~~ 440 (523)
.|+|||++... .++.++|||||||++|||++|+.||...... ..+....+........... ......
T Consensus 165 ~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~---~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (299)
T d1ua2a_ 165 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---DQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241 (299)
T ss_dssp TTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCC
T ss_pred hhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH---HHHHHHHHhcCCCChhhccchhccchhhhhccCC
Confidence 99999998754 5799999999999999999999998532221 1111111111110000000 000000
Q ss_pred CccH-----HHHHHHHHHhhhcccCCCCCCCCHHHHHH--HhccC
Q 046010 441 SCMA-----AELLKCIHIGLLCVQEDPADRPNMSSVAV--MLASD 478 (523)
Q Consensus 441 ~~~~-----~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~~ 478 (523)
..+. .....+++|+.+||+.||++|||++|+++ +|++.
T Consensus 242 ~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0111 11246788999999999999999999986 56543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.5e-30 Score=257.78 Aligned_cols=181 Identities=17% Similarity=0.169 Sum_probs=132.4
Q ss_pred eEeeeccccc-----cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC---CCCeeEeccc
Q 046010 278 AIWIAIGTTI-----PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH---EMNPKISDFG 349 (523)
Q Consensus 278 ~~~ia~g~~~-----~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~---~~~~kL~Dfg 349 (523)
.+|+.+.+|- .++.......+++.+++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccc
Confidence 4566655554 3343444567999999999999999999999999 999999999999986 4579999999
Q ss_pred cceeccCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCC
Q 046010 350 MARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGE 429 (523)
Q Consensus 350 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 429 (523)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ............
T Consensus 160 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~~~~~i~~~~ 233 (335)
T d2ozaa1 160 FAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKTRIRMGQ 233 (335)
T ss_dssp TCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS
T ss_pred eeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---HHHHHHHHhcCC
Confidence 998764332 23356799999999999999999999999999999999999999853322111 110011111100
Q ss_pred cccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 430 ALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 430 ~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
. .+...........+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 234 Y------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp S------SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred C------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 0111111122356788999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.96 E-value=1.4e-29 Score=253.94 Aligned_cols=185 Identities=18% Similarity=0.212 Sum_probs=136.4
Q ss_pred eEeeeccccc-cc---cccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeC--CCCCeeEeccccc
Q 046010 278 AIWIAIGTTI-PT---IYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLD--HEMNPKISDFGMA 351 (523)
Q Consensus 278 ~~~ia~g~~~-~~---~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~--~~~~~kL~Dfg~a 351 (523)
.+|+.+.+|- .. .+..++.+|++.+++.|+.||+.||+|||++| |+||||||+|||++ .++.+||+|||++
T Consensus 100 ~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla 176 (352)
T d1koba_ 100 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLA 176 (352)
T ss_dssp EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred EEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccc
Confidence 3455655554 11 23445567999999999999999999999999 99999999999998 5789999999999
Q ss_pred eeccCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcc
Q 046010 352 RIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEAL 431 (523)
Q Consensus 352 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (523)
+..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....... ......
T Consensus 177 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i-~~~~~~ 246 (352)
T d1koba_ 177 TKLNPD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNV-KRCDWE 246 (352)
T ss_dssp EECCTT---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHH-HHCCCC
T ss_pred eecCCC---CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH------HHHHHHH-HhCCCC
Confidence 886432 223456789999999999999999999999999999999999999853221 1111111 111110
Q ss_pred cccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH--HhccCCCC
Q 046010 432 ELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV--MLASDTVS 481 (523)
Q Consensus 432 ~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~~~~~ 481 (523)
. . ..........+.+|+.+||+.||.+|||+.|+++ +|++....
T Consensus 247 -~-~----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~~ 292 (352)
T d1koba_ 247 -F-D----EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 292 (352)
T ss_dssp -C-C----SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTT
T ss_pred -C-C----cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcch
Confidence 0 0 0011112245678999999999999999999987 46654333
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.96 E-value=1.1e-29 Score=246.74 Aligned_cols=184 Identities=22% Similarity=0.337 Sum_probs=131.2
Q ss_pred eEeeeccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 278 AIWIAIGTTI---PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 278 ~~~ia~g~~~---~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
..|+.+.+|. +.-+..+.+.+++.+++.++.||++||+|||+++ |+||||||+|||++.++..+|+|||.+...
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhh
Confidence 4566665555 1224556678999999999999999999999998 999999999999999999999999998765
Q ss_pred cCCCC-CccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccc
Q 046010 355 GGNQN-ESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALEL 433 (523)
Q Consensus 355 ~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (523)
..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... .................
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~------~~~~~~~~~~~~~~~~~ 235 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS------PVSVAYQHVREDPIPPS 235 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCCCCCGG
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC------HHHHHHHHHhcCCCCCc
Confidence 33222 223345679999999999999999999999999999999999999985321 12222223222221110
Q ss_pred cCccccCCccHHHHHHHHHHhhhcccCCCCCCC-CHHHHHHHhcc
Q 046010 434 MDPVLKQSCMAAELLKCIHIGLLCVQEDPADRP-NMSSVAVMLAS 477 (523)
Q Consensus 434 ~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RP-s~~ei~~~L~~ 477 (523)
.... .....+.+++.+||+.||++|| |++++++.|.+
T Consensus 236 ---~~~~----~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 236 ---ARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp ---GTSS----SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ---hhcc----CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 0111 1224677889999999999999 89999888764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.96 E-value=2.1e-29 Score=252.31 Aligned_cols=166 Identities=20% Similarity=0.262 Sum_probs=126.8
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC--CCCeeEeccccceeccCCCCCccccceeccC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH--EMNPKISDFGMARIFGGNQNESNTSKVVGTY 370 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~--~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~ 370 (523)
.+...+++.+++.++.||+.||.|||+++ ||||||||+|||++. ++.+||+|||+++.+... .......||+
T Consensus 116 ~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~---~~~~~~~gT~ 189 (350)
T d1koaa2 116 DEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK---QSVKVTTGTA 189 (350)
T ss_dssp CTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT---SCEEEECSCT
T ss_pred hhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc---cccceecCcc
Confidence 45567999999999999999999999999 999999999999964 578999999999876432 2234567899
Q ss_pred CCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHH
Q 046010 371 GYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKC 450 (523)
Q Consensus 371 ~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 450 (523)
.|+|||++.+..++.++|||||||++|+|++|+.||..... .... .. ....... . ..... ......+
T Consensus 190 ~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~---~~-i~~~~~~-~-~~~~~----~~~s~~~ 256 (350)
T d1koaa2 190 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETL---RN-VKSCDWN-M-DDSAF----SGISEDG 256 (350)
T ss_dssp TTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HH-HHHTCCC-S-CCGGG----GGCCHHH
T ss_pred cccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH---HHHH---HH-HHhCCCC-C-Ccccc----cCCCHHH
Confidence 99999999999999999999999999999999999853211 1111 11 1111110 0 00010 1112356
Q ss_pred HHHhhhcccCCCCCCCCHHHHHHH--hcc
Q 046010 451 IHIGLLCVQEDPADRPNMSSVAVM--LAS 477 (523)
Q Consensus 451 ~~li~~cl~~dP~~RPs~~ei~~~--L~~ 477 (523)
.+|+.+||+.||++|||++|+++. |..
T Consensus 257 ~~li~~~L~~dP~~R~t~~eil~hp~~~~ 285 (350)
T d1koaa2 257 KDFIRKLLLADPNTRMTIHQALEHPWLTP 285 (350)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHHSTTTSC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 788999999999999999999883 544
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2e-30 Score=256.02 Aligned_cols=171 Identities=25% Similarity=0.306 Sum_probs=131.5
Q ss_pred ccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCc--cccceec
Q 046010 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES--NTSKVVG 368 (523)
Q Consensus 291 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~--~~~~~~g 368 (523)
+......+++..++.++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++......... ......|
T Consensus 120 ~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~g 196 (311)
T d1r0pa_ 120 IRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 196 (311)
T ss_dssp HHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSC
T ss_pred hccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccc
Confidence 4556667889999999999999999999998 9999999999999999999999999998765432221 2233568
Q ss_pred cCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 369 TYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 369 t~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
|..|+|||.+..+.++.++||||||+++|||++|+.||...... ....... ..+.... . +.....
T Consensus 197 t~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i----~~g~~~~--~-------p~~~~~ 261 (311)
T d1r0pa_ 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYL----LQGRRLL--Q-------PEYCPD 261 (311)
T ss_dssp CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH----HTTCCCC--C-------CTTCCH
T ss_pred cccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHHH----HcCCCCC--C-------cccCcH
Confidence 89999999999999999999999999999999988887532221 1122111 1221111 1 111234
Q ss_pred HHHHHhhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 449 KCIHIGLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
.+.+|+.+||+.||++||++.||++.|++..
T Consensus 262 ~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 262 PLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 6778999999999999999999999998763
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=8e-30 Score=250.63 Aligned_cols=195 Identities=16% Similarity=0.177 Sum_probs=138.5
Q ss_pred ccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC---CCCeeEeccccceeccCCCCCc----
Q 046010 289 TIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH---EMNPKISDFGMARIFGGNQNES---- 361 (523)
Q Consensus 289 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~---~~~~kL~Dfg~a~~~~~~~~~~---- 361 (523)
.........+++..++.++.||+.||+|||+++ |+||||||+|||++. +..+||+|||+++.+.......
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~ 167 (299)
T d1ckia_ 91 DLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167 (299)
T ss_dssp HHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCC
T ss_pred hhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccccccceec
Confidence 334455678999999999999999999999999 999999999999864 4579999999999875433221
Q ss_pred -cccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccC
Q 046010 362 -NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQ 440 (523)
Q Consensus 362 -~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 440 (523)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||........................ +.+..
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 242 (299)
T d1ckia_ 168 RENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-----EVLCK 242 (299)
T ss_dssp CBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH-----HHHTT
T ss_pred cccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh-----hHhcc
Confidence 233567999999999999999999999999999999999999999654433322222111111111110 01111
Q ss_pred CccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCCCCCCCCCCCcccccc
Q 046010 441 SCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTVSLPQPTQPAFSVGRI 495 (523)
Q Consensus 441 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~l~~p~~p~~~~~~~ 495 (523)
..+..+.+|+..||+.||++||++++|.+.|+...........-+|.+...
T Consensus 243 ----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~~ 293 (299)
T d1ckia_ 243 ----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 293 (299)
T ss_dssp ----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHHG
T ss_pred ----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCchhh
Confidence 112457788999999999999999999998886533333333334555443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.9e-30 Score=256.51 Aligned_cols=168 Identities=27% Similarity=0.389 Sum_probs=130.9
Q ss_pred cccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCC
Q 046010 294 RRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYM 373 (523)
Q Consensus 294 ~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 373 (523)
....+++..++.++.||++||+|||+++ ++||||||+||+++.++.+||+|||.++...............||+.|+
T Consensus 138 ~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~ 214 (311)
T d1t46a_ 138 DELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWM 214 (311)
T ss_dssp --CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGC
T ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHc
Confidence 4457999999999999999999999998 9999999999999999999999999999876554444555678899999
Q ss_pred chhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHH
Q 046010 374 APEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHI 453 (523)
Q Consensus 374 aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 453 (523)
|||.+.++.++.++||||||+++|||++++.|+...... ... .+.....+.... .+......+.+|
T Consensus 215 aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~--~~~---~~~~i~~~~~~~---------~~~~~~~~l~~L 280 (311)
T d1t46a_ 215 APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV--DSK---FYKMIKEGFRML---------SPEHAPAEMYDI 280 (311)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS--SHH---HHHHHHHTCCCC---------CCTTSCHHHHHH
T ss_pred CHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH--HHH---HHHHHhcCCCCC---------CcccccHHHHHH
Confidence 999999999999999999999999999965554322211 111 112222211111 111223467889
Q ss_pred hhhcccCCCCCCCCHHHHHHHhccC
Q 046010 454 GLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 454 i~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
+.+||+.||++|||+.||+++|++.
T Consensus 281 i~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 281 MKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHHHHHh
Confidence 9999999999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.96 E-value=2.4e-29 Score=252.05 Aligned_cols=157 Identities=22% Similarity=0.221 Sum_probs=125.0
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCC
Q 046010 292 STRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYG 371 (523)
Q Consensus 292 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~ 371 (523)
..+.+.+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++.... ......||+.
T Consensus 132 l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~-----~~~~~~Gt~~ 203 (350)
T d1rdqe_ 132 LRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPE 203 (350)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS-----CBCCCEECGG
T ss_pred HhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc-----ccccccCccc
Confidence 455668999999999999999999999998 99999999999999999999999999987642 2234679999
Q ss_pred CCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 372 YMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 372 y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
|+|||++.+..++.++|||||||++|||++|+.||.... ......... ..... . .. .....+.
T Consensus 204 Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~-~~~~~-~-----p~----~~s~~~~ 266 (350)
T d1rdqe_ 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEKIV-SGKVR-F-----PS----HFSSDLK 266 (350)
T ss_dssp GCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHH-HCCCC-C-----CT----TCCHHHH
T ss_pred cCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC------HHHHHHHHh-cCCCC-C-----Cc----cCCHHHH
Confidence 999999999999999999999999999999999985321 111111111 11110 0 11 1123567
Q ss_pred HHhhhcccCCCCCCC-----CHHHHHH
Q 046010 452 HIGLLCVQEDPADRP-----NMSSVAV 473 (523)
Q Consensus 452 ~li~~cl~~dP~~RP-----s~~ei~~ 473 (523)
+|+.+||+.||.+|+ |++||++
T Consensus 267 ~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 267 DLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHHhhhCHHhccccccccHHHHHc
Confidence 889999999999994 8999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.5e-29 Score=249.38 Aligned_cols=187 Identities=21% Similarity=0.230 Sum_probs=133.5
Q ss_pred eEeeeccccc----cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 278 AIWIAIGTTI----PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 278 ~~~ia~g~~~----~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
.+++.+.++. .+........+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 89 KLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp EEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred eEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 4455554444 2333556677999999999999999999999998 99999999999999999999999999876
Q ss_pred ccCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCccc-
Q 046010 354 FGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALE- 432 (523)
Q Consensus 354 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 432 (523)
.. .........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+..............
T Consensus 166 ~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 166 YS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCGGGS
T ss_pred hc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH---HHHHHHHHhhCCCchhcc
Confidence 43 222344678999999999999999999999999999999999999998533211 11111111110000000
Q ss_pred ---------ccCccc---cCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 433 ---------LMDPVL---KQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 433 ---------~~~~~l---~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
...... ...........+.+|+.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000 00001112245678899999999999999999976
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.6e-29 Score=250.19 Aligned_cols=174 Identities=21% Similarity=0.241 Sum_probs=132.6
Q ss_pred eEeeeccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 278 AIWIAIGTTI---PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 278 ~~~ia~g~~~---~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
.+++.+.+|- +.-+..++..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred ccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccc
Confidence 3455544444 2334667788999999999999999999999999 999999999999999999999999999865
Q ss_pred cCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCccccc
Q 046010 355 GGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELM 434 (523)
Q Consensus 355 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (523)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+. ........ .+
T Consensus 156 ~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~---~~~~----~~i~~~~~-~~- 224 (337)
T d1o6la_ 156 ISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLF----ELILMEEI-RF- 224 (337)
T ss_dssp CCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH----HHHHHCCC-CC-
T ss_pred ccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH---HHHH----HHHhcCCC-CC-
Confidence 3222 233457899999999999999999999999999999999999999853221 1111 11222111 11
Q ss_pred CccccCCccHHHHHHHHHHhhhcccCCCCCCCC-----HHHHHH
Q 046010 435 DPVLKQSCMAAELLKCIHIGLLCVQEDPADRPN-----MSSVAV 473 (523)
Q Consensus 435 ~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~ei~~ 473 (523)
... ....+.+|+.+||+.||++||+ +.||++
T Consensus 225 ----p~~----~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 225 ----PRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ----CTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----Ccc----CCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 111 1235678999999999999995 777765
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.96 E-value=9e-30 Score=256.57 Aligned_cols=175 Identities=23% Similarity=0.219 Sum_probs=130.5
Q ss_pred eEeeeccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 278 AIWIAIGTTI---PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 278 ~~~ia~g~~~---~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
.+|+.+.+|. +.-+..++..+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++.+
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 3455555554 1223456778999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCccccceeccCCCCchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccc
Q 046010 355 GGNQNESNTSKVVGTYGYMAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALEL 433 (523)
Q Consensus 355 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (523)
.... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||....... ........ .... ..
T Consensus 158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~~~~~-~~~~-~~- 227 (364)
T d1omwa3 158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEIDRMT-LTMA-VE- 227 (364)
T ss_dssp SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC---HHHHHHHS-SSCC-CC-
T ss_pred CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhc-ccCC-CC-
Confidence 4332 334579999999999975 468999999999999999999999986433221 11111111 1110 00
Q ss_pred cCccccCCccHHHHHHHHHHhhhcccCCCCCCCC-----HHHHHH
Q 046010 434 MDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPN-----MSSVAV 473 (523)
Q Consensus 434 ~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~ei~~ 473 (523)
+... ....+.+|+.+||+.||++||| ++||++
T Consensus 228 ----~~~~----~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 228 ----LPDS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ----CCSS----SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ----CCCC----CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1111 1235678999999999999999 688864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.8e-29 Score=246.90 Aligned_cols=180 Identities=22% Similarity=0.282 Sum_probs=129.0
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcC-----CCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCc--ccccee
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDS-----RLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNES--NTSKVV 367 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g-----~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~--~~~~~~ 367 (523)
+..++|..+++++.|++.||.|||+.. ..+|+||||||+||||+.++.+||+|||+++......... ......
T Consensus 94 ~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~ 173 (303)
T d1vjya_ 94 RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173 (303)
T ss_dssp HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CC
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceecccccee
Confidence 457999999999999999999999731 1249999999999999999999999999998775433221 234567
Q ss_pred ccCCCCchhhhcCCC------CCcchhhHHHHHHHHHHHhCCCCCCCcccccc--------cchHHHHHHhhhcCCcccc
Q 046010 368 GTYGYMAPEYALGGV------ISVKSDVFSFGVLLLEIISGKKNSGFYLSEHG--------QSLLAYTWKLWCNGEALEL 433 (523)
Q Consensus 368 gt~~y~aPE~l~~~~------~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~ 433 (523)
||+.|+|||++.+.. ++.++|||||||++|||++|..||........ ...............
T Consensus 174 gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 249 (303)
T d1vjya_ 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK---- 249 (303)
T ss_dssp SCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC----
T ss_pred cccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccc----
Confidence 999999999987642 57789999999999999999887643221110 111122222221111
Q ss_pred cCccccCCc-cHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccC
Q 046010 434 MDPVLKQSC-MAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASD 478 (523)
Q Consensus 434 ~~~~l~~~~-~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~ 478 (523)
.++.+.... ..+....+.+|+.+||+.||++|||+.||++.|++.
T Consensus 250 ~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 250 LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 111111111 224556788999999999999999999999999764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=4.9e-29 Score=246.36 Aligned_cols=171 Identities=23% Similarity=0.228 Sum_probs=132.2
Q ss_pred eEeeeccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 278 AIWIAIGTTI---PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 278 ~~~ia~g~~~---~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
.+|+.+.+|. ...+...+..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 78 ~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~ 154 (316)
T d1fota_ 78 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV 154 (316)
T ss_dssp EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred eeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEe
Confidence 4555555554 2334567778999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCccccc
Q 046010 355 GGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELM 434 (523)
Q Consensus 355 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (523)
... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ....... ...+...
T Consensus 155 ~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~-i~~~~~~--- 219 (316)
T d1fota_ 155 PDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN------TMKTYEK-ILNAELR--- 219 (316)
T ss_dssp SSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHH-HHHCCCC---
T ss_pred ccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC------HHHHHHH-HHcCCCC---
Confidence 422 234679999999999999999999999999999999999999985321 1111111 1111110
Q ss_pred CccccCCccHHHHHHHHHHhhhcccCCCCCCC-----CHHHHHH
Q 046010 435 DPVLKQSCMAAELLKCIHIGLLCVQEDPADRP-----NMSSVAV 473 (523)
Q Consensus 435 ~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~ei~~ 473 (523)
+.. .....+.+++.+||+.||.+|+ |++||++
T Consensus 220 ---~p~----~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 220 ---FPP----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ---CCT----TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCC----CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 011 1123567889999999999996 8999976
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2e-30 Score=256.02 Aligned_cols=165 Identities=27% Similarity=0.305 Sum_probs=126.5
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.....|++.++++++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..... .......+|..|
T Consensus 119 ~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y 192 (309)
T d1fvra_ 119 STASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRW 192 (309)
T ss_dssp TBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEE---CCC----CCTTT
T ss_pred cccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCceEEcccccccccccc---ccccceecCCcc
Confidence 34578999999999999999999999998 999999999999999999999999999764321 222345689999
Q ss_pred CchhhhcCCCCCcchhhHHHHHHHHHHHhCCC-CCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHH
Q 046010 373 MAPEYALGGVISVKSDVFSFGVLLLEIISGKK-NSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCI 451 (523)
Q Consensus 373 ~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 451 (523)
+|||.+.++.++.++||||||+++|||++|.. ||.... ..+. .....++...+ .+......+.
T Consensus 193 ~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~------~~~~-~~~i~~~~~~~---------~~~~~~~~~~ 256 (309)
T d1fvra_ 193 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAEL-YEKLPQGYRLE---------KPLNCDDEVY 256 (309)
T ss_dssp CCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHH-HHHGGGTCCCC---------CCTTBCHHHH
T ss_pred cchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC------HHHH-HHHHHhcCCCC---------CCccCCHHHH
Confidence 99999999999999999999999999999765 453211 1111 11122221111 1112234677
Q ss_pred HHhhhcccCCCCCCCCHHHHHHHhccCC
Q 046010 452 HIGLLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 452 ~li~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
+|+.+||+.||++|||++||++.|++..
T Consensus 257 ~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 257 DLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 8999999999999999999999988753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.5e-29 Score=248.54 Aligned_cols=193 Identities=21% Similarity=0.252 Sum_probs=135.4
Q ss_pred Eeeeccccc----cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 279 IWIAIGTTI----PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 279 ~~ia~g~~~----~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
+++.+.++. .++.......+++.+++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||.++..
T Consensus 76 ~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 76 LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF 152 (298)
T ss_dssp EEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred eeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceec
Confidence 455544443 3444566778999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCCccccceeccCCCCchhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcc--
Q 046010 355 GGNQNESNTSKVVGTYGYMAPEYALGGV-ISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEAL-- 431 (523)
Q Consensus 355 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 431 (523)
... ........||+.|+|||.+.... ++.++|||||||++|+|++|+.||..... .................
T Consensus 153 ~~~--~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~ 227 (298)
T d1gz8a_ 153 GVP--VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE---IDQLFRIFRTLGTPDEVVW 227 (298)
T ss_dssp CCC--SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTS
T ss_pred cCC--cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH---HHHHHHHHHhcCCCchhhc
Confidence 432 22344567899999999887765 57899999999999999999999853221 11111111111100000
Q ss_pred ----c------ccCccccCCc---cHHHHHHHHHHhhhcccCCCCCCCCHHHHHH--HhccCC
Q 046010 432 ----E------LMDPVLKQSC---MAAELLKCIHIGLLCVQEDPADRPNMSSVAV--MLASDT 479 (523)
Q Consensus 432 ----~------~~~~~l~~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~~~ 479 (523)
. .......... .......+.+|+.+||+.||++|||+.|+++ +|++..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp TTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 0 0000000000 0011246788999999999999999999988 476543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.5e-30 Score=254.09 Aligned_cols=165 Identities=26% Similarity=0.344 Sum_probs=130.5
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++..+.+++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...............+++.|+||
T Consensus 128 ~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aP 204 (308)
T d1p4oa_ 128 APPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 204 (308)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCH
Confidence 45799999999999999999999998 999999999999999999999999999876544433444556789999999
Q ss_pred hhhcCCCCCcchhhHHHHHHHHHHHhCC-CCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHHHHHHHh
Q 046010 376 EYALGGVISVKSDVFSFGVLLLEIISGK-KNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELLKCIHIG 454 (523)
Q Consensus 376 E~l~~~~~s~ksDVwSlGvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~li 454 (523)
|.+.+..++.++||||||+++|||++|. .||.... ..+. .....++...... ......+.+|+
T Consensus 205 e~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~------~~~~-~~~i~~~~~~~~p---------~~~~~~l~~li 268 (308)
T d1p4oa_ 205 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------NEQV-LRFVMEGGLLDKP---------DNCPDMLFELM 268 (308)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------HHHH-HHHHHTTCCCCCC---------TTCCHHHHHHH
T ss_pred HHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC------HHHH-HHHHHhCCCCCCc---------ccchHHHHHHH
Confidence 9999999999999999999999999986 5553221 1111 1222222222211 11234688899
Q ss_pred hhcccCCCCCCCCHHHHHHHhccCC
Q 046010 455 LLCVQEDPADRPNMSSVAVMLASDT 479 (523)
Q Consensus 455 ~~cl~~dP~~RPs~~ei~~~L~~~~ 479 (523)
.+||+.||++|||+++|+++|++..
T Consensus 269 ~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 269 RMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHcCCChhHCcCHHHHHHHHHHhc
Confidence 9999999999999999999998863
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.4e-29 Score=243.71 Aligned_cols=157 Identities=24% Similarity=0.389 Sum_probs=123.8
Q ss_pred ccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCC-CCeeEeccccceeccCCCCCccccceecc
Q 046010 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE-MNPKISDFGMARIFGGNQNESNTSKVVGT 369 (523)
Q Consensus 291 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt 369 (523)
+..++..+++.+++.++.||++||+|||+++ |+||||||+|||++.+ +.+||+|||+++..... ......||
T Consensus 100 ~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~----~~~~~~GT 172 (273)
T d1xwsa_ 100 FITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGT 172 (273)
T ss_dssp HHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCSS----CBCCCCSC
T ss_pred HHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccceecccc----cccccccC
Confidence 4566788999999999999999999999998 9999999999999854 78999999999875322 23356799
Q ss_pred CCCCchhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 370 YGYMAPEYALGGVI-SVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 370 ~~y~aPE~l~~~~~-s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .... ... . +.... ..
T Consensus 173 ~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~-~~~--~----~~~~~----s~ 229 (273)
T d1xwsa_ 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIR-GQV--F----FRQRV----SS 229 (273)
T ss_dssp GGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHH-CCC--C----CSSCC----CH
T ss_pred CCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhh-ccc--C----CCCCC----CH
Confidence 99999999987765 577999999999999999999985311 0011 110 0 11111 23
Q ss_pred HHHHHhhhcccCCCCCCCCHHHHHH--Hhcc
Q 046010 449 KCIHIGLLCVQEDPADRPNMSSVAV--MLAS 477 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~RPs~~ei~~--~L~~ 477 (523)
.+.+|+.+||+.||++|||++|+++ +|++
T Consensus 230 ~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 230 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 5678899999999999999999986 4543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.7e-29 Score=244.28 Aligned_cols=177 Identities=18% Similarity=0.200 Sum_probs=131.0
Q ss_pred eEeeecccccc-c--cccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC----CeeEecccc
Q 046010 278 AIWIAIGTTIP-T--IYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM----NPKISDFGM 350 (523)
Q Consensus 278 ~~~ia~g~~~~-~--~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~----~~kL~Dfg~ 350 (523)
.+++.+.+|-. . -+..+++.+++..++.++.||+.||+|||+++ |+||||||+||+++.++ .+||+|||+
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence 34555554441 1 22355678999999999999999999999998 99999999999998876 499999999
Q ss_pred ceeccCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCc
Q 046010 351 ARIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEA 430 (523)
Q Consensus 351 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (523)
+....... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||..... .+. .........
T Consensus 164 a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~-~~~i~~~~~ 233 (293)
T d1jksa_ 164 AHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QET-LANVSAVNY 233 (293)
T ss_dssp CEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHH-HHHHHTTCC
T ss_pred hhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH------HHH-HHHHHhcCC
Confidence 98764322 23345788999999999999999999999999999999999999853221 111 111111111
Q ss_pred ccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 431 LELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 431 ~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
. ....... .....+.+|+.+||+.||++|||++||++
T Consensus 234 ~--~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 E--FEDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C--CCHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C--CCchhcC----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0010111 12345678999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.8e-29 Score=248.61 Aligned_cols=174 Identities=24% Similarity=0.287 Sum_probs=132.2
Q ss_pred eEeeeccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 278 AIWIAIGTTI---PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 278 ~~~ia~g~~~---~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
.+|+.+.++. +.-+..++..+++.+++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhc
Confidence 3455555443 2223556778999999999999999999999998 999999999999999999999999999865
Q ss_pred cCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCccccc
Q 046010 355 GGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELM 434 (523)
Q Consensus 355 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (523)
... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .+ ..........
T Consensus 154 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~------~~-~~~~i~~~~~---- 220 (320)
T d1xjda_ 154 MLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------EE-LFHSIRMDNP---- 220 (320)
T ss_dssp CCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-HHHHHHHCCC----
T ss_pred ccc--cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH------HH-HHHHHHcCCC----
Confidence 432 2233456789999999999999999999999999999999999999853221 11 1111111111
Q ss_pred CccccCCccHHHHHHHHHHhhhcccCCCCCCCCHH-HHHH
Q 046010 435 DPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMS-SVAV 473 (523)
Q Consensus 435 ~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~-ei~~ 473 (523)
.+... ....+.+|+.+||+.||++||++. ||++
T Consensus 221 --~~p~~----~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 --FYPRW----LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --CCCTT----SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CCCcc----CCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11111 123577899999999999999996 6753
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.95 E-value=9.4e-29 Score=242.05 Aligned_cols=193 Identities=15% Similarity=0.138 Sum_probs=139.3
Q ss_pred cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCC-----CCCeeEeccccceeccCCCCCc-
Q 046010 288 PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDH-----EMNPKISDFGMARIFGGNQNES- 361 (523)
Q Consensus 288 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~-----~~~~kL~Dfg~a~~~~~~~~~~- 361 (523)
..++...+..+++..+..++.|++.||+|||++| |+||||||+||+++. ++.+||+|||+++.........
T Consensus 88 ~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~ 164 (293)
T d1csna_ 88 EDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH 164 (293)
T ss_dssp HHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCB
T ss_pred HHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcccCccccc
Confidence 3344555668999999999999999999999999 999999999999974 5679999999999865332221
Q ss_pred ----cccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCcc
Q 046010 362 ----NTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPV 437 (523)
Q Consensus 362 ----~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (523)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........................+
T Consensus 165 ~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~----- 239 (293)
T d1csna_ 165 IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE----- 239 (293)
T ss_dssp CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH-----
T ss_pred eeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH-----
Confidence 23346799999999999999999999999999999999999999964433322222211111111111111
Q ss_pred ccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHhccCCCCCCCCCCCCccc
Q 046010 438 LKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAVMLASDTVSLPQPTQPAFSV 492 (523)
Q Consensus 438 l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~l~~p~~p~~~~ 492 (523)
+.... +.++.+|+..|+..+|++||+.+.+.+.|++..........-.|.|
T Consensus 240 l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw 290 (293)
T d1csna_ 240 LCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW 290 (293)
T ss_dssp HTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred hcCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 11111 2456778889999999999999999888876544443333334443
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.95 E-value=1.3e-28 Score=238.62 Aligned_cols=177 Identities=21% Similarity=0.289 Sum_probs=130.9
Q ss_pred eEeeeccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 278 AIWIAIGTTI---PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 278 ~~~ia~g~~~---~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
.+|+.+.++. +.-+...+..+++.+++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++.+
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeEc
Confidence 3455554443 1223456678999999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCccccceeccCCCCchhhhcC------CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcC
Q 046010 355 GGNQNESNTSKVVGTYGYMAPEYALG------GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNG 428 (523)
Q Consensus 355 ~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 428 (523)
.... ......||..|+|||.+.+ ..++.++||||+||++|+|++|+.||..... .. .......+
T Consensus 161 ~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~------~~-~~~~i~~~ 230 (277)
T d1phka_ 161 DPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------ML-MLRMIMSG 230 (277)
T ss_dssp CTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-HHHHHHHT
T ss_pred cCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH------HH-HHHHHHhC
Confidence 4322 2334678999999999863 3478899999999999999999999853221 11 11222222
Q ss_pred CcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 429 EALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 429 ~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
... ...+. ......++.+|+.+||+.||++|||+.||++
T Consensus 231 ~~~-~~~~~-----~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 231 NYQ-FGSPE-----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp CCC-CCTTT-----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCC-CCCcc-----cccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111 11110 1112246778999999999999999999865
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.7e-28 Score=243.15 Aligned_cols=190 Identities=23% Similarity=0.281 Sum_probs=131.7
Q ss_pred eEeeeccccc---cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceec
Q 046010 278 AIWIAIGTTI---PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIF 354 (523)
Q Consensus 278 ~~~ia~g~~~---~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 354 (523)
.+++.+.++- ...+......+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 91 ~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 91 SIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred eEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceeeec
Confidence 3455544443 3345566778999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCC--ccccceeccCCCCchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcC--C
Q 046010 355 GGNQNE--SNTSKVVGTYGYMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNG--E 429 (523)
Q Consensus 355 ~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--~ 429 (523)
...... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... ............. .
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---HQLALISQLCGSITPE 244 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTT
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH---HHHHHHHHhcCCCChh
Confidence 533222 122335789999999998765 6899999999999999999999998532221 1111111111100 0
Q ss_pred cc---------cccCccccCCccH-HH------HHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 430 AL---------ELMDPVLKQSCMA-AE------LLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 430 ~~---------~~~~~~l~~~~~~-~~------~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.. ..+.......... .. ...+++|+.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 00 0000000001111 11 235678999999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.1e-28 Score=245.80 Aligned_cols=190 Identities=19% Similarity=0.187 Sum_probs=131.7
Q ss_pred eEeeeccccccc------cccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC-CeeEecccc
Q 046010 278 AIWIAIGTTIPT------IYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM-NPKISDFGM 350 (523)
Q Consensus 278 ~~~ia~g~~~~~------~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~ 350 (523)
.+++.+.+|-.. -+...+..+++.+++.++.||++||+|||++| |+||||||+|||++.++ .+||+|||+
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccc
Confidence 455665555422 12455678999999999999999999999998 99999999999999875 899999999
Q ss_pred ceeccCCCCCccccceeccCCCCchhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchH--------HHH
Q 046010 351 ARIFGGNQNESNTSKVVGTYGYMAPEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLL--------AYT 421 (523)
Q Consensus 351 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~--------~~~ 421 (523)
++...... ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+ ...
T Consensus 170 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 246 (350)
T d1q5ka_ 170 AKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246 (350)
T ss_dssp CEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred hhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHh
Confidence 98764322 2234578999999998875 56899999999999999999999998643221110000 001
Q ss_pred HHhhhcC----CcccccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 422 WKLWCNG----EALELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 422 ~~~~~~~----~~~~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
+...... .....................+.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111 111100000000011122345778899999999999999999985
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.95 E-value=7.9e-29 Score=241.85 Aligned_cols=178 Identities=24% Similarity=0.342 Sum_probs=124.2
Q ss_pred cccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCcccccee
Q 046010 288 PTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVV 367 (523)
Q Consensus 288 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 367 (523)
...+...++.+++..++.++.||++||+|||+++ ||||||||+|||++.++.+||+|||.+....... .......
T Consensus 87 ~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~ 161 (286)
T d1ob3a_ 87 KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKYTHEI 161 (286)
T ss_dssp HHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------
T ss_pred HHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc--cccceec
Confidence 3444566788999999999999999999999998 9999999999999999999999999998764322 2233456
Q ss_pred ccCCCCchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcc------cc------c
Q 046010 368 GTYGYMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEAL------EL------M 434 (523)
Q Consensus 368 gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~------~ 434 (523)
+++.|+|||.+.+. .++.++|||||||++|||++|+.||...... ................ +. .
T Consensus 162 ~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T d1ob3a_ 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (286)
T ss_dssp CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred ccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH---HHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence 88999999998764 5689999999999999999999998532211 1111111111110000 00 0
Q ss_pred ---CccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 435 ---DPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 435 ---~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.+.............+.+|+.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000001112346778999999999999999999973
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=6.4e-28 Score=238.89 Aligned_cols=182 Identities=19% Similarity=0.237 Sum_probs=132.9
Q ss_pred eEeeecccccc-cc--cc-ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCC--CCeeEeccccc
Q 046010 278 AIWIAIGTTIP-TI--YS-TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHE--MNPKISDFGMA 351 (523)
Q Consensus 278 ~~~ia~g~~~~-~~--~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~--~~~kL~Dfg~a 351 (523)
.+|+.+.+|-. .+ +. .++..+++.+++.++.||++||+|||+++ |+||||||+|||++.+ ..+||+|||++
T Consensus 75 ~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~ 151 (321)
T d1tkia_ 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchh
Confidence 35666665541 12 22 34457999999999999999999999998 9999999999999854 47999999999
Q ss_pred eeccCCCCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcc
Q 046010 352 RIFGGNQNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEAL 431 (523)
Q Consensus 352 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (523)
+..... .......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...... ...... ......
T Consensus 152 ~~~~~~---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~~~~~i-~~~~~~ 221 (321)
T d1tkia_ 152 RQLKPG---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENI-MNAEYT 221 (321)
T ss_dssp EECCTT---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHH-HHTCCC
T ss_pred hccccC---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------HHHHHH-HhCCCC
Confidence 876422 2234567899999999999999999999999999999999999998532211 111111 111110
Q ss_pred cccCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH--HhccC
Q 046010 432 ELMDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV--MLASD 478 (523)
Q Consensus 432 ~~~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~~ 478 (523)
+....... ....+.+|+.+||+.||++|||+.|+++ ++++.
T Consensus 222 --~~~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 222 --FDEEAFKE----ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp --CCHHHHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred --CChhhccC----CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 01100011 1235678999999999999999999987 45443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.2e-27 Score=239.90 Aligned_cols=185 Identities=23% Similarity=0.242 Sum_probs=128.2
Q ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCC
Q 046010 293 TRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGY 372 (523)
Q Consensus 293 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y 372 (523)
.++..|++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++..... .....+|+.|
T Consensus 113 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y 184 (346)
T d1cm8a_ 113 MKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWY 184 (346)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGG
T ss_pred HHhccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccCCc-----cccccccccc
Confidence 34567999999999999999999999999 999999999999999999999999999875422 2346789999
Q ss_pred CchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhc--------C----------Ccccc
Q 046010 373 MAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCN--------G----------EALEL 433 (523)
Q Consensus 373 ~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--------~----------~~~~~ 433 (523)
+|||.+.+. .++.++|||||||++|+|++|+.||....... .+......... . ...+.
T Consensus 185 ~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (346)
T d1cm8a_ 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD---QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPEL 261 (346)
T ss_dssp CCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCC
T ss_pred cCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH---HHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcc
Confidence 999998764 57899999999999999999999985432111 10000000000 0 00000
Q ss_pred cCccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH--HhccCCCCCCCCCCCC
Q 046010 434 MDPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV--MLASDTVSLPQPTQPA 489 (523)
Q Consensus 434 ~~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~~~~~l~~p~~p~ 489 (523)
....+. .........+++|+.+||+.||++|||+.||++ +|++.......|..+.
T Consensus 262 ~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~~ 318 (346)
T d1cm8a_ 262 EKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQK 318 (346)
T ss_dssp CCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCCC
T ss_pred cccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCCC
Confidence 000000 000111235678999999999999999999987 4766543333444333
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2.2e-27 Score=237.82 Aligned_cols=178 Identities=25% Similarity=0.283 Sum_probs=125.1
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCC-ccccceeccCCCC
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNE-SNTSKVVGTYGYM 373 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~ 373 (523)
...+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++........ .......|++.|+
T Consensus 103 ~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~ 179 (345)
T d1pmea_ 103 TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179 (345)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGC
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceec
Confidence 457999999999999999999999998 999999999999999999999999999875432221 2234567899999
Q ss_pred chhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccc------------cCccccC
Q 046010 374 APEYALG-GVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALEL------------MDPVLKQ 440 (523)
Q Consensus 374 aPE~l~~-~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~l~~ 440 (523)
|||++.. ..++.++||||+||++|+|++|+.||....... ................. .......
T Consensus 180 aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (345)
T d1pmea_ 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKN 256 (345)
T ss_dssp CGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCC
T ss_pred hHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH---HHHHHhhhccCCChhhhhhhhhhhhhcccccCCccC
Confidence 9999854 567899999999999999999999985432211 11110000000000000 0000000
Q ss_pred CccH-----HHHHHHHHHhhhcccCCCCCCCCHHHHHHH--hccC
Q 046010 441 SCMA-----AELLKCIHIGLLCVQEDPADRPNMSSVAVM--LASD 478 (523)
Q Consensus 441 ~~~~-----~~~~~~~~li~~cl~~dP~~RPs~~ei~~~--L~~~ 478 (523)
..+. ....++++|+.+||+.||++|||+.|+++. |+..
T Consensus 257 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 257 KVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp CCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred CCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 0000 111357789999999999999999999873 5443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.94 E-value=3.4e-27 Score=234.76 Aligned_cols=189 Identities=18% Similarity=0.173 Sum_probs=129.6
Q ss_pred EeeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCC-CeeEeccccceeccCC
Q 046010 279 IWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEM-NPKISDFGMARIFGGN 357 (523)
Q Consensus 279 ~~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~~ 357 (523)
+++.+.+|....+....+.+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||+++.....
T Consensus 107 ~~~v~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEEEEECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eeEEEeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCC
Confidence 3444444443333344567999999999999999999999999 99999999999998765 5899999999876433
Q ss_pred CCCccccceeccCCCCchhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchH-H------HHHHhhh--c
Q 046010 358 QNESNTSKVVGTYGYMAPEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLL-A------YTWKLWC--N 427 (523)
Q Consensus 358 ~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~-~------~~~~~~~--~ 427 (523)
. ......+|..|+|||.+.+. .++.++||||+||++|+|++|+.||............ . ....... .
T Consensus 184 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 184 Q---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp C---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred C---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 2 23455789999999998765 4799999999999999999999998643322111000 0 0000000 0
Q ss_pred CCcc----ccc--------CccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 428 GEAL----ELM--------DPVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 428 ~~~~----~~~--------~~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
.... ... ...............+++|+.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 000 000011111112245778999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=5.6e-27 Score=232.20 Aligned_cols=166 Identities=22% Similarity=0.287 Sum_probs=124.5
Q ss_pred ccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccC
Q 046010 291 YSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTY 370 (523)
Q Consensus 291 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~ 370 (523)
+......+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.+..... .......|++
T Consensus 119 ~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~g~~ 194 (322)
T d1vzoa_ 119 HLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTI 194 (322)
T ss_dssp HHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG-GGGCGGGSCC
T ss_pred HHHhcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhccccc-cccccccccc
Confidence 3456677899999999999999999999998 99999999999999999999999999987643222 2233567899
Q ss_pred CCCchhhhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcccccCccccCCccHHHHH
Q 046010 371 GYMAPEYALGG--VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEALELMDPVLKQSCMAAELL 448 (523)
Q Consensus 371 ~y~aPE~l~~~--~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 448 (523)
.|++||.+.+. .++.++|||||||++|+|++|+.||......... ............. .+.....
T Consensus 195 ~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~---~~i~~~~~~~~~~----------~~~~~s~ 261 (322)
T d1vzoa_ 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---AEISRRILKSEPP----------YPQEMSA 261 (322)
T ss_dssp TTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH---HHHHHHHHHCCCC----------CCTTSCH
T ss_pred ccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcccCCCC----------CcccCCH
Confidence 99999998764 4678999999999999999999998644332221 1111111111110 1112234
Q ss_pred HHHHHhhhcccCCCCCCCC-----HHHHHH
Q 046010 449 KCIHIGLLCVQEDPADRPN-----MSSVAV 473 (523)
Q Consensus 449 ~~~~li~~cl~~dP~~RPs-----~~ei~~ 473 (523)
.+.+|+.+||+.||++||| ++|+++
T Consensus 262 ~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 262 LAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 6778899999999999994 788875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=7.3e-27 Score=228.34 Aligned_cols=181 Identities=20% Similarity=0.243 Sum_probs=127.8
Q ss_pred cccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceecc
Q 046010 290 IYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGT 369 (523)
Q Consensus 290 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt 369 (523)
.+....+.+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||.++....... ......++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~ 164 (292)
T d1unla_ 90 YFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVT 164 (292)
T ss_dssp HHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS--CCCSCCSC
T ss_pred cccccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCc--cceeeccc
Confidence 34566778999999999999999999999998 99999999999999999999999999987643322 22334567
Q ss_pred CCCCchhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcCCcc------cc--------c
Q 046010 370 YGYMAPEYALGGV-ISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNGEAL------EL--------M 434 (523)
Q Consensus 370 ~~y~aPE~l~~~~-~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~--------~ 434 (523)
..|+|||.+.... ++.++|||||||++|||++|+.||..... .................. .. .
T Consensus 165 ~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (292)
T d1unla_ 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242 (292)
T ss_dssp GGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCC
T ss_pred cchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC--HHHHHHHHHhhcCCCChhhhhhhhhcccccccccc
Confidence 8899999987655 68999999999999999999999742221 111111111111110000 00 0
Q ss_pred Cc-cccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH--Hhcc
Q 046010 435 DP-VLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV--MLAS 477 (523)
Q Consensus 435 ~~-~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~ 477 (523)
.. .............+.+|+.+||+.||++|||++||++ +|++
T Consensus 243 ~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred cccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 00 0000011122345778899999999999999999976 4543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.7e-26 Score=232.12 Aligned_cols=190 Identities=22% Similarity=0.219 Sum_probs=129.7
Q ss_pred eEeeeccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCC
Q 046010 278 AIWIAIGTTIPTIYSTRRAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGN 357 (523)
Q Consensus 278 ~~~ia~g~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 357 (523)
.+|+.+.+|...++..-...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+|++|||+++....
T Consensus 96 ~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~- 171 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT- 171 (355)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhcccc-
Confidence 67777777775555555677999999999999999999999999 99999999999999999999999999886542
Q ss_pred CCCccccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchH----------------HHH
Q 046010 358 QNESNTSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLL----------------AYT 421 (523)
Q Consensus 358 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~----------------~~~ 421 (523)
........+|+.|+|||.+.+..++.++||||+||++|+|++|+.||...........+ ...
T Consensus 172 --~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 172 --SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred --ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence 22334567899999999999999999999999999999999999998532211000000 000
Q ss_pred HHhhhcC------CcccccCccccCC---ccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 046010 422 WKLWCNG------EALELMDPVLKQS---CMAAELLKCIHIGLLCVQEDPADRPNMSSVAV 473 (523)
Q Consensus 422 ~~~~~~~------~~~~~~~~~l~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 473 (523)
....... ............. ........+++|+.+||+.||++|||++||++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000 0000111111111 11233457889999999999999999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.8e-27 Score=237.32 Aligned_cols=185 Identities=22% Similarity=0.254 Sum_probs=127.4
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCc
Q 046010 295 RAQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMA 374 (523)
Q Consensus 295 ~~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 374 (523)
.+++++.+++.++.||+.||+|||++| |+||||||+|||++.++.+|++|||.+.... .......|+..|+|
T Consensus 115 ~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~-----~~~~~~~g~~~y~a 186 (348)
T d2gfsa1 115 CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATRWYRA 186 (348)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCT-----GGGSSSCHHHHTSC
T ss_pred cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccC-----cccccccccccccC
Confidence 457999999999999999999999999 9999999999999999999999999987542 22334678899999
Q ss_pred hhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHHHhhhcC------------------CcccccC
Q 046010 375 PEYALGG-VISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTWKLWCNG------------------EALELMD 435 (523)
Q Consensus 375 PE~l~~~-~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~ 435 (523)
||.+.+. .++.++|||||||++|+|++|+.||........ ........... ...+...
T Consensus 187 pE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (348)
T d2gfsa1 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 263 (348)
T ss_dssp HHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCC
T ss_pred chhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCC
Confidence 9987765 468899999999999999999999854322111 11000000000 0000000
Q ss_pred ccccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH--HhccCCCCCCCCCCCCcc
Q 046010 436 PVLKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV--MLASDTVSLPQPTQPAFS 491 (523)
Q Consensus 436 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~~~~~l~~p~~p~~~ 491 (523)
..+.. ........+++|+.+||+.||++|||++|+++ +|++.......|..++|.
T Consensus 264 ~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~~~ 320 (348)
T d2gfsa1 264 MNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYD 320 (348)
T ss_dssp CCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCCCC
T ss_pred cchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCCCC
Confidence 00000 00011245678999999999999999999997 677655444455555444
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.92 E-value=2.2e-25 Score=224.50 Aligned_cols=194 Identities=20% Similarity=0.213 Sum_probs=135.4
Q ss_pred cccccccccCHHHHHHHHHHHHHHHHHHHh-cCCCcEEecCCCCCcEEeCCCCC------eeEeccccceeccCCCCCcc
Q 046010 290 IYSTRRAQLDWKRRISIINGIARGLLYLHE-DSRLKVFHRDLKASNVLLDHEMN------PKISDFGMARIFGGNQNESN 362 (523)
Q Consensus 290 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~g~~~ivH~Dlkp~NIll~~~~~------~kL~Dfg~a~~~~~~~~~~~ 362 (523)
........+++..++.++.||++||+|||+ .+ |+||||||+|||++.++. +||+|||.+..... .
T Consensus 114 ~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~-----~ 185 (362)
T d1q8ya_ 114 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-----H 185 (362)
T ss_dssp HHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB-----C
T ss_pred cccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccceeeEeeccccccccc-----c
Confidence 345666789999999999999999999998 77 999999999999987654 89999999986532 2
Q ss_pred ccceeccCCCCchhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcccccccchHHHHH---Hhhh-------------
Q 046010 363 TSKVVGTYGYMAPEYALGGVISVKSDVFSFGVLLLEIISGKKNSGFYLSEHGQSLLAYTW---KLWC------------- 426 (523)
Q Consensus 363 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwSlGvvl~elltG~~p~~~~~~~~~~~~~~~~~---~~~~------------- 426 (523)
.....||+.|+|||++....++.++||||+||++++|++|+.||................ ....
T Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~ 265 (362)
T d1q8ya_ 186 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYT 265 (362)
T ss_dssp CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTH
T ss_pred cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhccccc
Confidence 234678999999999999999999999999999999999999986432221111110000 0000
Q ss_pred -----cCCcccccCcc----------ccCCccHHHHHHHHHHhhhcccCCCCCCCCHHHHHH--HhccC--CCCCCCCCC
Q 046010 427 -----NGEALELMDPV----------LKQSCMAAELLKCIHIGLLCVQEDPADRPNMSSVAV--MLASD--TVSLPQPTQ 487 (523)
Q Consensus 427 -----~~~~~~~~~~~----------l~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei~~--~L~~~--~~~l~~p~~ 487 (523)
.......+... ............+.+|+.+||+.||.+|||++|+++ +|++. ..+...|.+
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~~~~~~~~p~~ 345 (362)
T d1q8ya_ 266 RTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDR 345 (362)
T ss_dssp HHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTCTTCCCTTS
T ss_pred ccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCCCcccCCCCCc
Confidence 00000000000 011223456678899999999999999999999987 36532 344556666
Q ss_pred CCcc
Q 046010 488 PAFS 491 (523)
Q Consensus 488 p~~~ 491 (523)
|.+.
T Consensus 346 ~~~~ 349 (362)
T d1q8ya_ 346 ELYG 349 (362)
T ss_dssp CTTC
T ss_pred ccCC
Confidence 6664
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.18 E-value=3.8e-12 Score=114.72 Aligned_cols=92 Identities=17% Similarity=0.150 Sum_probs=63.3
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCcEEeCCCCCeeEeccccceeccCCCCCccccceeccCCCCch
Q 046010 296 AQLDWKRRISIINGIARGLLYLHEDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARIFGGNQNESNTSKVVGTYGYMAP 375 (523)
Q Consensus 296 ~~l~~~~~~~i~~qi~~aL~~LH~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 375 (523)
..+++.....++.||+++|.|||++| |+||||||+|||++++ .++|+|||.+....+............. -.
T Consensus 98 ~~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~~l~rd~~~----~~ 169 (191)
T d1zara2 98 YRVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVRN----II 169 (191)
T ss_dssp GGCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHHHHHHHHHHH----HH
T ss_pred cchhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEECCCcccCCCCCcHHHHHHHHHH----HH
Confidence 34667778899999999999999999 9999999999999865 4899999999765322111100000000 00
Q ss_pred hhhcCCCCCcchhhHHHHHHH
Q 046010 376 EYALGGVISVKSDVFSFGVLL 396 (523)
Q Consensus 376 E~l~~~~~s~ksDVwSlGvvl 396 (523)
|. ....|+.++|+||+.--+
T Consensus 170 ~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 170 TY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp HH-HHHHHCCCCCHHHHHHHH
T ss_pred HH-HcCCCCCcccHHHHHHHH
Confidence 11 134577889999975433
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=89.86 E-value=0.085 Score=48.83 Aligned_cols=49 Identities=22% Similarity=0.077 Sum_probs=33.9
Q ss_pred HHHHHHHHHHHHHHhc-CCCcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 305 SIINGIARGLLYLHED-SRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 305 ~i~~qi~~aL~~LH~~-g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
..+..+...+...+.. -+..+||+|+.++||+++.+...-|.||+.+..
T Consensus 164 ~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 164 EEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 3344444444444332 133499999999999999887778999998753
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=88.28 E-value=0.12 Score=46.01 Aligned_cols=31 Identities=26% Similarity=0.314 Sum_probs=26.0
Q ss_pred CcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 323 LKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 323 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
..++|+|+.|.||++++++.+.|+||+.+..
T Consensus 183 ~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 183 LVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp EEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cEEEEeeccCcceeecCCceEEEeechhccc
Confidence 3489999999999999776667999987754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=87.17 E-value=0.13 Score=45.73 Aligned_cols=31 Identities=23% Similarity=0.286 Sum_probs=26.2
Q ss_pred CcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 323 LKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 323 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
..++|+|+.|.||+++.+..+.|+||+.+..
T Consensus 175 ~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 175 LVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 3589999999999999876678999987753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=84.20 E-value=0.42 Score=45.60 Aligned_cols=30 Identities=20% Similarity=0.272 Sum_probs=25.9
Q ss_pred CcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 323 LKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 323 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
..++|||+++.|||++++. ++|+||..+..
T Consensus 223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp CEEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred cceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 4599999999999998764 89999988764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=82.52 E-value=0.58 Score=43.21 Aligned_cols=48 Identities=23% Similarity=0.285 Sum_probs=30.9
Q ss_pred HHHHHHHHHHHHHHH-hcCCCcEEecCCCCCcEEeCCCCCeeEecccccee
Q 046010 304 ISIINGIARGLLYLH-EDSRLKVFHRDLKASNVLLDHEMNPKISDFGMARI 353 (523)
Q Consensus 304 ~~i~~qi~~aL~~LH-~~g~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 353 (523)
..++.++...+.-+- +..+..+||+|+.+.|||++++ ..++||+-+..
T Consensus 172 ~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 172 LKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp HHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred HHHHHHHHHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 334444444443322 2223458999999999999743 56899988764
|